STANDARD DATA DICTIONARY #165.5 -- ONCOLOGY PRIMARY FILE 3/24/25 PAGE 1
STORED IN ^ONCO(165.5, *** NO DATA STORED YET *** SITE: WWW.BMIRWIN.COM UCI: VISTA,VISTA (VERSION 2.2)
DATA NAME GLOBAL DATA
ELEMENT TITLE LOCATION TYPE
-----------------------------------------------------------------------------------------------------------------------------------
Tumor-related data for Oncology patients is stored in this file. (Demographic and follow-up data is in the Oncology Patient File).
File is populated in the field by using the abstracting options.
FILE SCREEN (SCR-node) : I ($G(DUZ(2))=$G(^ONCO(165.5,+Y,"DIV")))!(DUZ(0)["@")
APPLICATION GROUP(S): ONCO
IDENTIFIED BY: PRIMARY SITE (#20)[R]
"WRITE": S %I=Y,Y=$S('$D(^(0)):"",$D(^ONCO(160,+$P(^(0),U,2),0))#2:$P(^(0),U,1),1:""),C=$P(^DD(160,.01,0),U,2) D Y^DIQ:Y]"" W
?50,Y,@("$E("_DIC_"%I,0),0)") S Y=%I K %I
POINTED TO BY: SITE/GP* field (#.01) of the COMPUTED PRIMARY File (#165.59)
CROSS
REFERENCED BY: ACCESSION NUMBER(AA), DATE CASE COMPLETED(AAD), DATE CASE LAST CHANGED(AAE), CLASS OF CASE(AAY),
ACCESSION YEAR(AAY1), ACCESSION NUMBER(AC), ACCESSION YEAR(ACAY), SITE/GP(ACF), PRIMARY SURGEON(ACP),
FOLLOWING PHYSICIAN(ACP), MANAGING PHYSICIAN(ACP), PHYSICIAN #3(ACP), PHYSICIAN #4(ACP), PHYSICIAN STAGING(ACP),
LAST TUMOR STATUS(ACS), PRIMARY SITE(AD), DATE DX(ADX), ACCESSION NUMBER(AE), HEMA TRANS/ENDOCRINE PROC(AE),
HEMA TRANS/ENDOCRINE PROC @FAC(AE), ACCESSION NUMBER(AF), DATE OF FIRST CONTACT(AFC), FOLLOWING PHYSICIAN(AFP),
CLASS CATEGORY(AG), HISTOLOGY (ICD-O-2)(AH), SURGERY OF PRIMARY (R)(AI), RX SUMM--SURG PRIMSITE 03-2022(AI),
RADIATION(AJ), DATE OF NO TREATMENT(AK), HISTOLOGY (ICD-O-3)(AL), CHEMOTHERAPY(AM), MANAGING PHYSICIAN(AMP),
PALLIATIVE CARE(AN), HORMONE THERAPY(AN), IMMUNOTHERAPY(AO), PHYSICIAN #3(AOP3), PHYSICIAN #4(AOP4),
OTHER TREATMENT(AP), PRIMARY SURGEON(APC), FOLLOWING PHYSICIAN(APC), MANAGING PHYSICIAN(APC), PHYSICIAN #3(APC),
PHYSICIAN #4(APC), PHYSICIAN STAGING(APC), PCE INDICATOR(APCE), PRIMARY SURGEON(APS), PHYSICIAN STAGING(APST),
SURGICAL DX/STAGING PROC(AQ), SURG DX/STAGING PROC @FAC(AR), ABSTRACT STATUS(AS), STAGE GROUP CLINICAL(AS1),
STAGE GROUP PATHOLOGIC(AS2), SCOPE OF LN SURGERY (R)(ASC), SCOPE OF LN SURGERY (F)(ASC),
SCOPE OF LN SURGERY @FAC (R)(ASCF), SCOPE OF LN SURGERY @FAC (F)(ASCF), STAGE GROUPING-AJCC(ASG),
SURG PROC/OTHER SITE (R)(ASO), SURG PROC/OTHER SITE (F)(ASO), SURG PROC/OTHER SITE @FAC (R)(ASOF),
SURG PROC/OTHER SITE @FAC (F)(ASOF), SURGERY OF PRIMARY @FAC (R)(AT), RX HOSP--SURG PRIMSITE 03-2022(AT),
IMMUNOTHERAPY DATE(ATB), CHEMOTHERAPY DATE(ATC), HEMA TRANS/ENDOCRINE PROC DATE(ATE), HORMONE THERAPY DATE(ATH),
DATE OF NO TREATMENT(ATN), OTHER TREATMENT START DATE(ATO), RADIATION THERAPY TO CNS DATE(ATP),
DATE RADIATION STARTED(ATR), MOST DEFINITIVE SURG DATE(ATS), SCOPE OF LN SURGERY DATE(ATSC),
DATE FIRST SURGICAL PROCEDURE(ATSF), SURG PROC/OTHER SITE DATE(ATSO), RADIATION @FACILITY(AU),
CHEMOTHERAPY @FAC(AV), HORMONE THERAPY @FAC(AW), IMMUNOTHERAPY @FAC(AX), ACCESSION YEAR(AY),
OTHER TREATMENT @FAC(AZ), SITE/GP(B), PRIMARY SITE(BT), PATIENT NAME(C), SEQUENCE NUMBER(D),
ACCESSION NUMBER(D1), PRIMARY SITE(E), SURGERY OF PRIMARY SITE(F), AJCC TNM CLIN STAGE GROUP(G),
AJCC TNM PATH STAGE GROUP(H), LYMPH NODES(SS1)
LAST MODIFIED: NOV 21,2024@17:13:11
165.5,.01 SITE/GP 0;1 POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2) (Required)
LAST EDITED: AUG 12, 2005
HELP-PROMPT: Enter the SITE/GP which best categorizes the primary.
DESCRIPTION:
Enter the SITE/GP for this primary.
SCREEN: S DIC("S")="I '$P(^(0),U,3)"
EXPLANATION: Histologic site groups may not be selected.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^B
1)= S ^ONCO(165.5,"B",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"B",$E(X,1,30),DA)
CROSS-REFERENCE: 165.5^ACF^MUMPS
1)= S ^ONCO(165.59,DA,0)=X
2)= K ^ONCO(165.59,DA,0)
This cross reference creates an entry in File 165.59 which consists on;y of computed fields for
this file. It is a side-car/side-kick file which does not store any data, but references other data
for reports.
165.5,.0101 PRIMARY SITE/GP ; COMPUTED
MUMPS CODE: S X="" I D0>0 S X=$P(^ONCO(164.2,$P(^ONCO(165.5,D0,0),U),0),U)
ALGORITHM: S X=.01 OF ^ONCO(164.2)
DESCRIPTION:
A COMPUTED FIELD RECORDING THE PRIMARY SITE/GROUP FOR ONCOLOGY.
165.5,.015 SELECTED SITES ; COMPUTED
MUMPS CODE: S X="" D SICD^ONCOCOS
ALGORITHM: S X="" D SICD^ONCOCOS
LAST EDITED: JAN 11, 2007
DESCRIPTION:
This COMPUTED field displays selected SITE/GP (165.5,.01) values.
165.5,.017 SYSTEMS ; COMPUTED
MUMPS CODE: S X="" D SYS^ONCOCOS
ALGORITHM: S X="" D SYS^ONCOCOS
DESCRIPTION: COMPUTED FIELD RECORDING THE MAJOR BODY SYSTEMS, SUCH AS LYMPHATIC, GASTROINTESTINAL,
GENITOURINARY, ETC.
165.5,.02 PATIENT NAME 0;2 POINTER TO ONCOLOGY PATIENT FILE (#160) (Required)
INPUT TRANSFORM: I $D(X) D PSEX^ONCOCKI
LAST EDITED: JUN 20, 1996
DESCRIPTION:
Enter Oncology Patient Name.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^C
1)= S ^ONCO(165.5,"C",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"C",$E(X,1,30),DA)
Indexes file by PATIENT NAME.
165.5,.022 ICDO-SITE 0;22 POINTER TO ICDO-SITES FILE (#164.08) (Required)
LAST EDITED: APR 06, 1990
DESCRIPTION:
Listing of primary sites in accordance with ICDO-2 (1992).
165.5,.023 PRIMARY SITE CODE PREFIX ; COMPUTED
MUMPS CODE: S X=$P($G(^ONCO(165.5,D0,2)),U,1) I X'="" S X="C"_$E(X,3,4)
ALGORITHM: CUSTOM CODED
LAST EDITED: NOV 25, 2005
DESCRIPTION:
Identifies the three-digit code prefix for the primary site.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,.025 PATIENT ID ; COMPUTED
MUMPS CODE: S X="" D PID^ONCOCOP
ALGORITHM: S X="" D PID^ONCOCOP
DESCRIPTION:
COMPUTED FIELD FOR RECORDING THE PATIENT IDENTIFICATION NUMBER.
165.5,.03 REPORTING FACILITY 0;3 POINTER TO FACILITY FILE (#160.19) (Required)
OUTPUT TRANSFORM: I Y'="" S Y=$P($G(^ONCO(160.19,Y,0)),U,2)
LAST EDITED: OCT 22, 2008
DESCRIPTION:
REPORTING FACILITY identifies the facility reporting the case.
GROUP: ACOS-REQUIRED
165.5,.04 CLASS OF CASE 0;4 POINTER TO CLASS OF CASE FILE (#165.3) (Required)
INPUT TRANSFORM: D COCIT^ONCOSUR1
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(165.3,Y,0),U,1)_" "_$P(^ONCO(165.3,Y,0),U,2)
LAST EDITED: JUN 21, 2022
HELP-PROMPT: Enter a CLASS OF CASE code.
DESCRIPTION: CLASS OF CASE reflects the facility's role in managing the cancer, whether the cancer is required
to be reported by CoC, and whether the case was diagnosed after the program's Reference Date.
CLASS OF CASE divides cases into two groups.
Analytic cases (codes 00-22) are those that are required by CoC to be abstracted because of the
program's primary responsibility in managing the cancer. Analytic cases are grouped according to
the location of diagnosis and first course of treatment.
Nonanalytic cases (codes 30-49 and 99) may be abstracted by the facility to meet central registry
requirements or in response to a request by the facility's cancer program. Nonanalytic cases are
grouped according to the reason a patient who received care at the facility is nonanalytic, or the
reason a patient who never received care at the facility may have been abstracted.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: ^^TRIGGER^165.5^.042
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(1),U,20),X=X
S DIU=X K Y S X=DIV S X=$S(X>9:0,1:1) S DIH=$G(^ONCO(165.5,DIV(0),0)),DIV=X S $P(^(0),U,20)=DIV,DIH
=165.5,DIG=.042 D ^DICR
2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(1),U,20),X=X
S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),0)),DIV=X S $P(^(0),U,20)=DIV,DIH=165.5,DIG=.042 D ^
DICR
CREATE VALUE)= S X=$S(X>9:0,1:1)
DELETE VALUE)= @
FIELD)= CLASS CATEGORY
CLASS CATEGORY (165.5,.042) will be stuffed with either 1 (ANALYTIC) or 0 (NONANALYTIC) depending
on the CLASS OF CASE value.
CROSS-REFERENCE: 165.5^AAY^MUMPS
1)= I X>-1,X<10 S XX=$P(^ONCO(165.5,DA,0),U,7) S:XX'="" ^ONCO(165.5,"AAY",XX,DA)=""
2)= I X>-1,X<10 S XX=$P(^ONCO(165.5,DA,0),U,7) K:XX'="" ^ONCO(165.5,"AAY",XX,DA) K XX
Creates an index of analytic (CLASS OF CASE 00-22) cases cross-referenced by ACCESSION YEAR
(165.5,.07).
165.5,.041 CLASS NO. ; COMPUTED
MUMPS CODE: N COC S COC=$E($$GET1^DIQ(165.5,D0,.04,"E"),1,2),X=$S(COC="":"None",1:COC)
ALGORITHM: N COC S COC=$E($$GET1^DIQ(165.5,D0,.04,"E"),1,2),X=$S(COC="":"None",1:COC)
LAST EDITED: AUG 18, 2010
DESCRIPTION:
Computed CLASS OF CASE code. It is derived from CLASS OF CASE (165.5,.04).
165.5,.042 CLASS CATEGORY 0;20 SET (Required)
'0' FOR NONANALYTIC;
'1' FOR ANALYTIC;
LAST EDITED: OCT 29, 2002
HELP-PROMPT: DO NOT PROMPT-FIELD IS STUFFED BY #.04 (CLASS OF CASE)
DESCRIPTION:
Record the category of case, either Analytic or Nonanalytic.
NOTES: TRIGGERED by the CLASS OF CASE field of the ONCOLOGY PRIMARY File
CROSS-REFERENCE: 165.5^AG
1)= S ^ONCO(165.5,"AG",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"AG",$E(X,1,30),DA)
Indexes file by CLASS CATEGORY.
165.5,.043 ANALYTIC PRIMARY REQ FOLLOWUP ; COMPUTED
MUMPS CODE: D ARFPRI^ONCOCOM
ALGORITHM: D ARFPRI^ONCOCOM
LAST EDITED: OCT 08, 2014
165.5,.05 ACCESSION NUMBER 0;5 FREE TEXT (Required)
INPUT TRANSFORM: K:X[""""!($A(X)=45) X I $D(X) K:$L(X)>9!($L(X)<9)!'(X?.N)!($E(X,5,9)="00000") X I $D(X) D ACN^ONCOC
KI
LAST EDITED: DEC 07, 1999
HELP-PROMPT: Enter the 9-digit ACCESSION NUMBER.
DESCRIPTION: Provides a unique identifier for the patient consisting of the year in which the patient was first
seen at the reporting facility and the consecutive order in which the patient was abstracted.
For further information see FORDS page 33.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^D1^MUMPS
1)= S XX=$P(^ONCO(165.5,DA,0),U,6) Q:XX="" S ^ONCO(165.5,"D",$E(X,1,4)_"-"_$E(X,5,9)_"/"_XX,DA)=""
2)= S XX=$P(^ONCO(165.5,DA,0),U,6) Q:XX="" K ^ONCO(165.5,"D",$E(X,1,4)_"-"_$E(X,5,9)_"/"_XX,DA)
Indexes the file by the display value of ACCESSION NUMBER and SEQUENCE NUMBER.
CROSS-REFERENCE: 165.5^AE^MUMPS
1)= S ^ONCO(165.5,"AE",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
2)= K ^ONCO(165.5,"AE",X,$P(^ONCO(165.5,DA,0),U,2),DA)
Indexes the file by ACCESSION NUMBER and PATIENT NAME.
CROSS-REFERENCE: 165.5^AF^MUMPS
1)= S ^ONCO(165.5,"AF",999999999-X,DA)=""
2)= K ^ONCO(165.5,"AF",999999999-X,DA)
Indexes the file in inverse order by ACCESSION NUMBER.
CROSS-REFERENCE: 165.5^AA
1)= S ^ONCO(165.5,"AA",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"AA",$E(X,1,30),DA)
Indexes file by ACCESSION NUMBER.
CROSS-REFERENCE: 165.5^AC^MUMPS
1)= S ^ONCO(165.5,"AC",$P(^ONCO(165.5,DA,0),U,2),X,DA)=""
2)= K ^ONCO(165.5,"AC",$P(^ONCO(165.5,DA,0),U,2),X,DA)
Indexes the file by PATIENT NAME and ACCESSION NUMBER.
165.5,.06 SEQUENCE NUMBER 0;6 FREE TEXT
INPUT TRANSFORM: K:X[""""!($A(X)=45) X I $D(X) K:$L(X)>2!($L(X)<2) X I $D(X) D SEQ^ONCOCKI
LAST EDITED: AUG 16, 2000
HELP-PROMPT: Enter two numerics, e.g. '00' for one primary only.
DESCRIPTION: Indicates the sequence of malignant and non-malignant neoplasms over the lifetime of the patient.
Codes 00-59 and 99 indicate neoplasms of in situ or malignant behavior (Behavior equals 2 or 3).
Codes 60-88 indicate neoplasms of non-malignant behavior (Behavior equals 0 or 1).
Code 00 only if the patient has a single malignant primary. If the patient develops a subsequent
malignant or in situ primary tumor, change the code for the first tumor from 00 to 01, and number
subsequent tumors sequentially. Code 59 for the fifty-ninth of fifty-nine independent malignant or
in situ primaries. Code 99 for an unspecified malignant or in situ sequence number or unknown.
Code 60 only if the patient has a single non-malignant primary. If the patient develops a
subsequent non-malignant primary, change the code for the first tumor from 60 to 61, and assign
codes to subsequent non-malignant tumors sequentially. Code 87 for the twenty-seventh of
twenty-seven independent non- malignant primaries. Code 88 for an unspecified number of neoplasms
in this category.
For further information see FORDS pages 34-35.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^D^MUMPS
1)= S XX=$P(^ONCO(165.5,DA,0),U,5) Q:XX="" S ^ONCO(165.5,"D",$E(XX,1,4)_"-"_$E(XX,5,9)_"/"_X,DA)="
"
2)= S XX=$P(^ONCO(165.5,DA,0),U,5) Q:XX="" K ^ONCO(165.5,"D",$E(XX,1,4)_"-"_$E(XX,5,9)_"/"_X,DA)
Indexes the file by the display value of ACCESSION NO. and SEQUENCE NO.
165.5,.061 ACC/SEQ NUMBER ; COMPUTED
MUMPS CODE: X ^DD(165.5,.061,9.3) S X=$E(Y(165.5,.061,5),Y(165.5,.061,6),X) S Y=X,X=Y(165.5,.061,4),X=X_Y_"/"_$
P(Y(165.5,.061,1),U,6)
9.2 = S Y(165.5,.061,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(165.5,.061,1),U,5),Y(165.5,.06
1,2)=X S X=1,Y(165.5,.061,3)=X S X=4
9.3 = X ^DD(165.5,.061,9.2) S X=$E(Y(165.5,.061,2),Y(165.5,.061,3),X)_"-",Y(165.5,.061,4)=X S X=$P(
Y(165.5,.061,1),U,5),Y(165.5,.061,5)=X S X=5,Y(165.5,.061,6)=X S X=9
ALGORITHM: $E(ACCESSION NUMBER,1,4)_"-"_$E(ACCESSION NUMBER,5,9)_"/"_SEQUENCE NO.
LAST EDITED: DEC 07, 1999
DESCRIPTION: ACC/SEQ NUMBER concatinates the ACCESSION NUMBER and SEQUENCE NUMBER values.
165.5,.07 ACCESSION YEAR 0;7 FREE TEXT (Required)
INPUT TRANSFORM: K:X[""""!($A(X)=45) X I $D(X) K:$L(X)>4!($L(X)<4)!'(X?4N) X
LAST EDITED: DEC 07, 1999
HELP-PROMPT: Enter the year first seen for this primary.
DESCRIPTION: ACCESSION YEAR (aka YEAR FIRST SEEN FOR THIS PRIMARY) is the year the patient was first seen at
the reporting institution for diagnosis and/ or treatment of this primary. It is NOT the year that
the registrar accession the case. ACCESSION YEAR relates only to one primary tumor. A patient
with multiple primaries can have a different ACCESSION YEAR on each abstract.
This data item is used to produce an accession register. The accession register identifies all
primaries first treated or seen at the reporting institution for a given year.
CROSS-REFERENCE: 165.5^AY
1)= S ^ONCO(165.5,"AY",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"AY",$E(X,1,30),DA)
Indexes file by ACCESSION YEAR.
CROSS-REFERENCE: 165.5^AAY1^MUMPS
1)= S XX=$P($G(^ONCO(165.5,DA,0)),U,20) S:XX ^ONCO(165.5,"AAY",X,DA)="" K XX
2)= S XX=$P($G(^ONCO(165.5,DA,0)),U,20) K:XX ^ONCO(165.5,"AAY",X,DA) K XX
Maintains an index by ACCESSION YEAR for primaries with stages.
CROSS-REFERENCE: 165.5^ACAY^MUMPS
1)= S ^ONCO(165.5,"ACAY")=X
2)= S ^ONCO(165.5,"ACAY")=$E(DT,1)+17_$E(DT,2,3)
Maintains a default ACCESSION YEAR for the system.
165.5,.08 MEDICAL RECORD NUMBER ; COMPUTED
MUMPS CODE: X ^DD(165.5,.08,9.2) X $P(^DD(160,2,0),U,5,99) S Y(165.5,.08,101)=X S X=Y(165.5,.08,101) S D0=Y(165
.5,.08,80)
9.2 = S Y(165.5,.08,80)=$S($D(D0):D0,1:""),Y(165.5,.08,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P
(Y(165.5,.08,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
ALGORITHM: PATIENT NAME:SSN
DESCRIPTION: Records the medical record number usually assigned by the reporting facility's health information
management (HIM) department.
For further information see FORDS page 36.
165.5,.09 SOCIAL SECURITY NUMBER ; COMPUTED
MUMPS CODE: X ^DD(165.5,.09,9.2) X $P(^DD(160,2,0),U,5,99) S Y(165.5,.09,101)=X S X=Y(165.5,.09,101) S D0=Y(165
.5,.09,80)
9.2 = S Y(165.5,.09,80)=$S($D(D0):D0,1:""),Y(165.5,.09,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P
(Y(165.5,.09,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
ALGORITHM: PATIENT NAME:SSN
LAST EDITED: FEB 12, 2003
DESCRIPTION: Records the patient's Social Security Number.
For further information see FORDS page 37.
165.5,.091 STATUS ; COMPUTED
MUMPS CODE: X ^DD(165.5,.091,9.3) S X=$P($P(Y(165.5,.091,102),$C(59)_$P(Y(165.5,.091,101),U,1)_":",2),$C(59),1)
S D0=Y(165.5,.091,80)
9.2 = S Y(165.5,.091,80)=$S($D(D0):D0,1:""),Y(165.5,.091,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=
$P(Y(165.5,.091,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
9.3 = X ^DD(165.5,.091,9.2) S Y(165.5,.091,102)=$C(59)_$S($D(^DD(160,15,0)):$P(^(0),U,3),1:""),Y(16
5.5,.091,101)=$S($D(^ONCO(160,D0,1)):^(1),1:"")
ALGORITHM: PATIENT NAME:STATUS
LAST EDITED: FEB 06, 1991
DESCRIPTION:
STATUS IS EITHER ALIVE OR DEAD.
165.5,.093 PLACE OF BIRTH (STATE) ; COMPUTED
MUMPS CODE: X ^DD(165.5,.093,9.2) S Y(165.5,.093,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"") S X=$S('$D(^ONCO(165.2,
+$P(Y(165.5,.093,101),U,5),0)):"",1:$P(^(0),U,1)) S D0=Y(165.5,.093,80)
9.2 = S Y(165.5,.093,80)=$S($D(D0):D0,1:""),Y(165.5,.093,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=
$P(Y(165.5,.093,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
ALGORITHM: PATIENT NAME:PLACE OF BIRTH
DESCRIPTION:
THE STATE WHERE THE PATIENT WAS BORN.
165.5,.1 SEX ; COMPUTED
MUMPS CODE: X ^DD(165.5,.1,9.3) S X=$P($P(Y(165.5,.1,102),$C(59)_$P(Y(165.5,.1,101),U,8)_":",2),$C(59),1) S D0=
Y(165.5,.1,80)
9.2 = S Y(165.5,.1,80)=$S($D(D0):D0,1:""),Y(165.5,.1,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y
(165.5,.1,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
9.3 = X ^DD(165.5,.1,9.2) S Y(165.5,.1,102)=$C(59)_$S($D(^DD(160,10,0)):$P(^(0),U,3),1:""),Y(165.5,
.1,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"")
ALGORITHM: PATIENT NAME:SEX
LAST EDITED: MAY 26, 1999
DESCRIPTION: Code the patient's SEX.
165.5,.115 STATE ; COMPUTED
MUMPS CODE: X ^DD(165.5,.115,9.2) X $P(^DD(160,.115,0),U,5,99) S Y(165.5,.115,101)=X S X=Y(165.5,.115,101) S D0
=Y(165.5,.115,80)
9.2 = S Y(165.5,.115,80)=$S($D(D0):D0,1:""),Y(165.5,.115,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=
$P(Y(165.5,.115,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
ALGORITHM: PATIENT NAME:STATE
DESCRIPTION:
THE PATIENT'S STATE OF RESIDENCY AT THE TIME OF DIAGNOSIS.
165.5,.1157 ST-COUNTY ; COMPUTED
MUMPS CODE: D STCT^ONCOCOP
ALGORITHM: D STCT^ONCOCOP
LAST EDITED: MAR 22, 1991
DESCRIPTION:
STATE AND COUNTY COMPUTED FIELD.
165.5,.117 COUNTY ; COMPUTED
MUMPS CODE: X ^DD(165.5,.117,9.2) X $P(^DD(160,.117,0),U,5,99) S Y(165.5,.117,101)=X S X=Y(165.5,.117,101) S D0
=Y(165.5,.117,80)
9.2 = S Y(165.5,.117,80)=$S($D(D0):D0,1:""),Y(165.5,.117,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=
$P(Y(165.5,.117,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
ALGORITHM: PATIENT NAME:COUNTY
DESCRIPTION:
THE PATIENT'S RESIDENCE COUNTY AT THE TIME OF DIAGNOSIS.
165.5,.12 RACE ; COMPUTED
MUMPS CODE: X ^DD(165.5,.12,9.2) S Y(165.5,.12,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"") S X=$S('$D(^ONCO(164.46,+
$P(Y(165.5,.12,101),U,6),0)):"",1:$P(^(0),U,1)) S D0=Y(165.5,.12,80)
9.2 = S Y(165.5,.12,80)=$S($D(D0):D0,1:""),Y(165.5,.12,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P
(Y(165.5,.12,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
9.3 = X ^DD(165.5,.12,9.2) S Y(165.5,.12,102)=$C(59)_$S($D(^DD(160,8,0)):$P(^(0),U,3),1:""),Y(165.5
,.12,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"")
ALGORITHM: PATIENT NAME:RACE
LAST EDITED: NOV 12, 1996
DESCRIPTION:
"Race" is analyzed with the data item Spanish/Hispanic origin. Both items must be recorded.
165.5,.13 RACE-SEX ; COMPUTED
MUMPS CODE: S X="" D RSX^ONCOCOS
ALGORITHM: S X="" D RSX^ONCOCOS
DESCRIPTION:
COMPUTED FIELD COMBINING BOTH RACE AND SEX, USED IN CROSS TABULATIONS.
165.5,.14 SEX-RACE ; COMPUTED
MUMPS CODE: S X="" D SXR^ONCOCOS
ALGORITHM: S X="" D SXR^ONCOCOS
DESCRIPTION:
This is the combined race and sex code, used for cross tabulations.
165.5,1 DATE OF INPATIENT ADMISSION 0;8 DATE
INPUT TRANSFORM: D FADIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JUN 07, 2000
HELP-PROMPT: *** DATE OF INPATIENT ADMISSION MUST BE BEFORE/EQUAL DATE OF INPATIENT DISCHARGE
DESCRIPTION: Record the date of the inpatient admission to the facility for the most definitive surgery. If
the patient does not have surgery, use the inpatient admission date for any other cancer-directed
therapy. If the patient has no cancer-directed therapy, use the date of inpatient admission for
diagnostic evaluation.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1.1 DATE OF INPATIENT DISCHARGE 0;9 DATE
INPUT TRANSFORM: D DSDTIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JUN 07, 2000
HELP-PROMPT: DATE OF INPATIENT DISCHARGE MUST BE AFTER/EQUAL DATE OF INPATIENT ADMISSION
DESCRIPTION: Record the date of the inpatient discharge from the facility for the most definitive sugery. If
the patient did not have surgery, use the inpatient discharge date for any other cancer-directed
therapy. If the patient has no cancer-directed therapy, use the date of inpatient discharge for
diagnostic evaluation.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1.2 TYPE OF REPORTING SOURCE 0;10 POINTER TO TYPE OF REPORTING SOURCE FILE (#168)
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(168,Y,0),U,2)
LAST EDITED: MAR 28, 2006
DESCRIPTION: Code the source documents used to abstract the cancer being reported. This item is used by
central registries.
165.5,2 PRIMARY SURGEON 0;11 POINTER TO ONCOLOGY CONTACT FILE (#165)
INPUT TRANSFORM: S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
LAST EDITED: MAY 08, 2023
HELP-PROMPT: Enter the physician who performed the most definitive surgical procedure. You may not enter a new
physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.
DESCRIPTION: Records the physician who performed the most definitive surgical procedure.
For further information see FORDS page 77.
SCREEN: S DIC("S")="I $P(^(0),U,2)=2"
EXPLANATION: Enter a PHYSICIAN CONTACT.
GROUP: ACOS-RECOMMENDED
CROSS-REFERENCE: 165.5^ACP^MUMPS
1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
Creates a list under the Contact file of contacts, and associated patients orginating from the
Primary file pointers to the Contact File.
CROSS-REFERENCE: 165.5^APC^MUMPS
1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
Creates a list under the contact file of patients, and associated contacts originating from the
Primary file pointers to the contact file.
CROSS-REFERENCE: 165.5^APS^MUMPS
1)= S ^ONCO(165.5,"APS",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
2)= K ^ONCO(165.5,"APS",X,$P(^ONCO(165.5,DA,0),U,2),DA)
Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
165.5,2.1 FOLLOWING PHYSICIAN 0;12 POINTER TO ONCOLOGY CONTACT FILE (#165)
INPUT TRANSFORM: S DIC("S")="I ($P(^(0),U,2)=2)!($P(^(0),U,2)=4)" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
LAST EDITED: MAY 08, 2023
HELP-PROMPT: Enter the person currently responsible for the patient's medical care. You may not enter a new
physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.
DESCRIPTION: Records the person currently responsible for the patient's medical care.
For further information see FORDS page 76.
SCREEN: S DIC("S")="I ($P(^(0),U,2)=2)!($P(^(0),U,2)=4)"
EXPLANATION: Enter a PHYSICIAN or INSTITUTION CONTACT.
CROSS-REFERENCE: 165.5^ACP^MUMPS
1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
Creates a list under the Contact file of contacts, and associated patients orginating from the
Primary file pointers to the Contact File.
CROSS-REFERENCE: 165.5^APC^MUMPS
1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
Creates a list under the contact file of patients, and associated contacts originating from the
Primary file pointers to the contact file.
CROSS-REFERENCE: 165.5^AFP^MUMPS
1)= S ^ONCO(165.5,"AFP",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
2)= K ^ONCO(165.5,"AFP",X,$P(^ONCO(165.5,DA,0),U,2),DA)
Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
165.5,2.2 MANAGING PHYSICIAN 0;13 POINTER TO ONCOLOGY CONTACT FILE (#165)
INPUT TRANSFORM: S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
LAST EDITED: MAY 08, 2023
HELP-PROMPT: Enter the physician who is responsible for the overall management of the patient. You may not enter
a new physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.
DESCRIPTION: Identifies the physician who is responsible for the overall management of the patient during
diagnosis and/or treatment of this cancer.
SCREEN: S DIC("S")="I $P(^(0),U,2)=2"
EXPLANATION: Enter a PHYSICIAN TYPE ONCOLOGY CONTACT.
GROUP: ACOS-RECOMMENDED
CROSS-REFERENCE: 165.5^ACP^MUMPS
1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
Creates a list under the Contact file of contacts, and associated patients orginating from the
Primary file pointers to the Contact File.
CROSS-REFERENCE: 165.5^APC^MUMPS
1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
Creates a list under the contact file of patients, and associated contacts originating from the
Primary file pointers to the contact file.
CROSS-REFERENCE: 165.5^AMP^MUMPS
1)= S ^ONCO(165.5,"AMP",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
2)= K ^ONCO(165.5,"AMP",X,$P(^ONCO(165.5,DA,0),U,2),DA)
Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
165.5,2.3 PHYSICIAN #3 0;14 POINTER TO ONCOLOGY CONTACT FILE (#165)
INPUT TRANSFORM: S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
LAST EDITED: MAY 08, 2023
HELP-PROMPT: Enter another physician involved in the care of the patient. You may not enter a new physician
contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.
DESCRIPTION: Records another physician involved in the care of the patient. The Commission on Cancer
recommends that this data item identify the physician who performed the most definitive radiation
therapy.
For further information see FORDS page 78.
SCREEN: S DIC("S")="I $P(^(0),U,2)=2"
EXPLANATION: Enter a PHYSICIAN CONTACT.
GROUP: ACOS-RECOMMENDED
CROSS-REFERENCE: 165.5^ACP^MUMPS
1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
Creates a list under the Contact file of contacts, and associated patients orginating from the
Primary file pointers to the Contact File.
CROSS-REFERENCE: 165.5^APC^MUMPS
1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
Creates a list under the contact file of patients, and associated contacts originating from the
Primary file pointers to the contact file.
CROSS-REFERENCE: 165.5^AOP3^MUMPS
1)= S ^ONCO(165.5,"AOP3",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
2)= K ^ONCO(165.5,"AOP3",X,$P(^ONCO(165.5,DA,0),U,2),DA)
Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
165.5,2.4 PHYSICIAN #4 0;15 POINTER TO ONCOLOGY CONTACT FILE (#165)
INPUT TRANSFORM: S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
LAST EDITED: MAY 08, 2023
HELP-PROMPT: Enter another physician involved in the care of the patient. You may not enter a new physician
contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.
DESCRIPTION: Records another physician involved in the care of the patient. The Commission on Cancer
recommends that this data item identify the physician who gives the most definitive systemic
therapy.
For further information see FORDS page 79.
SCREEN: S DIC("S")="I $P(^(0),U,2)=2"
EXPLANATION: Enter a PHYSICIAN CONTACT.
GROUP: ACOS-RECOMMENDED
CROSS-REFERENCE: 165.5^ACP^MUMPS
1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
Creates a list under the Contact file of contacts, and associated patients orginating from the
Primary file pointers to the Contact File.
CROSS-REFERENCE: 165.5^APC^MUMPS
1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
Creates a list under the contact file of patients, and associated contacts originating from the
Primary file pointers to the contact file.
CROSS-REFERENCE: 165.5^AOP4^MUMPS
1)= S ^ONCO(165.5,"AOP4",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
2)= K ^ONCO(165.5,"AOP4",X,$P(^ONCO(165.5,DA,0),U,2),DA)
Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
165.5,3 DATE DX 0;16 DATE (Required)
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) I $D(X) D DTDXIT^ONC
ODXD
MAXIMUM LENGTH: 12
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JUN 21, 2022
HELP-PROMPT: Future dates are not allowed.
DESCRIPTION: Records the date of initial diagnosis by a physician for the tumor being reported.
For further information see FORDS pages 89-90.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ADX
1)= S ^ONCO(165.5,"ADX",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"ADX",$E(X,1,30),DA)
3)= DO NOT DELETE
Cross-reference by DATE DX
165.5,3.1 DIAGNOSIS EPISODE CARE ; COMPUTED
MUMPS CODE: S X="" D ADM^ONCOCON
ALGORITHM: S X="" D ADM^ONCOCON
DESCRIPTION:
RECORDS THE CARE THE PATIENT RECEIVED DURING THE CURRENT EPISODE OF TREATMENT AT DIAGNOSIS.
165.5,3.5 YEAR DX ; COMPUTED DATE
MUMPS CODE: S Y(165.5,3.5,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(165.5,3.5,1),U,16),X=X S X=X,X=$E(X,1
,3)_"0000" S:'X X=""
ALGORITHM: YEAR(INTERNAL(DATE DX))
LAST EDITED: MAR 10, 1998
DESCRIPTION:
DATE DX (165.5,3) year
165.5,4 AGE AT DX ; COMPUTED
MUMPS CODE: D AGE^ONCOCOM
ALGORITHM: D AGE^ONCOCOM
LAST EDITED: JUN 21, 1990
DESCRIPTION: Records the age of the patient at his or her last birthday before diagnosis.
For further information see FORDS page 58.
165.5,4.1 DX AGE-GP ; COMPUTED
MUMPS CODE: D DEC^ONCOCOM
ALGORITHM: D DEC^ONCOCOM
LAST EDITED: JUL 19, 1990
DESCRIPTION:
DIAGNOSIS AGE GROUP WILL GROUP PATIENTS BY AGE.
165.5,5 DX FACILITY 0;17 POINTER TO FACILITY FILE (#160.19)
OUTPUT TRANSFORM: S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
LAST EDITED: MAY 31, 1996
HELP-PROMPT: Enter Hospital which diagnosed this Primary.
DESCRIPTION:
Record the name of the facility where diagnosis was first made.
EXECUTABLE HELP: D HELP^ONCOFLF
165.5,6 FACILITY REFERRED FROM 0;18 POINTER TO FACILITY FILE (#160.19)
OUTPUT TRANSFORM: S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
LAST EDITED: NOV 06, 2002
DESCRIPTION: Identifies the facility that referred the patient to the reporting facility.
For further information see FORDS page 85.
EXECUTABLE HELP: D HELP^ONCOFLF
GROUP: ACOS-REQUIRED
165.5,7 FACILITY REFERRED TO 0;19 POINTER TO FACILITY FILE (#160.19)
OUTPUT TRANSFORM: S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
LAST EDITED: NOV 06, 2002
DESCRIPTION: Identifies the facility to which the patient was referred for further care after discharge from the
reporting facility.
For further information see FORDS page 86.
EXECUTABLE HELP: D HELP^ONCOFLF
GROUP: ACOS-RECOMMENDED
165.5,8 PATIENT ADDRESS AT DX 1;1 FREE TEXT
INPUT TRANSFORM: K:$L(X)>40!($L(X)<1) X I $D(X) D NP^ONCOIT
LAST EDITED: JUN 21, 2001
HELP-PROMPT: Enter 1-40 uppercase alphanumeric characters. No punctuation.
DESCRIPTION: Identifies the patient's address (number and street) at the time of diagnosis.
For further information see FORDS page 42.
GROUP: ACOS-RECOMMENDED
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,8.1 CITY/TOWN AT DX 1;12 FREE TEXT
INPUT TRANSFORM: K:$L(X)>20!($L(X)<1) X I $D(X) D NP^ONCOIT
LAST EDITED: JUN 21, 2001
HELP-PROMPT: Enter 1-20 uppercase alphanumeric characters. No punctuation.
DESCRIPTION: Identifies the name of the city or town in which the patient resides at the time the tumor is
diagnosed and treated.
For further information see FORDS page 44.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the POSTAL CODE AT DX field of the ONCOLOGY PRIMARY File
165.5,8.2 PATIENT ADDRESS AT DX - SUPP 1;13 FREE TEXT
INPUT TRANSFORM: K:$L(X)>40!($L(X)<1) X I $D(X) D NP^ONCOIT
LAST EDITED: NOV 04, 2002
HELP-PROMPT: Enter 1-40 uppercase alphanumeric characters. No punctuation.
DESCRIPTION: Provides the ability to store additional adress information such as the name of a place or
facility (ie, a nursing home or name of an apartment complex) at the time of diagnosis.
For further information see FORDS page 43.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,9 POSTAL CODE AT DX 1;2 FREE TEXT
INPUT TRANSFORM: D PCDX^ONCPCDX
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: AUG 25, 2010
HELP-PROMPT: Enter the 5-digit US postal code or 6-character Canadian postal code.
DESCRIPTION: Identifies the postal code of the patient's address at diagnosis.
For U.S. residents, record the patient's five-digit postal code at the time of diagnosis and
treatment.
For Canadian residents, record the six-character postal code.
GROUP: SEER
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: ^^TRIGGER^165.5^10
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(
^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,3),X=X S DIU=X K Y S X=DIV S X=ONCCOUNTY K ONCCOUNTY X
^DD(165.5,9,1,1,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,3)=DIV,DIH=165.5,DIG=10 D ^DICR
2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(
^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,3),X=X S DIU=X K Y S X="" X ^DD(165.5,9,1,1,2.4)
2.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,3)=DIV,DIH=165.5,DIG=10 D ^DICR
CREATE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
CREATE VALUE)= S X=ONCCOUNTY K ONCCOUNTY
DELETE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
DELETE VALUE)= @
FIELD)= COUNTY AT DX
COUNTY AT DX (165.5,10) will be stuffed with the COUNTY (5.12,2) value associated with the selected
POSTAL CODE. If the POSTAL CODE AT DX value is a Canadian postal code or 88888 or 99999, this
trigger cross-reference will not be executed.
CROSS-REFERENCE: ^^TRIGGER^165.5^16
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(
^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,4),X=X S DIU=X K Y S X=DIV S X=ONCSTATE K ONCSTATE X ^D
D(165.5,9,1,2,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,4)=DIV,DIH=165.5,DIG=16 D ^DICR
2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(
^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,4),X=X S DIU=X K Y S X="" X ^DD(165.5,9,1,2,2.4)
2.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,4)=DIV,DIH=165.5,DIG=16 D ^DICR
CREATE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
CREATE VALUE)= S X=ONCSTATE K ONCSTATE
DELETE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
DELETE VALUE)= @
FIELD)= STATE AT DX
STATE AT DX (165.5,16) will be stuffed with the STATE (5.12,3) value associated with the selected
POSTAL CODE. If the POSTAL CODE AT DX value is a Canadian postal code or 88888 or 99999, this
trigger cross-reference will not be executed.
CROSS-REFERENCE: ^^TRIGGER^165.5^8.1
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(
^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,12),X=X S DIU=X K Y S X=DIV S X=ONCCITY K ONCCITY X ^DD
(165.5,9,1,3,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,12)=DIV,DIH=165.5,DIG=8.1 D ^DICR
2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(
^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,12),X=X S DIU=X K Y S X="" X ^DD(165.5,9,1,3,2.4)
2.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,12)=DIV,DIH=165.5,DIG=8.1 D ^DICR
CREATE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
CREATE VALUE)= S X=ONCCITY K ONCCITY
DELETE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
DELETE VALUE)= @
FIELD)= CITY/TOWN AT DX
CITY/TOWN AT DX (165.5,8.1) will be stuffed with the CITY (5.12,1) value associated with the
selected POSTAL CODE. If the POSTAL CODE AT DX value is a Canadian postal code or 88888 or 99999,
this trigger cross-reference will not be executed.
165.5,10 COUNTY AT DX 1;3 FREE TEXT
INPUT TRANSFORM: D CCODE^XIPUTIL(X,.XIPC) K:(XIPC("COUNTY")="")&(X'=99998) X K XIPC
OUTPUT TRANSFORM: I Y'="" K XIPC D CCODE^XIPUTIL(Y,.XIPC) S Y=$S(XIPC("COUNTY")'="":XIPC("COUNTY"),1:Y) K XIPC
LAST EDITED: AUG 26, 2010
HELP-PROMPT: Enter the 5-digit FIPS code (2-digit state code + 3 digit county code). If unknown, enter 99998
(Outside state/county code unknown) or 99999 (County unknown).
DESCRIPTION: Identifies the county of the patient's residence at the time the reportable tumor is diagnosed.
The COUNTY AT DX value will be triggered by the entry of a valid U. S. POSTAL CODE AT DX value.
Canadian POSTAL CODE AT DX values will not trigger a COUNTY AT DX value.
If unknown, enter 99998 (Outside state/county code unknown) or 99999 (County unknown).
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the POSTAL CODE AT DX field of the ONCOLOGY PRIMARY File
165.5,11 MARITAL STATUS AT DX 1;5 SET
'1' FOR Single (never married);
'2' FOR Married (including common law);
'3' FOR Separated;
'4' FOR Divorced;
'5' FOR Widowed;
'6' FOR Unmarried or Domestic Partner;
'9' FOR Unknown;
LAST EDITED: MAR 14, 2011
HELP-PROMPT: Enter the patient's marital status at the time of diagnosis.
DESCRIPTION: This is the patient's marital status at the time of diagnosis for the reportable tumor. If the
patient has multiple tumors, marital status may be different for each tumor.
GROUP: ACOS-RECOMMENDED
165.5,12 PALLIATIVE CARE 3.1;26 SET
'0' FOR No palliative care;
'1' FOR Surgery;
'2' FOR Radiation;
'3' FOR Systemic tx;
'4' FOR Pain management;
'5' FOR Surg, rad, and/or systemic tx w/o pain mgt;
'6' FOR Surg, rad, and/or systemic tx w pain mgt;
'7' FOR Palliative care, type unknown;
'9' FOR Unknown, not stated;
LAST EDITED: MAR 03, 2006
DESCRIPTION: Identifies any care provided in an effort to palliate or alleviate symptoms. Palliative care is
performed to relieve symptoms and may include surgery, radiation therapy, systemic therapy
(chemotherapy, hormone therapy, or other systemic drugs), and/or pain management therapy.
For further information see FORDS pages 189-190.
CROSS-REFERENCE: 165.5^AN^MUMPS
1)= Q
2)= D PP^ONCDTX
165.5,13 PALLIATIVE CARE @FAC 3.1;27 SET
'0' FOR No palliative care;
'1' FOR Surgery;
'2' FOR Radiation;
'3' FOR Systemic tx;
'4' FOR Pain management;
'5' FOR Surg, rad, and/or systemic tx w/o pain mgt;
'6' FOR Surg, rad, and/or systemic tx w pain mgt;
'7' FOR Palliative care, type unknown;
'9' FOR Unknown, not stated;
LAST EDITED: MAY 20, 2004
DESCRIPTION: Identifies care provided at this facility in an effort to palliate or alleviate symptoms.
Palliative care is performed to relieve symptoms and may include surgery, radiation therapy,
systemic therapy (chemotherapy, hormone therapy, or other systemic drugs), and/or other pain
management therapy.
For further information see FORDS page 191.
165.5,14 READMISSION W/I 30 DAYS/SURG 3.1;28 SET
'0' FOR No surgery/not readmitted;
'1' FOR Unplanned readmission;
'2' FOR Planned readmission;
'3' FOR Planned and unplanned readmission;
'9' FOR Unknown if surgery or readmission;
LAST EDITED: JAN 08, 2003
DESCRIPTION: Records a readmission to the same hospital within 30 days of discharge following a hospitalization
for surgical resection of the primary site.
For further information see FORDS page 146.
165.5,15 SYSTEMIC/SURGERY SEQUENCE 3.1;39 SET
'0' FOR No systemic and/or surgery;
'2' FOR Systemic before surgery;
'3' FOR Systemic after surgery;
'4' FOR Systemic before and after surgery;
'5' FOR Intraoperative systemic;
'6' FOR Intraoperative/other before or after surgery;
'9' FOR Sequence unknown;
LAST EDITED: DEC 27, 2005
DESCRIPTION: Records the sequencing of systemic therapy and surgical procedures given as part of the first
course of treatment.
165.5,16 STATE AT DX 1;4 POINTER TO STATE FILE (#5)
LAST EDITED: SEP 04, 2009
HELP-PROMPT: Enter the patient's state of residence at the time of diagnosis.
DESCRIPTION: Identifies the patient's state of residence at the time of diagnosis.
For further information see FORDS page 45.
NOTES: TRIGGERED by the POSTAL CODE AT DX field of the ONCOLOGY PRIMARY File
165.5,17 SUSPENSE DATE 1;10 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 03, 1997
HELP-PROMPT: *** SUSPENSE DATE MUST BE AFTER OR EQUAL TO THE DATE DX ***
DESCRIPTION:
This is the date on which the primary was added to the suspense file.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,18 PRIMARY PAYER AT DX 1;11 POINTER TO PRIMARY PAYER AT DIAGNOSIS FILE (#160.3)
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(160.3,Y,0),U,2)
LAST EDITED: JUL 07, 2000
DESCRIPTION: Identifies the patient's primary payer/insurance carrier at the time of initial diagnosis and/or
treatment.
For further information see FORDS pages 67-68.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,19 STAGED BY (CLINICAL STAGE) 3;32 POINTER TO ONCOLOGY STAGED BY CODES FILE (#165.7)
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(165.7,Y,0),U,1)_" "_$P(^ONCO(165.7,Y,0),U,2)
LAST EDITED: APR 06, 2017
HELP-PROMPT: Record the role of the person who documented the Clinical AJCC staging data items and the Stage
Group.
DESCRIPTION: Identifies the person who recorded the clinical AJCC staging elements and the stage group in the
patient's medical record.
For further information refer to FORDS manual.
165.5,20 PRIMARY SITE 2;1 POINTER TO ICDO TOPOGRAPHY FILE (#164) (Required)
INPUT TRANSFORM: D TOPIT^ONCOSUR1
LAST EDITED: NOV 06, 2002
HELP-PROMPT: Record the ICD-O topography code for the site of origin.
DESCRIPTION: Identifies the primary site.
For further information see FORDS page 91.
EXECUTABLE HELP: S ONCOX=164 D HP^ONCOHICD
GROUP: ACOS-REQUIRED
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^BT^MUMPS
1)= S ^ONCO(165.5,"C"_$E(X,3,4),DA)=""
2)= K ^ONCO(165.5,"C"_$E(X,3,4),DA)
Indexes the file by the whole number value of the ICD-O second edition topography code.
CROSS-REFERENCE: 165.5^AD^MUMPS
1)= S $P(^ONCO(165.5,DA,0),U,22)=$E(X,1,4)
2)= S $P(^ONCO(165.5,DA,0),U,22)=""
Maintains the ICDO-SITE Field (#.022).
CROSS-REFERENCE: 165.5^E
1)= S ^ONCO(165.5,"E",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"E",$E(X,1,30),DA)
Indexes file by ICDO-TOPOGRAPHY.
165.5,20.1 PRIMARY SITE CODE ; COMPUTED
MUMPS CODE: S X=$P($G(^ONCO(165.5,D0,2)),U),X=$S(X="":"",1:"C"_$E(X,3,4)_"."_$E(X,5))
ALGORITHM: CUSTOM CODED
LAST EDITED: NOV 06, 2002
DESCRIPTION:
Identifies the primary site ICD-O topography code.
165.5,21 CASEFINDING SOURCE 1;6 POINTER TO CASEFINDING SOURCE FILE (#166) (Required)
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(166,Y,0),U,2)
LAST EDITED: AUG 30, 2022
HELP-PROMPT: Enter the appropriate code from the list.
DESCRIPTION:
This field codes the earliest source of identifying information.
165.5,21.5 INFRA/SUPRA 2;7 SET (Required)
'I' FOR INFRATENTORIAL;
'S' FOR SUPRATENTORIAL;
LAST EDITED: JUN 22, 1993
HELP-PROMPT: This field applies to brain tumors only.
DESCRIPTION: For brain tumors, enter 'I' or 'S' according to whether the tumor is infratentorial or
supratentorial.
This field does not apply to tumors other than brain tumors.
165.5,21.51 IRIS/CILIARY BODY 2;22 SET
'I' FOR Iris;
'C' FOR Ciliary body;
LAST EDITED: JUN 30, 1993
DESCRIPTION:
This field is used to determine the appropriate TNM encoding for malignant melanomas of the uvea.
165.5,21.52 UPPER/LOWER 24;4 SET
'U' FOR Upper 2/3;
'L' FOR Lower 1/3;
LAST EDITED: JUL 04, 1993
DESCRIPTION: This field is used to determine the appropriate N coding for tumors of the vagina. Enter U or L
according to whether the regional lymph node metastasis relates to the upper two-thirds or lower
one-third of the vagina.
165.5,22 HISTOLOGY (ICD-O-2) 2;3 POINTER TO ICD-O-2 MORPHOLOGY FILE (#164.1)
INPUT TRANSFORM: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2980101)!((Y<96002)!(Y>96423))&($P(^ONCO(165.5,DA,0),U,16
)<3010101)" D ^DIC K DIC S DIC=DIE,X=+Y D HIST23^ONCOHICD K:Y<0 X
LAST EDITED: JUN 12, 2003
HELP-PROMPT: Enter the code, e.g. 81203 or 8120/3, or name, e.g. TRANSITIONAL CELL CA.
DESCRIPTION: Record the histology using the ICD-O-2 codes.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2980101)!((Y<96002)!(Y>96423))&($P(^ONCO(165.5,DA,0),U,16
)<3010101)"
EXPLANATION: Codes 9600-9642 are not selectable for 1998 or later cases and this field is not editable at all fo
r 2001 or later cases.
EXECUTABLE HELP: S ONCOX=164.1 D HP^ONCOHICD
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AH
1)= S ^ONCO(165.5,"AH",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"AH",$E(X,1,30),DA)
3)= DO NOT DELETE
Cross Reference Histology, (pointer) used in hard-coded routines as FM will not use this index
being a pointer.
165.5,22.1 ICDO HISTOLOGY-CODE ; COMPUTED
MUMPS CODE: S X=$$HIST^ONCFUNC(D0),X=$S(X="":"",1:$E(X,1,4)_"/"_$E(X,5))
ALGORITHM: S X=""
LAST EDITED: MAY 22, 2001
DESCRIPTION: Display the Histology Code value, based on the primary's date DX: If Date DX is before 2001 use
the HISTOLOGY (ICD-O-2) value, if it is a 2001 or later case use the HISTOLOGY (ICD-O-3) value.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,22.2 PAPILLARY/FOLLICULAR 2;4 SET
'P' FOR PAPILLARY;
'F' FOR FOLLICULAR;
LAST EDITED: JUN 14, 1993
DESCRIPTION: This code assists in the characterization of tumors of the thyroid gland. It is only significant
for patients 45 years and over.
If the tumor is neither papillary nor follicular, leave this field blank.
TECHNICAL DESCR: For thyroid primaries only (C73.9), this field is set directly by the TBA cross-reference of the
HISTOLOGY Field (#22).
165.5,22.3 HISTOLOGY (ICD-O-3) 2.2;3 POINTER TO ICD-O-3 MORPHOLOGY FILE (#169.3)
INPUT TRANSFORM: D INIT^ONCCS
LAST EDITED: MAY 31, 2005
DESCRIPTION: Identifies the microscopic anatomy of cells for primaries diagnosed in 2001 or later.
This field also contains the BEHAVIOR CODE which records the behavior of the tumor being reported.
The fifth digit of the morphology code is the behavior code.
For further information see FORDS pages 93-95.
EXECUTABLE HELP: D ICDO3^ONCOHICD
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AL^MUMPS
1)= Q
2)= S $P(^ONCO(165.5,DA,8),U,2)=""
This cross-reference will delete the TEXT-HISTOLOGY TITLE (165.5,101) value if the HISTOLOGY
(ICD-O-3) value is changed.
165.5,22.4 BEHAVIOR CODE ; COMPUTED
MUMPS CODE: S Y(165.5,22.4,1)=$S($D(^ONCO(165.5,D0,2.2)):^(2.2),1:"") S X=$P(Y(165.5,22.4,1),U,3),X=X S X=X,Y(1
65.5,22.4,2)=$G(X) S X=5,X=$E(Y(165.5,22.4,2),X)
ALGORITHM: $E(INTERNAL(HISTOLOGY (ICD-O-3)),5)
LAST EDITED: SEP 21, 2023
DESCRIPTION: This field records the behavior of the tumor being reported. The behavior code corresponds to the
fifth digit of the morphology (HISTOLOGY ICD-O-3) so the field is calculated from there.
165.5,23 RECONSTRUCTION/RESTORATION 3;33 FREE TEXT
INPUT TRANSFORM: D RRDEFIT^ONCNTX1 K:+X'=X!(X>10)!(X<0)!(X?.E1"."1N.N) X I $D(X) S NTXDD=1 D RRIT^ONCRR Q
OUTPUT TRANSFORM: D RROT^ONCRR
LAST EDITED: SEP 21, 2004
DESCRIPTION: RECONSTRUCTIVE/RESTORATION is a surgical procdure that improves the shape and appearance or
function of body structures that are missing, defective, damaged or misshapen by cancer or its
treatment.
RECONSTRUCTION/RESTORATION is limited to procedures started during the first course of treatment.
For further information see ROADS page 195.
EXECUTABLE HELP: D RRHP^ONCRR
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,24 GRADE/DIFFERENTIATION 2;5 POINTER TO GRADE FILE (#164.43)
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(164.43,Y,0),U,1)
LAST EDITED: FEB 23, 2010
DESCRIPTION: Describes the tumor's resemblance to normal tissue. Well differentiated (Grade 1) is the most like
normal tissue, and undifferentiated (Grade 4) is the least like normal tissue. Grades 5-8 define
particular cell lines for lymphomas and leukemias.
For further information see FORDS 2010 pages 112-113.
165.5,24.1 GRADE PATH SYSTEM 2.3;1 SET
'2' FOR Two-Grade System;
'3' FOR Three-Grade System;
'4' FOR Four-Grade System;
LAST EDITED: OCT 01, 2009
HELP-PROMPT: Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.
DESCRIPTION: Indicates whether a two, three or four grade system was used in the pathology report.
Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.
165.5,24.2 GRADE PATH VALUE 2.3;2 SET
'1' FOR Recorded as Grade I or 1;
'2' FOR Recorded as Grade II or 2;
'3' FOR Recorded as Grade III or 3;
'4' FOR Recorded as Grade IV or 4;
LAST EDITED: OCT 01, 2009
HELP-PROMPT: Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.
DESCRIPTION: Describes the grade assigned according to the grading system in GRADE PATH SYSTEM.
Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.
165.5,24.3 GRADE CLINICAL 2.3;12 FREE TEXT
INPUT TRANSFORM: K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG
MAXIMUM LENGTH: 1
OUTPUT TRANSFORM: D OT^ONCSCHMG
LAST EDITED: MAR 13, 2019
HELP-PROMPT: Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S
DESCRIPTION: This data item records the grade of a solid primary tumor before any treatment (surgical resection
or initiation of any treatment including neoadjuvant).
EXECUTABLE HELP: D HLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,24.4 GRADE PATHOLOGICAL 2.3;13 FREE TEXT
INPUT TRANSFORM: K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG
MAXIMUM LENGTH: 1
OUTPUT TRANSFORM: D OT^ONCSCHMG
LAST EDITED: MAR 13, 2019
HELP-PROMPT: Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S
DESCRIPTION: This data item records the grade of a solid primary tumor that has been resected and for which no
neoadjuvant therapy was administered.
EXECUTABLE HELP: D HLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,24.5 GRADE POST THERAPY PATH (YP) 2.3;14 FREE TEXT
INPUT TRANSFORM: K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG
MAXIMUM LENGTH: 1
OUTPUT TRANSFORM: D OT^ONCSCHMG
LAST EDITED: JAN 14, 2021
HELP-PROMPT: Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S
DESCRIPTION: This data item records the grade of a solid primary tumor that has been resected following
neoadjuvant therapy.
EXECUTABLE HELP: D HLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,24.6 GRADE POST THERAPY CLIN (YC) 2.3;15 FREE TEXT
INPUT TRANSFORM: K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG
MAXIMUM LENGTH: 1
OUTPUT TRANSFORM: D OT^ONCSCHMG
LAST EDITED: JAN 14, 2021
HELP-PROMPT: Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S
DESCRIPTION: This data item records the grade of a solid primary tumor that has been microscopically sampled
following neoadjuvant therapy or primary systemic/radiation therapy.
EXECUTABLE HELP: D HLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,25 TNM FORM ASSIGNED 7;7 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date on which the TNM form was assigned to the Managing Physician.
DESCRIPTION:
Records the date on which the TNM form was assigned to the Managing Physician.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,25.1 TUMOR MARKER 1 24;2 POINTER TO TUMOR MARKERS FILE (#164.15)
Tumor Marker 1
INPUT TRANSFORM: S DIC("S")="D SCREEN^ONCOTM" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.15,+Y,0)),U,2)
LAST EDITED: FEB 27, 1998
DESCRIPTION:
Record prognostic indicators.
SCREEN: S DIC("S")="D SCREEN^ONCOTM"
EXPLANATION: 4th edition: 0-3, 8, 9. 5th edition: 0-3, 4-6 (Testis only), 8, 9.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,25.2 TUMOR MARKER 2 24;3 POINTER TO TUMOR MARKERS FILE (#164.15)
Tumor Marker 2
INPUT TRANSFORM: S DIC("S")="D SCREEN^ONCOTM" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.15,+Y,0)),U,2)
LAST EDITED: JAN 28, 1998
DESCRIPTION:
Record prognostic indicators.
SCREEN: S DIC("S")="D SCREEN^ONCOTM"
EXPLANATION: 4th edition: 0-3, 8, 9. 5th edition: 0-3, 4-6 (Testis only), 8, 9.
165.5,25.3 TUMOR MARKER 3 24;7 POINTER TO TUMOR MARKERS FILE (#164.15)
Tumor Marker 3
INPUT TRANSFORM: S DIC("S")="D SCREEN^ONCOTM" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.15,+Y,0)),U,2)
LAST EDITED: JAN 28, 1998
DESCRIPTION:
Record LDH prognostic indicators for testicular cancer.
SCREEN: S DIC("S")="D SCREEN^ONCOTM"
EXPLANATION: 4th edition: 0-3, 8, 9. 5th edition: 0-3, 4-6 (Testis only), 8, 9.
165.5,26 DIAGNOSTIC CONFIRMATION 2;6 SET
'1' FOR Positive histology;
'2' FOR Positive cytology;
'3' FOR Pos hist + pos immunophenotyping + pos genetic;
'4' FOR Positive microscopic;
'5' FOR Positive lab test;
'6' FOR Direct visual;
'7' FOR Rad/other imaging;
'8' FOR Clinical dx only;
'9' FOR Unknown;
LAST EDITED: DEC 02, 2009
DESCRIPTION: Records the best method of diagnostic confirmation of the cancer being reported at any time in the
patient's history.
For further information see FORDS 2010 pages 117-119.
165.5,27 HISTO-MORPHOLOGY ; COMPUTED
MUMPS CODE: D HM^ONCOCOM
ALGORITHM: D HM^ONCOCOM
LAST EDITED: JUL 27, 2005
DESCRIPTION: This field displays the HISTOLOGY ICD-O-3 (165.5,22.3) value concatinated with the
GRADE/DIFFERENTIATION (165.5,24) value.
165.5,28 LATERALITY 2;8 SET
'0' FOR Not a paired site;
'1' FOR Right;
'2' FOR Left;
'3' FOR One side involved, right/left not specified;
'4' FOR Bilateral involvement, side of origin unknown;
'5' FOR Paired site, midline tumor;
'9' FOR Paired site, no laterality information;
LAST EDITED: NOV 02, 2009
HELP-PROMPT: Enter the primary site laterality.
DESCRIPTION: Identifies the side of a paired organ or the side of the body on which the reportable tumor
originated. This applies to the primary site only.
For further information see FORDS page 92.
165.5,29 TUMOR SIZE 2;9 NUMBER
INPUT TRANSFORM: D STIT^ONCOOT
OUTPUT TRANSFORM: D STOT^ONCOOT
LAST EDITED: MAR 04, 2004
HELP-PROMPT: Code the exact size of the primary in millimeters (mm).
DESCRIPTION: Describes the largest dimension of the diameter of the primary tumor in millimeters (mm).
Code the exact size of the primary tumor in millimeters (mm).
EXCEPTION:
For melanomas of the skin (C44.0-C44.9), vulva (C51.0-C51.9), penis
(C60.0-C60.9), scrotum (C63.3), and conjunctiva (C69.0):
- code the depth of invasion in HUNDRETHS of millimeters.
- code 989 for melanomas which are 9.89 mm or greater in depth.
Code 998 when the following terms describe tumor involvement in these specific sites:
Esophagus (C15.0-C15.9): Entire circumference Stomach (C16.0-C16.9): Diffuse, widespread, 3/4
or more,
linitis plastica Colorectal (C18.0-C20.9): Familial/multiple polyposis
Lung (C34.0-C34.9): Diffuse, entire lobe of lung Breast (C50.0-C50.9): Inflammatory
carcinoma; diffuse, widespread,
3/4 or more of breast
Code 999, unknown, if only one size is given for a mixed in situ and invasive tumor.
Code 999 if the size of the tumor is unknown or the tumor size is not documented in the patient
record.
Code 999 for histologies or sites where size in not applicable:
Unknown or ill-defined primary (C76.0-C76.8, C80.9) Hematopoietic, reticuloendothelial,
immunoproliferative or
myeloproliferative disease Multiple myeloma (9732) Letterer-Siwe disease (9754)
For further information see FORDS pages 100-101.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,29.1 TUMOR SIZE/EXT EVAL (CS) CS;1 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(3,1,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 1 numeric.
DESCRIPTION: Records how the codes for the two items TUMOR SIZE (CS) and EXTENSION (CS) were determined, based
on the diagnostic methods employed.
EXECUTABLE HELP: D HELP^ONCWEBCS(3,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,29.2 TUMOR SIZE (CS) CS1;10 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(1,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics.
DESCRIPTION: FOR MALIGNANT MELANOMA: Record the size of the tumor in TUMOR SIZE (CS), not depth or thickness.
Depth or thickness is recorded in SITE-SPECIFIC FACTOR 1 (CS).
Records the largest dimension or diameter of the primary tumor, and is always recorded in
millimeters. To convert centimeters to millimeters, multiply the dimension by 10. If tumor size
is given in tenths of millimeters, round down if between .1 and .5 mm, and round up if between .6
and .9 mm.
EXECUTABLE HELP: D HELP^ONCWEBCS(1,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,29.3 TUMOR SIZE SUMMARY 2.1;20 NUMBER
INPUT TRANSFORM: D TSCPSIT^ONCOOT
OUTPUT TRANSFORM: D TSCPSOT^ONCOOT
LAST EDITED: MAR 23, 2017
HELP-PROMPT: Code the most accurate measurement of the primary tumor in millimeters (mm).
DESCRIPTION: Records the most accurate measurement of a solid primary tumor, usually measured on the surgical
resection specimen.
000 No mass/tumor found 001 1 mm or described as less than 1 mm 002-998 Exact size in
millimeters (2mm-998mm) 989 989 mm or larger 990 Microscopic focus or foci only and no
size of focus is given
998 SITE SPECIFIC CODES
Alternate descriptions of tumor size for specific sites:
Familial/multipl polyposis:
Rectosigmoid and rectum (C19.9, C20.9)
Colon (C18.0, C18.2-C18.9)
If no size is documented:
Circumferential:
Esophagus (C15.0-C15.5, C15.8, C15.9)
Diffuse; widespread: 3/4s or more; linitis plastica:
Stomach and Esophagus GE Junction (C16.0-C16.6m, C16.8-C16.9)
Diffuse, entire lung or NOS:
Lung and main stem bronchus (C34.0-C34.3, C34.8-C34.9)
Diffuse:
Breast (C50.0-C50.6, C50.8-C50.9)
999 Unknown; size not stated; Not documented in patient record; Size
of tumor cannot be assessed; Not applicable
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,29.4 TUMOR SIZE CLINICAL 2.1;21 NUMBER
INPUT TRANSFORM: D TSCPSIT^ONCOOT
OUTPUT TRANSFORM: D TSCPSOT^ONCOOT
LAST EDITED: MAR 23, 2017
HELP-PROMPT: Code the size of the solid primary tumor before any treatment in mm.
DESCRIPTION: Records the most accurate measurement of a solid primary tumor, usually measured on the surgical
resection specimen.
000 No mass/tumor found 001 1 mm or described as less than 1 mm 002-998 Exact size in
millimeters (2mm-998mm) 989 989 mm or larger 990 Microscopic focus or foci only and no
size of focus is given
998 SITE SPECIFIC CODES
Alternate descriptions of tumor size for specific sites:
Familial/multipl polyposis:
Rectosigmoid and rectum (C19.9, C20.9)
Colon (C18.0, C18.2-C18.9)
If no size is documented:
Circumferential:
Esophagus (C15.0-C15.5, C15.8, C15.9)
Diffuse; widespread: 3/4s or more; linitis plastica:
Stomach and Esophagus GE Junction (C16.0-C16.6m, C16.8-C16.9)
Diffuse, entire lung or NOS:
Lung and main stem bronchus (C34.0-C34.3, C34.8-C34.9)
Diffuse:
Breast (C50.0-C50.6, C50.8-C50.9)
999 Unknown; size not stated; Not documented in patient record; Size
of tumor cannot be assessed; Not applicable
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,29.5 TUMOR SIZE PATHOLOGIC 2.1;22 NUMBER
INPUT TRANSFORM: D TSCPSIT^ONCOOT
OUTPUT TRANSFORM: D TSCPSOT^ONCOOT
LAST EDITED: MAR 23, 2017
HELP-PROMPT: Code the size of the primary tumor that has been resected in mm.
DESCRIPTION: Records the most accurate measurement of a solid primary tumor, usually measured on the surgical
resection specimen.
000 No mass/tumor found 001 1 mm or described as less than 1 mm 002-998 Exact size in
millimeters (2mm-998mm) 989 989 mm or larger 990 Microscopic focus or foci only and no
size of focus is given
998 SITE SPECIFIC CODES
Alternate descriptions of tumor size for specific sites:
Familial/multipl polyposis:
Rectosigmoid and rectum (C19.9, C20.9)
Colon (C18.0, C18.2-C18.9)
If no size is documented:
Circumferential:
Esophagus (C15.0-C15.5, C15.8, C15.9)
Diffuse; widespread: 3/4s or more; linitis plastica:
Stomach and Esophagus GE Junction (C16.0-C16.6m, C16.8-C16.9)
Diffuse, entire lung or NOS:
Lung and main stem bronchus (C34.0-C34.3, C34.8-C34.9)
Diffuse:
Breast (C50.0-C50.6, C50.8-C50.9)
999 Unknown; size not stated; Not documented in patient record; Size
of tumor cannot be assessed; Not applicable
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,29.9 EXTENSION LIST USED ; COMPUTED
MUMPS CODE: S X=$$GETLIST^ONCODEL(D0,"E","OUT")
ALGORITHM: S X=$$GETLIST^ONCODEL(D0,"E","OUT")
LAST EDITED: JUL 14, 1994
DESCRIPTION: This is a brief description of the SEER extension code list that was selected by the system for
this primary. It is used for audit by print template ONCO PRIMARY EXTENT CODE AUDIT.
165.5,30 EXTENSION 2;10 NUMBER
INPUT TRANSFORM: S ONCOX="E",ONCFLD=30 D IN^ONCODEL
OUTPUT TRANSFORM: S ONCOX="E",ONCFLD=30 D OT^ONCODEL
LAST EDITED: AUG 09, 2001
DESCRIPTION:
Seer Extent of Disease coding schema.
EXECUTABLE HELP: S ONCOX="E",ONCFLD=30 D HP^ONCODEL
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,30.1 PATHOLOGIC EXTENSION 2.2;2 NUMBER
INPUT TRANSFORM: K:(X>99)!(X<0)!(X?.E1"."1N.N) X I $D(X) S ONCOX="E",ONCFLD=30.1 D IN^ONCODEL
OUTPUT TRANSFORM: S ONCOX="E",ONCFLD=30.1 D OT^ONCODEL
LAST EDITED: MAR 25, 1999
DESCRIPTION: Code the farthest documented pathologic extension of tumor from the prostate, either by contiguous
extension or distant metastasis.
EXECUTABLE HELP: S ONCOX="E",ONCFLD=30.1 D HP^ONCODEL
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,30.2 EXTENSION (CS) CS;11 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(2,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics.
DESCRIPTION: Identifies contiguous growth (extension) of the primary tumor within the organ of origin or its
direct extension into neighboring organs.
EXECUTABLE HELP: D HELP^ONCWEBCS(2,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,30.5 PERIPHERAL BLOOD INVOLVEMENT 24;5 SET
'B0' FOR Absence of significant involvement, 5% or less atypical;
'B0a' FOR Clone negative;
'B0b' FOR Clone positive;
'B1' FOR Low blood tumor burden, > 5% atypical;
'B1a' FOR Clone negative;
'B1b' FOR Clone positive;
'B2' FOR High blood tumor burden;
LAST EDITED: DEC 06, 2010
HELP-PROMPT: Enter the code designating the peripheral blood involvement.
DESCRIPTION: Identifies the percentage of circulating atypical cells of T-cell lymphoma. This information may
be found as part of a blood smear differential. It is only associated with an histology of Mycosis
fungoides or Sezary syndrome.
165.5,30.9 LYMPH NODE LIST USED ; COMPUTED
MUMPS CODE: S X=$$GETLIST^ONCODEL(D0,"L","OUT")
ALGORITHM: S X=$$GETLIST^ONCODEL(D0,"L","OUT")
LAST EDITED: JUL 14, 1994
DESCRIPTION: This is a brief description of the SEER lymph node code list that was selected by the system for
this primary. It is used for audit by print template ONCO PRIMARY EXTENT CODE AUDIT.
165.5,31 LYMPH NODES 2;11 NUMBER
INPUT TRANSFORM: S ONCOX="L" D IN^ONCODEL
OUTPUT TRANSFORM: S ONCOX="L" D OT^ONCODEL
LAST EDITED: AUG 09, 2001
HELP-PROMPT: Type a Number between 0 and 9, 0 Decimal Digits
DESCRIPTION:
Record SEER lymph node involvement.
EXECUTABLE HELP: S ONCOX="L" D HP^ONCODEL
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^SS1^MUMPS
1)= D SNHL^ONCOCRC
2)= D KNHL^ONCOCRC
Trigger to set SYSTEMIC SYMPTOMS field #843 for NON-HODGKIN'S LYMPHOMA'S.
165.5,31.1 LYMPH NODES (CS) CS;12 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(4,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics.
DESCRIPTION:
Identifies the regional lymph nodes involved with cancer at the time of diagnosis.
EXECUTABLE HELP: D HELP^ONCWEBCS(4,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,32 REGIONAL LYMPH NODES POSITIVE 2;12 NUMBER
INPUT TRANSFORM: K:X'?1.2N X I $D(X) S X=+X K:X>99!X<0 X I $D(X) K:(X>$P(^ONCO(165.5,D0,2),U,13))&($P(^ONCO(165.5,D0
,2),U,13)<91)&(X<91) X I $D(X) K:($P(^ONCO(165.5,D0,2),U,13)=99)&(X'=99) X I $D(X) D RNPIT^ONCOIT
OUTPUT TRANSFORM: D RNP^ONCOOT
LAST EDITED: APR 22, 2004
HELP-PROMPT: Regional Lymph Nodes Positive cannot exceed Regional Lymph Nodes Examined
DESCRIPTION: Records the exact number of regional lymph nodes examined by the pathologist and found to contain
metastases.
00 All nodes examined are negative. 01-89 1-89 nodes are positive. (Code exact number of
nodes positive)
90 90 or more nodes are positive.
95 Positive aspiration of lymph node(s) was performed.
97 Positive nodes are documented, but the number is unspecified.
98 No nodes were examined.
99 It is unknown whether nodes are positive; not applicable;
not stated in patient record.
For further information see FORDS page 103.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,32.1 LYMPH NODES EVAL (CS) CS;2 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(5,1,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 1 numeric.
DESCRIPTION: Records how the code for the item LYMPH NODES (CS) was determined, based on the diagnostic methods
employed.
EXECUTABLE HELP: D HELP^ONCWEBCS(5,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,33 REGIONAL LYMPH NODES EXAMINED 2;13 NUMBER
INPUT TRANSFORM: K:X'?1.2N X I $D(X) S X=+X K:X>99!(X<0) X I $D(X) D RNEIT^ONCOIT
OUTPUT TRANSFORM: D RNE^ONCOOT
LAST EDITED: NOV 08, 2002
HELP-PROMPT: Allowable Values: 00-90, 95-99
DESCRIPTION: Records the total number of regional lymph nodes examined by the pathologist.
00 No nodes were examined. 01-89 1-89 nodes were examined.
(Code the exact number of regional lymph nodes examined.)
90 90 or more nodes were examined.
95 No regional nodes were removed, but aspiration of regional
nodes was performed.
96 Regional lymph node removal was documented as a sampling,
and the number of nodes is unknown/not stated.
97 Regional lymph node removal was documented as a dissection,
and the number of nodes is unknown/not stated.
98 Regional lymph nodes were surgically removed, but the number
of lymph nodes is unknown/not stated and not documented as a
sampling or dissection; nodes were examined but the number
is unknown.
99 It is unknown whether nodes were examined; not applicable or
negative; not stated in patient record.
For further information see FORDS page 102.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,33.1 #NODES EXAMINED ; COMPUTED
MUMPS CODE: S Y=$P($G(^ONCO(165.5,D0,2)),U,13),X=$S(Y=98:"# Not Specified",Y=99:"Unknown if examined",1:Y)
ALGORITHM: S Y=$P($G(^ONCO(165.5,D0,2)),U,13),X=$S(Y=98:"# Not Specified",Y=99:"Unknown if examined",1:Y)
LAST EDITED: AUG 10, 1993
DESCRIPTION:
RECORD THE NUMBER OF LYMPH NODES EXAMINED BY PATHOLOGIST.
165.5,34 SITE OF DISTANT METASTASIS #1 2;14 SET
'0' FOR None;
'1' FOR Peritoneum;
'2' FOR Lung;
'3' FOR Pleura;
'4' FOR Liver;
'5' FOR Bone;
'6' FOR Central nervous system;
'7' FOR Skin;
'8' FOR Lymph nodes (distant);
'9' FOR Other/Gen/Carcinomatosis/Unkn;
LAST EDITED: FEB 14, 2003
DESCRIPTION: Code only the site(s) of distant metastasis identified during initial diagnosis and workup.
For further information see ROADS pages 131-132.
GROUP: ACOS-REQUIRED
165.5,34.1 SITE OF DISTANT METASTASIS #2 2;15 SET
'0' FOR None;
'1' FOR Peritoneum;
'2' FOR Lung;
'3' FOR Pleura;
'4' FOR Liver;
'5' FOR Bone;
'6' FOR Central nervous system;
'7' FOR Skin;
'8' FOR Lymph nodes (distant);
'9' FOR Other/Gen/Carcinomatosis/Unkn;
LAST EDITED: FEB 14, 2003
DESCRIPTION: Code the second site of distant metastasis identified during initial diagnosis and workup.
For further information see ROADS pages 133-134.
GROUP: ACOS-REQUIRED
165.5,34.2 SITE OF DISTANT METASTASIS #3 2;16 SET
'0' FOR None;
'1' FOR Peritoneum;
'2' FOR Lung;
'3' FOR Pleura;
'4' FOR Liver;
'5' FOR Bone;
'6' FOR Central nervous system;
'7' FOR Skin;
'8' FOR Lymph nodes (distant);
'9' FOR Other/Gen/Carcinomatosis/Unkn;
LAST EDITED: FEB 14, 2003
DESCRIPTION: Code the third site of distant metastasis identified during initial diagnosis and workup.
For further information see ROADS pages 135-136.
GROUP: ACOS-REQUIRED
165.5,34.3 METS AT DX (CS) CS;3 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(8,2,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 2 numerics.
DESCRIPTION:
Identifies the distant site(s) of metastatic involvement at time of diagnosis.
EXECUTABLE HELP: D HELP^ONCWEBCS(8,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,34.31 METS AT DX-BONE CS1;20 SET
'0' FOR None;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: NOV 30, 2009
HELP-PROMPT: Enter whether bone is an involved metastatic site.
DESCRIPTION:
Identifies the presence of distant metastatic involvement of bone at time of diagnosis.
165.5,34.32 METS AT DX-BRAIN CS1;21 SET
'0' FOR None;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: NOV 30, 2009
HELP-PROMPT: Enter whether the brain is an involved metastatic site.
DESCRIPTION:
Identifies the presence of distant metastatic involvement of the brain at time of diagnosis.
165.5,34.33 METS AT DX-LIVER CS1;22 SET
'0' FOR None;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: NOV 30, 2009
HELP-PROMPT: Enter whether the liver is an involved metastatic site.
DESCRIPTION:
Identifies the presence of distant metastatic involvement of the liver at time of diagnosis.
165.5,34.34 METS AT DX-LUNG CS1;23 SET
'0' FOR None;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: NOV 30, 2009
HELP-PROMPT: Enter whether the lung is an involved metastatic site.
DESCRIPTION:
Identifies the presence of distant metastatic involvement of the lung at time of diagnosis.
165.5,34.35 METS AT DX-DISTANT LN CS1;24 SET
'0' FOR None;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: FEB 13, 2017
HELP-PROMPT: Enter whether distant lymph nodes are an involved metastatic site.
DESCRIPTION: Identifies the presence of distant metastatic involvement of the distant lymph nodes at time of
diagnosis.
165.5,34.36 METS AT DX-OTHER CS1;25 SET
'0' FOR None;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: FEB 13, 2017
HELP-PROMPT: Enter whether there is any other involved metastatic site.
DESCRIPTION: Identifies the presence of distant metastatic involvement other than bone, brain, liver, lung or
distant lymph nodes at time of diagnosis.
165.5,34.4 METS EVAL (CS) CS;4 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(9,1,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 1 numeric.
DESCRIPTION: Records how the code for the item METS AT DX (CS) was determined based on the diagnostic methods
employed.
EXECUTABLE HELP: D HELP^ONCWEBCS(9,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,35 SEER SUMMARY STAGE 2000 2;17 SET
'0' FOR In situ;
'1' FOR Localized;
'2' FOR Regional by direct extension;
'3' FOR Regional to lymph nodes;
'4' FOR Regional by extension & to nodes;
'5' FOR Regional, NOS;
'7' FOR Distant metastasis/systemic disease;
'8' FOR NA/Benign;
'9' FOR Unknown;
LAST EDITED: SEP 08, 2015
HELP-PROMPT: Enter the code which indicates the extent of disease at time of diagnosis.
DESCRIPTION: Provides a site-specific description of the extent of disease at diagnosis.
For further information see FORDS page 124.
SCREEN: S DIC("S")="I ('$$LYMPHOMA^ONCFUNC(D0))!((Y'=0)&(Y'=2)&(Y'=3)&(Y'=4)&(Y'=8))"
EXPLANATION: Codes 0, 2, 3, 4 and 8 are not valid for HODGKIN AND NON-HODGKIN LYMPHOMAS.
GROUP: ACOS-REQUIRED
165.5,35.1 SEER SUMMARY STAGE ABBREVIATED ; COMPUTED
MUMPS CODE: S X="" D GSS^ONCOCOS
ALGORITHM: S X="" D GSS^ONCOCOS
LAST EDITED: DEC 19, 2006
DESCRIPTION:
This item abbreviates the SEER SUMMARY STAGE 2000 (165.5,35) output values for condensed display.
165.5,36 AJCC STAGING BASIS 2;18 SET
AJCC Staging Basis
'C' FOR Clinical-diagnostic;
'P' FOR Pathological (Post-surgical);
'R' FOR Retreatment Staging;
'A' FOR Autopsy;
'S' FOR Surgical Evaluative;
LAST EDITED: JUL 02, 1993
DESCRIPTION: Record the most appropriate code to reflect the basis on which the case was staged.
Clinical-diagnostic staging is used for those sites that are accessible, i.e. cervix, oral cavity,
larynx, and for those organs where evaluation of extent must be made only on the basis of
clinical-diagnostic findings. Clinical-diagnostic staging is based on the physical examination,
diagnostic imaging, clinical pathology, and biopsy of the primary.
Postsurgical pathological staging is a combination of all findings - clinical-diagnostic,
surgical-evaluative, and postsurgical retreatment-pathological.
TECHNICAL DESCR:
This field is referenced direction by PATHSTAG^ONCOU55.
SOURCE OF DATA: ACOS 3.53
GROUP: ACOS-REQUIRED
165.5,37 TNM CLINICAL ; COMPUTED
MUMPS CODE: S STGIND="C",X=$$TNMOUT^ONCOTNO(D0)
9.2 = S Y(165.5,37,2)=$S($D(^ONCO(165.5,D0,2)):^(2),1:"") S X="T",Y(165.5,37,1)=X,Y(165.5,37,3)=X,Y
=$P(Y(165.5,37,2),U,25) X:$D(^DD(165.5,37.1,2)) ^(2) S X=Y
9.3 = X ^DD(165.5,37,9.2) S Y=X,X=Y(165.5,37,1),X=X_Y_" N",Y(165.5,37,4)=X,Y(165.5,37,5)=X,Y=$P(Y(1
65.5,37,2),U,26) X:$D(^DD(165.5,37.2,2)) ^(2) S X=Y
9.4 = X ^DD(165.5,37,9.3) S Y=X,X=Y(165.5,37,4),X=X_Y_" M",Y(165.5,37,6)=X,Y(165.5,37,7)=X,Y=$P(Y(1
65.5,37,2),U,27) X:$D(^DD(165.5,37.3,2)) ^(2) S X=Y
ALGORITHM: S STGIND="C",X=$$TNMOUT^ONCOTNO(D0)
LAST EDITED: DEC 14, 2005
HELP-PROMPT: Use 6-12 characters, e.g. T1N0M0, T2aN1bM0, or T3NXMX
DESCRIPTION:
This is the combined Clinical T, N, and M codes, formatted for display.
SOURCE OF DATA: ACOS 3.54
GROUP: ACOS-REQUIRED
165.5,37.1 CLINICAL T 2;25 FREE TEXT
INPUT TRANSFORM: I $D(X) K:$L(X)>4!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="T",STGIND="C" D IN^ONCOTNM
MAXIMUM LENGTH: 4
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 23, 2017
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known
prior to the start of any therapy.
EXECUTABLE HELP: N ONCOX,STGIND S ONCOX="T",STGIND="C" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,37.2 CLINICAL N 2;26 FREE TEXT
INPUT TRANSFORM: K:$L(X)>8!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="N",STGIND="C" D IN^ONCOTNM
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 23, 2017
HELP-PROMPT: Answer must be 1-8 characters in length.
DESCRIPTION: Identifies the absence or presence of regional lymph node (N) metastasis and describes the extent
of regional lymph node metastasis of the tumor known prior to the start of any therapy.
EXECUTABLE HELP: N ONCOX,STGIND S ONCOX="N",STGIND="C" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,37.3 CLINICAL M 2;27 FREE TEXT
INPUT TRANSFORM: K:$L(X)>8!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="M",STGIND="C" D IN^ONCOTNM
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 23, 2017
HELP-PROMPT: Answer must be 1-8 characters in length.
DESCRIPTION: Identifies the presence or absence of distant metastasis (M) of the tumor known prior to the start
of any therapy.
EXECUTABLE HELP: N ONCOX,STGIND S ONCOX="M",STGIND="C" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,37.9 AUTOMATIC STAGING OVERRIDDEN 24;1 SET
'1' FOR Yes;
'0' FOR No;
LAST EDITED: JUL 20, 1993
DESCRIPTION:
This field is set to 'Yes' by the abstracting option if the operator overrides automatic staging.
TECHNICAL DESCR:
This field is referenced directly by input template ONCO ABSTRACT-I.
165.5,38 STAGE GROUP CLINICAL 2;20 FREE TEXT
INPUT TRANSFORM: K:X[""""!($A(X)=45) X I $D(X) S ONCOX="S",STGIND="C" D IN^ONCOTNS I $D(X) D INNUM^ONCOTNS
OUTPUT TRANSFORM: S X="" D OT^ONCOTNS
LAST EDITED: DEC 14, 2005
DESCRIPTION: Identifies the anatomic extent of disease based on the T , N, and M elements as recorded by the
physician.
For futher information see FORDS page 115.
EXECUTABLE HELP: S ONCOX="S",STGIND="C" D HP^ONCOTNS
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AS1^MUMPS
1)= D CSSG^ONCOCRC
2)= D KSG^ONCOCRC
Maintains STAGE GROUPING-AJCC Field (#38.5).
165.5,38.1 GP-I AJCC SUMMARY STAGE ; COMPUTED
MUMPS CODE: S X="" D SSG1^ONCOCOS
ALGORITHM: S X="" D SSG1^ONCOCOS
LAST EDITED: OCT 29, 1990
DESCRIPTION:
RECORD THE AJCC STAGE.
165.5,38.2 GP-II AJCC SUMMARY STAGE ; COMPUTED
MUMPS CODE: S X="" D SSG2^ONCOCOS
ALGORITHM: S X="" D SSG2^ONCOCOS
DESCRIPTION:
RECORD THE AJCC STAGE.
165.5,38.3 GP-III AJCC SUMMARY STAGE ; COMPUTED
MUMPS CODE: S X="" D SSG3^ONCOCOS
ALGORITHM: S X="" D SSG3^ONCOCOS
DESCRIPTION:
RECORD THE AJCC STAGE.
165.5,38.4 GP-IV AJCC SUMMARY STAGE ; COMPUTED
MUMPS CODE: S X="" D SSG4^ONCOCOS
ALGORITHM: S X="" D SSG4^ONCOCOS
DESCRIPTION:
RECORD THE AJCC STAGE.
165.5,38.5 STAGE GROUPING-AJCC 2;28 SET
'0' FOR 0;
'I' FOR I;
'II' FOR II;
'III' FOR III;
'IV' FOR IV;
'U' FOR Unk/Uns;
'NA' FOR NA;
LAST EDITED: APR 06, 2021
DESCRIPTION: This field is set by either the CLINICAL STAGE GROUP (38) or PATHOLOGIC STAGE GROUP (88) field
depending on which takes precedence. For 2018+ cases the AJCC TNM CLIN STAGE GROUP (5004) and AJCC
TNM PATH STAGE GROUP (5014) fields will be used instead. This field consists of the more general
stage group values of 0, I, II, III, IV, Unk/Uns or NA.
CROSS-REFERENCE: 165.5^ASG
1)= S ^ONCO(165.5,"ASG",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"ASG",$E(X,1,30),DA)
Indexes file by STAGE GROUPING-AJCC.
165.5,39 OTHER STAGING SYSTEM 2;21 POINTER TO OTHER STAGING FOR ONCOLOGY FILE (#164.3)
INPUT TRANSFORM: S DIC("S")="I (($P(^ONCO(165.5,DA,0),U,16)<3070000)!((Y>74)&(Y<78))!((Y>94)&(Y<100))!(Y>108))&((Y'=
29)&(Y'=30)&(Y'=31)&(Y'=32)&(Y'=33))" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
LAST EDITED: FEB 12, 2009
HELP-PROMPT: Enter an additional staging classification.
DESCRIPTION: OTHER STAGING SYSTEM allows institutions the opportunity to collect additional staging
classifications, for example, CDS, RAI, DS or FAB.
SCREEN: S DIC("S")="I (($P(^ONCO(165.5,DA,0),U,16)<3070000)!((Y>74)&(Y<78))!((Y>94)&(Y<100))!(Y>108))&((Y'=
29)&(Y'=30)&(Y'=31)&(Y'=32)&(Y'=33))"
EXPLANATION: For 2007+ cases choose from CDS, RAI, DS or FAB entries.
165.5,40 STAGE GROUP BEST ; COMPUTED
MUMPS CODE: S X="" D OT1^ONCOTNS
ALGORITHM: S X="" D OT1^ONCOTNS
LAST EDITED: DEC 14, 2005
DESCRIPTION: This field displays the "best" stage group as determined by the clinical/pathological hierarchy
rules.
165.5,40.1 TNM BEST ; COMPUTED
MUMPS CODE: S X="" D OT1^ONCOTNS S X=HIERTNM
ALGORITHM: S X="" D OT1^ONCOTNS S X=HIERTNM
LAST EDITED: DEC 14, 2005
DESCRIPTION: This field displays the "best" TNM string as determined by the clinical/pathological hierarchy
rules.
165.5,40.2 STAGED BY ; COMPUTED
MUMPS CODE: S X="" D STGBY^ONCOTNS
ALGORITHM: S X="" D STGBY^ONCOTNS
LAST EDITED: APR 23, 2003
DESCRIPTION: Choose from:
0 Not staged
1 Managing MD
2 Pathologist
3 Pathologist & managing MD
4 Committee chair, liaison MD, registry advisor
5 Registrar
6 Registrar & MD
7 Another facility
8 NA
9 Unknown
165.5,41 ASSOCIATED WITH HIV 2;23 SET
'1' FOR Yes;
'2' FOR No;
'999' FOR Unknown;
LAST EDITED: JUL 14, 1997
DESCRIPTION:
Record the presence/absence of HIV.
165.5,42 TREATMENT ABBREVIATED ; COMPUTED
MUMPS CODE: S X="" D TXS^ONCOCOS
ALGORITHM: S X="" D TXS^ONCOCOS
LAST EDITED: JUL 10, 2006
DESCRIPTION: TREATMENT ABBREVIATED lists the type(s) of therapies intended to modify or control the malignancy.
All cancer-directed therapies specified in TREATMENT ABBREVIATED are a part of the FIRST COURSE OF
TREATMENT.
The therapies have been abbreviated to a 1-character designation:
S - SURGERY OF PRIMARY SITE (F)
R - RADIATION
P - RADIATION THERAPY TO CNS
C - CHEMOTHERAPY
H - HORMONE THERAPY
B - IMMUMOTHERAPY
O - OTHER TREATMENT
E - HEMA TRANS/ENDOCRINE PROC
165.5,43 TREATMENT ; COMPUTED
MUMPS CODE: S X="" D TX^ONCOCOS
ALGORITHM: S X="" D TX^ONCOCOS
LAST EDITED: MAY 02, 1996
DESCRIPTION:
The treatment given to a patient, either curative or palliative in nature.
165.5,44 TNM FORM COMPLETED 7;14 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT K:Y<1 X I $D(X) S %DT="E",%DT(0)=$$GE
T1^DIQ(165.5,D0,25,"I") S:(%DT(0)="0000000")!(%DT(0)=8888888)!(%DT(0)=9999999) %DT(0)="-NOW" D ^%DT
K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 25, 2009
HELP-PROMPT: Enter the date on which the TNM form was completed by the Managing Physician. This date must be
greater than or equal to TNM FORM ASSIGNED and may not be a future date.
DESCRIPTION:
Records the date on which the TNM form was completed by the Managing Physician.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.1 SSF1 CS;5 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(10,3,D0)
MAXIMUM LENGTH: 30
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(10,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.101 SSF10 CS2;4 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(19,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(19,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.11 SSF11 CS2;5 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(20,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(20,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.12 SSF12 CS2;6 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(21,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(21,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.13 SSF13 CS2;7 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(22,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(22,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.14 SSF14 CS2;8 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(23,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(23,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.15 SSF15 CS2;9 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(24,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(24,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.16 SSF16 CS2;10 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(25,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(25,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.17 SSF17 CS2;11 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(26,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(26,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.18 SSF18 CS2;12 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(27,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(27,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.19 SSF19 CS2;13 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(28,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(28,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.2 SSF2 CS;6 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(11,3,D0)
MAXIMUM LENGTH: 30
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(11,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.201 SSF20 CS2;14 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(29,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(29,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.21 SSF21 CS2;15 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(30,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(30,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.22 SSF22 CS2;16 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(31,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(31,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.23 SSF23 CS2;17 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(32,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(32,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.24 SSF24 CS2;18 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(33,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(33,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.25 SSF25 CS2;19 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(34,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(34,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the CS SCHEMA DISCRIMINATOR field of the ONCOLOGY PRIMARY File
165.5,44.3 SSF3 CS;7 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(12,3,D0)
MAXIMUM LENGTH: 30
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(12,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.4 SSF4 CS;8 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(13,3,D0)
MAXIMUM LENGTH: 30
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(13,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.5 SSF5 CS;9 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(14,3,D0)
MAXIMUM LENGTH: 30
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(14,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.6 SSF6 CS;10 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(15,3,D0)
MAXIMUM LENGTH: 30
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(15,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.7 SSF7 CS2;1 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(16,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(16,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.8 SSF8 CS2;2 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(17,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(17,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,44.9 SSF9 CS2;3 FREE TEXT
INPUT TRANSFORM: D INPUT^ONCWEBCS(18,3,D0)
MAXIMUM LENGTH: 30
LAST EDITED: FEB 27, 2024
HELP-PROMPT: Answer must be 3 numerics, no decimal places.
DESCRIPTION: Identifies additional information needed to generate stage, or prognostic factors that have an
effect on stage or survival.
EXECUTABLE HELP: D HELP^ONCWEBCS(18,D0)
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,45 PERFORMANCE STATUS 2;24 SET
'100' FOR NORMAL;
'90' FOR MINOR SYMTOMS;
'80' FOR ACTIVITY W EFFORT;
'70' FOR NO WORK/SELF CARE;
'60' FOR OCCASIONAL ASSIST;
'50' FOR CONSIDERABLE ASSIST;
'40' FOR DISABLED/SPECIAL CARE;
'30' FOR SEVERLY DISABLED/HOSP;
'20' FOR VERY SICK/HOSP;
'10' FOR MORIBUND;
'0' FOR DEAD;
LAST EDITED: SEP 23, 1992
HELP-PROMPT: Enter Performance Status
DESCRIPTION:
This is the performance status of the patient.
165.5,46 CAP PROTOCOL REVIEW 7;19 SET
'0' FOR Failed;
'1' FOR Complied;
'9' FOR NA or exempt;
LAST EDITED: JUL 13, 2006
DESCRIPTION: The ACS (American College of Surgeons) requires CAP (College of American Pathologists) Protocol
Review of cases with surgical resection only. Biopsy only cases are exempt from review.
Records whether this case failed, complied with or was exempt from CAP Protocol Review.
To use code 1 (Complied), ALL elements of the CAP Cancer Protocol Checklist must be documented on
the pathology report.
165.5,47 CAP TEXT 7;20 FREE TEXT
INPUT TRANSFORM: K:$L(X)>50!($L(X)<1) X
LAST EDITED: JUL 19, 2006
HELP-PROMPT: Answer must be 1-50 characters in length.
DESCRIPTION:
Records the reason for CAP (College of American Pathologists) Protocol non-compliance.
165.5,48 OTHER PRIMARY SITES ; COMPUTED
MUMPS CODE: S X="" D SDP^ONCOCOM
ALGORITHM: S X="" D SDP^ONCOCOM
LAST EDITED: JUL 13, 1990
DESCRIPTION:
SITES OTHER THAN THE COMMON CANCER SITES ARE LISTED.
165.5,49 FIRST COURSE OF TREATMENT DATE ; COMPUTED
MUMPS CODE: S X="" D DFC^ONCOCOM
ALGORITHM: S X="" D DFC^ONCOCOM
LAST EDITED: AUG 04, 1997
DESCRIPTION: Records the date on which treatment (surgery, radiation, systemic, or other therapy) of the patient
begain at any facility.
For further information see FORDS pages 129-130.
165.5,49.1 FIRST TREATMENT DT-DATE DX ; COMPUTED
MUMPS CODE: S X="" D DDX^ONCOCOM
ALGORITHM: S X="" D DDX^ONCOCOM
LAST EDITED: OCT 28, 2014
DESCRIPTION:
A computed field derives from FIRST COURSE OF TREATMENT DATE minus DATE DX.
TECHNICAL DESCR:
This is a computed field derives from FIRST COURSE OF TREATMENT DATE minus DATE DX.
165.5,49.9 DATE INITIAL RX SEER ; COMPUTED
MUMPS CODE: S X="" D DRXS^ONCOCOM
ALGORITHM: S X="" D DRXS^ONCOCOM
LAST EDITED: FEB 09, 2022
DESCRIPTION: Records the date of initiation of the first course therapy for the tumor being reported, using the
SEER definition of first course.
165.5,50 MOST DEFINITIVE SURG DATE 3;1 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: NOV 09, 2004
HELP-PROMPT: *** MOST DEFINITIVE SURG DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Records the date of the most definitive surgical resection of the primary site performed as part
of the first course of treatment.
For further information see FORDS pages 133-134.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATS^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"S1")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"S1")
Records most definitive surgical resection of the primary on the unified treatment index.
165.5,50.1 SURGERY HOSPITAL 3;2 POINTER TO FACILITY FILE (#160.19)
Surgery hospital
INPUT TRANSFORM: S V="" D NT^ONCODSR
OUTPUT TRANSFORM: S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
LAST EDITED: MAR 02, 1998
HELP-PROMPT: Record the name of the institution providing treatment.
DESCRIPTION:
Record the name of the institution providing treatment.
EXECUTABLE HELP: D HELP^ONCOFLF
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,50.2 SURGERY OF PRIMARY @FAC (R) 3.1;7 FREE TEXT
INPUT TRANSFORM: S FIELD=50.2,SPSFLG=0 D SPSDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X),SPSFLG=0 S NTXDD=1
D SPSIT^ONCOSUR
OUTPUT TRANSFORM: S FIELD=50.2 D SPSOT^ONCOSUR
LAST EDITED: MAR 27, 2003
DESCRIPTION: Records the surgical procedure(s) performed to the primary site at this facilty.
For further information see ROADS page 190.
EXECUTABLE HELP: S FIELD=50.2 D SPSHP^ONCOSUR
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AT^MUMPS
1)= Q
2)= D SPSATF^ONCDTX1
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,50.3 MOST DEFINITIVE SURG @FAC DATE 3.1;8 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: NOV 09, 2004
HELP-PROMPT: *** MOST DEFINITIVE SURG @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Records the date of the most definitive surgical resection of the primary site performed as part
of the first course of treatment at this facility.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,51 DATE RADIATION STARTED 3;4 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JAN 28, 2003
HELP-PROMPT: *** DATE RADIATION STARTED MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Records the date on which radiation therapy began at any facility that is part of the first course
of treatment.
For further information see FORDS pages 148-149.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATR^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"R")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"R")
Records radiation date on the unified treatment index.
165.5,51.1 RADIATION HOSPITAL 3;5 POINTER TO FACILITY FILE (#160.19)
INPUT TRANSFORM: S V="" D NT^ONCODSR
OUTPUT TRANSFORM: S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
LAST EDITED: SEP 02, 1997
HELP-PROMPT: Enter Facility performing Radiation Therapy
DESCRIPTION:
Record the name of the institution administering the therapy.
EXECUTABLE HELP: D HELP^ONCOFLF
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,51.2 RADIATION 3;6 SET
'0' FOR None;
'1' FOR Beam radiation;
'2' FOR Radioactive implants;
'3' FOR Radioisotopes;
'4' FOR Beam + implants or radioisotopes;
'5' FOR Radiation, NOS;
'7' FOR Refused radiation;
'8' FOR Recommended, unknown if given;
'9' FOR Unknown if administered;
INPUT TRANSFORM: S V=0 D NT^ONCODSR
LAST EDITED: SEP 12, 1997
DESCRIPTION: Record the type of radiation administered to the primary site or any metastatic site. Include all
procedures that are part of the first course of treatment, whether delivered at the reporting
institution or at other institutions.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"
EXPLANATION: Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.
GROUP: ACOS-REQUIRED
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AJ^MUMPS
1)= Q
2)= D RAD^ONCDTX
When the value of this field is deleted, the KILL logic will delete the following associated field
values:
DATE RADIATION STARTED (165.5,51) LOCATION OF RADIATION TX (165.5,126) RADIATION
TREATMENT VOLUME (165.5,125) REGIONAL TREATMENT MODALITY (165.5,363) REGIONAL DOSE:cGy
(165.5,442) BOOST TREATMENT MODALITY (165.5,363.1) BOOST DOSE:cGy (165.5,443)
NUMBER OF TXS TO THIS VOLUME (165.5,56) RADIATION/SURGERY SEQUENCE (165.5,51.3) DATE RADIATION
ENDED (165.5,361) REASON FOR NO RADIATION (165.5,75) RX TEXT-RADIATION
(165.5,109)
165.5,51.3 RADIATION/SURGERY SEQUENCE 3;7 SET
'0' FOR No rad and/or surgery;
'2' FOR Rad before surgery;
'3' FOR Rad after surgery;
'4' FOR Rad both before/after surgery;
'5' FOR Intraoperative rad;
'6' FOR Intraoperative rad w rad before/after surgery;
'9' FOR Sequence unknown;
INPUT TRANSFORM: S V=0 D NT^ONCODSR
LAST EDITED: SEP 02, 1997
DESCRIPTION: Records the sequencing of radiation and surgical procedures given as part of the first course of
treatment.
For further information see FORDS pages 164-165.
GROUP: ACOS-RECOMMENDED
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,51.4 RADIATION @FACILITY 3.1;12 SET
'0' FOR None;
'1' FOR Beam radiation;
'2' FOR Radioactive implants;
'3' FOR Radioisotopes;
'4' FOR Beam + implants or radioisotopes;
'5' FOR Radiation, NOS;
'7' FOR Refused radiation;
'8' FOR Recommended, unknown if given;
'9' FOR Unknown if administered;
INPUT TRANSFORM: S V=0 D NT^ONCODSR
LAST EDITED: OCT 01, 1998
HELP-PROMPT: Enter the type of radiation administered to the primary site or any metastatic site at this
facility
DESCRIPTION: Records the type of radiation administered to the primary site or any metastatic site AT THIS
FACILITY. Includes all procedures that are part of the first course of treatment.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"
EXPLANATION: Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AU^MUMPS
1)= Q
2)= D RADATF^ONCDTX1
NOREINDEX)= 1
When the value of this field is deleted, the KILL logic will delete the following associated field
value:
RADIATION @FACILITY DATE (165.5,51.5)
165.5,51.5 RADIATION @FACILITY DATE 3.1;13 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JAN 21, 1999
HELP-PROMPT: *** RADIATION DATE AT THIS FACILITY MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Record the date that the first course of radiation therapy performed AT THIS FACILITY was started.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,52 RADIATION THERAPY TO CNS DATE 3;8 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: OCT 24, 2005
HELP-PROMPT: *** RADIATION THERAPY TO CNS DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: FOR LUNG AND LEUKEMIA ONLY: record the date radiation therapy to the brain and CNS was initiated.
ALL OTHER SITES: not a valid entry.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATP^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"P")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"P")
Records brain/CNS radiation date on the unified treatment index.
165.5,52.1 RADIATION THERAPY TO CNS HOSP 3;9 POINTER TO FACILITY FILE (#160.19)
INPUT TRANSFORM: S V="" D NT^ONCODSR
OUTPUT TRANSFORM: S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
LAST EDITED: SEP 02, 1997
HELP-PROMPT: Enter Facility giving the treatment.
DESCRIPTION: Record the name of the institution administering the therapy. This field is used only for LUNGS
and LEUKEMIAS.
EXECUTABLE HELP: D HELP^ONCOFLF
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,52.2 RADIATION THERAPY TO CNS 3;10 SET
'0' FOR No radiation to CNS;
'1' FOR Radiation;
'7' FOR Patient refused radiation;
'8' FOR Radiation recommended, unk if admin;
'9' FOR Unknown/NA;
INPUT TRANSFORM: S V=0 D NT^ONCODSR
LAST EDITED: AUG 11, 2003
HELP-PROMPT: Code '9' unless this is a lung or leukemia case
DESCRIPTION: These data are being kept for historical purposes. Do not code for cases diagnosed as of January
1, 1996. Case diagnosed on or after January 1, 1996 should be coded in the field RADIATION.
Radiation treatment to the central nervous system (CNS) codes 0-8 are valid only for patients with
lung or leukemia primaries. Code 9 (Unknown/NA) for all other cases.
GROUP: SEER
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,53 CHEMOTHERAPY DATE 3;11 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 11, 1998
HELP-PROMPT: *** CHEMOTHERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Record the date first course of CHEMOTHERAPY was started.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATC^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"C")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"C")
Records chemotheraphy date on the unified treatment index.
165.5,53.1 CHEMOTHERAPY HOSPITAL 3;12 POINTER TO FACILITY FILE (#160.19)
INPUT TRANSFORM: S V="" D NT^ONCODSR
OUTPUT TRANSFORM: S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
LAST EDITED: SEP 19, 1997
HELP-PROMPT: Enter the institution where CHEMOTHERPY was administered.
DESCRIPTION: Record the name of the institution where CHEMOTHERAPY was given.
EXECUTABLE HELP: D HELP^ONCOFLF
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,53.2 CHEMOTHERAPY 3;13 SET
'00' FOR None;
'01' FOR Chemotherapy, NOS;
'02' FOR Single-agent;
'03' FOR Multiagent;
'82' FOR Not administered/contraindicated;
'85' FOR Pt died prior to tx;
'86' FOR Recommended, not admin, no reason given;
'87' FOR Refusal;
'88' FOR Recommended, unknown if admin;
'99' FOR Unknown;
LAST EDITED: SEP 09, 2003
DESCRIPTION: Records the type of chemotherapy administered as first course of treatment at this and at all
other facilities. If chemotherapy was not administered, then this item records the reason it was
not administered to the patient. Chemotherapy consists of a group of anticancer drugs that inhibit
the reproduction of cancer cells by interfering with DNA synthesis and mitosis.
For further information see FORDS pages 171-172.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"
EXPLANATION: Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.
GROUP: ACOS-REQUIRED
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AM^MUMPS
1)= Q
2)= D CHE^ONCDTX
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,53.3 CHEMOTHERAPY @FAC 3.1;14 SET
'00' FOR None;
'01' FOR Chemotherapy, NOS;
'02' FOR Single-agent;
'03' FOR Multiagent;
'82' FOR Not administered/contraindicated;
'85' FOR Pt died prior to tx;
'86' FOR Recommended, not admin, no reason given;
'87' FOR Refusal;
'88' FOR Recommended, unknown if admin;
'99' FOR Unknown;
LAST EDITED: FEB 11, 2016
HELP-PROMPT: Enter the type of chemotherapy administered as first course of treatment at this facility
DESCRIPTION: Records the type of chemotherapy administered as first course of treatment at this facility. If
chemotherapy was not administered, then this item records the reason it was not administered to the
patient. Chemotherapy consists of a group of anticancer drugs that inhibit the reproduction of
cancer cells by interfering with DNA synthesis and mitosis.
For further information see FORDS pages 173-174.
CROSS-REFERENCE: 165.5^AV^MUMPS
1)= Q
2)= D CHEMATF^ONCDTX1
NOREINDEX)= 1
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,53.4 CHEMOTHERAPY @FAC DATE 3.1;15 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: FEB 25, 2003
HELP-PROMPT: *** CHEMOTHERAPY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
Record the date chemotherapy was administered as first course of treatment at this facility.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,54 HORMONE THERAPY DATE 3;14 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 11, 1998
HELP-PROMPT: *** HORMONE THERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Record the date HORMONE THERAPY was started.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATH^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"H")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"H")
Records hormone therapy date on the unified treatment index.
165.5,54.1 HORMONE THERAPY HOSPITAL 3;15 POINTER TO FACILITY FILE (#160.19)
INPUT TRANSFORM: S V="" D NT^ONCODSR
OUTPUT TRANSFORM: S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
LAST EDITED: OCT 03, 1997
HELP-PROMPT: Enter Hospital where Hormone Therapy was performed.
DESCRIPTION:
Record the name of the institution that administered the hormone therapy.
EXECUTABLE HELP: D HELP^ONCOFLF
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,54.2 HORMONE THERAPY 3;16 SET
'00' FOR None;
'01' FOR Hormone therapy;
'82' FOR Not administered/contraindicated;
'85' FOR Pt died prior to tx;
'86' FOR Recommended, not admin, no reason given;
'87' FOR Refusal;
'88' FOR Recommended, unknown if admin;
'99' FOR Unknown;
LAST EDITED: SEP 09, 2003
DESCRIPTION: Records the type of hormone therapy administered as first course treatment at this and all other
facilities. If hormone therapy was not administered, then this item records the reason it was not
administered to the patient. Hormone therapy consists of a group of drugs that may affect the
long-term control of a cancer's growth. It is not usually used as a curative measure.
For further information see FORDS pages 175-176.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"
EXPLANATION: Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.
GROUP: ACOS-REQUIRED
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AN^MUMPS
1)= Q
2)= D HOR^ONCDTX
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,54.3 HORMONE THERAPY @FAC 3.1;16 SET
'00' FOR None;
'01' FOR Hormone therapy;
'82' FOR Not administered/contraindicated;
'85' FOR Pt died prior to tx;
'86' FOR Recommended, not admin, no reason given;
'87' FOR Refusal;
'88' FOR Recommended, unknown if admin;
'99' FOR Unknown;
LAST EDITED: JUN 29, 2006
HELP-PROMPT: Enter the type of hormone therapy administered as first course of treatment at this facility
DESCRIPTION: Records the type of hormone therapy administered as first course treatment at this facility. If
hormone therapy was not administered, then this item records the reason it was not administered to
the patient. Hormone therapy consists of a group of drugs that may affect the long-term control of
a cancer's growth. It is not usually used as a curative measure.
For further information see FORDS pages 177-178.
CROSS-REFERENCE: 165.5^AW^MUMPS
1)= Q
2)= D HORATF^ONCDTX1
NOREINDEX)= 1
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,54.4 HORMONE THERAPY @FAC DATE 3.1;17 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: FEB 25, 2003
HELP-PROMPT: *** HORMONE THERAPY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
Records the date hormone therapy was administered as first course of treatment at this facility.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,55 IMMUNOTHERAPY DATE 3;17 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 11, 1998
HELP-PROMPT: *** IMMUNOTHERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
The date immunotherapy was started.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATB^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"B")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"B")
Records biological response modifier date on the unified treatment index.
165.5,55.1 IMMUNOTHERAPY HOSPITAL 3;18 POINTER TO FACILITY FILE (#160.19)
INPUT TRANSFORM: S V="" D NT^ONCODSR
OUTPUT TRANSFORM: S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
LAST EDITED: SEP 23, 1997
HELP-PROMPT: Record the ACOS number of the institution where immunotherapy was performed.
DESCRIPTION:
The ACOS number of the institution where immunotherapy was performed.
EXECUTABLE HELP: D HELP^ONCOFLF
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,55.2 IMMUNOTHERAPY 3;19 SET
'00' FOR None;
'01' FOR Immunotherapy;
'82' FOR Not administered/contraindicated;
'85' FOR Pt died prior to tx;
'86' FOR Recommended, not admin, no reason given;
'87' FOR Refusal;
'88' FOR Recommended, unknown if admin;
'99' FOR Unknown;
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: SEP 09, 2003
DESCRIPTION: Records the type of immunotherapy administered as first course treatment at this and all other
facilities. If immunotherapy was not administered, then this item records the reason it was not
administered to the patient. Immunotherapy consists of biological or chemical agents that alter
the immune system or change the host's response to the tumor cells.
For further information see FORDS pages 179-180.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)>2951231)!((Y'=3)&(Y'=4)&(Y'=5)&(Y'=6))"
EXPLANATION: Codes 3, 4, 5 and 6 should only be used for primaries with a DATE DX > 12/31/95.
GROUP: ACOS-REQUIRED
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AO^MUMPS
1)= Q
2)= D IMM^ONCDTX
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,55.3 IMMUNOTHERAPY @FAC 3.1;18 SET
'00' FOR None;
'01' FOR Immunotherapy;
'82' FOR Not administered/contraindicated;
'85' FOR Pt died prior to tx;
'86' FOR Recommended, not admin, no reason given;
'87' FOR Refusal;
'88' FOR Recommended, unknown if admin;
'99' FOR Unknown;
LAST EDITED: JAN 29, 2003
HELP-PROMPT: Enter the type of immunotherapy administered as first course of treatment at this facility
DESCRIPTION: Records the type of immunotherapy administered as first course treatment at this facility. If
immunotherapy was not administered, then this item records the reason it was not administered to
the patient. Immunotherapy consists of biological or chemical agents that alter the immune system
or change the host's response to the tumor cells.
For further information see FORDS page 181.
CROSS-REFERENCE: 165.5^AX^MUMPS
1)= Q
2)= D IMMATF^ONCDTX1
NOREINDEX)= 1
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,55.4 IMMUNOTHERAPY @FAC DATE 3.1;19 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: FEB 25, 2003
HELP-PROMPT: *** IMMUNOTHERAPY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
Records the date immunotherapy was administered as first course of treatment at this facility.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,56 NUMBER OF TXS TO THIS VOLUME 3;20 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X I $D(X) S V=0 D NT^ONCODSR
OUTPUT TRANSFORM: S Y=$S(Y="000":"None",Y=999:"Unknown",1:Y)
LAST EDITED: JUL 14, 2010
HELP-PROMPT: Type a Number between 0 and 999, 0 Decimal Digits
DESCRIPTION: Records the total number of treatment sessions (fractions) administered during the first course of
treatment.
For further information see FORDS page 163.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,57 OTHER TREATMENT START DATE 3;23 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JAN 31, 2003
HELP-PROMPT: *** OTHER TREATMENT START DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Records the date on which other treatment began at any facility.
For further information see FORDS pages 184-185.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATO^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"O")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"O")
Records other cancer-directed therapy date on the unified treatment index.
165.5,57.1 OTHER TREATMENT HOSPITAL 3;24 POINTER TO FACILITY FILE (#160.19)
Other treatment hospital
INPUT TRANSFORM: S V="" D NT^ONCODSR
OUTPUT TRANSFORM: S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
LAST EDITED: SEP 23, 1997
HELP-PROMPT: Enter facility where other treatment was given.
DESCRIPTION:
Record the name of the institution where other treatment was administered.
EXECUTABLE HELP: D HELP^ONCOFLF
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,57.2 OTHER TREATMENT 3;25 SET
'0' FOR None;
'1' FOR Other;
'2' FOR Other - Experimental;
'3' FOR Other - Double Blind;
'6' FOR Other - Unproven;
'7' FOR Refusal;
'8' FOR Recommended, unknown if administered;
'9' FOR Unknown;
LAST EDITED: SEP 09, 2003
DESCRIPTION: Identifies other treatment that cannot be defined as surgery, radiation, or systemic therapy
according to the defined data elements in the FORDS manual.
For further information see FORDS page 186.
GROUP: ACOS-REQUIRED
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AP^MUMPS
1)= Q
2)= D OTH^ONCDTX
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,57.3 OTHER TREATMENT @FAC 3.1;20 SET
'0' FOR None;
'1' FOR Other;
'2' FOR Other - Experimental;
'3' FOR Other - Double Blind;
'6' FOR Other - Unproven;
'7' FOR Refusal;
'8' FOR Recommended, unknown if administered;
'9' FOR Unknown;
LAST EDITED: SEP 09, 2003
HELP-PROMPT: Enter other treatment given at this facility that cannot be defined as surgery, radiation or
systemic therapy
DESCRIPTION: Identifies other treatment given at this facility that cannot be defined as surgery, radiation, or
systemic therapy according to the defined data elements in the FORDS manual.
For further information see FORDS page 187.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AZ^MUMPS
1)= Q
2)= D OTHATF^ONCDTX1
NOREINDEX)= 1
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,57.4 OTHER TREATMENT @FACILITY DATE 3.1;21 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JAN 21, 1999
HELP-PROMPT: *** OTHER TREATMENT AT THIS FACILITY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Record the month, day, and year first course of other treatment performed AT THIS FACILITY was
started.
Collecting dates for each treatment modality allows sequencing of multiple treatments and aids
evaluation of time intervals (from diagnosis to treatment and from treatment to recurrence).
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,58 REASON NO SURGERY OF PRIMARY 3;26 SET
'0' FOR Surgery performed;
'1' FOR Not part of 1st course;
'2' FOR Contraindicated;
'5' FOR Pt died prior to surgery;
'6' FOR Recommended, not performed, no reason given;
'7' FOR Refusal;
'8' FOR Recommended, unknown if performed;
'9' FOR Unknown;
INPUT TRANSFORM: Q
LAST EDITED: JAN 25, 2005
DESCRIPTION: Records the reason that no surgery was performed on the primary site.
For further information see FORDS page 147.
165.5,58.1 SURGICAL DX/STAGING PROC 3;27 FREE TEXT
INPUT TRANSFORM: D NCDSIT^ONCODSR
OUTPUT TRANSFORM: D NCDSOT^ONCODSR
LAST EDITED: NOV 08, 2002
DESCRIPTION: Identifies the surgical procedure(s) performed in an effort to diagnose and/or stage disease.
For further information see FORDS pages 109-110.
EXECUTABLE HELP: D HP0^ONCODSR
GROUP: SEER
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AQ^MUMPS
1)= Q
2)= D NCDS^ONCDTX
165.5,58.2 SURGERY OF PRIMARY (R) 3;38 NUMBER
INPUT TRANSFORM: S FIELD=58.2,NTXDD=1 D SPSIT^ONCOSUR
OUTPUT TRANSFORM: S FIELD=58.2 D SPSOT^ONCOSUR
LAST EDITED: MAR 27, 2003
DESCRIPTION: Records the surgical procedure(s) performed to the primary site.
For further information see ROADS pages 187-189.
EXECUTABLE HELP: S FIELD=58.2 D SPSHP^ONCOSUR
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AI^MUMPS
1)= Q
2)= D SURR^ONCDTX
165.5,58.3 SURGICAL DX/STAGING PROC DATE 3;31 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 29, 2007
HELP-PROMPT: Enter the date the surgical diagnostic and/or staging procedure was performed.
DESCRIPTION: Records the date on which the surgical diagnostic and/or staging procedure was performed.
For further information see FORDS pages 107-108.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,58.4 SURG DX/STAGING PROC @FAC 3.1;5 FREE TEXT
INPUT TRANSFORM: D NCDSIT^ONCODSR
OUTPUT TRANSFORM: D NCDSOT^ONCODSR
LAST EDITED: JAN 07, 2003
DESCRIPTION: Identifies the surgical procedure(s) performed in an effort to diagnose and/or stage disease at
this facility.
For further information see FORDS page 111.
EXECUTABLE HELP: D HP0^ONCODSR
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AR^MUMPS
1)= Q
2)= D NCDSATF^ONCDTX1
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,58.5 SURG DX/STAGING PROC @FAC DATE 3.1;6 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 29, 2007
HELP-PROMPT: Enter the date the surgical diagnostic and/or staging procedure was performed at this facility.
DESCRIPTION: Records the date on which the surgical diagnostic and/or staging procedure was performed at this
facility.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,58.6 RX SUMM--SURG PRIMSITE 03-2022 3.1;29 FREE TEXT
INPUT TRANSFORM: S FIELD=58.6,NTXDD=1 D SPSIT^ONCOSUR
MAXIMUM LENGTH: 30
OUTPUT TRANSFORM: S FIELD=58.6 D SPSOT^ONCOSUR
LAST EDITED: AUG 26, 2024
HELP-PROMPT: Enter the surgical procedure CODE. Alphabetic entries are prohibited.
DESCRIPTION: Records the surgical procedure(s) performed to the primary site.
For further information see FORDS page 135.
EXECUTABLE HELP: S FIELD=58.6 D SPSHP^ONCOSUR
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AI^MUMPS
1)= Q
2)= D SUR^ONCDTX
If SURGICAL PROC OF PRIMARY is deleted, the associated surgery fields are also deleted.
165.5,58.7 RX HOSP--SURG PRIMSITE 03-2022 3.1;30 FREE TEXT
INPUT TRANSFORM: S SPSFLG=0 D SPSDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X),SPSFLG=0 S FIELD=58.7,NTXDD=1
D SPSIT^ONCOSUR
MAXIMUM LENGTH: 2
OUTPUT TRANSFORM: S FIELD=58.7 D SPSOT^ONCOSUR
LAST EDITED: AUG 26, 2024
DESCRIPTION: Records the surgical procedure(s) performed to the primary at this facility.
For further information see FORDS page 136.
EXECUTABLE HELP: S FIELD=58.7 D SPSHP^ONCOSUR
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AT^MUMPS
1)= Q
2)= D SPSATF^ONCDTX1
If SURGICAL PROC OF PRIMARY @FAC is deleted, the associated surgery @FAC fields are also deleted.
165.5,58.8 RX HOSP--SURG PRIM SITE 2023 3.2;8 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<4) X I $D(X) D SPSIT23^ONCOSUR3
MAXIMUM LENGTH: 4
LAST EDITED: AUG 08, 2023
HELP-PROMPT: Answer must be 4 characters in length. Format: First character must be 'A' or 'B' followed by 3
numbers. See Appendix A of STORE Manual 2023 for allowable values for each primary site.
DESCRIPTION: Records the surgical procedure(s) performed to the primary site at this facility with a diagnosis
year of 2023 and forward.
EXECUTABLE HELP: D SPSHP23^ONCOSUR3
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,58.9 RX SUMM--SURG PRIM SITE 2023 3.2;9 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<4) X I $D(X) D SPSIT23^ONCOSUR3
MAXIMUM LENGTH: 4
LAST EDITED: AUG 08, 2023
HELP-PROMPT: Answer must be 4 characters in length. Format: First character must be 'A' or 'B' followed by 3
numbers. See Appendix A of STORE Manual 2023 for allowable values for each primary site.
DESCRIPTION: Surgery of Primary Site describes a surgical procedure that removes and/or destroys tissue of the
primary site that is performed as part of the initial diagnostic and staging work-up or first
course of therapy.
EXECUTABLE HELP: D SPSHP23^ONCOSUR3
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,59 SURGICAL MARGINS 3;28 SET
'0' FOR No residual tumor;
'1' FOR Residual tumor, NOS;
'2' FOR Microscopic residual tumor;
'3' FOR Macroscopic residual tumor;
'7' FOR Margins not evaluable;
'8' FOR No primary site surgery;
'9' FOR Unknown or NA;
LAST EDITED: FEB 25, 2010
HELP-PROMPT: Record the margin status as it appears in the pathology report.
DESCRIPTION: Records the final status of the surgical margins after resection of the primary tumor.
For further information see FORDS 2010 page 224.
165.5,60 SUBSEQUENT COURSE OF TREATMENT 4;0 DATE Multiple #165.51 (Add New Entry without Asking)
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: MAY 04, 1993
DESCRIPTION:
Enter subsequent therapy (therapy provided after completion of the first course of therapy).
165.51,.01 INITIATION DATE 0;1 DATE (Multiply asked)
Initiation Date
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 03, 1997
HELP-PROMPT: *** INITIATION DATE OF SUBSEQUENT COURSE OF THERAPY MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
Record the date that subsequent therapy was initiated.
TECHNICAL DESCR: Effective with Oncology V2.1 the name of this field has been changed from SUBSEQUENT TREATMENT
DATE.
SOURCE OF DATA: ACOS 3.113
GROUP: ACOS-REQUIRED
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,.02 HEMA TRANS/ENDOCRINE PROC 0;18 POINTER TO HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES FILE (#167)
OUTPUT TRANSFORM: I Y'="" S Y=$P($G(^ONCO(167,Y,0)),U,2)
LAST EDITED: JUL 08, 2003
DESCRIPTION: Identifies systemic therapeutic procedures administered as part of subsequent course of treatment
at this and all other facilities. If none of these procedures were administered, then this item
records the reason they were not performed. These include bone marrow transplants, stem cell
harvests, surgical and/or radiation endocrine therapy.
For further information see FORDS pages 182-183.
165.51,.021 HEMA TRANS/ENDOCRINE PROC DATE 0;19 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JUL 08, 2003
HELP-PROMPT: *** HEMA TRANS/ENDOCRINE PROC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
Records the date on which hematologic transplant and endocrine procedures were performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,.03 RADIATION THERAPY TO CNS 0;10 SET
'0' FOR None;
'1' FOR Radiation Given;
'7' FOR Refused Radiation;
'8' FOR Recommended, Unknown if Given;
'9' FOR Unknown if Recommended/Given or Not Applicable;
LAST EDITED: JUN 12, 1996
HELP-PROMPT: Radiation to the Brain and Central Nervous System - code '9' unless Lung/Leukemia
DESCRIPTION: This is a code indicating whether radiation therapy was performed to the brain and/or central
nervous system.
165.51,.031 RADIATION THERAPY TO CNS DATE 0;17 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 03, 1997
HELP-PROMPT: *** RADIATION THERAPY TO CNS DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
This is the date on which brain/CNS radiation therapy was initiated.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,.04 SURGERY OF PRIMARY SITE 0;4 NUMBER
INPUT TRANSFORM: S FIELD=.04,NTXDD=1 D SPSIT^ONCOSUR
OUTPUT TRANSFORM: S FIELD=.04 D SPSOT^ONCOSUR
LAST EDITED: FEB 27, 2004
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Records the surgical procedure(s) performed to the primary site.
For further information see FORDS page 135.
EXECUTABLE HELP: S FIELD=.04 D SPSHP^ONCOSUR
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^F^MUMPS
1)= Q
2)= D SCT^ONCDTX
165.51,.041 SURGERY OF PRIMARY SITE DATE 0;11 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 14, 2003
HELP-PROMPT: *** SURGERY OF PRIMARY SITE DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Records the date of the most definitive surgical resection of the primary site performed as part
of subsequent treatment.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,.05 RADIATION 0;5 SET
'0' FOR None;
'1' FOR Beam radiation;
'2' FOR Radioactive implants;
'3' FOR Radioisotopes;
'4' FOR Beam + implants or radioisotopes;
'5' FOR Radiation, NOS;
'7' FOR Refused radiation;
'8' FOR Recommended, unknown if given;
'9' FOR Unknown if administered;
LAST EDITED: DEC 10, 2009
DESCRIPTION:
Identifies the type of radiation given as part of subsequent treatment.
165.51,.051 RADIATION DATE 0;12 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 03, 1997
HELP-PROMPT: *** RADIATION DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
This is the date on which radiation therapy was given.
TECHNICAL DESCR:
This field is new with Patch ONC*2*11.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,.06 CHEMOTHERAPY 0;6 SET
'00' FOR None;
'01' FOR Chemotherapy, NOS;
'02' FOR Single agent;
'03' FOR Multiagent;
'82' FOR Not admin/contraindicated;
'85' FOR Pt died prior to tx;
'86' FOR Not admin, no reason given;
'87' FOR Refused by pt;
'88' FOR Unknown if admin;
'99' FOR Unknown, death cert;
LAST EDITED: FEB 24, 2003
DESCRIPTION: Records the type of chemotherapy administered as subsequent treatment at this and at all other
facilities. If chemotherapy was not administered, then this item records the reason it was not
administered to the patient. Chemotherapy consists of a group of anticancer drugs that inhibit
the reproduction of cancer cells by interfering with DNA synthesis and mitosis.
For further information see FORDS pages 171-172.
165.51,.061 CHEMOTHERAPY DATE 0;13 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 03, 1997
HELP-PROMPT: *** CHEMOTHERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
This is the date on which chemotherapy was initiated.
TECHNICAL DESCR:
This field is new with Patch ONC*2*10.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,.07 HORMONE THERAPY 0;7 SET
'00' FOR None;
'01' FOR Hormone therapy;
'82' FOR Not admin/contraindicated;
'85' FOR Pt died prior to tx;
'86' FOR Not admin, no reason given;
'87' FOR Refused by pt;
'88' FOR Unknown if admin;
'99' FOR Unknown, death cert;
LAST EDITED: FEB 25, 2003
DESCRIPTION: Records the type of hormone therapy administered as subsequent treatment at this and all other
facilities. If hormone therapy was not administered, then this item records the reason it was
not administered to the patient. Hormone therapy consists of a group of drugs that may affect
the long-term control of a cancer's growth. It is not usually used as a curative measure.
For further information see FORDS pages 175-176.
165.51,.071 HORMONE THERAPY DATE 0;14 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: FEB 25, 2003
HELP-PROMPT: *** HORMONE THERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
This is the date on which hormone/steroid therapy was initiated.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,.08 IMMUNOTHERAPY 0;8 SET
'00' FOR None;
'01' FOR Immunotherapy;
'82' FOR Not admin/contraindicated;
'85' FOR Pt died prior to tx;
'86' FOR Not admin, no reason given;
'87' FOR Refused by pt;
'88' FOR Unknown if admin;
'99' FOR Unknown, death cert;
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: JUL 14, 2003
DESCRIPTION: Records the type of immunotherapy administered as subsequent treatment at this and all other
facilities. If immunotherapy was not administered, then this item records the reason it was not
administered to the patient. Immunotherapy consists of biological or chemical agents that alter
the immune system or change the host's response to the tumor cells.
For further information see FORDS pages 179-180.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,D0,4,DA,0),U,1)>2951231)!((Y'=3)&(Y'=4)&(Y'=5)&(Y'=6))"
EXPLANATION: Codes 3, 4, 5 and 6 should only be used if the INITIATION DATE is > 12/31/95.
GROUP: ACOS-REQUIRED
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,.081 IMMUNOTHERAPY DATE 0;15 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 03, 1997
HELP-PROMPT: *** IMMUNOTHERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
The date immunotherapy was started.
TECHNICAL DESCR:
This field is new with Patch ONC*2*10.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,.09 OTHER TREATMENT 0;9 SET
'0' FOR None;
'1' FOR Other;
'2' FOR Other - Experimental;
'3' FOR Other - Double Blind;
'6' FOR Other - Unproven;
'7' FOR Refusal;
'8' FOR Reccommended, unknown if administered;
'9' FOR Unknown;
LAST EDITED: MAR 07, 2003
DESCRIPTION: Identifies other treatment that cannot be defined as surgery, radiation, or systemic therapy.
For further informatin see FORDS page 186.
165.51,.091 OTHER TREATMENT START DATE 0;16 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 07, 2003
HELP-PROMPT: *** OTHER TREATMENT START DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Records the date on which other treatment began at any facility.
For further information see FORDS pages 184-185.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,1 RADIATION SEQUENCE 0;2 SET
Radiation Sequence
'0' FOR Not Applicable;
'2' FOR Radiation Before Surgery;
'3' FOR Radiation After Surgery;
'4' FOR Both Before AND After Surgery;
'5' FOR Intraoperative Radiation;
'6' FOR Intraoperative Radiation with other radiation before/after surgery;
'9' FOR Sequence Unknown;
LAST EDITED: OCT 03, 1992
HELP-PROMPT: Record Sequence of Radiation and Surgery
DESCRIPTION:
This is the sequence of beam radiation therapy performed.
SOURCE OF DATA: DAM 3.119
GROUP: ACOS-RECOMMENDED
165.51,2 PLACE 0;3 POINTER TO FACILITY FILE (#160.19)
OUTPUT TRANSFORM: S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
LAST EDITED: MAY 31, 1996
HELP-PROMPT: Enter Hospital providing subsequent treatment
DESCRIPTION:
This is the institution performing the treatment.
EXECUTABLE HELP: D HELP^ONCOFLF
165.51,3 SUBSEQUENT THERAPY COMMENTS 1;0 WORD-PROCESSING #165.513
LAST EDITED: MAY 18, 1990
DESCRIPTION:
This is a multi-line free text field permitting comments to be entered.
LAST EDITED: SEP 18, 1987
DESCRIPTION:
This is a line of the free text field.
165.51,4 INTERSTITIAL RADIATION 2;1 SET
'1' FOR Yes;
'2' FOR No, not recommended;
'3' FOR Patient refused interstitial radiation;
'4' FOR Radiation planned, but not given;
'9' FOR Unknown;
OUTPUT TRANSFORM: S FILNUM=165.51,FLDNUM=4 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether the patient received interstitial radiation.
165.51,5 IODINE 125 2;2 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=5 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether Iodine 125 was used interstitially.
165.51,6 GOLD 198 2;3 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=6 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether Gold 198 was used interstitially.
165.51,7 PALLADIUM 103 2;4 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=7 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether Palladium 103 was used interstitially.
165.51,8 IRIDIUM 192 2;5 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=8 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether Iridium 192 was used interstitially.
165.51,9 OTHER INTERSTITIAL, NOS 2;6 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=9 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether other isotopes were used interstitially.
165.51,10 EXTERNAL RADIATION 2;7 SET
'1' FOR Yes;
'2' FOR No, not recommended;
'3' FOR Patient refused external radiation;
'4' FOR Radiation planned, but not given;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=10 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether the patient received external radiation.
165.51,11 PROSTATE REGION ONLY 2;8 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=11 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether the prostate region only was irradiated.
165.51,12 PROSTATE AND PELVIC NODES 2;9 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=12 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether the prostate and pelvic nodes were irradiated.
165.51,13 PROSTATE & PELVIC PARA-AORTIC 2;10 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=13 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether the prostate and pelvic para-aortic nodes were irradiated.
165.51,14 DISTANT METASTATIC SITES 2;11 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=14 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether distant metastatic sites were irradiated.
165.51,15 OTHER EXTERNAL SITES, NOS 2;12 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=15 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether other external sites were irradiated.
165.51,16 RADIATION PLANNED/GIVEN 2;13 SET
'1' FOR Yes;
'2' FOR No, not recommended;
'3' FOR Patient refused radiation therapy;
'4' FOR Radiation planned, but not given;
'9' FOR Unknown;
OUTPUT TRANSFORM: S FILNUM=165.51,FLDNUM=16 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether the patient received subsequent radiation therapy.
165.51,17 TOTAL RAD DOSE (PROSTATE) 2;14 SET
'1' FOR Less than 1999 rad;
'2' FOR 2000-3000 rad;
'3' FOR 3001-4000 rad;
'4' FOR 4001-5000 rad;
'5' FOR 5001-6000 rad;
'6' FOR 6001-7000 rad;
'7' FOR More than 7001 rad;
'8' FOR Not given;
'9' FOR Rad dose unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=17 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION: Record the total (external) rad dose given to the prostate; this includes boost dosage. Do not
include interstitial rad dose. If it is known that the patient received radiation therapy, but
the amount given is unknown, code 9 (rad dose unknown).
165.51,18 TOTAL RAD DOSE (PELVIC NODES) 2;15 SET
'1' FOR Less than 1999 rad;
'2' FOR 2000-3000 rad;
'3' FOR 3001-4000 rad;
'4' FOR 4001-5000 rad;
'5' FOR 5001-6000 rad;
'8' FOR Not given;
'9' FOR Rad dose unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=18 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION: Record the total (external) rad dose given to the pelvic nodes; this includes boost dosage. Do
not include interstitial rad dose. If it is known that the patient received radiation therapy,
but the amount given is unknown, code 9 (rad dose unknown).
165.51,19 TOTAL RAD DOSE (PARA-AORTIC) 2;16 SET
'1' FOR Less than 1999 rad;
'2' FOR 2000-3000 rad;
'3' FOR 3001-4000 rad;
'4' FOR 4001-5000 rad;
'5' FOR 5001-6000 rad;
'8' FOR Not given;
'9' FOR Rad dose unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=19 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION: Record the total (external) rad dose given to the para-aortic nodes; this includes boost
dosage. Do not include interstitial rad dose. If it is known that the patient received
radiation therapy, but the amount given is unknown, code 9 (rad dose unknown).
165.51,20 CHEMOTHERAPY PLANNED/GIVEN 2;17 SET
'1' FOR Yes;
'2' FOR No, not recommended;
'3' FOR Patient refused chemotherapy;
'4' FOR Chemotherapy planned, but not given;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=20 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether the patient received chemotherapy.
165.51,21 ADRIAMYCIN 2;18 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=21 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether Adriamycin was administered.
165.51,22 CYTOXAN 2;19 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=22 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether Cytoxan was administered.
165.51,23 METHOTREXATE 2;20 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=23 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether Methotrexate was administered.
165.51,24 5-FLUOROURACIL 2;21 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=24 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether 5-Fluorourcil was administered.
165.51,25 OTHER 2;22 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=25 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether other chemotherapy drugs were administered.
165.51,26 HORMONE THERAPY PLANNED/GIVEN 2;23 SET
'1' FOR Yes;
'2' FOR No, not recommended;
'3' FOR Patient refused hormone therapy;
'4' FOR Hormone therapy planned, but not given;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=26 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether the patient received hormonal therapy.
165.51,27 ESTROGENS 2;24 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=27 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION: Record whether estrogens were administered. Code 2 (no) if estrogens were not given.
Estrogens include diethylstilbestrol (DES), Stilphostrol, TACE (chlorotrianisene), and Emcyt
(estramustine phosphate).
165.51,28 ANTIANDROGENS 2;25 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=28 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION: Record whether antiandrogens were administered. Code 2 (no) if antiandrogens were not given.
The most widely used antiandrogen is Eulexin (fultamide).
165.51,29 PROGESTATIONAL AGENTS 2;26 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=29 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION: Record whether progestational agents were administered. Code 2 (no) if progestational agents
were not given. Progestational agents include Provera (medroxyprogesterone) and Megace
(megestrol acetate).
165.51,30 LUTEINIZING HORMONE-RELEASING 2;27 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=30 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION: Record whether luteinizing hormone-releasing hormones were administered. Code 2 (no) if
luteinizing hormone-releasing hormones were not given. Luteinizing hormone-releasing hormones
(LH/RH) include Lupron (leuprolide) and Zoladex (goserelin).
165.51,31 ORCHIECTOMY 2;28 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=31 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether an orchiectomy was administered. Code 2 (no) if an orchiectomy was not given.
165.51,32 OTHER HORMONES 2;29 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
OUTPUT TRANSFORM: S Y(0)=Y S FILNUM=165.51,FLDNUM=32 D SOC^ONCOOT
LAST EDITED: JUL 30, 1996
DESCRIPTION:
Record whether other hormones were administered. Code 2 (no) if no other hormones were given.
165.51,33 RECON/RESTORE - DELAYED 2;30 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>10)!(X<0)!(X?.E1"."1N.N) X I $D(X) S NTXDD=0 D RRIT^ONCRR
OUTPUT TRANSFORM: D RROT^ONCRR
LAST EDITED: OCT 29, 2004
HELP-PROMPT: Type a Number between 0 and 10, 0 Decimal Digits
DESCRIPTION: "Reconstruction/Restoration - Delayed" describes surgical procedures that improve the shape
and appearance or function of body structures that are missing, defective, damaged, or
misshapen by cancer or cancer-directed therapies. "Reconstruction/Restoration - Delayed" is
limited to procedures started after the first course of cancer- directed therapy is complete or
when it is unknown whether reconstruction was started during first or second course of therapy.
EXECUTABLE HELP: D RRHP^ONCRR
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,34 RECON/RESTORE - DELAYED DATE 2;31 DATE
INPUT TRANSFORM: S %DT="E" D ^%DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: FEB 10, 1998
165.51,35 SCOPE OF LYMPH NODE SURGERY 2;32 SET
'0' FOR None;
'1' FOR Bx/aspiration, NOS;
'2' FOR Sentinel Bx;
'3' FOR Nodes removed, number unk;
'4' FOR 1-3 nodes removed;
'5' FOR 4 or more nodes removed;
'6' FOR Sentinel + 3, 4 or 5, timing not stated;
'7' FOR Sentinel + 3, 4, or 5, diff times;
'9' FOR Unknown/NA;
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: DEC 27, 2002
DESCRIPTION: Indentifies the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery
of the primary site or during a separate surgical event.
For further information see FORDS pages 138-139.
165.51,36 SURGICAL PROC/OTHER SITE 2;33 SET
'0' FOR None;
'1' FOR Nonprimary surgical proc;
'2' FOR Nonprimary surgical proc/other regional sites;
'3' FOR Nonprimary surgical proc/distant lymph node(s);
'4' FOR Nonprimary surgical proc/distant site;
'5' FOR Combination of codes;
'9' FOR Unknown;
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: JAN 02, 2003
DESCRIPTION: Records the surgical removal of distant lymph nodes or other issue(s)/organ(s) beyond the
primary site.
For further information see FORDS page 142.
165.51,37 NUMBER OF NODES REMOVED 2;34 NUMBER
INPUT TRANSFORM: K:X'?1.2N X I $D(X) S NTXDD=0 S X=+X K:X>99!(X<0) X I $D(X) D NRIT^ONCOSUR1
OUTPUT TRANSFORM: D NROT^ONCOSUR1
LAST EDITED: DEC 04, 1998
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Enter the number of regional lymph nodes removed.
00 for No nodes removed
01 for 1 node removed
02 for 2 nodes removed
...
90 for 90 or more nodes removed
95 for No nodes removed, aspiration performed
96 for Node removal as a sampling, number unknown
97 for Node removal as dissection, number unknown
98 for Nodes surgically removed, number unknown
99 for Unknown; not stated; death certificate only
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,38 SCOPE OF LN SURGERY DATE 2;35 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: OCT 10, 2014
HELP-PROMPT: Enter the date that the SCOPE OF LYMPH NODE SURGERY (#35) sub-field was performed.
DESCRIPTION: This field records the date of the SCOPE OF LYMPH NODE SURGERY (#35) sub-field for this
subsequent course of treatment. The date entered must be after or equal to the DATE DX (#3)
field.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,39 SURGICAL PROC/OTHER SITE DATE 2;36 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: FEB 12, 2014
HELP-PROMPT: Enter the date that the SURGICAL PROC/OTHER SITE (#36) sub-field was performed.
DESCRIPTION: This field records the date of the SURGICAL PROC/OTHER SITE (#36) sub-field for this subsequent
course of therapy. The date entered must be after or equal to the DATE DX (#3) field.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,40 METS SITE RESECTED 2;37 SET
'0' FOR None;
'1' FOR Peritoneum;
'2' FOR Lung;
'3' FOR Pleura;
'4' FOR Liver;
'5' FOR Bone;
'6' FOR Brain;
'7' FOR Skin;
'8' FOR Distant LNS;
'9' FOR Other;
LAST EDITED: JUL 25, 2013
HELP-PROMPT: Enter the appropriate site from the list.
DESCRIPTION:
This is the Metastatic Site Resected for this subsequent treatment.
165.51,41 METS SITE RESECTED DATE 2;38 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: FEB 12, 2014
HELP-PROMPT: Enter the date the Metastatic Site was resected.
DESCRIPTION: This is the date the Metastatic Site was resected. The Date must be after or equal to the DATE
DX (#3) field.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.51,42 PALLIATIVE CARE 2;39 SET
'0' FOR No palliative care;
'1' FOR Surgery;
'2' FOR Radiation;
'3' FOR Systemic tx;
'4' FOR Pain management;
'5' FOR Surg, rad, and/or systemic tx w/o pain mgt;
'6' FOR Surg, rad, and/or systemic tx w pain mgt;
'7' FOR Palliative care, type unknown;
'9' FOR Unknown, not stated;
LAST EDITED: JUL 24, 2013
HELP-PROMPT: Enter the type of palliative care from the list.
DESCRIPTION: Identifies any care provided in an effort to palliate or alleviate symptoms. Palliative care
is performed to relieve symptoms and may include surgery, radiation therapy, systemic therapy
(chemotherapy, hormone therapy or other systemic drugs), and/or pain management therapy.
165.5,61 PID# ; COMPUTED
MUMPS CODE: S X="" D PID5^ONCOCOM
ALGORITHM: S X="" D PID5^ONCOCOM
DESCRIPTION:
RECORD THE PATIENT'S IDENTIFICATION NUMBER.
165.5,62 QA SELECTED 7;4 SET
'Y' FOR YES;
LAST EDITED: SEP 23, 1992
HELP-PROMPT: Abstract has been selected for QA Review (from QA option)
DESCRIPTION:
Field is stuffed if randomly selected for QA review.
165.5,63 QA REVIEW 7;8 SET
'N' FOR NO;
'Y' FOR YES;
LAST EDITED: SEP 23, 1992
HELP-PROMPT: Enter if QReview was performed on the selected Abstract.
DESCRIPTION:
Field only used if Abstract was randomly selected for QA Review.
165.5,64 QA DATE 7;9 DATE
INPUT TRANSFORM: S %DT="EPX" D ^%DT S X=Y K:Y<1 X I $D(X) S DTDX=$P($G(^ONCO(165.5,D0,0)),"^",16) I DTDX'="" K:X30!($L(X)<3) X
LAST EDITED: JUL 17, 2003
HELP-PROMPT: Answer must be 3-30 characters in length.
DESCRIPTION:
Records information regarding the physician's stage.
165.5,66 PHYSICIAN STAGING 7;11 POINTER TO ONCOLOGY CONTACT FILE (#165)
INPUT TRANSFORM: S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
LAST EDITED: MAY 11, 1999
HELP-PROMPT: Enter physician's name who did the staging
DESCRIPTION: This is the name of the physician performing the staging.
SCREEN: S DIC("S")="I $P(^(0),U,2)=2"
EXPLANATION: Contact Type is MD
CROSS-REFERENCE: 165.5^ACP^MUMPS
1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
Creates a list under the Contact file of contacts, and associated patients orginating from the
Primary file pointers to the Contact File.
CROSS-REFERENCE: 165.5^APC^MUMPS
1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
Creates a list under the contact file of patients, and associated contacts originating from the
Primary file pointers to the contact file.
CROSS-REFERENCE: 165.5^APST^MUMPS
1)= S ^ONCO(165.5,"APST",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
2)= K ^ONCO(165.5,"APST",X,$P(^ONCO(165.5,DA,0),U,2),DA)
Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
165.5,67 ACOS # ; COMPUTED
MUMPS CODE: S X=$$IIN^ONCFUNC
ALGORITHM: S X=$$IIN^ONCFUNC
LAST EDITED: NOV 03, 1999
DESCRIPTION: ACOS # is the equivalent of the INSTITUTION ID NUMBER as recorded in the ONCOLOGY SITE PARAMETERS
file.
165.5,68 STATE HOSPITAL # ; COMPUTED
MUMPS CODE: S X=$$SHN^ONCFUNC
ALGORITHM: S X=$$SHN^ONCFUNC
LAST EDITED: NOV 03, 1999
DESCRIPTION: This is the state identification number.
165.5,69 MULTIPLE TUMORS 2;31 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: JUL 01, 1993
HELP-PROMPT: If multiple tumors, enter a 1 or the exact number if known.
DESCRIPTION: This field documents the existence and (if known) number of multiple tumors at an anatomic site.
If there are NOT multiple tumors at this site, leave this field BLANK.
If there ARE multiple tumors at this site, enter the exact number of tumors here if known, or a 1
if the exact number if not known.
165.5,69.1 FAMILY HISTORY 2;32 SET
'0' FOR No;
'1' FOR Yes;
LAST EDITED: JUL 01, 1993
DESCRIPTION: If there is a known family history for this case, enter a 1.
Otherwise, enter a 0 or leave blank.
This field only applies to cancers of the retina.
165.5,69.2 DIFFUSE RETINAL INVOLVEMENT 3;30 SET
'0' FOR No;
'1' FOR Yes;
LAST EDITED: JUL 01, 1993
DESCRIPTION: If there is diffuse retinal involvement without the formation of discrete masses, enter a 1.
Otherwise, enter a 0 or leave blank.
This field applies only to cancers of the retina.
165.5,69.3 MULTIMODALITY THERAPY (CLIN) 7;16 SET
'Y' FOR Yes;
'N' FOR No;
LAST EDITED: MAY 30, 1997
DESCRIPTION: The first method of therapy is other than cancer-directed surgery. The patient is first treated
with radiation therapy, chemotherapy, hormone therapy, immunotherapy, "other" therapy, or any
combination of these therapies. The stage is based on a pathologic resection of the primary done
after at least one of the other therapies has started. The other therapy may or may not be
complete. This stage should supplement the clinical AJCC stage, not replace it.
165.5,69.4 MULTIMODALITY THERAPY 7;17 SET
'Y' FOR Yes;
'N' FOR No;
LAST EDITED: OCT 24, 2002
HELP-PROMPT: Enter Yes to prefix the pTNM category with "y".
DESCRIPTION: MULTIMODALITY THERAPY determines whether the pTNM category will have a "y Prefix" (eg yT1 N0 M0).
The "y Prefix" indicates those cases in which classification is performed during or following
initial multimodality therapy. The ypTNM categorizes the extent of tumor actually present at the
time of that examination. The "y" category is not an estimate of the extent of tumor prior to
multimodality therapy.
165.5,70 DATE OF FIRST RECURRENCE 5;1 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOPCE
LAST EDITED: SEP 02, 2015
HELP-PROMPT: *** DATE OF FIRST RECURRENCE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Records the date of the first recurrence.
For further information see FORDS pages 195-196.
GROUP: ACOS-REQUIRED
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: ^^TRIGGER^165.5^999.21
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,27)):^(27),1:"") S X=$P(Y(1),U,26),X=
X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),27)),DIV=X S $P(^(27),U,26)=DIV,DIH=165.5,DIG=999.
21 D ^DICR
2)= Q
CREATE VALUE)= @
DELETE VALUE)= NO EFFECT
FIELD)= RECURRENCE DATE-1ST F
If DATE OF FIRST RECURRENCE field is entered then delete the RECURRENCE DATE-1ST FLAG field value.
165.5,71 TYPE OF FIRST RECURRENCE 5;2 POINTER TO TYPE OF RECURRENCE FILE (#160.12)
INPUT TRANSFORM: S DIC("S")="I ($P(^(0),U,1)'=11)&($P(^(0),U,1)'=""01"")" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: S:Y'="" Y=$P($G(^ONCO(160.12,Y,0)),U,2)
LAST EDITED: FEB 04, 2003
DESCRIPTION: Identifies the type of first recurrence after a period of documented disease-free intermission or
remission.
For further information see FORDS pages 197-198.
SCREEN: S DIC("S")="I ($P(^(0),U,1)'=11)&($P(^(0),U,1)'=""01"")"
EXPLANATION: ROADS codes 01 and 11 have been discontinued.
165.5,71.1 DISTANT SITE 1 5;3 SET
'0' FOR None;
'1' FOR Peritoneum;
'2' FOR Lung;
'3' FOR Pleura;
'4' FOR Liver;
'5' FOR Bone;
'6' FOR Central Nervous System;
'7' FOR Skin;
'8' FOR Lymph Nodes (Distant);
'9' FOR Other/Generalized/NOS;
LAST EDITED: JUL 09, 2004
DESCRIPTION:
Record the first site of distant recurrence.
GROUP: ACOS-REQUIRED
165.5,71.2 DISTANT SITE 2 5;4 SET
'0' FOR None;
'1' FOR Peritoneum;
'2' FOR Lung;
'3' FOR Pleura;
'4' FOR Liver;
'5' FOR Bone;
'6' FOR Central Nervous System;
'7' FOR Skin;
'8' FOR Lymph Nodes (Distant);
'9' FOR Other/Generalized/NOS;
LAST EDITED: JUL 09, 2004
DESCRIPTION:
Record the second site of distant recurrence.
GROUP: ACOS-REQUIRED
165.5,71.3 DISTANT SITE 3 5;5 SET
'0' FOR None;
'1' FOR Peritoneum;
'2' FOR Lung;
'3' FOR Pleura;
'4' FOR Liver;
'5' FOR Bone;
'6' FOR Central Nervous System;
'7' FOR Skin;
'8' FOR Lymph Nodes (Distant);
'9' FOR Other/Generalized/NOS;
LAST EDITED: JUL 09, 2004
DESCRIPTION:
Record the third site of distant recurrence.
GROUP: ACOS-REQUIRED
165.5,71.4 OTHER TYPE OF FIRST RECURRENCE 5;6 POINTER TO TYPE OF RECURRENCE FILE (#160.12)
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(160.12,Y,0),"^",2)
LAST EDITED: MAR 17, 2000
DESCRIPTION: Record the OTHER TYPE OF FIRST RECURRENCE. The term "recurrence" means the return or reappearance
of the cancer after a disease-free intermission or remission.
The patient may have more than one site of recurrence (i.e., both regional and distant metastases).
Code regional in the data field TYPE OF FIRST RECURRENCE, and distant in this field.
If the patient has only one site of recurrence or has been disease-free since treatment, code 00.
165.5,72 SUBSEQUENT RECURRENCES 23;0 DATE Multiple #165.572
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
DESCRIPTION:
This multiple records information on subsequent recurrences of the tumor.
165.572,.01 DATE of SUBSEQUENT RECURRENCE 0;1 DATE (Multiply asked)
Date of Recurrence
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 03, 1997
HELP-PROMPT: *** DATE OF SUBSEQUENT RECURRENCE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
This is the date on which a recurrence was recorded to have occurred.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.572^B
1)= S ^ONCO(165.5,DA(1),23,"B",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,DA(1),23,"B",$E(X,1,30),DA)
165.572,.02 TYPE of SUBSEQUENT RECURRENCE 0;2 POINTER TO TYPE OF RECURRENCE FILE (#160.12)
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(160.12,Y,0),"^",2)
LAST EDITED: JAN 29, 1996
DESCRIPTION:
Record the code for the type of subsequent recurrence.
165.572,.03 DISTANT SITE 1 0;3 SET
'0' FOR None;
'1' FOR Peritoneum;
'2' FOR Lung;
'3' FOR Pleura;
'4' FOR Liver;
'5' FOR Bone;
'6' FOR Central Nervous System;
'7' FOR Skin;
'8' FOR Lymph Nodes (Distant);
'9' FOR Other/Generalized/NOS;
LAST EDITED: JUL 09, 2004
DESCRIPTION:
Record the first site of distant recurrence.
165.572,.031 DISTANT SITE 2 0;4 SET
'0' FOR None;
'1' FOR Peritoneum;
'2' FOR Lung;
'3' FOR Pleura;
'4' FOR Liver;
'5' FOR Bone;
'6' FOR Central Nervous System;
'7' FOR Skin;
'8' FOR Lymph Nodes (Distant);
'9' FOR Other/Generalized/NOS;
LAST EDITED: JUL 09, 2004
DESCRIPTION:
Record the second site of distant recurrence.
165.572,.032 DISTANT SITE 3 0;5 SET
'0' FOR None;
'1' FOR Peritoneum;
'2' FOR Lung;
'3' FOR Pleura;
'4' FOR Liver;
'5' FOR Bone;
'6' FOR Central Nervous System;
'7' FOR Skin;
'8' FOR Lymph Nodes (Distant);
'9' FOR Other/Generalized/NOS;
LAST EDITED: JUL 09, 2004
DESCRIPTION:
Record the third site of distant recurrence.
165.572,1 OTHER T 0;6 FREE TEXT
INPUT TRANSFORM: K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="T",STGIND="O" D IN^ONCOTNM
OUTPUT TRANSFORM: S ONCOX="T",STGIND="O" D OT^ONCOTNM
LAST EDITED: JAN 15, 1997
HELP-PROMPT: Answer must be appropriate "T" code from the AJCC Staging Manual
DESCRIPTION:
"Other T" evaluates the primary tumor and identifies tumor size and/or extension.
EXECUTABLE HELP: S ONCOX="T",STGIND="O" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.572,2 OTHER N 0;7 FREE TEXT
INPUT TRANSFORM: K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="N",STGIND="O" D IN^ONCOTNM
OUTPUT TRANSFORM: S ONCOX="N",STGIND="O" D OT^ONCOTNM
LAST EDITED: JAN 15, 1997
HELP-PROMPT: Answer must be appropriate "N" code from the AJCC Staging Manual
DESCRIPTION: "Other N" classifies the regional lymph nodes and describes the absence or presence and the
extent of node metastases.
EXECUTABLE HELP: S ONCOX="N",STGIND="O" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.572,3 OTHER M 0;8 FREE TEXT
INPUT TRANSFORM: K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="M",STGIND="O" D IN^ONCOTNM
OUTPUT TRANSFORM: S ONCOX="M",STGIND="O" D OT^ONCOTNM
LAST EDITED: JAN 15, 1997
HELP-PROMPT: Answer must be appropriate "M" code from the AJCC Staging Manual
DESCRIPTION: "Other M" records the presence or absence of distant metastases. Choose the lower (less
advanced) M category when there is any uncertainty.
EXECUTABLE HELP: S ONCOX="M",STGIND="O" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.572,4 OTHER STAGE GROUP 0;9 FREE TEXT
INPUT TRANSFORM: K:$L(X)>14!($L(X)<1) X S ONCOX="S",STGIND="O" D IN^ONCOTNS
OUTPUT TRANSFORM: S X="" D OT^ONCOTNS
LAST EDITED: JAN 15, 1997
HELP-PROMPT: Answer with the appropriate stage from the AJCC Stage Manual
DESCRIPTION: Record the apparent extent of disease in accordance with AJCC staging requirements.
Stage codes:
0 IB III IVB 0A IC IIIA Not applicable Occult II
IIIB Unknown 0is IIA IIIC I IIB IV IA IIC IVA
EXECUTABLE HELP: S ONCOX="S",STGIND="O" D HP^ONCOTNS
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.572,5 STAGED BY (OTHER STAGE) 0;10 SET
'0' FOR Not staged;
'1' FOR Managing physician;
'2' FOR Pathologist;
'3' FOR Other physician;
'4' FOR Any combination of 1, 2, or 3;
'5' FOR Registrar;
'6' FOR Any combination of 5 with 1, 2, or 3;
'7' FOR Other;
'8' FOR Staged, individual not specified;
'9' FOR Unknown if staged;
LAST EDITED: JAN 14, 1997
DESCRIPTION: "Staged By (Other Stage)" identifies the person who documented the other AJCC staging elements
and the stage group. The Commission requires analytic cases to be staged by the managing
physician. Compliance with Commission-approved program requirements can be analyzed using this
data.
165.5,73 TUMOR STATUS TS;0 DATE Multiple #165.573 (Add New Entry without Asking)
LAST EDITED: MAR 09, 1993
DESCRIPTION: This multiple is populated by the Post/Edit Follow-Up option of the Follow-Up Menu. It contains
the date of each follow-up for this patient, and the tumor status at each follow-up.
TECHNICAL DESCR:
This field is set directly by STSMONE^ONCOFTS. This field is killed directly by KTSMONE^ONCOFTS.
165.573,.01 TUMOR STATUS DATE 0;1 DATE (Required)
INPUT TRANSFORM: S %DT="E" D ^%DT S X=Y K:Y<1 X
LAST EDITED: OCT 06, 1992
HELP-PROMPT: Enter Date of Tumor Status Evaluation
DESCRIPTION:
This is the date on which the tumor status was evaluated.
CROSS-REFERENCE: 165.573^B
1)= S ^ONCO(165.5,DA(1),"TS","B",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,DA(1),"TS","B",$E(X,1,30),DA)
CROSS-REFERENCE: 165.573^AA^MUMPS
1)= S ^ONCO(165.5,DA(1),"TS","AA",9999999-X,DA)=""
2)= K ^ONCO(165.5,DA(1),"TS","AA",9999999-X,DA)
Indexes file in inverse order by tumor status date.
165.573,.02 CANCER STATUS 0;2 POINTER TO PRIMARY CANCER STATUS CODE FILE (#164.42) (Required)
LAST EDITED: JUN 24, 2005
DESCRIPTION: Records the presence or absence of clincial evidence of cancer as of the DATE OF LAST CONTACT OR
DEATH.
For further information see FORDS page 201.
SCREEN: S DIC("S")="N OD,VS X ^DD(165.573,.02,9.2) I ((VS=0)&(Y>3))!((VS'=0)&((Y=1)!(Y=2)!(Y=9)))"
EXPLANATION: The selections available depend on the patient's vital status at the time of follow-up.
CROSS-REFERENCE: 165.573^AC^MUMPS
1)= D LTS^ONCOU55(DA(1))
2)= D LTS^ONCOU55(DA(1),DA)
This cross-reference updates LAST TUMOR STATUS (95).
165.573,.03 DATE OF LAST CANCER STATUS 0;3 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: OCT 07, 2019
HELP-PROMPT: Enter the date of last cancer (tumor status)
DESCRIPTION: This data item documents the date of last cancer (tumor status) of the patient's malignant or
non-malignant tumor. Record in CCYYMMDD form where blank spaces are used for unknown trailing
portions of the date or where a date is not applicable. This data item is required for COC-
accredited facilities for cases diagnosed 1/1/2018 and later.
Record the last date on which the patient's cancer status (Cancer Status [1770]) WAS KNOWN TO BE
UPDATED. Cancer Status is based on information from the patient's physician or other official
source such as a death certificate.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.573,.04 DATE OF LAST CANCER STATUS FLG 0;4 SET
'12' FOR A proper value is applicable but not known. This event occurred, but the date is unknown.;
LAST EDITED: SEP 25, 2019
HELP-PROMPT: Enter 12 or leave BLANK
DESCRIPTION: This flag explains why there is no appropriate value in the corresponding date field, Date of Last
Cancer (tumor) Status [1772]. This data item is required for CoC-accredited facilities for cases
diagnosed 1/1/2018 and later.
165.5,74 SURGICAL APPROACH (R) 3;34 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D SAIT^ONCOSUR
OUTPUT TRANSFORM: D SAOT^ONCOSUR
LAST EDITED: MAY 13, 2003
HELP-PROMPT: Type a Number between 0 and 9, 0 Decimal Digits
DESCRIPTION: SURGICAL APPROACH describes the method used to approach the organ of origin and/or primary tumor.
Code the approach for surgery of the primary site only. If no primary site surgical procedure was
done (SURGERY OF PRIMARY SITE is coded 00), SURGICAL APPROACH must be coded 0. If the field
SURGERY OF PRIMARY SITE is 99 (Unknown if surgery performed; death certificate ONLY), code SURGICAL
APPROACH 9 (Unknown; not stated; death certificate ONLY).
For further information see ROADS page 186.
EXECUTABLE HELP: D SAHP^ONCOSUR
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,75 REASON FOR NO RADIATION 3;35 SET
'0' FOR Radiation administered;
'1' FOR Not part of 1st course;
'2' FOR Contraindicated;
'5' FOR Pt died prior to tx;
'6' FOR Recommended, not admin, no reason given;
'7' FOR Refusal;
'8' FOR Recommended, unknown if admin;
'9' FOR Unknown;
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: JAN 28, 2003
DESCRIPTION: Records the reason that no regional radiation therapy was administered to the primary site.
For further information see FORDS page 168.
165.5,76 REASON FOR NO CHEMOTHERAPY 3;36 SET
'0' FOR Chemo administered;
'1' FOR Chemo not recommended;
'2' FOR Contraindicated, autopsy-only cases;
'6' FOR Reason unk;
'7' FOR Pt refused chemo;
'8' FOR Chemo recommended, unk if administered;
'9' FOR Unk if administered, death cert-only cases;
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: AUG 07, 1997
DESCRIPTION: Record the reason the patient did not receive chemotherapy. REASON FOR NO CHEMOTHERAPY is useful
in survival analysis. It is a quality assurance monitor of appropriateness of treatment.
165.5,77 REASON FOR NO HORMONE THERAPY 3;37 SET
'0' FOR HT administered;
'1' FOR HT not recommended;
'2' FOR Contraindicated, autopsy-only cases;
'6' FOR Reason unk;
'7' FOR Pt refused HT;
'8' FOR HT recommended, unk if administered;
'9' FOR Unk if administered, death cert-only cases;
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: AUG 07, 1997
DESCRIPTION:
The reason the patient did not receive hormone therapy.
165.5,78 CONVERTED 24;6 SET
'Y' FOR YES;
'N' FOR NO;
LAST EDITED: FEB 01, 1996
DESCRIPTION: If this field is "YES" it means that the primary has had the pointers in fields
5,6,7,50.1,51.1,52.1,53.1,54.1,55.1,56.1,57.1 and 60 subfield 2 converted from pointers to the
ONCOLOGY CONTACT File (165) to pointers to the new ACOS NUMBER file (160.19) already, and should
not try to convert.
165.5,78.1 CONVERTED STAGED BY FIELDS 25;19 SET
'Y' FOR YES;
LAST EDITED: MAR 09, 2017
HELP-PROMPT: Enter 'Y' if this record had it's STAGED BY (CLINICAL) and STAGED BY (PATHOLOGIC) fields converted
to pointers to the Oncology Staged By Codes (#163) file.
DESCRIPTION: This field will flag the record as having the STAGED BY CLINICAL (#19) and STAGED BY PATHOLOGIC
(#89) fields converted for NAACCR Vol II V16. This conversion is done as part of Patch ONC*2.2*6
and this field will ensure that already converted records do not get converted again.
TECHNICAL DESCR:
This field should not be modified by user. It is set by the Post- Init routine of Patch ONC*2.2*6.
165.5,78.2 CONVERTED TNM FIELDS 25;20 SET
'Y' FOR YES;
LAST EDITED: MAR 09, 2017
HELP-PROMPT: Enter 'Y' if this record had its CLINICAL and PATHOLOGIC TNM fields converted to new NAACCR v16
format.
DESCRIPTION: This field will flag the record as having already converted the 6 TNM fields: CLINICAL T (#37.1),
CLINICAL N (#37.2), CLINICAL M (#37.3), PATHOLOGIC T (#85), PATHOLOGIC N (#86), PATHOLOGIC M (#87).
This conversion is being done in Patch ONC*2.2*6 as part of the update for NAACCR Vol II V16 and
will ensure that records that have already been converted will not be converted again.
TECHNICAL DESCR:
This field should not be modified by user. It is set by the Post- Init routine of Patch ONC*2.2*6.
165.5,79 SCREENING DATE 0;24 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(
0)
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: JUL 08, 1997
DESCRIPTION: Record the most recent date on which the patient participated in a screening program related to
this primary cancer.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,80 RADIATION TREATMENT 6;0 Multiple #165.52 (Add New Entry without Asking)
DESCRIPTION:
Record the type of radiation therapy.
165.52,.01 TARGET PLACE 0;1 FREE TEXT (Multiply asked)
INPUT TRANSFORM: K:$L(X)>24!($L(X)<3) X
LAST EDITED: OCT 07, 1987
HELP-PROMPT: ANSWER MUST BE 3-24 CHARACTERS IN LENGTH
DESCRIPTION:
Enter site irradiated.
CROSS-REFERENCE: 165.52^B
1)= S ^ONCO(165.5,DA(1),6,"B",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,DA(1),6,"B",$E(X,1,30),DA)
165.52,1 TARGET SITE 0;2 POINTER TO ICDO TOPOGRAPHY FILE (#164)
LAST EDITED: OCT 07, 1987
DESCRIPTION: This is the anatomic site toward which radiation treatment was directed, as listed in
International Classification of Diseases for Oncology, second edition.
165.52,2 RADIATION SOURCE 0;3 SET
'EB' FOR EXTERNAL BEAM;
'SS' FOR SEALED SOURCES;
'US' FOR UNSEALED SYSTEMIC;
'C' FOR COMBINATION;
'O' FOR OTHER;
'U' FOR UNKNOWN;
LAST EDITED: OCT 07, 1987
DESCRIPTION:
This is a code indicating the source of radiation.
165.52,3 TOTAL DOSE TO TARGET (cGy) 0;4 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9999)!(X<1)!(X?.E1"."1N.N) X
LAST EDITED: NOV 09, 1990
HELP-PROMPT: 1 cGy = 1 RAD 1Gy = 100 RADs
DESCRIPTION:
This is the total dose to the target site, in hundredths of grays.
EXECUTABLE HELP: I X="??" D RAD^ONCOHELP K X
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.52,4 # FRACTIONS 0;5 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<1)!(X?.E1"."1N.N) X
LAST EDITED: OCT 07, 1987
HELP-PROMPT: Type a Number between 1 and 99, 0 Decimal Digits
DESCRIPTION:
This is the number of fractions administered.
165.52,5 PREDOMINANT FXN SIZE (cGy) 0;6 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9999)!(X<1)!(X?.E1"."1N.N) X
LAST EDITED: OCT 07, 1987
HELP-PROMPT: Type a Number between 1 and 9999, 0 Decimal Digits
DESCRIPTION:
This is the predominant fraction size, in hundredths of grays.
165.52,6 # DAYS 0;7 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: JUL 21, 1993
HELP-PROMPT: Type a Number between 0 and 999, 0 Decimal Digits
DESCRIPTION:
This is the number of days of treatment administered.
165.52,7 START DATE 0;8 DATE
INPUT TRANSFORM:S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) I $D(X) S Y=$P(^ONCO(165.5,D0,6,D1,0),U,9) I
Y'="" K:X>Y X
LAST EDITED: FEB 04, 1997
HELP-PROMPT: START DATE must be before or equal to STOP DATE. Future dates are not allowed.
DESCRIPTION:
This is the date on which treatment began.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.52,8 STOP DATE 0;9 DATE
INPUT TRANSFORM:S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) I $D(X) S Y=$P(^ONCO(165.5,D0,6,D1,0),U,8) I
Y'="" K:X3!($L(X)<2) X
LAST EDITED: MAY 22, 1998
HELP-PROMPT: Answer must be 2-3 characters in length.
DESCRIPTION:
Record the initials of the person who completed the PCE.
165.5,82 REVIEWED BY CANCER COMMITTEE 7;13 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<2) X
LAST EDITED: MAY 22, 1998
HELP-PROMPT: Answer must be 2-3 characters in length.
DESCRIPTION: As a method of quality control, it is recommended that a member of the cancer committee review the
abstract for accuracy prior to the submission of data to the Commission on Cancer. Record the
initials of the chairman or member of the cancer committee who reviewed the completed PCE.
165.5,83 AFIP/JPC SUBMISSION 0;21 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JUN 02, 2011
HELP-PROMPT: Record if this case was submitted to the AFIP or JPC for a second opinion.
DESCRIPTION: AFIP/JPC SUBMISSION records whether the case was sent to the Armed Forces Institute of Pathology
(AFIP) or Joint Pathology Center (JPC) for a second opinion.
Effective April 1, 2011, all consultation cases must be sent to the Joint Pathology Center (JPC).
165.5,84 PCE INDICATOR 7;15 SET
'BLA' FOR Bladder;
'THY' FOR Thyroid;
'STS' FOR Soft Tissue Sarcoma;
'PRO' FOR Prostate (1992);
'COL' FOR Colorectal;
'NHL' FOR Non-Hodgkins Lymphoma;
'BRE' FOR Breast;
'PRO2' FOR Prostate (1998);
'MEL' FOR Melanoma;
'HEP' FOR Hepatocellular;
'CNS' FOR Intracranial/CNS;
'GAS' FOR Gastric;
'LNG' FOR Lung;
LAST EDITED: FEB 23, 2001
DESCRIPTION: This field indicates the existence of a PCE (Patient Care Evaluation) study.
CROSS-REFERENCE: 165.5^APCE
1)= S ^ONCO(165.5,"APCE",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"APCE",$E(X,1,30),DA)
This is a cross-reference of those primaries who have a PCE study.
165.5,85 PATHOLOGIC T 2.1;1 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="T",STGIND="P" D IN^ONCOTNM
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 23, 2017
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known
following the completion of surgical therapy.
EXECUTABLE HELP: N ONCOX,STGIND S ONCOX="T",STGIND="P" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,86 PATHOLOGIC N 2.1;2 FREE TEXT
INPUT TRANSFORM: K:$L(X)>8!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="N",STGIND="P" D IN^ONCOTNM
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 23, 2017
HELP-PROMPT: Answer must be 1-8 characters in length.
DESCRIPTION: Identifies the absence or presence of regional lymph node (N) metastasis and describes the extent
of regional lymph node metastasis of the tumor known following the completion of surgical therapy.
EXECUTABLE HELP: N ONCOX,STGIND S ONCOX="N",STGIND="P" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,87 PATHOLOGIC M 2.1;3 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="M",STGIND="P" D IN^ONCOTNM
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: FEB 23, 2017
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Identifies the presence or absence of distant metastasis (M) of the tumor known following the
completion of surgical therapy.
EXECUTABLE HELP: N ONCOX,STGIND S ONCOX="M",STGIND="P" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,88 STAGE GROUP PATHOLOGIC 2.1;4 FREE TEXT
INPUT TRANSFORM: K:$L(X)>14!($L(X)<1) X I $D(X) S ONCOX="S",STGIND="P" D IN^ONCOTNS I $D(X) D INNUM^ONCOTNS
OUTPUT TRANSFORM: S X="" D OT^ONCOTNS
LAST EDITED: DEC 14, 2005
DESCRIPTION: Identifies the anatomic extent of disease based on the T, N, and M elements as recorded by the
physician.
For futher information see FORDS page 121.
EXECUTABLE HELP: S ONCOX="S",STGIND="P" D HP^ONCOTNS
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AS2^MUMPS
1)= D PSSG^ONCOCRC
2)= D KSG^ONCOCRC
Maintains STAGE GROUPING-AJCC field (#38.5).
165.5,89 STAGED BY (PATHOLOGIC STAGE) 2.1;5 POINTER TO ONCOLOGY STAGED BY CODES FILE (#165.7)
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(165.7,Y,0),U,1)_" "_$P(^ONCO(165.7,Y,0),U,2)
LAST EDITED: APR 06, 2017
HELP-PROMPT: Record the role of the person who documented the Pathologic AJCC staging items and the Stage Group.
DESCRIPTION: Identifies the person who recorded the pathologic AJCC staging elements and the stage group in the
patient's medical record.
For further information refer to FORDS manual.
165.5,89.1 TNM PATHOLOGIC ; COMPUTED
MUMPS CODE: S STGIND="P",X=$$TNMOUT^ONCOTNO(D0)
ALGORITHM: S STGIND="P",X=$$TNMOUT^ONCOTNO(D0)
LAST EDITED: DEC 14, 2005
DESCRIPTION:
This is the combined Pathologic T, N, and M codes, formatted for display.
165.5,90 DATE CASE COMPLETED 7;1 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JUL 01, 2021
HELP-PROMPT: *** DATE CASE COMPLETED MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: The date that: (1) the abstractor decided that the case was complete, and (2) the abstract passed
all edit checks.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AAD^MUMPS
1)= S ^ONCO(165.5,"AAD",X,DA)=""
2)= K ^ONCO(165.5,"AAD",X,DA)
Used for QA - 10% abstracts completed in particular timeframe
165.5,91 ABSTRACT STATUS 7;2 SET
'0' FOR Incomplete;
'1' FOR Minimal data;
'2' FOR Partial;
'3' FOR Complete;
'A' FOR Accession only;
'D' FOR Pending delete;
INPUT TRANSFORM: D CHECK^ONCOEDC Q
LAST EDITED: SEP 26, 2023
HELP-PROMPT: Enter a code from the list that corresponds to the status of the abstract.
DESCRIPTION:
Enter the status of the abstract data entry.
EXECUTABLE HELP: D PRINT^ONCOEDC
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AS
1)= S ^ONCO(165.5,"AS",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"AS",$E(X,1,30),DA)
Allow sorting by status of abstract.
165.5,92 ABSTRACTED BY 7;3 POINTER TO NEW PERSON FILE (#200) (Required)
LAST EDITED: FEB 11, 2003
DESCRIPTION: Records the initials or assigned code of the individual abstracting the case.
For further information see FORDS page 207.
165.5,93 OTHER T 2.1;6 FREE TEXT
INPUT TRANSFORM: K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="T",STGIND="O" D IN^ONCOTNM
OUTPUT TRANSFORM: S ONCOX="T",STGIND="O" D OT^ONCOTNM
LAST EDITED: OCT 10, 1996
HELP-PROMPT: Answer must be appropriate "T" code from the AJCC Staging Manual
DESCRIPTION:
"Other T" evaluates the primary tumor and identifies tumor size and/or extension.
EXECUTABLE HELP: S ONCOX="T",STGIND="O" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,94 REPORTING DATE 7;5 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 03, 1997
HELP-PROMPT: *** REPORTING DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
Records automatically the default date as reporting date.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,95 LAST TUMOR STATUS 7;6 POINTER TO PRIMARY CANCER STATUS CODE FILE (#164.42)
Current Cancer Status
LAST EDITED: MAY 05, 1993
DESCRIPTION:
This field records the code that summarizes the cancer status.
TECHNICAL DESCR:
This field is populated by a call to LTS^ONCOU. This field is referenced directly by TRS^ONCOCOS.
SOURCE OF DATA: ACOS 3.118
GROUP: ACOS-REQUIRED
CROSS-REFERENCE: 165.5^ACS
1)= S ^ONCO(165.5,"ACS",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"ACS",$E(X,1,30),DA)
3)= NO DELTETE
DEVELOPERS NOTE: Please read the Technical Documentation for this field before making any changes
to this or any other cross-references for this field.
165.5,95.1 V STATUS/LAST TUMOR STATUS ; COMPUTED
MUMPS CODE: S X="" D TRS^ONCOCOS
ALGORITHM: S X="" D TRS^ONCOCOS
LAST EDITED: DEC 08, 2010
DESCRIPTION:
This COMPUTED field concatenates STATUS (160,15) and LAST TUMOR STATUS (165.5,95).
165.5,96 PSA DATE PRO2;50 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Record the date on which the PSA test was performed.
DESCRIPTION:
Records the date on which the Prostate Specific Antigen (PSA) test was performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,97 ABSTRACT INCOMPLETE ; BOOLEAN COMPUTED
MUMPS CODE: S Y(165.5,97,1)=$S($D(^ONCO(165.5,D0,7)):^(7),1:"") S X=$P(Y(165.5,97,1),U,2),X=X S X=X=0
9.2 = S Y(165.5,97,2)=$C(59)_$S($D(^DD(165.5,91,0)):$P(^(0),U,3),1:""),Y(165.5,97,1)=$S($D(^ONCO(16
5.5,D0,7)):^(7),1:"")
ALGORITHM: INTERNAL(#91)=0
LAST EDITED: AUG 10, 1990
DESCRIPTION:
RECORD THE ABSTRACT STATUS AS INCOMPLETE WHEN DATA IS MISSING.
TECHNICAL DESCR:
Looks at Internal value of field #91 (ABstract status) for those values=0
165.5,98 OTHER N 2.1;7 FREE TEXT
INPUT TRANSFORM: K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="N",STGIND="O" D IN^ONCOTNM
OUTPUT TRANSFORM: S ONCOX="N",STGIND="O" D OT^ONCOTNM
LAST EDITED: OCT 10, 1996
HELP-PROMPT: Answer must be appropriate "N" code from the AJCC Staging Manual
DESCRIPTION: "Other N" classifies the regional lymph nodes and describes the absence or presence and the extent
of node metastases.
EXECUTABLE HELP: S ONCOX="N",STGIND="O" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,99 OTHER M 2.1;8 FREE TEXT
INPUT TRANSFORM: K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="M",STGIND="O" D IN^ONCOTNM
OUTPUT TRANSFORM: S ONCOX="M",STGIND="O" D OT^ONCOTNM
LAST EDITED: JAN 15, 1997
HELP-PROMPT: Answer must be appropriate "M" code from the AJCC Staging Manual
DESCRIPTION: "Other M" records the presence or absence of distant metastases. Choose the lower (less advanced)
M category when there is any uncertainty.
EXECUTABLE HELP: S ONCOX="M",STGIND="O" D HP^ONCOTNM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,100 TEXT-PRIMARY SITE TITLE 8;1 FREE TEXT
INPUT TRANSFORM: K:$L(X)>40!($L(X)<1) X
LAST EDITED: OCT 12, 2000
HELP-PROMPT: ANSWER MUST BE 1-40 CHARACTERS IN LENGTH
DESCRIPTION: Text area for description of primary site in natural language.
165.5,101 TEXT-HISTOLOGY TITLE 8;2 FREE TEXT
INPUT TRANSFORM: K:$L(X)>40!($L(X)<1) X
LAST EDITED: OCT 12, 2000
HELP-PROMPT: Answer must be 1-40 characters in length.
DESCRIPTION: Text area for description of histologic type, behavior, and grade in natural language.
165.5,102 DRE +/- 24;10 SET
'0' FOR Clinically normal;
'1' FOR Clinically abnormal;
'9' FOR Not done/not documented;
LAST EDITED: AUG 15, 2007
HELP-PROMPT: Enter the DRE (Digital Rectal Examination) results.
DESCRIPTION: A clinically inapparent tumor is one that is neither palpable nor reliably visible by imaging. An
apparent tumor is palpable or visible by imaging.
DO NOT INFER inapparent or apparent tumor based on the registrar's interpretation of terms in the
DRE or imaging reports. A physician assignment of cT1C or cT2 is a clear statement of inapparent or
apparent respectively.
165.5,103 TEXT-DX PROC-OP 9;0 WORD-PROCESSING #165.5103 (NOWRAP)
DESCRIPTION:
Free text field.
165.5,104 TEXT-DX PROC-PE 10;0 WORD-PROCESSING #165.5104 (NOWRAP)
DESCRIPTION: Text area for information from history and physical examinations.
165.5,105 TEXT-DX PROC-X-RAY/SCAN 11;0 WORD-PROCESSING #165.5105 (NOWRAP)
DESCRIPTION:
Free text field.
165.5,106 TEXT-DX PROC-SCOPES 12;0 WORD-PROCESSING #165.5106 (NOWRAP)
DESCRIPTION:
Free text field.
165.5,107 TEXT-DX PROC-PATH 13;0 WORD-PROCESSING #165.5107 (NOWRAP)
DESCRIPTION:
Free text field.
165.5,108 RX TEXT-SURGERY 14;0 WORD-PROCESSING #165.5108 (NOWRAP)
LAST EDITED: OCT 13, 2000
DESCRIPTION:
Free text field.
165.5,109 RX TEXT-RADIATION 15;0 WORD-PROCESSING #165.5109 (NOWRAP)
LAST EDITED: JUN 04, 2003
DESCRIPTION:
Free text field.
165.5,110 RX TEXT-RADIATION OTHER 16;0 WORD-PROCESSING #165.53 (NOWRAP)
LAST EDITED: OCT 13, 2000
DESCRIPTION:
Free text field.
165.5,111 RX TEXT-CHEMO 17;0 WORD-PROCESSING #165.5111 (NOWRAP)
LAST EDITED: OCT 13, 2000
DESCRIPTION:
Free text field.
165.5,112 RX TEXT-HORMONE 18;0 WORD-PROCESSING #165.5112 (NOWRAP)
LAST EDITED: OCT 13, 2000
DESCRIPTION:
Free text field.
165.5,113 TEXT-REMARKS 19;0 WORD-PROCESSING #165.5113 (NOWRAP)
LAST EDITED: MAY 18, 1990
DESCRIPTION:
Free text field.
165.5,114 RX TEXT-BRM 20;0 WORD-PROCESSING #165.5114 (NOWRAP)
LAST EDITED: OCT 13, 2000
DESCRIPTION:
Free text field.
165.5,115 RX TEXT-OTHER 21;0 WORD-PROCESSING #165.5115 (NOWRAP)
LAST EDITED: OCT 13, 2000
DESCRIPTION:
Free text field.
165.5,116 TEXT-DX PROC-LAB TESTS 22;0 WORD-PROCESSING #165.5116 (NOWRAP)
LAST EDITED: OCT 13, 2000
DESCRIPTION: Text area for information from laboratory examinations other than cytology and histopatholgy.
165.5,117 OTHER STAGE GROUP 2.1;9 FREE TEXT
INPUT TRANSFORM: K:$L(X)>14!($L(X)<1) X S ONCOX="S",STGIND="O" D IN^ONCOTNS I $D(X) D INNUM^ONCOTNS
OUTPUT TRANSFORM: S X="" D OT^ONCOTNS
LAST EDITED: NOV 24, 1997
HELP-PROMPT: Answer with the appropriate stage from the AJCC Staging Manual.
DESCRIPTION: Record the apparent extent of disease in accordance with AJCC staging requirements.
Stage codes:
0 IB III IVB 0A IC IIIA IVC Occult II IIIB Not
applicable 0is IIA IIIC Unknown I IIB IV IA IIC IVA
EXECUTABLE HELP: S ONCOX="S",STGIND="O" D HP^ONCOTNS
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,118 STAGED BY (OTHER STAGE) 2.1;10 SET
'0' FOR Not staged;
'1' FOR Managing physician;
'2' FOR Pathologist;
'3' FOR Other physician;
'4' FOR Any combination of 1, 2, or 3;
'5' FOR Registrar;
'6' FOR Any combination of 5 with 1, 2, or 3;
'7' FOR Other;
'8' FOR Staged, individual not specified;
'9' FOR Unk if staged;
LAST EDITED: APR 19, 1999
DESCRIPTION: "Staged By (Other Stage)" identifies the person who documented the other AJCC staging elements and
the stage group. The Commission requires analytic cases to be staged by the managing physician.
Compliance with Commission-approved program requirements can be analyzed using this data.
165.5,119 SCREENING RESULT 0;25 SET
'0' FOR Within normal limits;
'1' FOR Abnormal/not suggestive of cancer;
'2' FOR Abnormal/suggestive of cancer;
'3' FOR Equivocal/no followup necessary;
'4' FOR Equivocal/evaluation recommended;
'8' FOR NA;
'9' FOR Unknown result, not specified;
LAST EDITED: JUL 16, 1997
DESCRIPTION: This item categorizes findings from the most recent screening(s), serves as a triage for patient
notification, and acts as a tickler file to aid the institution in meeting patient notification
requirements.
165.5,120 PRESENTATION AT CANCER CONF 0;26 SET
'0' FOR Not presented;
'1' FOR Prospective (diagnostic);
'2' FOR Prospective (treatment);
'3' FOR Prospective (follow-up);
'4' FOR Prospective (combinations);
'5' FOR Prospective, NOS;
'6' FOR Retrospective;
'7' FOR Follow-up;
'8' FOR Presentation, NOS;
'9' FOR Unknown;
LAST EDITED: NOV 12, 1996
DESCRIPTION: This item documents case presentation at a cancer conference and the type or format of
presentation. The number of cancer conferences, sites presented, and types of presentation can be
analyzed and reported for administrative use, quality control, and survey preperation.
165.5,121 DATE OF CANCER CONF 0;27 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(
0) W:'$D(X) !,"Future dates are not allowed"
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: JAN 30, 2001
HELP-PROMPT: Enter the Date of Cancer Conference
DESCRIPTION: Enter the date on which the case was first presented at a cancer conference. The number of cancer
conferences, sites presented, types of presentations, and dates can be analyzed and reported for
administration, quality control, and Commission on Cancer survey preparation. Update this item if
a patient is presented at a subsequent cancer conference.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,122 REFERRAL TO SUPPORT SERVICES 0;28 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: NOV 12, 1996
DESCRIPTION: Record if the patient was referred to any of the following services.
Enterostomal/stomal therapy
Home care
Hospice
Infusion/parenteral therapy
Nutritionist
Occupational therapy
Other
Patient services (American Cancer Society)
Patient services (other)
Patient support group (American Cancer Society)
Patient support group (hospital operated)
Patient support group (other organization/agency)
Physical therapy
Referral; service unspecified
Rehabilitation facility
Respiratory therapy
Speech therapy
Visiting nurse assistance
165.5,123 INPATIENT/OUTPATIENT STATUS 0;23 SET
'1' FOR Inpatient only;
'2' FOR Outpatient only;
'3' FOR In and outpatient;
'8' FOR Other, including physician's office;
'9' FOR Unknown;
LAST EDITED: DEC 20, 1996
DESCRIPTION: "Inpatient/Outpatient Status" allows the facility to identify points of access used to initially
diagnose and/or treat the patient.
165.5,124 DATE OF NO TREATMENT 2.1;11 DATE
INPUT TRANSFORM: D NTIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: OCT 28, 1997
HELP-PROMPT: *** DATE OF NO TREATMENT MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: If, for any reason, the patient is not treated, record the date of this decision as the DATE OF NO
TREATMENT. The physician may decide not to treat the patient because of comorbid conditions,
advanced disease, or because the accepted management of the cancer is to observe until the disease
progresses or until the patient becomes symptomatic. The patient may also refuse treatment.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATN^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"N")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"N")
Records NO TREATMENT DECISION DATE on the unified treatment index.
CROSS-REFERENCE: 165.5^AK^MUMPS
1)= Q
2)= S NTDEL="" D DEL^ONCDTX
165.5,125 RADIATION TREATMENT VOLUME 3;21 POINTER TO RADIATION TREATMENT VOLUME FILE (#164.7)
INPUT TRANSFORM: S V=1 D NT^ONCODSR
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(164.7,Y,0),"^",2)
LAST EDITED: SEP 02, 1997
DESCRIPTION: Identifies the volume or anatomic target of the most clinically significant regional radiation
therapy delivered to the patient during the first course of treatment.
For further information see FORDS pages 151-154.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,126 LOCATION OF RADIATION TX 3;22 SET
'0' FOR No radiation tx;
'1' FOR All radiation tx at this fac;
'2' FOR Regional tx at this fac, boost elsewhere;
'3' FOR Boost at this fac, regional elsewhere;
'4' FOR All radiation tx elsewhere;
'8' FOR Other;
'9' FOR Unknown;
INPUT TRANSFORM: S V=0 D NT^ONCODSR
LAST EDITED: JAN 09, 2003
DESCRIPTION: Identifies the location of the facility where radiation therapy was administered during the first
course of treatment.
For further information see FORDS page 150.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,127 INTENT OF RADIATION 3;29 SET
'0' FOR No radiation;
'1' FOR Curative (primary);
'2' FOR Curative (adjuvant);
'4' FOR Palliative (pain control);
'5' FOR Palliative (other, cosmetic);
'6' FOR Prophylactic (no symptoms, preventive);
'8' FOR Other, NOS;
'9' FOR Unknown;
LAST EDITED: APR 02, 2012
DESCRIPTION: Code the intent of radiation treatment.
This item is useful in assessing the appropriateness of treatment and correlating outcome with
original intent of the treatment. The choice in this data field is subjective.
The responsible radiation oncologist is the best person to provide this information.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: ^^TRIGGER^165.5^262
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,12
),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,127,1,1,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,12)=DIV,DIH=165.5,DIG=262 D ^DICR
2)= Q
CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0
DELETE VALUE)= NO EFFECT
FIELD)= #262
CROSS-REFERENCE: ^^TRIGGER^165.5^260
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,10
),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,127,1,2,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,10)=DIV,DIH=165.5,DIG=260 D ^DICR
2)= Q
CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0
DELETE VALUE)= NO EFFECT
FIELD)= #260
165.5,128 RADIATION COMPLETION STATUS 3;39 POINTER TO RADIATION COMPLETION STATUS FILE (#164.8)
INPUT TRANSFORM: S V=1 D NT^ONCODSR
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(164.8,Y,0),U,2)
LAST EDITED: JUN 03, 1998
DESCRIPTION: RADIATION COMPLETION STATUS is useful in evaluating treatment outcomes and the appropriateness of
the initial decision to treat.
This field indicates whether the patient's radiation therapy was completed as outlined in the
initial treatment plan. This information is generally available only in the radiation treatment
chart.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,129 RADIATION AUXILIARY VOLUME 3.1;1 POINTER TO RADIATION TREATMENT VOLUME FILE (#164.7)
INPUT TRANSFORM: S V=1 D NT^ONCODSR
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(164.7,Y,0),"^",2)
LAST EDITED: SEP 29, 1998
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,130 RADIATION AUXILIARY DATE 3.1;2 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 11, 1998
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,131 RADIATION AUXILIARY TEXT 15.1;0 WORD-PROCESSING #165.5131
LAST EDITED: AUG 25, 1997
165.5,132 RADIATION LOCAL CONTROL STATUS 3.1;3 SET
'0' FOR No radiation;
'1' FOR Tumor control status not evaluable;
'2' FOR Tumor/symptoms controlled;
'3' FOR Tumor/symptoms returned;
'4' FOR Tumor/symptoms never controlled;
'8' FOR Other, NOS;
'9' FOR Unknown;
INPUT TRANSFORM: S V=0 D NT^ONCODSR
LAST EDITED: OCT 03, 1997
DESCRIPTION: RADIATION LOCAL CONTROL STATUS records the radiation treatment results in terms of disease control
within the irradiated volume. The data may be used in quality assurance studies to assess the
effectiveness of treatment. This is a dynamic data item. To be clinically useful, this data must
be evaluated at each follow-up.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,133 YEAR PUT ON PROTOCOL 3.1;4 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<4)!'(X?4N) X
LAST EDITED: MAR 18, 1998
HELP-PROMPT: Answer must be a 4-digit year.
DESCRIPTION: Record the year in which the patient was entered into a protocol.
165.5,134 CLINICAL RISK FACTORS 2.1;12 SET
'0' FOR None;
'1' FOR hCG > 100,000 IU/24-hour urine;
'2' FOR Detection > 6 mo from term of pregnancy;
'3' FOR Both;
'U' FOR Unknown;
'L' FOR Low risk;
'H' FOR High risk;
LAST EDITED: AUG 19, 2010
DESCRIPTION: For Gestational Trophoblastic Tumors FIGO added nonsurgical-pathologic prognostic risk factors to
the classic anatomic staging system. These include B-hCG levels of greater than 100,000 and the
detection of disease more than 6 months from termination of the antecedent pregnancy. These risk
factors affect staging.
SCREEN: S DIC("S")="N ONCOED S ONCOED=$$TNMED^ONCOU55(D0) I ((ONCOED<6)&(Y?1N))!((ONCOED>5)&(Y?1A))"
EXPLANATION: For 1st-5th edition staging use codes 0-3. For 6th or greater edition staging use codes U, L and H
.
165.5,135 PATHOLOGIC RISK FACTORS 2.1;13 SET
'0' FOR None;
'1' FOR hCG > 100,000 IU/24-hour urine;
'2' FOR Detection > 6 mo from term of pregnancy;
'3' FOR Both;
'U' FOR Unknown;
'L' FOR Low risk;
'H' FOR High risk;
LAST EDITED: AUG 19, 2010
DESCRIPTION: For Gestational Trophoblastic Tumors FIGO added nonsurgical-pathologic prognostic risk factors to
the classic anatomic staging system. These include B-hCG levels of greater than 100,000 and the
detection of disease more than 6 months from termination of the antecedent pregnancy. These risk
factors affect staging.
SCREEN: S DIC("S")="N ONCOED S ONCOED=$$TNMED^ONCOU55(D0) I ((ONCOED<6)&(Y?1N))!((ONCOED>5)&(Y?1A))"
EXPLANATION: For 1st-5th edition staging use codes 0-3. For 6th or greater edition staging use codes U, L and H
.
165.5,136 SERUM TUMOR MARKERS 24;8 SET
'SX' FOR Not available;
'S0' FOR Normal;
'S1' FOR LDH < 1.5XN, hCG < 5000 mIU/ml, AFP < 1000 ng/ml;
'S2' FOR LDH 1.5-10XN or hCG 5000-50,000 mIu/ml or AFP 1000-10,000 ng/ml;
'S3' FOR LDH > 10XN or hCG > 50,000 mIu/ml or AFP > 10,000 ng/ml;
OUTPUT TRANSFORM: S FILNUM=165.5,FLDNUM=136 D SOC^ONCOOT
LAST EDITED: JAN 29, 1998
DESCRIPTION: Serum Tumor Markers (S)
SX Marker studies not available or not performed S0 Marker study levels within normal limits* S1
LDH < 1.5 X N AND
hCG (mIU/ml) < 5000 AND
AFP (ng/ml) < 1000 S2 LDH 1.5-10 X N OR
hCG (mIu/ml) 5000-50,000 OR
AFP (ng/ml) 1000-10,000 S3 LDH > 10 X N OR
hCG (mIu/ml) > 50,000 OR
AFP (ng/ml) > 10,000
N indicates the upper limit of normal for the LDH assay. * Check with your laboratory for normal
limits values.
165.5,137 DATE OF 1ST POSITIVE BIOPSY 2.2;1 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: FEB 04, 1998
DESCRIPTION: Record the date of the first positive incisional or excisional biopsy. The biopsy may be taken
from the primary or a secondary site. This data item refers to a tissue biopsy/positive histology
only. The first positive biopsy may be at any time during the disease course. It may be non
cancer-directed or cancer-directed surgery.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,138 SCOPE OF LN SURGERY (R) 3;40 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S FIELD=138,NTXDD=1 D SCIT^ONCOSUR1
OUTPUT TRANSFORM: S FIELD=138 D SCOT^ONCOSUR1 K FIELD
LAST EDITED: MAR 27, 2003
DESCRIPTION: Record the scope of regional lymph node surgery.
For further information see ROADS page 192.
EXECUTABLE HELP: S FIELD=138 D SCHP^ONCOSUR1 K FIELD
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ASC^MUMPS
1)= Q
2)= D SCOPE^ONCDTX
165.5,138.1 SCOPE OF LN SURGERY @FAC (R) 3.1;9 FREE TEXT
INPUT TRANSFORM: S SCPFLG=0 D SCPDFIT^ONCTXSM K:$L(X)>1!($L(X)<1)!'(X?1N) X I $D(X),SCPFLG=0 S FIELD=138.1,NTXDD=1 D
SCIT^ONCOSUR1
OUTPUT TRANSFORM: S FIELD=138.1 D SCOT^ONCOSUR1 K FIELD
LAST EDITED: APR 03, 2007
DESCRIPTION: Record the scope of regional lymph node surgery done AT THIS FACILITY.
For further information see ROADS page 190.
EXECUTABLE HELP: S FIELD=138.1 D SCHP^ONCOSUR1 K FIELD
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ASCF^MUMPS
1)= Q
2)= D SCPATF^ONCDTX1
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,138.2 SCOPE OF LN SURGERY DATE 3.1;22 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000",ONC138P2="YES" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAY 31, 2022
HELP-PROMPT: *** SCOPE OF LN SURGERY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
Record the date that SCOPE OF LN SURGERY was performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATSC^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"S2")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"S2")
Records the scope of regional lymph node surgery date on the unified treatment index.
165.5,138.3 SCOPE OF LN SURGERY @FAC DATE 3.1;23 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000",ONC138P2="YES" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAY 31, 2022
HELP-PROMPT: *** SCOPE OF LN SURGERY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
Record the date that SCOPE OF LN SURGERY @FAC was performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,138.4 SCOPE OF LN SURGERY (F) 3.1;31 SET
'0' FOR None;
'1' FOR Bx/aspiration, NOS;
'2' FOR Sentinel Bx;
'3' FOR Nodes removed, num unk;
'4' FOR 1-3 nodes removed;
'5' FOR 4 or more nodes removed;
'6' FOR Sentinel + 3, 4 or 5, timing not stated;
'7' FOR Sentinel + 3, 4, or 5, diff times;
'9' FOR Unknown/NA;
LAST EDITED: MAR 19, 2003
DESCRIPTION: Identifies the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of
the primary site or during a separate surgical event.
For further information see FORDS pages 138-139.
CROSS-REFERENCE: 165.5^ASC^MUMPS
1)= Q
2)= D SCOPE^ONCDTX
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,138.5 SCOPE OF LN SURGERY @FAC (F) 3.1;32 SET
'0' FOR None;
'1' FOR Bx/aspiration, NOS;
'2' FOR Sentinel Bx;
'3' FOR Nodes removed, num unk;
'4' FOR 1-3 nodes removed;
'5' FOR 4 or more nodes removed;
'6' FOR Sentinel + 3, 4 or 5, timing not stated;
'7' FOR Sentinel + 3, 4, or 5, diff times;
'9' FOR Unknown/NA;
LAST EDITED: MAR 19, 2003
DESCRIPTION: Identifies the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of
the primary site or during a separate surgical event at this facility.
For further information see FORDS pages 140-141.
CROSS-REFERENCE: 165.5^ASCF^MUMPS
1)= Q
2)= D SCPATF^ONCDTX1
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,139 SURG PROC/OTHER SITE (R) 3;41 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S FIELD=139,NTXDD=1 D SOIT^ONCOSUR1
OUTPUT TRANSFORM: S FIELD=139 D SOOT^ONCOSUR1 K FIELD
LAST EDITED: APR 01, 2003
DESCRIPTION: Enter the code for surgery of other regional site(s), distant site(s) or distant lymph node(s).
For further information see ROADS page 194.
EXECUTABLE HELP: S FIELD=139 D SOHP^ONCOSUR1 K FIELD
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ASO^MUMPS
1)= Q
2)= D SOSNR^ONCDTX
165.5,139.1 SURG PROC/OTHER SITE @FAC (R) 3.1;10 FREE TEXT
INPUT TRANSFORM: S SOSFLG=0 D SOSDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X),SOSFLG=0 S FIELD=139.1,NTXDD=1
D SOIT^ONCOSUR1
OUTPUT TRANSFORM: S FIELD=139.1 D SOOT^ONCOSUR1 K FIELD
LAST EDITED: MAR 27, 2003
DESCRIPTION: Enter the code for surgery of other regional site(s), distant site(s) or distant lymph node(s)
performed AT THIS FACILITY.
For further information see ROADS page 190.
EXECUTABLE HELP: S FIELD=139.1 D SOHP^ONCOSUR1 K FIELD
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ASOF^MUMPS
1)= Q
2)= D SOSNATF^ONCDTX1
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,139.2 SURG PROC/OTHER SITE DATE 3.1;24 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: NOV 05, 2004
HELP-PROMPT: *** SURG PROC/OTHER SITE DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Records the date of surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the
primary site.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATSO^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"S3")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"S3")
Records the surgery of other sites/nodes date on the unified treatment index.
165.5,139.3 SURG PROC/OTHER SITE @FAC DATE 3.1;25 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JAN 07, 2003
HELP-PROMPT: *** SURG PROC/OTHER SITE @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
Record the date that SURG PROC/OTHER SITE @FAC was performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,139.4 SURG PROC/OTHER SITE (F) 3.1;33 SET
'0' FOR None;
'1' FOR Nonprimary surg proc performed;
'2' FOR Nonprimary surg proc/other regional sites;
'3' FOR Nonprimary surg proc/distant lymph node(s);
'4' FOR Nonprimary surg proc/distant site;
'5' FOR Combination of codes;
'9' FOR Unknown;
LAST EDITED: MAR 19, 2003
DESCRIPTION: Records the surgical removal of distant lymph nodes or other issue(s)/organ(s) beyond the primary
site.
For further information see FORDS page 142.
CROSS-REFERENCE: 165.5^ASO^MUMPS
1)= Q
2)= D SOSN^ONCDTX
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,139.5 SURG PROC/OTHER SITE @FAC (F) 3.1;34 SET
'0' FOR None;
'1' FOR Nonprimary surg proc performed;
'2' FOR Nonprimary surg proc/other regional sites;
'3' FOR Nonprimary surg proc/distant lymph node(s);
'4' FOR Nonprimary surg proc/distant site;
'5' FOR Combination of codes;
'9' FOR Unknown;
LAST EDITED: MAR 19, 2003
DESCRIPTION: Records the surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the primary
site at this facility.
For further information see FORDS page 143.
CROSS-REFERENCE: 165.5^ASOF^MUMPS
1)= Q
2)= D SOSNATF^ONCDTX1
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,139.6 METS SITE RESECTED 3.1;41 SET
'1' FOR Peritoneum;
'2' FOR Lung;
'3' FOR Pleura;
'4' FOR Liver;
'5' FOR Bone;
'6' FOR Brain;
'7' FOR Skin;
'8' FOR Distant LNS;
'9' FOR Other;
LAST EDITED: AUG 07, 2013
HELP-PROMPT: Enter the appropriate site from the list.
DESCRIPTION:
This is the Metastatic Site Resected for the First Course of Treatment.
165.5,139.7 METS SITE RESECTED DATE 3.2;1 DATE
INPUT TRANSFORM: S %DT="E" D ^%DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JAN 23, 2014
HELP-PROMPT: Enter the date the Metastatic Site was resected.
DESCRIPTION: This is the date the Metastatic Site was resected. The date must be after or equal to the DATE DX
(#3) field.
165.5,140 NUMBER OF LN REMOVED (R) 3;42 NUMBER
INPUT TRANSFORM: K:X'?1.2N X I $D(X) S NTXDD=1 S X=+X K:X>99!(X<0) X I $D(X) D NRIT^ONCOSUR1
OUTPUT TRANSFORM: D NROT^ONCOSUR1
LAST EDITED: MAR 19, 2003
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the number of regional lymph nodes that were microscopically examined and identified in the
pathology report FOR THIS SURGICAL PROCEDURE ONLY. DO NOT add numbers of nodes removed during
different surgical events.
00 for No nodes removed
01 for 1 node removed
02 for 2 nodes removed
...
90 for 90 or more nodes removed
95 for No nodes removed, aspiration performed
96 for Node removal as a sampling, number unknown
97 for Node removal as dissection, number unknown
98 for Nodes surgically removed, number unknown
99 for Unknown, not stated, death cert ONLY
For further information see ROADS page 193.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,140.1 NUMBER OF LN REMOVED @FAC (R) 3.1;11 FREE TEXT
INPUT TRANSFORM: D NUMDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S NTXDD=1 S X=+X K:X>99!(X<0) X I $D(X) D
NRIT^ONCOSUR1
OUTPUT TRANSFORM: D NROT^ONCOSUR1
LAST EDITED: JAN 07, 2003
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the number of regional lymph nodes that were microscopically examined and identified at
this facility in the pathology report FOR THIS SURGICAL PROCEDURE ONLY. DO NOT add numbers of
nodes removed during different surgical events.
00 for No nodes removed
01 for 1 node removed
02 for 2 nodes removed
...
90 for 90 or more nodes removed
95 for No nodes removed, aspiration performed
96 for Node removal as a sampling, number unknown
97 for Node removal as dissection, number unknown
98 for Nodes surgically removed, number unknown
99 for Unknown, not stated, death cert ONLY
For further information see ROADS page 190.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,141 BIOPSY PROCEDURE 2.1;14 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D BP^ONCOIT
OUTPUT TRANSFORM: D BP^ONCOOT
LAST EDITED: JUL 10, 2001
DESCRIPTION: Records the biopsy procedure if the primary site is breast or prostate.
EXECUTABLE HELP: D BP^ONCOHELP
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,142 GUIDANCE 2.1;15 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D GUIT^ONCOTNMX
OUTPUT TRANSFORM: D GUOT^ONCOTNMX
LAST EDITED: AUG 27, 1998
HELP-PROMPT: Type a Number between 0 and 9, 0 Decimal Digits
DESCRIPTION:
Records the guidance if the primary site is breast or prostate.
EXECUTABLE HELP: D GUHP^ONCOTNMX
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,143 PALPABILITY OF PRIMARY 2.1;16 SET
'0' FOR Not palpable;
'1' FOR Palpable;
'9' FOR Not stated/death cert only;
LAST EDITED: FEB 04, 1998
DESCRIPTION:
Records the palpability of primary if the primary site is breast.
165.5,144 FIRST DETECTED BY 2.1;17 SET
'0' FOR Not a breast primary;
'1' FOR Patient felt lump/nipple discharge;
'2' FOR Physician felt lump;
'3' FOR Mammography - routine;
'4' FOR Occult, incidental finding;
'9' FOR Unknown;
LAST EDITED: FEB 04, 1998
DESCRIPTION:
Records how it was first detected if the primary site is breast.
165.5,145 APPROACH FOR BIOPSY OF PRIMARY 2.1;18 SET
'0' FOR No biopsy;
'1' FOR Transrectal;
'2' FOR Transperineal;
'3' FOR Transurethral;
'4' FOR Laparoscopic;
'5' FOR Open (laparotomy);
'9' FOR Unknown/death cert only;
LAST EDITED: FEB 09, 1998
DESCRIPTION:
Records the approach for biopsy of primary if the primary site is prostate.
165.5,146 BIOPSY OF OTHER THAN PRIMARY 2.1;19 SET
'0' FOR None;
'1' FOR Seminal vesicle(s), NOS;
'2' FOR Unilateral;
'3' FOR Bilateral;
'4' FOR Other than seminal vesicle;
'5' FOR 4 + 1;
'6' FOR 4 + 2;
'7' FOR 4 + 3;
'9' FOR Unknown/death cert only;
LAST EDITED: FEB 09, 1998
DESCRIPTION:
Records the biopsy of other than primary site if the primary site is prostate.
165.5,147 CENSUS TRACT 0;29 FREE TEXT
INPUT TRANSFORM: K:$L(X)>6!($L(X)<1)!'(X?1.6N) X
LAST EDITED: JUN 27, 2000
HELP-PROMPT: Answer must be 6 characters in length, all numeric.
DESCRIPTION: CENSUS TRACT identifies the patient's usual residence at the time the tumor was diagnosed.
A CENSUS TRACT is a small statistical subdivision of a county.
To code CENSUS TRACT, assume the decimal point is between the fourth and fifth positions of the
field. Add zeros to fill all six positions.
Example: CENSUS TRACT 409.6 would be coded 040960, and CENSUS TRACT
516.21 would be coded 051621.
000000 Area is not census tracted 999999 Area is census tracted, but census tract is not
available
165.5,148 OTHER CANCER 0;30 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: APR 24, 2009
HELP-PROMPT: Answer 'Yes' if the patient has other reportable malignancies.
DESCRIPTION:
Records if the patient has other reportable malignancies.
165.5,148.1 CANCER #1 0;31 POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2)
LAST EDITED: APR 24, 2009
HELP-PROMPT: If not applicable for this patient, choose NOT APPLICABLE.
DESCRIPTION: Records the 1st OTHER CANCER associated with this patient.
If not applicable for this patient, choose NOT APPLICABLE.
165.5,148.2 CANCER #2 0;32 POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2)
LAST EDITED: JAN 24, 2003
HELP-PROMPT: If not applicable for this patient, choose NOT APPLICABLE.
DESCRIPTION: Records the 2nd OTHER CANCER associated with this patient.
If not applicable for this patient, choose NOT APPLICABLE.
165.5,148.3 CANCER #3 0;33 POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2)
LAST EDITED: JAN 24, 2003
HELP-PROMPT: If not applicable for this patient, choose NOT APPLICABLE.
DESCRIPTION: Records the 3rd OTHER CANCER associated with this patient.
If not applicable for this patient, choose NOT APPLICABLE.
165.5,148.4 CANCER #4 0;34 POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2)
LAST EDITED: JAN 24, 2003
HELP-PROMPT: If not applicable for this patient, choose NOT APPLICABLE.
DESCRIPTION: Records the 4th OTHER CANCER associated with this patient.
If not applicable for this patient, choose NOT APPLICABLE.
165.5,149 LYMPH-VASCULAR INVASION (L) 2;19 SET
'0' FOR Not present;
'1' FOR LVI present-NOT for C73-C74;
'2' FOR Lym&sm vessel inv only OR lym only (C73-C74 ONLY);
'3' FOR Ven OR Angio (C73-C74 ONLY);
'4' FOR Lym&sm & ven/lg vessel inv OR lymph & angioinv (C73-C74 ONLY);
'8' FOR N/A;
'9' FOR UNK;
LAST EDITED: AUG 01, 2022
HELP-PROMPT: Enter the appropriate code. Allowable values are based on schema ID; refer to STORE manual pp.
152-156 for instructions for 2018+ cases.
DESCRIPTION: Indicates the presence or absence of tumor cells in lymphatic channels (not lymph nodes) or blood
vessels within the primary tumor as noted microscopically by the pathologist. LVI includes
lymphatic invasion, vascular invasion, and lymphovascular invasion.
Codes: 0 Lymphovascular Invasion stated as Not Present 1 Lymphovascular Invasion
Present/Identified (NOT
used for thyroid and adrenal) 2 Lymphatic and small vessel invasion only (L)
OR
Lymphatic invasion only (thyroid and adrenal only) 3 Venous (large vessel) invasion only (V)
OR
Angioinvasion (thyroid and adrenal gland only) 4 BOTH lymphatic and small vessel AND venous
(large
vessel) invasion
OR
BOTH lymphatic AND angioinvasion (thyroid and
adrenal only) 8 Not Applicable 9 Unknown/Indeterminate/not mentioned in path report
SCREEN: S DIC("S")="D SCRNLV^ONCSCHMM"
EXPLANATION: For <2018 cases only 0,1,8,9 are selectable; For 2018+ cases codes depend on Schema
165.5,150 FOLLOW-UP HISTORY ; COMPUTED
MUMPS CODE: S X="" D FHP^ONCODLF
ALGORITHM: S X="" D FHP^ONCODLF
DESCRIPTION:
RECORDS ALL FOLLOW SUCCESSFULLY COMPLETED.
165.5,151 VENOUS INVASION (V) 2;29 SET
'X' FOR Venous invasion cannot be assessed;
'0' FOR No venous invasion;
'1' FOR Microscopic venous invasion;
'2' FOR Macroscopic venous invasion;
LAST EDITED: OCT 22, 2002
DESCRIPTION:
VENOUS INVASION records whether venous invasion was involved.
165.5,152 DATE SYSTEMIC THERAPY STARTED ; COMPUTED
MUMPS CODE: S X="" D DSTS^ONCOCOM
ALGORITHM: S X="" D DSTS^ONCOCOM
LAST EDITED: FEB 10, 2003
DESCRIPTION: Records the date of initiation for systemic therapy that is part of the first course of treatment.
Systemic therapy includes the administration of chemotherapy agents, hormonal agents, biological
response modifiers, bone marrow transplants, stem cell harvests, and surgical and/or radiation
endocrine therapy.
For further information see FORDS pages 169-170.
165.5,153 HEMA TRANS/ENDOCRINE PROC 3.1;36 POINTER TO HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES FILE (#167)
OUTPUT TRANSFORM: I Y'="" S Y=$P($G(^ONCO(167,Y,0)),U,2)
LAST EDITED: MAY 16, 2003
DESCRIPTION: Identifies systemic therapeutic procedures administered as part of the first course of treatment
at this and all other facilities. If none of these procedures were administered, then this item
records the reason they were not performed. These include bone marrow transplants, stem cell
harvests, surgical and/or radiation endocrine therapy.
For further information see FORDS pages 182-183.
CROSS-REFERENCE: 165.5^AE^MUMPS
1)= Q
2)= D HTEP^ONCDTX
165.5,153.1 HEMA TRANS/ENDOCRINE PROC DATE 3.1;35 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAY 15, 2003
HELP-PROMPT: *** HEMA TRANS/ENDOCRINE PROC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
Records the date on which hematologic transplant and endocrine procedures were performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATE^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"E")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"E")
Records the hematologic transplant and endocrine procedures date on the unified treatment index.
165.5,153.2 HEMA TRANS/ENDOCRINE PROC @FAC 3.2;2 POINTER TO HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES FILE (#167)
OUTPUT TRANSFORM: I Y'="" S Y=$P($G(^ONCO(167,Y,0)),U,2)
LAST EDITED: FEB 10, 2016
HELP-PROMPT: Enter a Hematologic Transplant Endocrine Procedure at this facility administered for this primary.
DESCRIPTION: Identifies systemic therapeutic procedures administered as part of the first course of treatment
at this and all other facilities. If none of these procedures were administered, then this item
records the reason they were not performed. These include bone marrow transplants, stem cell
harvests, surgical and/or radiation endocrine therapy.
For further information see FORDS pages 182-183.
CROSS-REFERENCE: 165.5^AE^MUMPS
1)= Q
2)= D HTEATF^ONCDTX1
NOREINDEX)= 1
When the value of this field is deleted, the KILL logic will delete all of the associated field
values.
165.5,153.3 HEMA TRANS/ENDOCRINE PR@FAC DT 3.2;3 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: FEB 10, 2016
HELP-PROMPT: *** HEMATOLOGIC TRANSPLANT ENDOCRINE PROCEDURE AT THIS FACILITY DATE MUST BE AFTER OR EQUAL TO DATE
DX ***
DESCRIPTION:
Records the date on which hematologic transplant and endocrine procedures were performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,154 PAIN ASSESSMENT 3.1;37 SET
'0' FOR No pain assessment;
'1' FOR No need for palliative care;
'2' FOR Need for palliative care, no referral;
'3' FOR Need for palliative care, referral;
'9' FOR Unknown;
LAST EDITED: JAN 31, 2003
DESCRIPTION: Records whether or not a pain assessment was performed to determine the need for palliative care.
For further information see FORDS page 188.
165.5,155 DATE OF FIRST CONTACT 0;35 DATE (Required)
INPUT TRANSFORM: D FADIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JUN 21, 2022
HELP-PROMPT: Enter the date of first contact with the reporting facility.
DESCRIPTION: Date of first contact with the reporting facility for diagnosis and/or treatment of this cancer.
If this is an autopsy-only or death certificate-only case, then use the date of death.
When it is unknown when the first patient contact occurred use 99/99/9999 or 99999999.
00/00/0000 is not allowed.
For further information see FORDS page 87.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AFC
1)= S ^ONCO(165.5,"AFC",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"AFC",$E(X,1,30),DA)
This cross-reference was added in patch ONC*2.11*48. It enables the user to select a DATE OF FIRST
CONTACT date range for the [TIME Timeliness Report] option.
165.5,156 DRE DATE 24;11 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Record the date on which the DRE was performed.
DESCRIPTION:
Records the date on which the DRE (Digital Rectal Examination) was performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,157 ELAPSED DAYS TO COMPLETION ; COMPUTED
MUMPS CODE: D ET^ONCOCOM
ALGORITHM: D ET^ONCOCOM
LAST EDITED: OCT 04, 2006
DESCRIPTION: Computes the time interval in days between DATE OF FIRST CONTACT (165.5,155) and DATE CASE
COMPLETED (165.5,90).
165.5,157.1 ELAPSED MONTHS TO COMPLETION ; COMPUTED
MUMPS CODE: D EM^ONCOCOM
ALGORITHM: D EM^ONCOCOM
LAST EDITED: AUG 05, 2008
DESCRIPTION: Computes the time interval in months between DATE OF FIRST CONTACT (165.5,155) and DATE CASE
COMPLETED (165.5,90).
165.5,159 AMBIGUOUS TERMINOLOGY DX 24;12 SET
'0' FOR Conclusive term;
'1' FOR Ambiguous term only;
'2' FOR Ambiguous term followed by conclusive term;
'9' FOR Unknown term;
LAST EDITED: JAN 17, 2007
DESCRIPTION: Identifies cases for which an ambiguous term is the most definitive word or phrase used to
establish a cancer diagnosis (i.e., to determine whether or not the case is reportable). Do not
include cases where a definite statement of malignancy is made within two months following the
original/initial diagnosis. (This does not include the use of ambiguous terminology from cancer
screening followed by a positive cancer confirmation that is follow-up to the screening.)
165.5,160 DERIVED AJCC-6 T CS1;1 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<2) X
OUTPUT TRANSFORM: D TOT^ONCCSOT
LAST EDITED: NOV 13, 2009
HELP-PROMPT: Answer must be 2 characters in length.
DESCRIPTION: This is the AJCC 6th edition "T" component that is derived from CS coded fields, using the CS
algorithm, effective with 2004 diagnosis.
165.5,160.7 DERIVED AJCC-7 T CS1;13 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<2) X
OUTPUT TRANSFORM: D TOT^ONCCSOT
LAST EDITED: FEB 03, 2010
HELP-PROMPT: Answer must be 2 characters in length.
DESCRIPTION: This is the AJCC 7th edition "T" component that is derived from CS coded fields, using the CS
algorithm, effective with 2010 diagnosis.
165.5,161 DERIVED AJCC-6 T DESCRIPTOR CS1;2 SET
'c' FOR clinical;
'p' FOR pathological;
'a' FOR autopsy only;
'y' FOR y prefix;
'N' FOR Not applicable;
'0' FOR Not derived;
LAST EDITED: NOV 13, 2009
DESCRIPTION: This is the AJCC 6th edition "T Descriptor" component that is derived from CS coded fields, using
the CS algorithm, effective with 2004 diagnosis.
165.5,161.7 DERIVED AJCC-7 T DESCRIPTOR CS1;14 SET
'c' FOR clinical;
'p' FOR pathological;
'a' FOR autopsy only;
'y' FOR yp prefix;
'N' FOR Not applicable;
'0' FOR Not derived;
LAST EDITED: FEB 03, 2010
DESCRIPTION: This is the AJCC 7th edition "T Descriptor" component that is derived from CS coded fields, using
the CS algorithm, effective with 2010 diagnosis.
165.5,162 DERIVED AJCC-6 N CS1;3 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<2) X
OUTPUT TRANSFORM: D NOT^ONCCSOT
LAST EDITED: NOV 13, 2009
HELP-PROMPT: Answer must be 2 characters in length.
DESCRIPTION: This is the AJCC 6th edition "N" component that is derived from CS coded fields, using the CS
algorithm, effective with 2004 diagnosis.
165.5,162.7 DERIVED AJCC-7 N CS1;15 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<2) X
OUTPUT TRANSFORM: D NOT^ONCCSOT
LAST EDITED: FEB 03, 2010
HELP-PROMPT: Answer must be 2 characters in length.
DESCRIPTION: This is the AJCC 7th edition "N" component that is derived from CS coded fields, using the CS
algoritm, effective with 2010 diagnosis.
165.5,163 DERIVED AJCC-6 N DESCRIPTOR CS1;4 SET
'c' FOR clinical;
'p' FOR pathological;
'a' FOR autopsy only;
'y' FOR y prefix;
'N' FOR Not applicable;
'0' FOR Not derived;
LAST EDITED: NOV 13, 2009
DESCRIPTION: This is the AJCC 6th edition "N Descriptor" component that is derived from CS coded fields, using
the CS algorithm, effective with 2004 diagnosis.
165.5,163.7 DERIVED AJCC-7 N DESCRIPTOR CS1;16 SET
'c' FOR clinical;
'p' FOR pathological;
'a' FOR autopsy only;
'y' FOR yp prefix;
'N' FOR Not applicable;
'0' FOR Not derived;
LAST EDITED: FEB 03, 2010
DESCRIPTION: This is the AJCC 7th edition "N Descriptor" component that is derived from CS coded fields, using
the CS algorithm, effective with 2010 diagnosis.
165.5,164 DERIVED AJCC-6 M CS1;5 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<2) X
OUTPUT TRANSFORM: D MOT^ONCCSOT
LAST EDITED: NOV 13, 2009
HELP-PROMPT: Answer must be 2 characters in length.
DESCRIPTION: This is the AJCC 6th edition "N" component that is derived from CS coded fields, using the CS
algorithm, effective with 2004 diagnosis.
165.5,164.7 DERIVED AJCC-7 M CS1;17 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<2) X
OUTPUT TRANSFORM: D MOT^ONCCSOT
LAST EDITED: FEB 03, 2010
HELP-PROMPT: Answer must be 2 characters in length.
DESCRIPTION: This is the AJCC 7th edition "N" component that is derived from CS coded fields, using the CS
algorithm, effective with 2010 diagnosis.
165.5,165 DERIVED AJCC-6 M DESCRIPTOR CS1;6 SET
'c' FOR clinical;
'p' FOR pathological;
'a' FOR autopsy only;
'y' FOR y prefix;
'N' FOR Not applicable;
'0' FOR Not derived;
LAST EDITED: NOV 13, 2009
DESCRIPTION: This is the AJCC 6th edition "M Descriptor" component that is derived from CS coded fields, using
the CS algorithm, effective with 2004 diagnosis.
165.5,165.7 DERIVED AJCC-7 M DESCRIPTOR CS1;18 SET
'c' FOR clinical;
'p' FOR pathological;
'a' FOR autopsy only;
'y' FOR yp prefix;
'N' FOR Not applicable;
'0' FOR Not derived;
LAST EDITED: FEB 03, 2010
DESCRIPTION: This is the AJCC 7th edition "M Descriptor" component that is derived from CS coded fields, using
the CS algorithm, effective with 2010 diagnosis.
165.5,166 DERIVED AJCC-6 STAGE GROUP CS1;7 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<2) X
OUTPUT TRANSFORM: D SGOT^ONCCSOT
LAST EDITED: NOV 13, 2009
HELP-PROMPT: Answer must be 2 characters in length.
DESCRIPTION: This is the AJCC 6th edition "Stage Group" component that is derived from the CS detailed
site-specific codes, using the CS from the CS algorithm effective with 2004 diagnosis.
165.5,166.7 DERIVED AJCC-7 STAGE GROUP CS1;19 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<2) X
OUTPUT TRANSFORM: D SGOT^ONCCSOT
LAST EDITED: FEB 01, 2010
HELP-PROMPT: Answer must be 2 characters in length.
DESCRIPTION: This is the AJCC 7th edition "Stage Group" component that is derived from the CS detailed
site-specific codes, using the CS from the CS algorithm effective with 2010 diagnosis.
165.5,167 DERIVED SS1977 CS1;8 SET
'0' FOR In situ;
'1' FOR Localized;
'2' FOR Regional, direct extension;
'3' FOR Regional, lymph nodes only;
'4' FOR Regional, extension and nodes;
'5' FOR Regional, NOS;
'7' FOR Distant;
'8' FOR NA;
'9' FOR Unknown/Unstaged;
LAST EDITED: MAR 10, 2004
DESCRIPTION: This is the derived "SEER Summary Stage 1977" from the CS algorithm (or EOD codes) effective with
2004 diagnosis.
165.5,168 DERIVED SS2000 CS1;9 SET
'0' FOR In situ;
'1' FOR Localized;
'2' FOR Regional, direct extension;
'3' FOR Regional, lymph nodes only;
'4' FOR Regional, extension and nodes;
'5' FOR Regional, NOS;
'7' FOR Distant;
'8' FOR NA;
'9' FOR Unknown/Unstaged;
LAST EDITED: MAR 09, 2004
DESCRIPTION: This is the derived "SEER Summary Stage 2000" from the CS algorithm (or EOD codes) effective with
2004 diagnosis.
165.5,169 CS VERSION DERIVED CS1;11 FREE TEXT
INPUT TRANSFORM: K:$L(X)>6!($L(X)<6) X
LAST EDITED: MAR 31, 2009
HELP-PROMPT: Enter the 6 character version number of the most recently used CS version.
DESCRIPTION: This item indicates the Collaborative Staging (CS) version used most recently to derive the CS
output fields.
165.5,169.1 CS VERSION INPUT ORIGINAL CS1;12 FREE TEXT
INPUT TRANSFORM: K:$L(X)>6!($L(X)<6) X
LAST EDITED: NOV 04, 2009
HELP-PROMPT: Enter the 6 character version number of the CS version initially used.
DESCRIPTION: This item indicates the number of the version initially used to code Collaborative Staging (CS)
fields.
165.5,170 DATE FIRST SURGICAL PROCEDURE 3.1;38 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) D DFSPIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: NOV 05, 2004
HELP-PROMPT: *** DATE FIRST SURGICAL PROCEDURE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Records the earliest date on which any first course surgical procedure was performed.
For further information see FORDS pages 131-132.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^ATSF^MUMPS
1)= S ^ONCO(165.5,"ATX",DA,X_"S0")=""
2)= K ^ONCO(165.5,"ATX",DA,X_"S0")
Records the earliest date on which any first course surgical procedure was performed on the unified
treatment index.
165.5,171 DATE OF FIRST SYMPTOMS 2.2;4 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of first symptoms or abnormal test results.
DESCRIPTION: Records the date on which the patient was first seen with symptoms or had abnormal test results
which began the workup which led to the diagnosis of cancer. This date would be before or equal to
the DATE DX.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,172 DATE START OF WORKUP ORDERED 2.2;5 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date the physician ordered diagnostic tests.
DESCRIPTION: Records the date the physician placed consult to specialty clinic OR ordered diagnostic procedures
or tests.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,173 DATE WORKUP STARTED 2.2;6 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date the patient started diagnostic tests.
DESCRIPTION: Records the date when the patient was seen in the specialty clinic OR had diagnostic procedures or
tests performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,174 BLOOD IN SPUTUM PER PT 2.2;7 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/Not documented;
LAST EDITED: MAY 23, 2005
DESCRIPTION:
Record the presence of blood in the patient's sputum as reported by the patient.
165.5,174.1 DATE OF BLOOD IN SPUTUM PER PT 2.2;18 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of blood in the patient's sputum.
DESCRIPTION:
Records the date of the presence of blood in the patient's sputum (as reported by the patient).
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,175 CHEST X-RAY 2.2;8 SET
'0' FOR Not done;
'1' FOR Abnormal;
'2' FOR Within normal limits;
'9' FOR Unknown/not documented;
LAST EDITED: APR 04, 2005
DESCRIPTION:
Record the results of the diagnostic test CHEST X-RAY. If this test was not done, record a '0'.
165.5,175.1 DATE OF CHEST X-RAY 2.2;19 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of the diagnostic test CHEST X-RAY.
DESCRIPTION:
Records the date of the diagnostic test CHEST X-RAY.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,176 CT SCAN 2.2;9 SET
'0' FOR Not done;
'1' FOR Abnormal;
'2' FOR Within normal limits;
'9' FOR Unknown/not documented;
LAST EDITED: APR 05, 2005
DESCRIPTION:
Record the results of the diagnostic test CT SCAN. If this test was not done, record a '0'.
165.5,176.1 DATE OF CT SCAN 2.2;20 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of the diagnostic test CT SCAN.
DESCRIPTION:
Records the date of the diagnostic test CT SCAN.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,177 BRONCHOSCOPY 2.2;10 SET
'0' FOR Not done;
'1' FOR Abnormal;
'2' FOR Within normal limits;
'9' FOR Unknown/not documented;
LAST EDITED: APR 05, 2005
DESCRIPTION:
Record the results of the diagnostic test BRONCHOSCOPY. If this test was not done, record a '0'.
165.5,177.1 DATE OF BRONCHOSCOPY 2.2;21 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of the diagnostic test BRONCHOSCOPY.
DESCRIPTION:
Records the date of the diagnostic test BRONCHOSCOPY.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,178 MEDIASTINOSCOPY 2.2;11 SET
'0' FOR Not done;
'1' FOR Abnormal;
'2' FOR Within normal limits;
'9' FOR Unknown/not documented;
LAST EDITED: APR 05, 2005
DESCRIPTION: Record the results of the diagnostic test MEDIASTINOSCOPY. If this test was not done, record a
'0'.
165.5,178.1 DATE OF MEDIASTINOSCOPY 2.2;22 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of the diagnostic test MEDIASTINOSCOPY.
DESCRIPTION:
Records the date of the diagnostic test MEDIASTINOSCOPY.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,179 PET SCAN 2.2;12 SET
'0' FOR Not done;
'1' FOR Abnormal;
'2' FOR Within normal limits;
'9' FOR Unknown/not documented;
LAST EDITED: APR 05, 2005
DESCRIPTION:
Record the results of the diagnostic test PET SCAN. If this test was not done, record a '0'.
165.5,179.1 DATE OF PET SCAN 2.2;23 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of the diagnostic test PET SCAN.
DESCRIPTION:
Records the date of the diagnostic test PET SCAN.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,180 CHANGE IN BOWEL HABITS PER PT 2.2;13 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 23, 2005
DESCRIPTION:
Record all changes in bowel habits as reported by the patient.
165.5,180.1 DATE OF CHANGE IN BOWEL HABITS 2.2;24 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of a change in bowel habits.
DESCRIPTION:
Records the date of a change in bowel habits (as reported by the patient).
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,181 FECAL OCCULT BLOOD TEST (FOBT) 2.2;14 SET
'0' FOR Not done;
'1' FOR Positive (3-card sample);
'2' FOR Negative (3-card sample);
'3' FOR Positive (6-card sample);
'4' FOR Negative (6-card sample);
'5' FOR FIT Test;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 25, 2005
DESCRIPTION: Record the results of the diagnostic test FECAL OCCULT BLOOD TEST (FOBT). If this test was not
done, record a '0'.
165.5,181.1 DATE OF FOBT 2.2;25 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of the diagnostic test FOBT.
DESCRIPTION:
Records the date of the diagnostic test FECAL OCCULT BLOOD TEST (FOBT).
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,182 BARIUM ENEMA 2.2;15 SET
'0' FOR Not done;
'1' FOR Abnormal;
'2' FOR Within normal limits;
'9' FOR Unknown/not documented;
LAST EDITED: APR 05, 2005
DESCRIPTION:
Record the results of the diagnostic test BARIUM ENEMA. If this test was not done, record a '0'.
165.5,182.1 DATE OF BARIUM ENEMA 2.2;27 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the results of the diagnostic test BARIUM ENEMA.
DESCRIPTION:
Records the results of the diagnostic test BARIUM ENEMA.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,183 SIGMOIDOSCOPY 2.2;16 SET
'0' FOR Not done;
'1' FOR Abnormal;
'2' FOR Within normal limits;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 23, 2005
DESCRIPTION:
Record the results of the diagnostic test SIGMOIDOSCOPY. If this test was not done, record a '0'.
165.5,183.1 DATE OF SIGMOIDOSCOPY 2.2;28 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of the diagnostic test SIGMOIDOSCOPY.
DESCRIPTION:
Records the date of the diagnostic test SIGMOIDOSCOPY.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,184 CT OF ABDOMEN/PELVIS 2.2;17 SET
'0' FOR Not done;
'1' FOR Abnormal;
'2' FOR Within normal limits;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 23, 2005
DESCRIPTION: Record the results of the diagnostic test CT OF ABDOMEN/PELVIS. If this test was not done, record
a '0'.
165.5,184.1 DATE OF CT OF ABDOMEN/PELVIS 2.2;31 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of the diagnostic test CT OF ABDOMEN/PELVIS.
DESCRIPTION:
Records the date of the diagnostic test CT OF ABDOMEN/PELVIS.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,185 COLONOSCOPY 2.2;29 SET
'0' FOR Not done;
'1' FOR Abnormal;
'2' FOR Within normal limits;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 23, 2005
DESCRIPTION:
Record the results of the diagnostic test COLONOSCOPY. If this test was not done, record a '0'.
165.5,185.1 DATE OF COLONOSCOPY 2.2;30 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date of the diagnostic test COLONOSCOPY.
DESCRIPTION:
Records the date of the diagnostic test COLONOSCOPY. If this test was not done, record a '0'.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,186 DYSPNEA 2.2;32 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: JUN 03, 2005
DESCRIPTION:
Record whether the patient experienced dyspnea.
165.5,186.1 DATE OF DYSPNEA 2.2;33 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date on which the patient was affected by dyspnea.
DESCRIPTION:
Records the date on which the patient was affected by dyspnea.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,187 INCREASED COUGH 2.2;34 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 23, 2005
DESCRIPTION:
Record whether the patient experienced increased coughing.
165.5,187.1 DATE OF INCREASED COUGH 2.2;35 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date on which the patient experienced increased coughing.
DESCRIPTION:
Records the date on which the patient experienced increased coughing.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,188 FEVER 2.2;36 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 23, 2005
DESCRIPTION:
Record whether the patient experienced a fever.
165.5,188.1 DATE OF FEVER 2.2;37 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date on which the patient experienced a fever.
DESCRIPTION:
Records the date on which the patient experienced a fever.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,189 NIGHT SWEATS 2.2;38 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: JUN 03, 2005
DESCRIPTION:
Record whether the patient experienced night sweats.
165.5,189.1 DATE OF NIGHT SWEATS 2.2;39 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: SEP 21, 2006
HELP-PROMPT: Enter the date on which the patient experienced night sweats.
DESCRIPTION:
Records the date on which the patient experienced night sweats.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,190 WEIGHT LOSS PER PT 2.2;40 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 23, 2005
DESCRIPTION:
Record weight loss as reported by the patient.
165.5,191 ULCERATIVE COLITIS (UC) 2.2;41 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 24, 2005
DESCRIPTION:
Record whether the patient was affected by ulcerative colitis (UC).
165.5,192 SPORADIC POLYPS 2.2;42 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: JUN 03, 2005
DESCRIPTION: Sporadic polyps can also develop in people with no family history of colon cancer. They are
called "sporadic" to distinguish them from the familial kind. Certain types of sporadic polyps do
increase the risk of colon cancer. These polyps, known as adenomas, often can be removed during a
colonoscopic examination.
Record the existence of sporadic polyps.
165.5,193 DATE OF CONCLUSIVE DX 24;13 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X I $D(X) D DCD^ONCOCOM
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JAN 24, 2007
HELP-PROMPT: Enter the date of a definite state of malignancy.
DESCRIPTION: Documents the date when a conclusive cancer diagnosis (definite statement of malignancy) is made
following an initial diagnosis that was based only on ambiguous terminology. The date of the
conclusive diagnosis must be greater than two months following the initial (ambiguous terminology
only) diagnosis.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,194 MULT TUM RPT AS ONE PRIM 24;14 POINTER TO TYPE OF MULTIPLE TUMORS FILE (#169)
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(169,Y,0),U,2)
LAST EDITED: JAN 24, 2007
DESCRIPTION: This data item is used to identify cases with multiple tumors that are abstracted ans reported as
a single primary.
Codes Description
----- -----------
00 Single tumor 10 At least two benign tumors in same organ/primary site
(Intracranial and CNS sites only) 11 At least two borderline tumors in the same
organ/primary site
(Intracranial and CNS sites only) 12 Benign and borderline tumors in the same
organ/primary site
(Intracranial and CNS sites only) 20 At least two in situ tumors in the same
organ/primary site 30 One or more in situ and one or more invasive tumors in the same
organ/primary site 31 One or more in situ/invasive adenocarcinoma in a polyp and one
or more frank adenocarcinoma in one segment of colon 32 Familial polyposis with one or
more in situ/invasive carcinoma 40 At least two invasive tumors in the same organ (Includes one
or more invasive tumor with histology "NOS" and one or more
separate invasive tumor with a more specific histology) 80 Multiple tumors present in
the same organ/primary site, unknown
if in situ or invasive 88 Information on multiple tumors not collected/not applicable
for
this site 99 Unknown
165.5,195 DATE OF MULTIPLE TUMORS 24;15 FREE TEXT
INPUT TRANSFORM: D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JAN 24, 2007
HELP-PROMPT: Enter the date the patient was diagnosed with multiple tumors reported as a single primary.
DESCRIPTION: This data item is used to identify the month, day and year the patient is diagnosed with multiple
tumors reported as a single primary. Use the multiple primary rules for that specific site to
determine whether the tumors are a single primary or multiple primaries.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,196 MULTIPLICITY COUNTER 24;16 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<2)!'(X?2N)!((X>89)&(X<99)) X
LAST EDITED: MAR 16, 2011
HELP-PROMPT: Answer must be a 2-digit number. Allowable Values: 00-89, 99.
DESCRIPTION: Records the number of tumors (multiplicity) reported as a single primary.
Codes 00 No primary tumor identified 01 One tumor only 02 Two tumors present; bilateral ovaries
involved with cystic carcinoma 03 Three tumors present
..
..
88 Information on multiple tumors not collected/not applicable for this
site 89 Multicentric, multifocal, number unknown 99 Unknown if multiple tumors; not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,197 EDITS CHECKSUM EDITS;1 FREE TEXT
INPUT TRANSFORM: K:$L(X)>20!($L(X)<1) X
LAST EDITED: MAR 06, 2007
HELP-PROMPT: Answer must be 1-20 characters in length.
DESCRIPTION: Provides a checksum value for the NAACCR record associated with this abstract. This checksum will
be used to detect changes to the NAACCR record once the ABSTRACT STATUS (165.5,91) has been set to
3 (Complete).
165.5,197.1 CHECKSUM VERSION EDITS;2 FREE TEXT
INPUT TRANSFORM: K:$L(X)>10!($L(X)<1) X
LAST EDITED: JAN 12, 2010
HELP-PROMPT: Answer must be 1-10 characters in length.
DESCRIPTION:
Identifies the NAACCR version that was used to calculate EDITS CHECKSUM (165.5,197).
165.5,198 DATE CASE LAST CHANGED 7;21 DATE
INPUT TRANSFORM: S %DT="ESTX" D ^%DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATECLC^ONCOES
LAST EDITED: MAR 27, 2024
HELP-PROMPT: Record the date in which this case was last changed or updated.
DESCRIPTION:
Date the case was last changed or updated.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^AAE
1)= S ^ONCO(165.5,"AAE",$E(X,1,30),DA)=""
2)= K ^ONCO(165.5,"AAE",$E(X,1,30),DA)
This cross-reference will be used to facilitate the extraction of the data from specified start/end
dates.
CROSS-REFERENCE: ^^TRIGGER^165.5^199
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,7)):^(7),1:"") S X=$P(Y(1),U,22),X=X
S DIU=X K Y S X=DIV S X=DUZ S DIH=$G(^ONCO(165.5,DIV(0),7)),DIV=X S $P(^(7),U,22)=DIV,DIH=165.5,DIG
=199 D ^DICR
2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,7)):^(7),1:"") S X=$P(Y(1),U,22),X=X
S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),7)),DIV=X S $P(^(7),U,22)=DIV,DIH=165.5,DIG=199 D ^D
ICR
CREATE VALUE)= S X=DUZ
DELETE VALUE)= @
FIELD)= CASE LAST CHANGED BY
This trigger cross-reference is used to set the CASE LAST CHANGED BY (#199) field to the DUZ of the
user who created/modified the case.
165.5,199 CASE LAST CHANGED BY 7;22 POINTER TO NEW PERSON FILE (#200)
LAST EDITED: MAR 26, 2007
DESCRIPTION:
Records the name of the individual who last changed the case.
NOTES: TRIGGERED by the DATE CASE LAST CHANGED field of the ONCOLOGY PRIMARY File
165.5,200 DATE LAST CONTACT ; COMPUTED
MUMPS CODE: S X="" D PDLC^ONCOCRF,DATEOT^ONCOES
ALGORITHM: S X=""" D PDLC^ONCOCRF,DATEOT^ONCOES
LAST EDITED: FEB 26, 1997
DESCRIPTION:
Date last contact with the patient - computed from file #160.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,201 SURVIVAL DAYS ; COMPUTED
MUMPS CODE: S X="" D SDA^ONCOCRF S X=$J(X,0,0)
ALGORITHM: S X="" D SDA^ONCOCRF (ALWAYS 0 DECIMAL DIGITS)
LAST EDITED: SEP 11, 1990
DESCRIPTION:
COMPUTED SURVIVAL DATA IN DAYS.
165.5,202 SURVIVAL MONTHS ; COMPUTED
MUMPS CODE: S X="" D SUR^ONCOCRF S X=$J(X,0,1)
9.2 = X $P(^DD(165.5,200,0),U,5,99) S Y(165.5,202,1)=X S Y(165.5,202,2)=$S($D(^ONCO(165.5,D0,0)):^(
0),1:"") S X=Y(165.5,202,1),X1=X,X2=$P(Y(165.5,202,2),U,16),X="" D:X2 ^%DTC:X1 S X=X
ALGORITHM: S X="" D SUR^ONCOCRF (ALWAYS 1 DECIMAL DIGITS)
LAST EDITED: SEP 11, 1990
DESCRIPTION:
COMPUTED SURVIVAL DATA IN MONTHS.
165.5,203 SURVIVAL (YEARS) ; COMPUTED
MUMPS CODE: S X="" D SYR^ONCOCRF S X=$J(X,0,1)
9.2 = X $P(^DD(165.5,200,0),U,5,99) S Y(165.5,203,1)=X S Y(165.5,203,2)=$S($D(^ONCO(165.5,D0,0)):^(
0),1:"") S X=Y(165.5,203,1),X1=X,X2=$P(Y(165.5,203,2),U,16),X="" D:X2 ^%DTC:X1 S X=X
ALGORITHM: S X="" D SYR^ONCOCRF (ALWAYS 1 DECIMAL DIGITS)
LAST EDITED: SEP 11, 1990
DESCRIPTION:
COMPUTED SURVIVAL DATA IN YEARS.
165.5,204 WEEKS of FOLLOW-UP ; COMPUTED
MUMPS CODE: S X="" D SWK^ONCOCRF S X=$J(X,0,0)
9.2 = X $P(^DD(165.5,201,0),U,5,99) S Y(165.5,204,1)=X S Y(165.5,204,3)=$S($D(^ONCO(165.5,D0,0)):^(
0),1:"") S X=Y(165.5,204,1),Y(165.5,204,2)=X S X=$P(Y(165.5,204,3),U,16)
ALGORITHM: S X="" D SWK^ONCOCRF (ALWAYS 0 DECIMAL DIGITS)
LAST EDITED: SEP 11, 1990
DESCRIPTION:
FOLLOW UP IN WEEKS.
165.5,205 OVER-RIDE AGE/SITE/MORPH OVRD;1 SET
'1' FOR Reviewed;
'2' FOR Reviewed, Dx in utero;
'3' FOR Reviewed, Codes 1 and 2 both apply;
LAST EDITED: MAR 25, 2009
HELP-PROMPT: Enter the appropriate code to override this edit.
DESCRIPTION: Used with CoC Metafile and the EDITS software to override the edit Age, Primary Site, Morphology
(Coc) and/or the edit Age, Primary Site, Morphology ICD-O-3 (CoC).
For further information see FORDS page 215.
165.5,206 OVER-RIDE SEQNO/DXCONF OVRD;2 SET
'1' FOR Reviewed;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,207 OVER-RIDE SITE/LAT/SEQNO OVRD;3 SET
'1' FOR Reviewed;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,208 OVER-RIDE SURG/DXCONF OVRD;4 SET
'1' FOR Reviewed;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,209 OVER-RIDE SITE/TYPE OVRD;5 SET
'1' FOR Reviewed;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,210 OVER-RIDE HISTOLOGY OVRD;6 SET
'1' FOR Reviewed - allow flags Morphology-Type & Behavior;
'2' FOR Reviewed - allow flags Dx Conf, Behavior Code;
'3' FOR Reviewed - conditions 1 & 2 both apply;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,211 OVER-RIDE REPORT SOURCE OVRD;7 SET
'1' FOR Reviewed;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,212 OVER-RIDE ILL-DEFINE SITE OVRD;8 SET
'1' FOR Reviewed;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,213 OVER-RIDE LEUK,LYMPHOMA OVRD;9 SET
'1' FOR Reviewed;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,214 OVER-RIDE SITE/BEHAVIOR OVRD;10 SET
'1' FOR Reviewed;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,215 OVER-RIDE SITE/EOD/DX DT OVRD;11 SET
'1' FOR Reviewed;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,216 OVER-RIDE SITE/LAT/EOD OVRD;12 SET
'1' FOR Reviewed;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,217 OVER-RIDE SITE/LAT/MORPH OVRD;13 SET
'1' FOR Reviewed;
LAST EDITED: NOV 30, 2000
DESCRIPTION: This is one of the thirteen flags used to override certain interfield and interrecord edits
defined by SEER.
165.5,218 OVER-RIDE SS/NODESPOS OVRD;14 SET
'1' FOR Reviewed;
LAST EDITED: JUL 27, 2001
DESCRIPTION: This is one of the flags used to override certain interfield and interrecord edits defined by
NAACCR.
165.5,219 OVER-RIDE SS/TNM-N OVRD;15 SET
'1' FOR Reviewed;
LAST EDITED: JUL 27, 2001
DESCRIPTION: This is one of the flags used to override certain interfield and interrecord edits defined by
NAACCR.
165.5,220 OVER-RIDE SS/TNM-M OVRD;16 SET
'1' FOR Reviewed;
LAST EDITED: JUL 27, 2001
DESCRIPTION: This is one of the flags used to override certain interfield and interrecord edits defined by
NAACCR.
165.5,221 OVER-RIDE SS/DISMET1 OVRD;17 SET
'1' FOR Reviewed;
LAST EDITED: JUL 27, 2001
DESCRIPTION: This is one of the flags used to override certain interfield and interrecord edits defined by
NAACCR.
165.5,222 OVER-RIDE ACSN/CLASS/SEQ OVRD;18 SET
'1' FOR Reviewed;
LAST EDITED: JUL 27, 2001
DESCRIPTION: This is one of the flags used to override certain interfield and interrecord edits defined by
NAACCR.
165.5,223 OVER-RIDE HOSPSEQ/DXCONF OVRD;19 SET
'1' FOR Reviewed;
LAST EDITED: JUL 27, 2001
DESCRIPTION: This is one of the flags used to override certain interfield and interrecord edits defined by
NAACCR.
165.5,224 OVER-RIDE COC-SITE/TYPE OVRD;20 SET
'1' FOR Reviewed;
LAST EDITED: JUL 27, 2001
DESCRIPTION: This is one of the flags used to override certain interfield and interrecord edits defined by
NAACCR.
165.5,225 OVER-RIDE HOSPSEQ/SITE OVRD;21 SET
'1' FOR Reviewed;
LAST EDITED: JUL 27, 2001
DESCRIPTION: This is one of the flags used to override certain interfield and interrecord edits defined by
NAACCR.
165.5,226 OVER-RIDE SITE/TNM-STGGRP OVRD;22 SET
'1' FOR Reviewed;
LAST EDITED: JUL 27, 2001
DESCRIPTION: This is one of the flags used to override certain interfield and interrecord edits defined by
NAACCR.
165.5,227 PERFORMANCE STATUS AT DX 1;7 SET
'0' FOR ECOG 0;
'1' FOR ECOG 1;
'2' FOR ECOG 2;
'3' FOR ECOG 3;
'4' FOR ECOG 4;
'5' FOR ECOG 5;
'9' FOR UNKNOWN;
'10' FOR KPS 10;
'20' FOR KPS 20;
'30' FOR KPS 30;
'40' FOR KPS 40;
'50' FOR KPS 50;
'60' FOR KPS 60;
'70' FOR KPS 70;
'80' FOR KPS 80;
'90' FOR KPS 90;
'100' FOR KPS 100;
LAST EDITED: MAR 25, 2016
HELP-PROMPT: Enter the score which indicates the patient's general well-being.
DESCRIPTION: Records an attempt to quantify the patient's general well-being.
ECOG 0 - Fully active, able to carry on all pre-disease
activities without restriction
ECOG 1 - Restricted in physically strenuous activity but ambulatory
and able to carry out work of a light or sedentary nature.
For example, light housework, office work
ECOG 2 - Ambulatory and capable of all self care but unable to carry out
and any work activities. Up and about more than 50% of waking
hours
ECOG 3 - Capable of only limited self-care, confined to bed or chair
50% or more of waking hours
ECOG 4 - Completely disabled. Cannot carry on any self-care.
Totally confined to bed or chair)
UNKNOWN - Unknown/not documented
KPS 100 - Normal, no complaints; no evidence of disease
KPS 90 - Able to carry on normal activity; minor signs or symptoms
of disease
KPS 80 - Normal activity with effort, some signs or symptoms of disease
KPS 70 - Cares for self but unable to carry on normal activity or
to do active work
KPS 60 - Requires occasional assistance but is able to care
for most of personal needs
KPS 50 - Requires considerable assistance and frequent medical care
KPS 40 - Disabled; requires special care and assistance
KPS 30 - Severely disabled; hospitalization is indicated
although death not imminent
KPS 20 - Very ill; hospitalization and active
supportive care necessary
KPS 10 - Moribund
165.5,228 TREATMENT GUIDELINE #1 24;17 SET
'0' FOR None;
'1' FOR NCCN;
'2' FOR ASCO;
'3' FOR ASH;
'4' FOR AUA;
'5' FOR PDQ;
'6' FOR SSO;
'7' FOR Other;
'8' FOR NA;
'99' FOR Unknown;
LAST EDITED: APR 12, 2010
HELP-PROMPT: Enter the first guideline used to determine the first course of treatment.
DESCRIPTION: Identifies the first guideline used to determine the first course of treatment.
NCCN (National Comprehensive Cancer Network) ASCO (American Society of Clinical Oncology) ASH
(American Society of Hematology) AUA (American Urologic Association) PDQ (Physician Data Query)
SSO (The Society of Surgical Oncology)
165.5,229 TREATMENT GUIDELINE #2 24;18 SET
'0' FOR None;
'1' FOR NCCN;
'2' FOR ASCO;
'3' FOR ASH;
'4' FOR AUA;
'5' FOR PDQ;
'6' FOR SSO;
'7' FOR Other;
'8' FOR NA;
'99' FOR Unknown;
LAST EDITED: APR 12, 2010
HELP-PROMPT: Enter the second guideline used to determine the first course of treatment.
DESCRIPTION: Identifies the second guideline used to determine the first course of treatment.
NCCN (National Comprehensive Cancer Network) ASCO (American Society of Clinical Oncology) ASH
(American Society of Hematology) AUA (American Urologic Association) PDQ (Physician Data Query)
SSO (The Society of Surgical Oncology)
165.5,230 TREATMENT GUIDELINE #3 24;19 SET
'0' FOR None;
'1' FOR NCCN;
'2' FOR ASCO;
'3' FOR ASH;
'4' FOR AUA;
'5' FOR PDQ;
'6' FOR SSO;
'7' FOR Other;
'8' FOR NA;
'99' FOR Unknown;
LAST EDITED: APR 12, 2010
HELP-PROMPT: Enter the third guideline used to determine the first course of treatment.
DESCRIPTION: Identifies the third guideline used to determine the first course of treatment.
NCCN (National Comprehensive Cancer Network) ASCO (American Society of Clinical Oncology) ASH
(American Society of Hematology) AUA (American Urologic Association) PDQ (Physician Data Query)
SSO (The Society of Surgical Oncology)
165.5,231 TREATMENT GUIDELINE LOCATION 24;20 FREE TEXT
INPUT TRANSFORM: K:$L(X)>30!($L(X)<1) X
LAST EDITED: JUN 12, 2009
HELP-PROMPT: Answer must be 1-30 characters in length.
DESCRIPTION: Identifies where the treatment guidelines used in treatment planning are documented in the medical
record.
165.5,232 TREATMENT GUIDELINE DOC DATE 24;21 DATE
INPUT TRANSFORM: S %DT="E" D ^%DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JUL 07, 2009
HELP-PROMPT: Enter the date treatment guidelines were documented in the medical record.
DESCRIPTION:
Records the date when treatment guidelines were documented in the medical record.
165.5,233 INPATIENT STATUS 2.3;3 SET
'0' FOR Patient was never an inpatient;
'1' FOR Patient was inpatient;
'9' FOR Unknown if patient was an inpatient;
LAST EDITED: OCT 09, 2009
HELP-PROMPT: Enter the appropriate INPATIENT STATUS code.
DESCRIPTION: This data item records whether there was an inpatient admission for the most definitive therapy,
or in the absence of therapy, for diagnostic evaluation.
165.5,234 RX HOSP--SURG APP 2010 2.3;4 SET
'0' FOR No surgery/Dx at autopsy;
'1' FOR Robotic assisted;
'2' FOR Robotic converted to open;
'3' FOR Endoscopic/Laparoscopic;
'4' FOR Endoscopic/Laparoscopic converted to open;
'5' FOR Open/Approach, NOS;
'9' FOR Not stated/Death cert only;
LAST EDITED: JUL 27, 2022
HELP-PROMPT: Enter the appropriate code to describe the surgical method used to approach the primary site.
DESCRIPTION: This item is used to describe the surgical method used to approach the primary site for patients
undergoing surgery of the primary site at this facility. If the patient has multiple surgeries to
the primary site, this item describes the approach used for the most invasive, definitive surgery.
165.5,235 TREATMENT STATUS 2.3;5 SET
'0' FOR No treatment given;
'1' FOR Treatment given;
'2' FOR Active surveillance (watchful waiting);
'9' FOR Unknown if treatment was given;
LAST EDITED: OCT 14, 2009
HELP-PROMPT: Enter the appropriate TREATMENT STATUS code.
DESCRIPTION: This data item summarizes whether the patient received any treatment or the tumor was under active
surveillance.
165.5,236 DATE CASE INITIATED 2.3;6 DATE
INPUT TRANSFORM: S %DT="EX" D ^%DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAY 05, 2010
HELP-PROMPT: Enter the date the abstract was initiated in the reporting facility's cancer registry database.
DESCRIPTION:
Date the electronic abstract is initiated in the reporting facility's cancer registry database.
165.5,237 FEE BASIS 2.3;7 SET
'0' FOR No;
'1' FOR Yes;
LAST EDITED: JUN 05, 2024
HELP-PROMPT: Enter "Yes" if the patient was referred to a FEE BASIS/CONTRACT facility.
DESCRIPTION: Indicates if the patient was referred to another facility for treatment or to a facility closer to
the patient's residence either on a "Fee Basis" or via a CONTRACT with the reporting facility.
165.5,237.1 FEE BASIS LOCATION 2.3;11 FREE TEXT
INPUT TRANSFORM: K:$L(X)>30!($L(X)<3) X
LAST EDITED: MAY 24, 2012
HELP-PROMPT: Answer must be 3-30 characters in length.
DESCRIPTION: In many cases the FACILITY REFERRED TO may not be the same place that the FEE BASIS treatment was
performed. Therefore, this field enables facilities to track where the patient was referred to.
This field is available to be displayed on ad hoc reports.
Enter the name of the FEE BASIS LOCATION in free text.
165.5,238 OUTSIDE SLIDES REVIEWED 2.3;8 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: NOV 25, 2009
HELP-PROMPT: Enter whether tissue slides diagnosed elsewhere were reviewed at this facility.
DESCRIPTION: Identifies if tissue slides diagnosed at another facility were reviewed at this facility.
0 (No) Outside tissue diagnosis done, slides not reviewed
at this facility. 1 (Yes) Outside tissue diagnosis done, slides requested and
reviewed at this facility. 8 (NA) Not applicable. No outside tissue diagnosis
done. 9 (Unknown) Unknown if outside tissue diagnosis done.
165.5,239 MITOTIC RATE 2.3;9 SET
'L' FOR Low <5/50 HPF;
'H' FOR High >5/50 HPF;
'U' FOR Unknown;
LAST EDITED: DEC 21, 2009
HELP-PROMPT: Enter the code for MITOTIC RATE.
DESCRIPTION:
Identifies the rate or speed of cell division.
165.5,240 CS SCHEMA DISCRIMINATOR CS3;1 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<3) X I $D(X) D IN^ONCSUBS
LAST EDITED: NOV 03, 2010
HELP-PROMPT: Answer must be 3 characters in length.
DESCRIPTION: This case requires a CS SCHEMA DISCRIMINATOR to determine the correct tables for CSv2
(Collaborative Staging v2) calculations.
For example, Melanomas of CILIARY BODY AND IRIS (C69.4) require a CS SCHEMA DISCRIMINATOR to
discriminate between tumors arising in either ciliary body or iris, both coded C69.4 but requiring
different CS schemas.
For melanomas of the ciliary body CS SCHEMA DISCRIMINATOR should be coded 010. For melanomas of
the Iris CS SCHEMA DISCRIMINATOR should be coded 020.
CS SCHEMA DISCRIMINATOR values will be stuffed into SSF25 for use in CS calculations.
EXECUTABLE HELP: D HELP^ONCSUBS
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: ^^TRIGGER^165.5^44.25
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"CS2")):^("CS2"),1:"") S X=$P(Y(1),U,
19),X=X S DIU=X K Y S X=DIV S SSF25=X S DIH=$G(^ONCO(165.5,DIV(0),"CS2")),DIV=X S $P(^("CS2"),U,19)
=DIV,DIH=165.5,DIG=44.25 D ^DICR
2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"CS2")):^("CS2"),1:"") S X=$P(Y(1),U,
19),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),"CS2")),DIV=X S $P(^("CS2"),U,19)=DIV,DIH=16
5.5,DIG=44.25 D ^DICR
CREATE VALUE)= S SSF25=X
DELETE VALUE)= @
FIELD)= SSF25
SSF25 (165.5,44.25) will be stuffed with the CS SCHEMA DISCRIMINATOR value.
165.5,241 TNM CLIN DESCRIPTOR 24;22 SET
'0' FOR None;
'1' FOR E (Extranodal);
'2' FOR S (Spleen);
'3' FOR M (Multiple primary tumors in a single site);
'5' FOR E&S (Extranodal and spleen);
'9' FOR Unknown, not stated in patient record;
LAST EDITED: FEB 04, 2016
HELP-PROMPT: Enter the appropriate descriptor suffix.
DESCRIPTION: Identifies the AJCC clinical stage (suffix) descriptor as recorded by the physician. AJCC stage
descriptors identify special cases that need separate data analysis. The descriptors are adjuncts
to and do not change the stage group.
0 - None: There are no prefix or suffix descriptors that would be used
for this case
1 E - Extranodal, lymphomas only: A lymphoma case involving an
extranodal site.
2 S - Spleen, lymphomas only: A lymphoma case involving the spleen
3 M - Multiple primary tumors in a single site: This is one primary
with multiple tumors in the organ of origin at the time
of diagnosis
5 E&S - Extranodal and spleen, lymphomas only: A lymphoma case with
involvement of both an extranodal site and the spleen
9 - Unknown, not stated in patient record: A prefix or suffix would
describe this stage, but it is not known which would be correct
165.5,242 TNM PATH DESCRIPTOR 24;23 SET
'0' FOR None;
'1' FOR E (Extranodal);
'2' FOR S (Spleen);
'3' FOR M (Multiple primary tumors);
'4' FOR Y (Initial multimodality therapy);
'5' FOR E&S (Extranodal and spleen);
'6' FOR M&Y (Multiple and multimodality);
'9' FOR Unknown;
LAST EDITED: FEB 04, 2016
HELP-PROMPT: Enter the appropriate descriptor suffix.
DESCRIPTION: Identifies the AJCC clinical stage (suffix) descriptor as recorded by the physician. AJCC stage
descriptors identify special cases that need separate data analysis. The descriptors are adjuncts
to and do not change the stage group.
0 - None: There are no prefix or suffix descriptors that would be used
for this case
1 E - Extranodal, lymphomas only: A lymphoma case involving an
extranodal site
2 S - Spleen, lymphomas only: A lymphoma case involving the spleen
3 M - Multiple primary tumors in a single site: This is one primary
with multiple tumors in the organ of origin at the time
of diagnosis
4 Y - Classification during or after initial multimodality therapy
5 E&S - Extranodal and spleen, lymphomas only: A lymphoma case
with involvement of both an extranodal site and the spleen
6 M&Y - Multiple primary tumors and initial multimodality therapy:
A case meeting the parameters of both codes 3 and 4
9 - Unknown, not stated in patient record: A prefix or suffix would
describe this stage, but it's not known which would be correct
165.5,244 INITIATED BY 2.3;10 POINTER TO NEW PERSON FILE (#200)
LAST EDITED: MAR 08, 2011
HELP-PROMPT: Enter the name of the person initiating the abstract.
DESCRIPTION: The name of the person initiating the abstract in the reporting facility's cancer registry
database.
This field is stuffed with the user's DUZ when a new entry is added to this file. No user
interaction is required and it may not be changed.
165.5,245 NEOADJUVANT THERAPY (PRE-2021) 3.1;40 SET
'0' FOR Not recommended/NA;
'1' FOR Radiation;
'2' FOR Chemotherapy;
'3' FOR Hormone therapy;
'4' FOR Immunotherapy;
'5' FOR Combination of neoadjuvant tx;
'7' FOR Refusal;
'8' FOR Recommended but not done;
'9' FOR Unknown if recommended or done;
LAST EDITED: MAR 08, 2021
HELP-PROMPT: Enter if NEOADJUVANT THERAPY was performed.
DESCRIPTION: Neoadjuvant therapy is the administration of therapeutic agents before the main treatment. This
field documents if neoadjuvant therapy was performed for this patient and, if so, the type of
neoadjuvant therapy performed.
165.5,245.1 NEOADJUVANT THERAPY EOD;5 SET
'0' FOR No neoadjuvant therapy;
'1' FOR Neoadjuvant therapy completed;
'2' FOR Neoadjuvant therapy started, but not completed/unk if completed;
'3' FOR Limited systemic exposure;
'9' FOR Unknown;
LAST EDITED: MAR 08, 2021
HELP-PROMPT: Enter the code describing the patient's neoadjuvant therapy
DESCRIPTION: This data item records whether the patient had neoadjuvant therapy prior to planned definitive
surgical resection of the primary site.
Rationale This data items provides information related to the quality of care and describes whether
a patient had neoadjuvant therapy.
For the purposes of this data item, neoadjuvant therapy is defined as systemic treatment
(chemotherapy, endocrine / hormone therapy, targeted therapy, immunotherapy, or biological therapy)
and/or radiation therapy before intended or performed surgical resection to improve local therapy
and long term outcomes. Codes 0 No neoadjuvant therapy, no treatment before surgery, surgical
resection
not part of first course of treatment plan
Autopsy only 1 Neoadjuvant therapy completed according to treatment plan and guidelines 2
Neoadjuvant therapy started, but not completed OR unknown if completed 3 Limited systemic exposure
when the intent was not neoadjuvant; treatment
did not meet the definition of neoadjuvant therapy 9 Unknown if neoadjuvant therapy performed
Death Certificate only (DCO)
165.5,245.2 NEOADJUVANT THERAPY-CLIN RESP EOD;6 SET
'0' FOR Not given;
'1' FOR Complete CR;
'2' FOR Partial CR;
'3' FOR Progressive Disease;
'4' FOR Stable disease;
'5' FOR No response;
'6' FOR Done, interpretation not available;
'7' FOR Path Report;
'8' FOR Not documented;
'9' FOR Unknown;
LAST EDITED: JAN 28, 2021
HELP-PROMPT: Enter the neoadjuvant therapy-clinical response for the patient
DESCRIPTION: This data item records the clinical outcomes of neoadjuvant therapy prior to planned surgical
resection. Rationale: This data items provides information related to the quality of care and
describes the clinical outcomes after neoadjuvant therapy. This data item provides prognostically
relevant information by quantifying the extent of therapy-induced tumor regression. Therefore,
this item can provide a better risk stratification for patients who received neoadjuvant therapy.
In addition, this data item can contribute to assessments of cancer care quality.
This data item records the clinical outcomes of neoadjuvant therapy as determined by the managing
physician (oncologic surgeon, radiation oncologist or medical oncologist).
For the purposes of this data item, neoadjuvant therapy is defined as systemic treatment
(chemotherapy, endocrine/hormone therapy, targeted therapy, immunotherapy, or biological therapy)
and/or radiation therapy given to shrink a tumor before surgical resection. Codes: 0 Neoadjuvant
therapy not given 1 Complete clinical response (CR)(per managing/treating
physician statement) 2 Partial clinical response (PR) (per managing/treating
physician statement) 3 Progressive disease (PD)(per managing/treating
physician statement) 4 Stable disease (SD)(per managing/treating physician statement) 5 No
response (NR) (per managing/treating physician statement
Not stated as progressive disease (PD) or stable disease (SD) 6 Neoadjuvant therapy done,
managing/treating physician
interpretation not available, treatment response inferred
from imaging, biomarkers, or yc stage 7 Complete clinical response based on pathology report
(per
pathologist assessment) 8 Neoadjuvant therapy done, response not documented or unknown 9
Unknown if neoadjuvant therapy performed
Death Certificate only (DCO)
165.5,245.3 NEOADJUVANT THERAPY-TX EFFECT EOD;7 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D NEOIT^ONCOEOD1
LAST EDITED: JAN 28, 2021
HELP-PROMPT: Type a number between 0 and 9, 0 decimal digits.
DESCRIPTION: This data item records the pathologist's statement of neoadjuvant treatment effect on the primary
tumor from the surgical pathology report. Whenever treatment effect definitions are recommended by
or available in CAP Cancer Protocols, this data item follows the CAP definitions indicating absent
or present effect. When specific CAP definitions are not available, registrars should use treatment
effect general use categories. Rationale: This data item provides information related to the
quality of care and describes the pathological outcomes after neoadjuvant therapy. This data item
provides prognostically relevant information by quantifying the extent of therapy-induced tumor
regression. Therefore, this item can provide a better risk stratification for patients who
received neoadjuvant therapy. In addition, this data item can contribute to assessments of cancer
care quality. Codes: 0 Neoadjuvant therapy not given/no known presurgical therapy 1-4
Site-specific code; type of response 6 Neoadjuvant therapy completed and surgical resection
performed, response not documented or unknown
Cannot be determined 7 Neoadjuvant therapy completed and planned surgical
resection not performed 9 Unknown if neoadjuvant therapy performed
Unknown if planned surgical procedure performed after
completion of neoadjuvant therapy
Death Certificate only (DCO)
EXECUTABLE HELP: D NEOHLP^ONCOEOD1
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,247 CS REVIEW REQUIRED CS3;2 SET
'0' FOR Reviewed;
'1' FOR Needs review;
LAST EDITED: APR 14, 2011
HELP-PROMPT: Enter 'Reviewed' once this case has been reviewed for accuracy.
DESCRIPTION: When a new version of Collaborative Staging (CS) is implemented some cases require manual
review/conversion by the registrar.
This field identifies cases for which Collaborative Staging review is either required or
recommended in accordance with the Collaborative Staging Conversion Specifications.
When the patch implementing the new CS version is installed the post-install program will flag any
cases needing manual review by setting CS REVIEW REQUIRED to 1 (Needs review).
Once a case has been reviewed by the registrar, the review flag can be cleared by setting CS REVIEW
REQUIRED to 0 (Reviewed).
165.5,248 NOTE TITLE 25;1 FREE TEXT
INPUT TRANSFORM: K:$L(X)>30!($L(X)<1) X
LAST EDITED: JUN 17, 2011
HELP-PROMPT: Answer must be 1-30 characters in length.
DESCRIPTION:
Records the name of the note which documents cancer staging in the medical record.
165.5,249 NOTE DATE 25;2 DATE
INPUT TRANSFORM: S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: FEB 15, 2012
HELP-PROMPT: Enter the date of the note used for staging. Future dates are not allowed.
DESCRIPTION:
Records the date of the note which documents cancer staging in the medical record.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,250 GLEASON SCORE (PATHOLOGIC) 25;3 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1) X
OUTPUT TRANSFORM: S Y=$S(Y=99:"99 Unknown, not reported, or NA",1:Y)
LAST EDITED: AUG 05, 2011
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Record the pathologic Gleason Score. Gleason Score (pathologic) is obtained from a curative
prostatectomy specimen.
For cases where Gleason Score is unknown, not reported or not applicable, code 99.
165.5,251 NSLC STAGE 1-3 PATH LN STAGING PM;1 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA (Stage 0 and 4);
'9' FOR Unknown;
LAST EDITED: APR 02, 2012
HELP-PROMPT: Enter whether mediastinal lymph node staging was performed at the reporting facility.
DESCRIPTION:
Documents if mediastinal lymph node staging was performed at the reporting facility.
CROSS-REFERENCE: ^^TRIGGER^165.5^253
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,3)
,X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,25
1,1,1,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,3)=DIV,DIH=165.5,DIG=253 D ^DICR
2)= Q
CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
DELETE VALUE)= NO EFFECT
FIELD)= #253
CROSS-REFERENCE: ^^TRIGGER^165.5^255
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,5)
,X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,25
1,1,2,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,5)=DIV,DIH=165.5,DIG=255 D ^DICR
2)= Q
CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
DELETE VALUE)= NO EFFECT
FIELD)= #255
CROSS-REFERENCE: ^^TRIGGER^165.5^256
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,6)
,X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,25
1,1,3,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,6)=DIV,DIH=165.5,DIG=256 D ^DICR
2)= Q
CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
DELETE VALUE)= NO EFFECT
FIELD)= #256
CROSS-REFERENCE: ^^TRIGGER^165.5^264
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,14
),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,2
51,1,4,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,14)=DIV,DIH=165.5,DIG=264 D ^DICR
2)= Q
CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
DELETE VALUE)= NO EFFECT
FIELD)= #264
CROSS-REFERENCE: ^^TRIGGER^165.5^265
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,15
),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,2
51,1,5,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,15)=DIV,DIH=165.5,DIG=265 D ^DICR
2)= Q
CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
DELETE VALUE)= NO EFFECT
FIELD)= #265
CROSS-REFERENCE: ^^TRIGGER^165.5^266
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,16
),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,2
51,1,6,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,16)=DIV,DIH=165.5,DIG=266 D ^DICR
2)= Q
CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
DELETE VALUE)= NO EFFECT
FIELD)= #266
CROSS-REFERENCE: ^^TRIGGER^165.5^252
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,2)
,X=X S DIU=X K Y S X=DIV S:(X'=1) X=DIU S:(X=1) X=8 X ^DD(165.5,251,1,7,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,2)=DIV,DIH=165.5,DIG=252 D ^DICR
2)= Q
CREATE VALUE)= S:(X'=1) X=DIU S:(X=1) X=8
DELETE VALUE)= NO EFFECT
FIELD)= #252
165.5,252 REASON FOR NO LN BIOPSY PM;2 SET
'1' FOR Contraindicated;
'2' FOR Patient declined;
'3' FOR Patient transferred;
'4' FOR Patient expired;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAR 06, 2012
HELP-PROMPT: Enter the reason mediastinal lymph nodes were not biopsied at the reporting facility.
DESCRIPTION:
Records the reason that mediastinal lymph nodes were not biopsied at the reporting facility.
NOTES: TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
165.5,253 DATE OF SURGERY CONSULT PM;3 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 02, 2012
HELP-PROMPT: Enter the surgery consult date.
DESCRIPTION: Records the surgery consult date. If NO surgery consult was ordered or not DONE, enter
00/00/0000; if UNKNOWN, enter 99/99/9999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
CROSS-REFERENCE: ^^TRIGGER^165.5^254
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,4)
,X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X=0 X ^DD(165.5,253,1,1,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,4)=DIV,DIH=165.5,DIG=254 D ^DICR
2)= Q
CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X=0
DELETE VALUE)= NO EFFECT
FIELD)= #254
165.5,254 INTENT OF SURGERY PM;4 SET
'0' FOR No surgery;
'1' FOR Curative (primary);
'2' FOR Curative (adjuvant);
'4' FOR Palliative (pain control);
'5' FOR Palliative (other);
'6' FOR Prophylactic (no symptoms, preventive);
'8' FOR Other, NOS;
'9' FOR Unknown;
LAST EDITED: FEB 21, 2012
HELP-PROMPT: Enter the intent of the surgery performed.
DESCRIPTION: Code the intent of surgical treatment.
This item is useful in assessing the appropriateness of treatment and correlating outcome with
original intent of the treatment.
NOTES: TRIGGERED by the DATE OF SURGERY CONSULT field of the ONCOLOGY PRIMARY File
165.5,255 DATE ONCOLOGY CONSULT ORDERED PM;5 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 02, 2012
HELP-PROMPT: Enter the date the oncology consult was ordered.
DESCRIPTION: Records the date the oncology consult was ordered. If NO oncology consult was ordered or not
DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
CROSS-REFERENCE: ^^TRIGGER^165.5^256
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,6)
,X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X="0000000" X ^DD(165.5,255,1,1,1.4
)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,6)=DIV,DIH=165.5,DIG=256 D ^DICR
2)= Q
CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X="0000000"
DELETE VALUE)= NO EFFECT
FIELD)= #256
165.5,256 DATE ONCOLOGY CONSULT DONE PM;6 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 06, 2012
HELP-PROMPT: Enter the oncology consult date.
DESCRIPTION: Records the date the oncology consult was done. If NO oncology consult was done, enter
00/00/0000; if UNKNOWN, enter 99/99/9999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
TRIGGERED by the DATE ONCOLOGY CONSULT ORDERED field of the ONCOLOGY PRIMARY File
165.5,257 CHEMOTHERAPY RECOMMENDED PM;7 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: APR 02, 2012
HELP-PROMPT: Record if there is documentation that chemotherapy was recommended.
DESCRIPTION:
Records if there is documentation that chemotherapy was recommended.
CROSS-REFERENCE: ^^TRIGGER^165.5^258
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,8)
,X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,257,1,1,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,8)=DIV,DIH=165.5,DIG=258 D ^DICR
2)= Q
CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0
DELETE VALUE)= NO EFFECT
FIELD)= #258
CROSS-REFERENCE: ^^TRIGGER^165.5^259
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,9)
,X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,257,1,2,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,9)=DIV,DIH=165.5,DIG=259 D ^DICR
2)= Q
CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0
DELETE VALUE)= NO EFFECT
FIELD)= #259
CROSS-REFERENCE: ^^TRIGGER^165.5^261
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,11
),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=8 X ^DD(165.5,257,1,3,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,11)=DIV,DIH=165.5,DIG=261 D ^DICR
2)= Q
CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=8
DELETE VALUE)= NO EFFECT
FIELD)= #261
CROSS-REFERENCE: ^^TRIGGER^165.5^382
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"BLA2")):^("BLA2"),1:"") S X=$P(Y(1),
U,41),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,257,1,4,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"BLA2")),DIV=X S $P(^("BLA2"),U,41)=DIV,DIH=165.5,DIG=382 D ^DICR
2)= Q
CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0
DELETE VALUE)= NO EFFECT
FIELD)= #382
165.5,258 INTENT OF CHEMOTHERAPY PM;8 SET
'0' FOR No chemotherapy;
'1' FOR Curative (primary);
'2' FOR Curative (adjuvant);
'4' FOR Palliative (pain control);
'5' FOR Palliative (other);
'6' FOR Prophylactic (no symptoms, preventive);
'8' FOR Other, NOS;
'9' FOR Unknown;
LAST EDITED: JUN 12, 2012
HELP-PROMPT: Enter the documented intent of chemotherapy.
DESCRIPTION: Code the intent of chemotherapy treatment.
This item is useful in assessing the appropriateness of treatment and correlating outcome with
original intent of the treatment.
NOTES: TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File
CROSS-REFERENCE: ^^TRIGGER^165.5^259
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X=0 I X S X=DIV S Y(1)=$S($D(^ONCO(165.
5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,9),X=X S DIU=X K Y S X=DIV S X="0" X ^DD(165.5,258,1,1,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,9)=DIV,DIH=165.5,DIG=259 D ^DICR
2)= Q
CREATE CONDITION)= INTERNAL(INTENT OF CHEMOTHERAPY)=0
CREATE VALUE)= "0"
DELETE VALUE)= NO EFFECT
FIELD)= #259
CROSS-REFERENCE: ^^TRIGGER^165.5^382
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X=0 I X S X=DIV S Y(1)=$S($D(^ONCO(165.
5,D0,"BLA2")):^("BLA2"),1:"") S X=$P(Y(1),U,41),X=X S DIU=X K Y S X=DIV S X="0" X ^DD(165.5,258,1,2
,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"BLA2")),DIV=X S $P(^("BLA2"),U,41)=DIV,DIH=165.5,DIG=382 D ^DICR
2)= Q
CREATE CONDITION)= INTERNAL(INTENT OF CHEMOTHERAPY)=0
CREATE VALUE)= "0"
DELETE VALUE)= NO EFFECT
FIELD)= #382
CROSS-REFERENCE: ^^TRIGGER^165.5^272
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X=0 I X S X=DIV S Y(1)=$S($D(^ONCO(165.
5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,21),X=X S DIU=X K Y S X=DIV S X="0000000" X ^DD(165.5,258,1
,3,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,21)=DIV,DIH=165.5,DIG=272 D ^DICR
2)= Q
CREATE CONDITION)= INTERNAL(INTENT OF CHEMOTHERAPY)=0
CREATE VALUE)= "0000000"
DELETE VALUE)= NO EFFECT
FIELD)= #272
165.5,259 TYPE OF CHEMOTHERAPY PM;9 SET
'0' FOR No chemotherapy;
'1' FOR Adjuvant;
'2' FOR Neoadjuvant;
'3' FOR Concomitant or concurrent;
'4' FOR Palliative;
'9' FOR Unknown;
LAST EDITED: AUG 18, 2011
HELP-PROMPT: Enter the type of chemotherapy administered.
DESCRIPTION: Records the type of chemotherapy administered.
Adjuvant - refers to additional treatment, usually given after surgery where all detectable disease
has been removed, but where there remains a statistical risk of relapse due to occult disease.
Neoadjuvant - in contrast to adjuvant therapy, is given prior to primary treatment, for example,
before surgery to remove the tumor. The most common reason for neoadjuvant therapy is to reduce
the size of the tumor so as to facilitate more effective surgery.
Concomitant or concurrent - chemotherapy at the same time as other therapies, such as radiation.
Palliative - chemotherapy given without expectation of a cure.
NOTES: TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File
TRIGGERED by the INTENT OF CHEMOTHERAPY field of the ONCOLOGY PRIMARY File
165.5,260 REASON RADIATION STOPPED PM;10 SET
'0' FOR Treatment completed, NA;
'1' FOR Complications;
'2' FOR Disease progression;
'3' FOR Recommended but medically contraindicated;
'8' FOR Other;
'9' FOR Unknown;
LAST EDITED: SEP 27, 2011
HELP-PROMPT: Enter the reason radiation therapy was discontinued.
DESCRIPTION: Record the reason radiation therapy was discontinued. If therapy ended when treatment was
complete, or if the patient never received radiation therapy code 0 (treatment completed, NA).
NOTES: TRIGGERED by the INTENT OF RADIATION field of the ONCOLOGY PRIMARY File
165.5,261 DOC FOR NO PLAT-BASED CHEMO PM;11 SET
'0' FOR No documentation;
'1' FOR Documentation;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: AUG 24, 2011
HELP-PROMPT: Enter if there is documentation why platinum-based chemotherapy was not recommended.
DESCRIPTION: Records if there is a documented reason in the Progress Notes stating why platinum-based
chemotherapy was not recommended.
NOTES: TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File
165.5,262 MULTIMODALITY RADIATION TYPE PM;12 SET
'0' FOR No multimodality radiation therapy;
'1' FOR Adjuvant;
'2' FOR Neoadjuvant;
'3' FOR Concomitant or concurrent;
'4' FOR Palliative;
'9' FOR Unknown;
LAST EDITED: MAY 06, 2013
HELP-PROMPT: Enter the type of multimodality radiation therapy administered.
DESCRIPTION: Records the type of radiation therapy administered.
Adjuvant - refers to additional treatment, usually given after surgery where all detectable disease
has been removed, but where there remains a statistical risk of relapse due to occult disease.
Neoadjuvant - in contrast to adjuvant therapy, is given prior to primary treatment, for example,
before surgery to remove the tumor. The most common reason for neoadjuvant therapy is to reduce
the size of the tumor so as to facilitate more effective surgery.
Concomitant or concurrent - radiation therapy at the same time as chemotherapy.
Palliative - radiation therapy given without expectation of a cure.
NOTES: TRIGGERED by the INTENT OF RADIATION field of the ONCOLOGY PRIMARY File
165.5,263 REASON HORMONE THERAPY STOPPED PM;28 SET
'0' FOR Treatment completed, NA;
'1' FOR Complications;
'2' FOR Disease progression;
'3' FOR Recommended but medically contraindicated;
'8' FOR Other;
'9' FOR Unknown;
LAST EDITED: SEP 27, 2011
HELP-PROMPT: Enter the reason hormone therapy was discontinued.
DESCRIPTION: Record the reason hormone therapy was discontinued. If therapy ended when treatment was complete,
or if the patient never received hormone therapy code 0 (treatment completed, NA).
165.5,264 DATE HOSPICE CONSULT INITIATED PM;14 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 02, 2012
HELP-PROMPT: Enter the date a hospice consult was initiated.
DESCRIPTION: Records the date a hospice consult was initiated. If NO date a hospice consult was initiated or
not DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
CROSS-REFERENCE: ^^TRIGGER^165.5^265
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,15
),X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X="0000000" X ^DD(165.5,264,1,1,1.
4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,15)=DIV,DIH=165.5,DIG=265 D ^DICR
2)= Q
CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X="0000000"
DELETE VALUE)= NO EFFECT
FIELD)= #265
CROSS-REFERENCE: ^^TRIGGER^165.5^266
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,16
),X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X="0000000" X ^DD(165.5,264,1,2,1.
4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,16)=DIV,DIH=165.5,DIG=266 D ^DICR
2)= Q
CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X="0000000"
DELETE VALUE)= NO EFFECT
FIELD)= #266
165.5,265 DATE HOSPICE CONSULT COMPLETED PM;15 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 06, 2012
HELP-PROMPT: Enter the date the hospice consult was completed.
DESCRIPTION: Records the date the hospice consult was created. If NO hospice consult created or DONE, enter
00/00/0000; if UNKNOWN, enter 99/99/9999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
TRIGGERED by the DATE HOSPICE CONSULT INITIATED field of the ONCOLOGY PRIMARY File
165.5,266 DATE HOSPICE CARE INITIATED PM;16 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 06, 2012
HELP-PROMPT: Enter the date the patient entered hospice care.
DESCRIPTION: Records the date the patient entered hospice care. If there is NO date entered in hospice care or
not DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
TRIGGERED by the DATE HOSPICE CONSULT INITIATED field of the ONCOLOGY PRIMARY File
165.5,267 EGFR MUTATION TESTING PM;17 SET
'0' FOR No testing;
'1' FOR EGFR mutation positive, NOS;
'2' FOR EGFR mutation negative;
'8' FOR NA;
'9' FOR Unknown/not documented;
LAST EDITED: JUN 19, 2012
HELP-PROMPT: Enter if an Epidermal Growth Factor Receptor (EGFR) mutation test was performed and the results.
DESCRIPTION: Records if the Pathology Department performed an EGFR (Epidermal Growth Factor Receptor) mutation
test and the results.
CROSS-REFERENCE: ^^TRIGGER^165.5^268
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X="0" I X S X=DIV S Y(1)=$S($D(^ONCO(16
5.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,18),X=X S DIU=X K Y S X=DIV S X="9" X ^DD(165.5,267,1,1,1
.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,18)=DIV,DIH=165.5,DIG=268 D ^DICR
2)= Q
CREATE CONDITION)= INTERNAL(EGFR MUTATION TESTING)="0"
CREATE VALUE)= "9"
DELETE VALUE)= NO EFFECT
FIELD)= #268
CROSS-REFERENCE: ^^TRIGGER^165.5^269
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X="0" I X S X=DIV S Y(1)=$S($D(^ONCO(16
5.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,19),X=X S DIU=X K Y S X=DIV S X="9" X ^DD(165.5,267,1,2,1
.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,19)=DIV,DIH=165.5,DIG=269 D ^DICR
2)= Q
CREATE CONDITION)= INTERNAL(EGFR MUTATION TESTING)="0"
CREATE VALUE)= "9"
DELETE VALUE)= NO EFFECT
FIELD)= #269
165.5,268 EGFR MUTATION 1 PM;18 SET
'1' FOR Wild type;
'2' FOR G719 (exon 18);
'3' FOR Exon 19 deletion;
'4' FOR Exon 20 insertion;
'5' FOR T790M (exon 20);
'6' FOR L858R (exon 21);
'7' FOR L861Q (exon 21);
'8' FOR Other;
'9' FOR Unknown;
LAST EDITED: FEB 07, 2012
HELP-PROMPT: Enter the first EGFR mutation type.
DESCRIPTION:
Records the first EGFR (Epidermal Growth Factor Receptor) mutation type.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the EGFR MUTATION TESTING field of the ONCOLOGY PRIMARY File
165.5,269 EGFR MUTATION 2 PM;19 SET
'1' FOR Wild type;
'2' FOR G719 (exon 18);
'3' FOR Exon 19 deletion;
'4' FOR Exon 20 insertion;
'5' FOR T790M (exon 20);
'6' FOR L858R (exon 21);
'7' FOR L861Q (exon 21);
'8' FOR Other;
'9' FOR Unknown;
LAST EDITED: FEB 07, 2012
HELP-PROMPT: Enter the second EGFR mutation type.
DESCRIPTION:
Records the second EGFR (Epidermal Growth Factor Receptor) mutation type.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the EGFR MUTATION TESTING field of the ONCOLOGY PRIMARY File
165.5,270 PREOP OBSTRUCTING LESION PM;13 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA (in situ lesion/non-invasive polyp);
'9' FOR Unknown/not documented;
LAST EDITED: SEP 26, 2011
HELP-PROMPT: Enter if a preoperative obstructing lesion was found.
DESCRIPTION:
Records if a preoperative obstructing lesion was found.
165.5,271 ONCOLOGY REFERRAL PM;20 SET
'1' FOR Referred;
'2' FOR Not referred, no reason stated;
'3' FOR Not referred, reason documented in notes;
'8' FOR NA (in situ lesion/non-invasive polyp);
'9' FOR Unknown if referred;
LAST EDITED: SEP 26, 2011
HELP-PROMPT: Enter if the patient was referred to Oncology.
DESCRIPTION:
Records if the patient was referred to Oncology.
165.5,272 DATE CHEMOTHERAPY RECOMMENDED PM;21 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 24, 2012
HELP-PROMPT: Enter the date on which chemotherapy was recommended.
DESCRIPTION:
Records the date on which chemotherapy was recommended.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
TRIGGERED by the INTENT OF CHEMOTHERAPY field of the ONCOLOGY PRIMARY File
165.5,273 ANTI-EGFR MoAB THERAPY PM;22 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA (Stage < 4);
'9' FOR Unknown/not documented;
LAST EDITED: SEP 27, 2011
HELP-PROMPT: Enter if anti-EFGR MoAB therapy was administered.
DESCRIPTION: For metastatic colorectal cancer, records if anti-EGFR (Epidermal Growth Factor Receptor) MoAb
(monoclonal antibody) therapy was administered. e.g. Cetuximab/Panitumumab
165.5,274 PERIRECTAL LN INVOLVEMENT PM;23 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA (no surgery);
'9' FOR Unknown/not documented;
LAST EDITED: SEP 26, 2011
HELP-PROMPT: Enter if perirectal lymph node involvement was indicated.
DESCRIPTION:
Records the detection of perirectal lymph node involvement.
165.5,275 RISK OF RECURRENCE PM;24 SET
'1' FOR Low;
'2' FOR Medium;
'3' FOR High;
'8' FOR NA;
'9' FOR Unknown/not documented;
LAST EDITED: SEP 26, 2011
HELP-PROMPT: Enter the risk of recurrence after treatment value.
DESCRIPTION:
Records the risk of recurrence after treatment as documented on the Progress Notes.
165.5,276 ANDROGEN DEPRIVATION THERAPY PM;25 SET
'0' FOR ADT not administered;
'1' FOR GnRH/LHRH agonist;
'2' FOR Antiandrogen;
'3' FOR CYP17 inhibitor;
'4' FOR Combination;
'5' FOR Orchiectomy;
'8' FOR NA;
'9' FOR Unknown/not documented;
LAST EDITED: DEC 17, 2012
HELP-PROMPT: Enter the type of ADT administered.
DESCRIPTION: Records the type of ADT (Androgen Deprivation Therapy) administered.
1 GnRH/LHRH agonist
Goserelin Acetate
Leuprolide Acetate
2 Antiandrogen
Bicalutamide
Flutamide
Nilutamide
3 CYP17 inhibitor
Abiraterone acetate
Ketoconazole
4 Combination
5 Orchiectomy
165.5,277 DATE ADT INITIATED PM;26 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 24, 2012
HELP-PROMPT: Enter the date Androgen Deprivation Therapy was initiated.
DESCRIPTION:
Records the date on which ADT (Androgen Deprivation Therapy) was initiated.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,278 NON-ADT CHEMOTHERAPY PM;27 SET
'0' FOR No non-ADT chemotherapy administered;
'1' FOR Docetaxel;
'2' FOR Cabazitaxel;
'3' FOR Sipuleucel-T;
'4' FOR Other;
'9' FOR Unknown/not documented;
LAST EDITED: SEP 27, 2011
HELP-PROMPT: Enter the type of non-ADT chemotherapy administered.
DESCRIPTION: Records whether non-ADT (Androgen Deprivation Therapy) chemotherapy was administered and, if so,
what chemotherapeutic agent was used.
165.5,279 CLINICAL TRIALS DISCUSSION 25;4 SET
'0' FOR NA (Not discussed);
'1' FOR With patient;
'2' FOR With Tumor Board;
'3' FOR With both patient and Tumor Board;
'9' FOR Unknown;
LAST EDITED: OCT 05, 2011
HELP-PROMPT: Enter if clinical trials were discussed with the patient and/or the Tumor Board.
DESCRIPTION:
Records if clinical trials were discussed with the patient and/or the Tumor Board.
165.5,280 CLIN TNM DOCUMENTATION PRE-TX 25;5 SET
'1' FOR Yes;
'2' FOR No;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: FEB 16, 2012
HELP-PROMPT: Enter whether this case had a clinical stage documented prior to treatment.
DESCRIPTION:
Records whether this case had a clinical stage documented prior to treatment.
165.5,280.1 CL TNM DOCUMENTATION LOCATION 25;7 FREE TEXT
INPUT TRANSFORM: K:$L(X)>30!($L(X)<3) X
LAST EDITED: FEB 16, 2012
HELP-PROMPT: Answer must be 3-30 characters in length. Enter the location of pre-treatment clinical stage
documentation.
DESCRIPTION:
Records the location of pre-treatment clinical stage documentation.
165.5,280.2 CL TNM DOCUMENTATION DATE 25;8 DATE
INPUT TRANSFORM: S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X
LAST EDITED: FEB 21, 2012
HELP-PROMPT: Enter the date of pre-treatment clinical stage documentation.
DESCRIPTION:
Records the date of pre-treatment clinical stage documentation.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,281 TX GUIDELINES DISCUSSION 25;6 SET
'0' FOR NA (Not eligible);
'1' FOR Eligible;
'2' FOR Eligible but not discussed;
'3' FOR Discussed;
'9' FOR Unknown;
LAST EDITED: OCT 05, 2011
HELP-PROMPT: Enter if this case was eligible for a treatment guidelines discussion.
DESCRIPTION:
Records if this case was eligible for a treatment guidelines discussion.
165.5,282 VACCR EXTRACT INDICATOR EDITS;3 SET
'N' FOR New;
'U' FOR Update;
LAST EDITED: OCT 19, 2011
HELP-PROMPT: Enter N (New) for newly completed cases. Enter U (Update) for changes to completed cases.
DESCRIPTION: Records whether this case has been newly 'Completed' or is an update to an already 'Completed'
case.
165.5,283 CS FIELD NEEDING REVIEW CS3;3 FREE TEXT
INPUT TRANSFORM: K:$L(X)>70!($L(X)<1) X
LAST EDITED: NOV 09, 2011
HELP-PROMPT: Answer must be 1-70 characters in length.
DESCRIPTION: Records the CS (Collaborative Staging) item(s) which need manual review/recoding by a registrar
after the CS conversion.
165.5,284 UDF1 25;9 FREE TEXT
INPUT TRANSFORM: K:$L(X)>10!($L(X)<1) X
LAST EDITED: OCT 22, 2015
HELP-PROMPT: Answer must be 1-10 characters in length.
DESCRIPTION:
This will be a User Defined Field.
165.5,284.1 UDF2 25;10 FREE TEXT
INPUT TRANSFORM: K:$L(X)>10!($L(X)<1) X
LAST EDITED: OCT 22, 2015
HELP-PROMPT: Answer must be 1-10 characters in length.
DESCRIPTION:
This will be a User Defined Field.
165.5,284.2 UDF3 25;11 FREE TEXT
INPUT TRANSFORM: K:$L(X)>10!($L(X)<1) X
LAST EDITED: OCT 22, 2015
HELP-PROMPT: Answer must be 1-10 characters in length.
DESCRIPTION:
This will be a User Defined Field.
165.5,284.3 UDF4 25;12 FREE TEXT
INPUT TRANSFORM: K:$L(X)>10!($L(X)<1) X
LAST EDITED: OCT 22, 2015
HELP-PROMPT: Answer must be 1-10 characters in length.
DESCRIPTION:
This will be a User Defined Field.
165.5,284.4 UDF5 25;13 FREE TEXT
INPUT TRANSFORM: K:$L(X)>10!($L(X)<1) X
LAST EDITED: OCT 22, 2015
HELP-PROMPT: Answer must be 1-10 characters in length.
DESCRIPTION:
This will be a User Defined Field.
165.5,284.5 UDF6 25;14 FREE TEXT
INPUT TRANSFORM: K:$L(X)>10!($L(X)<1) X
LAST EDITED: OCT 22, 2015
HELP-PROMPT: Answer must be 1-10 characters in length.
DESCRIPTION:
This will be a User Defined Field.
165.5,284.6 UDF7 25;15 FREE TEXT
INPUT TRANSFORM: K:$L(X)>10!($L(X)<1) X
LAST EDITED: OCT 22, 2015
HELP-PROMPT: Answer must be 1-10 characters in length.
DESCRIPTION:
This will be a User Defined Field.
165.5,284.7 UDF8 25;16 FREE TEXT
INPUT TRANSFORM: K:$L(X)>10!($L(X)<1) X
LAST EDITED: OCT 22, 2015
HELP-PROMPT: Answer must be 1-10 characters in length.
DESCRIPTION:
This will be a User Defined Field.
165.5,284.8 UDF9 25;17 FREE TEXT
INPUT TRANSFORM: K:$L(X)>10!($L(X)<1) X
LAST EDITED: OCT 22, 2015
HELP-PROMPT: Answer must be 1-10 characters in length.
DESCRIPTION:
This will be a User Defined Field.
165.5,284.9 UDF10 25;18 FREE TEXT
INPUT TRANSFORM: K:$L(X)>10!($L(X)<1) X
LAST EDITED: OCT 22, 2015
HELP-PROMPT: Answer must be 1-10 characters in length.
DESCRIPTION:
This will be a User Defined Field.
165.5,285 TEXT-STAGING 22.1;0 WORD-PROCESSING #165.5285 (IGNORE "|")
DESCRIPTION: Text area for information related to the new NAACCR 2018 staging guidelines for the primary site.
LAST EDITED: APR 09, 2018
HELP-PROMPT: Enter any text relating to the staging of the primary.
DESCRIPTION:
This field will store any text relating to the staging of the primary.
165.5,286 TEXT-SITE SPECIFIC DATA ITEMS 22.2;0 WORD-PROCESSING #165.5286 (IGNORE "|")
DESCRIPTION: Text area for information related to the Site Specific Data Items (SSDI) for the primary site.
The SSDI are a new data item introduced in NAACCR 2018.
LAST EDITED: APR 09, 2018
HELP-PROMPT: Enter text relating to the Site Specific Data items for the primary.
DESCRIPTION:
This field will store any text relating to the site specific data items for the primary.
165.5,287 TEXT-COVID-19 22.3;0 WORD-PROCESSING #165.5287 (IGNORE "|")
DESCRIPTION: This word-processing field records any notes or descriptions relevant or related to COVID-19 for
the patient.
LAST EDITED: FEB 02, 2021
HELP-PROMPT: Enter text relating to the COVID-19 NCDB data items
DESCRIPTION:
This word-processing field will store any text related to the COVID-19 data items.
165.5,288 TOBACCO USE SMOKING STATUS 25;21 SET
'0' FOR Never smoker;
'1' FOR Current smoker (or if quit within 30 days prior to dx);
'2' FOR Former smoker (must have quit 31 days or more prior to dx);
'3' FOR Smoker, current status unknown;
'9' FOR Unknown if ever smoked;
LAST EDITED: SEP 26, 2023
HELP-PROMPT: Enter a code from the list that corresponds to the smoking status for this patient.
DESCRIPTION: Instructions for Coding (see SEER Program Coding and Staging Manual 2023 for complete instructions)
Tobacco smoking history can be obtained from sections such as the Nursing Interview Guide, Flow
Chart, Vital Stats or Nursing Assessment section, or other available sources from the patient's
hospital medical record or physician office record.
- Record the past or current use of tobacco. Tobacco use includes cigarette, cigar, and/or pipe. -
Do not record the patient's past or current use of e-cigarette vaping devices. - Assign code 2
when the medical record indicates patient has smoked tobacco in the past but does not smoke now -
If there is evidence in the medical record that the patient quit recently (within 30 days prior to
diagnosis), assign code 1, current smoker. The 30 days prior information, if available, is intended
to differentiate patients who may have quit recently due to symptoms that lead to a cancer
diagnosis. - Assign code 9 when the medical record only indicates "No". This data item is for the
specific use of tobacco products. Electronic cigarettes are not considered tobacco use as they use
liquid nicotine and do not contain tobacco. However, these users may have a history of tobacco use
that should be considered. Smoking, vaping or consuming products other than tobacco, such as liquid
nicotine, CBD or marijuana is not included.
165.5,289 TEXT-HIV, SCA, DRUG & ETOH 22.4;0 WORD-PROCESSING #165.5289 (IGNORE "|")
LAST EDITED: SEP 26, 2023
HELP-PROMPT: Enter information regarding HIV/AIDS, Sickle Cell Anemia, Drug and Alcohol Abuse.
DESCRIPTION: TEXT-HIV, SCA, DRUG & ETOH is a VA ONLY text field for medical conditions covered by 38 U.S.C.
Section 7332, which prohibits the sharing of information regarding HIV/AIDS, Sickle Cell Anemia
and Drug and Alcohol abuse with outside entities. This optional field is to record relevant
information associated with these conditions, if applicable.
165.5,300 PATIENT REFERRED FOR TREATMENT BLA1;1 SET
'1' FOR Another hospital;
'2' FOR Staff physician office;
'3' FOR Non-staff physician office;
'4' FOR Free standing facility;
'5' FOR Other;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: If the patient was referred elsewhere for part or all of the first course of therapy, record the
type of facility to which the referral was made.
165.5,301 LENGTH OF STAY BLA1;2 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S(Y=888:"Never an inpatient",Y=999:"Unknown",Y=1:Y_" day",1:Y_" days")
LAST EDITED: SEP 06, 1996
HELP-PROMPT: Type a Number between 0 and 999, 0 Decimal Digits
DESCRIPTION: Record the length of stay in days for inpatient cases only. If the patient has multiple inpatient
stays, record the length of the admission for the most definitive treatment. If the patient was
never an inpatient at your institution, record 888. If the length of stay cannot be determined,
code as 999 (unknown).
165.5,302 HISTORY OF CERVIX CA (PT) BLA1;3 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether cervix cancer was diagnosed prior to the patient's bladder cancer or simultaneously
with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder
cancer.
165.5,303 HISTORY OF COLON CA (PT) BLA1;4 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether colon cancer was diagnosed prior to the patient's bladder cancer or simultaneously
with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder
cancer.
165.5,304 HISTORY OF BLADDER CA (PT) BLA1;5 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether bladder cancer was diagnosed prior to the patient's bladder cancer or simultaneously
with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder
cancer.
165.5,305 HISTORY OF HEAD & NECK CA (PT) BLA1;6 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether head and neck cancer was diagnosed prior to the patient's bladder cancer or
simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the
diagnosis of bladder cancer.
165.5,306 HISTORY OF KIDNEY CA (PT) BLA1;7 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether kidney cancer was diagnosed prior to the patient's bladder cancer or simultaneously
with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder
cancer.
165.5,307 HISTORY OF PROSTATE CA (PT) BLA1;8 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether prostate cancer was diagnosed prior to the patient's bladder cancer or
simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the
diagnosis of bladder cancer.
165.5,308 HISTORY OF OTHER CA (PT) BLA1;9 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether other cancer was diagnosed prior to the patient's bladder cancer or simultaneously
with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder
cancer.
165.5,309 HISTORY OF BLADDER CA (FAM) BLA1;10 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record any familial history of bladder cancer documented in the medical record. If the record does
not mention familial history of bladder cancer, code 9 (unknown).
165.5,310 HISTORY OF COLON CA (FAM) BLA1;11 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record any familial history of colon cancer documented in the medical record. If the record does
not mention familial history of colon cancer, code 9 (unknown).
165.5,311 HISTORY OF LUNG CA (FAM) BLA1;12 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record any familial history of lung cancer documented in the medical record. If the record does
not mention familial history of lung cancer, code 9 (unknown).
165.5,312 HISTORY OF PROSTATE CA (FAM) BLA1;13 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record any familial history of prostate cancer documented in the medical record. If the record
does not mention familial history of prostate cancer, code 9 (unknown).
165.5,313 HISTORY OF OTHER CA (FAM) BLA1;14 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record any familial history of other cancer documented in the medical record. If the record does
not mention familial history of other cancer, code 9 (unknown).
165.5,314 SMOKING HISTORY BLA1;15 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S(Y=0:"Never smoked",$L(Y)=1:"0"_Y,Y=98:"98 Currently does not smoke, but did previously",Y=99
:"99 Unknown",1:Y)
LAST EDITED: APR 24, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the actual number of packs of cigarettes smoked per day. A zero must precede single-digit
packs. If one or less packs per day are smoked, code as 01. If the patient was never a smoker,
code 00. If the patient currently does not smoke, but did previously, code as 98. If the medical
record does not mention tobacco use, code as 99 (unknown).
165.5,315 DURATION OF SMOKING HISTORY BLA1;16 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S(Y=0:"Never smoked",$L(Y)=1:"0"_Y_" years",Y=98:"Currently does not smoke, but did previously
",Y=99:"Unknown",1:Y_" years")
LAST EDITED: SEP 06, 1996
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the number of years the patient has smoked. A zero must precede single-digit years. If the
patient never smoked, code 00. If the medical record does not mention duration of years, code 99
(unknown).
165.5,316 DURATION OF SMOKE FREE HISTORY BLA1;17 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S(Y=0:"Never smoked",Y=88:"Not applicable",Y=99:"Unknown",Y=1:Y_" year",1:Y_" years")
LAST EDITED: SEP 06, 1996
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: If the patient was a previous smoker and no longer smokes, record the number of years since his/her
last cigarette. A zero must precede single- digit years. If the patient never smoked, code 00.
If the patient never stopped smoking code 88 (not applicable). If the duration is unknown, code 99
(unknown).
165.5,317 GROSS HEMATURIA BLA1;18 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the patient was presented with a clinical finding of gross hematuria. If not
present, code 0 (no).
165.5,318 MICROSCOPIC HEMATURIA BLA1;19 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the patient was presented with a clinical finding of microscopic hematuria. If not
present, code 0 (no).
165.5,319 URINARY FREQUENCY BLA1;20 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the patient was presented with a clinical finding of urinary frequency. If not
present, code 0 (no).
165.5,320 BLADDER IRRITABILITY BLA1;21 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the patient was presented with a clinical finding of bladder irritability. If not
present, code 0 (no).
165.5,321 DYSURIA BLA1;22 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the patient was presented with a clinical finding of dysuria. If not present, code
0 (no).
165.5,322 OTHER CLINICAL DETECTIONS BLA1;23 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the patient was presented with other clinical findings. If not present, code 0
(no).
165.5,323 ONSET OF SYMPTOMS BLA1;24 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(
0) W !,"Future dates are not allowed"
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: OCT 15, 1997
DESCRIPTION: Record the date (mm/dd/ccyy) on which the symptoms were noted to begin. If the patient did not
experience any symptoms, or if the documentation of symptoms was not recorded, enter date as
00/00/0000. If symptoms were present, but date of onset was unknown, record date as 99/99/9999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,324 DURATION OF GROSS HEMATURIA BLA1;25 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S(Y=0:"Symptoms not present",Y=1:Y_" month",Y=99:"Unknown",1:Y_" months")
LAST EDITED: SEP 06, 1996
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the duration (in months) of the patient's symptoms of gross hematuria prior to the diagnosis
of cancer. If symptoms were not present, code 00. If symptoms were present and the duration
unknown, code 99.
165.5,325 DURATION OF DYSURIA BLA1;26 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S(Y=0:"Symptoms not present",Y=1:Y_" month",Y=99:"Unknown",1:Y_" months")
LAST EDITED: SEP 06, 1996
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the duration (in months) of the patient's symptoms of dysuria prior to the diagnosis of
cancer. If symptoms were not present, code 00. If symptoms were present and the duration unknown,
code 99.
165.5,326 BIMANAUL EXAM OF BLADDER BLA1;27 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: SEP 18, 1996
DESCRIPTION: Record whether a bimanual examination of the bladder was used to diagnose the bladder cancer. If
the procedure was not performed, code 0 (not done).
165.5,327 CYSTOSCOPY WITH BIOPSY BLA1;28 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: SEP 18, 1996
DESCRIPTION: Record whether a cystoscopy with biopsy was used to diagnose the bladder cancer. If the procedure
was not performed, code 0 (not done).
165.5,328 CYSTOSCOPY WITHOUT BIOPSY BLA1;29 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: SEP 18, 1996
DESCRIPTION: Record whether a cystoscopy without biopsy was used to diagnose the bladder cancer. If the
procedure was not performed, code 0 (not done).
165.5,329 FLOW CYTOMETRY BLA1;30 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: SEP 18, 1996
DESCRIPTION: Record whether a flow cytometry was used to diagnose this cancer. If the procedure was not
performed, code 0 (not done).
165.5,330 INTRAVENOUS PYELOGRAM (BLA) BLA1;31 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record whether an intravenous pyelogram was used to diagnose the bladder cancer. If the procedure
was not performed, code 0 (not done).
165.5,331 URINE CYTOLOGY BLA1;32 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: SEP 18, 1996
DESCRIPTION: Record whether a urine cytology was used to diagnose the bladder cancer. If the procedure was not
performed, code 0 (not done).
165.5,332 URINALYSIS BLA1;33 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: SEP 18, 1996
DESCRIPTION: Record whether a urinalysis was used to diagnose the bladder cancer. If the procedure was not
performed, code 0 (not done).
165.5,333 OTHER DIAGNOSTIC PROCEDURES BLA1;34 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: SEP 18, 1996
DESCRIPTION: Record whether other diagnostic procedures were used to diagnose the bladder cancer. If no other
procedure was performed, code 0 (not done).
165.5,334 SPECIALTY MAKING DIAGNOSIS BLA1;35 SET
'0' FOR Internal Medicine;
'1' FOR Family Practice;
'2' FOR General Surgeon;
'3' FOR Surgical Oncologist;
'4' FOR Urologist;
'5' FOR Urologic Oncologist;
'6' FOR Medical Oncologist;
'7' FOR Radiation Oncologist;
'8' FOR Other;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Provide the specialty of the practitioner (other than the pathologist) who diagnosed this case of
bladder cancer.
165.5,335 ABDOMINAL ULTRASOUND BLA1;36 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION:
Record whether an abdominal ultrasound procedure was performed to stage this case.
165.5,336 BONE IMAGING BLA1;37 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION:
Record whether a bone imaging procedure was performed to stage this case.
165.5,337 CHEST X-RAY (BLADDER) BLA1;38 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION:
Record whether a chest x-ray was performed to stage this case.
165.5,338 CT CHEST/LUNG BLA1;39 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION:
Record whether a CT chest/lung procedure was performed to stage this case.
165.5,339 CT ABDOMEN/PELVIS BLA1;40 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION:
Record whether a CT abdomen/pelvis procedure was performed to stage this case.
165.5,340 CT OTHER BLA1;41 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION:
Record whether other CT procedures were performed to stage this case.
165.5,341 MRI PELVIS/ABDOMEN BLA1;42 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION:
Record whether an MRI pelvis/abdomen procedure was performed to stage this case.
165.5,342 MRI OTHER BLA1;43 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION:
Record whether other MRI procedures were performed to stage this case.
165.5,343 OTHER STAGING PROCEDURES BLA1;44 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION:
Record whether other staging procedures were performed to stage this case.
165.5,344 PRESENCE OF HYDRONEPHROSIS BLA1;45 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the patient was noted at any time to have hydronephrosis. If the medical record
does not mention hydronephrosis, code as 9 (unknown).
165.5,345 PRESENCE OF MULTIPLE TUMORS BLA1;46 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the presence of multiple primary bladder tumors was detected either clinically or
pathologically.
165.5,346 PROTOCOL ELIGIBILITY STATUS BLA2;1 SET
'0' FOR Not available;
'1' FOR On protocol;
'2' FOR Ineligible (age,stage,etc.);
'3' FOR Ineligible (comorbidity, preexist cond);
'4' FOR Entered but withdrawn;
'6' FOR Eligible, not entered;
'7' FOR Eligible, refused;
'8' FOR Not recommended;
'9' FOR Unknown;
LAST EDITED: MAY 22, 1997
DESCRIPTION: Record the eligibility status of the patient to be entered into a protocol. Analysis of protocol
eligibility status assists program planning.
165.5,347 MANAGING PHYSICIAN (PRIMARY) BLA2;2 POINTER TO BLADDER PHYSICIAN SPECIALTY FILE (#166.12)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(166.12,+Y,0)),"^",2)
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record the specialty of the primary-care physician who managed the patient upon discharge. If it
cannot be determined who the primary managing physician is, code 99 (unknown).
165.5,348 MANAGING PHYSICIAN (SECONDARY) BLA2;3 POINTER TO BLADDER PHYSICIAN SPECIALTY FILE (#166.12)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(166.12,+Y,0)),"^",2)
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record the specialty of the secondary-care physician who managed the patient upon discharge. If it
cannot be determined who the secondary managing physician is, code 99 (unknown).
165.5,349 TUMOR RESECTION DURING TURB BLA2;4 SET
'1' FOR Visibly complete resection;
'2' FOR Visibly incomplete resection;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: For all bladder cases undergoing a transurethral resection of the bladder (code 10) for the first
course of treatment, record whether or not a tumor was grossly visible or not after resection.
This information should be found in the operative report. For primary tumors of the prostatic
utricle (C68.0), code 8 (not applicable).
165.5,350 TYPE OF URINARY DIVERSION BLA2;5 SET
'1' FOR Ileoconduit;
'2' FOR Continent cutaneous;
'3' FOR Neobladder;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: If cancer-directed surgery codes 20-70 are reported, code the type of urinary diversion performed.
This information should be found in the operative report. For primary tumors of the prostatic
utricle (C68.0), code 8 (not applicable).
165.5,351 PELVIC LYMPH NODE DISSECT (BL) BLA2;6 SET
'0' FOR Not done;
'1' FOR Done;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: If cancer-directed surgery code 70 is reported, code whether a pelvic lymph node dissection for
radical surgery was performed. This information should be obtained from the operative and
pathology reports. If the patient had a type of cancer-directed surgery other than a code 70, code
8 (not applicable).
165.5,352 BLEEDING REQUIRING TRANSFUSION BLA2;7 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether this surgical complication resulted from operation. If this complication did not
occur, code 0 (none).
165.5,353 DEEP VENOUS THROMBOSIS BLA2;8 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether this surgical complication resulted from operation. If this complication did not
occur, code 0 (none).
165.5,354 MYOCARDIAL INFARCTION (MI) BLA2;9 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior medical condition.
165.5,355 PELVIC ABSCESS BLA2;10 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether this surgical complication resulted from operation. If this complication did not
occur, code 0 (none).
165.5,356 PNEUMONIA REQ ANTIBIOTICS BLA2;11 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether this surgical complication resulted from operation. If this complication did not
occur, code 0 (none).
165.5,357 POST-OPERATIVE DEATH BLA2;12 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether this surgical complication resulted from operation. If this complication did not
occur, code 0 (none).
165.5,358 PULMONARY EMBOLISM/THROMBOSIS BLA2;13 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether this surgical complication resulted from operation. If this complication did not
occur, code 0 (none).
165.5,359 REOPERATION BLA2;14 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether this surgical complication resulted from operation. If this complication did not
occur, code 0 (none).
165.5,360 OTHER SURGICAL COMPLICATIONS BLA2;15 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, surgery not performed;
'9' FOR Unknown;
LAST EDITED: MAR 27, 2000
DESCRIPTION: This field describes a complication or event that occurred after surgery of the primary site and
before the date of patient discharge from the hospital.
165.5,361 DATE RADIATION ENDED BLA2;16 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: MAR 31, 2000
HELP-PROMPT: *** DATE RADIATION ENDED MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: The date on which the patient completes or receives the last radiation treatment at any facility.
For further information see FORDS pages 166-167.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,362 TOTAL RAD (cGy/rad) DOSE BLA2;17 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: AUG 29, 1996
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: Record the total external rad dose and brachytherapy dosage given to all sites treated, including
boost dosage. If the patient did not receive radiation therapy, code 00000. If it is known that
the patient received radiation therapy but the amount is unknown, code 99999.
165.5,363 REGIONAL TREATMENT MODALITY BLA2;18 POINTER TO REGIONAL TREATMENT MODALITY FILE (#166.13)
INPUT TRANSFORM: S DIC("S")="I ((+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)),(($P(^ONCO(165.5,DA,0),U,16)<3030101)!((Y'=46)
&(Y'=47)))" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(166.13,+Y,0)),U,2)
LAST EDITED: NOV 22, 2004
DESCRIPTION: Records the dominant modality of radiation therapy used to deliver the most clinically significant
regional dose to the primary volume of interest during the first course of treatment.
For further information see FORDS pages 155-157.
SCREEN: S DIC("S")="I ((+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)),(($P(^ONCO(165.5,DA,0),U,16)<3030101)!((Y'=46)
&(Y'=47)))"
EXPLANATION: Codes 01-16 have been discontinued. Codes 80 and 85 are prohibited for 2003+ cases.
165.5,363.1 BOOST TREATMENT MODALITY 24;9 POINTER TO REGIONAL TREATMENT MODALITY FILE (#166.13)
INPUT TRANSFORM: S DIC("S")="I (+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X I $D(X) S V
=1 D NT^ONCODSR
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(166.13,+Y,0)),U,2)
LAST EDITED: JAN 09, 2003
DESCRIPTION: Records the dominant modality of radiation therapy used to deliver the most clinically significant
boost dose to the primary volume of interest during the first course of treatment. This is
accomplished with external beam fields of reduced size (relative to the regional treatment fields),
implants, stereotactic radiosurgery, conformal therapy, or IMRT. External beam boosts may consist
of two or more successive phases with progressively smaller fields generally coded as a single
entry.
For further information see FORDS pages 159-161.
SCREEN: S DIC("S")="I (+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)"
EXPLANATION: ROADS codes 01-16 have been discontinued.
165.5,364 URINARY INCONTINENCE BLA2;19 SET
'0' FOR None;
'1' FOR Yes;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the patient experienced any urinary incontinence as a result of radiation therapy.
If the patient did not receive radiation therapy, code 8 (not applicable).
165.5,365 HEMATURIA BLA2;20 SET
'0' FOR None;
'1' FOR Yes;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the patient experienced any hematuria as a result of radiation therapy. If the
patient did not receive radiation therapy, code 8 (not applicable).
165.5,366 RADIATION BOWEL INJURY BLA2;21 SET
'0' FOR None;
'1' FOR Yes;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the patient experienced a radiation bowel injury as a result of radiation therapy.
If the patient did not receive radiation therapy, enter 8 (not applicable).
165.5,367 DATE CHEMOTHERAPY ENDED BLA2;22 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: APR 03, 1997
HELP-PROMPT: *** DATE CHEMOTHERAPY ENDED MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Record the date on which the entire first course of chemotherapy was completed. If chemotherapy
was not given, code date as 00/00/0000.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,368 ROUTE CHEMOTHERAPY ADMIN BLA2;23 SET
'0' FOR No chemotherapy;
'1' FOR Systemic;
'2' FOR Intravesicle;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record the route by which the chemotherapy was administered. If the patient did not receive
chemotherapy, code 0 (no chemotherapy).
165.5,369 ADRIAMYCIN BLA2;24 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the chemotherapeutic agent, Adriamycin, was given. If no chemotherapy was given,
code as 0 (no).
165.5,370 CARBOPLATINUM BLA2;25 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the chemotherapeutic agent, Carboplatinum, was given. If no chemotherapy was given,
code as 0 (no).
165.5,371 CISPLATIN BLA2;26 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,372 CYCLOPHOSPHAMIDE BLA2;27 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,373 5-FLUOROURACIL BLA2;28 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the chemotherapeutic agent, 5-fluorouracil, was given. If no chemotherapy was
given, code as 0 (no).
165.5,374 GALLIUM NITRATE BLA2;29 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the chemotherapeutic agent, Gallium Nitrate, was given. If no chemotherapy was
given, code as 0 (no).
165.5,375 IFOSFAMIDE BLA2;30 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record whether the chemotherapeutic agent, Ifosfamide, was given. If no chemotherapy was given,
code as 0 (no).
165.5,376 METHOTREXATE BLA2;31 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,377 TAXOL BLA2;32 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the chemotherapeutic agent, Taxol, was given. If no chemotherapy was given, code as
0 (no).
165.5,378 THIOTEPA BLA2;33 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the chemotherapeutic agent, Thiotepa, was given. If no chemotherapy was given, code
as 0 (no).
165.5,379 VINBLASTINE BLA2;34 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record whether the chemotherapeutic agent, Vinblastine, was given. If no chemotherapy was given,
code as 0 (no).
165.5,380 OTHER CHEMOTHERAPEUTIC AGENTS BLA2;35 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, no chemotherapy administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,381 INDICATION FOR ADMIN OF AGENTS BLA2;36 SET
'0' FOR No agents administered, NA;
'1' FOR Metastatic disease;
'2' FOR Adjuvant therapy;
'3' FOR Neoadjuvant therapy;
'8' FOR Other;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record the reason for chemotherapy. If the patient never received chemotherapy, code 0 (no agents
administered, na).
165.5,382 REASON CHEMOTHERAPY STOPPED BLA2;41 SET
'0' FOR Treatment completed, NA;
'1' FOR Complications;
'2' FOR Disease progression;
'3' FOR Recommended but medically contraindicated;
'8' FOR Other;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
HELP-PROMPT: Enter the reason chemotherapy treatment was discontinued.
DESCRIPTION: Record the reason chemotherapy was discontinued. If therapy ended when treatment was complete, or
if the patient never received chemotherapy, code 0 (treatment completed, NA).
NOTES: TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File
TRIGGERED by the INTENT OF CHEMOTHERAPY field of the ONCOLOGY PRIMARY File
165.5,383 BCG BLA2;37 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 1999
DESCRIPTION:
Record whether BCG immunotherapy was administered for the first course of therapy.
165.5,384 INTERFERON BLA2;38 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,385 INTERLEUKIN-2 BLA2;39 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 14, 1999
DESCRIPTION:
Record whether Interleukin-2 immunotherapy was administered for the first course of therapy.
SCREEN: S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
EXPLANATION: Code 8 should not be used for cases with a DATE DX < 1/1/1999
165.5,386 OTHER TYPE OF IMMUNOTHERAPY BLA2;40 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 14, 1999
DESCRIPTION:
Record whether other immunotherapy was administered for the first course of therapy.
SCREEN: S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
EXPLANATION: Code 8 should not be used for cases with a DATE DX < 1/1/1999
165.5,387 TYPE OF 1ST RECURRENCE/BLADDER BLA2;42 SET
'0' FOR No recurrence;
'1' FOR Bladder, superficial;
'2' FOR Bladder, muscle invasion;
'3' FOR Bladder, NOS;
'4' FOR Pelvis;
'5' FOR Distant;
'8' FOR Never disease-free;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record the type of the first recurrence. "Pelvic recurrence" is tumor that has invaded any of the
following sites: prostate, uterus, vagina, pelvic wall, or abdominal wall. "Distant recurrence"
occurs in a site considered distant from the organ or origin as presented in most staging schemes.
165.5,400 HISTORY OF THYROID CA (FAM) THY1;1 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION: Record any familial history of thyroid cancer documented in the medical record. If the record does
not mention familial history of thyroid cancer, code 9 (unknown).
165.5,401 HISTORY OF LYMPHOMA (PT) THY1;2 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION:
Record whether the patient has a history of Lymphoma, including Hodgkin's Disease.
165.5,402 HISTORY OF CHILDHOOD MALIG THY1;3 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION:
Record whether the patient has a history of childhood malignancies, other than lymphoma.
165.5,403 PRIOR EXPOSURE TO RADIATION THY1;4 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION: This field describes a patient's known prior radiation exposure. Exposure to fluoroscopy,
exposure to radioactive isotopes, or actual radiation treatments should be considered prior
radiation exposure. Do not consider routine chest or dental x-rays as prior radiation exposure.
165.5,404 HISTORY OF GOITER (PT) THY1;5 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION:
Record history of enlarged thyroid gland for a period of greater than 5 years prior to diagnosis.
165.5,405 HISTORY OF GOITER (FAM) THY1;6 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION:
Record any familial history of thyroid enlargement (goiter), Graves Disease or thyroiditis.
165.5,406 HISTORY OF GRAVES DISEASE (PT) THY1;7 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record whether the patient has a history of Graves Disease, i.e., autoimmune hyperthyroidism with
or withour eye symptoms.
165.5,407 HISTORY OF THYROIDITIS (PT) THY1;8 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record whether the patient has a history of Hashimoto's thyroiditis or any other type of
thyroiditis. Thyroiditis is often associated with hypothyroidism.
165.5,408 DYSPHAGIA THY1;9 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION:
Record whether the sign/symptom 'DYSPHAGIA' was present at the time of diagnosis.
165.5,409 HOARSENESS OR VOICE CHANGE THY1;10 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION:
Record whether the sign/symptom 'HOARSENESS OR VOICE CHANGE' was present at the time of diagnosis.
165.5,410 NECK NODAL MASS THY1;11 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION:
Record whether the sign/symptom 'NECK NODAL MASS' was present at the time of diagnosis.
165.5,411 PAIN, BONE THY1;12 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION:
Record whether the sign/symptom 'PAIN, BONE' was present at the time of diagnosis.
165.5,412 PAIN, NECK THY1;13 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION:
Record whether the sign/symptom 'PAIN, NECK' was present at the time of diagnosis.
165.5,413 PATHOLOGIC FRACTURE THY1;14 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION:
Record whether the sign/symptom 'PATHOLOGIC FRACTURE' was present at the time of diagnosis.
165.5,414 STRIDOR/DIFFICULTY BREATHING THY1;15 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record whether the sign/symptom 'STRIDOR OR DIFFICULTY BREATHING' was present at the time of
diagnosis.
165.5,415 THYROID MASS THY1;16 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION:
Record whether the sign/symptom 'THYROID MASS' was present at the time of diagnosis.
165.5,416 WEIGHT LOSS THY1;17 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION:
Record whether the sign/symptom 'WEIGHT LOSS' was present at the time of diagnosis.
165.5,417 OTHER SIGNS/SYMPTOMS THY1;18 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION:
Record whether any OTHER signs/symptoms were present at the time of diagnosis.
165.5,418 BONE SCAN (THYROID) THY1;19 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'BONE SCAN', if it was performed to evaluate
this Thyroid cancer. If this test was not done record a '0'.
165.5,419 CHEST X-RAY (THYROID) THY1;20 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'CHEST X-RAY', if it was performed to
evaluate this Thyroid cancer. If this test was not done record a '0'.
165.5,420 CT SCAN OF NECK (THYROID) THY1;21 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'CT SCAN OF NECK', if it was performed to
evaluate this Thyroid cancer. If this test was not done record a '0'.
165.5,421 CT SCAN OF CHEST THY1;22 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'CT SCAN OF CHEST', if it was performed to
evaluate this cancer. If this test was not done record a '0'.
165.5,422 INCISIONAL BIOPSY OF THYROID THY1;23 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'INCISIONAL BIOPSY OF THYROID', if it was
performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
165.5,423 LARYNGOSCOPY THY1;24 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'LARYNGOSCOPY', if it was performed to
evaluate this Thyroid cancer. If this test was not done record a '0'.
165.5,424 NECK X-RAY (AP & LATERAL) THY1;25 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'NECK X-RAY (AP & LATERAL)', if it was
performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
165.5,425 NEEDLE ASPIRATION OF NECK NODE THY1;26 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'NEEDLE ASPIRATION OF NECK NODE', if it was
performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
165.5,426 NEEDLE ASPIRATION OF THYROID THY1;27 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'NEEDLE ASPIRATION OF THYROID', if it was
performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
165.5,427 MRI OF NECK THY1;28 SET
'0' FOR Test not donw;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'MRI OF NECK', if it was performed to
evaluate this Thyroid cancer. If this test was not done record a '0'.
165.5,428 THYROID SCAN THY1;29 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'THYROID SCAN', if it was performed to
evaluate this Thyroid cancer. If this test was not done record a '0'.
165.5,429 ULTRASOUND OF THYROID THY1;30 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic/Surgical Work-up 'ULTRASOUND OF THYROID', if it was performed
to evaluate this Thyroid cancer. If this test was not done record a '0'.
165.5,430 OTHER DIAGNOSTIC/SURGICAL TEST THY1;31 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if other test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of any OTHER Diagnostic/Surgical Work-ups done, if any were performed to
evaluate this Thyroid cancer. If other test were not done record a '0'.
165.5,431 BLOOD VESSEL INVASION THY1;32 SET
'0' FOR No invasion;
'1' FOR Yes;
'8' FOR No surgery, not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the presence of blood vessel invasion. NOTE: This refers to the presence of tumor cells
inside blood vessels of a caliber larger than capil- laries, located in the tumor capsule or
beyond. The tumor cells should be attached to the vessel wall.
165.5,432 EXTRA-THYROIDAL EXTENSION THY1;33 SET
'0' FOR No extension;
'1' FOR Esophagus;
'2' FOR Trachea;
'3' FOR Larynx;
'4' FOR Strap muscles;
'5' FOR Soft tissue;
'6' FOR Multiple sites;
'7' FOR Extension, NOS;
'8' FOR Not applicable, no surgery;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record any gross or microscopic extension beyond thyroid capsule. NOTE: Do not code invasion of
the tumor capsule around a follicular cancer as an extra-thyroidal extension.
165.5,433 MULTIFOCAL THY1;34 SET
'0' FOR No;
'1' FOR Microscopic;
'2' FOR Gross;
'3' FOR Multifocal, NOS;
'9' FOR Unknown;
LAST EDITED: AUG 29, 1996
DESCRIPTION:
Record whether the tumor was multifocal. Pathologic confirmation is required.
165.5,434 LOCATION OF POSITIVE NODES THY1;35 SET
'0' FOR No positive nodes;
'1' FOR Perithyroid only;
'2' FOR Lateral neck only;
'3' FOR Mediastinum only;
'4' FOR Multiple regions;
'5' FOR Other;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: AUG 29, 1996
DESCRIPTION:
Record the location of regional nodes if they are positive.
165.5,435 DATE MOST DEFINITIVE SURG DIS THY1;36 DATE
INPUT TRANSFORM: D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 29, 2013
HELP-PROMPT: Enter the date the patient was discharged following primary site surgery.
DESCRIPTION: Source of Standard: NAACCR Item #: 3180 This is the date the patient was discharged following
primary site surgery. The date must be after or equal to the DATE DX (#3) field. The date
corresponds to the event recorded in SURGERY OF PRIMARY (F) (#58.6) and MOST DEFINITIVE SURG DATE
(#50) fields.
For further information see FORDS pages 144-145.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,436 AIRWAY PROBLEM THY1;37 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'AIRWAY PROBLEM REQUIRING TRACHEOSTOMY',
which resulted from cancer-directed surgery. If no cancer-directed surgery was performed, code 8
(not applicable).
165.5,437 BLEEDING/HEMATOMA THY1;38 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'BLEEDING HEMATOMA', which resulted from
cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).
165.5,438 HYPOCALCEMIA THY1;39 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'HYPOCALCEMIA (NEEDS ORAL CALCIUM', which
resulted from cancer-directed surgery. If no cancer- directed surgery was performed, code 8 (not
applicable).
165.5,439 RECURRENT NERVE INJURY THY1;40 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'RECURRENT NERVE INJURY (OR VOCAL CORD
PARESIS)', which resulted from cancer-directed surgery. If no cancer-directed surgery was
performed, code 8 (not applicable).
165.5,440 WOUND INFECTION THY1;41 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'WOUND INFECTION', which resulted from
cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).
165.5,441 POSTOPERATIVE DEATH THY1;42 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR Not applicable, no surgery;
'9' FOR Unknown;
LAST EDITED: AUG 30, 1996
DESCRIPTION: Record operative death occurring within 30 days of the cancer-directed surgery. If no
cancer-directed surgery was performed, code 8 (not applicable).
165.5,442 REGIONAL DOSE: cGy THY1;43 NUMBER
INPUT TRANSFORM: K:X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X I $D(X) S V=0 D NT^ONCODSR I $D(X) S ONCL=5 D RDIT^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="00000":"Radiation tx not administered",Y=88888:"NA, brachytherapy/radioisotopes administe
red",Y=99999:"Dose unknown/unknown if administered",1:Y)
LAST EDITED: JAN 09, 2003
HELP-PROMPT: Type a Number between 0 and 99999
DESCRIPTION: Records the dominant or most clinically significant total dose of regional radiation therapy
delivered to the patient during the first course of treatment. The unit of measure is centiGray
(cGy).
Code 88888 (NA, brachytherapy/radioisotopes administered) if not applicable or when brachytherapy
or radioisotopes were administered to the patient.
For further information see FORDS page 248.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,443 BOOST DOSE: cGy THY1;44 NUMBER
INPUT TRANSFORM: K:X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X I $D(X) S V=0 D NT^ONCODSR I $D(X) S ONCL=5 D RDIT^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="00000":"Boost tx not administered",Y=88888:"NA, brachytherapy/radioisotopes administered"
,Y=99999:"Dose unknown/unknown if administered",1:Y)
LAST EDITED: FEB 21, 2003
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: Records the additional boost dosage delivered to that part of the treatment volume encompassed by
the boost fields or devices. The unit of measure is centiGray (cGy).
Code 88888 (NA, brachytherapy/radioisotopes administered) if not applicable or when brachytherapy
or radioisotopes were administered to the patient.
For further information see FORDS page 252.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,444 INITIAL DOSE OF RADIOIODINE THY1;45 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: SEP 03, 1996
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: Record the total Millicuries (mCi) of radioiodine given as part of initial therapy, whether for the
purpose of ablation or therapy. If none received, code 00000. If unknown, code 99999.
165.5,445 SECOND DOSE OF RADIOIODINE THY1;46 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: SEP 03, 1996
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: Record the total Millicuries (mCi) of radioiodine given as second dose within the next 6 months
after date of diagnosis. If none received, code 00000. If unknown, code 99999.
165.5,446 ADJUVANT CHEMOTHERAPY (THY) THY1;47 SET
'0' FOR No concomitant treatment;
'1' FOR Radiation treatment and concomitant adjuvant chemotherapy;
'9' FOR Unknown if therapy concomitant;
LAST EDITED: FEB 21, 1997
DESCRIPTION: Record the Adjuvant Chemotherapy with Concomitant External Beam Radiation. If patient receives
chemotherapy at any time during radiation as a radio- sensitizing agent, code 1. If chemotherapy
is stopped more than 2 days prior to radiation therapy and not given until external beam therapy is
completed, code 0. If unknown, code 9.
165.5,500 HISTORY OF SOFT TIS SARC (FAM) STS1;1 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record any familial history of soft tissue sarcoma documented in the medical record. If the record
does not mention familial history of soft tissue sarcoma, code 9 (unknown).
165.5,501 HISTORY OF ANY CANCER (PT) STS1;2 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record the personal history of any cancer documented in the medical record. If the record does not
mention personal history of any cancer, code 9 (unknown).
165.5,502 ANGIOGRAM OF PRIMARY STS1;3 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 24, 1996
DESCRIPTION: Record the results of the Diagnostic Workup 'Angiogram for Primary', if it was performed to
evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
165.5,503 BONE MARROW ASPIRATE OR BIOPSY STS1;4 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 06, 1996
DESCRIPTION: Record the results of the Diagnostic Workup 'Bone marrow aspirate and/or Biopsy', if it was
performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
165.5,504 BONE SCAN (SOFT TIS SARCOMA) STS1;5 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record the results of the Diagnostic Workup 'Bone scan', if it was performed to evaluate this soft
tissue sarcoma. If this test was not done, record a '0'.
165.5,505 CHEST X-RAY (STS/NHL) STS1;6 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 18, 1997
DESCRIPTION: Record the results of the Diagnostic Workup 'Chest X-RAY', if it was performed to evaluate this
primary. If this test was not done, record a '0'.
165.5,506 CT SCAN OF CHEST (STS) STS1;7 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic Workup 'CT scan of chest', if it was performed to evaluate
this soft tissue sarcoma. If this test was not done, record a '0'.
165.5,507 CT SCAN OF PRIMARY STS1;8 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic Workup 'CT scan of primary', if it was performed to evaluate
this soft tissue sarcoma. If this test was not done, record a '0'.
165.5,508 LIVER FUNCTION STUDIES (STS) STS1;9 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record the results of the Diagnostic Workup 'Liver Function Studies', if it was performed to
evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
165.5,509 LYMPHANGIOGRAM STS1;10 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic Workup 'Lymphangiogram', if it was performed to evaluate this
soft tissue sarcoma. If this test was not done, record a '0'.
165.5,510 MRI OF PRIMARY STS1;11 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic Workup 'MRI of primary', if it was performed to evaluate this
soft tissue sarcoma. If this test was not done, record a '0'.
165.5,511 MRI OF OTHER STS1;12 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic Workup 'MRI of other', if it was performed to evaluate this
soft tissue sarcoma. If this test was not done, record a '0'.
165.5,512 SKELETAL X-RAY STS1;13 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic Workup 'Skeletal X-RAY', if it was performed to evaluate this
soft tissue sarcoma. If this test was not done, record a '0'.
165.5,513 SONOGRAM STS1;14 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record the results of the Diagnostic Workup 'Sonogram', if it was performed to evaluate this soft
tissue sarcoma. If this test was not done, record a '0'.
165.5,514 CYTOGENETICS STS1;15 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record whether the 'Cytogenetics' test was performed to evaluate this primary. If this test was
not done, record a '0'.
165.5,515 ELECTRON MICROSCOPY STS1;16 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record whether the Histologic Workup 'Electron microscopy' was performed to evaluate this soft
tissue sarcoma. If this test was not done, record a '0'.
165.5,516 IMMUNOHISTOCHEMISTRY STS1;17 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record whether the 'Immunohistochemistry/Tumor Surface Marker' test was performed to evaluate this
primary. If this test was not done, record a '0'.
165.5,517 IN SITU HYBRIDIZATION STS1;18 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: SEP 09, 1996
DESCRIPTION: Record whether the Histologic Workup 'In situ hybridization' was performed to evaluate this soft
tissue sarcoma. If this test was not done, record a '0'.
165.5,518 OUTSIDE CONFIRMATION REQUESTED STS1;19 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 10, 1996
DESCRIPTION:
Record whether an outside confirmation of a biopsy was requested.
165.5,519 SUBSITE STS1;20 POINTER TO ONCOLOGY SUBSITE FILE (#166.3)
LAST EDITED: SEP 10, 1996
DESCRIPTION:
Record the appropriate subsite code.
165.5,520 TYPE OF ADDITIONAL CODING SYS STS1;21 SET
'1' FOR 1 to 3 system;
'2' FOR 1 to 2 or high/low system;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 10, 1996
DESCRIPTION: If your institution uses an additional grade coding system, record the additional system that is
used. Code '1' if the coding system is a 1 to 3 scale. Code '2' if the coding system is a 1 to 2
or high/low scale. If not applicable code '8', and if unknown, code '9'.
165.5,521 VALUE OF ADDITIONAL CODING SYS STS1;22 SET
'1' FOR 1;
'2' FOR 2;
'3' FOR 3;
'5' FOR Low;
'6' FOR High;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 10, 1996
DESCRIPTION: Enter the numeric (1,2 or 3) value from the additional coding system. If code is 'low', code '5';
if code is 'high', code 6. If not applicable code '8', and if unknown, code '9'.
165.5,522 PATHOLOGIC SIZE OF TUMOR STS1;23 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)
LAST EDITED: SEP 24, 1996
HELP-PROMPT: Type a Number between 0 and 999, 0 Decimal Digits
DESCRIPTION: Record the largest diameter of the primary tumor in milimeters (1 cm = 10 mm) as specified in the
pathology report. If there is more than one tumor in the same primary site (multifocal), record
the largest diameter of the largest tumor. Do not use size of the entire specimen for tumor size.
In cases where the tumor diameter is not specified in the pathology report, size of tumor should be
obtained from the operative report, followed by x-rays, or physical examinations.
165.5,523 DEPTH OF TUMOR STS1;24 SET
'1' FOR Superficial (above muscle fascia);
'2' FOR Deep (all else);
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 10, 1996
DESCRIPTION: Tumor depth is applicable for extremity, trunk and head and neck lesions. Code 8 if not applicable
and 9 if unknown.
165.5,524 CONSULTATIONS (MED ONCOLOGIST) STS1;25 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 10, 1996
DESCRIPTION:
Enter whether there was a consultation with a medical oncologist.
165.5,525 CONSULTATIONS (RAD ONCOLOGIST) STS1;26 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 10, 1996
DESCRIPTION:
Enter whether there was a consultation with a radiation oncologist.
165.5,526 TREATING SURGEON STS2;1 SET
'1' FOR General surgeon;
'2' FOR Orthopedic surgeon;
'3' FOR Urologist;
'4' FOR Gynecologist;
'5' FOR ENT (ear, nose and throat);
'6' FOR Other;
'8' FOR Not applicable, no surgery;
'9' FOR Unknown;
LAST EDITED: SEP 10, 1996
DESCRIPTION:
Record the appropriate code for the type of treating surgeon.
165.5,527 ASA CLASS STS2;2 SET
'1' FOR No systemic disturbance;
'2' FOR Mild to moderate systemic disturbance;
'3' FOR Severe systemic disturbance;
'4' FOR Life-threatening disturbance;
'5' FOR Moribund with little chance of survival;
'9' FOR Class unknown or not applicable;
LAST EDITED: SEP 20, 1996
DESCRIPTION: Record appropriate code from anesthesiologist's report. If no organic, physiologic, biochemical or
psychiatric disturbance, code 1. If not recorded or if the patient did not receive surgery, code
9.
165.5,528 FINE NEEDLE ASPIRATION STS1;27 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X
OUTPUT TRANSFORM: S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)
LAST EDITED: SEP 11, 1996
HELP-PROMPT: Type a Number between 000000 and 999999, 0 Decimal Digits. Must be 6 characters long.
DESCRIPTION: Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent
the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the
GRADE. For example, if this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was
'3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".
If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was
done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's
where unknown. For example, if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is
unknown, then enter "869337".
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,529 CORE NEEDLE BIOPSY STS1;28 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X
OUTPUT TRANSFORM: S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)
LAST EDITED: SEP 11, 1996
HELP-PROMPT: Type a Number between 0 and 999999, 0 Decimal Digits. Must be 6 characters long.
DESCRIPTION: Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent
the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the
GRADE. For example, if this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was
'3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".
If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was
done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's
where unknown. For example, if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is
unknown, then enter "869337".
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,530 INCISIONAL BIOPSY (STS PCE) STS1;29 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X
OUTPUT TRANSFORM: S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)
LAST EDITED: SEP 11, 1996
HELP-PROMPT: Type a Number between 0 and 999999, 0 Decimal Digits. Must be 6 characters long.
DESCRIPTION: Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent
the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the
GRADE. For example, if this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was
'3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".
If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was
done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's
where unknown. For example, if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is
unknown, then enter "869337".
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,531 EXCISIONAL BIOPSY STS1;30 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X
OUTPUT TRANSFORM: S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)
LAST EDITED: SEP 11, 1996
HELP-PROMPT: Type a Number between 0 and 999999, 0 Decimal Digits. Must be 6 characters long.
DESCRIPTION: Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent
the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the
GRADE. For example, if this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was
'3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".
If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was
done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's
where unknown. For example, if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is
unknown, then enter "869337".
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,532 EXTERNAL BEAM RADIATION STS2;3 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 12, 1996
DESCRIPTION:
Record whether any external beam radiation therapy was performed.
165.5,533 EXTERNAL BEAM RAD FRACTIONS STS2;4 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)
LAST EDITED: SEP 13, 1996
HELP-PROMPT: Type a Number between 0 and 999, 0 Decimal Digits
DESCRIPTION:
Record the number of fractions for external beam radiation.
165.5,534 EXTERNAL BEAM RADIATION ENERGY STS2;5 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0"_Y,1:Y)
LAST EDITED: SEP 12, 1996
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION:
Record the units (MV) of radiation energy if external beam radiation was performed .
165.5,535 INTRAOPERATIVE RADIATION STS2;6 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 12, 1996
DESCRIPTION:
Record whether intraoperative radiation was performed.
165.5,536 INTRAOPERATIVE RADIATION DOSE STS2;7 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: SEP 12, 1996
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: Record the total intraoperative radiation dose given. If the patient did not receive this type of
radiation therapy, code 0's. If it is known that the patient received this type of radiation
therapy but the dose is not known, code 9's.
165.5,537 INTRAOPERATIVE RADIATION ENER STS2;8 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0"_Y,1:Y)
LAST EDITED: SEP 12, 1996
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION:
Record the units (MV) of intraoperative radiation energy if this was performed.
165.5,538 BRACHYTHERAPY STS2;9 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION:
Record whether brachytherapy was performed.
165.5,539 BRACHYTHERAPY DAYS STS2;10 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)
LAST EDITED: SEP 13, 1996
HELP-PROMPT: Type a Number between 0 and 999, 0 Decimal Digits
DESCRIPTION:
Record the number of days brachytherapy was given.
165.5,540 BRACHYTHERAPY RADIATION DOSE STS2;11 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: SEP 13, 1996
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: Record the total brachytherapy radiation dose given. If the patient did not receive this type of
radiation therapy, code 0's. If it is known that the patient received this type of radiation
therapy, but the dose is unknown, code 9's.
165.5,541 DATE BRACHYTHERAPY STARTED STS2;12 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DBTS^ONCODSR
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: APR 04, 1997
HELP-PROMPT: *** DATE BRACHYTHERAPY STARTED MUST BE AFTER OR EQUAL TO THE DATE DX, AND BEFORE OR EQUAL TO THE
DATE BRACHYTHERAPY ENDED ***
DESCRIPTION: Record the date on which brachytherapy was started. If brachytherapy was not given, code the date
as 00/00/00. If it is unknown code as 99/99/99.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,542 DATE BRACHYTHERAPY ENDED STS2;13 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DBTE^ONCODSR
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: APR 07, 1997
HELP-PROMPT: *** DATE BRACHYTHERAPY ENDED MUST BE AFTER OR EQUAL TO THE DATE BRACHYTHERAPY STARTED ***
DESCRIPTION: Record the date on which brachytherapy ended. If brachytherapy was not given, code the date as
00/00/00. If it is unknown code as 99/99/99.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,543 CYTOXAN STS2;14 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record whether the chemotherapeutic agent, Cytoxan, was given. If no chemotherapy was given, code
as 0.
165.5,544 DTIC STS2;15 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record whether the chemotherapeutic agent, DTIC, was administered. If no chemotherapy was given,
code as 0.
165.5,545 DOXORUBICIN (STS) STS2;16 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 31, 1997
DESCRIPTION: Record whether the chemotherapeutic agent, Doxorubicin, was administered. If no chemotherapy was
given, code as 0.
165.5,546 ETOPOSIDE STS2;17 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record whether the chemotherapeutic agent, Etoposide, was administered. If no chemotherapy was
given, code as 0.
165.5,547 CISPLATIN METHOD OF DELIVERY STS2;18 SET
'1' FOR Bolus;
'2' FOR Infusion;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if
unknown code 9.
165.5,548 CYTOXAN METHOD OF DELIVERY STS2;19 SET
'1' FOR Bolus;
'2' FOR Infusion;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if
unknown code 9.
165.5,549 DTIC METHOD OF DELIVERY STS2;20 SET
'1' FOR Bolus;
'2' FOR Infusion;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if
unknown code 9.
165.5,550 DOXORUBICIN METHOD OF DELIVERY STS2;21 SET
'1' FOR Bolus;
'2' FOR Infusion;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if
unknown code 9.
165.5,551 ETOPOSIDE METHOD OF DELIVERY STS2;22 SET
'1' FOR Bolus;
'2' FOR Infusion;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if
unknown code 9.
165.5,552 IFOSFAMIDE METHOD OF DELIVERY STS2;23 SET
'1' FOR Bolus;
'2' FOR Infusion;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if
unknown code 9.
165.5,553 CISPLATIN LOCATION STS2;24 SET
'1' FOR Intra-arterial;
'2' FOR Intravenous;
'3' FOR Oral;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable,
code 8, and if unknown code 9.
165.5,554 CYTOXAN LOCATION STS2;25 SET
'1' FOR Intra-arterial;
'2' FOR Intravenous;
'3' FOR Oral;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable,
code 8, and if unknown code 9.
165.5,555 DTIC LOCATION STS2;26 SET
'1' FOR Intra-arterial;
'2' FOR Intravenous;
'3' FOR Oral;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable,
code 8, and if unknown code 9.
165.5,556 DOXORUBICIN LOCATION STS2;27 SET
'1' FOR Intra-arterial;
'2' FOR Intravenous;
'3' FOR Oral;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable,
code 8, and if unknown code 9.
165.5,557 ETOPOSIDE LOCATION STS2;28 SET
'1' FOR Intra-arterial;
'2' FOR Intravenous;
'3' FOR Oral;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable,
code 8, and if unknown code 9.
165.5,558 IFOSFAMIDE LOCATION STS2;29 SET
'1' FOR Intra-arterial;
'2' FOR Intravenous;
'3' FOR Oral;
'8' FOR Not applicable;
'9' FOR Unknown;
LAST EDITED: SEP 13, 1996
DESCRIPTION: Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable,
code 8, and if unknown code 9.
165.5,559 COLONY STIMULATING FACTORS STS2;30 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 14, 1999
DESCRIPTION:
Record whether colony stimulating factors were used.
SCREEN: S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
EXPLANATION: Code 8 should not be used for cases with a DATE DX < 1/1/1999
165.5,560 PROTOCOL PARTICIPATION STS2;31 SET
'00' FOR Not on/NA;
'01' FOR NSABP;
'02' FOR GOG;
'03' FOR RTOG;
'04' FOR SWOG;
'05' FOR ECOG;
'06' FOR POG;
'07' FOR CCG;
'08' FOR CALGB;
'09' FOR NCI;
'10' FOR ACS;
'11' FOR National protocol, NOS;
'12' FOR Local protocol, NOS;
'99' FOR Unknown;
LAST EDITED: JAN 11, 1999
DESCRIPTION: Record whether the patient was enrolled in and treated on a protocol. A physician may treat a
patient following the guidelines of an established protocol; however, the patient is not enrolled
into the protocol. For these patients, use code 00 (Not on/NA).
SCREEN: S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=12)"
EXPLANATION: Code 12 should not be used for cases with a DATE DX < 1/1/1999
165.5,561 OTHER PROTOCOL STS2;32 SET
'0' FOR Not on protocol/not applicable;
'1' FOR In house protocol;
'2' FOR Non-cooperative, multi-institutional protocol;
'3' FOR On protocol, type unknown;
'9' FOR Unknown;
LAST EDITED: SEP 16, 1996
DESCRIPTION:
Record whether therapy was given under another protocol.
165.5,562 REFERRED TO REHAB SERVICES STS2;33 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 16, 1996
DESCRIPTION:
Record whether the patient was referred to rehabilitation services.
165.5,563 PHYSICAL THERAPY/REHABILTATION STS2;34 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 16, 1996
DESCRIPTION:
Record whether the patient was referred to physical therapy or rehabilitation service.
165.5,564 TRANSFERRED TO REHABILITATION STS2;35 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: SEP 16, 1996
DESCRIPTION: Record whether the patient was transferred to a rehabilitation facility after being released from
the hospital.
165.5,565 NUMBER OF HOSPITALIZATIONS STS2;36 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0"_Y,1:Y)
LAST EDITED: SEP 16, 1996
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the number of hospitalizations for this patient, counting only overnight stays during the
first six months after diagnosis. Do not count stays for 23 hour observation. If unknown, code
9's.
165.5,566 TOTAL LENGTH OF STAYS STS2;37 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)
LAST EDITED: SEP 16, 1996
HELP-PROMPT: Type a Number between 0 and 999, 0 Decimal Digits
DESCRIPTION: Add all days for each overnight hospitalization together to get a cumulative total for all stays
during the first six months after diagnosis. Do not count stays for 23 hour observation. If
unknown, code 9's.
165.5,567 DATE EXT BEAM RAD STARTED STS2;38 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: APR 03, 1997
HELP-PROMPT: *** DATE EXT BEAM RADIATION STARTED MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Record the date external beam radiation therapy was started. Code 0's if not given. Code 9's if
unknown.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,600 CLINICAL DX WITH BONE LESION PRO1;1 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record whether the Method of Diagnosis: CLINICAL DIAGNOSIS WITH BONE LESION was used to diagnose
this case of prostate cancer.
165.5,601 CLINICAL DX BY RECTAL EXAM PRO1;2 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record whether the Method of Diagnosis: CLINICAL DIAGNOSIS BY RECTAL EXAM was used to diagnose this
case of prostate cancer.
165.5,602 CYTOLOGY PRO1;3 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION:
Record whether the Method of Diagnosis: CYTOLOGY was used to diagnose this case of prostate cancer.
165.5,603 INCIDENTAL FINDING IN TURP PRO1;4 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record whether the Method of Diagnosis: INCIDENTAL FINDING IN TRANSURETHRAL RESECTION OF PROSTATE
(TURP) FOR BENIGN DISEASE was used to diagnose this case of prostate cancer.
165.5,604 NEEDLE ASPIRATION BIOPSY PRO1;5 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record whether the Method of Diagnosis: NEEDLE ASPIRATION BIOPSY was used to diagnose this case of
prostate cancer.
165.5,605 NEEDLE BIOPSY, NOS PRO1;6 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record whether the Method of Diagnosis: NEEDLE BIOPSY, NOS was used to diagnose this case of
prostate cancer.
165.5,606 PERINEAL BIOPSY PRO1;7 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record whether the Method of Diagnosis: PERINEAL BIOPSY was used to diagnose this case of prostate
cancer.
165.5,607 TRANSRECTAL BIOPSY PRO1;8 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record whether the Method of Diagnosis: TRANSRECTAL BIOPSY was used to diagnose this case of
prostate cancer.
165.5,608 TRUS PRO1;9 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record whether the Method of Diagnosis: TRANSRECTAL ULTRASONOGRAPHICALLY GUIDED BIOPSY (TRUS) was
used to diagnose this case of prostate cancer.
165.5,609 TRANSURETHRAL RESECTION PRO1;10 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record whether the Method of Diagnosis: TRANSURETHRAL RESECTION OF PROSTATE, NOS was used to
diagnose this case of prostate cancer.
165.5,610 OTHER METHOD OF DX (PROSTATE) PRO1;11 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION:
Record whether the Method of Diagnosis: OTHER was used to diagnose this case of prostate cancer.
165.5,611 BONE MARROW ASPIRATION PRO1;12 SET
'1' FOR Normal;
'2' FOR Abnormal/elevated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record the results of the BONE MARROW ASPIRATION diagnostic test performed to evaluate the prostate
tumor. If the study was done and the results cannot be determined, code 9 (Test done, results
unknown).
165.5,612 BONE SCAN (PROSTATE) PRO1;13 SET
'1' FOR Normal;
'2' FOR Abnormal/elevated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record the results of the BONE SCAN diagnostic test performed to evaluate the prostate tumor. If
the study was done and the results cannot be determined, code 9 (Test done, results unknown).
165.5,613 BONE X-RAY PRO1;14 SET
'1' FOR Normal;
'2' FOR Abnormal/elevated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record the results of the BONE X-RAY diagnostic test performed to evaluate the prostate tumor. If
the study was done and the results cannot be determined, code 9 (Test done, results unknown).
165.5,614 CHEST X-RAY (PROSTATE) PRO1;15 SET
'1' FOR Normal;
'2' FOR Abnormal/elevated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record the results of the CHEST X-RAY diagnostic test performed to evaluate the prostate tumor. If
the study was done and the results cannot be determined, code 9 (Test done, results unknown).
165.5,615 CT SCAN OF PRIMARY SITE PRO1;16 SET
'1' FOR Normal;
'2' FOR Abnormal/elevated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record the results of the CT SCAN OF PRIMARY SITE diagnostic test performed to evaluate the
prostate tumor. If a scan of the abdomen was performed by computed tomography (CT), record the
results under CT SCAN OF PRIMARY SITE. If the study was done and the results cannot be determined,
code 9 (Test done, results unknown).
165.5,616 INTRAVENOUS PYELOGRAM (PRO) PRO1;17 SET
'1' FOR Normal;
'2' FOR Abnormal/elevated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the INTRAVENOUS PYELOGRAM (IVP) diagnostic test performed to evaluate the
prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done,
results unknown).
165.5,617 LIVER SCAN PRO1;18 SET
'1' FOR Normal;
'2' FOR Abnormal/elevated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record the results of the LIVER SCAN diagnostic test performed to evaluate the prostate tumor. If
the study was done and the results cannot be determined, code 9 (Test done, results unknown).
165.5,618 MRI (PRO) PRO1;19 SET
'1' FOR Normal;
'2' FOR Abnormal/elevated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: FEB 14, 1997
DESCRIPTION: Record the results of the MAGNETIC RESONANCE IMAGING (MRI) diagnostic test performed to evaluate
the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done,
results unknown).
165.5,619 PELVIC LYMPH NODE DISSECT (PR) PRO1;20 SET
'1' FOR Normal;
'2' FOR Abnormal/elevated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record the results of the PELVIC LYMPH NODE DISSECTION diagnostic test performed to evaluate the
prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done,
results unknown).
165.5,620 PROSTATIC ACID PHOSPHATASE PRO1;21 SET
'1' FOR Normal;
'2' FOR Abnormal/elevated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record the results of the PROSTATIC ACID PHOSPHATASE (PAP) diagnostic test performed to evaluate
the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done,
results unknown).
165.5,621 PROSTATE SPECIFIC ANTIGEN PRO1;22 SET
'1' FOR Normal;
'2' FOR Abnormal/elevated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record the results of the PROSTATE SPECIFIC ANTIGEN (PSA) diagnostic test performed to evaluate the
prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done,
results unknown).
165.5,622 OTHER DIAGNOSTIC INFORMATION PRO1;23 SET
'1' FOR Normal;
'2' FOR Abnormal/elelvated;
'8' FOR Test not done/unknown if done;
'9' FOR Test done, results unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION: Record the results of OTHER diagnostic tests performed to evaluate the prostate tumor. If the
study was done and the results cannot be determined, code 9 (Test done, results unknown).
165.5,623 GLEASON SCORE (CLINICAL) PRO1;24 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1) X
OUTPUT TRANSFORM: S Y=$S(Y=99:"99 Unknown, not reported, or NA",1:Y)
LAST EDITED: AUG 05, 2011
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Record the clinical Gleason Score. Gleason Score (clinical) is obtained from a needle biopsy or
TURP specimen.
For cases where Gleason Score is unknown, not reported or not applicable, code 99.
165.5,623.1 PREDOMINANT PATTERN (02-40) PRO2;43 NUMBER
INPUT TRANSFORM: K:+X'=X!(X=6)!(X=7)!(X=8)!($L(X)>1)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 11, 1998
HELP-PROMPT: Type a Number between 0 and 5, 0 Decimal Digits
DESCRIPTION: Record the predominant (primary) pattern of tumor for Biopsy, Local Resection, or Simple
Prostatectomy, surgical codes 02-40. Gleason's grading system assigns histologic grade ranging
from 1-5 to predominant pattern of tumor. Record the predominant pattern as stated in the
pathology report. If the grade is not provided and only a Gleason score is available, enter a '0'.
165.5,623.2 LESSER PATTERN (02-40) PRO2;44 NUMBER
INPUT TRANSFORM: D LP25^ONCOIT
LAST EDITED: MAY 12, 1998
HELP-PROMPT: Type a Number between 0 and 5, 0 Decimal Digits
DESCRIPTION: Record the lesser (secondary) pattern of tumor for Biopsy, Local Resection, or Simple
Prostatectomy, surgical codes 02-40. Gleason's grading system assigns histologic grade ranging
from 1-5 to lesser pattern of tumor. Record the lesser pattern as stated in the pathology report.
If the grade is not provided and only a Gleason score is available, enter a '0'.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,623.3 GLEASON'S SCORE (50-70) PRO2;45 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!'(X?1.2N&(((+X>1)&(X<11))!(X=99))) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0"_Y,Y=99:"99 Unknown, not reported, or NA",1:Y)
LAST EDITED: MAY 12, 1998
HELP-PROMPT: Answer 02-10 or 99 (Score unknown, not reported or NA)
DESCRIPTION: Record the Gleason's score for Radical Prostatectomy, surgical codes 50-70. Gleason's grading
system assigns histologic grade ranging from 1-5 to predominant (primary) and lesser (secondary)
patterns of tumor. The grade numbers of the two patterns are added to obtain the Gleason score,
which ranges from 02 to 10. Record the Gleason's score by adding the predominant and lesser
patterns as stated in the pathology report. For example, if predominant pattern is 3 and lesser
pattern is 4, then Gleason's score is 3 + 4 = 7. For cases where Gleason's score is unknown, not
reported or not applicable, code 99.
165.5,623.4 PREDOMINANT PATTERN (50-70) PRO2;46 NUMBER
INPUT TRANSFORM: K:+X'=X!(X=6)!(X=7)!(X=8)!($L(X)>1)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 11, 1998
HELP-PROMPT: Type a Number between 0 and 5, 0 Decimal Digits
DESCRIPTION: Record the predominant (primary) pattern of tumor for Radical Prostatectomy, surgical codes 50-70.
Gleason's grading system assigns histologic grade ranging from 1-5 to predominant pattern of tumor.
Record the predominant pattern as stated in the pathology report. If the grade is not provided and
only a Gleason score is available, enter a '0'.
165.5,623.5 LESSER PATTERN (50-70) PRO2;47 NUMBER
INPUT TRANSFORM: D LP26^ONCOIT
LAST EDITED: MAY 13, 1998
HELP-PROMPT: Type a Number between 0 and 5, 0 Decimal Digits
DESCRIPTION: Record the lesser (secondary) pattern of tumor for Radical Prostatectomy, surgical codes 50-70.
Gleason's grading system assigns histologic grade ranging from 1-5 to lesser pattern of tumor.
Record the lesser pattern as stated in the pathology report. If the grade is not provided and only
a Gleason score is available, enter a '0'.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,624 RESEARCH PROTOCOL PRO1;25 SET
'1' FOR In-house;
'2' FOR Cooperative group;
'3' FOR Not in a protocol;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION:
Record whether the patient was entered into a protocol.
165.5,625 RAD THERAPY PLANNED/GIVEN PRO1;26 SET
'1' FOR Yes;
'2' FOR No, not recommended;
'3' FOR Patient refused radiation therapy;
'4' FOR Radiation was planned, but not given;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION:
Record whether the patient received radiation therapy.
165.5,626 INTERSTITIAL RAD PLANNED/GIVEN PRO1;27 SET
'1' FOR Yes;
'2' FOR No, not recommended;
'3' FOR Patient refused radiation therapy;
'4' FOR Radiation was planned, but not given;
'9' FOR Unknown;
LAST EDITED: OCT 25, 1996
DESCRIPTION:
Record whether the patient received interstitial radiation.
165.5,627 IODINE 125 PRO1;28 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 13, 2000
DESCRIPTION: Record whether the isotope IODINE 125 was administered interstitially.
165.5,628 GOLD 198 PRO1;29 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 13, 2000
DESCRIPTION: Record whether the isotope GOLD 198 was administered interstitially.
165.5,629 PALLADIUM 103 PRO1;30 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 13, 2000
DESCRIPTION: Record whether the isotope PALLADIUM 103 was administered interstitially.
165.5,630 IRIDIUM 192 PRO1;31 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 13, 2000
DESCRIPTION: Record whether the isotope IRIDIUM 192 was administered interstitially.
165.5,631 OTHER INTERSTITIAL, NOS PRO1;32 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 13, 2000
DESCRIPTION: Record whether OTHER INTERSTITIAL, NOS isotopes were administered.
165.5,632 EXTERNAL RAD PLANNED/GIVEN PRO1;33 SET
'1' FOR Yes;
'2' FOR No, not recommended;
'3' FOR Patient refused external radiation;
'4' FOR Radiation was planned, but not given;
'9' FOR Unknown;
LAST EDITED: OCT 29, 1996
DESCRIPTION:
Record whether the patient received external radiation.
165.5,633 PROSTATE REGION ONLY PRO1;34 SET
'0' FOR No, region/site not targeted;
'1' FOR Yes;
'8' FOR NA, external radiation not administered;
'9' FOR Unknown;
LAST EDITED: MAR 13, 2000
DESCRIPTION: Record whether the PROSTATE REGION ONLY was irradiated.
165.5,634 PROSTATE AND PELVIC NODES PRO1;35 SET
'0' FOR No, region/site not targeted;
'1' FOR Yes;
'8' FOR NA, external radiation not administered;
'9' FOR Unknown;
LAST EDITED: MAR 13, 2000
DESCRIPTION: Record whether PROSTATE AND PELVIC NODES were irradiated.
165.5,635 PROSTATE & PELVIC PARA-AORTIC PRO1;36 SET
'0' FOR No, region/site not targeted;
'1' FOR Yes;
'8' FOR NA, external radiation not administered;
'9' FOR Unknown;
LAST EDITED: MAR 13, 2000
DESCRIPTION: Record whether PROSTATE AND PELVIC PARA-AORTIC NODES were irradiated.
165.5,636 DISTANT METASTATIC SITES PRO1;37 SET
'0' FOR No, region/site not targeted;
'1' FOR Yes;
'8' FOR NA, external radiation not administered;
'9' FOR Unknown;
LAST EDITED: MAR 13, 2000
DESCRIPTION: Record whether DISTANT METASTATIC SITES were irradiated.
165.5,637 OTHER EXTERNAL SITES, NOS PRO1;38 SET
'0' FOR No, region/site not targeted;
'1' FOR Yes;
'8' FOR NA, external radiation not administered;
'9' FOR Unknown;
LAST EDITED: MAR 13, 2000
DESCRIPTION: Record whether OTHER EXTERNAL SITES, NOS were irradiated.
165.5,638 TOTAL RAD DOSE (PROSTATE) PRO1;39 SET
'1' FOR Less than 1999 rad;
'2' FOR 2000-3000 rad;
'3' FOR 3001-4000 rad;
'4' FOR 4001-5000 rad;
'5' FOR 5001-6000 rad;
'6' FOR 6001-7000 rad;
'7' FOR More than 7001 rad;
'8' FOR Not given;
'9' FOR Rad does unknown;
LAST EDITED: OCT 29, 1996
DESCRIPTION: Record the TOTAL (external) RAD DOSE given to the PROSTATE; this includes boost dosage. Do not
include interstitial rad dose. If it is known that the patient received radiation therapy, but the
amount given is unknown, code 9 (rad dose unknown).
165.5,639 TOTAL RAD DOSE (PELVIC NODES) PRO1;40 SET
'1' FOR Less than 1999 rad;
'2' FOR 2000-3000 rad;
'3' FOR 3001-4000 rad;
'4' FOR 4001-5000 rad;
'5' FOR More than 5001 rad;
'8' FOR Not given;
'9' FOR Rad dose unknown;
LAST EDITED: OCT 29, 1996
DESCRIPTION: Record the TOTAL (external) RAD DOSE given to the PELVIC NODES; this includes boost dosage. Do not
include interstitial rad dose. If it is known that the patient received radiation therapy, but the
amount given is unknown, code 9 (rad dose unknown).
165.5,640 TOTAL RAD DOSE (PARA-AORTIC) PRO1;41 SET
'1' FOR Less than 1999 rad;
'2' FOR 2000-3000 rad;
'3' FOR 3001-4000 rad;
'5' FOR More than 5001 rad;
'8' FOR Not given;
'9' FOR Rad dose unknown;
LAST EDITED: OCT 29, 1996
DESCRIPTION: Record the TOTAL (external) RAD DOSE given to the PARA-AORTIC NODES; this includes boost dosage.
Do not include interstitial rad dose. If it is known that the patient received radiation therapy,
but the amount given is unknown, code 9 (rad dose unknown).
165.5,641 RESEARCH PROTOCOL (RADIATION) PRO1;42 SET
'1' FOR In-house;
'2' FOR Cooperative group;
'3' FOR Not in a protocol;
'9' FOR Unknown;
LAST EDITED: OCT 29, 1996
DESCRIPTION:
Record the patient was entered into a protocol.
165.5,642 HORMONE THERAPY PLANNED/GIVEN PRO1;43 SET
'1' FOR Yes;
'2' FOR No, not recommended;
'3' FOR Patient refused hormonal therapy;
'4' FOR Hormonal therapy was planned, but not given;
'9' FOR Unknown;
LAST EDITED: OCT 29, 1996
DESCRIPTION:
Record whether the patient received hormonal therapy.
165.5,643 ESTROGENS PRO1;44 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
'2' FOR No;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record all types of hormonal drugs given.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"
EXPLANATION: Record all types of hormonal drugs given.
165.5,644 ANTIANDROGENS PRO1;45 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
'2' FOR No;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record all types of hormonal drugs given.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"
EXPLANATION: Record all types of hormonal drugs given.
165.5,645 PROGESTATIONAL AGENTS PRO1;46 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
'2' FOR No;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record all types of hormonal drugs given.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"
EXPLANATION: Record all types of hormonal drugs given.
165.5,646 LUTEINIZING HORMONES PRO1;47 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
'2' FOR No;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record all types of hormonal drugs given.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"
EXPLANATION: Record all types of hormonal drugs given.
165.5,647 ORCHIECTOMY PRO1;48 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 29, 1996
DESCRIPTION:
Record whether an ORCHIECTOMY was administered. Code 2 (No) if an ORCHIECTOMY was not given.
165.5,648 OTHER EXOGENOUS HORMONE AGENTS PRO1;49 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
'2' FOR No;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record all types of hormonal drugs given.
SCREEN: S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"
EXPLANATION: Record all types of hormonal drugs given.
165.5,649 BACKACHE (1ST RECURRENCE) PRO1;50 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 30, 1996
DESCRIPTION:
Record whether a BACKACHE was used to diagnose the first recurrence.
165.5,650 BONE SCAN (1ST RECURRENCE) PRO1;51 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 30, 1996
DESCRIPTION:
Record if a BONE SCAN was used to diagnose the first recurrence.
165.5,651 LETHARGY PRO1;52 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 30, 1996
DESCRIPTION:
Record if LETHARGY was used to diagnose the first recurrence.
165.5,652 RECTAL EXAM (1ST RECURRENCE) PRO1;53 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 30, 1996
DESCRIPTION: Record whether a RECTAL EXAMINATION FOLLOWED BY NEEDLE BIOPSY was used to diagnose the first
recurrence.
165.5,653 TUMOR MARKER (1ST RECURRENCE) PRO1;54 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 30, 1996
DESCRIPTION:
Record whether TUMOR MARKER ELEVATION was used to diagnose the first recurrence.
165.5,654 WEIGHT LOSS (1ST RECURRENCE) PRO1;55 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 30, 1996
DESCRIPTION:
Record whether WEIGHT LOSS was used to diagnose the first recurrence.
165.5,655 OTHER METHODS (1ST RECURRENCE) PRO1;56 SET
'1' FOR Yes;
'2' FOR No;
'9' FOR Unknown;
LAST EDITED: OCT 30, 1996
DESCRIPTION:
Record whether OTHER methods were used to diagnose the first recurrence.
165.5,656 REASON FOR 2ND COURSE PRO1;57 SET
'1' FOR Recurrence;
'2' FOR Progression of disease;
'8' FOR No therapy;
'9' FOR Unknown;
LAST EDITED: OCT 31, 1996
DESCRIPTION:
Record whether the patient received treatment for recurrence or progression of disease.
165.5,657 FAM HIST OF PROSTATE CA (PR98) PRO2;1 SET
'0' FOR No;
'1' FOR Yes, 1st degree relative;
'2' FOR Yes, relative other than 1st degree;
'3' FOR Yes, degree of relative unknown;
'9' FOR Unknown;
LAST EDITED: MAY 13, 1998
DESCRIPTION: Record any familial history of prostate cancer documented in the medical record. First degree
relatives include the patient's father, brother, or son. A grandfather, uncle, or cousin would not
be considered a first degree relative.
165.5,658 HEMATURIA (PR98) PRO2;2 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAY 13, 1998
DESCRIPTION: Record all symptoms specific to prostate cancer that were reported by the patient and included in
the medical chart.
165.5,659 LOWER BACK PAIN (PR98) PRO2;3 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAY 13, 1998
DESCRIPTION: Record all symptoms specific to prostate cancer that were reported by the patient and included in
the medical chart.
165.5,660 TROUBLE URINATING (PR98) PRO2;4 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAY 13, 1998
DESCRIPTION: Record all symptoms specific to prostate cancer that were reported by the patient and included in
the medical chart.
165.5,661 CLIN DX W/ BONE LESION (PR98) PRO2;5 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: NOV 30, 1998
DESCRIPTION: Record whether the Initial Method of Diagnosis: CLINICAL DIAGNOSIS WITH BONE LESION was performed
to diagnose this case of prostate cancer.
165.5,662 CLIN DX BY RECTAL EXAM (PR98) PRO2;6 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: NOV 30, 1998
DESCRIPTION: Record whether the Initial Method of Diagnosis: CLINICAL DIAGNOSIS BY RECTAL EXAM was performed to
diagnose this case of prostate cancer.
165.5,663 CYTOLOGY (PR98) PRO2;7 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: NOV 30, 1998
DESCRIPTION: Record whether the Initial Method of Diagnosis: CYTOLOGY was performed to diagnose this case of
prostate cancer.
165.5,664 DIGITAL TRANSRECTAL BIO (PR98) PRO2;8 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: NOV 30, 1998
DESCRIPTION: Record whether the Initial Method of Diagnosis: DIGITAL TRANSRECTAL BIOPSY was performed to
diagnose this case of prostate cancer.
165.5,665 INCIDENTAL FIND IN TURP (PR98) PRO2;9 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: NOV 30, 1998
DESCRIPTION: Record whether the Method of Diagnosis: INCIDENTAL FINDING IN TRANSURETHRAL RESECTION OF PROSTATE
(TURP) FOR BENIGN DISEASE was performed to diagnose this case of prostate cancer.
165.5,666 NEEDLE BIOPSY, NOS (PR98) PRO2;10 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: NOV 30, 1998
DESCRIPTION: Record whether the Initial Method of Diagnosis: NEEDLE BIOPSY, NOS was performed to diagnose this
case of prostate cancer.
165.5,667 PERINEAL BIOPSY (PR98) PRO2;11 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: NOV 30, 1998
DESCRIPTION: Record whether the Initial Method of Diagnosis: PERINEAL BIOPSY was performed to diagnose this
case of prostate cancer.
165.5,668 PSA METHOD OF DIAGNOSIS (PR98) PRO2;12 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: NOV 30, 1998
DESCRIPTION: Record whether the Initial Method of Diagnosis: PROSTATIC SPECIFIC ANTIGEN (PSA) was performed to
diagnose this case of prostate cancer.
165.5,669 TRANSRECTAL BIOPSY (PR98) PRO2;13 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: NOV 30, 1998
DESCRIPTION: Record whether the Initial Method of Diagnosis: TRANSRECTAL ULTRASONOGRAPHICALLY GUIDED BIOPSY
(TRUS) was performed to diagnose this case of prostate cancer.
165.5,670 TRANSURETHRAL RESECTION (PR98) PRO2;14 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: NOV 30, 1998
DESCRIPTION: Record whether the Initial Method of Diagnosis: TRANSURETHRAL RESECTION OF PROSTATE, NOS was
performed to diagnose this case of prostate cancer.
165.5,671 BONE MARROW ASPIRATION (PR98) PRO2;15 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the BONE MARROW ASPIRATION diagnostic test performed to evaluate the
prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done,
results unknown). If it is unknown if the test was done code 9 (Unknown if test done).
165.5,672 BONE SCAN (PR98) PRO2;16 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the BONE SCAN diagnostic test performed to evaluate the prostate tumor. If
the study was done and the results cannot be determined, code 8 (Test done, results unknown). If
it is unknown if the test was done code 9 (Unknown if test done).
165.5,673 BONE X-RAY (PR98) PRO2;17 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the BONE X-RAY diagnostic test performed to evaluate the prostate tumor. If
the study was done and the results cannot be determined, code 8 (Test done, results unknown). If
it is unknown if the test was done code 9 (Unknown if test done).
165.5,674 CHEST X-RAY (PR98) PRO2;18 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the CHEST X-RAY diagnostic test performed to evaluate the prostate tumor.
If the study was done and the results cannot be determined, code 8 (Test done, results unknown).
If it is unknown if the test was done code 9 (Unknown if test done).
165.5,675 CT SCAN OF ABDOMEN (PR98) PRO2;19 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the CT SCAN OF ABDOMEN diagnostic test performed to evaluate the prostate
tumor. If the study was done and the results cannot be determined, code 8 (Test done, results
unknown). If it is unknown if the test was done code 9 (Unknown if test done).
165.5,676 CT SCAN OF PELVIS (PR98) PRO2;20 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the CT SCAN OF PELVIS diagnostic test performed to evaluate the prostate
tumor. If the study was done and the results cannot be determined, code 8 (Test done, results
unknown). If it is unknown if the test was done code 9 (Unknown if test done).
165.5,677 INTRAVENOUS PYELOGRAM (PR98) PRO2;21 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the INTRAVENOUS PYELOGRAM (IVP) diagnostic test performed to evaluate the
prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done,
results unknown). If it is unknown if the test was done code 9 (Unknown if test done).
165.5,678 MRI (PR98) PRO2;22 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the MAGNETIC RESONANCE IMAGING (MRI) diagnostic test performed to evaluate
the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done,
results unknown). If it is unknown if the test was done code 9 (Unknown if test done).
165.5,679 PELVIC LYMPH ND DISSECT (PR98) PRO2;23 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the PELVIC LYMPH NODE DISSECTION diagnostic test performed to evaluate the
prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done,
results unknown). If it is unknown if the test was done code 9 (Unknown if test done).
165.5,680 POLYMERASE CHAIN REACT (PR98) PRO2;24 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the POLYMERASE CHAIN REACTION ASSAY (PCR) diagnostic test performed to
evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8
(Test done, results unknown). If it is unknown if the test was done code 9 (Unknown if test done).
165.5,681 PROSTATIC ACID PHOSPH (PR98) PRO2;25 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the PROSTATIC ACID PHOSPHATASE (PAP) diagnostic test performed to evaluate
the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done,
results unknown). If it is unknown if the test was done code 9 (Unknown if test done).
165.5,682 PSA DIAGNOSTIC EVAL (PR98) PRO2;26 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the PROSTATE SPECIFIC ANTIGEN (PSA) diagnostic test performed to evaluate
the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done,
results unknown). If it is unknown if the test was done code 9 (Unknown if test done).
165.5,683 ULTRASOUND OF ABDOMEN (PR98) PRO2;27 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record the results of the ULTRASOUND OF ABDOMEN diagnostic test performed to evaluate the prostate
tumor. If the study was done and the results cannot be determined, code 8 (Test done, results
unknown). If it is unknown if the test was done code 9 (Unknown if test done).
165.5,684 PSA PRO2;28 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1) X I $D(X) D PSA^ONCOIT
OUTPUT TRANSFORM: D PSA^ONCOOT
LAST EDITED: OCT 29, 2002
HELP-PROMPT: Answer must be between 000.0 and 999.9, up to 1 decimal digit
DESCRIPTION: Records the results of the highest pre-treatment Prostate Specific Antigen (PSA) test given within
the last 12 months.
If the first course of treatment was Watchful Waiting, the date the decision was made is considered
the first course of treatment. Round the test result to the nearest single decimal point.
Record 999.6 if PSA value was 999.6 or higher. Record 999.7 if no PSA test was performed. Record
999.8 if the test was done and results are unknown/not reported. Record 999.9 if it is unknown if
the test was performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,685 WATCHFUL WAITING (PR98) PRO2;29 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAY 08, 1998
DESCRIPTION: Record whether or not the patient chose to forego surgery, radiation therapy, chemotherapy, and
hormone therapy in favor of no immediate medical intervention.
165.5,686 LENGTH OF STAY (PR98) PRO2;30 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0"_Y,1:Y) S Y=$S(Y=88:Y_" NA",Y=99:Y_" Unknown",Y="01":Y_" day",1:Y_" days")
LAST EDITED: MAY 13, 1998
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the number of days the patient remained in the hospital following cancer-directed surgery.
Include the day on which the patient was admitted to the hospital for treatment, and the day before
the patient was discharged from the hospital. For example, if patient was admitted 1/12/98 and
discharged 1/18/98, the length of stay is 6 days. If not applicable code, 88. If unknown, code
99.
165.5,687 LAPAROSCOPIC (PR98) PRO2;31 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 13, 1998
DESCRIPTION: Record whether the LAPAROSCOPIC Type of Regional Lymph Node surgery was performed. If not
applicable, code 8. If unknown, code 9.
165.5,688 OPEN (PR98) PRO2;32 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 13, 1998
DESCRIPTION: Record whether the OPEN Type of Regional Lymph Node surgery was performed. If not applicable,
code 8. If unknown, code 9.
165.5,689 PERMANENT RECTAL INJURY (PR98) PRO2;33 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, no surgery;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record whether permanent rectal injury was a surgical complication which was reported within 30
days of first course of treatment cancer- directed surgery. If not applicable, code 8. If
unknown, code 9.
165.5,690 THROMBOEMBOLISM (PR98) PRO2;34 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, no surgery;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record whether thromboembolism was a surgical complication which was reported within 30 days of
first course of treatment cancer- directed surgery. If not applicable, code 8. If unknown, code
9.
165.5,691 URETHRAL STRICTURE (PR98) PRO2;35 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, no surgery;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record whether urethral stricture was a surgical complication which was reported within 30 days of
first course of treatment cancer- directed surgery. If not applicable, code 8. If unknown, code
9.
165.5,692 RADIATION FACILITY PRO2;36 SET
'1' FOR Reporting hospital;
'2' FOR Other hospital;
'3' FOR Freestanding facility;
'4' FOR NOS;
'8' FOR NA, radiation not administered;
'9' FOR Unknown;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record whether radiation was administered at reporting hospital or administered elsewhere. Record
8 if no radiation administered. Record 9 if the radiation facility is unknown.
165.5,693 ROUTE OF INTERSTITIAL RAD PRO2;37 SET
'1' FOR Perineal;
'2' FOR Open;
'8' FOR NA, not administered;
'9' FOR Unknown;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record the route by which interstitial radiation/brachytherapy was administered. Record 8 if not
applicable. Record 9 if unknown.
165.5,694 TYPE OF RADIATION ADMIN PRO2;38 SET
'1' FOR Conformal therapy;
'2' FOR Standard;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record the method by which external beam radiation was administered. Conformal therapy is a three
dimensional radiation technique that minimizes exposure to normal tissue. Record 8 if not
applicable. Record 9 if unknown.
165.5,695 GASTROINTESTINAL COMPLICATIONS PRO2;39 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record whether or not acute gastrointestinal complications were reported within 90 days of the
start of radiation therapy. Record 8 if not applicable. Record 9 if unknown.
165.5,696 GASTROURINARY COMPLICATIONS PRO2;40 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record whether or not acute gastrourinary complications were reported within 90 days of the start
of radiation therapy. Record 8 if not applicable. Record 9 if unknown.
165.5,697 ANORECTAL COMPLICATIONS PRO2;41 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record whether or not anorectal complications were reported within 90 days of the start of
radiation therapy. Record 8 if not applicable. Record 9 if unknown.
165.5,698 CHRONIC COMPLICATIONS PRO2;42 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record whether or not chronic complications requiring surgery or prolonged hospitalization were
reported within 90 days of the start of radiation therapy. Record 8 if not applicable. Record 9
if unknown.
165.5,699 URETHRAL/BLADDER COMPLICATIONS PRO2;48 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 22, 1998
DESCRIPTION: Record whether or not urethral or bladder complications were reported within 90 days of the start
of radiation therapy. Record 8 if not applicable. Record 9 if unknown.
165.5,699.1 DATE OF ORCHIECTOMY PRO2;49 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: MAY 22, 1998
HELP-PROMPT: *** DATE OF ORCHIECTOMY MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Record the date of the orchiectomy. If no orchiectomy was performed, code 00/00/0000. If an
orchiectomy was performed, but the month, day or year is unknown, code the unknown item with 9's.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,700 HISTORY OF COLORECTAL CA (FAM) COL1;1 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION:
Record any familial history of colorectal cancer documented in the medical record.
165.5,701 HISTORY OF COLORECTAL CA (PT) COL1;2 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION: Record and personal history of a previous colorectal cancer documented in the medical record prior
to 1997.
165.5,702 MULTIPLE COLORECTAL PRIMARIES COL1;3 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION: Record if a second colorectal primary was diagnosed in addition to this reported cancer. If a
patient has more than one colorectal primary and more than one record will be submitted, answer
'yes' on all records submitted for the patient.
Note: If a second primary is accessioned late in the year, please remember to change the data item
on any earlier records.
165.5,703 HISTORY OF BREAST CA (PT) COL1;4 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION:
Record whether the patient has a history of breast cancer.
165.5,704 HISTORY OF LUNG CA (PT) COL1;5 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION:
Record whether the patient has a history of lung cancer.
165.5,705 HISTORY OF OVARIAN CA (PT) COL1;6 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION:
Record whether the patient has a history of ovarian cancer.
165.5,706 HISTORY OF OVARIAN CARCINOMA COL1;7 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION: Record whether the patient has a history of ovarian carcinoma, peritoneal site. Note: Ovarian
carcinoma, peritoneal site does not refer to metastatic disease. It is a primary ovarian cancer
arising in the peritoneum, not in the ovary.
165.5,707 HISTORY OF STOMACH CA (PT) COL1;8 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION:
Record whether the patient has a history of stomach cancer.
165.5,708 HISTORY OF THYROID CA (PT) COL1;9 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION:
Record whether the patient has a history of thyroid cancer.
165.5,709 HISTORY OF UTERUS CA (PT) COL1;10 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION:
Record whether the patient has a history of uterus cancer.
165.5,710 PREVIOUS TAH/BSO COL1;11 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 10, 1997
DESCRIPTION:
TAH/BSO (Total abdominal hysterectomy/bilateral salpingo-oophorectomy) Record the appropriate code.
165.5,711 FAMILIAL ADENOMATOUS POLYPS COL1;12 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 24, 2005
DESCRIPTION:
Record whether the patient was affected by FAP (Familial adenomatous polyposis).
165.5,712 HNPCC COL1;13 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 24, 2005
DESCRIPTION:
Record whether the patient is affected by hereditary nonpolyposis colon cancer (HNPCC) syndrome.
165.5,713 INFLAMMATORY BOWEL DISEASE COL1;14 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 24, 2005
DESCRIPTION:
Record whether the patient was affected by inflammatory bowel disease (IBD).
165.5,714 PRIOR POLYPS COL1;15 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 11, 1997
DESCRIPTION:
Record the appropriate code for prior polyps.
165.5,715 POLYPS COL1;16 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0"_Y,Y=88:"NA, no adenomas",Y=90:"Unknown number",Y=99:"Unknown if adenomas",1:Y)
LAST EDITED: FEB 11, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record number of adenomas. If no adenomas, record 88. If number of adenomas unknown, record 90.
If unknown if adenomas, record 99.
165.5,716 DURATION OF ANEMIA COL1;17 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w
/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",
1:Y_" months")
LAST EDITED: FEB 12, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record all anemia symptoms specific to the colorectal cancer that were reported by the patient and
included in the medical chart. Round down to the nearest whole number if months fall into a range.
For example, if the patient had symptoms for two to three months, record 02. If a symptom was not
reported in the chart, code 99 (Unknown).
165.5,717 DURATION OF BOWEL OBSTRUCTION COL1;18 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w
/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",
1:Y_" months")
LAST EDITED: FEB 12, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record all bowel obstruction symptoms specific to the colorectal cancer that were reported by the
patient and included in the medical chart. Round down to the nearest whole number if months fall
into a range. For example, if the patient had symptoms for two to three months, record 02. If a
symptom was not reported in the chart, code 99 (Unknown).
165.5,718 DURATION OF BOWEL HABIT CHANGE COL1;19 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w
/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",
1:Y_" months")
LAST EDITED: FEB 12, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record all change in bowel habit symptoms specific to the colorectal cancer that were reported by
the patient and included in the medical chart. Round down to the nearest whole number if months
fall into a range. For example, if the patient had symptoms for two to three months, record 02.
If a symptom was not reported in the chart, code 99 (Unknown).
165.5,719 DURATION OF EMERGENCY PRES-OBS COL1;20 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w
/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",
1:Y_" months")
LAST EDITED: FEB 12, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record all emergency presentation-obstruction symptoms specific to the colorectal cancer that were
reported by the patient and included in the medical chart. Round down to the nearest whole number
if months fall into a range. For example, if the patient had symptoms for two to three months,
record 02. If a symptom was not reported in the chart, code 99 (Unknown).
165.5,720 DURATION OF JAUNDICE COL1;21 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w
/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",
1:Y_" months")
LAST EDITED: FEB 12, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record all jaundice symptoms specific to the colorectal cancer that were reported by the patient
and included in the medical chart. Round down to the nearest whole number if months fall into a
range. For example, if the patient had symptoms for two to three months, record 02. If a symptom
was not reported in the chart, code 99 (Unknown).
165.5,721 DURATION OF MALAISE COL1;22 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w
/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",
1:Y_" months")
LAST EDITED: FEB 12, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record all malaise symptoms specific to the colorectal cancer that were reported by the patient and
included in the medical chart. Round down to the nearest whole number if months fall into a range.
For example, if the patient had symptoms for two to three months, record 02. If a symptom was not
reported in the chart, code 99 (Unknown).
165.5,722 DURATION OF BLOOD IN STOOL COL1;23 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w
/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",
1:Y_" months")
LAST EDITED: FEB 12, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record all occult blood in stool symptoms specific to the colorectal cancer that were reported by
the patient and included in the medical chart. Round down to the nearest whole number if months
fall into a range. For example, if the patient had symptoms for two to three months, record 02.
If a symptom was not reported in the chart, code 99 (Unknown).
165.5,723 DURATION OF PAIN (ABDOMINAL) COL1;24 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w
/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",
1:Y_" months")
LAST EDITED: FEB 12, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record all abdominal pain symptoms specific to the colorectal cancer that were reported by the
patient and included in the medical chart. Round down to the nearest whole number if months fall
into a range. For example, if the patient had symptoms for two to three months, record 02. If a
symptom was not reported in the chart, code 99 (Unknown).
165.5,724 DURATION OF PAIN (PELVIC) COL1;25 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w
/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",
1:Y_" months")
LAST EDITED: FEB 12, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record all pelvic pain symptoms specific to the colorectal cancer that were reported by the patient
and included in the medical chart. Round down to the nearest whole number if months fall into a
range. For example, if the patient had symptoms for two to three months, record 02. If a symptom
was not reported in the chart, code 99 (Unknown).
165.5,725 DURATION OF RECTAL BLEEDING COL1;26 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w
/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",
1:Y_" months")
LAST EDITED: FEB 12, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record all rectal bleeding symptoms specific to the colorectal cancer that were reported by the
patient and included in the medical chart. Round down to the nearest whole number if months fall
into a range. For example, if the patient had symptoms for two to three months, record 02. If a
symptom was not reported in the chart, code 99 (Unknown).
165.5,726 DURATION OF OTHER COL1;27 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w
/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",
1:Y_" months")
LAST EDITED: FEB 12, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record all other symptoms specific to the colorectal cancer that were reported by the patient and
included in the medical chart. Round down to the nearest whole number if months fall into a range.
For example, if the patient had symptoms for two to three months, record 02. If a symptom was not
reported in the chart, code 99 (Unknown).
165.5,727 ENDOSCOPIC METHOD COL1;28 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: FEB 13, 1997
DESCRIPTION:
Record whether 'endoscopic' initial method of diagnosis was performed. If unknown, code a '9'.
165.5,728 RADIOGRAPHIC METHOD COL1;29 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: FEB 13, 1997
DESCRIPTION:
Record whether 'radiographic' initial method of diagnosis was performed. If unknown, code a '9'.
165.5,729 SCREENING DIGITAL RECTAL EXAM COL1;30 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record whether 'screening digital rectal exam' initial method of diagnosis was performed. If
unknown, code a '9'.
165.5,730 SCREENING PHYSICAL EXAM METHOD COL1;31 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record whether 'screening physical exam' initial method of diagnosis was performed. If unknown,
code a '9'.
165.5,731 OTHER INITIAL METHOD COL1;32 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if done;
LAST EDITED: FEB 13, 1997
DESCRIPTION:
Record whether other initial method of diagnosis was performed. If unknown, code a '9'.
165.5,732 REASON LEADING TO EVENTUAL DX COL1;33 SET
'0' FOR General screening (endoscopy, hemocult);
'1' FOR Symptoms;
'2' FOR Familial history;
'3' FOR Genetic test;
'4' FOR Other;
'9' FOR Unknown;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the appropriate code for the precipitating reason or procedure which eventually lead to
diagnosing this patient with this cancer. If unknown, code a '9'.
165.5,733 BARIUM ENEMA, DOUBLE CONTRAST COL1;34 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'BARIUM ENEMA, DOUBLE CONTRAST', if it was performed to
evaluate this cancer. If this test was not done record a '0'.
165.5,734 BARIUM ENEMA, SINGLE CONTRAST COL1;35 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'BARIUM ENEMA, SINGLE CONTRAST', if it was performed to
evaluate this cancer. If this test was not done record a '0'.
165.5,735 BARIUM ENEMA, NOS COL1;36 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'BARIUM ENEMA, NOS', if it was performed to evaluate this
cancer. If this test was not done record a '0'.
165.5,736 BIOPSY OF PRIMARY SITE COL1;37 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'BIOPSY OF PRIMARY SITE', if it was performed to evaluate
this cancer. If this test was not done record a '0'.
165.5,737 BIOPSY OF METASTATIC SITE COL1;38 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'BIOPSY OF METASTATIC SITE', if it was performed to
evaluate this cancer. If this test was not done record a '0'.
165.5,738 CT SCAN OF LIVER COL1;39 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'CT SCAN OF LIVER', if it was performed to evaluate this
cancer. If this test was not done record a '0'.
165.5,739 CT SCAN OF PRIMARY SITE (COL) COL1;40 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'CT SCAN OF PRIMARY SITE', if it was performed to
evaluate this cancer. If this test was not done record a '0'.
165.5,740 CARCINOEMBRYONIC ANTIGEN (CEA) COL1;41 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'CARCINOEMBRYONIC ANTIGEN (CEA)', if it was performed to
evaluate this cancer. If this test was not done record a '0'.
165.5,741 CHEST ROENTGENOGRAM COL1;42 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'CHEST ROENTGENOGRAM', if it was performed to evaluate
this cancer. If this test was not done record a '0'.
165.5,742 COLONOSCOPY COL1;43 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'COLONOSCOPY', if it was performed to evaluate this
cancer. If this test was not done record a '0'.
165.5,743 DIGITAL RECTAL EXAM COL1;44 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'DIGITAL RECTAL EXAM', if it was performed to evaluate
this cancer. If this test was not done record a '0'.
165.5,744 FLEXIBLE SIGMOIDOSCOPY COL1;45 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 13, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'FLEXIBLE SIGMOIDOSCOPY', if it was performed to evaluate
this cancer. If this test was not done record a '0'.
165.5,745 INTRAVENOUS PYELOGRAM (COL) COL1;46 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 14, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'INTRAVENOUS PYELOGRAM (IVP)', if it was performed to
evaluate this cancer. If this test was not done record a '0'.
165.5,746 SERUM-LIVER FUNCTION TEST COL1;47 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 14, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'SERUM-LIVER FUNCTION TEST', if it was performed to
evaluate this cancer. If this test was not done record a '0'.
165.5,747 MRI (COL) COL1;48 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 14, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'MAGNETIC RESONANCE IMAGING (MRI)', if it was performed
to evaluate this cancer. If this test was not done record a '0'.
165.5,748 PROCTOSCOPY (RIGID) COL1;49 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 14, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'PROCTOSCOPY (RIGID)', if it was performed to evaluate
this cancer. If this test was not done record a '0'.
165.5,749 STOOL GUAIAC (OCCULT BLOOD) COL1;50 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 14, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'STOOL GUAIAC (OCCULT BLOOD)', if it was performed to
evaluate this cancer. If this test was not done record a '0'.
165.5,750 ULTRASOUND, LIVER, ABDOMEN COL1;51 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 14, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'ULTRASOUND, LIVER, ABDOMEN', if it was performed to
evaluate this cancer. If this test was not done record a '0'.
165.5,751 ULTRASOUND, ENDORECTAL COL1;52 SET
'0' FOR Test not done;
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Procedure attempted and incomplete;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: FEB 14, 1997
DESCRIPTION: Record the results of the Diagnostic Test 'ULTRASOUND, ENDORECTAL', if it was performed to evaluate
this cancer. If this test was not done record a '0'.
165.5,752 TUMOR LEVEL-ENDOSCOPIC EXAM COL2;1 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: D TLEEOT^ONCOES
LAST EDITED: FEB 14, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the level of tumor from anal verge by endoscopic exam in centimeters if less than 61
centimeters. If greater than 60 centi- meters, record the appropriate code for tumor site in
colon. If examination performed but tumor not visualized, record a '70'. If examination was
performed, but results unknown, record '80'. If unknown whether examination was performed, record
'99'. If this exam- ination was not performed code '00'.
165.5,753 LEVEL OF RECTAL TUMOR COL2;2 SET
'0' FOR Not measured;
'1' FOR Low (0-5 cm);
'2' FOR Medium (6-10 cm);
'3' FOR High (11-15 cm);
'7' FOR Measured but results unknown;
'8' FOR NA, not a rectal tumor;
'9' FOR Unknown if measured;
LAST EDITED: FEB 19, 1997
DESCRIPTION: Record the appropriate code for the level of rectal tumor. If level not measured, record '0'. If
level measured, but results unknown, record '7'. If not applicable, record '8'. Record '9' if
unknown if measured.
165.5,754 PROXIMAL MARGIN OF RESECTION COL2;3 SET
'0' FOR Negative;
'1' FOR Microscopically positive;
'2' FOR Grossly positive;
'8' FOR NA;
'9' FOR Unknown, not described;
LAST EDITED: MAR 19, 1997
DESCRIPTION:
Record the appropriate code for the Proximal margin of resection.
165.5,755 DISTAL MARGIN OF RESECTION COL2;4 SET
'0' FOR Negative;
'1' FOR Microscopically positive;
'2' FOR Grossly positive;
'8' FOR NA;
'9' FOR Unknown, not described;
LAST EDITED: MAR 19, 1997
DESCRIPTION:
Record the appropriate code for the Distal margin of resection.
165.5,756 RADIAL MARGIN OF RESECTION COL2;5 SET
'0' FOR Negative;
'1' FOR Microscopically positive;
'2' FOR Grossly positive;
'8' FOR NA;
'9' FOR Unknown, not described;
LAST EDITED: MAR 19, 1997
DESCRIPTION:
Record the appropriate code for the Radial margin of resection.
165.5,757 DIST TO CLOSEST MUCOSAL MARGIN COL2;6 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y=88:"Not applicable",Y=99:"Unknown",1:Y_" mm")
LAST EDITED: FEB 18, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the distance in millimeters (mm) to the closest mucosal margin (or to dentate for abdominal
perineal resection). This may also be described as the lateral or circumferential margin. Record
the distance in millimeters. Record 88 if not applicable. If unknown, record 99.
165.5,758 DIST TO CLOSEST RADIAL MARGIN COL2;7 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y=88:"Not applicable",Y=99:"Unknown",1:Y_" mm")
LAST EDITED: FEB 18, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the distance in millimeters (mm) to the closest radial margin (or to the base of excision,
if polyp). Record the distance in millimeters. Record 88 if not applicable. If unknown, record
99.
165.5,759 BLOOD VESSEL OR LYMPHATIC INV COL2;8 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 18, 1997
DESCRIPTION:
Record the appropriate code for blood vessel or lymphatic invasion.
165.5,760 EXTRAMURAL VENOUS INVASION COL2;9 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 18, 1997
DESCRIPTION:
Record the appropriate code for extramural venous invasion.
165.5,761 PROMINENT LYMPHOID INFILTRATE COL2;10 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 18, 1997
DESCRIPTION:
Record the appropriate code for prominent lymphoid infiltrate (Crohn's lymphoid follicle).
165.5,762 PHYS PROVIDING DEF TREATMENT COL2;11 SET
'1' FOR Colorectal board certified surgeon;
'2' FOR Gastroenterologist;
'3' FOR General surgeon;
'4' FOR Radiation therapist;
'5' FOR Other;
'9' FOR Unknown;
LAST EDITED: FEB 19, 1997
DESCRIPTION:
Record the appropriate code representing the physician that provided the definitive treatment.
165.5,763 ADDITIONAL SURGICAL PROCEDURES COL2;12 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X I $D(X) D ASPIT^ONCOES
OUTPUT TRANSFORM: D ASPOT^ONCOES
LAST EDITED: FEB 20, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Enter any modified or additional surgical procedures for primary rectosigmoid or rectal cancer.
Record the appropriate code if any of the specified procedures were performed. Please note that
these codes do not represent the procedures as defined for the required surgery codes. For this
field, these codes identify only the specified procedures. Record 88 for not applicable, not
performed. Record 99 for unknown if performed.
EXECUTABLE HELP: D ASPHP^ONCOES
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,764 LAPAROSCOPY USED DURING CDS COL2;13 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAR 19, 1997
DESCRIPTION: Record whether a laparoscopic procedure was used during cancer- directed surgery. Record an '8' if
not applicable.
165.5,765 METHOD OF ANASTOMOSIS COL2;14 SET
'0' FOR Not done;
'1' FOR Staple;
'2' FOR Created by hand;
'8' FOR Method not recorded;
'9' FOR Unknown if done;
LAST EDITED: FEB 20, 1997
DESCRIPTION:
Record the appropriate code for the method of anastomosis.
165.5,766 CM FROM ANASTOMOSIS TO DENTATE COL2;15 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."2N.N) X
LAST EDITED: FEB 20, 1997
HELP-PROMPT: Type a Number between 0 and 99, 1 Decimal Digit
DESCRIPTION:
Record the distance in centimeters of anastomosis from dentate.
165.5,767 COLOSTOMY COL2;16 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 20, 1997
DESCRIPTION:
Record whether a colonscopy was performed.
165.5,768 OOPHORECTOMY COL2;17 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 20, 1997
DESCRIPTION: Record whether an oophorectomy was performed. If an oophorectomy was performed, record the
pathological status in the pathological status field.
165.5,769 PATHOLOGICAL STATUS COL2;18 SET
'0' FOR Not involved;
'1' FOR Involved;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAR 19, 1997
DESCRIPTION: Record the appropriate code. If an oophorectomy was performed, then record the pathological status
in this field. If not performed, code an '8' (NA).
165.5,770 ABDOMINAL INFECTION COL2;19 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'BLEEDING/HEMATOMA', which resulted from
treatment. If the complication did not occur, code a '0' (no). If no treatment was performed,
code 8 (NA).
165.5,771 ABSCESS COL2;20 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'ABSCESS', which resulted from treatment.
If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
165.5,772 ADMISSION FOR NEUTROPENIA COL2;21 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'ADMISSION FOR NEUTROPENIA', which
resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was
performed, code 8 (NA).
165.5,773 ANASTOMOTIC DEHISCENCE COL2;22 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'ANASTOMOTIC DEHISCENCE', which resulted
from treatment. If the complication did not occur, code a '0' (no). If no treatment was
performed, code 8 (NA).
165.5,774 DEHYDRATION COL2;23 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'DEHYDRATION', which resulted from
treatment. If the complication did not occur, code a '0' (no). If no treatment was performed,
code 8 (NA).
165.5,775 DIARRHEA COL2;24 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'DIARRHEA', which resulted from treatment.
If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
165.5,776 EARLY BOWEL OBSTRUCTION COL2;25 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'EARLY BOWEL OBSTRUCTION', which resulted
from treatment. If the complication did not occur, code a '0' (no). If no treatment was
performed, code 8 (NA).
165.5,777 PERINEAL INFECTION COL2;26 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'PERINEAL INFECTION', which resulted from
treatment. If the complication did not occur, code a '0' (no). If no treatment was performed,
code 8 (NA).
165.5,778 PNEUMONIA (COL) COL2;27 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'PNEUMONIA', which resulted from
treatment. If the complication did not occur, code a '0' (no). If no treatment was performed,
code 8 (NA).
165.5,779 PROCTITIS COL2;28 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'PROCTITIS', which resulted from
treatment. If the complication did not occur, code a '0' (no). If no treatment was performed,
code 8 (NA).
165.5,780 PULMONARY EMBOLISM (COL) COL2;29 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'PULMONARY EMBOLISM', which resulted from
treatment. If the complication did not occur, code a '0' (no). If no treatment was performed,
code 8 (NA).
165.5,781 RADIATION ENTERITIS COL2;30 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'RADIATION ENTERITIS', which resulted from
treatment. If the complication did not occur, code a '0' (no). If no treatment was performed,
code 8 (NA).
165.5,782 STOMA COMPLICATION COL2;31 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'STOMA COMPLICATION', which resulted from
treatment. If the complication did not occur, code a '0' (no). If no treatment was performed,
code 8 (NA).
165.5,783 URINARY TRACT INFECTION COL2;32 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: APR 04, 1997
DESCRIPTION: Record whether the patient had the surgical complication 'URINARY TRACT INFECTION', which resulted
from treatment. If the complication did not occur, code a '0' (no). If no treatment was
performed, code 8 (NA).
165.5,784 ENDOCAVITARY RADIATION (ECRT) COL2;33 SET
'0' FOR None;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 21, 1997
DESCRIPTION: Record the appropriate code for whether endocavitary radiation (ECRT) was given. ECRT refers to
contact radiation delivered through the bowel lumen, usually proctoscopically, especially for
rectal cancer.
165.5,785 INTRA-OPERATIVE RAD THERAPY COL2;34 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 21, 1997
DESCRIPTION: Record the appropriate code for whether intra-operative radiation therapy (IORT) was given. IORT
is beam radiation and/or radioactive implants and/or radioisotopes at time of surgery.
165.5,786 PRIMARY TUMOR RAD DOSE (cGy) COL2;35 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: D PTRDOT^ONCOES
LAST EDITED: FEB 21, 1997
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: Record the primary tumor total rad dose (cGy) given, including boost. If the patient did not
receive radiation therapy, code 00000. If it is known that the patient received radiation therapy
but the dose is unknown, code 88888. If it is unknown if patient received radiation, code 99999.
165.5,787 NUMBER OF RADIATION TREATMENTS COL2;36 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"None",Y=88:"Given but number unknown",Y=99:"Unknown if radiation g
iven",1:Y)
LAST EDITED: FEB 21, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the number of radiation treatments. If none, record 00. If given, but number unknown,
record 88. If unknown if radiation given, record 99.
165.5,788 ADJUVANT CHEMOTHERAPY (COL) COL2;37 SET
'0' FOR No concomitant treatment;
'1' FOR Radiation and concomitant bolus chemo;
'2' FOR Radiation and concomitant infusion chemo;
'9' FOR Unknown if therapy concomitant;
LAST EDITED: MAR 27, 1997
DESCRIPTION: Record the Adjuvant Chemotherapy with Concomitant External Beam Radiation. If patient receives
chemotherapy at any time during radiation as a radio- sensitizing agent, code 1. If chemotherapy
is stopped more than 2 days prior to radiation therapy and not given until external beam therapy is
completed, code 0. If unknown, code 9.
165.5,789 5 FU (FLUOROURACIL) COL2;38 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 21, 1997
DESCRIPTION: Record whether the adjuvant therapy 5 FU (Fluorouracil) was given. If it is unknown if it was
given, record a 9.
165.5,790 LEUCOVORIN COL2;39 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 21, 1997
DESCRIPTION: Record whether the adjuvant therapy Leucovorin was given. If it is unknown if it was given, record
a 9.
165.5,791 LEVAMISOLE COL2;40 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 14, 1999
DESCRIPTION: Record whether the adjuvant therapy Levamisole was given. If it is unknown if it was given, record
a 9.
SCREEN: S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
EXPLANATION: Code 8 should not be used for cases with a DATE DX < 1/1/1999
165.5,792 CPT 11 COL2;41 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 21, 1997
DESCRIPTION: Record whether the adjuvant therapy CPT 11 was given. If it is unknown if it was given, record a
9.
165.5,793 OTHER ADJUVANT THERAPY COL2;42 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 21, 1997
DESCRIPTION: Record whether any other adjuvant therapy was given. If it is unknown if any was given, record a
9.
165.5,794 DURATION OF ADJUVANT THERAPY COL2;43 SET
'0' FOR No adjuvant therapy;
'1' FOR 1 to 6 months;
'2' FOR 7 to 12 months;
'8' FOR Therapy given but duration unknown;
'9' FOR Unknown if therapy given;
LAST EDITED: FEB 21, 1997
DESCRIPTION:
Record the appropriate code for the duration of adjuvant therapy.
165.5,795 COMPLETED DURATION OF THERAPY COL2;44 SET
'0' FOR No (0-1 cycle);
'1' FOR Yes (2 or more cycles);
'7' FOR No therapy planned, not applicable;
'8' FOR Unknown if therapy completed;
'9' FOR Unknown if therapy given;
LAST EDITED: FEB 21, 1997
DESCRIPTION: Record the appropriate code. If one or less than one cycle completed, record 0. If two or more
cycles completed, record 1. If there was no adjuvant therapy planned, record 7. If therapy was
given, but unknown if completed, record 8. If unknown if therapy given, record 9.
165.5,796 NUTRITIONAL CONSULTATION COL2;45 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 21, 1997
DESCRIPTION:
Record whether the other referral, nutritional consultation was made. If unknown, record 9.
165.5,797 OCCUPATIONAL THERAPY COL2;46 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 21, 1997
DESCRIPTION:
Record whether the other referral, occupational therapy was made. If unknown, record 9.
165.5,798 OSTOMY CONSULTATION COL2;47 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 21, 1997
DESCRIPTION:
Record whether the other referral, ostomy consultation was made. If unknown, record 9.
165.5,799 PSYCHOSOCIAL COL2;48 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 21, 1997
DESCRIPTION:
Record whether the other referral, psychosocial was made. If unknown, record 9.
165.5,800 HISTORY OF LEUKEMIA (FAM) NHL1;1 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 25, 1997
DESCRIPTION: Record any familial history of leukemia documented in the medical record. If the record does not
mention familial history of cancer, code 9 (unknown).
165.5,801 HISTORY OF NON-HODGKIN'S LYMPH NHL1;2 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 25, 1997
DESCRIPTION: Record any familial history of Non-Hodgkin's lymphoma documented in the medical record. If the
record does not mention familial history of cancer, code 9 (unknown).
165.5,802 HISTORY OF HODGKIN'S LYMPHOMA NHL1;3 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 25, 1997
DESCRIPTION: Record any familial history of Hodgkin's lymphoma documented in the medical record. If the record
does not mention familial history of cancer, code 9 (unknown).
165.5,803 1ST PRIMARY SITE NHL1;4 POINTER TO ICDO TOPOGRAPHY FILE (#164)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
9.1 = D CHFPS^ONCOMNI
LAST EDITED: OCT 07, 1997
DESCRIPTION: Record the ICD-O-2 code for the first site of any personal history of cancer documented in the
medical record. If not applicable record 8's. If record does not mention personal history of any
cancer, record 9's.
WRITE AUTHORITY: ^
165.5,804 1ST PRIMARY HISTOLOGY NHL1;5 POINTER TO ICD-O-2 MORPHOLOGY FILE (#164.1)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.1,+Y,0)),U,2)_" "_$P($G(^ONCO(164.1,+Y,0)),U,1)
9.1 = D CHFPH^ONCOMNI
LAST EDITED: OCT 07, 1997
DESCRIPTION: Record the 5-digit histology (including behavior) code for the first histology of any personal
history of cancer documented in the medical record. If not applicable record 8's. If record does
not mention personal history of any cancer, record 9's.
WRITE AUTHORITY: ^
165.5,805 2ND PRIMARY SITE NHL1;6 POINTER TO ICDO TOPOGRAPHY FILE (#164)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
9.1 = D CHSPS^ONCOMNI
LAST EDITED: OCT 07, 1997
DESCRIPTION: Record the ICD-O-2 code for the second site of any personal history of cancer documented in the
medical record. If not applicable record 8's. If record does not mention personal history of any
cancer, record 9's.
WRITE AUTHORITY: ^
165.5,806 2ND PRIMARY HISTOLOGY NHL1;7 POINTER TO ICD-O-2 MORPHOLOGY FILE (#164.1)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.1,+Y,0)),U,2)_" "_$P($G(^ONCO(164.1,+Y,0)),U,1)
9.1 = D CHSPH^ONCOMNI
LAST EDITED: OCT 07, 1997
DESCRIPTION: Record the 5-digit histology (including behavior) code for the second histology of any personal
history of cancer documented in the medical record. If not applicable record 8's. If record does
not mention personal history of any cancer, record 9's.
WRITE AUTHORITY: ^
165.5,807 ORGAN TRANSPLANT NHL1;8 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 27, 1997
DESCRIPTION: Record the appropriate code for whether an organ transplant was a pre-existing condition. If
unknown, code 9.
165.5,808 HIV POSITIVE NHL1;9 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: FEB 27, 1997
DESCRIPTION: Record the appropriate code for whether being HIV positive was a pre-existing condition. If
unknown, code 9.
165.5,809 CROHN'S DISEASE NHL1;10 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown/not documented;
LAST EDITED: MAY 24, 2005
DESCRIPTION:
Record whether Crohn's disease was a pre-existing condition.
165.5,810 HASHIMOTO'S THYROIDITIS NHL1;11 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 06, 1997
DESCRIPTION: Record the appropriate code for whether Hashimoto's thyroiditis was a pre-existing condition. If
unknown, code 9.
165.5,811 SYSTEMIC LUPUS ERYTHEMATOSUS NHL1;12 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 06, 1997
DESCRIPTION: Record the appropriate code for whether systemic lupus erythematosus was a pre-existing condition.
If unknown, code 9.
165.5,812 RHEUMATOID ARTHRITIS NHL1;13 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 06, 1997
DESCRIPTION: Record the appropriate code for whether rheumatoid arthritis, including Sjogren's syndrome was a
pre-existing condition. If unknown, code 9.
165.5,813 PNEUMOCYSTIS CARINII NHL1;14 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 06, 1997
DESCRIPTION: Record the appropriate code for whether pneumocystis carinii was a pre-existing condition. If
unknown, code 9.
165.5,814 CMV INFECTION NHL1;15 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 06, 1997
DESCRIPTION: Record the appropriate code for whether CMV infection was a pre-existing condition. If unknown,
code 9.
165.5,815 TUBERCULOSIS NHL1;16 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 06, 1997
DESCRIPTION: Record the appropriate code for whether tuberculosis was a pre-existing condition. If unknown,
code 9.
165.5,816 MYCOBACTERIUM AVIUM NHL1;17 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 06, 1997
DESCRIPTION: Record the appropriate code for whether mycobacterium avium was a pre-existing condition. If
unknown, code 9.
165.5,817 OTHER PARASITIC INFECTIONS NHL1;18 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 06, 1997
DESCRIPTION: Record the appropriate code for whether there were any other parasitic infections that were
pre-existing conditions. If unknown, code 9.
165.5,818 OTHER CONGENITAL DISEASES NHL1;19 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 06, 1997
DESCRIPTION: Record the appropriate code for whether there were any other congenital diseases that were
pre-existing conditions. If unknown, code 9.
165.5,819 OPPORTUNISTIC DISEASE NHL1;20 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 06, 1997
DESCRIPTION: Record the appropriate code for whether opportunistic disease was a pre-existing condition, ONLY IF
IT WAS WITHIN THE LAST 2 YEARS. If unknown, code 9.
165.5,820 PREVIOUS CHEMOTHERAPY NHL1;21 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 11, 1997
DESCRIPTION: Record the appropriate code for whether the patient received any previous chemotherapy. If
unknown, code 9.
165.5,821 PREVIOUS RADIATION THERAPY NHL1;22 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 11, 1997
DESCRIPTION: Record the appropriate code for whether the patient received any previous radiation therapy. If
unknown, code 9.
165.5,822 AIDS RISK CATEGORY NHL1;23 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S Y=X D ARCHP^ONCOMNI W " ",Y K Y
OUTPUT TRANSFORM: D ARCHP^ONCOMNI
LAST EDITED: APR 23, 1997
DESCRIPTION: Record the appropriate code. The risk categories listed (1-8) only apply to those patients who are
HIV positive. Record 0 if the patient is not HIV positive. Record 7 if the patient has more than
one risk category (2-6). Record 8 if the patient's risk category is other or unknown. Record 9 if
it is unknown if the patient is HIV positive.
EXECUTABLE HELP: D ARCHHLP^ONCOMNI
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,823 CT SCAN OF BRAIN NHL1;24 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 19, 1997
DESCRIPTION: Record the results of the CT SCAN OF BRAIN if the test was performed to evaluate this non-Hodgkin's
Lymphoma. If the test was not done, code 0. Do not leave blank.
165.5,824 CT SCAN OF ABDOMEN/PELVIS NHL1;25 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 19, 1997
DESCRIPTION: Record the results of the CT SCAN OF ABDOMEN/PELVIS if the test was performed to evaluate this
non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.
165.5,825 MRI OF BRAIN NHL1;26 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 19, 1997
DESCRIPTION: Record the results of the MRI OF BRAIN if the test was performed to evaluate this non-Hodgkin's
Lymphoma. If the test was not done, code 0. Do not leave blank.
165.5,826 MRI OF CHEST NHL1;27 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 19, 1997
DESCRIPTION: Record the results of the MRI OF CHEST if the test was performed to evaluate this non-Hodgkin's
Lymphoma. If the test was not done, code 0. Do not leave blank.
165.5,827 MRI OF ABDOMEN/PELVIS NHL1;28 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 19, 1997
DESCRIPTION: Record the results of the MRI OF ABDOMEN/PELVIS if the test was performed to evaluate this
non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.
165.5,828 GALLIUM SCAN NHL1;29 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 19, 1997
DESCRIPTION: Record the results of the GALLIUM SCAN if the test was performed to evaluate this non-Hodgkin's
Lymphoma. If the test was not done, code 0. Do not leave blank.
165.5,829 PET SCAN NHL1;30 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 19, 1997
DESCRIPTION: Record the results of the PET SCAN if the test was performed to evaluate this non-Hodgkin's
Lymphoma. If the test was not done, code 0. Do not leave blank.
165.5,830 LUMBAR PUNCTURE NHL1;31 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 19, 1997
DESCRIPTION: Record the results of the LUMBAR PUNCTURE if the test was performed to evaluate this non-Hodgkin's
Lymphoma. If the test was not done, code 0. Do not leave blank.
165.5,831 HEMOGLOBIN/HEMATOCRIT NHL1;32 SET
'0' FOR Test not done;
'1' FOR Normal;
'2' FOR Higher than normal;
'3' FOR Lower than normal;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record the appropriate code for the results of the hemoglobin/hematocrit laboratory test, if it was
performed. If the test was not performed, record a '0'.
165.5,832 WHITE COUNT NHL1;33 SET
'0' FOR Test not done;
'1' FOR Normal;
'2' FOR Higher than normal;
'3' FOR Lower than normal;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record the appropriate code for the results of the white count laboratory test, if it was
performed. If the test was not performed, record a '0'.
165.5,833 PLATELET COUNT NHL1;34 SET
'0' FOR Test not done;
'1' FOR Normal;
'2' FOR Higher than normal;
'3' FOR Lower than normal;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record the appropriate code for the results of the platelet count laboratory test, if it was
performed. If the test was not performed, record a '0'.
165.5,834 LACTIC DEHYDROGENASE (LDH) NHL1;35 SET
'0' FOR Test not done;
'1' FOR Normal;
'2' FOR Higher than normal;
'3' FOR Lower than normal;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record the appropriate code for the results of the lactic dehydrogenase (LDH) laboratory test, if
it was performed. If the test was not performed, record a '0'.
165.5,835 LIVER FUNCTION STUDIES (NHL) NHL1;36 SET
'0' FOR Test not done;
'1' FOR Normal;
'2' FOR Higher than normal;
'3' FOR Lower than normal;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record the appropriate code for the results of the liver function studies laboratory test, if it
was performed. If the test was not performed, record a '0'.
165.5,836 TOTAL PROTEIN/ALBUMIN NHL1;37 SET
'0' FOR Test not done;
'1' FOR Normal;
'2' FOR Higher than normal;
'3' FOR Lower than normal;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record the appropriate code for the results of the total protein/albumin laboratory test, if it was
performed. If the test was not performed, record a '0'.
165.5,837 GENE REARRANGEMENTS NHL1;38 SET
'0' FOR Not done;
'1' FOR Done;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record whether the 'Gene rearrangements' test was performed to evaluate this primary. If this test
was not done, record a '0'.
165.5,838 REVIEW OF PATHOLOGY/OTHER INST NHL1;39 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown if done;
LAST EDITED: MAY 28, 1997
DESCRIPTION: Record the appropriate code for whether there was a review of pathology at another institution by
another pathologist.
165.5,839 LYMPH NODE BIOPSY NHL1;40 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record the appropriate code for lymph node biopsy, if it was performed. If this biopsy was not
performed record a '0'.
165.5,840 BONE MARROW BIOPSY NHL1;41 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record the appropriate code for bone marrow biopsy, if it was performed. If this biopsy was not
performed record a '0'.
165.5,841 CSF CYTOLOGY NHL1;42 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record the appropriate code for CSF cytology biopsy, if it was performed. If this biopsy was not
performed record a '0'.
165.5,842 OTHER SITE BIOPSY NHL1;43 SET
'0' FOR Test not done;
'1' FOR Positive for cancer;
'2' FOR Negative for cancer;
'3' FOR Equivocal, suggestive of cancer;
'7' FOR Test attempted but not completed;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record the appropriate code for other site biopsy, if it was performed. If this biopsy was not
performed record a '0'.
165.5,843 SYSTEMIC SYMPTOMS NHL1;44 SET
'1' FOR A (no symptoms);
'2' FOR B (defined systemic symptoms);
'9' FOR Unknown whether A or B;
LAST EDITED: MAR 20, 1997
DESCRIPTION: Record whether the patient was category A (without defined systemic symptoms) or B (with defined
systemic symptoms). These symptoms include unexplained weight loss of at least 10% within 6 months
prior to diagnosis, unexplained fever above 38 C, and drenching night sweats. Neither pruritus
alone or short febrile illness associated with infection qualify within these systemic symptoms.
165.5,844 CD4 COUNT NHL1;45 SET
'0' FOR Test not done;
'1' FOR < 1,000 copies/ml;
'2' FOR 1,000 to 9,999 copies/ml;
'3' FOR > or = to 10,000 copies/ml;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: APR 15, 1997
DESCRIPTION: Record the appropriate code for CD4 count, a diagnostic test specifically related to HIV disease.
If the test was not performed, record a '0'.
165.5,845 HIV VIRAL LOADS NHL1;46 SET
'0' FOR Test not done;
'1' FOR < 10,000 copies/ml;
'2' FOR > or = to 10,000 copies/ml;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: APR 15, 1997
DESCRIPTION: Record the appropriate code for HIV viral loads, a diagnostic test specifically related to HIV
disease. If the test was not performed, record a '0'.
165.5,846 SPECIFIC HISTOLOGIC INFO NHL2;1 SET
'1' FOR Mantle cell lymphoma;
'2' FOR MALT lymphoma;
'3' FOR Peripheral T-cell lymphoma;
'4' FOR Anaplastic, large cell (Ki-1) lymphoma;
'8' FOR NA, no additional histologies noted;
'9' FOR Unknown if any histologies noted;
LAST EDITED: APR 15, 1997
DESCRIPTION: This field is used to record any additional specific histologic data. For this field record the
appropriate code (1-4) if any of the specified histologies were noted. (Please note that 1-Mantle
cell lymphoma is not the same histology as mantle zone lymphoma which is listed in the ICD-0-2 code
book as 9673). Record '8' for not applicable, if none of these listed were noted. Record '9' if
unknown if any of these histologies were noted.
165.5,847 CELL TYPE OF LYMPHOMA NHL2;2 SET
'1' FOR T cell;
'2' FOR B cell;
'3' FOR Null cell;
'4' FOR N X cell (natural killer cell);
'9' FOR Cell type unknown;
LAST EDITED: MAR 21, 1997
DESCRIPTION: Record the appropriate code for the cell type of the lymphoma. If the cell type is unknown, record
a '9'.
165.5,848 PATIENT STATUS AT DIAGNOSIS NHL2;3 SET
'0' FOR Bedridden < or = to 50%;
'1' FOR Bedridden > 50%;
'9' FOR Unknown;
LAST EDITED: APR 15, 1997
DESCRIPTION: Record the appropriate code for the patient's status at diagnosis. If completely ambulatory,
record a '0'. If unknown, record a '9'.
165.5,849 TYPE OF STAGING SYSTEM (PED) NHL2;4 POINTER TO TYPE OF STAGING SYSTEM (PEDIATRIC) FILE (#164.6)
OUTPUT TRANSFORM: S Y=$S(Y'="":$P($G(^ONCO(164.6,Y,0)),"^",2),1:"")
LAST EDITED: APR 29, 1997
DESCRIPTION: If recording a pediatric case, enter the type of staging system used to stage this patient. If not
applicable, code '88'. If unknown, code '99'.
165.5,850 PEDIATRIC STAGE NHL2;5 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1) X I $D(X) S STGIND="X" D IN^ONCOTNS
OUTPUT TRANSFORM: S X="" D OT^ONCOTNS
LAST EDITED: MAY 01, 1997
HELP-PROMPT: Answer with the appropriate stage from the AJCC Staging Manual.
DESCRIPTION: Enter the pediatric stage as specified in the pediatric staging system selected. If not
applicable, code '88'. If the pediatric stage is unknown, code '99'.
EXECUTABLE HELP: S STGIND="X" D HP^ONCOTNS
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,851 STAGED BY (PEDIATRIC STAGE) NHL2;6 SET
'0' FOR Not staged;
'1' FOR Managing physician;
'2' FOR Pathologist;
'3' FOR Other physician;
'4' FOR Any combination of 1,2 or 3;
'5' FOR Registrar;
'6' FOR Any combination of 5 w/ 1,2 or 3;
'7' FOR Other;
'8' FOR Staged, individual not specified;
'9' FOR Unknown if staged;
LAST EDITED: APR 18, 1997
DESCRIPTION: Record the appropriate code for the individual who staged this pediatric case. If the patient was
not staged, code '0'.
165.5,852 EXTRANODAL SITE 1 NHL2;7 FREE TEXT
INPUT TRANSFORM: K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI
OUTPUT TRANSFORM: D EXNSOT^ONCOMNI
LAST EDITED: MAR 26, 1997
DESCRIPTION: Provide ICD-O-2 site codes for the 1st clinically and/or pathologically involved extranodal site
(in addition to the primary site). If no 1st extranodal site, code 8's. If unknown, code 9's.
EXECUTABLE HELP: D XHP^ONCOMNI
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,853 EXTRANODAL SITE 2 NHL2;8 FREE TEXT
INPUT TRANSFORM: K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI
OUTPUT TRANSFORM: D EXNSOT^ONCOMNI
LAST EDITED: MAR 26, 1997
DESCRIPTION: Provide ICD-O-2 site codes for the 2nd clinically and/or pathologically involved extranodal site
(in addition to the primary site). If no 2nd extranodal site, code 8's. If unknown, code 9's.
EXECUTABLE HELP: D XHP^ONCOMNI
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,854 EXTRANODAL SITE 3 NHL2;9 FREE TEXT
INPUT TRANSFORM: K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI
OUTPUT TRANSFORM: D EXNSOT^ONCOMNI
LAST EDITED: MAR 26, 1997
DESCRIPTION: Provide ICD-O-2 site codes for the 3rd clinically and/or pathologically involved extranodal site
(in addition to the primary site). If no 3rd extranodal site, code 8's. If unknown, code 9's.
EXECUTABLE HELP: D XHP^ONCOMNI
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,855 EXTRANODAL SITE W/C-D SURGERY NHL2;10 FREE TEXT
INPUT TRANSFORM: K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI
OUTPUT TRANSFORM: D EXNSOT^ONCOMNI
LAST EDITED: MAR 26, 1997
DESCRIPTION: Record the ICD-O-2 site code for any extranodal cancer-directed surgery, other than the
primary-site surgery. If no additional cancer-directed surgery to an extranodal site, code 8's.
If unknown, code 9's.
EXECUTABLE HELP: D XHP^ONCOMNI
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,856 EXTRANODAL SITE SURGICAL PROC NHL2;11 NUMBER
INPUT TRANSFORM: D ESSPIT^ONCODSR
OUTPUT TRANSFORM: D ESSPOT^ONCODSR
LAST EDITED: MAR 28, 1997
HELP-PROMPT: Type a Number between 0 and 90, 0 Decimal Digits
DESCRIPTION: Record the appropriate cancer-directed surgical code for the first extranodal site. If there is no
additional cancer-directed surgical procedure to an extranodal site, code '00'.
EXECUTABLE HELP: D ESSHP^ONCODSR
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,857 LYMPH NODES ABOVE DIAPHRAGM NHL2;12 SET
'1' FOR Irradiated;
'2' FOR Not irradiated;
'8' FOR NA, unknown if radiation therapy given;
'9' FOR Radiation given, unknown if irradiated;
LAST EDITED: APR 18, 1997
DESCRIPTION: Record the appropriate code for whether the lymph nodes above the diaphragm were irradiated.
Please see the "Lymph Node Location Relative to Diaphragm" handout for additional information.
165.5,858 LYMPH NODES BELOW DIAPHRAGM NHL2;13 SET
'1' FOR Irradiated;
'2' FOR Not irradiated;
'8' FOR NA, unknown if radiation therapy given;
'9' FOR Radiation therapy administered, unknown if this field irradiated;
LAST EDITED: MAR 31, 1997
DESCRIPTION: Record the appropriate code for whether the lymph nodes below the diaphragm were irradiated.
Please see the "Lymph Node Location Relative to Diaphragm" handout for additional information.
165.5,859 BRAIN NHL2;14 SET
'1' FOR Irradiated;
'2' FOR Not irradiated;
'8' FOR NA, unknown if radiation therapy given;
'9' FOR Radiation therapy administered, unknown if this field irradiated;
LAST EDITED: MAR 28, 1997
DESCRIPTION: Record the appropriate code for whether the brain was irradiated. If it is unknown if radiation
therapy was given, code 8. If radiation therapy was administered but it is unknown if the brain
was irradiated, code 9.
165.5,860 OTHER EXTRANODAL SITE(S) NHL2;15 SET
'1' FOR Irradiated;
'2' FOR Not irradiated;
'8' FOR NA, unknown if radiation therapy given;
'9' FOR Radiation therapy administered, unknown if this field irradiated;
LAST EDITED: MAR 28, 1997
DESCRIPTION: Record the appropriate code for whether other extranodal site(s) were irradiated. If it is unknown
if radiation therapy was given, code 8. If radiation therapy was administered but it is unknown if
other extranodal sites were irradiated, code 9.
165.5,861 TOTAL BODY NHL2;16 SET
'1' FOR Irradiated;
'2' FOR Not irradiated;
'8' FOR NA, unknown if radiation therapy given;
'9' FOR Radiation therapy administered, unknown if this field irradiated;
LAST EDITED: MAR 31, 1997
DESCRIPTION: Record the appropriate code for whether the total body was irradiated. If it is unknown if
radiation therapy was given, code 8. If radiation therapy was administered but it is unknown if
the total body was irradiated, code 9.
165.5,862 RADIATION/CHEMO SEQUENCE NHL2;17 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D RCSIT^ONCOMNI
OUTPUT TRANSFORM: D RCSOT^ONCOMNI
LAST EDITED: MAR 28, 1997
HELP-PROMPT: Type a Number between 0 and 9, 0 Decimal Digits
DESCRIPTION:
Record the appropriate code for radiation/chemotherapy sequence.
EXECUTABLE HELP: D RCSHP^ONCOMNI
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,863 PROTOCOL NHL2;18 SET
'0' FOR Not on protocol;
'1' FOR Cancer cooperative group trial;
'2' FOR Other investigative, IRB-approved protocol;
'9' FOR Unknown if on protocol;
LAST EDITED: MAR 31, 1997
DESCRIPTION:
Record the appropriate code for systemic and/or intrathecal chemotherapy. If unknown, code 9.
165.5,864 SYSTEMIC CHEMOTHERAPY NHL2;19 SET
'0' FOR None;
'1' FOR Systemic chemotherapy, NOS;
'2' FOR Systemic chemotherapy, single agent;
'3' FOR Systemic chemotherapy, multiple agents;
'9' FOR Unknown if administered;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record the appropriate code for the administration of systemic chemotherapy. If unknown if
administered, code 9.
165.5,865 SYSTEMIC CHEMOTHERAPY DATE NHL2;20 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: APR 03, 1997
HELP-PROMPT: *** SYSTEMIC CHEMOTHERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION:
Record the first date on which systemic chemotherapy was administered.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,866 SYSTEMIC CHEMOTHERAPY CYCLES NHL2;21 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
OUTPUT TRANSFORM: S:$L(Y)=1 Y="0"_Y S Y=$S(Y="01":Y_" cycle",Y=88:"NA",Y=97:"Given but number unknown",Y=98:"No termi
nation date assigned at onset of chemotherapy",Y=99:"Unknown if chemotherapy given",1:Y_" cycles")
LAST EDITED: APR 22, 1997
HELP-PROMPT: Type a Number between 0 and 99, 0 Decimal Digits
DESCRIPTION: Record the number of planned cycles of systemic chemotherapy. If not applicable (no systemic
chemotherapy given), code 88. If given, but number unknown, code 97. If no termination date
assigned at onset of systemic chemotherapy, code 98. If unknown if systemic chemotherapy was
administered, code 99.
165.5,867 CHLORAMBUCIL NHL2;22 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown if given;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not
applicable (chemotherapy not given), code 8. If unknown if given, code 9.
165.5,868 CYCLOPHOSPHAMIDE (NHL) NHL2;23 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown if given;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not
applicable (chemotherapy not given), code 8. If unknown if given, code 9.
165.5,869 DOXORUBICIN (NHL) NHL2;24 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown if given;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not
applicable (chemotherapy not given), code 8. If unknown if given, code 9.
165.5,870 FLUDARABINE NHL2;25 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown if given;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not
applicable (chemotherapy not given), code 8. If unknown if given, code 9.
165.5,871 CHOP NHL2;26 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown if given;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record whether the combination chemotherapy agents, CHOP were administered during systemic
chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
165.5,872 CVP NHL2;27 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown if given;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record whether the combination chemotherapy agents, CVP were administered during systemic
chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
165.5,873 COMLA NHL2;28 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown if given;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record whether the combination chemotherapy agents, COMLA were administered during systemic
chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
165.5,874 MACOP-B NHL2;29 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown if given;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record whether the combination chemotherapy agents, MACOP-B were administered during systemic
chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
165.5,875 M-BACOD NHL2;30 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown if given;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record whether the combination chemotherapy agents, M-BACOD were administered during systemic
chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
165.5,876 PRO-MACE-Cyta BOM NHL2;31 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown if given;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record whether the combination chemotherapy agents, PRO-MACE-Cyta BOM were administered during
systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given,
code 9.
165.5,877 OTHER SYSTEMIC CHEMO AGENTS NHL2;32 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown if given;
LAST EDITED: APR 22, 1997
DESCRIPTION: Record whether any other combination chemotherapy agents were administered during systemic
chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
165.5,878 HIGH DOSE SYSTEMIC CHEMO NHL2;33 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown if given;
LAST EDITED: APR 01, 1997
DESCRIPTION: Record the appropriate code for whether high dose systemic chemotherapy with stem cell rescue was
done. If unknown if done, code 9.
165.5,879 INTRATHECAL CHEMOTHERAPY NHL2;34 SET
'0' FOR None;
'1' FOR Administered;
'9' FOR Unknown if administered;
LAST EDITED: APR 23, 1997
DESCRIPTION: Record the appropriate code for whether intrathecal chemotherapy was administered. If unknown if
administered, code 9.
165.5,880 PURPOSE OF INTRATHECAL CHEMO NHL2;35 SET
'1' FOR Treatment;
'2' FOR Prophylaxis;
'7' FOR NA, not administered;
'8' FOR Administered, purpose unknown;
'9' FOR Unknown if administered;
LAST EDITED: APR 23, 1997
DESCRIPTION: Record the appropriate code for the purpose of intrathecal chemotherapy. If not applicable,
intrathecal chemetherapy not administered, code 7. If intrathecal chemotherapy administered, but
purpose unknown, code 8. If unknown whether intrathecal chemotherapy administered, code 9.
165.5,881 INTERFERON (NHL) NHL2;36 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 1999
DESCRIPTION: Record the appropriate code for whether this type of immunotherapy was performed. If unknown if
performed, code 9.
165.5,882 INTERLEUKIN-2 (IL-2) (NHL) NHL2;37 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 1999
DESCRIPTION: Record the appropriate code for whether this type of immunotherapy was performed. If unknown if
performed, code 9.
165.5,883 MONOCLONAL ANTIBODIES NHL2;38 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 1999
DESCRIPTION: Record the appropriate code for whether this type of immunotherapy was performed. If unknown if
performed, code 9.
165.5,884 VACCINE THERAPY NHL2;39 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 14, 1999
DESCRIPTION: Record the appropriate code for whether this type of immunotherapy was performed. If unknown if
performed, code 9.
SCREEN: S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
EXPLANATION: Code 8 should not be used for cases with a DATE DX < 1/1/1999
165.5,900 DAUGHTER (BR98) BRE1;1 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record any familial history of breast cancer documented in the medical record. Record 8 if not
applicable. Record 9 if unknown.
165.5,901 MATERNAL AUNT (BR98) BRE1;2 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record any familial history of breast cancer documented in the medical record. Record 8 if not
applicable. Record 9 if unknown.
165.5,902 MATERNAL GRANDMOTHER (BR98) BRE1;3 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record any familial history of breast cancer documented in the medical record. Record 8 if not
applicable. Record 9 if unknown.
165.5,903 MOTHER (BR98) BRE1;4 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record any familial history of breast cancer documented in the medical record. Record 8 if not
applicable. Record 9 if unknown.
165.5,904 ONE SISTER (BR98) BRE1;5 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record any familial history of breast cancer documented in the medical record. Record 8 if not
applicable. Record 9 if unknown.
165.5,905 MORE THAN ONE SISTER (BR98) BRE1;6 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record any familial history of breast cancer documented in the medical record. Record 8 if not
applicable. Record 9 if unknown.
165.5,906 FATHER (BR98) BRE1;7 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record any familial history of breast cancer documented in the medical record. Record 8 if not
applicable. Record 9 if unknown.
165.5,907 BROTHER (BR98) BRE1;8 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record any familial history of breast cancer documented in the medical record. Record 8 if not
applicable. Record 9 if unknown.
165.5,908 FAM HISTORY BREAST CA (BR98) BRE1;9 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: MAY 15, 1998
DESCRIPTION: Record any familial history of breast cancer documented in the medical record. Record 8 if not
applicable. Record 9 if unknown.
165.5,909 HISTORY OF BREAST CA (BR98) BRE1;10 SET
'0' FOR None;
'1' FOR Invasive;
'2' FOR Ductal carcinoma in situ;
'3' FOR Lobular carcinoma in situ;
'4' FOR Other histology;
'8' FOR History of breast ca, type unknown;
'9' FOR Unknown;
LAST EDITED: JUN 25, 1998
DESCRIPTION: For females, record any personal history of breast cancer not synchronous (diagnosed 6 months or
more prior) with the current breast cancer. For males, leave this field blank.
165.5,910 SYNCHRONOUS BREAST CA (BR98) BRE1;11 SET
'0' FOR No;
'1' FOR Ipsilateral;
'2' FOR Contralateral;
'3' FOR Both;
'8' FOR Yes, but laterality unknown;
'9' FOR Unknown;
LAST EDITED: JUN 02, 1998
DESCRIPTION: Record any synchronous breast cancer diagnosed up to but not including 6 months prior to current
breast cancer.
165.5,911 COLON (BR98) BRE1;12 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 04, 1998
DESCRIPTION: Record whether the patient had colon cancer diagnosed either prior to this breast cancer or at the
same time that this breast cancer was diagnosed.
165.5,912 OVARY (BR98) BRE1;13 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 04, 1998
DESCRIPTION: Record whether the patient had ovarian cancer diagnosed either prior to this breast cancer or at
the same time that this breast cancer was diagnosed. If the patient is a male leave this field
blank.
165.5,913 UTERUS (BR98) BRE1;14 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 04, 1998
DESCRIPTION: Record whether the patient had uterine cancer diagnosed either prior to this breast cancer or at
the same time that this breast cancer was diagnosed. If the patient is a male leave this field
blank.
165.5,914 PROSTATE (BR98) BRE1;15 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 04, 1998
DESCRIPTION: Record whether the patient had prostate cancer diagnosed either prior to this breast cancer or at
the same time that this breast cancer was diagnosed. If the patient is a female leave this field
blank.
165.5,915 OTHER (BR98) BRE1;16 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 04, 1998
DESCRIPTION: Record whether the patient had other cancer diagnosed either prior to this breast cancer or at the
same time that this breast cancer was diagnosed.
165.5,916 HORMONE REPLACEMENT TPY (BR98) BRE1;17 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JUN 05, 1998
DESCRIPTION: Record whether the patient was/is on hormone replacement therapy (estrogen/progesterone). If the
patient is a male leave this field blank.
165.5,917 HORMONE REPLACEMENT YRS (BR98) BRE1;18 SET
'1' FOR Less than 5 years;
'2' FOR 5 to 9 years;
'3' FOR 10 years or more;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 08, 1998
DESCRIPTION: Record the appropriate code for the number of years of hormone replacement therapy the patient
had. If patient is not on this therapy, code 8, not applicable. If the patient is a male leave
this field blank.
165.5,918 UNKNOWN MAMMOGRAM (BR98) BRE1;19 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JUN 05, 1998
DESCRIPTION: For FEMALE patients ONLY, record the appropriate code for whether a mammogram was given, but the
type was unknown. If the type is known then record a 0. If the patient is male, leave this field
blank.
165.5,919 UNKNOWN MAMMOGRAM DT (BR98) BRE1;20 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: JUN 05, 1998
HELP-PROMPT: *** UNKNOWN MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: For FEMALE patients ONLY, record the date the mammogram was given if the type of mammogram is
unknown. Use the most recent date if this unknown type of mammogram was done more than once.
Record 0's if this type of mammogram was not given. Record 9's if it is unknown if this type was
given. If the patient is male, leave this field blank.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,920 SCREENING MAMMOGRAM (BR98) BRE1;21 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JUN 05, 1998
DESCRIPTION: For FEMALE patients ONLY, record the appropriate code for whether a screening mammogram was given.
If the patient is male, leave this field blank.
165.5,921 SCREENING MAMMOGRAM DT (BR98) BRE1;22 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: JUN 05, 1998
HELP-PROMPT: *** SCREENING MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: For FEMALE patients ONLY, record the date the screening mammogram was given. Use the most recent
date if screening mammogram was done more than once. Record 0's if screening mammogram was not
given. Record 9's if it is unknown if screening mammogram was given. If the patient is male,
leave this field blank.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,922 DIAGNOSTIC MAMMOGRAM (BR98) BRE1;23 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JUN 05, 1998
DESCRIPTION: For FEMALE patients ONLY, record the appropriate code for whether a diagnostic mammogram was
given. If the patient is male, leave this field blank.
165.5,923 DIAGNOSTIC MAMMOGRAM DT (BR98) BRE1;24 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: JUN 05, 1998
HELP-PROMPT: *** DIAGNOSTIC MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: For FEMALE patients ONLY, record the date the diagnostic mammogram was given. Use the most recent
date if diagnostic mammogram was done more than once. Record 0's if diagnostic mammogram was not
given. Record 9's if it is unknown if diagnostic mammogram was given. If the patient is male,
leave this field blank.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,924 MAGNIFICATION MAMMOGRAM (BR98) BRE1;25 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JUN 05, 1998
DESCRIPTION: For FEMALE patients ONLY, record the appropriate code for whether a magnification mammogram was
given. A magnification mammogram can be identified by finding the word "magnification" or
"compression" in the title or body of the report. If the patient is male, leave this field blank.
165.5,925 MAGNIFICATION MAMM DT (BR98) BRE1;26 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: JUN 05, 1998
HELP-PROMPT: *** MAGNIFICATION MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: For FEMALE patients ONLY, record the date the magnification mammogram was given. Use the most
recent date if magnification mammogram was done more than once. Record 0's if magnification
mammogram was not given. Record 9's if it is unknown if magnification mammogram was given. If the
patient is male, leave this field blank.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,926 MAMMOGRAM (BR98) BRE1;27 SET
'0' FOR Test not done;
'1' FOR Results positive for cancer;
'2' FOR Results negative for cancer;
'8' FOR Test done, results equivocal/unknown;
'9' FOR Unknown if test done;
LAST EDITED: JUN 08, 1998
DESCRIPTION: For MALES ONLY, record the results of the mammogram performed to evaluate the extent of breast
cancer. If the mammogram was done but the results cannot be determined, code 8. If it is unknown
if a mammogram was performed, code 9. If no mammogram was done, code 0.
165.5,927 ULTRASOUND (BR98) BRE1;28 SET
'0' FOR Test not done;
'1' FOR Results positive for cancer;
'2' FOR Results negative for cancer;
'8' FOR Test done, results equivocal/unknown;
'9' FOR Unknown if test done;
LAST EDITED: JUN 08, 1998
DESCRIPTION: Record the results of the ultrasound if one was performed to evaluate the extent of breast cancer.
If the ultrasound was done but the results cannot be determined, code 8. If it is unknown if an
ultrasound was performed, code 9. If no ultrasound was done, code 0.
165.5,928 MOST DEFINITIVE MAMM (BR98) BRE1;29 SET
'0' FOR Negative/no abnormality;
'1' FOR Localized calcifications;
'2' FOR Diffuse calcifications;
'3' FOR Mass, no calcifications;
'4' FOR Mass plus one quad calcification;
'5' FOR Mass plus multiple quad calcifications;
'6' FOR NOS;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 08, 1998
DESCRIPTION: For FEMALES ONLY, record the results of the patient's most definitive mammogram in this field. If
no mammogram was done record 8, not applicable. For males, leave this field blank.
165.5,929 DATE OF PATHOLOGIC DX (BR98) BRE1;30 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: JUN 08, 1998
HELP-PROMPT: *** DATE OF PATHOLOGIC DX MUST BE AFTER OR EQUAL TO DATE DX ***
DESCRIPTION: Record the date that this breast cancer was first pathologically diagnosed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,930 DCSI ALSO PRESENT (BR98) BRE1;31 FREE TEXT
INPUT TRANSFORM: K:$L(X)>1!($L(X)<1) X I $D(X) D DCISIT^ONCOOT
OUTPUT TRANSFORM: D DCISOT^ONCOOT
LAST EDITED: JUN 09, 1998
HELP-PROMPT: Answer must be 1 character in length.
DESCRIPTION: If invasive ductal carcinoma is reported (Behavior code = 3), code if ductal carcinoma in situ
(DCIS) is also present. If DCIS is not present, code 0. If DCIS is also present as a separate,
simultaneous tumor, record 1. If DCIS is also present as mixed histology (in situ/invasive) in one
tumor, record 2. If DCIS is also present, both as a separate tumor and in a tumor with mixed
histology, record 3. If DCIS is also present, but unknown whether as a separate tumor or mixed
histology, record 4. If reported tumor is not invasive ductal carcinoma, record 8, not applicable.
If unknown whether DCIS is also present, record 9.
EXECUTABLE HELP: D DCISHP^ONCOOT
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,931 ARCHITECTURE PATTERN (BR98) BRE1;32 SET
'1' FOR Cribriform;
'2' FOR Micro papillary;
'3' FOR Comedo;
'4' FOR Solid;
'5' FOR Other;
'6' FOR NOS;
'7' FOR Mixed (any combination);
'8' FOR NA, not DCIS;
'9' FOR Pattern unknown;
LAST EDITED: JUN 12, 1998
DESCRIPTION: Record the architecture pattern, if DCIS is present (either as the reported tumor, or as a
separate tumor simultaneous with an invasive ductal carcinoma, or as a tumor with mixed histology -
in situ/invasive ductal carcinoma). This information is found on the pathology report, often under
the histology description, or it may be found in the diagnostic report.
165.5,932 NUCLEAR GRADE (BR98) BRE1;33 SET
'1' FOR Low;
'2' FOR Intermediate;
'3' FOR High;
'4' FOR NOS;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 12, 1998
DESCRIPTION: Record the nuclear grade, if DCIS is present (either as the reported tumor, or as a separate tumor
simultaneous with an invasive ductal carcinoma, or as a tumor with mixed histology - in
situ/invasive ductal carcinoma). This information is found on the pathology report, often under
the histology description, or it may be in the diagnostic report. It is identified by the terms
low, intermediate and high.
165.5,933 SKIN INVOLVEMENT (BR98) BRE1;34 SET
'0' FOR No involvement;
'1' FOR Involvement;
'9' FOR Unknown;
LAST EDITED: JUN 12, 1998
DESCRIPTION: For male patients, record the extent of involvement of the skin. For female patients, leave this
field blank.
165.5,934 CHEST WALL INVOLVEMENT (BR98) BRE1;35 SET
'0' FOR No involvement;
'1' FOR Involvement;
'9' FOR Unknown;
LAST EDITED: JUN 12, 1998
DESCRIPTION: For male patients, record the extent of involvement of the chest wall. For female patients, leave
this field blank.
165.5,935 PECTORAL INVOLVEMENT (BR98) BRE1;36 SET
'0' FOR No involvement;
'1' FOR Involvement;
'9' FOR Unknown;
LAST EDITED: JUN 12, 1998
DESCRIPTION: For male patients, record the extent of involvement of the pectoral muscles. For female patients,
leave this field blank.
165.5,936 DERMAL/LYMPHATIC INV (BR98) BRE1;37 SET
'0' FOR No involvement;
'1' FOR Involvement;
'9' FOR Unknown;
LAST EDITED: JUN 12, 1998
DESCRIPTION: For male patients, record the extent of dermal/lymphatic involvement. For female patients, leave
this field blank.
165.5,937 DNA INDEX/PLOIDY (BR98) BRE1;38 SET
'0' FOR Test not done;
'1' FOR Diploid;
'2' FOR Non-diploid;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: JUN 12, 1998
DESCRIPTION: For male patients, record the DNA Index/Ploidy. This is usually determined by flow symmetry. For
females, leave this field blank.
165.5,940 ANDROGEN RECEPTOR (BR98) BRE1;41 SET
'0' FOR Not done;
'1' FOR Positive;
'2' FOR Negative;
'3' FOR Low borderline;
'7' FOR NA;
'8' FOR Test done, results unknown;
'9' FOR Unknown if test done;
LAST EDITED: JUN 12, 1998
DESCRIPTION: For male patients, record the results of the androgen receptor protein test. The results of these
tests are sometimes shown as percents. For females, leave this field blank.
165.5,941 TYPE OF TEST (BR98) BRE1;42 SET
'0' FOR Neither ERA nor PRA was done;
'1' FOR Immunohistochemical test;
'2' FOR Biochemical test;
'8' FOR ERA or PSA was done, type of test unknown;
'9' FOR Unknown if ERA/PRA was done;
LAST EDITED: JUN 18, 1998
DESCRIPTION: If possible to determine, indicate which type of test was used for the ERA/PRA. Answer for
estrogen receptor protein (ERA) first, and if that was not done, then answer for progesterone
receptor protein (PRA). If neither ERA or PRA tests were done, record 0.
165.5,942 SIZE OF DCIS TUMOR (MM) (BR98) BRE1;43 NUMBER
INPUT TRANSFORM: K:X>999!(X<0)!(X?.E1"."1N.N) X I $D(X) D DCSZIT^ONCOOT
OUTPUT TRANSFORM: D DCSZOT^ONCOOT
LAST EDITED: JUN 19, 1998
HELP-PROMPT: Type a Number between 0 and 999, 0 Decimal Digits
DESCRIPTION: Record the size of DCIS tumor. If the tumor being reported is coded as invasive ductal carcinoma
and ductal carcinoma in situ is also present either as a separate, simultaneous tumor or in a tumor
with mixed histology (in situ/invasive), record the largest dimension or diameter of the DCIS tumor
in millimeters. Do not guess the size of the tumor. Do not use specimen size. Use size as recorded
in the pathology report, if it is present. If invasive ductal carcinoma is reported but DCIS is
not present, record 000. If invasive ductal carcinoma is not reported, record 888, not applicable.
If invasive ductal carcinoma is reported and DCIS is also present but its size is not known, record
988. If ductal carcinoma is reported but presence of DCIS is unknown, record 999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,943 SENTINEL NODE BIOPSY BRE1;44 SET
'0' FOR No;
'1' FOR Yes, positive;
'2' FOR Yes, negative;
'3' FOR Yes, results unknown;
'4' FOR Attempted, unsuccessful;
'8' FOR NA, not done, ocular site;
'9' FOR Unknown;
LAST EDITED: JAN 29, 1999
DESCRIPTION: Record whether a sentinel node biopsy was performed. The sentinel node is the first lymph node(s)
in the axillary lymph node basin receiving the lymphatic drainage of the breast. There may be one
or several sentinel nodes identified by radionuclide injection, dye injection, or combination of
the two. If surgeon could not find a sentinel node, record 4 - attempted, unsuccessful.
SCREEN: S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
EXPLANATION: Code 8 should not be used for cases with a DATE DX < 1/1/1999.
165.5,944 SENTINEL NODES EXAMINED (BR98) BRE1;45 SET
'0' FOR None;
'1' FOR 1 node examined;
'2' FOR 2 nodes examined;
'3' FOR 3 nodes examined;
'4' FOR 4 nodes examined;
'5' FOR 5 nodes examined;
'6' FOR 6 nodes examined;
'7' FOR 7 or more nodes examined;
'8' FOR Examined, number unknown;
'9' FOR Unknown if examined;
LAST EDITED: JUN 17, 1998
DESCRIPTION: Enter the number of sentinel nodes examined. Record 0 if no sentinel nodes examined. Record 8 if
nodes examined, but the number is unknown and record 9 if it is unknown if sentinel nodes were
examined.
165.5,945 SENTINEL NODES POSITIVE (BR98) BRE1;46 SET
'0' FOR None positive;
'1' FOR 1 positive node;
'2' FOR 2 positive nodes;
'3' FOR 3 positive nodes;
'4' FOR 4 positive nodes;
'5' FOR 5 positive nodes;
'6' FOR 6 or more positive nodes;
'7' FOR None examined;
'8' FOR Positive, number unknown;
'9' FOR Unknown if positive;
LAST EDITED: JUN 17, 1998
DESCRIPTION: Enter the number of sentinel nodes positive. Record 0 if none are positive. Record 7 if none
were examined. Record 8 if the positive number is unknown, and record 9 if it is unknown if any
were positive.
165.5,946 SENTINEL NODES DETECTED (BR98) BRE1;47 SET
'1' FOR Vital blue dye;
'2' FOR Radionuclide;
'3' FOR Combination;
'8' FOR NA, not done;
'9' FOR Method unknown;
LAST EDITED: JUN 17, 1998
DESCRIPTION: Record the method by which the sentinel node was detected.
165.5,947 SPECIMEN RADIOGRAPH (BR98) BRE1;48 SET
'0' FOR Not done;
'1' FOR Calcification;
'2' FOR Mass;
'3' FOR Both calcification and mass;
'4' FOR Radiograph done, results NOS;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 18, 1998
DESCRIPTION: Record the results of the radiograph. The radiograph is a film of the excised specimen.
165.5,948 SUBMITTED TO PATHOLOGY (BR98) BRE1;49 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 18, 1998
DESCRIPTION: Record whether the entire specimen was submitted to pathology.
165.5,949 MARGIN DISTANCE (BR98) BRE1;50 SET
'0' FOR Margins not free, involved;
'1' FOR Less than 1 mm;
'2' FOR 1 to 2 mm;
'3' FOR 3 to 5 mm;
'4' FOR Greater than 5 mm;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 18, 1998
DESCRIPTION: If margins are free, record the distance in millimeters from the tumor to the edge of the specimen
(margin).
165.5,950 RE-EXCISION (BR98) BRE1;51 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 18, 1998
DESCRIPTION: Record whether a re-excision was performed following examination of the margins. Record 8 if
margins were clear, not applicable. (NOTE: A mastectomy after an excisional biopsy does not count
as a re-excision).
165.5,951 MICROSCOPIC STATUS (BR98) BRE1;52 SET
'0' FOR Uninvolved;
'1' FOR Involved;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 18, 1998
DESCRIPTION: Record the microscopic status of final margin after re-excision. If re-excision was performed
indicate the status. If re-excision was not done, record 8, not applicable.
165.5,952 PRE-RADIATION MAMMOGRAM (BR98) BRE1;53 SET
'0' FOR Not done;
'1' FOR Done, and entire lesion removed;
'2' FOR Done, and entire lesion not removed;
'8' FOR Done, but status of lesion unknown;
'9' FOR Unknown if done;
LAST EDITED: JUN 18, 1998
DESCRIPTION: Record whether there was a pre-radiation therapy mammogram of the patient. If unknown, record 9.
165.5,953 SITES IRRADIATED (BR98) BRE1;54 SET
'0' FOR No radiation;
'1' FOR Breast only;
'2' FOR Breast and regional lymphatics;
'3' FOR Other;
'8' FOR Radiation, sites unknown;
'9' FOR Unknown if radiation;
LAST EDITED: JUN 19, 1998
DESCRIPTION: Record the sites which were irradiated. Regional lymphatics includes axilla, chest wall, internal
mammary lymph nodes and supraclavicular lymph nodes. Breast refers to 'whole' or 'entire' breast.
If radiation was given, but site(s) unknown, record 8. If it is unknown if radiation was given,
record 9.
165.5,954 cGy DOSE TO BREAST (BR98) BRE1;55 NUMBER
INPUT TRANSFORM: K:X>99999!(X<0)!(X?.E1"."1N.N) X I $D(X) D CGYIT^ONCOOT
OUTPUT TRANSFORM: D CGYOT^ONCOOT
LAST EDITED: JUN 19, 1998
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: For female patients ONLY, record the cGy dose (00001-88887) given to the whole breast or chest
wall. Do not include boost dose. If the patient did not receive radiation therapy, code 00000.
If it is known that the patient received radiation therapy, but the dose is unknown, code 88888.
If it is unknown if the patient raceived radiation, code 99999. For male patients, leave this
field blank.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,955 SPECIFIC HORMONE THPY (BR98) BRE1;56 SET
'0' FOR None;
'1' FOR Tamoxifen;
'2' FOR Orchiectomy;
'3' FOR Estrogen;
'4' FOR Other;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JUN 19, 1998
DESCRIPTION: For male patients ONLY, record the specific hormone treatment. Estrogen includes
Diethylstilbestrol. For females, leave blank.
165.5,956 CHEMOTHERAPY REGIME (BR98) BRE1;57 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, no chemotherapy;
'9' FOR Unknown;
LAST EDITED: JUN 19, 1998
DESCRIPTION: Record the chemotherapeutic regime containing doxorubicin. Doxorubicin includes Adriamycin,
Adriamycin-TM, Adriblastina, FT-106, 14-hydroxy daunomycin and Rubex.
165.5,993 REGIONAL TX MODALITY CONV FLAG 27;7 SET
'Y' FOR YES;
LAST EDITED: FEB 06, 2003
DESCRIPTION: This field will flag this record as having its REGIONAL TREATMENT MODALITY values converted from
ROADS TO FORDS. The purpose of this field is to avoid converting already converted values.
165.5,994 TYPE OF FIRST RECUR CONV FLAG 27;6 SET
'Y' FOR YES;
LAST EDITED: JAN 31, 2003
DESCRIPTION: This field will flag this record as having its TYPE OF FIRST RECURRENCE values converted from ROADS
TO FORDS. The purpose of this field is to avoid converting already converted values.
165.5,995 STAGED BY CONV FLAG 27;5 SET
'Y' FOR YES;
LAST EDITED: JAN 06, 2003
DESCRIPTION: This field will flag this record as having its STAGED BY (CLINICAL STAGE and STAGED BY (PATHOLOGIC
STAGE) values converted from ROADS to FORDS. The purpose of this field is to avoid converting
already converted values.
165.5,996 SURGICAL MARGINS CONV FLAG 27;2 SET
'Y' FOR YES;
LAST EDITED: JAN 06, 2003
DESCRIPTION: This field will flag this record as having its SURGICAL MARGINS value converted from ROADS to
FORDS. The purpose of this field is to avoid converting already converted values.
165.5,997 STAGE FLAG 27;1 SET
'Y' FOR YES;
'N' FOR NO;
LAST EDITED: OCT 04, 1996
DESCRIPTION:
Staging conversion flag.
165.5,998 SCOPE OF LN SURGERY CONV FLAG 27;3 SET
'Y' FOR YES;
LAST EDITED: JAN 06, 2003
DESCRIPTION: This field will flag this record as having its SCOPE OF LYMPH NODE SURGERY and SCOPE OF LN SURG
@FACILITY values converted from ROADS to FORDS. The purpose of this field is to avoid converting
already
165.5,999 SURGICAL PROC/OTHER CONV FLAG 27;4 SET
'Y' FOR YES;
LAST EDITED: JAN 06, 2003
DESCRIPTION: This field will flag this record as having its SURGICAL PROC/OTHER SITE and SURGICAL PROC/OTHER
SITE @FAC values converted from ROADS to FORDS. The purpose of this field is to avoid converting
already converted values.
165.5,999.1 DATE OF DIAGNOSIS FLAG 27;8 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 391 This field is a flag that explains why no appropriate
value is entered for DATE DX (#3) field.
EXECUTABLE HELP: S ONCITM=391 D DTFLGHLP^ONCOHELP
165.5,999.11 RX DATE SURG DISCH FLAG 27;17 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 3181 This field is a flag that explains why no appropriate
value is entered for DATE MOST DEFINITIVE SURG DIS (#435) field.
EXECUTABLE HELP: S ONCITM=3181 D DTFLGHLP^ONCOHELP
165.5,999.12 RX DATE-RADIATION FLAG 27;18 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1211 This field is a flag that explains why no appropriate
value is entered for DATE RADIATION STARTED (#51) field.
EXECUTABLE HELP: S ONCITM=1211 D DTFLGHLP^ONCOHELP
165.5,999.13 RX DATE RAD ENDED FLAG 27;19 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 3221 This field is a flag that explains why no appropriate
value is entered for DATE RADIATION ENDED (#361) field.
EXECUTABLE HELP: S ONCITM=3221 D DTFLGHLP^ONCOHELP
165.5,999.14 RX DATE SYSTEMIC FLAG 27;20 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 3231 This field is a flag that explains why no appropriate
value is entered for DATE SYSTEMIC THERAPY STARTED (#152) field.
EXECUTABLE HELP: S ONCITM=3231 D DTFLGHLP^ONCOHELP
165.5,999.15 RX DATE-CHEMO FLAG 27;21 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1221 This field is a flag that explains why no appropriate
value is entered for CHEMOTHERAPY DATE (#53) field.
EXECUTABLE HELP: S ONCITM=1221 D DTFLGHLP^ONCOHELP
165.5,999.16 RX DATE-HORMONE FLAG 27;22 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1231 This field is a flag that explains why no appropriate
value is entered for HORMONE THERAPY DATE (#54) field.
EXECUTABLE HELP: S ONCITM=1231 D DTFLGHLP^ONCOHELP
165.5,999.17 RX DATE-BRM FLAG 27;23 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1241 This field is a flag that explains why no appropriate
value is entered for IMMUNOTHERAPY DATE (#55) field.
EXECUTABLE HELP: S ONCITM=1241 D DTFLGHLP^ONCOHELP
165.5,999.18 RX DATE-OTHER FLAG 27;24 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1251 This field is a flag that explains why no appropriate
value is entered for OTHER TREATMENT START DATE (#57) field.
EXECUTABLE HELP: S ONCITM=1251 D DTFLGHLP^ONCOHELP
165.5,999.19 RX DATE-DX/STG PROC FLAG 27;25 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1281 This field is a flag that explains why no appropriate
value is entered for SURGICAL DX/STAGING PROC DATE (#58.3) field.
EXECUTABLE HELP: S ONCITM=1281 D DTFLGHLP^ONCOHELP
165.5,999.2 DATE CONCLUSIVE DX FLAG 27;9 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR ITEM #: 448 This field is a flag that explains why no appropriate
value is entered for DATE OF CONCLUSIVE DX (#193) field.
EXECUTABLE HELP: S ONCITM=448 D DTFLGHLP^ONCOHELP
165.5,999.21 RECURRENCE DATE-1ST FLAG 27;26 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1861 This field is a flag that explains why no appropriate
value is entered for DATE OF FIRST RECURRENCE (#70) field.
EXECUTABLE HELP: S ONCITM=1861 D DTFLGHLP^ONCOHELP
NOTES: TRIGGERED by the DATE OF FIRST RECURRENCE field of the ONCOLOGY PRIMARY File
165.5,999.22 DATE OF LAST CONTACT FLAG 27;27 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1751 This field is a flag that explains why no appropriate
value is entered for the FOLLOW-UP (#400) multiple of the ONCOLOGY PATIENT (#160) file.
EXECUTABLE HELP: S ONCITM=1751 D DTFLGHLP^ONCOHELP
165.5,999.23 SUBSQ RX 2ND CRS DATE FLAG 27;28 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1661 This field is a flag that explains why no appropriate
value is entered for SUBSEQUENT COURSE OF TREATMENT (#60) multiple field.
EXECUTABLE HELP: S ONCITM=1661 D DTFLGHLP^ONCOHELP
165.5,999.24 SUBSQ RX 3RD CRS DATE FLAG 27;29 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1681 This field is a flag that explains why no appropriate 2nd
value is entered for SUBSEQUENT COURSE OF TREATMENT (#60) multiple field.
EXECUTABLE HELP: S ONCITM=1681 D DTFLGHLP^ONCOHELP
165.5,999.25 SUBSQ RX 4TH CRS DATE FLAG 27;30 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1701 This field is a flag that explains why no appropriate 3rd
value is entered for SUBSEQUENT COURSE OF TREATMENT (#60) multiple field.
EXECUTABLE HELP: S ONCITM=1701 D DTFLGHLP^ONCOHELP
165.5,999.26 ADDRESS AT DX--STATE 27;31 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<2)!'(X?2U) X
LAST EDITED: AUG 26, 2014
HELP-PROMPT: Answer must be 2 characters in length.
DESCRIPTION: Source of Standard: NAACCR Item #: 80 This field is for the patient's State from their Address at
time of Diagnosis.
165.5,999.27 ADDRESS AT DX--COUNTRY 27;32 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<3)!'(X?3U) X
LAST EDITED: AUG 26, 2014
HELP-PROMPT: Answer must be 3 characters in length.
DESCRIPTION: Source of Standard: NAACCR Item #: 102 This field is for the patient's Country from their Address
at the time of diagnosis.
165.5,999.28 ADDRESS CURRENT--STATE 27;33 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<2)!'(X?2U) X
LAST EDITED: AUG 26, 2014
HELP-PROMPT: Answer must be 2 characters in length.
DESCRIPTION: Source of Standard: NAACCR Item #: 1820 This field is for the patient's State from their current
Address.
165.5,999.289 ADDRESS CURRENT--POSTAL CODE 27;35 FREE TEXT
INPUT TRANSFORM: K:$L(X)>9!($L(X)<5) X
MAXIMUM LENGTH: 9
LAST EDITED: AUG 13, 2021
HELP-PROMPT: Answer must be 5-9 characters in length.
DESCRIPTION: Source of Standard: NAACCR Item #: 1830. Address current Postal Code of the patient. This data
field is an override field of the patient zip code.
165.5,999.29 ADDRESS CURRENT--COUNTRY 27;34 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<3)!'(X?3U) X
LAST EDITED: AUG 26, 2014
HELP-PROMPT: Answer must be 3 characters in length.
DESCRIPTION: Source of Standard: NAACCR Item #: 1832 This field is for the patient's Country from their
current Address.
165.5,999.3 DATE OF MULT TUMORS FLAG 27;10 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 439 This field is a flag that explains why no appropriate
value is entered for DATE OF MULTIPLE TUMORS (#195) field.
EXECUTABLE HELP: S ONCITM=439 D DTFLGHLP^ONCOHELP
165.5,999.4 DATE OF FIRST CONTACT FLAG 27;11 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 581 This field is a flag that explains why no appropriate
value is entered for DATE OF FIRST CONTACT (#155) field.
EXECUTABLE HELP: S ONCITM=581 D DTFLGHLP^ONCOHELP
165.5,999.5 DATE OF INPT ADM FLAG 27;12 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 591 This field is a flag that explains why no appropriate
value is entered for DATE OF INPATIENT ADMISSION (#1) field.
EXECUTABLE HELP: S ONCITM=591 D DTFLGHLP^ONCOHELP
165.5,999.6 DATE OF INPT DISCH FLAG 27;13 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 601 This field is a flag that explains why no appropriate
value is entered for DATE OF INPATIENT DISCHARGE (#1.1) field.
EXECUTABLE HELP: S ONCITM=601 D DTFLGHLP^ONCOHELP
165.5,999.7 DATE 1ST CRS RX FLAG 27;14 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: JUL 18, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1271 This field is a flag that explains why no appropriate
value is entered for FIRST COURSE OF TREATMENT DATE (#49) field.
EXECUTABLE HELP: S ONCITM=1271 D DTFLGHLP^ONCOHELP
165.5,999.8 RX DATE-SURGERY FLAG 27;15 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 1201 This field is a flag that explains why no appropriate
value is entered for DATE FIRST SURGICAL PROCEDURE (#170) field.
EXECUTABLE HELP: S ONCITM=1201 D DTFLGHLP^ONCOHELP
165.5,999.9 RX DATE MST DEFN SRG FLAG 27;16 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: MAY 29, 2013
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: Source of Standard: NAACCR Item #: 3171 This field is a flag that explains why no appropriate
value is entered for MOST DEFINITIVE SURG DATE (#50) field.
EXECUTABLE HELP: S ONCITM=3171 D DTFLGHLP^ONCOHELP
165.5,1000 ORAL CONTRACEPTIVES HEP1;1 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 06, 2000
DESCRIPTION: This field describes whether the patient was receiving prescribed hormonal therapy at the time of
diagnosis. This information can typically be found in either the patient's clinic chart or the
managing physician's notes.
165.5,1001 ESTROGEN REPLACEMENT HEP1;2 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 06, 2000
DESCRIPTION:
This field describes whether the patient was receiving prescribed hormonal therapy at the time of
diagnosis. This information can typically be found in either the patient's clinic chart or the
managing physician's notes.
165.5,1002 TAMOXIFEN HEP1;3 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 06, 2000
DESCRIPTION: This field describes whether the patient was receiving prescribed hormonal therapy at the time of
diagnosis. This information can typically be found in either the patient's clinic chart or the
managing physician's notes.
165.5,1003 OTHER HORMONES HEP1;4 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 06, 2000
DESCRIPTION: This field describes whether the patient was receiving prescribed hormonal therapy at the time of
diagnosis. This information can typically be found in either the patient's clinic chart or the
managing physician's notes.
165.5,1004 ASCITES HEP1;5 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 06, 2000
DESCRIPTION: This field describes all conditions relevant to liver cancer which were reported as occurring in
the patient at the time of diagnosis. This information can typically be found in the managing
physician's notes.
165.5,1005 CIRRHOSIS HEP1;6 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 06, 2000
DESCRIPTION: This field describes all conditions relevant to liver cancer which were reported as occurring in
the patient at the time of diagnosis. This information can typically be found in the managing
physician's notes.
165.5,1006 CHILD'S CLASS A HEP1;7 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 06, 2000
DESCRIPTION: This field describes all conditions relevant to liver cancer which were reported as occurring in
the patient at the time of diagnosis. This information can typically be found in the managing
physician's notes.
165.5,1007 CHILD'S CLASS B HEP1;8 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 06, 2000
DESCRIPTION: This field describes all conditions relevant to liver cancer which were reported as occurring in
the patient at the time of diagnosis. This information can typically be found in the managing
physician's notes.
165.5,1008 CHILD'S CLASS C HEP1;9 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 06, 2000
DESCRIPTION: This field describes all conditions relevant to liver cancer which were reported as occurring in
the patient at the time of diagnosis. This information can typically be found in the managing
physician's notes.
165.5,1009 HEPATITIS B HEP1;10 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 06, 2000
DESCRIPTION: This field describes all conditions relevant to liver cancer which were reported as occurring in
the patient at the time of diagnosis. This information can typically be found in the managing
physician's notes.
165.5,1010 HEPATITIS C HEP1;11 SET
'0' FOR Patient screened, negative results;
'1' FOR Patient screened, positive results for Hep C;
'8' FOR Patient refused;
'9' FOR Unknown if patient screened;
LAST EDITED: APR 16, 2003
DESCRIPTION: This field describes all conditions relevant to liver cancer which were reported as occurring in
the patient at the time of diagnosis. This information can typically be found in the managing
physician's notes.
165.5,1011 HEMOCHROMATOSIS HEP1;12 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 06, 2000
DESCRIPTION: This field describes all conditions relevant to liver cancer which were reported as occurring in
the patient at the time of diagnosis. This information can typically be found in the managing
physician's notes.
165.5,1012 ALCOHOL CONSUMPTION HEP1;13 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Never
consumed alcohol" W:X="999" " Number of drinks unknown"
OUTPUT TRANSFORM: S Y=$S(Y="000":"Never consumed alcohol",Y=999:"Number of drinks unknown",1:Y)
LAST EDITED: JUN 30, 2000
HELP-PROMPT: Enter 000-Never consumed alcohol; 001-998; 999-Number of drinks unknown
DESCRIPTION: This field describes the number of drinks (beer, wine, other alcohol) consumed by the patient per
week. If the patient has never consumed alcohol, code 000. If the number of drinks per week is
unknown, code 999. This information can typically be found in either the patient's clinic chart or
the managing physician's notes.
165.5,1013 AFP (IU/ml) HEP1;14 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: JAN 06, 2000
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: This field describes the absolute value of each tumor marker test administered to the patient
prior to the start of the first course of treatment. Tumor markers considered in this study
include: AFP (IU/ml); CEA (mg/ml); and CA19.9 (U/ml). This information can typically be found in
either the patient's hospital chart or laboratory records. Record tumor markers as whole numbers,
round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be
rounded down to 4. If a particular tumor marker test was not administered code 00000. If a test
was administered but the results is unknown, code 99999.
165.5,1014 CEA (mg/ml) HEP1;15 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: JAN 06, 2000
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: This field describes the absolute value of each tumor marker test administered to the patient
prior to the start of the first course of treatment. Tumor markers considered in this study
include: AFP (IU/ml); CEA (mg/ml); and CA19.9 (U/ml). This information can typically be found in
either the patient's hospital chart or laboratory records. Record tumor markers as whole numbers,
round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be
rounded down to 4. If a particular tumor marker test was not administered code 00000. If a test
was administered but the results is unknown, code 99999.
165.5,1015 CA19.9 (U/ml) HEP1;16 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: JAN 06, 2000
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: This field describes the absolute value of each tumor marker test administered to the patient
prior to the start of the first course of treatment. Tumor markers considered in this study
include: AFP (IU/ml); CEA (mg/ml); and CA19.9 (U/ml). This information can typically be found in
either the patient's hospital chart or laboratory records. Record tumor markers as whole numbers,
round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be
rounded down to 4. If a particular tumor marker test was not administered code 00000. If a test
was administered but the results is unknown, code 99999.
165.5,1016 PROTIME (sec) HEP1;17 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: This field describes the absolute value of each liver function test administered to the patient
prior to the start of the first course of treatment. This information can typically be found in
either the patient's hospital chart or laboratory records. Record test results as whole numbers,
round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be
rounded down to 4. If a particular test was not administered, code 00000. If a test was
administered but the result unknown, code 99999.
165.5,1017 BILIRUBIN (mg/ml) HEP1;18 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: This field describes the absolute value of each liver function test administered to the patient
prior to the start of the first course of treatment. This information can typically be found in
either the patient's hospital chart or laboratory records. Record test results as whole numbers,
round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be
rounded down to 4. If a particular test was not administered, code 00000. If a test was
administered but the result unknown, code 99999.
165.5,1018 ALBUMIN (g/dl) HEP1;19 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: This field describes the absolute value of each liver function test administered to the patient
prior to the start of the first course of treatment. This information can typically be found in
either the patient's hospital chart or laboratory records. Record test results as whole numbers,
round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be
rounded down to 4. If a particular test was not administered, code 00000. If a test was
administered but the result unknown, code 99999.
165.5,1019 LDH (U/I) HEP1;20 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Type a Number between 0 and 99999, 0 Decimal Digits
DESCRIPTION: This field describes the absolute value of each liver function test administered to the patient
prior to the start of the first course of treatment. This information can typically be found in
either the patient's hospital chart or laboratory records. Record test results as whole numbers,
round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be
rounded down to 4. If a particular test was not administered, code 00000. If a test was
administered but the result unknown, code 99999.
165.5,1020 CT ARTERIAL PORT-PERFORMED HEP1;21 SET
'0' FOR Not performed;
'1' FOR Performed;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1021 CT ARTERIAL PORT-CIRRHOSIS HEP1;22 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1022 CT ARTERIAL PORT-VASCULAR INV HEP1;23 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1023 CT ARTERIAL PORT-BILOBAR DIS HEP1;24 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1024 CT ARTERIAL PORT-LYMPH NODES HEP1;25 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1025 CT ARTERIAL PORT-SIZE OF TUMOR HEP1;26 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not pe
rformed" W:X="999" " Performed, size unknown"
OUTPUT TRANSFORM: S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Enter 000-Not performed; 001-998; 999 Performed, size unknown
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
The size of the dominant tumor describes the dimension or diameter of the largest identified tumor
in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For
example, if the dominant or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1026 CT ARTERIAL PORT-NUM 0F TUMORS HEP1;27 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99
" " Performed, number unknown"
OUTPUT TRANSFORM: S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Enter 00-Not performed; 01-98; 99-Performed, number unknown
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1027 SPIRAL CT-PERFORMED HEP1;28 SET
'0' FOR Not performed;
'1' FOR Performed;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1028 SPIRAL CT-CIRRHOSIS HEP1;29 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1029 SPIRAL CT-VASCULAR INV HEP1;30 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1030 SPIRAL CT-BILOBAR DIS HEP1;31 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1031 SPIRAL CT-LYMPH NODES HEP1;32 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1032 SPIRAL CT-SIZE OF TUMOR HEP1;33 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not pe
rformed" W:X="999" " Performed, size unknown"
OUTPUT TRANSFORM: S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Enter 000-Not performed; 001-998; 999 Performed, size unknown
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
The size of the dominant tumor describes the dimension or diameter of the largest identified tumor
in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For
example, if the dominant or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1033 SPIRAL CT-NUM OF TUMORS HEP1;34 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99
" " Performed, number unknown"
OUTPUT TRANSFORM: S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Enter 00-Not performed; 01-98; 99-Performed, number unknown
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1034 INCREMENTAL CT-PERFORMED HEP1;35 SET
'0' FOR Not performed;
'1' FOR Performed;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1035 INCREMENTAL CT-CIRRHOSIS HEP1;36 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1036 INCREMENTAL CT-VASCULAR INV HEP1;37 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1037 INCREMENTAL CT-BILOBAR DIS HEP1;38 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1038 INCREMENTAL CT-LYMPH NODES HEP1;39 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1039 INCREMENTAL CT-SIZE OF TUMOR HEP1;40 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not pe
rformed" W:X="999" " Performed, size unknown"
OUTPUT TRANSFORM: S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Enter 000-Not performed; 001-998; 999 Performed, size unknown
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
The size of the dominant tumor describes the dimension or diameter of the largest identified tumor
in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For
example, if the dominant or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1040 INCREMENTAL CT-NUM 0F TUMORS HEP1;41 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99
" " Performed, number unknown"
OUTPUT TRANSFORM: S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Enter 00-Not performed; 01-98; 99-Performed, number unknown
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1041 ULTRASOUND-PERFORMED HEP1;42 SET
'0' FOR Not performed;
'1' FOR Performed;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1042 ULTRASOUND-CIRRHOSIS HEP1;43 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1043 ULTRASOUND-VASCULAR INV HEP1;44 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1044 ULTRASOUND-BILOBAR DIS HEP1;45 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1045 ULTRASOUND-LYMPH NODES HEP1;46 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1046 ULTRASOUND-SIZE OF TUMOR HEP1;47 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not pe
rformed" W:X="999" " Performed, size unknown"
OUTPUT TRANSFORM: S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Enter 000-Not performed; 001-998; 999 Performed, size unknown
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
The size of the dominant tumor describes the dimension or diameter of the largest identified tumor
in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For
example, if the dominant or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1047 ULTRASOUND-NUM 0F TUMORS HEP1;48 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99
" " Performed, number unknown"
OUTPUT TRANSFORM: S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Enter 00-Not performed; 01-98; 99-Performed, number unknown
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1048 MRI-PERFORMED HEP1;49 SET
'0' FOR Not performed;
'1' FOR Performed;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1049 MRI-CIRRHOSIS HEP1;50 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1050 MRI-VASCULAR INV HEP1;51 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1051 MRI-BILOBAR DIS HEP1;52 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1052 MRI-LYMPH NODES HEP1;53 SET
'0' FOR NO;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 07, 2000
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
165.5,1053 MRI-SIZE OF TUMOR HEP1;54 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not pe
rformed" W:X="999" " Performed, size unknown"
OUTPUT TRANSFORM: S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Enter 000-Not performed; 001-998; 999 Performed, size unknown
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
The size of the dominant tumor describes the dimension or diameter of the largest identified tumor
in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For
example, if the dominant or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1054 MRI-NUM 0F TUMORS HEP1;55 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99
" " Performed, number unknown"
OUTPUT TRANSFORM: S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)
LAST EDITED: JAN 07, 2000
HELP-PROMPT: Enter 00-Not performed; 01-98; 99-Performed, number unknown
DESCRIPTION: This field describes the findings from each type of radiological imaging technique utilized in the
evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was
performed; 2) whether the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged
lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4)
the number of tumor nodules present. This information can typically be found in either the
patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1055 DEFINITIVE DIAGNOSIS HEP1;56 SET
'1' FOR Percutaneous biopsy;
'2' FOR At definitive cancer-directed surgery;
'3' FOR Incidental at liver transplantation;
'9' FOR Unknown;
LAST EDITED: JAN 10, 2000
DESCRIPTION: This field describes whether the DEFINITIVE DIAGNOSIS was achieved by percutaneous biopsy; at the
time of the definitive cancer-directed surgical procedure; or at the time of pathologic examination
of an explanted liver specimen. This information can typically by found in either the patient's
hospital or clinical chart, or operative note.
165.5,1056 RADIO-FREQUENCY DESTRUCTION HEP1;57 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 10, 2000
DESCRIPTION: This field describes cancer-directed surgery of the primary site which does not appear as part of
the Commission on Cancer's required surgical codes. If SURGERY OF PRIMARY SITE (question 36) was
coded 17 then record whether the patient received RADIO-FREQUENCY DESTRUCTION of the tumor.
165.5,1057 ABLATION & RESECTION HEP1;58 SET
'00' FOR Ablation & resection not administered;
'11' FOR Photodynamic therapy;
'12' FOR Electrocautery, fulguration;
'13' FOR Cryosurgery;
'14' FOR Laser;
'15' FOR Alcohol;
'16' FOR Heat;
'17' FOR Radio-frequency;
'18' FOR Other;
'88' FOR NA;
'99' FOR Ablation administered, type unknown;
LAST EDITED: JAN 10, 2000
DESCRIPTION: This field describes the combination of ablative surgery and resection administered to the primary
site. If the patient received both ablation and resection, record the ablative surgical therapy
administered. If the patient did not receive a combination of surgical ablation and resection,
code 00. If no cancer-directed surgery was administered, code 88.
165.5,1058 DISTANCE TO CLOSEST MARGIN HEP1;59 SET
'0' FOR Margins involved;
'1' FOR Negative margins, < 1cm;
'2' FOR Negative margins, 1cm - 2cm;
'3' FOR Negative margins, > 2cm;
'8' FOR NA;
'9' FOR Unknown, not described;
LAST EDITED: JAN 10, 2000
DESCRIPTION: This field describes the distance from the resected tumor to the closest margin. Code distance of
margin ONLY if the tumor was surgically resected, this includes tumors which were ablated and
resected. If no cancer-directed surgery was administered, or if the tumor was surgically ablated
only, code 8.
165.5,1059 ABLATION HEP1;60 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 10, 2000
DESCRIPTION: This field describes the surgical treatment of either microscopic or macroscopic residual tumor
remaining AFTER the most definitive surgery of the primary site. Record whether this remaining
tumor was ablated and/or resected. Ablation includes: photodynamic therapy; electrocautery;
fulguration; cryosurgery; laser; alcohol; heat; radio-frequency; ultra- sound; acetic acid.
165.5,1060 RESECTION HEP1;61 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 10, 2000
DESCRIPTION: This field describes the surgical treatment of either microscopic or macroscopic residual tumor
remaining AFTER the most definitive surgery of the primary site. Record whether this remaining
tumor was ablated and/or resected. Resection includes: wedge resection, NOS; segmental resection;
lobectomy, NOS (simple and extended); total hepatectomy with transplant; hepatectomy, NOS.
165.5,1061 CISPLATIN HEP1;62 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR Recommended, not known if administered;
'9' FOR Unknown if recommended or administered;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes whether this type of chemotherapeutic agent was administered. This
information can typically be found in either the patient's hospital chart or the managing medical
oncologist's notes.
165.5,1062 FUDR HEP1;63 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR Recommended, not known if administered;
'9' FOR Unknown if recommended or administered;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes whether this type of chemotherapeutic agent was administered. This
information can typically be found in either the patient's hospital chart or the managing medical
oncologist's notes.
165.5,1063 5-FU HEP1;64 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR Recommended, not known if administered;
'9' FOR Unknown if recommended or administered;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes whether this type of chemotherapeutic agent was administered. This
information can typically be found in either the patient's hospital chart or the managing medical
oncologist's notes.
165.5,1064 FU & LEUCOVORIN HEP1;65 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR Recommended, not known if administered;
'9' FOR Unknown if recommended or administered;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes whether this type of chemotherapeutic agent was administered. This
information can typically be found in either the patient's hospital chart or the managing medical
oncologist's notes.
165.5,1065 IRINOTECAN (CPT-11) HEP1;66 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR Recommended, not known if administered;
'9' FOR Unknown if recommended or administered;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes whether this type of chemotherapeutic agent was administered. This
information can typically be found in either the patient's hospital chart or the managing medical
oncologist's notes.
165.5,1066 MITOMYCIN C HEP1;67 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR Recommended, now known if administered;
'9' FOR Unknown if recommended or administered;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes whether this type of chemotherapeutic agent was administered. This
information can typically be found in either the patient's hospital chart or the managing medical
oncologist's notes.
165.5,1067 OXALIPLATIN HEP1;68 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR Recommended, not known if administered;
'9' FOR Unknown if recommended or administered;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes whether this type of chemotherapeutic agent was administered. This
information can typically be found in either the patient's hospital chart or the managing medical
oncologist's notes.
165.5,1068 GEMCITABINE HEP1;69 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR Recommended, not known if administered;
'9' FOR Unknown if recommended or administered;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes whether this type of chemotherapeutic agent was administered. This
information can typically be found in either the patient's hospital chart or the managing medical
oncologist's notes.
165.5,1069 ROUTE CHEMO ADMIN HEP1;70 SET
'01' FOR Intrathecal;
'02' FOR Intra-arterial, bolus;
'03' FOR Intravenous inf;
'04' FOR Hepatic inf;
'05' FOR Intra-arterial chemoembolization;
'06' FOR Intratumoral inj of alcohol;
'07' FOR Portal inf;
'08' FOR Orally;
'09' FOR Intramuscular;
'88' FOR NA;
'99' FOR Chemo admin, route unk;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes the route/method by which chemotherapy was administered. This information
can typically be found in either the patient's hospital chart or the managing medical oncologist's
notes.
165.5,1070 CHEMOTHERAPY/SURGERY SEQUENCE HEP1;71 SET
'0' FOR No chemotherapy and/or no surgery;
'1' FOR Chemotherapy before surgery;
'2' FOR Chemotherapy after surgery;
'3' FOR Chemotherapy before and after surgery;
'9' FOR Chemotherapy and surgery, sequence unknown;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes the sequence in which chemotherapy and primary tumor cancer-directed surgery
were administered.
165.5,1071 ARTERIAL EMBOLIZATION HEP1;72 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes whether the patient had their tumor embolized without chemotherapy. This
procedure involves the embolizing or clotting of a portion of the hepatic artery to disrupt the
blood flow to the tumor. Information about this treatment modality can be found in the
Vascular/Interventional Radiology procedure notes.
165.5,1072 DEATH W/I 30 DAYS START TX HEP1;73 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 11, 2000
DESCRIPTION: This field describes whether the patient died from any cause within 30 days of the start of
cancer-directed therapy.
165.5,1100 HISTORY OF MELANOMA (PT) MEL1;1 SET
'0' FOR None;
'1' FOR Yes, synchronous or <2 months;
'2' FOR Yes, 2 months to <4 years;
'3' FOR Yes, 4 years to <7 years;
'4' FOR Yes, 7 years to <15 years;
'5' FOR Yes, 15 years or more;
'6' FOR Yes, time period unknown;
'9' FOR Unk if history of melanoma exists;
LAST EDITED: JAN 06, 1999
DESCRIPTION: Record if patient had or currently has any personal history of other melanoma and, if so, how far
back it occurred in relation to the present melanoma.
165.5,1101 HISTORY OF OTHER CANCER (PT) MEL1;2 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 08, 1999
DESCRIPTION: Record if the patient had any history of other types of cancer.
165.5,1102 FIRST SITE CODE MEL1;3 POINTER TO ICDO TOPOGRAPHY FILE (#164)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
LAST EDITED: JAN 07, 1999
DESCRIPTION: Record the primary site of the most recent other cancer with which the patient has been diagnosed,
if any. If no previous cancer was diagnosed, code 000. If a previous cancer was diagnosed, but
the site is unknown, code 888. If it is unknown whether a history of other cancers exists for the
patient, code 999.
165.5,1103 FIRST SITE DIAGNOSIS DATE MEL1;4 DATE
INPUT TRANSFORM: D CHDTIT^ONCOPCE
OUTPUT TRANSFORM: D CHDTOT^ONCOPCE
LAST EDITED: JAN 08, 1999
DESCRIPTION: Record the date on which the most recent other cancer was diagnosed. If no previous cancer was
diagnosed, code the date with 0's. If a previous cancer was diagnosed, but the date is unknown,
code the date with 8's. If it is unknown whether a history of other cancers exists for the
patient, code the date with 9's.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1104 SECOND SITE CODE MEL1;5 POINTER TO ICDO TOPOGRAPHY FILE (#164)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
LAST EDITED: JAN 07, 1999
DESCRIPTION: Record the primary site of the second most recent other cancer with which the patient has been
diagnosed, if any. If no previous cancer was diagnosed, code 000. If a previous cancer was
diagnosed, but the site is unknown, code 888. If it is unknown whether a history of other cancers
exists for the patient, code 999.
165.5,1105 SECOND SITE DIAGNOSIS DATE MEL1;6 DATE
INPUT TRANSFORM: D CHDTIT^ONCOPCE
OUTPUT TRANSFORM: D CHDTOT^ONCOPCE
LAST EDITED: JAN 08, 1999
DESCRIPTION: Record the date on which the second most recent other cancer was diagnosed. If no previous cancer
was diagnosed, code the date 00/00/00. If a previous cancer was diagnosed, but the date is
unknown, code the date 88/88/88. If it is unknown whether a history of other cancers exists for
the patient, code the date 99/99/99.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1106 PREGNANCY AT INITIAL DIAGNOSIS MEL1;7 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, male;
'9' FOR Unknown;
LAST EDITED: JAN 08, 1999
DESCRIPTION: Record whether the patient was pregnant at the time of initial diagnosis.
165.5,1107 EXOGENOUS HORMONES MEL1;8 SET
'0' FOR None;
'1' FOR Yes, HRT (hormone replacement therapy);
'2' FOR Yes, OC (oral contraceptives);
'3' FOR Yes, both HRT and OC;
'4' FOR Yes, type unknown;
'8' FOR NA, male;
'9' FOR Unknown;
LAST EDITED: JAN 12, 1999
DESCRIPTION: Record whether the patient was receiving prescribed exogenous therapy at the time of initial
diagnosis and the number of years of therapy. For this question, exogenous hormones are estrogen
165.5,1108 DISEASE PRESENTATION LOCATION MEL1;9 SET
'1' FOR Solitary cutaneous/subcutaneous;
'2' FOR Multiple cutaneous/subcutaneous;
'3' FOR Nodal;
'4' FOR Visceral;
'5' FOR Other;
'8' FOR NA, primary site known;
'9' FOR Unknown;
LAST EDITED: JAN 08, 1999
DESCRIPTION: Record the location of the disease presentation. If the primary site is known, code as 8, not
applicable.
165.5,1109 TYPE OF BIOPSY MEL1;10 SET
'0' FOR No biopsy performed;
'1' FOR Excisional;
'2' FOR Punch;
'3' FOR Incisional;
'4' FOR Shave;
'5' FOR Saucerization;
'6' FOR Fine needle aspiration;
'8' FOR NA, non-cutaneous melanoma;
'9' FOR Unknown;
LAST EDITED: JAN 11, 1999
DESCRIPTION: Record the appropriate code for cutaneous melanomas only. Code 8, not applicable, for
non-cutaneous sites.
165.5,1110 EXTRANODAL EXTENSION MEL1;11 SET
'0' FOR None;
'1' FOR Microscopic, 2mm or less;
'2' FOR Gross, greater than 2mm;
'3' FOR Present, size unknown;
'8' FOR NA, no nodes examined;
'9' FOR Unknown;
LAST EDITED: JAN 08, 1999
DESCRIPTION: Record whether extranodal extension was determined on gross (greater than 2mm) observation or
microscopic (2mm or less) observation.
165.5,1111 MICROSATELLITOSIS MEL1;12 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, non-cutaneous melanoma;
'9' FOR Unknown;
LAST EDITED: JAN 08, 1999
DESCRIPTION: Record the presence of microsatellitosis. They are visualized with the aid of a microscope and
defined as discrete nests of melanoma cells >0.05mm, noncontiguous and clearly separated from the
main body of the tumor by normal reticular dermal collagen or subcutaneous fat.
165.5,1112 NUMBER OF SATELLITE NODULES MEL1;13 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1) X I $D(X) D NSNIT^ONCOMNI
OUTPUT TRANSFORM: D NSNOT^ONCOMNI
LAST EDITED: JAN 08, 1999
HELP-PROMPT: Answer must be 1-2 numbers, no decimal point.
DESCRIPTION: Record the number of satellite nodules within 2 cm of the primary tumor. If there were no
satellite nodules, microsatellitosis not present, record 00. If there were multiple nodules but an
exact number is not stated, record 97. Record 98 if not applicable, non- cutaneous melanoma.
Record 99 if it is unknown whether there were satellite nodules.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1113 LOCATION OF IN-TRANSIT NODULES MEL1;14 SET
'0' FOR None;
'1' FOR Regional;
'2' FOR Distant;
'3' FOR Other;
'4' FOR Present, location unknown;
'8' FOR NA, non-cutaneous melanoma;
'9' FOR Unknown;
LAST EDITED: JAN 08, 1999
DESCRIPTION: Record the location of in-transit nodules that were farthest from the primary lesion but not
beyond the site of primary lymph node drainage.
165.5,1114 BRESLOW'S THICKNESS MEL1;15 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1) X I $D(X) D BTIT^ONCOMNI
OUTPUT TRANSFORM: D BTOT^ONCOMNI
LAST EDITED: JAN 08, 1999
HELP-PROMPT: Answer must be 1-3 numbers, no decimal point.
DESCRIPTION: Record the thickness of the primary lesion in millimeters using Breslow's method to measure the
depth of the invasion. Record from the pathology report. Record 997 if cutaneous melanoma,
Breslow's thickness unknown. Record 998, not applicable if non-cutaneous melanoma. Record 999 if
cutaneous melanoma, but the primary site is unknown.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1115 CLARK'S LEVEL OF INVASION MEL1;16 SET
'1' FOR I;
'2' FOR II;
'3' FOR III;
'4' FOR IV;
'5' FOR V;
'8' FOR NA, primary site unknown;
'9' FOR Unknown;
LAST EDITED: JAN 08, 1999
DESCRIPTION: There are 5 levels of invasion. Convert level from Roman to Arabic numerals. Code 8, not
applicable, if primary site unknown or non- cutaneous melanoma. Code 9 if Clark's level is
unknown.
1. Level I: All tumor cells confined to the epidermis with no invasion
through the basement membrane (in situ melanoma).
2. Level II: Tumor cells penetrating through the basement membrane into
the papillary dermis but not extending to the reticular dermis.
3. Level III: Tumor cells filling the papillary dermis and abutting against
the reticular dermis but not invading it.
4. Level IV: Extension of tumor cells between the bundles of collagen
characteristic of the reticular dermis.
5. Level V: Invasion into the subcutaneous tissue.
165.5,1116 ANGIOLYMPHATIC INVASION MEL1;17 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, site unknown or ocular;
'9' FOR Unknown;
LAST EDITED: JAN 29, 1999
DESCRIPTION: Record if this histologic feature was noted in the pathology report. Angiolymphatic invasion can
be pathologically evaluated using either the whole tissue specimen or tissue taken from a core
biopsy. Code 8, not applicable, in situations in which either there was no specimen, a specimen
was not adequately large enough to determine these factors, or the primary site was unknown.
165.5,1117 PERINEURAL INVASION MEL1;18 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, site unknown or ocular;
'9' FOR Unknown;
LAST EDITED: JAN 29, 1999
DESCRIPTION: Record if this histologic feature was noted in the pathology report. Perineural invasion can be
pathologically evaluated using either the whole tissue specimen or tissue taken from a core biopsy.
Code 8, not applicable, in situations in which either there was no specimen, a specimen was not
adequately large enough to determine these factors, or the primary site was unknown.
165.5,1118 ULCERATION MEL1;19 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, site unknown or ocular;
'9' FOR Unknown;
LAST EDITED: JAN 29, 1999
DESCRIPTION: Record whether the primary site was ulcerated. Ulceration is defined as a microscopic
interruption of the surface epithelium involved by tumor. This does not alter the staging
procedure but is typically associated with a worse prognosis. Code 8, not applicable, if a primary
site is mucosal, occular or unknown.
165.5,1119 CLINICALLY AMELANOTIC MEL1;20 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, site unknown or ocular;
'9' FOR Unknown;
LAST EDITED: JAN 29, 1999
DESCRIPTION: Record whether the primary site was lacking in melanin. Frequently, terms such as brownish,
black, blue or tan are used to describe a primary site with melanin. Primary sites lacking melanin
may be described as non-pigmented or not dark. Primary sites which are reported to appear red or
have redness should be considered amelanotic. Code 8, not applicable, if primary site is mucosal,
ocular or unknown.
165.5,1120 MARGIN DISTANCE (MEL) MEL1;21 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1) X I $D(X) D MDIT^ONCOMNI
OUTPUT TRANSFORM: D MDOT^ONCOMNI
LAST EDITED: JAN 12, 1999
HELP-PROMPT: Answer must be 1-3 numbers, no decimal point.
DESCRIPTION: If margins are free according to the operative report, record the shortest distance in millimeters
from the tumor to the edge of specimen (margin).
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1121 SURGICAL CLOSURE MEL1;22 SET
'1' FOR Primary or suture closure;
'2' FOR Split-thickness skin graft;
'3' FOR Flap;
'4' FOR Full-thickness skin graft;
'5' FOR Other, NOS;
'8' FOR NA, surgery not performed;
'9' FOR Unknown;
LAST EDITED: JAN 12, 1999
DESCRIPTION: Record the type of surgical closure. Code 8, not applicable if surgery was not performed for this
site.
165.5,1122 PRE-OP LYMPHOSCINTIGRAPHY MEL1;23 SET
'0' FOR No;
'1' FOR Yes, unidirectional flow;
'2' FOR Yes, multidirectional flow;
'3' FOR Yes, flow unknown;
'8' FOR NA, ocular site;
'9' FOR Unknown;
LAST EDITED: JAN 12, 1999
DESCRIPTION: Record whether lymphoscintigraphy was performed, and if done, what was the flow. Unidirectional
flow indicates that only one lynph node basin drained the site. Multidirectional flow indicates
that more than one lymph node basin drained the site.
165.5,1123 SENTINEL NODES DETECTED BY MEL1;24 SET
'0' FOR Not done;
'1' FOR Vital blue die;
'2' FOR Radiolabeled colloid;
'3' FOR Combination of 1 and 2;
'4' FOR Done, method unknown;
'8' FOR NA, not done, ocular site;
'9' FOR Unknown;
LAST EDITED: JAN 29, 1999
DESCRIPTION: Record the method of detecion of the sentinel node.
165.5,1124 SENTINEL NODES EXAMINED (MEL) MEL1;25 SET
'0' FOR No nodes;
'1' FOR 1 node;
'2' FOR 2 nodes;
'3' FOR 3 nodes;
'4' FOR 4 nodes;
'5' FOR 5 nodes;
'6' FOR 6 or more nodes;
'7' FOR Nodes examined, number unknown;
'8' FOR NA, not done, ocular site;
'9' FOR Unknown;
LAST EDITED: JAN 29, 1999
DESCRIPTION: Enter the exact number of sentinel nodes examined.
165.5,1125 SENTINEL NODES POSITIVE (MEL) MEL1;26 SET
'0' FOR No nodes;
'1' FOR 1 node;
'2' FOR 2 nodes;
'3' FOR 3 nodes;
'4' FOR 4 nodes;
'5' FOR 5 nodes;
'6' FOR 6 or more nodes;
'7' FOR Nodes positive, number unknown;
'8' FOR NA, not done, no exam, ocular site;
'9' FOR Unknown;
INPUT TRANSFORM: D SNPIT^ONCOMNI
LAST EDITED: FEB 26, 1999
DESCRIPTION: Enter the exact number of sentinel nodes positive.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1126 METHOD OF PATHOLOGIC EXAM MEL1;27 SET
'0' FOR Not examined;
'1' FOR Routine staining;
'2' FOR Immunochemistry;
'3' FOR Serial sectioning;
'4' FOR PCR;
'5' FOR Other;
'6' FOR Any comb of 1,2,3,4;
'7' FOR Examined, method unknown;
'8' FOR NA, not done, ocular site;
'9' FOR Unknown;
LAST EDITED: FEB 05, 1999
DESCRIPTION: Record the method of pathological examination of the sentinel node.
165.5,1127 LYMPH NODE DISSECTION MEL1;28 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, not done, no + nodes, ocular site;
'9' FOR Unknown;
LAST EDITED: FEB 05, 1999
DESCRIPTION: If sentinel node(s) positive, record if a complete node dissection was performed. A complete node
dissection is the dissection of all nodes found in a particular basin.
165.5,1128 NUMBER OF BASINS DISSECTED MEL1;29 SET
'0' FOR No basins;
'1' FOR 1 basin;
'2' FOR 2 basins;
'3' FOR 3 basins;
'4' FOR 4 basins;
'5' FOR 5 basins;
'6' FOR 6 or more basins;
'7' FOR Basins dissected, number unknown;
'8' FOR NA, not done, no + nodes, ocular site;
'Unknown' FOR Unknown;
LAST EDITED: FEB 05, 1999
DESCRIPTION: If sentinel node(s) positive, record the number of basins dissected.
165.5,1129 NUMBER OF BASINS POSITIVE MEL1;30 SET
'0' FOR No basins;
'1' FOR 1 basin;
'2' FOR 2 basins;
'3' FOR 3 basins;
'4' FOR 4 basins;
'5' FOR 5 basins;
'6' FOR 6 or more basins;
'7' FOR Basins positive, number unknown;
'8' FOR NA, not done, no basins dissected, ocular;
'9' FOR Unknown;
INPUT TRANSFORM: D NBPIT^ONCOMNI
LAST EDITED: MAR 08, 1999
DESCRIPTION: If sentinel node(s) positive, record the number of basins positive. A positive basin is one in
which at least one lymph node, other than the sentinel node, is determined to be positive.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1130 INTRAVENOUS THERAPY MEL1;31 SET
'1' FOR Yes, systemic;
'2' FOR Yes, regional;
'3' FOR Yes, combination of 1 and 2;
'7' FOR Yes, type unknown;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown if chemotherapy administered;
LAST EDITED: MAR 01, 1999
DESCRIPTION: Record how the intravenous therapy was given.
165.5,1131 GENE THERAPY MEL1;32 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA;
'9' FOR Unknown;
LAST EDITED: JAN 14, 1999
DESCRIPTION: Record whether the patient received this adjuvant immunotherapy.
165.5,1132 SIZE OF TUMOR (MELANOMA) MEL1;33 NUMBER
INPUT TRANSFORM: D STMIT^ONCOOT
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y) D STMOT^ONCOOT
LAST EDITED: APR 28, 1999
HELP-PROMPT: Record the largest dimension or diameter, not depth, of the primary tumor.
DESCRIPTION: SIZE OF TUMOR (MELANOMA) is the largest dimension, or the diameter of the primary tumor, and is
always recorded in millimeters. Record the largest diameter of the primary tumor for cutaneous
melanomas. Record the tumor size for clinically diagnosed ocular melanoma. Record 998 for mucosal
melanomas. Record 999 when the primary site is unknown or tumor size is not recorded or not
available.
IMPORTANT NOTE: Do NOT confuse this item with SIZE OF TUMOR in ROADS. For malignant melanoma SIZE
OF TUMOR in ROADS records "depth of invasion" and is equivalent to PCE item #30 (BRESLOW'S
THICKNESS). SIZE OF TUMOR (MELANOMA) records the largest dimension or diameter of the primary
tumor.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1200 HANDEDNESS CNS1;1 SET
'1' FOR Left handed;
'2' FOR Right handed;
'3' FOR Ambidextrous;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes whether the patient is left handed, right handed or ambidextrous.
165.5,1201 HYPERTENSION CNS1;2 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior medical condition.
165.5,1202 MULTIPLE SCLEROSIS (MS) CNS1;3 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior medical condition.
165.5,1203 DIABETES CNS1;4 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior medical condition.
165.5,1204 CEREBROVASCULAR DISEASE CNS1;5 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior medical condition.
165.5,1205 BRAIN CNS1;6 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior history of any cancers.
165.5,1206 BREAST CNS1;7 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior history of any cancers.
165.5,1207 PROSTATE CNS1;8 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior history of any cancers.
165.5,1208 MALIGNANT MELANOMA CNS1;9 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior history of any cancers.
165.5,1209 OTHER SKIN CANCER CNS1;10 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior history of any cancers.
165.5,1210 LEUKEMIA CNS1;11 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior history of any cancers.
165.5,1211 COLON OR OTHER GI CANCERS CNS1;12 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 14, 2000
DESCRIPTION: This field describes a patient's prior history of any cancers.
165.5,1212 OTHER PERSONAL HISTORY OF CA CNS1;13 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a patient's prior history of any cancers.
165.5,1213 NEUROFIBROMATOSIS CNS1;14 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes a patient's predispostion to brain/CNS tumors.
165.5,1214 VON HIPPEL-LINDAU DISEASE CNS1;15 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes a patient's predispostion to brain/CNS tumors.
165.5,1215 TUBEROUS SCLEROSIS CNS1;16 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes a patient's predispostion to brain/CNS tumors.
165.5,1216 TURCOT SYNDROME CNS1;17 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes a patient's predispostion to brain/CNS tumors.
165.5,1217 LI-FRAUMENI SYNDROME CNS1;18 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes a patient's predispostion to brain/CNS tumors.
165.5,1218 KOWDEN DISEASE CNS1;19 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes a patient's predispostion to brain/CNS tumors.
165.5,1219 NEVOID BASAL CELL CARCINOMA CNS1;20 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes a patient's predispostion to brain/CNS tumors.
165.5,1220 HEADACHE CNS1;21 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1221 NAUSEA/VOMITING CNS1;22 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1222 CHANGE IN SENSE OF SMELL/TASTE CNS1;23 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1223 ALTERED ALERTNESS CNS1;24 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1224 FATIGUE CNS1;25 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1225 SPEECH DISTURBANCE CNS1;26 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1226 PERSONALITY CHANGES CNS1;27 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1227 DEPRESSION CNS1;28 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1228 MEMORY LOSS CNS1;29 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1229 LACK OF CONCENTRATION CNS1;30 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1230 DOUBLE VISION CNS1;31 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1231 OTHER VISUAL DISTURBANCE CNS1;32 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1232 DECREASED HEARING CNS1;33 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1233 VERTIGO CNS1;34 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1234 TINNITUS CNS1;35 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1235 NUMBNESS/TINGLING CNS1;36 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1236 WEAKNESS OR PARALYSIS CNS1;37 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1237 DIFFICULTY IN COORD/BALANCE CNS1;38 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1238 GENERALIZED SEIZURE CNS1;39 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1239 FOCAL SEIZURE CNS1;40 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1240 BLADDER INCONTINENCE CNS1;41 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1241 BOWEL INCONTINENCE CNS1;42 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1242 PAIN (OTHER THAN HEADACHE) CNS1;43 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1243 WEIGHT CHANGE CNS1;44 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1244 OTHER SYMPTOMS CNS1;45 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown, not stated;
LAST EDITED: JAN 18, 2000
DESCRIPTION: This field describes one of the symptoms specific to the brain tumor as reported by the patient or
recorded in the medical chart.
165.5,1245 ALERTNESS CNS1;46 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 19, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1246 SPEECH CNS1;47 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 19, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1247 PERSONALITY CNS1;48 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 19, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1248 MEMORY OR JUDGEMENT CNS1;49 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 19, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1249 VISUAL ACUITY CNS1;50 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 19, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1250 VISUAL FIELDS CNS1;51 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 19, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1251 EYE MOVEMENTS (EOM) CNS1;52 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 19, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1252 FACIAL SENSATION CNS1;53 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 24, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1253 FACIAL MOVEMENT CNS1;54 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 24, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1254 HEARING CNS1;55 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 24, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1255 GAG REFLEX CNS1;56 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 24, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1256 STERNOCLEIDOMASTOID/SHLD STR CNS1;57 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 25, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1257 ARTICULATION OR ENUNCIATION CNS1;58 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 25, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1258 PAPILLEDEMA CNS1;59 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 25, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1259 TONGUE FASCICULATIONS/ATROPHY CNS1;60 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 25, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1260 DECREASE IN SENSATION/ANY SITE CNS1;61 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 25, 2000
DESCRIPTION:
Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1261 CORTICAL SENSORY DEFICIT CNS1;62 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1262 WEAKNESS/ATROPHY/FASCICULATION CNS1;63 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1263 ATAXIA OF GAIT CNS1;64 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1264 TRUNCAL ATAXIA CNS1;65 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1265 DYSMETRIA CNS1;66 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1266 RAPID ALTERNATING MOVEMENTS CNS1;67 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1267 FINGER TO FINGER NOSE TESTING CNS1;68 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1268 HEEL TO KNEE TO SHIN TESTING CNS1;69 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1269 DEEP TENDON REFLEXES/UPPER EXT CNS1;70 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1270 DEEP TENDON REFLEXES/LOWER EXT CNS1;71 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1271 BABINSKI SIGN CNS1;72 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1272 HOFFMAN REFLEX CNS1;73 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1273 OTHER ABNORMAL REFLEXES CNS1;74 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, examination not done;
'9' FOR Unknown;
LAST EDITED: JAN 26, 2000
DESCRIPTION: Record all findings from the neurological examination that evaluated the status of the tumor.
165.5,1274 ANGIOGRAPHY CNS1;75 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JUN 07, 2000
DESCRIPTION: This field describes the results of a neurodiagnostic study performed to evaluate the patient's
tumor.
165.5,1275 COMPUTED TOMOGRAPHY (CT) SCAN CNS1;76 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JAN 26, 2000
DESCRIPTION: This field describes the results of a neurodiagnostic study performed to evaluate the
patient's tumor.
165.5,1276 CT SCAN OF SPINE CNS1;77 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JAN 26, 2000
DESCRIPTION: This field describes the results of a neurodiagnostic study performed to evaluate the
patient's tumor.
165.5,1277 ELECTROENCEPHALOGRAPHY (EEG) CNS1;78 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JAN 26, 2000
DESCRIPTION: This field describes the results of a neurodiagnostic study performed to evaluate the
patient's tumor.
165.5,1278 ISOTOPE BRAIN SCAN CNS1;79 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JAN 26, 2000
DESCRIPTION: This field describes the results of a neurodiagnostic study performed to evaluate the
patient's tumor.
165.5,1279 POSITRON EMISSION TOMOGRAPHY CNS1;80 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JAN 26, 2000
DESCRIPTION: This field describes the results of a neurodiagnostic study performed to evaluate the
patient's tumor.
165.5,1280 SPECT SCAN CNS1;81 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JAN 26, 2000
DESCRIPTION: This field describes the results of a neurodiagnostic study performed to evaluate the
patient's tumor.
165.5,1281 MRI OF BRAIN CNS1;82 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JAN 26, 2000
DESCRIPTION: This field describes the results of a neurodiagnostic study performed to evaluate the
patient's tumor.
165.5,1282 MRI OF SPINE CNS1;83 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JAN 26, 2000
DESCRIPTION: This field describes the results of a neurodiagnostic study performed to evaluate the
patient's tumor.
165.5,1283 FUNCTIONAL MRI CNS1;84 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JAN 26, 2000
DESCRIPTION: This field describes the results of a neurodiagnostic study performed to evaluate the
patient's tumor.
165.5,1284 MYELOGRAPHY CNS1;85 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JAN 26, 2000
DESCRIPTION: This field describes the results of a neurodiagnostic study performed to evaluate the
patient's tumor.
165.5,1285 MAGNETIC RES SPECTROSCOPY CNS1;86 SET
'0' FOR Results -, no evidence of brain tumor;
'1' FOR Results +, some indication of disease;
'2' FOR Results unknown, equivocal/inconclusive;
'8' FOR NA, test not done;
'9' FOR Unknown if test done;
LAST EDITED: JAN 26, 2000
DESCRIPTION:
This field describes the results of a neurodiagnostic study performed to evaluate the patient's
tumor.
165.5,1286 FRONTAL LOBE CNS2;1 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1287 TEMPORAL LOBE CNS2;2 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1288 PARIETAL LOBE CNS2;3 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1289 OCCIPITAL LOBE CNS2;4 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1290 OPTIC NERVES CNS2;5 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1291 PITUITARY GLAND CNS2;6 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1292 PINEAL GLAND CNS2;7 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1293 CEREBELLUM CNS2;8 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1294 BRAIN STEM CNS2;9 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1295 SKULL BASE CNS2;10 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1296 OTHER SKULL CNS2;11 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1297 SPINAL CORD CNS2;12 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1298 CEREBRAL SPINAL FLUID (CSF) CNS2;13 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1299 CRANIAL MENINGES CNS2;14 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1300 SPINAL MENINGES CNS2;15 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1301 OTHER TUMOR LOC/INVOLVEMENT CNS2;16 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes a location involved by the tumor. If more than one location is involved,
record all locations involved by the tumor.
165.5,1302 LEFT CNS2;17 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes which side of the brain the tumor is located. Some tumors typically involve
midline structures, such as pineal and pituitary gland tumors, and extend to the left or right.
For these tumors code midline yes and indicate the side of the brain into which the tumor extends.
Bilateral tumors should be coded as left and right.
165.5,1303 RIGHT CNS2;18 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes which side of the brain the tumor is located. Some tumors typically involve
midline structures, such as pineal and pituitary gland tumors, and extend to the left or right.
For these tumors code midline yes and indicate the side of the brain into which the tumor extends.
Bilateral tumors should be coded as left and right.
165.5,1304 MIDLINE CNS2;19 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes which side of the brain the tumor is located. Some tumors typically involve
midline structures, such as pineal and pituitary gland tumors, and extend to the left or right.
For these tumors code midline yes and indicate the side of the brain into which the tumor extends.
Bilateral tumors should be coded as left and right.
165.5,1305 NUMBER OF TUMORS CNS2;20 SET
'1' FOR One tumor only;
'2' FOR Multiple tumors;
'9' FOR Unknown;
LAST EDITED: JAN 27, 2000
DESCRIPTION: This field describes whether the tumor is singular or multiple.
165.5,1306 DATE OF FIRST SYMPTOMS CNS2;21 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(
0) W:'$D(X) !,"Future dates are not allowed"
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: FEB 01, 2000
DESCRIPTION: This field describes the date of the first onset of symptoms. This information can typically be
found in the patient's history & physical. If the date can not be determined or is unknown, code
99999999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1307 DATE OF PATHOLOGIC DIAGNOSIS CNS2;22 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(
0) W:'$D(X) !,"Future dates are not allowed"
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: FEB 01, 2000
DESCRIPTION: This field describes the month, day, and year that this cancer was first pathologically diagnosed.
If no pathologic diagnosis was determined, code 00000000; if the date of pathologic diagnosis is
unknown or cannot be determined, code 99999999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1308 WHO HISTOLOGICAL CL CNS2;23 POINTER TO WHO HISTOLOGICAL CLASSIFICATION FILE (#164.9)
LAST EDITED: MAR 06, 2000
DESCRIPTION: This field describes the WHO histological classfication of the tumor. Report the appropriate WHO
code that corresponds to the written description of the tumor appearing on the pathology report.
165.5,1309 MOLECULAR MARKERS CNS2;24 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, no pathologic diagnosis;
'9' FOR Unknown if molecular markers used;
LAST EDITED: MAR 06, 2000
DESCRIPTION: This field describes whether molecular markers were used in the pathologic evaluation of the
tumor. The most commonly used markers are GFAP, DNA analysis, and KI-67 (MIB antibody). If a
pathologic diagnosis was not made, code 8.
165.5,1310 TUMOR SIZE (SOURCE) CNS2;25 SET
'0' FOR Size not recorded;
'1' FOR CT scan w or w/o contrast;
'2' FOR MRI w/o contrast;
'3' FOR MRI w contrast;
'4' FOR PET scan;
'5' FOR SPECT scan;
'6' FOR Operative report;
'7' FOR Other;
'9' FOR Size recorded, source unknown;
LAST EDITED: MAR 06, 2000
DESCRIPTION: This field describes the source of the data from which the reported size of tumor was documented.
DO NOT use the pathology report to determine tumor size.
165.5,1311 KARNOFSKY'S RATING PRIOR TO TX CNS2;26 POINTER TO KARNOFSKY'S RATING FILE (#164.17)
INPUT TRANSFORM: S DIC("S")="I $P(^(0),U,1)'=888" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
LAST EDITED: JUL 19, 2000
DESCRIPTION: This field describes the physical status of the patient prior to the beginning of intial treatment
using Karnofsky's Rating. This is prior to any definitive therapy. If the rating is not recorded,
assign a rating based upon the best available information.
SCREEN: S DIC("S")="I $P(^(0),U,1)'=888"
EXPLANATION: Enter the appropriate Karnofsky's Rating.
165.5,1312 PROTOCOL PARTICIPATION (CNS) CNS2;27 SET
'00' FOR Not on;
'01' FOR RTOG;
'02' FOR SWOG;
'03' FOR ECOG;
'04' FOR POG;
'05' FOR CCG;
'06' FOR NCI;
'07' FOR NABTT;
'08' FOR NABTC;
'09' FOR National protcol, NOS;
'10' FOR Other institutional protocols;
LAST EDITED: MAR 10, 2000
DESCRIPTION: This field describes whether the patient was enrolled in and treated on a protocol. A physician
may treat a patient following the guidelines of an established protocol but not enroll the patient.
For these cases, code 00.
165.5,1313 PROTOCOL PHASE CNS2;28 SET
'0' FOR Not on;
'1' FOR Phase I;
'2' FOR Phase I/II;
'3' FOR Phase II;
'4' FOR Phase III;
'9' FOR On protocol, phase unknown;
LAST EDITED: MAR 10, 2000
DESCRIPTION: This field describes the phase of the protocol in which the patient is enrolled. If the patient
is not enrolled into a protocol, code 0.
165.5,1314 NONE, NO NON-CA DIR SURGERY CNS2;29 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 17, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1315 VENTRICULOSTOMY/EXT VENT DRAIN CNS2;30 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 17, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1316 CSF SHUNT/VENTRICULOPERITONEAL CNS2;31 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 20, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1317 CSF SHUNT/3RD VENTRICULOSTOMY CNS2;32 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 20, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1318 CSF SHUNT/OTHER CNS2;33 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 20, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1319 STEREOTACTIC BIOPSY CNS2;34 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 20, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1320 OPEN BRAIN BIOPSY CNS2;35 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 20, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1321 OPEN BX OF SPINCAL CORD TUMOR CNS2;36 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 20, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1322 LAMINECTOMY W/O RESECT/DURA CNS2;37 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 20, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1323 LAMINECTOMY W/O RESECT W DURA CNS2;38 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 20, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1324 SURGERY, NOS CNS2;39 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 20, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1325 UNKNOWN IF SURGERY DONE CNS2;40 SET
'0' FOR No;
'1' FOR Yes;
'9' FOR Unknown;
LAST EDITED: MAR 20, 2000
DESCRIPTION: This field describes one of the surgical procedures performed to diagnose/ stage disease
(exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
165.5,1326 SURGICAL APPROACH (CNS) CNS2;41 SET
'0' FOR None, no ca-directed surgery;
'1' FOR Craniotomy/craniectomy, w/o stereotactic/image guidance;
'2' FOR Craniotomy/craniectomy, w sterotactic/image guidance;
'3' FOR Endoscopy;
'4' FOR Laminectomy;
'5' FOR Other;
'9' FOR Surgical approach unknown;
LAST EDITED: MAR 23, 2000
DESCRIPTION: This field describes the method used to approach the organ of origin and/or primary tumor. Code
the approach for cancer-directed surgery of the primary site only. Stereotactic image guidance,
with regard to SURGICAL APPROACH, is not the same as stereotactic radiosurgery, a method of
radiation therapy. Stereotactic radiosurgery is addressed in question 57. BCNU wafer implants are
surgically placed following resection of tumor. Report whether a wafer implantation occurred in
questions 63 & 64.
165.5,1327 EXTENT OF SURGICAL RESECTION CNS2;42 SET
'0' FOR None, no surgery performed;
'1' FOR Subtotal resection;
'2' FOR Total or gross resection;
'3' FOR Lobectomy;
'4' FOR Surgery, NOS;
'9' FOR Unknown if surgery performed;
LAST EDITED: MAR 23, 2000
DESCRIPTION: This field describes only surgeries of the primary site. Record the most definitive surgery
performed to the primary site. Biospy procedures are addressed in question 42. Codes 0, 1, 2, 4
and 9 may apply to brain and spinal cord tumors. Code 3 applies to brain tumors only.
165.5,1328 SIZE OF RESIDUAL TUMOR CNS2;43 NUMBER
INPUT TRANSFORM: D SRPTIT^ONCOOT
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y) D SRPTOT^ONCOOT
LAST EDITED: MAR 24, 2000
HELP-PROMPT: Record the size of the remaining primary tumor AFTER the most definitive therapy.
DESCRIPTION: This field describes the size of remaining primary tumor AFTER the most definitive therapy.
Record the largest dimension or diameter of the residual primary tumor in millimeters (1 cm = 10
mm). If the residual tumor has multiple measurements, code the largest size. For example, a
residual tumor measuring 3 x 4.4 x 2.5 cm is coded as 044. Use information from postoperative or
follow-up imaging studies (MRI, CT, PET, SPECT) to determine tumor size. Do not guess at the size
of tumor.
000-No residual tumor
995-Size not specified, tumor judged smaller
996-Size not specified, tumor judged unchanged
997-Size not specified, tumor judged larger
998-NA, surgical treatment not administered
999-Unknown, tumor not evaluated
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1329 SIZE OF RES TUMOR (SOURCE) CNS2;44 SET
'0' FOR Size not recorded;
'1' FOR CT scan w or w/o contrast;
'2' FOR MRI w/o contrast;
'3' FOR MRI w contrast;
'4' FOR PET scan;
'5' FOR SPECT scan;
'6' FOR Operative report;
'7' FOR Other;
'9' FOR Size recorded, source unknown;
LAST EDITED: MAR 24, 2000
DESCRIPTION: This field describes the source of the data from which the reported size of the residual tumor was
documented.
165.5,1330 ANESTHETIC PROBLEM CNS2;45 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, surgery not performed;
'9' FOR Unknown;
LAST EDITED: MAR 27, 2000
DESCRIPTION: This field describes a complication or event that occurred after surgery of the primary site and
before the date of patient discharge from the hospital.
165.5,1331 HEMORRHAGE AT OPERATIVE SITE CNS2;46 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, surgery not performed;
'9' FOR Unknown;
LAST EDITED: MAR 27, 2000
DESCRIPTION: This field describes a complication or event that occurred after surgery of the primary site and
before the date of patient discharge from the hospital.
165.5,1332 SEIZURE CNS2;47 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, surgery not performed;
'9' FOR Unknown;
LAST EDITED: MAR 27, 2000
DESCRIPTION: This field describes a complication or event that occurred after surgery of the primary site and
before the date of patient discharge from the hospital.
165.5,1333 INFECTION(S) CNS2;48 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, surgery not performed;
'9' FOR Unknown;
LAST EDITED: MAR 27, 2000
DESCRIPTION: This field describes a complication or event that occurred after surgery of the primary site and
before the date of patient discharge from the hospital.
165.5,1334 DVT (DEEP VENOUS THROMBOSIS) CNS2;49 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, surgery not performed;
'9' FOR Unknown;
LAST EDITED: MAR 27, 2000
DESCRIPTION: This field describes a complication or event that occurred after surgery of the primary site and
before the date of patient discharge from the hospital.
165.5,1335 PERSISTENT NEUROL WORSENING CNS2;50 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, surgery not performed;
'9' FOR Unknown;
LAST EDITED: MAR 27, 2000
DESCRIPTION: This field describes a complication or event that occurred after surgery of the primary site and
before the date of patient discharge from the hospital.
165.5,1336 TOTAL RADIATION DOSE (cGy) CNS2;51 SET
'0' FOR No radiation administered;
'1' FOR Less than 3000 cGy;
'2' FOR 3000-3999 cGy;
'3' FOR 4000-4999 cGy;
'4' FOR 5000-5999 cGy;
'5' FOR 6000-6999 cGy;
'6' FOR 7000-7999 cGy;
'7' FOR 8000-8999 cGy;
'8' FOR 10000 or more cGy;
'9' FOR Dose unknown;
LAST EDITED: MAR 31, 2000
DESCRIPTION: This field describes the total dose delivered to the primary volume of interest, include any boost
doses.
165.5,1337 TYPE OF EXT BEAM RADIATION CNS2;52 SET
'0' FOR No radiation therapy;
'1' FOR Cobalt;
'2' FOR >=2 and <4 MV X-rays;
'3' FOR >=4 and <6 MV X-rays;
'4' FOR >=6 and <10 MV X-rays;
'5' FOR >=10 MV X-rays;
'6' FOR Protons;
'7' FOR Neutrons;
'9' FOR Unknown;
LAST EDITED: MAR 31, 2000
DESCRIPTION: This field describes the type of external beam radiation therapy delivered to the primary volume
of interest.
165.5,1338 INTERSTITIAL RAD/BRACHYTHERAPY CNS2;53 SET
'0' FOR None, brachytherapy not given;
'1' FOR Iodine-125;
'2' FOR Iridium-192;
'3' FOR Other;
'9' FOR Unknown;
LAST EDITED: MAR 31, 2000
DESCRIPTION: This field describes any radioactive implant used to treat the patient.
165.5,1339 STEREOTACTIC RADIOSURGERY CNS2;54 SET
'0' FOR None, not administered;
'1' FOR Gamma knife;
'2' FOR Linear accelerator (linac);
'3' FOR Other;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes the type of delivery of the external radiation dose. Stereotactic
radiosurgery is a method by which the focus and target of the radiation beam is precisely directed,
and is different from external beam radiation which is a less controlled means of radiation therapy
delivery.
165.5,1340 SKIN REACTIONS CNS2;55 SET
'0' FOR No, not present;
'1' FOR Present, no tx delay, not req medication;
'2' FOR Present, no tx delay, req medication;
'3' FOR Present, tx delay or cessation;
'8' FOR NA, radiation tx not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes a complication that resulted during or subsequent to radiation therapy.
165.5,1341 ANOREXIA CNS2;56 SET
'0' FOR No, not present;
'1' FOR Present, no tx delay, not req medication;
'2' FOR Present, no tx delay, req medication;
'3' FOR Present, tx delay or cessation;
'8' FOR NA, radiation tx not administered;
'9' FOR Unknown;
LAST EDITED: APR 18, 2000
DESCRIPTION: This field describes a complication that resulted during or subsequent to radiation therapy.
165.5,1342 NAUSEA OR VOMITING CNS2;57 SET
'0' FOR No, not present;
'1' FOR Present, no tx delay, not req medication;
'2' FOR Present, no tx delay, req medication;
'3' FOR Present, tx delay or cessation;
'8' FOR NA, radiation tx not administered;
'9' FOR Unknown;
LAST EDITED: APR 18, 2000
DESCRIPTION: This field describes a complication that resulted during or subsequent to radiation therapy.
165.5,1343 FATIGUE CNS2;58 SET
'0' FOR No, not present;
'1' FOR Present, no tx delay, not req medication;
'2' FOR Present, no tx delay, req medication;
'3' FOR Present, tx delay or cessation;
'8' FOR NA, radiation tx not administered;
'9' FOR Unknown;
LAST EDITED: APR 18, 2000
DESCRIPTION: This field describes a complication that resulted during or subsequent to radiation therapy.
165.5,1344 NEUROLOGIC WORSENING CNS2;59 SET
'0' FOR No, not present;
'1' FOR Present, no tx delay, not req medication;
'2' FOR Present, no tx delay, req medication;
'3' FOR Present, tx delay or cessation;
'8' FOR NA, radiation tx not administered;
'9' FOR Unknown;
LAST EDITED: APR 18, 2000
DESCRIPTION: This field describes a complication that resulted during or subsequent to radiation therapy.
165.5,1345 RADIATION THERAPY CNS2;60 SET
'0' FOR None;
'1' FOR Ext beam;
'2' FOR RA implants (brachytherapy);
'3' FOR Radioisotopes;
'4' FOR Stereotactic radiosurgery;
'5' FOR Ext beam/RA implants or radioisotopes;
'6' FOR Ext beam/stereotactic radiosurgery;
'7' FOR Radiation, NOS;
'9' FOR Unk, death cert cases only;
LAST EDITED: APR 18, 2000
DESCRIPTION: This field describes the type of radiation administered to the primary site. Include all
procedures that are part of the first course of treatment, whether delivered at the reporting
institution or at other institutions.
165.5,1346 PROCARBAZINE CNS2;61 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1347 CCNU CNS2;62 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1348 VINCRISTINE CNS2;63 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1349 HYDROXYUREA CNS2;64 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1350 BCNU CNS2;65 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1351 BCNU WAFER IMPLANT CNS2;66 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1352 VP-16 CNS2;67 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1353 CARBOPLATIN CNS2;68 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1354 TEMOZOLOMIDE CNS2;69 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1355 CPT-11 CNS2;70 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1356 TAMOXIFEN CNS2;71 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1357 CYTARABINE (ARA-C) CNS2;72 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one type of chemotherapeutic agent administered to the patient.
165.5,1358 CHEMOTHERAPEUTIC ROUTE CNS2;73 SET
'1' FOR Intrathecal;
'2' FOR Intra-arterial;
'3' FOR Intravenous;
'4' FOR Orally;
'5' FOR Intramuscular;
'6' FOR BCNU wafer implant;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes the route or method used to administer the chemotherapy.
165.5,1359 HEARING LOSS CNS2;74 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one of the complications which resulted from the administration of
chemotherapy.
165.5,1360 INFECTION CNS2;75 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one of the complications which resulted from the administration of
chemotherapy.
165.5,1361 NAUSEA AND VOMITING CNS2;76 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one of the complications which resulted from the administration of
chemotherapy.
165.5,1362 BLOOD COUNT DROP/BLEEDING CNS2;77 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one of the complications which resulted from the administration of
chemotherapy.
165.5,1363 PERIPHERAL NEUROPATHY CNS2;78 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one of the complications which resulted from the administration of
chemotherapy.
165.5,1364 RENAL FAILURE CNS2;79 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one of the complications which resulted from the administration of
chemotherapy.
165.5,1365 PULMONARY TOXICITY CNS2;80 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one of the complications which resulted from the administration of
chemotherapy.
165.5,1366 OTHER CHEMO COMPLICATIONS CNS2;81 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 20, 2000
DESCRIPTION: This field describes one of the complications which resulted from the administration of
chemotherapy.
165.5,1367 KARNOFSKY'S RATING @ DIS/TRANS CNS2;82 POINTER TO KARNOFSKY'S RATING FILE (#164.17)
INPUT TRANSFORM: S DIC("S")="I $P(^(0),U,1)'=888" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
LAST EDITED: JUL 19, 2000
DESCRIPTION: This field describes the physical status of the patient at the time of discharge or transfer from
the treating facility following definitive therapy. In some cases, the patient may be discharged
from the treating facility and transferred to another care facility; use codes 030 and 020 to
describe these cases. If rating is not recorded, assign a rating based upon the best available
information.
SCREEN: S DIC("S")="I $P(^(0),U,1)'=888"
EXPLANATION: Enter the appropriate Karnofsky's Rating.
165.5,1368 DATE OF PROGRESSION CNS2;83 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(
0) W:'$D(X) !,"Future dates are not allowed"
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: APR 21, 2000
DESCRIPTION: This field describes the date the medical practitioner determines that the tumor has progressed
and that the first course of therapy has failed, necessitating consideration of a subsequent course
of treatment. Patients with tumor progression were never disease free following the first course
of treatment. Record the month, day and year of the determined progression, based on the best
available information. If the patient was disease free following the first course of treatment,
code 00000000; if no progression was noted or first course of therapy was not administered, code
88888888; if the date of tumor progression is unknown, code 99999999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1369 TYPE OF PROGRESSION CNS2;84 SET
'0' FOR None, disease-free;
'1' FOR Local;
'2' FOR Regional, same hemisphere;
'3' FOR Regional, opposite hemisphere;
'4' FOR Distant, spine/spinal cord;
'5' FOR Distant, abdomen;
'6' FOR Distant, other;
'8' FOR NA, no progression, or no 1st course;
'9' FOR Unknown if progressed;
LAST EDITED: APR 24, 2000
DESCRIPTION: This field describes the progression of the cancer after the completion of the first course of
therapy.
165.5,1370 RECURRENCE/PROGRESSION DOC CNS2;85 SET
'0' FOR No recurrence/progression;
'1' FOR Neurological or Karnofsky's deterioration;
'2' FOR CT scan;
'3' FOR MRI scan;
'4' FOR Comb of 1 + 2, or 1 + 3;
'5' FOR Other;
'9' FOR Unknown;
LAST EDITED: APR 24, 2000
165.5,1371 KARNOFSKY'S RATING RECURRENCE CNS2;86 POINTER TO KARNOFSKY'S RATING FILE (#164.17)
LAST EDITED: APR 24, 2000
DESCRIPTION: This field describes the patient's physical status at the time that either recurrence or
progression was noted.
165.5,1372 TYPE OF 1ST RECURRENCE/CNS CNS2;87 SET
'0' FOR None, disease free;
'1' FOR Local;
'2' FOR Regional, same hemisphere;
'3' FOR Regional, opposite hemisphere;
'4' FOR Distant, spine/spincal cord;
'5' FOR Distant, abdomen;
'6' FOR Distant, other;
'8' FOR NA, never disease free;
'9' FOR Unknown if recurred;
LAST EDITED: APR 24, 2000
DESCRIPTION: This field describes the return or reappearance of the cancer after a disease free intermission or
remission. Record the type of the first recurrence. If the patient has been disease-free since
treatment, code 0.
165.5,1373 PROTOCOL PARTICIPATION (SUBTX) CNS2;88 SET
'00' FOR Not on;
'01' FOR RTOG;
'02' FOR SWOG;
'03' FOR ECOG;
'04' FOR POG;
'05' FOR CCG;
'06' FOR NCI;
'07' FOR NABTT;
'08' FOR NABTC;
'09' FOR National protcol, NOS;
'10' FOR Other institutional protocols;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes whether the patient was enrolled in and treated on a protocol as part of
their treatment for progression or recurrence of disease. A physician may treat a patient
following the guidelines of an established protocol but not enroll the patient. For these cases,
code 00.
165.5,1374 TYPE OF SUBSEQUENT SURGICAL TX CNS2;89 SET
'0' FOR None, no subsequent surgery;
'1' FOR Subtotal resection;
'2' FOR Total or gross resection;
'3' FOR Lobectomy;
'4' FOR Surgery, NOS;
'9' FOR Unknown if subsequent surgery performed;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes subsequent surgical treatment administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1375 TYPE OF SUBSEQUENT RADIATION CNS2;90 SET
'0' FOR None;
'1' FOR Beam radiation;
'2' FOR RA implants;
'3' FOR Radioisotopes;
'4' FOR Stereotactic radiosurgery;
'5' FOR Beam rad/RA implants or radioisotopes;
'6' FOR Beam rad/stereotactic radiosurgery;
'7' FOR Radiation, NOS;
'9' FOR Unknown if administered;
LAST EDITED: NOV 24, 2004
DESCRIPTION: This field describes subsequent radiation treatment administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1376 PROCARBAZINE (SUB TX) CNS3;1 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1377 CCNU (SUB TX) CNS3;2 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1378 VINCRISTINE (SUB TX) CNS3;3 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1379 HYDROXYUREA (SUB TX) CNS3;4 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1380 METHOTREXATE (SUB TX) CNS3;5 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1381 CISPLATIN (SUB TX) CNS3;6 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1382 BCNU (SUB TX) CNS3;7 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1383 BCNU WAFER IMPLANT (SUB TX) CNS3;8 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1384 VP-16 (SUB TX) CNS3;9 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1385 CARBOPLATIN (SUB TX) CNS3;10 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1386 TEMOZOLOMIDE (SUB TX) CNS3;11 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1387 CYCLOPHOSPHAMIDE (SUB TX) CNS3;12 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1388 CPT-11 (SUB TX) CNS3;13 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1389 TAMOXIFEN (SUB TX) CNS3;14 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1390 INTERFERON (SUB TX) CNS3;15 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1391 CYTARABINE (ARA-C) (SUB TX) CNS3;16 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1392 OTHER CHEMOTHERAPY (SUB TX) CNS3;17 SET
'0' FOR No;
'1' FOR Yes;
'8' FOR NA, chemotherapy not administered;
'9' FOR Unknown;
LAST EDITED: APR 27, 2000
DESCRIPTION: This field describes one type of subsequent chemotherapy administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1393 OTHER SUBSEQUENT TREATMENT CNS3;18 SET
'0' FOR No other tx;
'1' FOR Ca-directed tx, NOS;
'2' FOR Monoclonal antibodies;
'3' FOR Other experimental ca-dir tx;
'4' FOR Double-blind clin trial;
'6' FOR Unproven tx;
'7' FOR Patient refused tx;
'8' FOR Other tx rec, unk if admin;
'9' FOR Unk if administered;
LAST EDITED: APR 28, 2000
DESCRIPTION: This field describes other types of subsequent treatment administered to the patient. Subsequent
therapy begins after the first course of therapy is complete, stopped, or changed.
165.5,1394 TUMOR SIZE CNS3;19 NUMBER
INPUT TRANSFORM: D TSIT^ONCOOT
OUTPUT TRANSFORM: S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y) D TSOT^ONCOOT
LAST EDITED: JAN 10, 2001
HELP-PROMPT: Record the tumor size from the most significant imaging test.
DESCRIPTION: This field describes the largest dimension or diameter of the primary tumor in millimeters (1 cm =
10 mm). If the tumor has multiple measurements, code the largest size. For example, a tumor
measuring 3 x 4.4 x 2.5 cm is coded as 044. If there are multiple tumors, code the size of the
largest tumor. For example, if the first tumor measures 2 x .5 cm and the second measures 1 x .5
cm, code 020. See ROADS for instructions on converting centimeters to millimeters. Use
information from preoperative imaging (MRI, CT, PET, SPECT) to determine TUMOR SIZE. DO NOT use
the pathology report to determine TUMOR SIZE. DO NOT guess at the TUMOR SIZE. Code 999 if TUMOR
SIZE cannot be determined.
Codes: 001 thru 997 - tumor size (mm)
999 - Unknown, cannot be determined, not recorded
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1400 LNG CO-MORBID CONDITION 1 LUN1;1 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 000.00
001.00 thru 994.90 (valid ICD-CM codes)
If no co-morbid conditions were documented, answer "No" to the CO-MORBID CONDITIONS (YES/NO)
prompt.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1400.1 LNG CO-MORBID CONDITION 2 LUN1;2 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)
If there was only one co-morbid condition, leave this field blank.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
165.5,1400.2 LNG CO-MORBID CONDITION 3 LUN1;3 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)
If there was only one co-morbid condition, leave this field blank.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
165.5,1400.3 LNG CO-MORBID CONDITION 4 LUN1;4 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)
If there was only one co-morbid condition, leave this field blank.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
165.5,1400.4 LNG CO-MORBID CONDITION 5 LUN1;5 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)
If there was only one co-morbid condition, leave this field blank.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
165.5,1400.5 LNG CO-MORBID CONDITION 6 LUN1;6 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)
If there was only one co-morbid condition, leave this field blank.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
165.5,1400.6 LNG CO-MORBID CONDITION Y/N LUN1;76 SET (Required)
'0' FOR No;
'1' FOR Yes;
LAST EDITED: MAY 01, 2001
DESCRIPTION: Are CO-MORBID CONDITIONS associated with this cancer (Yes/No)?
This item records if there were pre-existing medical conditions present at the time of diagnosis
for this cancer.
Answering "Yes" will prompt you for CO-MORBID CONDITIONS #1-6.
Answering "No" will code CO-MORBID CONDITION #1 with 000.00 and leave the remaining co-morbid
fields blank.
165.5,1401 LNG DURATION OF TOBACCO USE LUN1;7 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D DTU^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="00":"Never used tobacco",Y=99:"Not documented",Y="01":Y_" year",1:Y_" years")
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION: This item describes the number of known years the patient used some form of tobacco, even if the
patient is not presently using tobacco. If the patient has never used tobacco, code 00. If the
patient's tobacco use cannot be determined, or if the duration of use is not known, code 99.
Allowable Codes: 00 - never used tobacco
01 thru 98 - one or more years of tobacco use
99 - duration of tobacco use not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1402 LNG DATE OF FIRST TISSUE DX LUN1;8 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(
0) D:'$D(X) EN^DDIOL("Future dates are not allowed")
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: JUL 19, 2001
DESCRIPTION: This item describes the month, day, and year (MMDDCCYY) that this primary cancer was first
diagnosed using a tissue sample to arrive at a positive histologic or cytologic evaluation of the
tumor.
If a positive histologic or cytologic evaluation was made but the date is unknown code 99/99/9999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1403 LNG PERSONAL HIST OTH MALIG LUN1;9 POINTER TO ICDO TOPOGRAPHY FILE (#164)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the patient's prior history of other invasive malignancies. If the patient
has a history of other malignancies report the ICD-O-3 site code for the most recently diagnosed
disease. If the patient has no personal history of other cancer, code C88.8. If the patient's
personal history of other invasive malignancies is not documented, code C99.9.
Allowable Codes: C00.0 thru C80.9 - valid ICD-0-3 site (topography) codes
C88.8 - no personal history of other cancer
C99.9 - personal history of other cancer not documented
EXECUTABLE HELP: D ITEM3^ONCLPC1
165.5,1404 LNG COUGH LUN1;10 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented if present;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the presence of a cough specific to lung (NSCLC) cancer that was recorded in
the medical chart.
165.5,1404.1 LNG SHORTNESS OF BREATH LUN1;11 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented if present;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the presence of shortness of breath specific to lung (NSCLC) cancer that was
recorded in the medical chart.
165.5,1404.2 LNG WEIGHT LOSS LUN1;12 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented if present;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the presence of weight loss specific to lung (NSCLC) cancer that was recorded
in the medical chart.
165.5,1404.3 LNG HEMOPTYSIS LUN1;13 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented if present;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the presence of hemoptysis specific to lung (NSCLC) cancer that was recorded
in the medical chart.
165.5,1404.4 LNG PALPABLE LYMPH NODES LUN1;14 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented if present;
LAST EDITED: APR 30, 2002
DESCRIPTION: This item describes the presence of palpable lymph nodes specific to lung (NSCLC) cancer that was
recorded in the medical chart.
165.5,1405 LNG CHEST X-RAY LUN1;15 SET
'1' FOR Used;
'2' FOR Not used;
'9' FOR Not documented if used;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item identifies patients who are screened routinely or due to a high risk history of cardiac
and/or pulmonary disease. Record whether a chest x-ray method was used.
165.5,1405.1 LNG CT SCAN LUN1;16 SET
'1' FOR Used;
'2' FOR Not used;
'9' FOR Not documented if used;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item identifies patients who are screened routinely or due to a high risk history of cardiac
and/or pulmonary disease. Record whether a CT scan method was used.
165.5,1405.2 LNG BRONCHOSCOPY LUN1;17 SET
'1' FOR Used;
'2' FOR Not used;
'9' FOR Not documented if used;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item identifies patients who are screened routinely or due to a high risk history of cardiac
and/or pulmonary disease. Record whether a bronchoscopy method was used.
165.5,1406 LNG HISTORY AND PHYSICAL LUN1;18 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal results;
'8' FOR Not performed, not mentioned in record;
'9' FOR Done, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the methods and results of the history and physical performed to evaluate and
or diagnose the primary tumor before definitive therapy.
165.5,1406.1 LNG BRONCHOSCOPY PRE-THERAPY LUN1;19 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal results;
'8' FOR Not performed, not mentioned in record;
'9' FOR Done, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the methods and results of the bronchoscopy performed to evaluate and or
diagnose the primary tumor before definitive therapy.
165.5,1406.2 LNG FNAB LUN1;20 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal results;
'8' FOR Not performed, not mentioned in record;
'9' FOR Done, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the methods and results of the FNAB (fine needle aspiration biopsy) performed
to evaluate and or diagnose the primary tumor before definitive therapy.
165.5,1406.3 LNG MEDIASTINOSCOPY LUN1;21 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal results;
'8' FOR Not performed, not mentioned in record;
'9' FOR Done, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the methods and results of the mediastinoscopy performed to evaluate and or
diagnose the primary tumor before definitive therapy.
165.5,1406.4 LNG THOROCOTOMY/OPEN BIOPSY LUN1;22 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal results;
'8' FOR Not performed, not mentioned in record;
'9' FOR Done, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the methods and results of the thorocotomy/open biopsy (open technique)
performed to evaluate and or diagnose the primary tumor before definitive therapy.
165.5,1406.5 LNG VATS LUN1;23 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal results;
'8' FOR Not performed, not mentioned in record;
'9' FOR Done, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the methods and results of the VATS (visual assisted thorocotomy surgery)
performed to evaluate and or diagnose the primary tumor before definitive therapy.
165.5,1407 LNG FVC LUN1;24 NUMBER
INPUT TRANSFORM: K:X>9.99!(X<0)!(X?.E1"."3N.N) X I $D(X) S ONCL=1,ONCF=2 D PFT^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="0.00":"Not done",Y=9.98:"Done, results not documented",Y=9.99:"Not documented if performe
d",1:Y_" liter(s)")
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 0.00 and 9.99, 2 Decimal Digits
DESCRIPTION: This item describes the results of the FVC (forced vital capacity) pulmonary function test (PFT).
Record the absolute value of the result in liters (L). Record results to the precision of 2
decimal points and record zeros in unused positions; for example 2.54L would be coded as 2.54; 1.2L
would be coded as 1.20; 0.5L would be coded as 0.50. If a test was administered but the result is
not documented, code 9.98; if it's not documented whether the test was administered, code 9.99.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1407.1 LNG FEV LUN1;25 NUMBER
INPUT TRANSFORM: K:X>9.99!(X<0)!(X?.E1"."3N.N) X I $D(X) S ONCL=1,ONCF=2 D PFT^ONCOIT
OUTPUT TRANSFORM: S Y=$S(+Y=0:"Not done",Y=9.98:"Done, results not documented",Y=9.99:"Not documented if performed",1
:Y_" liter(s)")
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 0.00 and 9.99, 2 Decimal Digits
DESCRIPTION: This item describes the results of the FEV (forced expiratory volume) pulmonary function test
(PFT). Record the absolute value of the result in liters (L). Record results to the precision of
2 decimal points and record zeros in unused positions; for example 2.54L would be coded as 2.54;
1.2L would be coded as 1.20; 0.5L would be coded as 0.50. If a test was administered but the
result is not documented, code 9.98; if it's not documented whether the test was administered, code
9.99.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1408 LNG LIVER FUNCTION TESTS LUN1;26 SET
'1' FOR Abnormal results, for at least one test;
'2' FOR Normal results on all tests;
'8' FOR Test(s) not performed, not mentioned;
'9' FOR Test(s) done, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the results of any test performed to evaluate the patient's liver function.
Liver function tests typically include protime, bilirubin, albumin and LDH. If ANY of these tests
were performed and were documented with abnormal results, code 1. If ALL liver function tests had
normal results, code 2.
165.5,1409 LNG BONE SCAN LUN1;27 SET
'1' FOR Performed;
'2' FOR Not performed;
'9' FOR Requested, not documented if performed;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records whether or not a bone scan was performed.
165.5,1409.1 LNG EMPHYSEMA (BONE SCAN) LUN1;28 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of emphysema as detected in the bone scan.
165.5,1409.2 LNG VASCULAR INV (BONE SCAN) LUN1;29 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of vascular invasion as detected in the bone scan.
165.5,1409.3 LNG MEDIASTINAL LN (BONE SCAN) LUN1;30 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the
bone scan.
165.5,1409.4 LNG TUMOR SIZE (BONE SCAN) LUN1;31 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 000 and 999
DESCRIPTION:
Record the size in millimeters of the dominant (largest) tumor as detected by the bone scan.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1409.5 LNG NUM OF TUMORS (BONE SCAN) LUN1;32 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION:
Record the number of tumor nodules found (or identified) by the bone scan.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1409.6 LNG METASTASIS (BONE SCAN) LUN1;33 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of metastasis as detected in the bone scan.
165.5,1410 LNG CT SCAN OF CHEST LUN1;34 SET
'1' FOR Performed;
'2' FOR Not performed;
'9' FOR Requested, not documented if performed;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records whether or not a CT scan of the chest was performed.
165.5,1410.1 LNG EMPHYSEMA (CHEST CT) LUN1;35 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of emphysema as detected in the CT scan of the chest.
165.5,1410.2 LNG VASCULAR INV (CHEST CT) LUN1;36 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of vascular invasion as detected in the CT scan of the
chest.
165.5,1410.3 LNG MEDIASTINAL LN (CHEST CT) LUN1;37 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the
CT scan of the chest.
165.5,1410.4 LNG TUMOR SIZE (CHEST CT) LUN1;38 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 000 and 999
DESCRIPTION: Record the size in millimeters of the dominant (largest) tumor as detected by the CT scan of the
chest.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1410.5 LNG NUM OF TUMORS (CHEST CT) LUN1;39 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION:
Record the number of tumor nodules found (or identified) by the CT scan of the chest.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1410.6 LNG METASTASIS (CHEST CT) LUN1;40 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of metastasis as detected in the CT scan of the chest.
165.5,1411 LNG CT SCAN OF BRAIN LUN1;41 SET
'1' FOR Performed;
'2' FOR Not performed;
'9' FOR Requested, not documented if performed;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records whether or not a CT scan of the brain was performed.
165.5,1411.1 LNG EMPHYSEMA (BRAIN CT) LUN1;42 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of emphysema as detected in the CT scan of the brain.
165.5,1411.2 LNG VASCULAR INV (BRAIN CT) LUN1;43 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of vascular invasion as detected in the CT scan of the
brain.
165.5,1411.3 LNG MEDIASTINAL LN (BRAIN CT) LUN1;44 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the
CT scan of the brain.
165.5,1411.4 LNG TUMOR SIZE (BRAIN CT) LUN1;45 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 000 and 999
DESCRIPTION: Record the size in millimeters of the dominant (largest) tumor as detected by the CT scan of the
brain.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1411.5 LNG NUM OF TUMORS (BRAIN CT) LUN1;46 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION:
Record the number of tumor nodules found (or identified) by the CT scan of the brain.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1411.6 LNG METASTASIS (BRAIN CT) LUN1;47 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of metastasis as detected in the CT scan of the brain.
165.5,1412 LNG MRI SCAN OF CHEST LUN1;48 SET
'1' FOR Performed;
'2' FOR Not performed;
'9' FOR Requested, not documented if performed;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records whether or not a MRI scan of the chest was performed.
165.5,1412.1 LNG EMPHYSEMA (CHEST MRI) LUN1;49 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of emphysema as detected in the MRI of the chest.
165.5,1412.2 LNG VASCULAR INV (CHEST MRI) LUN1;50 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of vascular invasion as detected in the MRI scan of
chest.
165.5,1412.3 LNG MEDIASTINAL LN (CHEST MRI) LUN1;51 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the
MRI scan of the chest.
165.5,1412.4 LNG TUMOR SIZE (CHEST MRI) LUN1;52 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 000 and 999
DESCRIPTION: Record the size in millimeters of the dominant (largest) tumor as detected by the MRI scan of the
chest.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1412.5 LNG NUM OF TUMORS (CHEST MRI) LUN1;53 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION:
Record the number of tumor nodules found (or identified) by the MRI scan of the chest.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1412.6 LNG METASTASIS (CHEST MRI) LUN1;54 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of metastasis as detected in the MRI scan of the chest.
165.5,1413 LNG MRI SCAN OF BRAIN LUN1;55 SET
'1' FOR Performed;
'2' FOR Not performed;
'9' FOR Requested, not documented if performed;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records whether or not a MRI scan of the brain was performed.
165.5,1413.1 LNG EMPHYSEMA (BRAIN MRI) LUN1;56 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of emphysema as detected in the MRI of the brain.
165.5,1413.2 LNG VASCULAR INV (BRAIN MRI) LUN1;57 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of vascular invasion as detected in the MRI scan of the
brain.
165.5,1413.3 LNG MEDIASTINAL LN (BRAIN MRI) LUN1;58 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the
MRI scan of the brain.
165.5,1413.4 LNG TUMOR SIZE (BRAIN MRI) LUN1;59 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 000 and 999
DESCRIPTION: Record the size in millimeters of the dominant (largest) tumor as detected by the MRI scan of the
brain.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1413.5 LNG NUM OF TUMORS (BRAIN MRI) LUN1;60 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION:
Record the number of tumor nodules found (or identified) by the MRI scan of the brain.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1413.6 LNG METASTASIS (BRAIN MRI) LUN1;61 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of metastasis as detected in the MRI scan of the brain.
165.5,1414 LNG PET SCAN LUN1;62 SET
'1' FOR Performed;
'2' FOR Not performed;
'9' FOR Requested, not documented if performed;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records whether or not a PET (positron emission tomography) scan was performed.
165.5,1414.1 LNG EMPHYSEMA (PET SCAN) LUN1;63 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of emphysema as detected in the PET (positron emission
tomography) scan.
165.5,1414.2 LNG VASCULAR INV (PET SCAN) LUN1;64 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of vascular invasion as detected in the PET (positron
emission tomography) scan.
165.5,1414.3 LNG MEDIASTINAL LN (PET SCAN) LUN1;65 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the
PET (positron emission tomography) scan.
165.5,1414.4 LNG TUMOR SIZE (PET SCAN) LUN1;66 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 000 and 999
DESCRIPTION: Record the size in millimeters of the dominant (largest) tumor as detected by the PET (positron
emission tomography) scan.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1414.5 LNG NUM OF TUMORS (PET SCAN) LUN1;67 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION: Record the number of tumor nodules found (or identified) by the PET (positron emission tomography)
scan.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1414.6 LNG METASTASIS (PET SCAN) LUN1;68 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of metastasis as detected in the PET (positron emission
tomography) scan.
165.5,1415 LNG X-RAY OF CHEST LUN1;69 SET
'1' FOR Performed;
'2' FOR Not performed;
'9' FOR Requested, not documented if performed;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records whether or not a chest x-ray was performed.
165.5,1415.1 LNG EMPHYSEMA (CHEST XRAY) LUN1;70 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of emphysema as detected in the X-Ray of the chest.
165.5,1415.2 LNG VASCULAR INV (CHEST XRAY) LUN1;71 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of vascular invasion as detected in the X-ray of the
chest.
165.5,1415.3 LNG MEDIASTINAL (CHEST XRAY) LUN1;72 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the
X-ray of the chest.
165.5,1415.4 LNG TUMOR SIZE (CHEST XRAY) LUN1;73 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 000 and 999
DESCRIPTION: Record the size in millimeters of the dominant (largest) tumor as detected by the X-ray of the
chest.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1415.5 LNG NUM OF TUMORS (CHEST XRAY) LUN1;74 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
OUTPUT TRANSFORM: D RE^ONCOOT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION:
Record the number of tumor nodules found (or identified) by the X-ray of the chest.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1415.6 LNG METASTASIS (CHEST XRAY) LUN1;75 SET
'1' FOR Present;
'2' FOR Absent;
'8' FOR NA, test not performed;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item records the presence or absence of metastasis as detected in the X-ray of the chest.
165.5,1416 LNG HIGH MEDIASTINAL (PRE-OP) LUN2;1 SET
'1' FOR No nodes sampled;
'2' FOR Sampled, no evidence of positive nodes;
'3' FOR Sampled, evidence of positive nodes;
'4' FOR Node sampling not mentioned;
'5' FOR Sampled, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether the highest mediastinal (level 1) nodes were sampled prior to the
first course of therapy and if so, whether any positive nodes were found.
165.5,1416.1 LNG UPPER PARATRACH (PRE-OP) LUN2;2 SET
'1' FOR No nodes sampled;
'2' FOR Sampled, no evidence of positive nodes;
'3' FOR Sampled, evidence of positive nodes;
'4' FOR Node sampling not mentioned;
'5' FOR Sampled, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether the upper paratracheal (level 2) nodes were sampled prior to the first
course of therapy and if so, whether any positive nodes were found.
165.5,1416.2 LNG PREVASC/RETRO (PRE-OP) LUN2;3 SET
'1' FOR No nodes sampled;
'2' FOR Sampled, no evidence of positive nodes;
'3' FOR Sampled, evidence of positive nodes;
'4' FOR Node sampling not mentioned;
'5' FOR Sampled, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether the prevascular and retrotracheal (level 3) nodes were sampled prior
to the first course of therapy and if so, whether any positive nodes were found.
165.5,1416.3 LNG LOWER PARATRACH (PRE-OP) LUN2;4 SET
'1' FOR No nodes sampled;
'2' FOR Sampled, no evidence of positive nodes;
'3' FOR Sampled, evidence of positive nodes;
'4' FOR Node sampling not mentioned;
'5' FOR Sampled, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether the lower paratracheal (level 4) nodes were sampled prior to the first
course of therapy and if so, whether any positive nodes were found.
165.5,1416.4 LNG SUBAORTIC (PRE-OP) LUN2;5 SET
'1' FOR No nodes sampled;
'2' FOR Sampled, no evidence of positive nodes;
'3' FOR Sampled, evidence of positive nodes;
'4' FOR Node sampling not mentioned;
'5' FOR Sampled, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether the subaortic (level 5) nodes were sampled prior to the first course
of therapy and if so, whether any positive nodes were found.
165.5,1416.5 LNG PARAORTIC (PRE-OP) LUN2;6 SET
'1' FOR No nodes sampled;
'2' FOR Sampled, no evidence of positive nodes;
'3' FOR Sampled, evidence of positive nodes;
'4' FOR Node sampling not mentioned;
'5' FOR Sampled, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether the paraortic (level 6) nodes were sampled prior to the first course
of therapy and if so, whether any positive nodes were found.
165.5,1416.6 LNG SUBCARINAL (PRE-OP) LUN2;7 SET
'1' FOR No nodes sampled;
'2' FOR Sampled, no evidence of positive nodes;
'3' FOR Sampled, evidence of positive nodes;
'4' FOR Node sampling not mentioned;
'5' FOR Sampled, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether the subcarinal (level 7) nodes were sampled prior to the first course
of therapy and if so, whether any positive nodes were found.
165.5,1416.7 LNG PARAESOPHAGEAL (PRE-OP) LUN2;8 SET
'1' FOR No nodes sampled;
'2' FOR Sampled, no evidence of positive nodes;
'3' FOR Sampled, evidence of positive nodes;
'4' FOR Node sampling not mentioned;
'5' FOR Sampled, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether the paraesophageal (level 8) nodes were sampled prior to the first
course of therapy and if so, whether any positive nodes were found.
165.5,1416.8 LNG PULMONARY LIG (PRE-OP) LUN2;9 SET
'1' FOR No nodes sampled;
'2' FOR Sampled, no evidence of positive nodes;
'3' FOR Sampled, evidence of positive nodes;
'4' FOR Node sampling not mentioned;
'5' FOR Sampled, results not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether the pulmonary ligament (level 9) nodes were sampled prior to the first
course of therapy and if so, whether any positive nodes were found.
165.5,1417 LNG FROZEN SECTION LUN2;10 SET
'1' FOR Surgery performed, no frozen section taken;
'2' FOR Surgery performed, frozen section taken;
'8' FOR NA, no surgery;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item describes whether or not a frozen section was taken according to the pathology report.
165.5,1418 LNG VASCULAR INVASION LUN2;11 SET
'1' FOR Structure not involved;
'2' FOR Yes, structure involved;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item describes any tumor invasion of the vascular structure.
165.5,1418.1 LNG LYMPHATICS INVASION LUN2;12 SET
'1' FOR Structure not involved;
'2' FOR Yes, structure involved;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item describes any tumor invasion of the lymphatics structure.
165.5,1418.2 LNG PLEURA INVASION LUN2;13 SET
'1' FOR Structure not involved;
'2' FOR Yes, structure involved;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item describes any tumor invasion of the pleura structure.
165.5,1418.3 LNG CHEST WALL INVASION LUN2;14 SET
'1' FOR Structure not involved;
'2' FOR Yes, structure involved;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item describes any tumor invasion of the chest wall.
165.5,1418.4 LNG OTHER INVASION LUN2;15 SET
'1' FOR Structure not involved;
'2' FOR Yes, structure involved;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item describes any tumor invasion of any other structure.
165.5,1419 LNG HIGH MEDIASTINAL (SCOPE) LUN2;16 SET
'1' FOR Nodes not sampled;
'2' FOR Nodes sampled, but not removed en bloc;
'3' FOR Nodes removed en bloc;
'9' FOR Lymph node assessment not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the scope of operative mediastinal lymph node assessment during surgery of the
primary site. Record whether the highest mediastinal (level 1) nodes were sampled or taken en
bloc.
165.5,1419.1 LNG UPPER PARATRACHEAL (SCOPE) LUN2;17 SET
'1' FOR Nodes not sampled;
'2' FOR Nodes sampled, but not removed en bloc;
'3' FOR Nodes removed en bloc;
'9' FOR Lymph node assessment not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the scope of operative mediastinal lymph node assessment during surgery of the
primary site. Record whether the upper paratracheal (level 2) nodes were sampled or taken en bloc.
165.5,1419.2 LNG PREVASC/RETROTRACH (SCOPE) LUN2;18 SET
'1' FOR Nodes not sampled;
'2' FOR Nodes sampled, but not removed en bloc;
'3' FOR Nodes removed en bloc;
'9' FOR Lymph node assessment not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the scope of operative mediastinal lymph node assessment during surgery of the
primary site. Record whether the prevascular & retrotracheal (level 3) nodes were sampled or taken
en bloc.
165.5,1419.3 LNG LOWER PARATRACHEAL (SCOPE) LUN2;19 SET
'1' FOR Nodes not sampled;
'2' FOR Nodes sampled, but not removed en bloc;
'3' FOR Nodes removed en bloc;
'9' FOR Lymph node assessment not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the scope of operative mediastinal lymph node assessment during surgery of the
primary site. Record whether the lower paratracheal (level 4) nodes were sampled or taken en bloc.
165.5,1419.4 LNG SUBAORTIC (SCOPE) LUN2;20 SET
'1' FOR Nodes not sampled;
'2' FOR Nodes sampled, but not removed en bloc;
'3' FOR Nodes removed en bloc;
'9' FOR Lymph node assessment not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the scope of operative mediastinal lymph node assessment during surgery of the
primary site. Record whether the subaortic (level 5) nodes were sampled or taken en bloc.
165.5,1419.5 LNG PARAORTIC (SCOPE) LUN2;21 SET
'1' FOR Nodes not sampled;
'2' FOR Nodes sampled, but not removed en bloc;
'3' FOR Nodes removed en bloc;
'9' FOR Lymph node assessment not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the scope of operative mediastinal lymph node assessment during surgery of the
primary site. Record whether the paraortic (level 6) nodes were sampled or taken en bloc.
165.5,1419.6 LNG SUBCARINAL (SCOPE) LUN2;22 SET
'1' FOR Nodes not sampled;
'2' FOR Nodes sampled, but not removed en bloc;
'3' FOR Nodes removed en bloc;
'9' FOR Lymph node assessment not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the scope of operative mediastinal lymph node assessment during surgery of the
primary site. Record whether the subcarinal (level 7) nodes were sampled or taken en bloc.
165.5,1419.7 LNG PARAESOPHAGEAL (SCOPE) LUN2;23 SET
'1' FOR Nodes not sampled;
'2' FOR Nodes sampled, but not removed en bloc;
'3' FOR Nodes removed en bloc;
'9' FOR Lymph node assessment not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the scope of operative mediastinal lymph node assessment during surgery of the
primary site. Record whether the paraesophageal (level 8) nodes were sampled or taken en bloc.
165.5,1419.8 LNG PULMONARY LIGAMENT (SCOPE) LUN2;24 SET
'1' FOR Nodes not sampled;
'2' FOR Nodes sampled, but not removed en bloc;
'3' FOR Nodes removed en bloc;
'9' FOR Lymph node assessment not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the scope of operative mediastinal lymph node assessment during surgery of the
primary site. Record whether the pulmonary ligament (level 9) nodes were sampled or taken en bloc.
165.5,1420 LNG PERI-OPERATIVE BLOOD REP LUN2;25 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D TPBR^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="00":"No transfusion",Y=98:"Transfusion, # of units not documented",Y=99:"Not recorded if
transfusion done",Y="01":Y_" unit",1:Y_" units")
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION: This item describes the total number of units of blood transfused within 30 days of operation. If
the patient was transfused but the number of units is unknown, code 98.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1421 LNG PERI-OPERATIVE DEATH LUN2;26 SET
'1' FOR Died within same hospitalization;
'2' FOR Died within 30 days of surgery;
'3' FOR Both 1 & 2;
'4' FOR Discharged/alive 30 days after surgery;
'9' FOR Unknown;
LAST EDITED: MAY 01, 2001
DESCRIPTION:
This item describes whether or not the patient died peri-operatively.
165.5,1422 LNG BOOST DOSE (cGy) LUN2;27 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) S ONCL=5 D BD^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="00000":"Not administered",Y=99999:Not documented",1:Y)
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00000 and 99999
DESCRIPTION: This item describes the boost dose of radiation administered to the central tumor field of the
patient. If radiation was administered but boost dose is unknown, code 99999.
Allowable Codes: 00000 - no radiation boost dose administered
00001 thru 99998 - boost dose administered (cGy)
99999- boost dose administered, dose not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1423 CHEMOTHERAPEUTIC AGENT #1 LUN2;28 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)
LAST EDITED: SEP 13, 2007
HELP-PROMPT: Enter the first chemotherapeutic agent administered to the patient.
DESCRIPTION: Records the first chemotherapeutic agent administered to the patient as part of the first course
of therapy.
Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.
165.5,1423.1 CHEMOTHERAPEUTIC AGENT #2 LUN2;29 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)
LAST EDITED: SEP 13, 2007
HELP-PROMPT: Enter the second chemotherapeutic agent administered to the patient.
DESCRIPTION: Records the second chemotherapeutic agent administered to the patient as part of the first course
of therapy.
Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.
165.5,1423.2 CHEMOTHERAPEUTIC AGENT #3 LUN2;30 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)
LAST EDITED: SEP 13, 2007
HELP-PROMPT: Enter the third chemotherapeutic agent administered to the patient.
DESCRIPTION: Records the third chemotherapeutic agent administered to the patient as part of the first course
of therapy.
Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.
165.5,1423.3 CHEMOTHERAPEUTIC AGENT #4 LUN2;44 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)
LAST EDITED: SEP 12, 2007
HELP-PROMPT: Enter the fourth chemotherapeutic agent administered to the patient.
DESCRIPTION: Records the fourth chemotherapeutic agent administered to the patient as part of the first course
of therapy.
Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.
165.5,1423.4 CHEMOTHERAPEUTIC AGENT #5 LUN2;45 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)
LAST EDITED: SEP 12, 2007
HELP-PROMPT: Enter the fifth chemotherapeutic agent administered to the patient.
DESCRIPTION: Records the fifth chemotherapeutic agent administered to the patient as part of the first course
of therapy.
Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.
165.5,1424 LNG CHEMOTHERAPEUTIC TOXICITY LUN2;31 SET
'1' FOR Chemo discontinued due to toxicity;
'2' FOR No chemo toxicity;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether the administration of chemotherapy was discontinued as a result of
toxicity.
165.5,1425 LNG CHEMOTHERAPY/SURG SEQUENCE LUN2;32 SET
'1' FOR Chemo before surgery;
'2' FOR Chemo after surgery;
'3' FOR Chemo before and after surgery;
'8' FOR Chemo administered, no surgery;
'9' FOR Chemo and surgery, sequence unknown;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This data item describes the sequence in which chemotherapy and surgery of the primary site were
administered.
165.5,1426 LNG COMPLICATION #1 LUN2;33 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This item describes the first medical complication acquired by the patient during or resulting
from the first course of therapy. Record valid ICD-CM codes.
Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
E930.0 - E949.7 (valid ICD-CM adverse effect codes)
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
EXPLANATION: If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
165.5,1426.1 LNG COMPLICATION #2 LUN2;34 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This item describes the second medical complication acquired by the patient during or resulting
from the first course of therapy.
Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
E930.0 - E949.7 (valid ICD-CM adverse effect codes)
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
EXPLANATION: If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
165.5,1426.2 LNG COMPLICATION #3 LUN2;35 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This item describes the third medical complication acquired by the patient during or resulting
from the first course of therapy.
Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
E930.0 - E949.7 (valid ICD-CM adverse effect codes)
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
EXPLANATION: If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
165.5,1426.3 LNG COMPLICATION #4 LUN2;36 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This item describes the fourth medical complication acquired by the patient during or resulting
from the first course of therapy.
Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
E930.0 - E949.7 (valid ICD-CM adverse effect codes)
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
EXPLANATION: If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
165.5,1426.4 LNG COMPLICATION #5 LUN2;37 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This item describes the fifth medical complication acquired by the patient during or resulting
from the first course of therapy.
Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
E930.0 - E949.7 (valid ICD-CM adverse effect codes)
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
EXPLANATION: If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
165.5,1426.5 LNG TREATMENT COMPLICATION Y/N LUN2;40 SET (Required)
'0' FOR No;
'1' FOR Yes;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item records if there were medical complications acquired by the patient during or resulting
from first course of therapy for this cancer.
If no complications are listed, answer "No". COMPLICATION #1 will be automatically coded 000.00
with the remaining complication fields left blank.
165.5,1427 LNG CASE ABSTRACTOR INITIALS LUN2;38 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1) X
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: This item records the initials of the person responsible for abstracting this case and having
reviewed all the special study items for completeness and validity.
165.5,1428 LNG DATE CASE WAS ABSTRACTED LUN2;39 DATE
INPUT TRANSFORM: S %DT="EX" D ^%DT S X=Y K:Y<1 X
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the month, day and year (in the MMDDCCYY format) that this case was reviewed
for completeness and validity by the case abstractor.
165.5,1429 LNG PROXIMAL MARGIN LUN2;41 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D DMCM^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="000":"No free margins",Y=998:"NA, no surgery of primary site",Y=999:"Unknown, not documen
ted",1:Y_" mm")
LAST EDITED: MAY 08, 2001
HELP-PROMPT: Type a number between 0 and 999
DESCRIPTION: This item describes the distance of the closest proximal free margin in millimeters of the
resected primary tumor specimen. This information can be obtained from the pathology report. If
surgery of primary site was performed but the extent of the free margin is unknown, code 999.
Allowable Codes: 000 - no free margins in this segment
001 thru 997 - distance of closest free margin (mm)
998 - NA, no surgery of primary site
999 - unknown, extent of free margin not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1429.1 LNG DISTAL MARGIN LUN2;42 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D DMCM^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="000":"No free margins",Y=998:"NA, no surgery of primary site",Y=999:"Unknown, not documen
ted",1:Y_" mm")
LAST EDITED: MAY 08, 2001
HELP-PROMPT: Type a Number between 0 and 999
DESCRIPTION: This item describes the distance of the closest distal free margin in millimeters of the resected
primary tumor specimen. This information can be obtained from the pathology report. If surgery of
primary site was performed but the extent of the free margin is unknown, code 999.
Allowable Codes: 000 - no free margins in this segment
001 thru 997 - distance of closest free margin (mm)
998 - NA, no surgery of primary site
999 - unknown, extent of free margin not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1430 LNG HCT VAL BEFORE TRANSFUSION LUN2;43 NUMBER
INPUT TRANSFORM: K:(X>99.9)!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=2,ONCF=1 D HVBT^ONCOIT
OUTPUT TRANSFORM: S Y=$S(+Y=0:"No transfusion",Y=99.9:"Transfusion, % Hct not documented",1:Y_"% Hct")
LAST EDITED: MAY 08, 2001
HELP-PROMPT: Type a Number between 0.00 and 99.9, 1 Decimal Digit
DESCRIPTION: This item describes the percent (%) of hematocrit before the first transfusion. Record results to
the precision of one decimal point, record zeros in unused positions; for example 9.5% would be
coded as 09.5. If the patient was transfused but hematocrit value is not documented, code 99.9.
Allowable Codes: 00.0 - no transfusion
00.1 thru 99.0 - % Hct
99.9 - transfusion, % Hct not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1500 GAS PRIOR EXPOSURE TO RAD GAS1;1 SET
'1' FOR Documented exposure;
'2' FOR Documented no exposure;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes a patient's known prior radiation exposure. Exposure to fluoroscopy, exposure
to radioactive isotopes, or actual radiation treatments should be considered prior radiation
exposure. Occupational exposure to radiation should be considered: radioisotope lab worker;
radiation therapist; radiology technician; miner. Do not code routine chest or dental x-rays as
prior radiation exposure.
165.5,1501 GAS ALCOHOL COMSUMPTION GAS1;2 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D AC^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="00":"Never consumed alcohol",Y=97:"97 or more drinks per week",Y=98:"Yes, number of drink
s unknown",Y=99:"Not documented",1:Y_" drink(s) per week")
LAST EDITED: APR 30, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION: This item describes the number of drinks (beer, wine, other alcohol) consumed by the patient per
week. If the patient has never consumed alcohol, code 00. If the number of drinks per week is not
documented, code 99. This information can typically be found in either the patient's clinic chart
or the managing physician's notes.
Allowable Codes: 00 - never consumed alcohol
01 thru 96 - 1 or more drinks up to 96 drinks per week
97 - 97 or more drinks per week
98 - alcohol consumption, number of drinks unknown
99 - alcohol consumption not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1502 GAS MENOPAUSAL STATUS/HOR TX GAS1;3 SET
'1' FOR Menopause, no hormome tx;
'2' FOR Menopause, hormone tx stopped before dx;
'3' FOR Menopause, hormone tx at dx;
'8' FOR NA, male patient;
'9' FOR Menopause not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether a female patient has experienced menopause and, if so, whether or not
she was receiving prescribed hormone replacement therapy. Menopause may occur naturally or as a
result of a hysterectomy. If the patient is male, code 8. If the woman's menopausal status can
not be determined, code 9. This information can typically be found in either the patient's clinic
chart or the managing physician's notes.
165.5,1503 GAS H2 BLOCKER/PROTON PUMP GAS1;4 SET
'1' FOR H2 blocker;
'2' FOR Proton pump inhibitor;
'3' FOR Both;
'8' FOR Neither;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient was either self-medicating or taking prescribed H2 blocker
or proton pump inhibitor drugs to suppress gastric acidity and control reflux. Common drug names
for H2 blocker include: Pepcid (famotidine), Tagamet (cimetidine), Zantac (ranitidine), and Axid
(nizatidine). Common names for proton pump inhibitors include: Prilosec (omeprazole), Prevacid
(lansoprazole), Protonix (pantaprazol), Aciphex (rebeprazol), and Nexium (es-omeprazole).
165.5,1504 GAS FAMILY HIST OF GASTRIC CA GAS1;5 SET
'1' FOR No 1st or 2nd deg relatives;
'2' FOR 1 1st deg relative;
'3' FOR 2 1st deg relatives;
'4' FOR 3 or more 1st deg relatives;
'5' FOR 1 or more 2nd deg relatives;
'6' FOR Both 1st and 2nd deg relatives;
'9' FOR Familial history, relation not indicated;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether there is any familial history of gastric cancer. Record familial
history of gastric cancer in first degree relatives (parent, siblings, and child) or 2nd degree
relatives (1st cousins, aunt, uncle, grandparent, grandchild).
165.5,1505 GAS H-PYLORI INFECTION GAS1;6 SET
'1' FOR Past history, present at dx;
'2' FOR No past history, present at dx;
'3' FOR Past history, not present at dx;
'4' FOR Documented never present;
'9' FOR Unknown, not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient had at any time the following associated benign gastric
condition:
Helicobacter pylori (H-pylori) infection
165.5,1506 GAS DUODENAL ULCER GAS1;7 SET
'1' FOR Past history, present at dx;
'2' FOR No past history, present at dx;
'3' FOR Past history, not present at dx;
'4' FOR Documented never present;
'9' FOR Unknown, not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient had at any time the following associated benign gastric
condition:
Duodenal ulcer
165.5,1507 GAS GASTRIC ULCER GAS1;8 SET
'1' FOR Past history, present at dx;
'2' FOR No past history, present at dx;
'3' FOR Past history, not present at dx;
'4' FOR Documented never present;
'9' FOR Unknown, not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient had at any time the following associated benign gastric
condition:
Gastric ulcer
165.5,1508 GAS HEARTBURN (BENIGN COND) GAS1;9 SET
'1' FOR Past history, present at dx;
'2' FOR No past history, present at dx;
'3' FOR Past history, not present at dx;
'4' FOR Documented never present;
'9' FOR Unknown, not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient had at any time the following associated benign gastric
condition:
Heartburn
165.5,1509 GAS PERNICIOUS ANEMIA GAS1;10 SET
'1' FOR Past history, present at dx;
'2' FOR No past history, present at dx;
'3' FOR Past history, not present at dx;
'4' FOR Documented never present;
'9' FOR Unknown, not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient had at any time the following associated benign gastric
condition:
Pernicious anemia
165.5,1510 GAS POLYPS OF STOMACH GAS1;11 SET
'1' FOR Past history, present at dx;
'2' FOR No past history, present at dx;
'3' FOR Past history, not present at dx;
'4' FOR Documented never present;
'9' FOR Unknown, not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient had at any time the following associated benign gastric
condition:
Polyps of stomach
165.5,1511 GAS POLYPOSIS OF BOWEL GAS1;12 SET
'1' FOR Past history, present at dx;
'2' FOR No past history, present at dx;
'3' FOR Past history, not present at dx;
'4' FOR Documented never present;
'9' FOR Unknown, not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient had at any time the following associated benign gastric
condition:
Polyposis of small or large bowel
165.5,1512 GAS BARRET'S ESOPHAGUS GAS1;13 SET
'1' FOR Past history, present at dx;
'2' FOR No past history, present at dx;
'3' FOR Past history, not present at dx;
'4' FOR Documented never present;
'9' FOR Unknown, not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient had at any time the following associated benign gastric
condition:
Barret's esophagus
165.5,1513 GAS ATROPHIC GASTRITIS GAS1;14 SET
'1' FOR Past history, present at dx;
'2' FOR No past history, present at dx;
'3' FOR Past history, not present at dx;
'4' FOR Documented never present;
'9' FOR Unknown, not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient had at any time the following associated benign gastric
condition:
Atrophic gastritis
165.5,1514 GAS GASTRIC METAPLASIA GAS1;15 SET
'1' FOR Past history, present at dx;
'2' FOR No past history, present at dx;
'3' FOR Past history, not present at dx;
'4' FOR Documented never present;
'9' FOR Unknown, not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient had at any time the following associated benign gastric
condition:
Gastric metaplasia
165.5,1515 GAS ANTIBIOTICS GAS1;16 SET
'1' FOR Regimen given;
'2' FOR H-pylori present, regimen not given;
'8' FOR H-pylori not present;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item records the use of antibiotics for H-pylori infection prior to diagnosis of gastric
cancer. Examples of antibiotics include: ampicillin, amoxicillin, clarithromycin, etc.
165.5,1516 GAS PROTON PUMP INHIBITORS GAS1;17 SET
'1' FOR Regimen given;
'2' FOR H-pylori present, regimen not given;
'8' FOR H-pylori not present;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item records the use of proton pump inhibitors for H-pylori infection prior to diagnosis of
gastric cancer. Examples of proton pump inhibitors include: omeprazole, lansoprazole, rabeprazole,
pantoprazol, es-omeprazole.
165.5,1517 GAS H2 BLOCKERS GAS1;18 SET
'1' FOR Regimen given;
'2' FOR H-pylori present, regimen not given;
'8' FOR H-pylori not present;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item records the use of H2 blockers for H-pylori infection prior to diagnosis of gastric
cancer. Examples of H2 blockers include: ranitidine (Zantac), famotidine (Pepcid), nizatidine
(Axid), cimetidine (Tagamet).
165.5,1518 GAS BISMUTH COMPOUNDS GAS1;19 SET
'1' FOR Regimen given;
'2' FOR H-pylori present, regimen not given;
'8' FOR H-pylori not present;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item records the use of bismuth compounds for H-pylori infection prior to diagnosis of
gastric cancer. Examples of bismuth compounds include: Pepo Bismol, prescription bismuth drugs.
165.5,1519 GAS PRIOR INTRA-ABDOMINAL SURG GAS1;20 SET
'1' FOR Documented;
'2' FOR Documented No;
'9' FOR Not mentioned;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether the patient had undergone any intra- abdominal surgery including a
prior gastric resection, before the diagnosis of this cancer. Do not record retroperitoneal or
extraperitoneal procedures as intra-abdominal surgeries.
165.5,1520 GAS YEAR OF GASTRIC RESECTION GAS1;21 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<4)!'(X?4N) X I $D(X) D GYGR^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="0000":"No prior gastric resection",Y=9999:"Not documented",1:Y)
LAST EDITED: JUL 19, 2001
HELP-PROMPT: Type a Number between 0000 and 9999
DESCRIPTION: This item describes the year that the patient received a gastric resection prior to this
diagnosis. If the patient has a documented prior abdominal surgical resection indicate whether
that surgery included a gastric resection by coding the year the resection occurred. If the
patient has received more than one gastric resection, code the earliest (first) year.
Allowable Codes: 0000 - documented no prior gastric resection
1901 thru 2001 - year of prior gastric resection
9999 - not documented whether there was prior gastric
resection
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1521 GAS PERFORMANCE STATUS AT DX GAS1;22 SET
'1' FOR Normal, no symptoms;
'2' FOR Symptoms/ambulatory/min limits;
'3' FOR Out of bed > 50% of day/mod limits;
'4' FOR In bed > 50% of day/severe limits;
'5' FOR Bedridden/moribund;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the performance status of the patient at initial diagnosis. The scale used in
this study is widely known as the ECOG performance status.
165.5,1522 GAS HEARTBURN (SYMPTOMS) GAS1;23 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the presence of heartburn specific to gastric cancer that was recorded in the
medical chart.
165.5,1523 GAS FEVER/NIGHT SWEATS GAS1;24 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the presence of fever/night sweats specific to gastric cancer that was
recorded in the medical chart.
165.5,1524 GAS ACUTE HEMATEMESIS GAS1;25 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the presence of acute hematemesis specific to gastric cancer that was recorded
in the medical chart.
165.5,1525 GAS TRANSFUSIONS FOR BLD LOSS GAS1;26 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the presence of transfusions for blood loss specific to gastric cancer that
were recorded in the medical chart.
165.5,1526 GAS MELENA GAS1;27 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the presence of melena specific to gastric cancer that was recorded in the
medical chart.
165.5,1527 GAS PAIN GAS1;28 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the presence of pain specific to gastric cancer that was recorded in the
medical chart.
165.5,1528 GAS EARLY SATIETY GAS1;29 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the presence of early satiety specific to gastric cancer that was recorded in
the medical chart.
165.5,1529 GAS CT SCAN OF ABDOMEN GAS1;30 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Not performed;
'8' FOR Performed, results not documented;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the results of a CT scan of abdomen performed to evaluate the primary tumor.
165.5,1530 GAS CT SCAN OF CHEST GAS1;31 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Not performed;
'8' FOR Performed, results not documented;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the results of a CT scan of chest performed to evaluate the primary tumor.
165.5,1531 GAS CT PELVIS GAS1;32 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Not performed;
'8' FOR Performed, results not documented;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the results of a CT pelvis performed to evaluate the primary tumor.
165.5,1532 GAS CHEST X-RAY GAS1;33 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Not performed;
'8' FOR Performed, results not documented;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the results of a chest x-ray performed to evaluate the primary tumor.
165.5,1533 GAS GALLIUM SCAN GAS1;34 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Not performed;
'8' FOR Performed, results not documented;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the results of a gallium scan performed to evaluate the primary tumor.
165.5,1534 GAS BIPEDAL LYMPHANGIOGRAM GAS1;35 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Not performed;
'8' FOR Performed, results not documented;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the results of a bipedal lymphangiogram (LAB) performed to evaluate the
primary tumor.
165.5,1535 GAS MRI GAS1;36 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Not performed;
'8' FOR Performed, results not documented;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the results of an MRI performed to evaluate the primary tumor.
165.5,1536 GAS PET SCAN GAS1;37 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Not performed;
'8' FOR Performed, results not documented;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the results of a PET scan performed to evaluate the primary tumor.
165.5,1537 GAS LAPAROSCOPY GAS1;38 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Not performed;
'8' FOR Performed, results not documented;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the results of a laparoscopy performed to evaluate the primary tumor.
165.5,1538 GAS EUS GAS1;39 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Not performed;
'8' FOR Performed, results not documented;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the results of an EUS (endoscopic ultrasound) performed to evaluate the
primary tumor.
165.5,1539 GAS PERITONEAL LAVAGE GAS1;40 SET
'1' FOR Abnormal, suggestive of cancer;
'2' FOR Abnormal, not suggestive of cancer;
'3' FOR Normal;
'4' FOR Not performed;
'8' FOR Performed, results not documented;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the results of a peritoneal lavage performed to evaluate the primary tumor.
165.5,1540 GAS LDH (IU/L) GAS1;41 NUMBER
INPUT TRANSFORM: K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9
":"Not documented",1:Y)
LAST EDITED: APR 30, 2001
HELP-PROMPT: Type a Number between 0000.0 and 9999.9, 1 Decimal Digit
DESCRIPTION: This item describes the absolute value of the LDH (IU/L) study administered to the patient prior
to the start of the first course of treatment. This information can typically be found in either
the patient's hospital chart or laboratory records. Record results to the precision of one decimal
point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would
be coded as 0004.4. If a particular test was not administered, code 0000.0; if a test was
administered but the result is unknown, code 8888.8; if it is not documented whether a test is
administered, code 9999.9.
Allowable Codes: 0000.0 - test not administered
0000.1 thru 8888.7 - absolute value of test
8888.8 - test administered, results unknown
9999.9 - not documented if test administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1541 GAS CEA (ng/ml) GAS1;42 NUMBER
INPUT TRANSFORM: K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9
":"Not documented",1:Y)
LAST EDITED: APR 30, 2001
HELP-PROMPT: Type a Number between 0000.0 and 9999.9, 1 Decimal Digit
DESCRIPTION: This item describes the absolute value of the Carcinoembryonic antigen, CEA (ng/ml) study
administered to the patient prior to the start of the first course of treatment. This information
can typically be found in either the patient's hospital chart or laboratory records. Record
results to the precision of one decimal point; record zeros in unused positions; for example 12.5
would be coded as 0012.5, and 4.4 would be coded as 0004.4. If a particular test was not
administered, code 0000.0; if a test was administered but the result is unknown, code 8888.8; if it
is not documented whether a test is administered, code 9999.9.
Allowable Codes: 0000.0 - test not administered
0000.1 thru 8888.7 - absolute value of test
8888.8 - test administered, results unknown
9999.9 - not documented if test administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1542 GAS CA125 (U/ml) GAS1;43 NUMBER
INPUT TRANSFORM: K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9
":"Not documented",1:Y)
LAST EDITED: APR 30, 2001
HELP-PROMPT: Type a Number between 0000.0 and 9999.9, 1 Decimal Digit
DESCRIPTION: This item describes the absolute value of the CA125 (U/ml) study administered to the patient prior
to the start of the first course of treatment. This information can typically be found in either
the patient's hospital chart or laboratory records. Record results to the precision of one decimal
point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would
be coded as 0004.4. If a particular test was not administered, code 0000.0; if a test was
administered but the result is unknown, code 8888.8; if it is not documented whether a test is
administered, code 9999.9.
Allowable Codes: 0000.0 - test not administered
0000.1 thru 8888.7 - absolute value of test
8888.8 - test administered, results unknown
9999.9 - not documented if test administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1543 GAS BETA2 MICROGLOBULIN GAS1;44 NUMBER
INPUT TRANSFORM: K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9
":"Not documented",1:Y)
LAST EDITED: APR 30, 2001
HELP-PROMPT: Type a Number between 0000.0 and 9999.9, 1 Decimal Digit
DESCRIPTION: This item describes the absolute value of the Beta2 microglobulin (ng/ml) study administered to
the patient prior to the start of the first course of treatment. This information can typically be
found in either the patient's hospital chart or laboratory records. Record results to the
precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded
as 0012.5, and 4.4 would be coded as 0004.4. If a particular test was not administered, code
0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented
whether a test is administered, code 9999.9.
Allowable Codes: 0000.0 - test not administered
0000.1 thru 8888.7 - absolute value of test
8888.8 - test administered, results unknown
9999.9 - not documented if test administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1544 GAS URINARY 5-HIAA (mg/24hr) GAS1;45 NUMBER
INPUT TRANSFORM: K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9
":"Not documented",1:Y)
LAST EDITED: APR 30, 2001
HELP-PROMPT: Type a Number between 0000.0 and 9999.9, 1 Decimal Digit
DESCRIPTION: This item describes the absolute value of the Urinary 5-HIAA (mg/24hr) study administered to the
patient prior to the start of the first course of treatment. This information can typically be
found in either the patient's hospital chart or laboratory records. Record results to the
precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded
as 0012.5, and 4.4 would be coded as 0004.4. If a particular test was not administered, code
0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented
whether a test is administered, code 9999.9.
Allowable Codes: 0000.0 - test not administered
0000.1 thru 8888.7 - absolute value of test
8888.8 - test administered, results unknown
9999.9 - not documented if test administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1545 GAS CLINICAL/VISUAL EXAM GAS1;46 SET
'1' FOR Results positive for cancer;
'2' FOR Results negative for caner;
'8' FOR Not performed;
'9' FOR Not documented, exam type not mentioned;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the most definitive results of a gastroscopic clinical/visual examination.
165.5,1545.1 GAS BIOPSY GAS1;47 SET
'1' FOR Results positive for cancer;
'2' FOR Results negative for cancer;
'8' FOR Not performed;
'9' FOR Not documented, exam type not mentioned;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the most definitive results of a gastrscopic biopsy.
165.5,1546 GAS GASTRO-ESOPHAGEAL JUNCTION GAS1;48 SET
'1' FOR Siewart II <= 2cm from squamocolunmar junc;
'2' FOR Siewart III > 2cm from squamocolumnar junc;
'9' FOR No documented Siewart type or distance;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item distinguishes tumors that clearly arise within the stomach (type III) from those that
start at or near the esophageal gastric junction (type II). Siewert type I tumors are excluded
from this study as these are considered esophageal (C15.0-C15.9). This information may be obtained
from the pathology report.
165.5,1547 GAS STOMACH GAS1;49 SET
'1' FOR Site of initial histologic dx;
'2' FOR Not site of initial histologic dx;
'9' FOR Site not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the site(s) of the initial histologic diagnosis of this cancer.
165.5,1547.1 GAS LIVER GAS1;50 SET
'1' FOR Site of initial histologic dx;
'2' FOR Not site of initial histologic dx;
'9' FOR Site not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the site(s) of the initial histologic diagnosis of this cancer.
165.5,1547.2 GAS EXTRA-ABDOMINAL GAS1;51 SET
'1' FOR Site of initial histologic dx;
'2' FOR Not site of initial histologic dx;
'9' FOR Site not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the site(s) of the initial histologic diagnosis of this cancer.
165.5,1547.3 GAS LYMPH NODES GAS1;52 SET
'1' FOR Site of initial histologic dx;
'2' FOR Not site of initial histologic dx;
'9' FOR Site not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the site(s) of the initial histologic diagnosis of this cancer.
165.5,1547.4 GAS PERITONEUM GAS1;53 SET
'1' FOR Site of initial histologic dx;
'2' FOR Not site of initial histologic dx;
'9' FOR Site not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the site(s) of the initial histologic diagnosis of this cancer.
165.5,1548 GAS DATE OF FIRST TISSUE DX GAS1;54 DATE
INPUT TRANSFORM: S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(
0) D:'$D(X) EN^DDIOL("Future dates are not allowed")
OUTPUT TRANSFORM: D DATEOT^ONCOPCE
LAST EDITED: JUL 19, 2001
DESCRIPTION: This item describes the month, day, and year (MMDDCCYY) that this primary cancer was first
diagnosed using a tissue sample to arrive at a positive histologic or cytologic evaluation of the
tumor.
If a positive histologic or cytologic evaluation was made but the date is unknown code 99/99/9999.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1549 GAS LAUREN'S CLASSIFICATION GAS1;55 SET
'1' FOR Diffuse;
'2' FOR Intestinal;
'3' FOR Mixed;
'4' FOR Other;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes Lauren's classification which divides gastric carcinoma into two main
histologic types, diffuse or intestinal. Record the classification if it is stated in the
pathology report.
165.5,1550 GAS GOSEKI'S CLASSIFICATION GAS1;56 SET
'1' FOR Type I tubular diff well/mucin poor;
'2' FOR Type II tubular diff well/mucin rich;
'3' FOR Type III tubular diff poor/mucin poor;
'3' FOR Type IV tubular diff poor/mucin rich;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes Goseki's classification which divides gastric carcinoma into four histologic
types, depending upon the degree of tubular differentiation and mucin content. It is thought that
this classification scheme can aid in predicting a tumor's mode of extension, recurrence and
conditions of metastasis. This information may not appear on the pathology report. Request
assistance from the attending pathologist to determine the appropriate code.
165.5,1551 GAS GASTRIN GAS1;57 SET
'1' FOR Used in pathologic evaluation;
'2' FOR Not used;
'8' FOR NA, pathologic dx not made;
'9' FOR Not documented if used;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether molecular marker gastrin was used in the pathologic evaluation of the
tumor. If a pathologic diagnosis was not made, code 8.
165.5,1551.1 GAS 5-HIAA GAS1;58 SET
'1' FOR Used in pathologic evaluation;
'2' FOR Not used;
'8' FOR NA, pathologic dx not made;
'9' FOR Not documented if used;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether molecular marker 5-HIAA was used in the pathologic evaluation of the
tumor. If a pathologic diagnosis was not made, code 8.
165.5,1551.2 GAS CEA GAS1;59 SET
'1' FOR Used in pathologic evaluation;
'2' FOR Not used;
'8' FOR NA, pathologic dx not made;
'9' FOR Not documented if used;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether molecular marker CEA was used in the pathologic evaluation of the
tumor. If a pathologic diagnosis was not made, code 8.
165.5,1551.3 GAS CA125 GAS1;60 SET
'1' FOR Used in pathologic evaluation;
'2' FOR Not used;
'8' FOR NA, pathologic dx not made;
'9' FOR Not documented if used;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether molecular marker CA124 was used in the pathologic evaluation of the
tumor. If a pathologic diagnosis was not made, code 8.
165.5,1551.4 GAS OTHER MOLECULAR MARKER GAS1;61 SET
'1' FOR Used in pathologic evaluation;
'2' FOR Not used;
'8' FOR NA, pathologic dx not made;
'9' FOR Not documented if used;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes whether other molecular markers were used in the pathologic evaluation of the
tumor. If a pathologic diagnosis was not made, code 8.
165.5,1552 GAS MITOTIC RATE GAS1;62 SET
'1' FOR < or equal to 2/10 HPF;
'2' FOR > 2 and < 5/10 HPF;
'3' FOR Equal to or > 5/10 HPF;
'9' FOR Not documented;
LAST EDITED: APR 30, 2001
DESCRIPTION: This item describes the number of mitoses per high power field (HPF).
165.5,1553 GAS TUMOR NECROSIS GAS1;63 SET
'1' FOR Frequent, larger areas;
'2' FOR Few small areas (rare/scattered);
'3' FOR No tumor cell necrosis;
'9' FOR Not documented;
LAST EDITED: MAR 07, 2001
DESCRIPTION: This item describes the presence and degree of tumor necrosis.
165.5,1554 GAS FLOW CYTOMETRY/FRESH TISS GAS1;64 SET
'1' FOR Used;
'2' FOR Not used;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This data item describes if the flow cytometry on fresh tissue phenotype modality was performed on
the lymphoma tissue in this case.
165.5,1554.1 GAS IMMUNOHISTOCHEM/FROZEN TIS GAS1;65 SET
'1' FOR Used;
'2' FOR Not used;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This data item describes if the immunohistochemistry on frozen tissue phenotype modality was
performed on the lymphoma tissue in this case.
165.5,1554.2 GAS IMMUNOHISTOCHEM/PARAFFIN GAS1;66 SET
'1' FOR Used;
'2' FOR Not used;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This data item describes if the immunohistochemistry on paraffin embedded tissue phenotype
modality was performed on the lymphoma tissue in this case.
165.5,1554.3 GAS MOLECULAR GENETICS GAS1;67 SET
'1' FOR Used;
'2' FOR Not used;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This data item describes if the molecular genetics phenotype modality was performed on the
lymphoma tissue in this case.
165.5,1554.4 GAS POLYMERASE CHAIN REACTION GAS1;68 SET
'1' FOR Used;
'2' FOR Not used;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This data item describes if the polymerase chain reaction technique phenotype modality was
performed on the lymphoma tissue in this case.
165.5,1554.5 GAS SOUTHERN BLOT TECHNIQUE GAS1;69 SET
'1' FOR Used;
'2' FOR Not used;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This data item describes if the Southern blot technique phenotype modality was performed on the
lymphoma tissue in this case.
165.5,1555 GAS ANN ARBOR STAGING GAS1;70 SET
'1' FOR Stage IE (stomach);
'2' FOR Stage IIEi (stomach/perigastric ln);
'3' FOR Stage IIEii (stomach/periaortic ln);
'4' FOR Stage III (spleen tumor);
'5' FOR Stage IV (distant/liver/bone marrow);
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: Gastric lymphoma staging is performed differently than adenocarcinoma staging, using a
modification of the Ann Arbor System with Stage IE confined to the stomach, Stage IIEi confined to
the stomach and perigastric lymph nodes, Stage IIEii confined to stomach and periaortic lymph
nodes, Stage III involvement of the spleen, tumor on both sides of diaphragm and Stage IV
involvement of distant sites (liver, bone marrow).
165.5,1556 GAS ADHERENCE OF RESECTED PRIM GAS1;71 SET
'1' FOR No tumor adherence;
'2' FOR Tumor adherence lysed w/o resection;
'3' FOR Tumor adherence, adj organ resected en bloc;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item evaluates adherence of the resected primary specimen to other structures.
165.5,1557 GAS MARGIN STAT OF RESECT PRIM GAS1;72 SET
'1' FOR Negative proximal and distal;
'2' FOR Positive proximal, negative distal;
'3' FOR Negative proximal, positive distal;
'4' FOR Positive proximal and distal;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item evaluates the margin status of the resected primary specimen.
165.5,1558 GAS PROXIMAL MARGIN GAS1;73 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D EFM^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="000":"No free margins",Y=999:"Not documented",1:Y_" mm")
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 0 and 999
DESCRIPTION: This item describes the extent of the proximal free margin around the resected primary tumor
specimen. Record the extent of the closest free margin in millimeters. If surgery of primary site
was performed but the extent of the free margin is not documented, code 999. This information can
be obtained from the pathology report.
Allowable Codes: 000 - no free margins in this segment
001 thru 997 - extent of free margin (mm)
999 - extent of free margin not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1558.1 GAS DISTAL MARGIN GAS1;74 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D EFM^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="000":"No free margins",Y=999:"Not documented",1:Y_" mm")
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 0 and 999
DESCRIPTION: This item describes the extent of the distal free margin around the resected primary tumor
specimen. Record the extent of the closest free margin in millimeters. If surgery of primary site
was performed but the extent of the free margin is not documented, code 999. This information can
be obtained from the pathology report.
Allowable Codes: 000 - no free margins in this segment
001 thru 997 - extent of free margin (mm)
999 - extent of free margin not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1559 GAS SPLEEN GAS2;1 SET
'1' FOR Resected, tumor adherence;
'2' FOR Resected, no tumor adherence;
'3' FOR Not resected, tumor adherence;
'4' FOR Not resected, no tumor adherence;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1559.1 GAS TRANSVERSE COLON GAS2;2 SET
'1' FOR Resected, tumor adherence;
'2' FOR Resected, no tumor adherence;
'3' FOR Not resected, tumor adherence;
'4' FOR Not resected, no tumor adherence;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1559.2 GAS LIVER GAS2;3 SET
'1' FOR Resected, tumor adherence;
'2' FOR Resected, no tumor adherence;
'3' FOR Not resected, tumor adherence;
'4' FOR Not resected, no tumor adherence;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1559.3 GAS DIAPHRAGM GAS2;4 SET
'1' FOR Resected, tumor adherence;
'2' FOR Resected, no tumor adherence;
'3' FOR Not resected, tumor adherence;
'4' FOR Not resected, no tumor adherence;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1559.4 GAS PANCREAS GAS2;5 SET
'1' FOR Resected, tumor adherence;
'2' FOR Resected, no tumor adherence;
'3' FOR Not resected, tumor adherence;
'4' FOR Not resected, no tumor adherence;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1559.5 GAS ABDOMINAL WALL GAS2;6 SET
'1' FOR Resected, tumor adherence;
'2' FOR Resected, no tumor adherence;
'3' FOR Not resected, tumor adherence;
'4' FOR Not resected, no tumor adherence;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1559.6 GAS ADRENAL GLAND GAS2;7 SET
'1' FOR Resected, tumor adherence;
'2' FOR Resected, no tumor adherence;
'3' FOR Not resected, tumor adherence;
'4' FOR Not resected, no tumor adherence;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1559.7 GAS KIDNEY GAS2;8 SET
'1' FOR Resected, tumor adherence;
'2' FOR Resected, no tumor adherence;
'3' FOR Not resected, tumor adherence;
'4' FOR Not resected, no tumor adherence;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1559.8 GAS SMALL INTESTINE GAS2;9 SET
'1' FOR Resected, tumor adherence;
'2' FOR Resected, no tumor adherence;
'3' FOR Not resected, tumor adherence;
'4' FOR Not resected, no tumor adherence;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1559.9 GAS RETROPERITONEUM GAS2;10 SET
'1' FOR Resected, tumor adherence;
'2' FOR Resected, no tumor adherence;
'3' FOR Not resected, tumor adherence;
'4' FOR Not resected, no tumor adherence;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1560 GAS PERIGASTRIC LYMPH NODES GAS2;11 SET
'2' FOR Resected;
'4' FOR Not resected;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1560.1 GAS COMMON HEPATIC LYMPH NODES GAS2;12 SET
'2' FOR Resected;
'4' FOR Not resected;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1560.2 GAS CELIAC LYMPH NODES GAS2;13 SET
'2' FOR Resected;
'4' FOR Not resected;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1560.3 GAS SPLENIC LYMPH NODES GAS2;14 SET
'2' FOR Resected;
'4' FOR Not resected;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1560.4 GAS OTHER INTRA-ABDOMINAL NDES GAS2;15 SET
'2' FOR Resected;
'4' FOR Not resected;
'9' FOR Extent of resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the removal of an organ or lymph node structure beyond the stomach and if
there was tumor adherence to this structure. This information should be obtained from both the
surgical and pathology report.
165.5,1561 GAS GROSSLY INVOLVED REG LN GAS2;16 SET
'1' FOR Resected;
'2' FOR Not resected;
'9' FOR Resection not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether regional nodes were grossly involved at surgical resection. This
information should only be recorded from the operative report. Do not report pathologically
involved nodes.
165.5,1562 GAS HCT VAL BEFORE TRANSFUSION GAS2;17 NUMBER
INPUT TRANSFORM: K:(X>99.9)!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=2,ONCF=1 D HVBT^ONCOIT
OUTPUT TRANSFORM: S Y=$S(+Y=0:"No transfusion",Y=99.9:"Not documented",1:Y_"% Hct")
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00.0 and 99.9, 1 Decimal Digit
DESCRIPTION: This item describes the percent (%) of hematocrit before the first transfusion. Record results to
the precision of one decimal point, record zeros in unused positions; for example 9.5% would be
coded as 09.5. If the patient was transfused but hematocrit value is not documented, code 99.9.
Allowable Codes: 00.0 - no transfusion
00.1 thru 99.0 - % Hct
99.9 - transfusion, % Hct not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1563 GAS TOTAL OPERATIVE BLOOD REPL GAS2;18 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) D GTOBR^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="00":"No transfusion",Y=98:"Transfusion, # of units not documented",Y=99:"Not recorded if
transfusion done",1:Y_" unit(s) tranfused")
LAST EDITED: JUL 19, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION: This item describes the total number of units of blood transfused during the surgery of primary
site and within 24 hours postoperatively. If the patient was transfused but the number of units is
not documented, code 99.
Allowable Codes: 00 - no transfusion performed
01 thru 97 - units transfused
98 - transfusion, # of units not documented
99 - not recorded if transfusion done
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1564 GAS INTRA/PERI-OPERATIVE DEATH GAS2;19 SET
'1' FOR Pt died intra-operatively;
'2' FOR Pt died w/i 30 days while hospitalized ;
'3' FOR Pt died > 30 days while hospitalized;
'4' FOR Pt died w/i 30 days/discharged;
'5' FOR Pt alive and discharged 30 days following;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether or not the patient died intra-operatively or peri-operatively.
165.5,1565 GAS ANASTOMATIC LEAK GAS2;20 SET
'1' FOR Caused re-operation;
'2' FOR Did not cause re-operation;
'3' FOR Did not occur;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether an anastomotic leak required re-operation during the same
hospitalization.
165.5,1565.1 GAS STUMP LEAK GAS2;21 SET
'1' FOR Caused re-operation;
'2' FOR Did not cause re-operation;
'3' FOR Did not occur;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether a stump leak required re-operation during the same hospitalization.
165.5,1565.2 GAS BLEEDING GAS2;22 SET
'1' FOR Caused re-operation;
'2' FOR Did not cause re-operation;
'3' FOR Did not occur;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether bleeding required re-operation during the same hospitalization.
165.5,1565.3 GAS WOUND INFECTION GAS2;23 SET
'1' FOR Caused re-operation;
'2' FOR Did not cause re-operation;
'3' FOR Did not occur;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether a wound infection required re-operation during the same
hospitalization.
165.5,1565.4 GAS SEPSIS GAS2;24 SET
'1' FOR Caused re-operation;
'2' FOR Did not cause re-operation;
'3' FOR Did not occur;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether sepsis required re-operation during the same hospitalization.
165.5,1565.5 GAS PANCREATITIS GAS2;25 SET
'1' FOR Caused re-operation;
'2' FOR Did not cause re-operation;
'3' FOR Did not occur;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether pancreatitis required re-operation during the same hospitalization.
165.5,1565.6 GAS DEAD BOWEL GAS2;26 SET
'1' FOR Caused re-operation;
'2' FOR Did not cause re-operation;
'3' FOR Did not occur;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether a dead bowel required re-operation during the same hospitalization.
165.5,1565.7 GAS OTHER COMPLICATIONS GAS2;27 SET
'1' FOR Caused re-operation;
'2' FOR Did not cause re-operation;
'3' FOR Did not occur;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether other complications required re-operation during the same
hospitalization.
165.5,1566 GAS DATE OF SURGICAL DISCHARGE GAS2;28 DATE
INPUT TRANSFORM: S %DT="EX" D ^%DT S X=Y K:Y<1 X
LAST EDITED: MAY 01, 2001
DESCRIPTION: The date of surgical discharge is used to calculate a patient's length of stay in the hospital and
is the month, day, and year that the patient was discharged from the hospital following surgery of
primary site. Surgical treatment is defined as the surgical event which corresponds to the
procedure recorded in the ROADS data item "Date of Surgery and includes surgical procedures of the
primary site, scope of regional lymph nodes, or surgery to other regional sites, distant sites or
distant lymph nodes.
165.5,1567 GAS INTRA-OPERATIVE RADIATION GAS2;29 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) S ONCL=5 D IRTD^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="00000":"Not administered",Y=88888:"Administered, dose not documented",Y=99999:"Not docume
nted",1:Y)
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00000 and 99999
DESCRIPTION: This item describes the intra-operative dose of radiation was administered to the patient. The
intra-operative dose may not be the dominant or most clinically significant dose delivered (data
item #38), record the intra-operative dose separately from the dose recorded in data item #38. If
intra-operative radiation therapy was not administered, code 00000. If intra-operative radiation
was administered but the dose is not documented, code 88888.
Allowable Codes: 00000 - no intraoperative radiation therapy
00001 thru 99998 - intraoperative dose administered
88888 - intraoperative radiation administered,
dose not documented
99999 - not documented if administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1568 GAS CONCURRENT CHEMOTHERAPY GAS2;30 SET
'1' FOR Chemo concurrent with radiation;
'2' FOR Chemo not concurrent with radiation;
'8' FOR No chemo/unknown if chemo administered;
'9' FOR Timing of chemo not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether radiation therapy and chemotherapy were administered to the patient at
the same time during the first course of treatment.
165.5,1569 GAS INTRAPERITONEAL CMX GAS2;31 SET
'1' FOR Catheter, mitoycin;
'2' FOR Catheter, 5-fluorouracil;
'3' FOR Catheter, other;
'4' FOR Portal vein, mitomycin;
'5' FOR Portal vein, 5-fluorouracil;
'6' FOR Portal vein, other;
'8' FOR Administered, method not documented;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the method of intraperitoneal chemotherapy administration and the chemotherapy
agent used.
165.5,1570 GAS ADMIN OF INTERFERON GAS2;32 SET
'1' FOR Administered;
'2' FOR Not administered;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes whether the patient was administered Interferon to treat the primary tumor.
165.5,1571 GAS CO-MORBID CONDITION 1 GAS2;33 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 000.00
001.00 thru 994.90 (valid ICD-CM codes)
If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining
co-morbid fields blank.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: Enter the ICD-CM code.
165.5,1571.1 GAS CO-MORBID CONDITION 2 GAS2;34 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 000.00
001.00 thru 994.90 (valid ICD-CM codes)
If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining
co-morbid fields blank.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: Enter the ICD-CM code.
165.5,1571.2 GAS CO-MORBID CONDITION 3 GAS2;35 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION:
This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 000.00
001.00 thru 994.90 (valid ICD-CM codes)
If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining
co-morbid fields blank.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: Enter the ICD-CM code.
165.5,1571.3 GAS CO-MORBID CONDITION 4 GAS2;36 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 000.00
001.00 thru 994.90 (valid ICD-CM codes)
If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining
co-morbid fields blank.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: Enter the ICD-CM code.
165.5,1571.4 GAS CO-MORBID CONDITION 5 GAS2;37 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 000.00
001.00 thru 994.90 (valid ICD-CM codes)
If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining
co-morbid fields blank.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: Enter the ICD-CM code.
165.5,1571.5 GAS CO-MORBID CONDITION 6 GAS2;38 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This field records a pre-existing medical condition that was present at the time of diagnosis for
this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM
code. Pre- existing conditions should be coded; do NOT code conditions which the patient acquired
while being treated for this condition.
Allowable Codes: 000.00
001.00 thru 994.90 (valid ICD-CM codes)
If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining
co-morbid fields blank.
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
EXPLANATION: Enter the ICD-CM code.
165.5,1572 GAS DURATION OF TOBACCO USE GAS2;39 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D DTU^ONCOIT
OUTPUT TRANSFORM: S Y=$S(Y="00":"Never used tobacco",Y=99:"Not documented",Y="01":Y_" year",1:Y_" years")
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00 and 99
DESCRIPTION: This item describes the number of known years the patient used some form of tobacco, even if the
patient is not presently using tobacco. If the patient has never used tobacco, code 00. If the
patient's tobacco use cannot be determined, or if the duration of use is not known, code 99.
Allowable Codes: 00 - never used tobacco
01 thru 98 - one or more years of tobacco use
99 - duration of tobacco use not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1573 GAS PERSONAL HIST OTH MALIG GAS2;40 POINTER TO ICDO TOPOGRAPHY FILE (#164)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the patient's prior history of other invasive malignancies. If the patient
has a history of other malignancies report the ICD-O-3 site code for the most recently diagnosed
disease. If the patient has no personal history of other cancer, code C88.8. If the patient's
personal history of other invasive malignancies is not documented, code C99.9.
Allowable Codes: C00.0 thru C80.9 - valid ICD-0-3 site (topography) codes
C88.8 - no personal history of other cancer
C99.9 - personal history of other cancer not documented
EXECUTABLE HELP: D ITEM3^ONCLPC1
165.5,1574 GAS WEIGHT LOSS GAS2;41 SET
'1' FOR Present;
'2' FOR Not present;
'9' FOR Not documented;
LAST EDITED: MAY 01, 2001
DESCRIPTION: This item describes the presence of weight loss specific to gastric cancer that was recorded in
the medical chart.
165.5,1575 GAS BOOST DOSE (cGy) GAS2;42 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) S ONCL=5 D BD^ONCOIT
LAST EDITED: MAY 01, 2001
HELP-PROMPT: Type a Number between 00000 and 99999
DESCRIPTION: This item describes the boost dose of radiation administered to the central tumor field of the
patient. If radiation was administered but boost dose is unknown, code 99999.
Allowable Codes: 00000 - no radiation boost dose administered
00001 thru 99998 - boost dose administered (cGy)
99999- boost dose administered, dose not documented
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1576 GAS CHEMOTHERAPEUTIC AGENT #1 GAS2;43 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.18,Y,0)),"^",2)_" "_$P($G(^ONCO(164.18,Y,0)),"^",1)
LAST EDITED: MAY 02, 2001
DESCRIPTION: This item records the first chemotherapeutic agent administered to the patient as part of the
first course of therapy. If chemotherapy was administered but the type(s) of agent(s) are unknown,
code 999999.
Allowable Codes: Valid NSC (National Service Center) number for
chemotherapeutic agents listed in the Self
Instructional Manual for Tumor Registrars, Book 8,
Surveillance, Epidemiology and End Results Program,
National Cancer Institute.
165.5,1576.1 GAS CHEMOTHERAPEUTIC AGENT #2 GAS2;44 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.18,Y,0)),"^",2)_" "_$P($G(^ONCO(164.18,Y,0)),"^",1)
LAST EDITED: MAY 02, 2001
DESCRIPTION: This item records the second chemotherapeutic agent administered to the patient as part of the
first course of therapy. If chemotherapy was administered but the type(s) of agent(s) are unknown,
code 999999.
Allowable Codes: Valid NSC (National Service Center) number for
chemotherapeutic agents listed in the Self
Instructional Manual for Tumor Registrars, Book 8,
Surveillance, Epidemiology and End Results Program,
National Cancer Institute.
165.5,1576.2 GAS CHEMOTHERAPEUTIC AGENT #3 GAS2;45 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.18,Y,0)),"^",2)_" "_$P($G(^ONCO(164.18,Y,0)),"^",1)
LAST EDITED: MAY 02, 2001
DESCRIPTION: This item records the third chemotherapeutic agent administered to the patient as part of the
first course of therapy. If chemotherapy was administered but the type(s) of agent(s) are unknown,
code 999999.
Allowable Codes: Valid NSC (National Service Center) number for
chemotherapeutic agents listed in the Self
Instructional Manual for Tumor Registrars, Book 8,
Surveillance, Epidemiology and End Results Program,
National Cancer Institute.
165.5,1577 GAS CHEMOTHERAPEUTIC TOXICITY GAS2;46 SET
'1' FOR Chemo discontinued due to toxicity;
'2' FOR No chemo toxicity;
'9' FOR Not documented;
LAST EDITED: MAY 02, 2001
DESCRIPTION: This item describes whether the administration of chemotherapy was discontinued as a result of
toxicity.
165.5,1578 GAS CHEMOTHERAPY/SURG SEQUENCE GAS2;47 SET
'1' FOR Chemo administered, no surgery;
'2' FOR Chemo administered before surgery;
'3' FOR Chemo administered after surgery;
'4' FOR Chemo administered before and after surgery;
'9' FOR Chemo and surgery administered, seq unk;
LAST EDITED: MAY 02, 2001
DESCRIPTION: This data item describes the sequence in which chemotherapy and surgery of the primary site were
administered.
165.5,1579 GAS COMPLICATION #1 GAS2;48 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This item describes the first medical complication acquired by the patient during or resulting
from the first course of therapy. Record valid ICD-CM codes.
Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
E930.0 - E949.7 (valid ICD-CM adverse effect codes)
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
EXPLANATION: If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
165.5,1579.1 GAS COMPLICATION #2 GAS2;49 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This item describes the first medical complication acquired by the patient during or resulting
from the first course of therapy. Record valid ICD-CM codes.
Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
E930.0 - E949.7 (valid ICD-CM adverse effect codes)
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
EXPLANATION: If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
165.5,1579.2 GAS COMPLICATION #3 GAS2;50 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This item describes the first medical complication acquired by the patient during or resulting
from the first course of therapy. Record valid ICD-CM codes.
Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
E930.0 - E949.7 (valid ICD-CM adverse effect codes)
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
EXPLANATION: If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
165.5,1579.3 GAS COMPLICATION #4 GAS2;51 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This item describes the first medical complication acquired by the patient during or resulting
from the first course of therapy. Record valid ICD-CM codes.
Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
E930.0 - E949.7 (valid ICD-CM adverse effect codes)
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
EXPLANATION: If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
165.5,1579.4 GAS COMPLICATION #5 GAS2;52 POINTER TO ICD DIAGNOSIS FILE (#80)
INPUT TRANSFORM: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(O
NCICD,U,4)
LAST EDITED: JUN 08, 2012
DESCRIPTION: This item describes the first medical complication acquired by the patient during or resulting
from the first course of therapy. Record valid ICD-CM codes.
Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
E930.0 - E949.7 (valid ICD-CM adverse effect codes)
SCREEN: S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
EXPLANATION: If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
165.5,1764 SUMMARY STAGE 2018 EOD;4 SET
'0' FOR In situ;
'1' FOR Localized only;
'2' FOR Regional by direct extension only;
'3' FOR Regional lymph nodes only;
'4' FOR Regional BOTH direct ext and LN;
'7' FOR Distant site(s)/node(s) involved;
'8' FOR Benign/Borderline;
'9' FOR Unknown;
LAST EDITED: NOV 12, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This item stores the directly assigned Summary Stage 2018. Effective for cases diagnosed 1/1/2018+.
Rationale: The SEER program has collected staging information on cases since its inception in 1973.
Summary Stage groups cases into broad categories of in situ, local, regional, and distant. Summary
Stage can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over
time. Codes: 0 In situ 1 Localized only 2 Regional by direct extension only 3 Regional lymph
nodes only 4 Regional by BOTH direct extension AND lymph node involvement 7 Distant site(s)/node(s)
involved 8 Benign/borderline* 9 Unknown if extension or metastasis (unstaged, unknown, or
unspecified)
Death certificate only case
SCREEN: S DIC("S")="D SCRNSS^ONCSCHMM"
EXPLANATION: Applicable codes depend on the Schema
CROSS-REFERENCE: ^^TRIGGER^165.5^7012
1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"NCR18")):^("NCR18"),1:"") S X=$P(Y(1
),U,13),X=X S DIU=X K Y S X=DIV S X=9,X=X X ^DD(165.5,1764,1,1,1.4)
1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"NCR18")),DIV=X S $P(^("NCR18"),U,13)=DIV,DIH=165.5,DIG=7012 D ^D
ICR
2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"NCR18")):^("NCR18"),1:"") S X=$P(Y(1
),U,13),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),"NCR18")),DIV=X S $P(^("NCR18"),U,13)=DI
V,DIH=165.5,DIG=7012 D ^DICR
CREATE VALUE)= INTERNAL(9)
DELETE VALUE)= @
FIELD)= DERIVED SUMM
This field will set the DERIVED SUMMARY STAGE to be set to '9'.
165.5,1772 EOD PRIMARY TUMOR EOD;1 NUMBER
INPUT TRANSFORM: K:X'?1.3N X I $D(X) D PTIT^ONCOEOD1
LAST EDITED: MAR 13, 2019
HELP-PROMPT: Type a number between 0 and 999, 0 decimal digits.
DESCRIPTION: EOD Primary Tumor is part of the EOD 2018 data collection system and is used to classify continuous
growth (extension) of primary tumor.
EXECUTABLE HELP: D PTHLP^ONCOEOD1
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1774 EOD REGIONAL NODES EOD;2 NUMBER
INPUT TRANSFORM: K:X'?1.3N X I $D(X) D RNIT^ONCOEOD1
LAST EDITED: MAR 13, 2019
HELP-PROMPT: Type a number between 0 and 999, 0 decimal digits.
DESCRIPTION: EOD Regional Nodes is part of the EOD 2018 data collection system and is used to classify the
regional lymph nodes involved with cancer at the time of diagnosis.
EXECUTABLE HELP: D RNHLP^ONCOEOD1
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,1776 EOD METS EOD;3 NUMBER
INPUT TRANSFORM: K:X'?1.3N X I $D(X) D MTIT^ONCOEOD1
LAST EDITED: MAR 13, 2019
HELP-PROMPT: Type a number between 0 and 99, 0 decimal digits.
DESCRIPTION: EOD Mets is part of the EOD 2018 data collection system and is used to classify the distant site(s)
of metastatic involvement at time of diagnosis.
EXECUTABLE HELP: D MTHLP^ONCOEOD1
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,2000 DIVISION DIV;1 POINTER TO INSTITUTION FILE (#4) (Required)
LAST EDITED: DEC 17, 1999
DESCRIPTION: DIVISION is the division to which this primary belongs.
165.5,3000 CLASS OF CASE CONVERSION FLAG CONV;1 SET
'1' FOR Converted;
LAST EDITED: SEP 16, 2009
HELP-PROMPT: Enter 1 (Converted) if CLASS OF CASE has been converted to NAACCR v12.
DESCRIPTION:
Indicates that the CLASS OF CASE value has been converted to NAACCR v12.
165.5,3001 STATE AT DX CONVERSION FLAG CONV;2 SET
'1' FOR Converted;
LAST EDITED: SEP 16, 2009
HELP-PROMPT: Enter 1 (Converted) if STATE AT DX has been converted to NAACCR v12.
DESCRIPTION:
Indicates that the STATE AT DX value has been converted to NAACCR v12.
165.5,3700 SEER SSF1-HPV STATUS SSD4;33 SET
'0' FOR Neg vrl DNA (ISH);
'1' FOR Pos vrl DNA (ISH);
'2' FOR Neg vrl DNA (PCR);
'3' FOR Pos vrl DNA (PCR);
'4' FOR Neg ISH E6/E7 RNA;
'5' FOR Pos ISH E6/E7 RNA;
'6' FOR Neg RT-PCR;
'7' FOR Pos RT-PCR;
'8' FOR Reported, status unk;
'9' FOR Unk if performed;
LAST EDITED: SEP 12, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: SEER Site-specific Factor 1 is new for 2018. This data item is reserved for human papilloma virus
(HPV) status. This data item only applies to:
Oropharynx (p16+): C019, C024, C051-C052, C090-C091,
C098-C099, C100, C102-C103, C108-C109, C111
Oropharynx (p16-) and Hypopharynx: C019, C024, C051-C052,
C090-C091, C098-C099, C100, C102-C103, C108-C109, C111
C129, C130-C132, C138-C139
Lip and Oral Cavity: C000-C009, C020-C023, C028-C029, C030-C031,
C039, C040-C041, C048-C049, C050, C058-C059, C060-C062, C068-C069 There is evidence that
human papilloma virus (HPV) plays a role in the pathogenesis of some cancers. HPV testing may be
performed for prognostic purposes; testing may also be performed on metastatic sites to aid in
determination of the primary site.
0 HPV negative for viral DNA by ISH test 1 HPV positive for viral DNA by ISH test 2 HPV
negative for viral DNA by PCR test 3 HPV positive for viral DNA by PCR test 4 HPV negative by
ISH E6/E7 RNA test 5 HPV positive by ISH E6/E7 RNA test 6 HPV negative by RT-PCR E6/E7 RNA
test 7 HPV positive by RT-PCR E6/E7 RNA test 8 HPV status reported in medical records as
positive or negative but test type is unknown 9 Unknown if HPV test detecting viral DNA
and or RNA was performed
165.5,3800 SCHEMA ID SSD1;1 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<5) X
MAXIMUM LENGTH: 5
LAST EDITED: SEP 07, 2018
HELP-PROMPT: Answer must be 5 characters in length.
DESCRIPTION: This field contains the SCHEMA ID for the Abstract which is calculated using the Site/GP, Histology
and possibly Schema Discriminators.
165.5,3800.1 SCHEMA ID DESCRIPTION SSD5;6 FREE TEXT
INPUT TRANSFORM: K:$L(X)>70!($L(X)<5) X
MAXIMUM LENGTH: 70
LAST EDITED: DEC 20, 2021
HELP-PROMPT: Answer must be 5-70 characters in length.
DESCRIPTION:
This field will contain the Schema ID and description which will be useful for the Cancer Cube.
165.5,3801 CHROMOSOME 1P: (LOH) SSD1;2 SET
'0' FOR LOH not identified/not present;
'1' FOR LOH identified/present;
'6' FOR Benign or borderline tumor;
'7' FOR Test ordered, results not in chart;
'8' FOR Not applicable;
'9' FOR Not documented in patient record;
LAST EDITED: JUN 21, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Chromosome 1p: Loss of Heterozygosity (LOH) refers to the loss of genetic material normally found
on the short arm of one of the patient's two copies of chromosome 1. Codeletion of Chromosome 1p
and 19q is a diagnostic, prognostic and predictive marker for gliomas and is strongly associated
with the oligodendroglioma phenotype. Codes: 0 Chromosome 1p deletion/LOH not identified/not
present 1 Chromosome 1p deletion/LOH identified/present 6 Benign or borderline tumor 7 Test
ordered, results not in chart 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of
code 8 will result in an edit error.) 9 Not documented in patient record
Cannot be determined by the pathologist
Chromosome 1p deletion/LOH not assessed or unknown if assessed
165.5,3802 CHROMOSOME 19Q: (LOH) SSD1;3 SET
'0' FOR LOH not identified/not present;
'1' FOR LOH present;
'6' FOR Benign or borderline tumor;
'7' FOR Test ordered, results not in chart;
'8' FOR Not applicable;
'9' FOR Not documented in patient record;
LAST EDITED: JUN 21, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Chromosome 19q: Loss of Heterozygosity (LOH) refers to the loss of genetic material normally found
on the long arm of one of the patient's two copies of chromosome 19. Codeletion of Chromosome 1p
and 19q is a diagnostic, prognostic and predictive marker for gliomas and is strongly associated
with the oligodendroglioma phenotype. Codes: 0 Chromosome 19q deletion/LOH not identified/not
present 1 Chromosome 19q deletion/LOH present 6 Benign or borderline tumor 7 Test ordered,
results not in chart 8 Not applicable: Information not collected for this case
If this item is required by your standard setter, use of code 8 will
result in an edit error.) 9 Not documented in patient record
Cannot be determined by the pathologist
Chromosome 19q: LOH not assessed or unknown if assessed
165.5,3803 ADENOID CYSTIC BASALOID PTTRN SSD1;4 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM
MAXIMUM LENGTH: 5
LAST EDITED: OCT 09, 2019
HELP-PROMPT: Answer must be 1-5 characters in length.
DESCRIPTION: Adenoid Cystic Basaloid Pattern, the presence of a basaloid pattern on pathological examination is
a prognostic factor for adenoid cystic carcinoma of the lacrimal gland. Rationale: Adenoid Cystic
Basaloid Pattern is a Registry Data Collection Variable in AJCC 8. This data item was previously
collected as Lacrimal Gland, SSF#6. Codes: 0.0-100.0 0.0 to 100.0 percent basaloid pattern XXX.5
Basaloid pattern present, percentage not stated XXX.8 Not applicable: Information not collected
for this case
(If this item is required by your standard setter, use of code
XXX.8 will result in an edit error.) XXX.9 Not documented in medical record
Adenoid Cystic Basaloid Pattern not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3804 ADENOPATHY SSD1;5 SET
'0' FOR Adenopathy not identified/not present;
'1' FOR Adenopathy present;
'5' FOR NA, site not C421;
'9' FOR Not documented in medical record;
LAST EDITED: JUN 27, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Adenopathy is defined as the presence of lymph nodes greater than 1.5 cm on physical examination
(PE) and is part of the staging criteria for Chronic Lymphocytic Leukemia/Small Lymphocytic
Lymphoma (CLL/SLL). Rationale: Adenopathy is a prognostic factor required for staging of Chronic
Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79 Hodgkin
and Non-Hodgkin Lymphomas. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0
Adenopathy not identified/not present
No lymph nodes >1.5 cm 1 Adenopathy present
Presence of lymph nodes >1.5 cm 5 Not applicable: Primary site is not C421 9 Not documented
in medical record
Adenopathy not assessed or unknown if assessed
SCREEN: S DIC("S")="D SCRNFIV^ONCSCHMM"
EXPLANATION: Codes depend on appropriate primary site
165.5,3805 AFP POST-ORCHIECTOMY LAB VAL SSD1;6 FREE TEXT
INPUT TRANSFORM: K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM
MAXIMUM LENGTH: 7
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-7 characters in length.
DESCRIPTION: AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value refers to the lowest AFP value measured
post-orchiectomy. AFP is a serum tumor marker that is often elevated in patients with
nonseminomatous germ cell tumors of the testis. The Post-Orchiectomy lab value is used to monitor
response to therapy. Rationale: AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value is a Registry
Data Collection Variable in AJCC. It was previously collected as Testis CS SSF#12. Codes: 0.0
0.0 nanograms/milliliter (ng/mL) 0.1-99999.9 0.1-99,999.9 ng/mL XXXXX.1 100,000 ng/mL or
greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information not
collected for this case
(If this information is required by your standard setter,
use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical
record
Noorchiectomy performed
AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value
not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3806 AFP POST-ORCHIECTOMY RANGE SSD1;7 SET
'0' FOR Within normal limits;
'1' FOR Above normal & <1000ng/mL;
'2' FOR 1000-10000ng/mL;
'3' FOR >10000ng/mL;
'4' FOR AFP stated to be elevated;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 09, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: AFP (Alpha Fetoprotein) Post-Orchiectomy Range identifies the range category of the lowest AFP
value measured post-orchiectomy. AFP is a serum tumor marker that is often elevated in patients
with nonseminomatous germ cell tumors of the testis. The Post-Orchiectomy lab value is used to
monitor response to therapy. Rationale: AFP (Alpha Fetoprotein) Post-Orchiectomy Range is a
Registry Data Collection Variable in AJCC. AFP (Alpha Fetoprotein) Post-Orchiectomy Range is used
to assign the S Category Pathological and was previously collected as Testis CS SSF#13. Codes: 0
Within normal limits 1 Above normal and less than 1,000 nanograms/milliliter (ng/mL) 2 1,000
-10,000 ng/mL 3 Greater than 10,000 ng/mL 4 Post-Orchiectomy alpha fetoprotein (AFP) stated to
be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected
for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error.) 9 Not documented in medical record
No orchiectomy performed
AFP (Alpha Fetoprotein) Post-Orchiectomy Range not assessed or
unknown if assessed
165.5,3807 AFP PRE-ORCHIECTOMY LAB VALUE SSD1;8 FREE TEXT
INPUT TRANSFORM: K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM
MAXIMUM LENGTH: 7
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-7 characters in length.
DESCRIPTION: AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value refers to the AFP value measured prior to
treatment. AFP is a tumor marker that is often elevated in patients with nonseminomatous germ cell
tumors of the testis. Rationale: AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value is a Registry
Data Collection Variable in AJCC. It was previously collected as Testis CS SSF#6 Codes: 0.0
0.0 nanograms/milliliter (ng/mL) 0.1-99999.9 0.1-99,999.9 ng/mL XXXXX.1 100,000 ng/mL or
greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information not
collected for this case
(If this information is required by your standard setter,
use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical
record
AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value
not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3808 AFP PRE-ORCHIECTOMY RANGE SSD1;9 SET
'0' FOR Within normal limits;
'1' FOR Above normal & <1000ng/mL;
'2' FOR 1000-10000ng/mL;
'3' FOR >10000ng/mL;
'4' FOR AFP stated to be elevated;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 09, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: AFP (Alpha Fetoprotein) Pre-Orchiectomy Range identifies the range category of the highest AFP
value measured prior to treatment. AFP is a serum tumor marker that is often elevated in patients
with nonseminomatous germ cell tumors of the testis. Rationale: AFP (Alpha Fetoprotein)
Pre-Orchiectomy Range is a Registry Data Collection Variable in AJCC. AFP (Alpha Fetoprotein)
Pre-Orchiectomy Range is used to assign the S Category Clinical and was previously collected as
Testis CS SSF#7. Codes: 0 Within normal limits 1 Above normal and less than 1,000
nanograms/milliliter (ng/mL) 2 1,000 -10,000 ng/mL 3 Greater than 10,000 ng/mL 4
Pre-Orchiectomy alpha fetoprotein (AFP) stated to be elevated 7 Test ordered, results not in
chart 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
AFP (Alpha Fetoprotein) Pre-Orchiectomy Range not assessed
or unknown if assessed
165.5,3809 AFP PRETREATMENT INTERPRET SSD1;10 SET
'0' FOR Within normal limits;
'1' FOR Positive/elevated;
'2' FOR Borderline;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUN 28, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: AFP (Alpha Fetoprotein) Pretreatment Interpretation, a nonspecific serum protein that generally is
elevated in the setting of hepatocellular carcinoma (HCC), is a prognostic factor for liver cancer.
Rationale: AFP (Alpha Fetoprotein) Pretreatment Interpretation is a Registry Data Collection
Variable in AJCC. This data item was previously collected for Liver, CS SSF# 1. Codes: 0
Negative/normal; within normal limits 1 Positive/elevated 2 Borderline; undetermined if
positive or negative 7 Test ordered, results not in chart 8 Not applicable: Information not
collected for this case
(If this item is required by your standard setter, use of code 8 will
result in an edit error.) 9 Not documented in medical record
AFP pretreatment interpretation not assessed or unknown if assessed
165.5,3810 AFP PRETREATMENT LAB VALUE SSD1;11 FREE TEXT
INPUT TRANSFORM: K:$L(X)>6!($L(X)<1)!'(X?0.4AN0.1"."1N) X I $D(X) D DEC4^ONCSCHMM
MAXIMUM LENGTH: 6
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-6 characters in length.
DESCRIPTION: AFP (Alpha Fetoprotein) Pretreatment Lab Value is a nonspecific serum protein that generally is
elevated in the setting of hepatocellular carcinoma (HCC). This data item pertains to the
pre-treatment lab value. Rationale: AFP (Alpha Fetoprotein) Pretreatment Lab Value is a Registry
Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 3.
Codes: 0.0 0.0 nanograms/milliliter (ng/ml); not detected 0.1-9999.9 0.1-9999.9 ng/ml
(Exact value to nearest tenth of ng/ml) XXXX.1 10,000.0 ng/ml or greater XXXX.7
Test ordered, results not in chart XXXX.8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of
code XXXX.8 will result in an edit error.) XXXX.9 Not documented in medical record
AFP (Alpha Fetoprotein) Pretreatment Lab Value not
assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3811 ANEMIA SSD1;12 SET
'0' FOR Anemia not present, Hgb GT or equal 11.0 g/dL;
'1' FOR Anemia present, Hgb<11.0 g/dL;
'5' FOR NA, site not C421;
'6' FOR Lab value unk, physician states pt is anemic;
'7' FOR Test ordered, results not in chart;
'9' FOR Not documented in medical record;
LAST EDITED: MAY 03, 2023
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Anemia is defined by a deficiency of red blood cells or of hemoglobin in the blood. In staging of
Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL), anemia is defined as Hgb less
than 11.0 g/dL. Rationale: Anemia is a prognostic factor required for staging of Chronic
Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79 Hodgkin
and Non-Hodgkin Lymphomas. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Anemia
not present
Hgb >=11.0 g/dL
Physician states RAI stage 0-II 1 Anemia present
Hgb <11.0 g/dL 5 Not applicable: Primary site is not C421 6 Lab value unknown,
physician states patient is anemic
Physician states RAI stage III 7 Test ordered, results not in chart 9 Not documented in
medical record
Anemia not assessed or unknown if assessed
SCREEN: S DIC("S")="D SCRNFIV^ONCSCHMM"
EXPLANATION: Codes depend on appropriate primary site
165.5,3812 B SYMPTOMS SSD1;13 SET
'0' FOR No B symptoms (asymptomatic);
'1' FOR Any B symptom(s);
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUN 28, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: B symptoms refer to systemic symptoms of fever, night sweats, and weight loss which can be
associated with both Hodgkin lymphoma and some non-Hodgkin lymphomas. The presence of B symptoms is
a prognostic factor for some lymphomas. Rationale: B symptoms is a Registry Data Collection
Variable in AJCC. This data item was previously collected for Lymphomas, SSF# 2. Codes: 0 No B
symptoms (asymptomatic)
Classified as "A" by physician when asymptomatic 1 Any B symptom(s)
Night sweats (drenching)
Unexplained fever (above 38 degrees C)
Unexplained weight loss (generally greater than 10% of body
weight in the six months before admission)
B symptoms, NOS
Classified as "B" by physician when symptomatic 8 Not applicable: Information not collected
for this case
(If this item is required by your standard setter, use of code 8 will
result in an edit error.) 9 Not documented in medical record
B symptoms not assessed or unknown if assessed
165.5,3813 BILIRUBIN PRE TOTAL LAB VALUE SSD1;14 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM
MAXIMUM LENGTH: 5
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-5 characters in length.
DESCRIPTION: Bilirubin Pretreatment Total Lab Value records the bilirubin value prior to treatment. Bilirubin
level is an indicator of how effectively the liver excretes bile and is required to calculate the
Model for End-Stage Liver Disease (MELD) score used to assign priority for liver transplant.
Rationale: Bilirubin Pretreatment Total Lab Value is a Registry Data Collection Variable in AJCC.
This data item was previously collected as Liver, CS SSF# 6. Codes: 0.0 0.0
milligram/deciliter (mg/dL)
0.0 micromole/liter (umol/L) 0.1-999.9 0.1-999.9 milligram/deciliter (mg/dL)
0.1-999.9 micromole/liter (umol/L) XXX.1 1000 milligram/deciliter (mg/dL) or greater
1000 micromole/liter (umol/L) or greater XXX.7 Test ordered, results not in chart XXX.8
Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of
code XXX.8 will result in an edit error.) XXX.9 Not documented in medical record
Bilirubin Pretreatment Total Lab Value not assessed or unknown
if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3814 BILIRUBIN PRETREATMENT UNIT SSD1;15 SET
'1' FOR Milligrams per deciliter (mg/dL);
'2' FOR Micromoles/liter (umol/L);
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUN 28, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Bilirubin Pretreatment Unit of Measure identifies the unit of measure for the bilirubin value
measured prior to treatment. Bilirubin is commonly measured in units of Milligrams/deciliter
(mg/dL) in the United States and Micromoles/liter (umol/L) in Canada and Europe. Rationale:
Bilirubin Pretreatment is a Registry Data Collection Variable in AJCC. Bilirubin Pretreatment Unit
of Measure is needed to identify the unit in which bilirubin is measured and was previously
collected as Liver, CS SSF# 7. Codes: 1 Milligrams per deciliter (mg/dL) 2 Micromoles/liter
(umol/L) 7 Test ordered, results not in chart 8 Not applicable: Information not collected for
this case
(If this item is required by your standard setter, use of
code 8 will result in an edit error.) 9 Not documented in medical record
Bilirubin unit of measure not assessed or unknown if assessed
165.5,3815 BONE INVASION SSD1;16 SET
'0' FOR Bone invasion not present/not identified on imaging;
'1' FOR Bone invasion present/identified on imaging;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 09, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Bone invasion, the presence or absence of bone invasion based on imaging, is a prognostic factor
for soft tissue sarcomas. Rationale: Bone Invasion is a Registry Data Collection Variable in AJCC.
This data item was previously collected for Soft Tissue, SSF# 3. Codes: 0 Bone invasion not
present/not identified on imaging 1 Bone invasion present/identified on imaging 8 Not
applicable: Information not collected for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error.) 9 Not documented in medical record
Bone invasion not assessed or unknown if assessed
165.5,3816 BRAIN MOLECULAR MARKERS SSD1;17 POINTER TO ONCO BRAIN MOLECULAR MARKERS FILE (#167.1)
LAST EDITED: JUL 09, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Multiple brain molecular markers have become standard pathology components necessary for diagnosis.
This data item captures clinically important brain cancer subtypes identified by molecular markers
that are not distinguishable by ICD-O-3 codes. Rationale: Collection of these clinically important
brain cancer subtypes has been recommended by CBTRUS. Codes: 01 Diffuse astrocytoma, IDH-mutant
(9400/3) 02 Diffuse astrocytoma, IDH-wildtype (9400/3) 03 Anaplastic astrocytoma, IDH-mutant
(9401/3) 04 Anaplastic astrocytoma, IDH-wildtype (9401/3) 05 Glioblastoma, IDH-wildtype
(9440/3) 06 Oligodendroglioma, IDH-mutant and 1 p/19q
co-deleted (9450/3) 07 Anaplastic oligodendroglioma, IDH-mutant and 1 p/19q
co-deleted (9451/3) 08 Medulloblastoma, SHH-activated and TP53-wildtype (9471/3) 09
Embryonal tumor with multilayered rosettes, C19MC-
altered (9478/3) 85 Not applicable: Histology not 9400/3, 9401/3, 9440/3,
9450/3, 9451/3, 9471/3, 9478/3 86 Benign or borderline tumor 87 Test ordered, results
not in chart 88 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code 88 will result in an edit error.) 99 Not documented in patient record
No microscopic confirmation
Brain molecular markers not assessed or unknown if assessed
165.5,3817 BRESLOW TUMOR THICKNESS SSD1;18 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1) X I $D(X) D BTTIT^ONCSCHMM
MAXIMUM LENGTH: 4
LAST EDITED: SEP 18, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Breslow Tumor Thickness, the measurement of the thickness of a Melanoma as defined by Dr. Alexander
Breslow, is a prognostic factor for Melanoma of the Skin. Rationale: Breslow Tumor Thickness is a
Registry Data Collection Variable in AJCC. It was previously collected as Melanoma Skin, CS SSF# 1.
Codes:
0.0 No mass/tumor found
0.1 Greater than 0.0 and less than or equal to 0.1 0.2-99.9 0.2 - 99.9 millimeters XX.1 100
millimeters or larger A0.1-A9.9 Stated as "at least" some measured value of 0.1 to 9.9 AX.0
Stated as greater than 9.9 mm XX.8 Not applicable: Information not collected for this schema
(If this item is required by your standard setter, use of
code XX.8 will result in an edit error) XX.9 Not documented in medical record
Microinvasion; microscopic focus or foci only and no depth given
Cannot be determined by pathologist
In situ melanoma
Breslow Tumor Thickness not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3818 CA-125 PRETREATMENT INTER SSD1;19 SET
'0' FOR Negative/normal;
'1' FOR Positive/elevated;
'2' FOR Stated as borderline;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 09, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Carbohydrate Antigen 125 (CA-125) is a tumor marker that is useful for following the response to
therapy in patients with ovarian cancer, who may have elevated levels of this marker. Rationale:
Preoperative CA-125 is a Registry Data Collection Variable listed in AJCC. It was previously
collected as Ovary, CS SSF# 1. Codes: 0 Negative/normal; within normal limits 1
Positive/elevated 2 Stated as borderline; undetermined whether positive or negative 7 Test
ordered, results not in chart 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of
code 8 will result in an edit error) 9 Not documented in medical record
CA-125 not assessed or unknown if assessed
165.5,3819 CEA PRETREATMENT INTER SSD1;20 SET
'0' FOR CEA negative/normal;
'1' FOR CEA positive/elevated;
'2' FOR Borderline;
'3' FOR Undetermined if positive or negative;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 09, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: CEA (Carcinoembryonic Antigen) Pretreatment Interpretation refers to the interpretation of the CEA
value prior to treatment. CEA is a glycoprotein that is produced by adenocarcinomas from all sites
as well as many squamous cell carcinomas of the lung and other sites. CEA may be measured in
blood, plasma or serum. CEA is a prognostic marker for adenocarcinomas of the appendix, colon and
rectum and is used to monitor response to treatment Rationale: CEA (Carcinoembryonic Antigen) is a
Registry Data Collection Variable for AJCC 8. CEA (Carcinoembryonic Antigen) Pretreatment
Interpretation was previously collected as Colon and Rectum, CS SSF #1. Codes: 0 CEA
negative/normal; within normal limits 1 CEA positive/elevated 2 Borderline 3 Undetermined if
positive or negative (normal values not available)
AND no MD interpretation 7 Test ordered, results not in chart 8 Not applicable:
Information not collected for this case
(If this data item is required by your standard setter, use of
code 8 will result in an edit error.) 9 Not documented in medical record
CEA (Carcinoembryonic Antigen) Pretreatment Interpretation not
assessed or unknown if assessed
165.5,3820 CEA PRETREATMENT LAB VALUE SSD1;21 FREE TEXT
INPUT TRANSFORM: K:$L(X)>6!($L(X)<1)!'(X?0.4AN0.1"."1N) X I $D(X) D DEC4^ONCSCHMM
MAXIMUM LENGTH: 6
LAST EDITED: JUL 31, 2019
HELP-PROMPT: Answer must be 1-6 characters in length.
DESCRIPTION: CEA (Carcinoembryonic Antigen) Pretreatment Lab Value records the CEA value prior to treatment. CEA
is a nonspecific tumor marker that has prognostic significance for colon and rectum cancer.
Rationale: CEA (Carcinoembryonic Antigen) Pretreatment Lab Value is a Registry Data Collection
Variable in AJCC. It was previously collected as Colon and Rectum, CS SSF# 3. Codes: 0.0 0.0
nanograms/milliliter (ng/m) exactly 0.1-9999.9 0.1-9999.9 ng/ml
(Exact value to nearest tenth in ng/ml) XXXX.1 10,000 ng/ml or greater XXXX.7 Test
ordered, results not in chart XXXX.8 Not applicable: Information not collected for this case
(If this information is required by your standard setter, use
of code XXXX.8 may result in an edit error.) XXXX.9 Not documented in medical record
CEA (Carcinoembryonic Antigen) Pretreatment Lab Value not
assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3821 CHROMOSOME 3 STATUS SSD1;22 SET
'0' FOR No loss of chromosome 3;
'1' FOR Partial loss of chromosome 3;
'2' FOR Complete loss of chromosome 3;
'3' FOR Loss of chromosome 3, NOS;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 09, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Chromosome 3 Status refers to the partial or total loss of Chromosome 3, which is a prognostic
factor for uveal melanoma. Rationale: Chromosome 3 Status is a Registry Data Collection Variable
in AJCC. This data item was previously collected as Uveal Melanoma, CS SSF# 5. Codes: 0 No loss
of chromosome 3 1 Partial loss of chromosome 3 2 Complete loss of chromosome 3 3 Loss of
chromosome 3, NOS 7 Test ordered, results not in chart 8 Not applicable: Information not
collected for this case
(If this information is required by your standard setter, use
of code 8 may result in an edit error.) 9 Not documented in medical record
Chromosome 3 status not assessed or unknown if assessed
165.5,3822 CHROMOSOME 8Q STATUS SSD1;23 SET
'0' FOR No gain in chromosome 8q;
'1' FOR Gain in chromosome 8q;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 09, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Chromosome 8q Status refers to gain in Chromosome 8q, which is a prognostic factor for uveal
melanoma. Rationale: Chromosome 8q Status is a Registry Data Collection Variable in AJCC. This
data item was previously collected as Uveal Melanoma, CS SSF# 7. Codes: 0 No gain in chromosome
8q 1 Gain in chromosome 8q 7 Test ordered, results not in chart 8 Not applicable: Information
not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
Chromosome 8q status not assessed or unknown if assessed
165.5,3823 CIRCUMFERENTIAL RESECT MARGIN SSD1;24 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
MAXIMUM LENGTH: 4
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Circumferential or Radial Resection Margin, the distance in millimeters between the leading edge of
the tumor and the surgically dissected margin as recorded on the pathology report, is a prognostic
indicator for colon and rectal cancer. This may also be referred to as the Radial Resection Margin
or surgical clearance. Rationale: Circumferential or Radial Resection Margin is a Registry Data
Collection Variable in AJCC. It was previously collected as Colon and Rectum CS SSF# 6. Codes:
0.0 Circumferential resection margin (CRM) positive
Margin IS involved with tumor
Described as "less than 1 millimeter (mm)" 0.1-99.9 Distance of tumor from margin: 0.1-
99.9 millimeters (mm)
(Exact size to nearest tenth of millimeter) XX.0 100 mm or greater XX.1 Margins clear,
distance from tumor not stated
Circumferential or radial resection margin negative, NOS
No residual tumor identified on specimen XX.2 Margins cannot be assessed XX.3
Described as "at least" 1 mm XX.4 Described as "at least" 2 mm XX.5 Described as "at least" 3
mm XX.6 Described as "greater than" 3 mm XX.7 No resection of primary site
Surgical procedure did not remove enough tissue to measure
the circumferential or radial resection margin
(Examples include: polypectomy only, endoscopic mucosal
resection (EMR), excisional biopsy only, transanal disk excision) XX.8 Not applicable:
Information not collected for this case
(If this information is required by your standard setter, use of
code XX.8 may result in an edit error.) XX.9 Not documented in medical record
Circumferential or radial resection margin not assessed
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3824 CREATININE PRETREAT LAB VALUE SSD1;25 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
MAXIMUM LENGTH: 4
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Creatinine Pretreatment Lab Value, an indicator of kidney function is required to calculate the
Model for End-Stage Liver Disease (MELD) score, which is used to assign priority for liver
transplant. Rationale: Creatinine Pretreatment Lab Value is a Registry Data Collection Variable in
AJCC. This data item was previously collected for Liver, CS SSF# 4. Codes:
0.0 0.0 milligram/deciliter (mg/dl)
0.0 micromole/liter (umol/L) 0.1-99.9 0.1-99.9 milligram/deciliter (mg/dl)
0.1-99.9 micromole/liter (umol/L)
(Exact value to nearest tenth of mg/dl or umol/L) XX.1 100 mg/dl or greater
100 umol/L or greater XX.7 Test ordered, results not in chart XX.8 Not applicable:
Information not collected for this case
(If this item is required by your standard setter, use of
code XX.8 will result in an edit error.) XX.9 Not documented in medical record
Creatinine Pretreatment Lab Value not assessed or
unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3825 CREATININE PRETREAT UNIT SSD1;26 SET
'1' FOR Milligrams/deciliter;
'2' FOR Micromoles/liter;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 10, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Creatinine Pretreatment Unit of Measure identifies the unit of measure for the creatinine value
measured in blood or serum prior to treatment. Creatinine is commonly measured in units of
Milligrams/deciliter (mg/dL) in the United States and Micromoles/liter (umol/L) in Canada and
Europe. Rationale: Creatinine Pretreatment is a Registry Data Collection Variable in AJCC.
Creatinine Pretreatment Unit of Measure is needed to identify the unit in which creatinine is
measured and was previously collected as Liver, CS SSF# 5. Codes: 1 Milligrams/deciliter (mg/dL)
2 Micromoles/liter (umol/L) 7 Test ordered, results not in chart 8 Not applicable:
Information not collected for this case
(If this item is required by your standard setter, use of
code 8 will result in an edit error.) 9 Not documented in medical record
Creatinine unit of measure not assessed or
unknown if assessed
165.5,3826 ER PERCENT POSITIVE SSD1;27 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3AN) X I $D(X) D ERR^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: JUN 25, 2020
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: Estrogen Receptor, Percent Positive Range is the percent of cells staining estrogen receptor
positive by IHC. Rationale: Estrogen Receptor, Percent Positive Range is a Registry Data
Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 000 ER
negative, or stated as less than 1% 001-100 1-100 percent R10 Stated as 1-10% R20 Stated as
11-20% R30 Stated as 21-30% R40 Stated as 31-40% R50 Stated as 41-50% R60 Stated as 51-60%
R70 Stated as 61-70% R80 Stated as 71-80% R90 Stated as 81-90% R99 Stated as 91-100% XX8
Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of
code XX8 will result in an edit error.) XX9 Not documented in medical record
Estrogen Receptor, Percent Positive Range not assessed
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3827 ER SUMMARY SSD1;28 SET
'0' FOR ER negative;
'1' FOR ER positive;
'7' FOR Test ordered, results not in chart;
'9' FOR Not documented in medical record;
LAST EDITED: OCT 21, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: ER (Estrogen Receptor) Summary is a summary of results of the estrogen receptor (ER) assay.
Rationale: This data item is required for prognostic stage grouping in AJCC 8th ed- ition, Chapter
48, Breast. It was previously collected as Breast CS SSF # 1. Codes: 0 ER negative 1 ER
positive 7 Test ordered, results not in chart 9 Not documented in medical record
Cannot be determined (indeterminate)
ER (Estrogen Receptor) Summary status not assessed
or unknown if assessed
165.5,3828 ER ALLRED SCORE SSD1;29 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D ERTA^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: OCT 22, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Estrogen Receptor, Total Allred Score is based on the percentage of cells that stain positive by
IHC for estrogen receptor (ER) and the intensity of that staining. Rationale: Estrogen Receptor,
Total Allred Score is a Registry Data Collection Variable in AJCC. It is a new data item for cases
diagnosed 1/1/2018+. Codes: 00 Total ER Allred score of 0 01 Total ER Allred score of 1 02
Total ER Allred score of 2 03 Total ER Allred score of 3 04 Total ER Allred score of 4 05
Total ER Allred score of 5 06 Total ER Allred score of 6 07 Total ER Allred score of 7 08
Total ER Allred score of 8 X8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of
code X8 will result in an edit error.) X9 Not documented in medical record
Estrogen Receptor, Total Allred Score not assessed,
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3829 ESOPHAGUS EGJ TUMOR EPICENTER SSD1;30 SET
'0' FOR U - Upper;
'1' FOR M - Middle;
'2' FOR L - Lower;
'9' FOR X - Esophagus, NOS;
LAST EDITED: JUL 11, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Esophagus and Esophagogastric Junction (EGJ), Squamous Cell (including adenosquamous), Tumor
Location refers to the position of the epicenter of the tumor in the esophagus. Rationale: This
data item is required for prognostic stage grouping for squamous and adenosquamous carcinoma in
AJCC 8th edition, Chapter 16. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 U:
Upper (Cervical/Proximal esophagus to lower border
of azygos vein) 1 M: Middle (Lower border of azygos vein to lower border
of inferior pulmonary vein) 2 L: Lower (Lower border of inferior pulmonary vein to
stomach,
including gastroesophageal junction) 9 X: Esophagus, NOS
Specific location of epicenter not documented in medical record
Specific location of epicenter not assessed or unknown if assessed
165.5,3830 ENE CLIN (NON-HEAD AND NECK) SSD1;31 SET
'0' FOR ENE not present/not identified;
'1' FOR ENE present based on exam or imaging;
'2' FOR ENE present based on microscopic confirmation;
'7' FOR No LN involvement;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: SEP 09, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Extranodal Extension (ENE) Clinical is defined as "the extension of a nodal metastasis through the
lymph node capsule into adjacent tissue" during the diagnostic workup. This data item defines
clinical ENE for sites other than Head and Neck. Rationale: Extranodal Extension Clinical
(non-Head and Neck) is a Registry Data Collection Variable for AJCC. This data item was previously
collected for Penis, SSF# 17. Codes: 0 Regional lymph nodes involved, ENE not present/not
identified
during diagnostic workup 1 Regional lymph nodes involved, ENE present/identified during
diagnostic workup, based on physical exam and/or imaging 2 Regional lymph nodes involved,
ENE present/identified during
diagnostic workup, based on microscopic confirmation 7 No lymph node involvement during
diagnostic workup (cN0) 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error) 9 Not documented in medical record
Clinical ENE not assessed or unknown if assessed during
diagnostic workup
Clinical assessment of lymph nodes not done, or unknown if done
165.5,3831 ENE HEAD AND NECK CLINICAL SSD1;32 SET
'0' FOR ENE not present/not identified;
'1' FOR ENE present based on physical exam;
'2' FOR ENE present based on microscopic confirmation;
'7' FOR No LN involvement;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: SEP 09, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Extranodal extension (ENE) is defined as "the extension of a nodal metastasis through the lymph
node capsule into adjacent tissue" and is a prognostic factor for most head and neck tumors. This
data item pertains to clinical staging extension. Rationale Extranodal Extension Head and Neck
Clinical is a Registry Data Collection Variable in AJCC. It was previously collected as Head and
Neck SSF# 8 (Common SSF). Codes: 0 Regional lymph nodes involved, ENE not present/not identified
during diagnostic workup 1 Regional lymph nodes involved, ENE present/identified during
diagnostic workup, based on physical exam and/or imaging 2 Regional lymph nodes involved,
ENE present/identified during
diagnostic workup, based on microscopic confirmation 7 No lymph node involvement during
diagnostic workup (cN0) 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error) 9 Not documented in medical record
Clinical ENE not assessed or unknown if assessed during
diagnostic workup
Clinical assessment of lymph nodes not done, or unknown if done
165.5,3832 ENE HEAD AND NECK PATHOLOGICAL SSD1;33 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?0.1AN0.1"."1N) X I $D(X) D DEC1^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: Extranodal extension (ENE) is defined as "the extension of a nodal metastasis through the lymph
node capsule into adjacent tissue" and is a prognostic factor for most head and neck tumors. This
data item pertains to pathological staging extension. Rationale: Extranodal Extension Head and
Neck Pathological is a Registry Data Collection Variable in AJCC. It was previously collected as
Head and Neck SSF# 9 (Common SSF). Codes: 0.0 Lymph nodes positive for cancer but ENE not
identified
or negative 0.1-9.9 ENE 0.1 to 9.9 mm X.1 ENE 10 mm or greater X.2 ENE microscopic,
size unknown
Stated as ENE (mi) X.3 ENE major, size unknown
Stated as ENE (ma) X.4 ENE present, microscopic or major unknown, size unknown X.7
Surgically resected regional lymph nodes negative for cancer (pN0) X.8 Not applicable:
Information not collected for this case
(If this information is required by your standard setter, use of
code X.8 may result in an edit error) X.9 Not documented in medical record
No surgical resection of regional lymph nodes
ENE not assessed pathologically, or unknown if assessed
Pathological assessment of lymph nodes not done,
or unknown if done
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3833 ENE PATH (NON-HEAD AND NECK) SSD1;34 SET
'0' FOR ENE not present/not identified;
'1' FOR ENE present from surgical resection;
'7' FOR No LN involvement from surgical resection;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: SEP 09, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Extranodal Extension Pathological is defined as "the extension of a nodal metastasis through the
lymph node capsule into adjacent tissue" identified as part of the surgical resection. This data
item defines pathological ENE for sites other than Head and Neck. Rationale: Extranodal Extension
Pathological (non-Head and Neck) is a Registry Data Collection Variable for AJCC. This data item
was previously collected for Penis, SSF# 17. Codes: 0 Regional lymph nodes involved, ENE not
present/not identified
from surgical resection 1 Regional lymph nodes involved, ENE present/identified
from surgical resection 7 No lymph node involvement from surgical resection (pN0) 8 Not
applicable: Information not collected for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error) 9 Not documented in medical record
No surgical resection of regional lymph nodes
Cannot be determined
Pathological assessment of lymph nodes not done,
or unknown if done
Extranodal Extension Pathological not assessed
or unknown if assessed
165.5,3834 EXTRAVASCULAR MATRIX PATTERNS SSD1;35 SET
'0' FOR Extravascular matrix pattern not present/not identified;
'1' FOR Extravascular matrix pattern present/identified;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 11, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Extravascular Matrix Patterns, the presence of loops and networks in extracellular matrix patterns,
is a prognostic factor for uveal melanoma. Rationale: Extravascular Matrix Pattern is a Registry
Data Collection Variable in AJCC 8. This data item was previously collected as Uveal Melanoma, CS
SSF #11 and CS SSF# 12. These two data items were combined and simplified into one data for cases
diagnosed 1/1/2018+. Codes: 0 Extravascular matrix pattern not present/not identified 1
Extravascular matrix pattern present/identified 8 Not applicable: Information not collected for
this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error.) 9 Not documented in medical record
Extravascular Matrix Pattern not assessed
or unknown if assessed
165.5,3835 FIBROSIS SCORE SSD2;1 SET
'0' FOR Ishak fibrosis score 0-4;
'1' FOR Ishak fibrosis score 5-6;
'7' FOR Clinical statement of advanced/severe fibrosis or cirrhosis;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 12, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Fibrosis Score, the degree of fibrosis of the liver based on pathological examination, is a
prognostic factor for liver cancer. Rationale: Fibrosis Score is a Registry Data Collection
Variable in AJCC. This data item was previously collected for Liver, CS SSF# 2. Codes: 0 Ishak
fibrosis score 0-4
No to moderate fibrosis
METAVIR score F0-F3
Batt-Ludwig score 0-3 1 Ishak fibrosis score 5-6
Advanced/severe fibrosis
METAVIR score F4
Batt-Ludwig score 4
Developing cirrhosis
Incomplete cirrhosis
Transition to cirrhosis
Cirrhosis, probable or definite
Cirrhosis, NOS 7 Clinical statement of advanced/severe fibrosis or cirrhosis, AND
Not histologically confirmed or unknown if histologically confirmed 8 Not applicable:
Information not collected for this case
(If this item is required by your standard setter, use of
code 8 will result in an edit error.) 9 Not documented in medical record
Stated in medical record that patient does not have advanced
cirrhosis/advanced fibrosis, not histologically confirmed or
unknown if histologically confirmed
Fibrosis score stated but cannot be assigned to codes 0 or 1
Fibrosis score stated but scoring system not recorded
Fibrosis Score not assessed or unknown if assessed
165.5,3836 FIGO STAGE SSD2;2 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1) X I $D(X) D FIGO^ONCSCHMM
MAXIMUM LENGTH: 5
OUTPUT TRANSFORM: NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
LAST EDITED: AUG 23, 2021
HELP-PROMPT: Answer must be 1-5 characters in length.
DESCRIPTION: Federation Internationale de Gynecologie et d'Obstetrique (FIGO) is a staging system for female
reproductive cancers. Rationale: FIGO stage is a Registry Data Collection Variable in AJCC for the
female genital cancers. This data item was previously collected for the female genital cancers as:
Vulva SSF #10, Vagina SSF #1, Cervix SSF #1, Corpus Carcinoma SSF #1, Corpus Sarcoma SSF #1, Ovary
SSF #2, Fallopian Tube SSF #1, Peritoneum Female Genital SSF #1, and Placenta SSF #2.
EXECUTABLE HELP: D FIGOHLP^ONCSCHMM
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3837 GESTATIONAL TROPHOBLASTIC SSD2;3 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1AN1N) X
MAXIMUM LENGTH: 2
LAST EDITED: JUL 12, 2018
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Gestational Trophoblastic Prognostic Scoring Index, a score based on the FIGO-modified World Health
Organization (WHO) Prognostic Scoring Index, is used to stratify women with gestational
trophoblastic neoplasia in addition to the anatomical stage group. The risk score is appended to
the anatomic stage. Rationale: This data item is required for prognostic stage grouping in AJCC
8th edition, Chapter 56 Gestational Trophoblastic Neoplasms. It was previously collected as
Placenta, CS SSF # 1. Codes: 00-25 Risk factor score
X9 Not documented in medical record
Prognostic scoring index not assessed, or unknown if assessed
165.5,3838 GLEASON PATTERNS CLINICAL SSD2;4 POINTER TO GLEASON PATTERNS FILE (#167.2)
INPUT TRANSFORM: S DIC("S")="I 1 K ONCGPAT" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(167.2,Y,0),U,1)_" "_$P(^ONCO(167.2,Y,0),U,2)
LAST EDITED: JUN 22, 2020
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Prostate cancers are graded using Gleason score or pattern. This data item represents the Gleason
primary and secondary patterns from needle core biopsy or TURP. Rationale Gleason Patterns
Clinical is a Registry Data Collection Variable for Clinical Stage for AJCC. This data item was
previously collected as Prostate, CS SSF# 7.
SCREEN: S DIC("S")="I 1 K ONCGPAT"
EXPLANATION: Use Description field for Code X7
EXECUTABLE HELP: K ONCGPAT
165.5,3839 GLEASON PATTERNS PATHOLOGICAL SSD2;5 POINTER TO GLEASON PATTERNS FILE (#167.2)
INPUT TRANSFORM: S DIC("S")="I 1 S ONCGPAT=1" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(167.2,Y,0),U,1)_" "_$S(Y=32:$P(^ONCO(167.2,Y,0),U,3),1:$P(^ONCO(167.2,Y,0),U,2))
LAST EDITED: JUN 22, 2020
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Prostate cancers are graded using Gleason score or pattern. This data item represents the Gleason
primary and secondary patterns from prostatectomy or autopsy. Rationale Gleason Patterns
Pathological is a Registry Data Collection Variable for AJCC. This data item was previously
collected as Prostate, CS SSF# 9.
SCREEN: S DIC("S")="I 1 S ONCGPAT=1"
EXPLANATION: Use Second Description field for Code X7
EXECUTABLE HELP: S ONCGPAT=1
165.5,3840 GLEASON SCORE CLINICAL SSD2;6 SET
'02' FOR Gleason 2;
'03' FOR Gleason 3;
'04' FOR Gleason 4;
'05' FOR Gleason 5;
'06' FOR Gleason 6;
'07' FOR Gleason 7;
'08' FOR Gleason 8;
'09' FOR Gleason 9;
'10' FOR Gleason 10;
'X7' FOR No needle core biopsy/TURP performed;
'X8' FOR N/A;
'X9' FOR Not documented;
LAST EDITED: JUL 16, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This data item records the Gleason score based on adding the values for primary and secondary
patterns in Needle Core Biopsy or TURP. Rationale: Gleason Score Clinical is a Registry Data
Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 8.
Codes: 02 Gleason score 2 03 Gleason score 3 04 Gleason score 4 05 Gleason score 5 06
Gleason score 6 07 Gleason score 7 08 Gleason score 8 09 Gleason score 9 10 Gleason score
10 X7 No needle core biopsy/TURP performed X8 Not applicable: Information not collected for
this case
(If this information is required by your standard setter, use of
code X8 may result in an edit error.) X9 Not documented in medical record
Gleason Score Clinical not assessed or unknown if assessed
165.5,3841 GLEASON SCORE PATHOLOGICAL SSD2;7 SET
'02' FOR Gleason 2;
'03' FOR Gleason 3;
'04' FOR Gleason 4;
'05' FOR Gleason 5;
'06' FOR Gleason 6;
'07' FOR Gleason 7;
'08' FOR Gleason 8;
'09' FOR Gleason 9;
'10' FOR Gleason 10;
'X7' FOR No prostatectomy done;
'X8' FOR N/A;
'X9' FOR Not documented;
LAST EDITED: JUL 16, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This data item records the Gleason score based on adding the values for primary and secondary
patterns from prostatectomy or autopsy. Rationale: Gleason Score Pathological is a Registry Data
Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 10.
Codes: 02 Gleason score 2 03 Gleason score 3 04 Gleason score 4 05 Gleason score 5 06
Gleason score 6 07 Gleason score 7 08 Gleason score 8 09 Gleason score 9 10 Gleason score
10 X7 No prostatectomy done X8 Not applicable: Information not collected for this case
(If this information is required by your standard setter, use of
code X8 may result in an edit error.) X9 Not documented in medical record
Gleason Score Pathological not assessed or unknown if assessed
165.5,3842 GLEASON TERTIARY PATTERN SSD2;8 SET
'10' FOR Tertiary pattern 1;
'20' FOR Tertiary pattern 2;
'30' FOR Tertiary pattern 3;
'40' FOR Tertiary pattern 4;
'50' FOR Tertiary pattern 5;
'X7' FOR No prostatectomy/autopsy performed;
'X8' FOR N/A;
'X9' FOR Not documented in medical record;
LAST EDITED: JUL 16, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Prostate cancers are graded using Gleason score or pattern. This data item represents the tertiary
pattern value from prostatectomy or autopsy. Rationale: Tertiary Gleason pattern on prostatectomy
is a Registry Data Collection Variable for AJCC. This data item was previously collected as
Prostate, CS SSF# 11. Codes: 10 Tertiary pattern 1 20 Tertiary pattern 2 30 Tertiary pattern
3 40 Tertiary pattern 4 50 Tertiary pattern 5 X7 No prostatectomy/autopsy performed X8 Not
applicable: Information not collected for this case
(If this information is required by your standard setter, use of
code X8 may result in an edit error.) X9 Not documented in medical record
Gleason Tertiary Pattern not assessed or unknown if assessed
165.5,3846 HCG POST-ORCHIECTOMY LAB VALUE SSD2;12 FREE TEXT
INPUT TRANSFORM: K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM
MAXIMUM LENGTH: 7
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-7 characters in length.
DESCRIPTION: hCG (Human Chorionic Gonadotropin) Post-orchiectomy Lab Value refers to the lowest hCG value
measured post-orchiectomy. hCG is a serum tumor marker that is often elevated in patients with
nonseminomatous germ cell tumors of the testis. The Post- Orchiectomy lab value is used to monitor
response to therapy. Rationale: hCG (Human Chorionic Gonadotropin) Post-orchiectomy Lab Value is a
Registry Data Collection Variable in AJCC. It was previously collected as Testis CS SSF# 14.
Codes:
0.0 0.0 milli-International Units/milliliter (mIU/mL) 0.1-99999.9 0.1-99,999.9 mIU/mL
XXXXX.1 100,000 mIU/mL or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not
applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical
record
No orchiectomy performed
hCG (Human Chorionic Gonadotropin) Post-orchiectomy
Lab Value not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3847 HCG POST-ORCHIECTOMY RANGE SSD2;13 SET
'0' FOR Within normal limits;
'1' FOR Above normal and <5000mlU;
'2' FOR 5000-50000mlU;
'3' FOR >50000mlU;
'4' FOR Stated to be elevated;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 17, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Human Chorionic Gonadotropin (hCG) Post-orchiectomy Range identifies the range category of the
lowest hCG value measured post-orchiectomy. hCG is a serum tumor marker that is often elevated in
patients with nonseminomatous germ cell tumors of the testis. The Post-Orchiectomy lab value is
used to monitor response to therapy. Rationale: hCG (Human Chorionic Gonadotropin) is a Registry
Data Collection Variable in AJCC. hCG (Human Chorionic Gonadotropin) Post- orchiectomy Range is
used to assign the S Category Pathological and was previously collected as Testis CS SSF# 15.
Codes: 0 Within normal limits 1 Above normal and less than 5,000 milli-International
Units/milliliter (mIU/mL) 2 5,000-50,000 mIU/mL 3 Greater than 50,000 mIU/mL 4
Post-orchiectomy human chorionic gonadotropin (hCG) stated
to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not
collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
No orchiectomy performed
hCG (Human Chorionic Gonadotropin) Post-orchiectomy
Range not assessed or unknown if assessed
165.5,3848 HCG PRE-ORCHIECTOMY LAB VALUE SSD2;14 FREE TEXT
INPUT TRANSFORM: K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM
MAXIMUM LENGTH: 7
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-7 characters in length.
DESCRIPTION: hCG (Human Chorionic Gonadotropin) Pre-orchiectomy Lab Value refers to the hCG value measured prior
to treatment. hCG is a serum tumor marker that is often elevated in patients with nonseminomatous
germ cell tumors of the testis. Rationale: hCG (Human Chorionic Gonadotropin) Pre-orchiectomy Lab
Value is a Registry Data Collection Variable in AJCC. It was previously collected as Testis CS SSF#
8. Codes:
0.0 0.0 milli-International Units/milliliter (mIU/mL) 0.1-99999.9 0.1-99,999.9 mIU/mL
XXXXX.1 100,000 mIU/mL or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not
applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical
record
hCG (Human Chorionic Gonadotropin) Pre-orchiectomy
Lab Value not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3849 HCG PRE-ORCHIECTOMY RANGE SSD2;15 SET
'0' FOR Within normal limits;
'1' FOR Above normal and <5000mlU;
'2' FOR 5000-50000mlU;
'3' FOR >50000mlU;
'4' FOR Stated to be elevated;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 17, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Human Chorionic Gonadotropin (hCG) Pre-orchiectomy Range identifies the range category of the
highest hCG value measured prior to treatment. hCG is a serum tumor marker that is often elevated
in patients with nonseminomatous germ cell tumors of the testis. Rationale: hCG (Human Chorionic
Gonadotropin) is a Registry Data Collection Variable in AJCC. hCG (Human Chorionic Gonadotropin)
Pre- orchiectomy Range is used to assign the S Category Clinical and was previously collected as
Testis CS SSF# 9. Codes: 0 Within normal limits 1 Above normal and less than 5,000
milli-International
Units/milliliter (mIU/mL) 2 5,000 - 50,000 mIU/mL 3 Greater than 50,000 mIU/mL 4
Pre-orchiectomy human chorionic gonadotropin (hCG)
stated to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information
not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
hCG pre-orchiectomy range not assessed or unknown if assessed
165.5,3850 HER2 IHC SUMMARY SSD2;16 SET
'0' FOR Negative (Score 0);
'1' FOR Negative (Score 1+);
'2' FOR Equivocal (Score 2+);
'3' FOR Positive (Score 3+);
'4' FOR Stated as negative, but score not stated;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 17, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: HER2 IHC Summary is the summary score for HER2 testing by IHC. Rationale: HER2 IHC Summary is a
Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.
Codes: 0 Negative (Score 0) 1 Negative (Score 1+) 2 Equivocal (Score 2+)
Stated as equivocal 3 Positive (Score 3+)
Stated as positive 4 Stated as negative, but score not stated 7 Test ordered, results not
in chart 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of
code 8 will result in an edit error.) 9 Not documented in medical record
Cannot be determined (indeterminate)
HER2 IHC Summary not assessed or unknown if assessed
165.5,3851 HER2 ISH DUAL PROBE COPY NUM SSD2;17 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
MAXIMUM LENGTH: 4
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: HER2 in situ hybridization (ISH) Dual Probe Copy Number is the HER2 copy number based on a dual
probe test. Rationale: HER2 ISH Dual Probe Copy Number is a Registry Data Collection Variable in
AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0.0-99.9 Reported HER2 copy
number of 0.0-99.9
XX.1 Reported HER2 copy number of 100 or greater
XX.7 Test ordered, results not in chart
XX.8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of
code XX.8 will result in an edit error.)
XX.9 Not documented in medical record
Cannot be determined (indeterminate)
HER2 ISH Dual Probe Copy Number not assessed or
unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3852 HER2 ISH DUAL PROBE RATIO SSD2;18 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
MAXIMUM LENGTH: 4
LAST EDITED: AUG 26, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: HER2 in situ hybridization (ISH) Dual Probe Ratio is the summary score for HER2 testing using a
dual probe. The test will report results for both HER2 and CEP17, the latter used as a control.
The HER2/CEP17 ratio is reported. Rationale: HER2 ISH Dual Probe Ratio is a Registry Data
Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0.0-99.9
Ratio of 0.0 to 99.9 XX.2 Less than 2.0 XX.3 Greater than or equal to 2.0 XX.7 Test ordered,
results not in chart XX.8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of
code XX.8 will result in an edit error.) XX.9 Not documented in medical record
Results cannot be determined (indeterminate)
HER2 ISH Dual Probe Ratio not assessed or
unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3853 HER2 ISH SINGLE PROBE COPY NUM SSD2;19 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
MAXIMUM LENGTH: 4
LAST EDITED: AUG 26, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: HER2 in situ hybridization (ISH) Single Probe Copy Number is the HER2 copy number based on a single
probe test. Rationale: HER2 ISH Single Probe Copy Number is a Registry Data Collection Variable in
AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0.0-99.9 Reported HER2 copy
number of 0.0-99.9 XX.1 Reported HER2 copy number of 100 or greater XX.7 Test ordered, results
not in chart XX.8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of
code XX.8 will result in an edit error.) XX.9 Not documented in medical record
Cannot be determined (indeterminate)
HER2 ISH Single Probe Copy Number not assessed
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3854 HER2 ISH SUMMARY SSD2;20 SET
'0' FOR Negative [not amplified];
'2' FOR Equivocal;
'3' FOR Positive [amplified];
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 17, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: HER2 in situ hybridization (ISH) Summary is the summary score for results of testing for ERBB2 gene
copy number by any ISH method. An immunohistochemistry (IHC) test identifies the protein expressed
by the gene (ERBB2), and an ISH test identifies the number of copies of the gene (ERBB2) itself.
Rationale: HER2 ISH Summary is a Registry Data Collection Variable in AJCC. It is a new data item
for cases diagnosed 1/1/2018+. Codes: 0 Negative [not amplified] 2 Equivocal 3 Positive
[amplified] 7 Test ordered, results not in chart 8 Not applicable: Information not collected
for this case
(If this item is required by your standard setter, use of
code 8 will result in an edit error.) 9 Not documented in medical record
Results cannot be determined (indeterminate)
HER2 ISH Summary not assessed or unknown if assessed
165.5,3855 HER2 OVERALL SUMMARY SSD2;21 SET
'0' FOR HER2 negative, equivocal;
'1' FOR HER2 positive;
'7' FOR Test ordered, results not in chart;
'8' FOR NA;
'9' FOR Not documented in medical record;
LAST EDITED: JUN 27, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: HER2 Overall Summary is a summary of results from HER2 testing. Rationale: This data item is
required for prognostic stage grouping in AJCC 8th edition Chapter 48, Breast. It was previously
collected as Breast, CS SSF # 15. Codes: 0 HER2 negative; equivocal 1 HER2 positive 7 Test
ordered, results not in chart 8 Not applicable/Not collected 9 Not documented in medical record
Cannot be determined (indeterminate)
HER2 Overall Summary status not assessed or unknown if assessed
165.5,3856 HERITABLE TRAIT SSD2;22 SET
'0' FOR H0-Normal RB1 alleles;
'1' FOR H1-RB1 gene mutation;
'7' FOR Test ordered, results not in chart;
'9' FOR HX-Not documented in medical record;
LAST EDITED: JUL 23, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Heritable trait pertains to evidence that a tumor is associated with a heritable mutation. In
retinoblastoma, the heritable trait is a germline mutation in the RB1 gene, which is associated
with bilateral disease, family history of retinoblastoma, presence of concomitant CNS midline
embryonic tumor (commonly in pineal region), or retinoblastoma with an intracranial primitive
neuroectodermal tumor (i.e., trilateral retinoblastoma). Children with any of these features may
be assigned the H1 status without molecular testing. High quality molecular testing for RB1
mutation is required to determine the presence or absence of RB1 mutation for children without
clinical features of a heritable mutation. Heritable trait is required for prognostic stage
grouping in AJCC 8th edition, Chapter 68 Retinoblastoma. It is a new data item for cases diagnosed
1/1/2018+. Codes: 0 H0: Normal RB1 alleles
No clinical evidence of mutation 1 H1: RB1 gene mutation OR
Clinical evidence of mutation 7 Test ordered, results not in chart 9 HX: Not
documented in medical record
Test not done, or unknown if done
Insufficient evidence of a constitutional RB1 gene mutation
165.5,3857 HIGH RISK CYTOGENETICS SSD2;23 SET
'0' FOR High-risk cytogenetics not identified/not present;
'1' FOR High-risk cytogenetics present;
'5' FOR Schema Discriminator 1 coded to 1 or 9;
'7' FOR Test ordered, results not in chart;
'9' FOR Not documented in medical record;
LAST EDITED: JUN 28, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: High Risk Cytogenetics is defined as one or more of t(4;14), t(14;16), or del 17p identified from
FISH test results and is part of the staging criteria for plasma cell myeloma. Rationale: High
Risk Cytogenetics is a prognostic factor required in AJCC 8th edition, Chapter 82 Plasma Cell
Myeloma and Plasma Cell Disorders, for staging of plasma cell myeloma. It is a new data item for
cases diagnosed 1/1/2018+. Codes: 0 High-risk cytogenetics not identified/not present 1
High-risk cytogenetics present 5 Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to
1 or 9 7 Test ordered, results not in chart 9 Not documented in medical record
High Risk Cytogenetics not assessed or unknown if assessed
SCREEN: S DIC("S")="D SCRN555^ONCSCHMM"
EXPLANATION: Codes depend on appropriate schema discriminator
165.5,3858 HIGH RISK HISTOLOGIC FEATURES SSD2;24 SET
'0' FOR No high risk features;
'1' FOR Desmoplasia;
'2' FOR Poor differentiation (grade 3);
'3' FOR Sarcomatoid differentiation;
'4' FOR Undifferentiated (grade 4);
'5' FOR Multiple features;
'6' FOR Histologic features NOS;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 23, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: High Risk Histologic Features are defined in AJCC 8 Chapter 15 to include the terms "poor
differentiation, desmoplasia, sarcomatoid differentiation, undifferentiated." High risk histologic
features are a prognostic factor for cutaneous squamous cell carcinomas of the head and neck.
Rationale: High Risk Histologic Features is a Registry Data Collection Variable in AJCC. It was
previously collected as Skin, CS SSF # 12. Codes: 0 No high risk histologic features 1
Desmoplasia 2 Poor differentiation (grade 3) 3 Sarcomatoid differentiation 4 Undifferentiated
(grade 4) 5 Multiple high risk histologic features 6 Histologic features, NOS (type of high
risk histologic
feature not specified) 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error) 9 Not documented in medical record
High risk histologic features not assessed or unknown if assessed
165.5,3859 HIV STATUS SSD2;25 SET
'0' FOR Not associated with HIV/AIDS;
'1' FOR Associated with HIV/AIDS;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 23, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: HIV status refers to infection with the Human Immunodeficiency Virus which causes Acquired Immune
Deficiency Syndrome (AIDS). AIDS is associated with increased risk of developing some lymphomas.
Rationale: HIV status may be collected by the surveillance community for neoplasms (e.g., Kaposi
Sarcoma, Lymphomas) that are closely related to HIV/AIDS. Prior to 2018, Lymphoma SSF#1 and Kaposi
Sarcoma SSF# 1, were used for HIV Status. Codes: 0 Not associated with Human Immunodeficiency
Virus (HIV)/Acquired Immune Deficiency Syndrome(AIDS)
HIV negative 1 Associated with HIV/AIDS
HIV positive 7 Test ordered, results not in chart 8 Not applicable: Information not
collected for this case
(If this item is required by your standard setter, use of
code 8 will result in an edit error.) 9 Not documented in medical record
HIV status not assessed or unknown if assessed
165.5,3860 INR PROTHROMBIN TIME SSD2;26 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?0.1AN0.1"."1N) X I $D(X) D DEC1^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: International Normalized Ratio for Prothrombin Time (INR), an indicator of the liver's ability to
make clotting factors, is required to calculate the Model for End-Stage Liver Disease (MELD) score,
which is used to assign priority for liver transplant. Rationale: International Normalized Ratio
for Prothrombin Time (INR) is a Registry Data Collection Variable in AJCC. This data item was
previously collected for Liver, CS SSF# 8. Codes: 0.0 0.0 0.1 0.1 or less 0.2-9.9 0.2 - 9.9
(Exact ratio to nearest tenth) X.1 10 or greater X.7 Test ordered, results not in chart X.8
Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code X.8 may result in an edit error.) X.9 Not documented in medical record
INR (International Normalized Ratio for Prothrombin Time)
not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3861 IPSILATERANL ADRENAL GLAND INV SSD2;27 SET
'0' FOR Not present/not identified;
'1' FOR Direct involvement (contiguous involvement);
'2' FOR Separate nodule (noncontiguous involvement);
'3' FOR Combo of 1-2;
'4' FOR Involvement, unk if direct or separate;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 23, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Ipsilateral adrenal gland involvement pertains to direct extension of the tumor into the
ipsilateral adrenal gland (continuous) or ipsilateral adrenal gland involvement by a separate
nodule (noncontiguous). Rationale: Ipsilateral adrenal gland involvement for Kidney is a Registry
Data Collection Variable in AJCC. It was previously collected as Kidney, CS SSF #3. Codes: 0
Ipsilateral adrenal gland involvement not present/not identified 1 Adrenal gland involvement by
direct involvement (contiguous
involvement) 2 Adrenal gland involvement by separate nodule (noncontiguous
involvement) 3 Combination of code 1-2 4 Ipsilateral adrenal gland involvement, unknown
if direct
involvement or separate nodule 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error.) 9 Not documented in medical record
Ipsilateral adrenal gland not resected
Ipsilateral adrenal gland involvement not assessed or
unknown if assessed
No surgical resection of primary site is performed
165.5,3862 JAK2 SSD2;28 SET
'0' FOR Stated as negative;
'1' FOR Positive for mutation V617F w or w/o other;
'2' FOR Positive for exon 12;
'3' FOR Positive for oth spec mutation;
'4' FOR Positive for more than 1 other than V617F;
'5' FOR Positive NOS;
'7' FOR Results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 24, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Janus Kinase 2 (JAK2, JAK 2) is a gene mutation that increases susceptibility to several
myeloproliferative neoplasms (MPNs). Testing for the JAK2 mutation is done on whole blood. Nearly
all people with polycythemia vera, and about half of those with primary myelofibrosis and essential
thrombocythemia, have the mutation. JAK2 analysis continues to increase in use for hematopoietic
neoplasms. Rationale: JAK2 can be collected by the surveillance community for myeloproliferative
neoplasms. Prior to 2018, HemeRetic SSF#1 was used for JAK2. Codes: 0 JAK2 result stated as
negative 1 JAK2 positive for mutation V617F WITH or WITHOUT other mutations 2 JAK2 positive for
exon 12 mutation 3 JAK2 positive for other specified mutation 4 JAK2 positive for more than one
mutation other than V617F 5 JAK2 positive NOS
Specific mutation(s) not stated 7 Test ordered, results not in chart 8 Not applicable:
Information not collected for this case
(If this item is required by your standard setter, use of
code 8 will result in an edit error.) 9 Not documented in medical record
JAK2 not assessed or unknown if assessed
165.5,3863 KI-67 SSD2;29 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM
MAXIMUM LENGTH: 5
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-5 characters in length.
DESCRIPTION: Ki-67 (MIB-1) is a marker of cell proliferation. A high value indicates a tumor that is
proliferating more rapidly. Rationale: Ki-67 (MIB-1) is a Registry Data Collection Variable in
AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0.0-100.0 0.0 to 100.0
percent positive: enter percent positive XXX.7 Test done, actual percentage not stated XXX.8
Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of
code XXX.8 will result in an edit error.) XXX.9 Not documented in medical record
Ki-67 (MIB-1) not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3864 INVASION BEYOND CAPSULE SSD2;30 SET
'0' FOR Invasion beyond capsule not identified;
'1' FOR Perinephric (beyond renal capsule) fat or tissue;
'2' FOR Renal sinus;
'3' FOR Gerota's fascia;
'4' FOR Any combo of codes 1-3;
'5' FOR Invasion beyond capsule, NOS;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 24, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Invasion beyond capsule pertains to the pathologically confirmed invasion of the tumor beyond the
fibrous capsule in which the kidney is enclosed. Rationale: Invasion beyond capsule into specific
tissues for Kidney is a Registry Data Collection Variable in AJCC. It was previously collected as
Kidney, CS SSF #1. Codes: 0 Invasion beyond capsule not identified 1 Perinephric (beyond renal
capsule) fat or tissue 2 Renal sinus 3 Gerota's fascia 4 Any combination of codes 1-3 5
Invasion beyond capsule, NOS 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error.) 9 Not documented in medical record
Invasion beyond capsule not assessed or unknown if assessed
No surgical resection of primary site is performed
165.5,3865 KIT GENE IMMUNOHISTOCHEMISTRY SSD2;31 SET
'0' FOR KIT negative,normal-within normal limits;
'1' FOR KIT positive;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 25, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: KIT Gene Immunohistochemistry (IHC) is the expression of the KIT gene in tumor tissue specimens
based on immunohistochemical (IHC) stains. A positive test is a diagnostic and predictive marker
for GIST tumors. Rationale: KIT Gene Immunohistochemistry (IHC) is a Registry Data Collection
Variable in AJCC. This data item was previously collected for GIST schemas in CS (different SSF's).
Codes: 0 KIT negative/normal; within normal limits 1 KIT positive 7 Test ordered, results not
in chart 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error.) 9 Not documented in medical record
Cannot be determined by pathologist
KIT not assessed or unknown if assessed
165.5,3866 KRAS SSD2;32 SET
'0' FOR Normal (wild type);
'1' FOR Abnormal in codons 12,13 and or 61;
'2' FOR Abnormal in codon 146 only;
'3' FOR Abnormal but not in codons 12,13,61 or 146;
'4' FOR Abnormal NOS, codon not specified;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 25, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: KRAS is an important signaling intermediate in the growth receptor pathway which controls cell
proliferation and survival. KRAS is a protein with production controlled by the K-ras gene. When
the K-ras gene is activated through mutation during colorectal carcinogenesis, production of KRAS
continuously stimulates cell proliferation and prevents cell deaths. Activating mutations in KRAS
are an adverse prognostic factor for colorectal carcinoma and predict a poor response to monoclonal
anti-EGFR antibody therapy in advanced colorectal carcinoma. Rationale: KRAS is a Registry Data
Collection Variable in AJCC. It was previously collected as Colon and Rectum CS SSF# 9. Codes: 0
Normal (wild type)
Negative for mutations 1 Abnormal (mutated) in codon(s) 12, 13 and/or 61 2 Abnormal
(mutated) in codon 146 only 3 Abnormal (mutated), but not in codon(s) 12, 13, 61, or 146 4
Abnormal (mutated), NOS, codon(s) not specified 7 Test ordered, results not in chart 8 Not
applicable: Information not collected for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error.) 9 Not documented in medical record
KRAS not assessed or unknown if assessed
165.5,3867 LDH POST-ORCHIECTOMY RANGE SSD2;33 SET
'0' FOR Within normal limits;
'1' FOR Less than 1.5xN;
'2' FOR 1.5 to 10xN;
'3' FOR Greater than 10xN;
'4' FOR LDH range stated to be elevated;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 25, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: LDH (Lactate Dehydrogenase) Post-Orchiectomy Range identifies the range category of the lowest LDH
value measured post-orchiectomy. LDH is a nonspecific marker for testicular cancer that is
elevated in some germ cell tumors. The Post-Orchiectomy lab value is used to monitor response to
therapy. Rationale: LDH (Lactate Dehydrogenase) is a Registry Data Collection Variable in AJCC.
LDH (Lactate Dehydrogenase) Post-Orchiectomy Range is used to assign the S Category Pathological
and was previously collected as Testis CS SSF# 16. Codes: 0 Within normal limits 1 Less than
1.5 x N
(Less than 1.5 times the upper limit of normal for LDH) 2 1.5 to 10 x N
(Between 1.5 and 10 times the upper limit of normal for LDH) 3 Greater than 10 x N
(Greater than 10 times the upper limit of normal for LDH) 4 Post-Orchiectomy lactate
dehydrogenase (LDH) range stated
to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not
collected for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error.) 9 Not documented in medical record
No orchiectomy performed
LDH (Lactate Dehydrogenase) Post-Orchiectomy Range
not assessed or unknown if assessed
165.5,3868 LDH PRE-ORCHIECTOMY RANGE SSD2;34 SET
'0' FOR Within normal limits;
'1' FOR Less than 1.5xN;
'2' FOR 1.5 to 10xN;
'3' FOR Greater than 10xN;
'4' FOR LDH range stated to be elevated;
'7' FOR Test ordered;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 25, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Lactate Dehydrogenase (LDH) Range identifies the range category of the highest LDH value measured
prior to treatment. LDH is a nonspecific marker for testicular cancer that is elevated in some germ
cell tumors. This data item refers to the Pre-Orchiectomy range. Rationale: LDH (Lactate
Dehydrogenase) is a Registry Data Collection Variable in AJCC. LDH (Lactate Dehydrogenase)
Pre-Orchiectomy Range is used to assign the S Category Clinical and was previously collected as
Testis CS SSF# 10. Codes: 0 Within normal limits 1 Less than 1.5 x N
(Less than 1.5 times the upper limit of normal for LDH) 2 1.5 to 10 x N
(Between 1.5 and 10 times the upper limit of normal for LDH) 3 Greater than 10 x N
(Greater than 10 times the upper limit of normal for LDH) 4 Pre-Orchiectomy lactate
dehydrogenase (LDH) range stated
to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not
collected for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error.) 9 Not documented in medical record
LDH (Lactate Dehydrogenase) Pre-Orchiectomy Range
not assessed or unknown if assessed
165.5,3869 LDH LEVEL SSD2;35 SET
'0' FOR Normal LDH level;
'1' FOR Above normal LDH level - High;
'5' FOR Schema Discriminator 1 coded to 1 or 9;
'7' FOR Test ordered, results not in chart;
'9' FOR Not documented in medical record;
LAST EDITED: JUN 28, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: LDH (Lactate Dehydrogenase) is an enzyme involved in conversion of sugars to energy and present in
most cells in the body. Elevated pretreatment LDH is an adverse prognostic factor for plasma cell
myeloma and melanoma of the skin. Rationale: LDH (Lactate Dehydrogenase) Level is a prognostic
factor required in AJCC 8th edition for Chapter 83 Plasma Cell Myeloma and Plasma Cell Disorders
and Chapter 47 Melanoma Skin. For Plasma Cell Myeloma, LDH is part of the RISS Stage and is new for
cases diagnosed 1/1/2018+. For Melanoma Skin, LDH is used to define the M subcategories and was
previously collected as Melanoma Skin, SSF #4. Codes: 0 Normal LDH level
Low, below normal 1 Above normal LDH level; High 5 Schema Discriminator 1: Plasma Cell
Myeloma Terminology coded to 1 or 9 7 Test ordered, results not in chart 9 Not documented in
medical record
LDH (Lactate Dehydrogenase) Pretreatment Level not assessed
or unknown if assessed
SCREEN: S DIC("S")="D SCRN555^ONCSCHMM"
EXPLANATION: Codes depend on appropriate schema discriminator
165.5,3870 LDH UPPER LIMITS OF NORMAL SSD2;36 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?0.2AN1N) X I $D(X) D GEN3^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: LDH (Lactate Dehydrogenase), an enzyme involved in converting sugars to energy in the body, is
elevated in some malignancies. LDH level is a prognostic factor for patients with Stage IV
melanoma. This data Item refers to the Upper Limit of Normal in the laboratory test used to
interpret the Serum LDH result. Rationale: LDH (Lactate Dehydrogenase) Upper Limits of Normal is a
Registry Data Collection Variable in AJCC. It was previously collected as Melanoma Skin, CS SSF# 6.
Codes: 001-999 001 - 999 upper limit of normal
(Exact upper limit of normal) XX8 Not applicable: Information not collected for this
case
(If this information is required by your standard setter,
use of code XX8 may result in an edit error.) XX9 Not documented in medical record
LDH Upper Limit not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3871 LN ASSESS METH FEMORAL-INGUIN SSD3;1 SET
'0' FOR Radiography, imaging;
'1' FOR Incisional biopsy, fine needle aspiration (FNA);
'2' FOR Lymphadenectomy;
'7' FOR Regional LN(s) assessed, unknown assessment method;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 26, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This data item describes the method used to assess involvement of femoral-inguinal lymph nodes
associated with certain female genital cancers. Rationale: Method of assessment of regional nodal
status is listed as a Registry Data Collection Variable in the AJCC GYN chapters. This data item
was previously collected as Vulva, SSF# 15. Codes: 0 Radiography, imaging
(Ultrasound (US), computed tomography scan (CT), magnetic
resonance imaging (MRI), positron emission tomography scan (PET))
Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2 Lymphadenectomy
Excisional biopsy or resection with microscopic confirmation 7 Regional lymph node(s)
assessed, unknown assessment method 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code 8
will result in an edit error.) 9 Not documented in medical record
Regional lymph nodes not assessed or unknown if assessed
165.5,3872 LN ASSESS METHOD PARA-AORTIC SSD3;2 SET
'0' FOR Radiography, imaging;
'1' FOR Incisional biopsy, fine needle aspiration (FNA);
'2' FOR Lymphadenectomy;
'7' FOR Regional LN(s) assessed, unknown assessment method;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 26, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This data item describes the method used to assess involvement of para-aortic lymph nodes
associated with certain female genital cancers. Rationale: Method of assessment of regional nodal
status is listed as a Registry Data Collection Variable in the AJCC GYN chapters. This data item
was previously collected as Vagina, CS SSF# 5. Codes: 0 Radiography, imaging
(Ultrasound (US), computed tomography scan (CT), magnetic
resonance imaging (MRI), positron emission tomography scan (PET))
Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2 Lymphadenectomy
Excisional biopsy or resection with microscopic confirmation 7 Regional lymph node(s)
assessed, unknown assessment method 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code 8
will result in an edit error.) 9 Not documented in medical record
Regional lymph nodes not assessed or unknown if assessed
165.5,3873 LN ASSESSMENT METHOD PELVIC SSD3;3 SET
'0' FOR Radiography, imaging;
'1' FOR Incisional biopsy, fine needle aspiration (FNA);
'2' FOR Lymphadenectomy;
'7' FOR Regional LN(s) assessed, unknown assessment method;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 26, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This data item describes the method used to assess involvement of pelvic lymph nodes associated
with certain female genital cancers. Rationale: Method of assessment of regional nodal status is
listed as a Registry Data Collection Variable in the AJCC GYN chapters. This data item was
previously collected as Vagina, CS SSF# 3. Codes: 0 Ultrasound (US), computed tomography scan
(CT), magnetic
resonance imaging (MRI), positron emission tomography scan (PET))
Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2
Lymphadenectomy
Excisional biopsy or resection with microscopic confirmation 7 Regional lymph node(s)
assessed, unknown assessment method 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code 8 will
result in an edit error.) 9 Not documented in medical record
Regional lymph nodes not assessed or unknown if assessed
165.5,3874 LN DISTANT ASSESSMENT METHOD SSD3;4 SET
'0' FOR Radiography, imaging;
'1' FOR Incisional biopsy, fine needle aspiration (FNA);
'2' FOR Lymphadenectomy;
'7' FOR Distant LN(s) assessed, unknown assessment method;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 26, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This data item describes the method used to assess involvement of Distant (mediastinal, scalene)
nodes associated with certain female genital cancers. Rationale: Method of assessment of distant
nodal status is listed as a Registry Data Collection Variable in the AJCC GYN chapters. This data
item was previously collected as Vagina, CS SSF# 7. Codes: 0 Radiography, imaging
(Ultrasound (US), computed tomography scan (CT), magnetic
resonance imaging (MRI), positron emission tomography scan (PET))
Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2 Lymphadenectomy
Excisional biopsy or resection with microscopic confirmation 7 Distant lymph node(s)
assessed, unknown assessment method 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code 8
will result in an edit error.) 9 Not documented in medical record
Distant lymph nodes not assessed or unknown if assessed
165.5,3875 LN DISTANT MEDIASTINAL,SCALENE SSD3;5 SET
'0' FOR Negative mediastinal and scalene lymph nodes;
'1' FOR Positive mediastinal lymph nodes;
'2' FOR Positive scalene lymph nodes;
'3' FOR Positive mediastinal and scalene lymph nodes;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 26, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This data item describes the status of Distant (mediastinal, scalene) nodes associated with certain
female genital cancers. Rationale: Specific distant lymph node involvement is listed as a Registry
Data Collection Variable in the AJCC. This data was previously collected as Vagina, CS SSF# 6.
Codes: 0 Negative mediastinal and scalene lymph nodes 1 Positive mediastinal lymph nodes 2
Positive scalene lymph nodes 3 Positive mediastinal and scalene lymph nodes 8 Not applicable:
Information not collected for this case
(If this item is required by your standard setter, use of code 8
will result in an edit error.) 9 Not documented in medical record
Mediastinal and scalene lymph nodes not assessed or
unknown if assessed
165.5,3876 LN HEAD & NECK LEVELS I-III SSD3;6 SET
'0' FOR No inv of Levels I,II or III;
'1' FOR Level I;
'2' FOR Level II;
'3' FOR Level III;
'4' FOR Level I & II;
'5' FOR Level I & III;
'6' FOR Level II & III;
'7' FOR Levels I,II and III;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUL 26, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Lymph Nodes for Head and Neck, Levels I-III records the involvement of Levels I-III lymph nodes.
Rationale: Level of nodal involvement is a Registry Data Collection Variable in AJCC for several
head and neck chapters. This data item was previously collected as Head and Neck SSF# 3 (common
SSF). Codes: 0 No involvement in Levels I, II, or III lymph nodes 1 Level I lymph node(s)
involved 2 Level II lymph node(s) involved 3 Level III lymph node(s) involved 4 Levels I and
II lymph nodes involved 5 Levels I and III lymph nodes involved 6 Levels II and III lymph nodes
involved 7 Levels I, II and III lymph nodes involved 8 Not applicable: Information not
collected for this case
(If this item is required by your standard setter, use of code 8
will result in an edit error) 9 Not documented in medical record
Positive nodes, but level of positive node(s) unknown
Lymph node levels I-III not assessed, or unknown if assessed
165.5,3877 LN HEAD & NECK LEVELS IV-V SSD3;7 SET
'0' FOR No inv of Levels IV or V;
'1' FOR Level IV;
'2' FOR Level V;
'3' FOR Levels IV & V;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 26, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Lymph Nodes for Head and Neck, Levels IV-V records the involvement of Levels IV-V lymph nodes.
Rationale: Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data
item was previously collected as Head and Neck SSF# 4 (common SSF). Codes: 0 No involvement in
Levels IV or V lymph nodes 1 Level IV lymph node(s) involved 2 Level V lymph node(s) involved 3
Levels IV and V lymph node(s) involved 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code 8
will result in an edit error) 9 Not documented in medical record
Positive nodes, but level of positive node(s) unknown
Lymph node levels IV-V not assessed, or unknown if assessed
165.5,3878 LN HEAD & NECK LEVELS VI-VII SSD3;8 SET
'0' FOR No inv in Levels VI or VII;
'1' FOR Level VI;
'2' FOR Level VII;
'3' FOR Levels VI and VII;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 26, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Lymph Nodes for Head and Neck, Levels VI-VII records the involvement of Levels VI-VII lymph nodes.
Rationale: Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data
item was previously collected as Head and Neck SSF# 5 (common SSF). Codes: 0 No involvement in
Levels VI or VII lymph nodes 1 Level VI lymph node(s) involved 2 Level VII lymph node(s)
involved 3 Levels VI and VII lymph node(s) involved 8 Not applicable: Information not collected
for this case
(If this item is required by your standard setter, use of
code 8 will result in an edit error) 9 Not documented in medical record
Positive nodes, but level of positive node(s) unknown
Lymph nodes levels VI-VII not assessed, or unknown if assessed
165.5,3879 LN HEAD AND NECK OTHER SSD3;9 SET
'0' FOR No inv other head & neck LN regions;
'1' FOR Buccinator LN(s);
'2' FOR Parapharyngeal LN(s);
'3' FOR Periparotid & intraparotid LN(s);
'4' FOR Preauricular LN(s);
'5' FOR Retropharyngeal LN(s);
'6' FOR Suboccipital;
'7' FOR Any combo 1-6;
'8' FOR N/A;
'9' FOR Not;
LAST EDITED: JUL 26, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Lymph Nodes for Head and Neck, Other records the involvement of lymph nodes other than Levels
I-III, IV-V, and VI-VII. Rationale: Level of nodal involvement is a Registry Data Collection
Variable in AJCC. This data item was previously collected as Head and Neck SSF# 6 (common SSF).
Codes: 0 No involvement in other head and neck lymph node regions 1 Buccinator (facial) lymph
node(s) involved 2 Parapharyngeal lymph node(s) involved 3 Periparotid and intraparotid lymph
node(s) involved 4 Preauricular lymph node(s) involved 5 Retropharyngeal lymph node(s) involved
6 Suboccipital/retroauricular lymph node(s) involved 7 Any combination of codes 1-6 8 Not
applicable: Information not collected for this case
(If this item is required by your standard setter, use of code 8
will result in an edit error.) 9 Not documented in medical record
Positive nodes, but level of positive node(s) unknown
Other Head and Neck lymph nodes not assessed,
or unknown if assessed
165.5,3880 LN ISOLATED TUMOR CELLS (ITC) SSD3;10 SET
'0' FOR Regional lymph nodes negative for ITCs;
'1' FOR Regional lymph nodes positive;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUL 26, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Lymph Nodes Isolated Tumor Cells (ITC), the presence of isolated tumor cells in regional lymph
node(s) that may be detected by hematoxylin and eosin or by immunohistochemical staining, is a
potential prognostic factor for Merkel Cell Carcinoma. Rationale: Regional lymph nodes positive
for ITCs (Tumor cell clusters not greater than 0.2 millimeter (mm)) Codes: 0 Regional lymph nodes
negative for ITCs 1 Regional lymph nodes positive for ITCs
(Tumor cell clusters not greater than 0.2 millimeter (mm)) 8 Not applicable: Information
not collected for this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error.) 9 Not documented in medical record
ITCs not assessed or unknown if assessed
165.5,3881 LN LATERALITY SSD3;11 SET
'0' FOR No regional lymph node involvement;
'1' FOR Unilateral;
'2' FOR Bilateral;
'3' FOR Laterality unknown;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: AUG 07, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This data item describes whether positive regional lymph nodes are unilateral or bilateral.
Rationale: Laterality of regional node metastasis is a Registry Data Collection Variable in AJCC.
This data item was previously collected as Vulva, CS SSF# 11. Codes: 0 No regional lymph node
involvement 1 Unilateral - all positive regional nodes with same laterality OR
only one regional node positive 2 Bilateral - positive bilateral regional lymph nodes 3
Laterality unknown - positive regional lymph nodes with
unknown laterality 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
Lymph node laterality not assessed or unknown if assessed
165.5,3882 LN POSITIVE AXILLARY LVL I-II SSD3;12 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: This data item pertains to the number of positive ipsilateral level I and II axillary lymph nodes
and intramammary lymph nodes based on pathological information. Rationale: Lymph Nodes Positive
Axillary Level I-II can be collected by the surveillance community for breast cancers. Prior to
2018, Breast SSF#3 was used for Lymph Nodes Positive Axillary Level I-II. Codes: 00 All
ipsilateral axillary nodes examined negative 01-99 1 - 99 nodes positive
(Exact number of nodes positive) X1 100 or more nodes positive X5 Positive nodes,
number unspecified X6 Positive aspiration or needle core biopsy of lymph node(s) X8 Not
applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code X8 will result in an edit error.) X9 Not documented in medical record
Level I-II axillary nodes not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3883 LN SIZE SSD3;13 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
MAXIMUM LENGTH: 4
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Lymph Nodes Size records diameter of the involved regional lymph node(s) with the largest diameter
of any involved regional lymph node(s). Pathological measurement takes precedence over a clinical
measurement for the same node. Rational: Lymph Nodes Size is a Registry Data Collection Variable
in AJCC for several chapters. It was previously collected in the Head and Neck chapters as Size of
Lymph Nodes, SSF# 1 Codes: 0.0 No involved regional nodes 0.1-99.9 0.1-99.9 millimeters (mm)
(Exact size of lymph node to nearest tenth of a mm) XX.1 100 millimeters (mm) or
greater XX.2 Microscopic focus or foci only and no size of focus given XX.3 Described as "less
than 1 centimeter (cm)" XX.4 Described as "at least" 2 cm XX.5 Described as "at least" 3 cm
XX.6 Described as "at least" 4 cm XX.7 Described as greater than 5 cm XX.8 Not applicable:
Information not collected for this case
(If this item is required by your standard setter,
use of code XX.8 will result in an edit error) XX.9 Not documented in medical record
Regional lymph node(s) involved, size not stated
Lymph Nodes Size not assessed, or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3884 LN STATUS FEM-ING,PAR-AOR,PLV SSD3;14 POINTER TO ONCO LN STATUS FILE (#167.3)
OUTPUT TRANSFORM: S:Y'="" Y=$P(^ONCO(167.3,Y,0),U,1)_" "_$P(^ONCO(167.3,Y,0),U,2)
LAST EDITED: NOV 07, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This data item describes the status of femoral-inguinal, para-aortic and pelvic lymph nodes
associated with certain female genital cancers. Rationale: Specific regional lymph node
involvement is listed as a Registry Data Collection Variable in AJCC. This information was
previously collected as Vagina, CS SSF# 2 and CS SSF# 4 Codes: 0 Negative femoral-inguinal,
para-aortic and pelvic lymph nodes 1 Positive femoral-inguinal lymph nodes 2 Positive
para-aortic lymph nodes 3 Positive pelvic lymph nodes 4 Positive femoral-inguinal and
para-aortic lymph nodes 5 Positive femoral-inguinal and pelvic lymph nodes 6 Positive
para-aortic and pelvic lymph nodes 7 Positive para-aortic, pelvic, and femoral-inguinal lymph
nodes 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
Femoral-Inguinal, Para-aortic and Pelvic lymph nodes
not assessed or unknown if assessed
165.5,3885 LYMPHOCYTOSIS SSD3;15 SET
'0' FOR Not present, count LT or EQ 5000;
'1' FOR Present, count > 5000;
'5' FOR NA, not C421;
'6' FOR Lab value unk, physician states lymphocytosis present;
'7' FOR Test ordered, results not in chart;
'9' FOR Not documented;
LAST EDITED: MAY 09, 2023
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Lymphocytosis is defined by an excess of lymphocytes in the blood. In staging of Chronic
Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), lymphocytosis is defined as an absolute
lymphocyte count (ALC) greater than 5,000 cells/µL. Rationale: Lymphocytosis is a prognostic
factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) in
AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new data item for cases
diagnosed 1/1/2018+. Codes: 0 Lymphocytosis not present
Absolute lymphocyte count <= 5,000 cells/ µL 1 Lymphocytosis present
Absolute lymphocyte count > 5,000 cells/µL 5 Not applicable: Primary site is not C421 6
Lab value unknown, physician states lymphocytosis is present
Physician states RAI stage 0-IV 7 Test ordered, results not in chart 9 Not documented in
medical record
Lymphocytosis not assessed or unknown if assessed
SCREEN: S DIC("S")="D SCRNFIV^ONCSCHMM"
EXPLANATION: Codes depend on appropriate primary site
165.5,3886 MAJOR VEIN INVOLVEMENT SSD3;16 SET
'0' FOR Not present or not identified;
'1' FOR Renal vein or its segmental branches;
'2' FOR Inferior vena cava (IVC);
'3' FOR Major vein invasion, NOS;
'4' FOR Any combination of codes 1-3;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: AUG 14, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Major vein involvement pertains to the invasion of the kidney tumor into major veins. Rationale:
Involvement of major veins for Kidney is a Registry Data Collection Variable in AJCC. It was
previously collected as Kidney, CS SSF #2. Codes: 0 Major vein involvement not present/not
identified 1 Renal vein or its segmental branches 2 Inferior vena cava (IVC) 3 Major vein
invasion, NOS 4 Any combination of codes 1-3 8 Not applicable: Information not collected for
this case
(If this information is required by your standard setter, use of
code 8 may result in an edit error.) 9 Not documented in medical record
Vein involvement not assessed or unknown if assessed
No surgical resection of primary site is performed
165.5,3887 MEASURED BASAL DIAMETER SSD3;17 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
MAXIMUM LENGTH: 4
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Measured Basal Diameter, the largest basal diameter of a uveal melanoma, is a prognostic indicator
for this tumor. Rationale: Measured Basal Diameter is listed as a Registry Data Collection
Variable in AJCC. It was previously collected as Uveal Melanoma, CS SSF# 2. Codes: 0.0 No
mass/tumor found 0.1-99.9 0.1-99.9 millimeters (mm)
(Exact measurement to nearest tenth of mm) XX.0 100 millimeters (mm) or larger XX.1
Described as "less than 3 mm" XX.2 Described as "at least" 3 mm XX.3 Described as "at least" 6
mm XX.4 Described as "at least" 9 mm XX.5 Described as "at least" 12 mm XX.6 Described as "at
least" 15 mm XX.8 Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code XX.8 may result in an edit error.) XX.9 Not documented in medical record
Cannot be determined by pathologist
Measured Basal Diameter not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3888 MEASURED THICKNESS SSD3;18 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
MAXIMUM LENGTH: 4
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Measured Thickness, or height, of a uveal melanoma, is a prognostic indicator for this tumor.
Rationale: Measured Thickness is listed as a Registry Data Collection Variable in AJCC. It was
previously collected as Uveal Melanoma, CS SSF# 3. Codes: 0.0 No mass/tumor found 0.1-99.9
0.1-99.9 millimeters (mm)
(Exact measurement to nearest tenth of mm) XX.0 100 millimeters (mm) or larger XX.1
Described as "less than 3 mm" XX.2 Described as "at least" 3 mm XX.3 Described as "at least" 6
mm XX.4 Described as "at least" 9 mm XX.5 Described as "at least" 12 mm XX.6 Described as
"greater than" 15 mm XX.8 Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code XX.8 may result in an edit error.) XX.9 Not documented in medical record
Cannot be determined
Measured Thickness not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3889 METHYLATION OF MGMT SSD3;19 SET
'0' FOR Absent or not present, unmethylated MGMT;
'1' FOR Present, low level;
'2' FOR Present, high level;
'3' FOR Present, level unspecified;
'6' FOR Benign or borderline tumor;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: AUG 14, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: O6-Methylguanine-Methyltransferase (MGMT) is an enzyme in cells that repairs DNA. Methylation of
the MGMT gene reduces production of MGMT enzyme and the ability of tumor cells to repair damage
caused by chemotherapy. Methylation of MGMT is a prognostic and predictive factor for high grade
gliomas. Rationale: Methylation of O6-Methylguanine-Methyltransferase (MGMT) is a Registry Data
Collection Variable in AJCC. It was previously collected as Brain, CS SSF #4. Codes: 0 MGMT
methylation absent/not present, unmethylated MGMT 1 MGMT methylation present, low level
Hypomethylated
Partial methylated 2 MGMT methylation present, high level
Hypermethylated 3 MGMT Methylation present, level unspecified 6 Benign or borderline
tumor 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this
case
(If this item is required by your standard setter,
use of code 8 will result in an edit error.) 9 Not documented in patient record
Cannot be determined by the pathologist
MGMT not assessed or unknown if assessed
165.5,3890 MICROSATELLITE INSTABILITY SSD3;20 SET
'0' FOR Microsatellite instability (MSI) stable, microsatellite stable (MSS), negative NOS;
'1' FOR MSI unstable low (MSI-L);
'2' FOR MSI unstable high (MSI-H);
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: AUG 14, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Microsatellite Instability (MSI) is a form of genetic instability manifested by changes in the
length of repeated single- to six-nucleotide sequences (known as DNA microsatellite sequences).
High MSI, found in about 15% of colorectal carcinomas, is an adverse prognostic factor for
colorectal carcinomas and predicts poor response to 5-FU chemotherapy (although the addition of
oxaliplatin in FOLFOX regimens negates the adverse effects [page 266 AJCC manual]). High MSI is a
hallmark of hereditary nonpolyposis colorectal carcinoma, also known as Lynch syndrome. Rationale:
Microsatellite Instability (MSI) is a Registry Data Collection Variable in AJCC. It was previously
collected as Colon and Rectum, CS SSF# 7. Codes: 0 Microsatellite instability (MSI) stable;
microsatellite stable (MSS); negative NOS
AND/OR Mismatch repair (MMR) intact, no loss of nuclear expression of MMR proteins 1 MSI
unstable low (MSI-L) 2 MSI unstable high (MSI-H)
AND/OR
MMR-D (loss of nuclear expression of one or more MMR proteins,
MMR protein deficient) 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
MSI-indeterminate
Microsatellite instability not assessed or unknown if assessed
165.5,3891 MICROVASCULAR DENSITY SSD3;21 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Microvascular Density (MVD), a quantitative measure of tumor vascularity, is a prognostic factor
for uveal melanoma. Rationale: Microvascular Density (MVD), is a Registry Data Collection Variable
in AJCC. This data item was previously collected as Uveal Melanoma, CS SSF# 13. Codes: 00 No
vessels involved 01-99 01-99 vessels per 0.3 square millimeter (mm2) X1 Greater than or equal
to 100 vessels per 0.3 square millimeter (mm2) X2 Lowest quartile for laboratory X3 Second
quartile for laboratory X4 Third quartile for laboratory X5 Highest quartile for laboratory X7
Test ordered, results not in chart X8 Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) X9 Not documented in medical record
Microvascular Density (MVD) not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3892 MITOTIC COUNT UVEAL MELANOMA SSD3;22 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
MAXIMUM LENGTH: 4
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Mitotic Count Uveal Melanoma, the number of mitoses per 40 high-power fields (HPF) based on
pathological evaluation, is a prognostic factor for uveal melanoma. Rationale: Mitotic Count Uveal
Melanoma is listed as a Registry Data Collection Variable in AJCC. It was previously collected as
Uveal Melanoma, CS SSF# 9. Codes: 0.0 0 mitoses per 40 high-power fields (HPF)
Mitoses absent, no mitoses present, no mitotic activity 0.1-99.9 0.1-99.9 mitosis per 40
HPF XX.1 100 or more mitoses per 40 HPF XX.2 Stated as low mitotic count or rate with no
specific number XX.3 Stated as high mitotic count or rate with no specific number XX.4 Mitotic
count described with denominator other than 40 HPF XX.7 Test ordered, results not in chart XX.8
Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code XX.8 may result in an edit error.) XX.9 Not documented in medical record
Mitotic Count Uveal Melanoma not assessed or
unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3893 MITOTIC RATE MELANOMA SSD3;23 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Mitotic Rate Melanoma, the number of mitoses per square millimeter based on pathological
evaluation, is a prognostic factor for melanoma of the skin. Rationale: Mitotic Rate Melanoma is a
Registry Data Collection Variable in AJCC. It was previously collected as Melanoma Skin, CS SSF#
7. Codes: 00 0 mitoses per square millimeter (mm)
Mitoses absent
No mitoses present 01-99 1 - 99 mitoses/square mm
(Exact measurement in mitoses/square mm) X1 100 mitoses/square mm or more X2 Stated as
"less than 1 mitosis/square mm"
Stated as "nonmitogenic" X3 Stated as "at least 1 mitosis/square mm"
Stated as "mitogenic" X4 Mitotic rate described with denominator other
than square millimeter (mm) X7 Test ordered, results not in chart X8 Not applicable:
Information not collected for this case
(If this information is required by your standard setter,
use of code X8 may result in an edit error.) X9 Not documented in medical record
Mitotic Rate Melanoma not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3894 MULTIGENE SIGNATURE METHOD SSD3;24 SET
'1' FOR Mammaprint;
'2' FOR PAM50 (Prosigna);
'3' FOR Breast Cancer Index;
'4' FOR EndoPredict;
'5' FOR Test performed, type of test unknown;
'6' FOR Multiple tests, any test in codes 1-4;
'7' FOR Test ordered;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: AUG 14, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended
to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate
prognosis or the likelihood of future metastasis. This data item identifies the multigene signature
method used. Oncotype Dx is coded elsewhere. Rationale: Multigene Signature Method is a Registry
Data Collection Variable in AJCC. It was previously collected as Breast, CS SSF #22. See also
Multigene Signature Results. Codes: 1 Mammaprint 2 PAM50 (Prosigna) 3 Breast Cancer Index 4
EndoPredict 5 Test performed, type of test unknown 6 Multiple tests, any tests in codes 1-4 7
Test ordered, results not in chart 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code 8 will result in an edit error.) 9 Not documented in medical record
Multigene Signature Method not assessed or unknown if assessed
165.5,3895 MULTIGENE SIGNATURE RESULTS SSD3;25 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended
to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate
prognosis or the likelihood of future metastasis. This data item identified the multigene signature
result. Oncotype Dx is coded elsewhere. Rationale: Multigene Signature Results is a Registry Data
Collection Variable in AJCC. It was previously collected as Breast, CS SSF #23. See also Multigene
Signature Method. Codes: 00-99 Enter actual recurrence score
Note: Depending on the test, the range of values
may be different X1 Score 100 X2 Low risk X3 Moderate [intermediate] risk X4 High
risk X7 Test ordered, results not in chart X8 Not applicable: Information not collected for
this case
(If this item is required by your standard setter,
use of code X8 will result in an edit error.) X9 Not documented in medical record
Multigene Signature Results not assessed or
unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3896 NCCN IPI SSD3;26 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: The NCCN International Prognostic Index (IPI) (previously only "IPI") is used to define risk groups
for specific lymphomas using a 0-5 score range, based on age, stage, number of extranodal sites of
involvement, patient's performance status and pretreatment LDH level. Rationale: NCCN International
Prognostic Index (IPI) is a Registry Data Collection Variable in AJCC. It was previously collected
for Lymphomas, SSF# 3. Codes: 00-08 0-8 points X1 Stated as low risk (0-1 point) X2 Stated
as low intermediate risk (2-3 points) X3 Stated as intermediate risk (4-5 points) X4 Stated as
high risk (6-8 points) X8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code X8 will result in an edit error.) X9 Not documented in medical record
NCCN International Prognostic Index (IPI) not assessed
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3897 NUMBER OF CORES EXAMINED SSD3;27 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: MAY 11, 2020
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: This data item represents the number of cores examined as documented in the pathology report from
needle biopsy of the prostate gland. Rationale: Number of Cores Examined is a Registry Data
Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 13.
Codes: 01-99 1 - 99 cores examined
(Exact number of cores examined) X1 100 or more cores examined X6 Biopsy cores
examined, number unknown X7 No needle core biopsy performed X8 Not applicable: Information not
collected for this case
(If this information is required by your standard setter,
use of code X8 may result in an edit error.) X9 Not documented in medical record
Number of cores examined not assessed
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3898 NUMBER OF CORES POSITIVE SSD3;28 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: MAY 11, 2020
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: This data item represents the number of positive cores documented in the pathology report from
needle biopsy of the prostate gland. Rationale: Number of Cores Positive is a Registry Data
Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 12.
Codes: 00 All examined cores negative 01-99 1 - 99 cores positive
(Exact number of cores positive) X1 100 or more cores positive X6 Biopsy cores
positive, number unknown X7 No needle core biopsy performed X8 Not applicable: Information not
collected for this case
(If this information is required by your standard setter,
use of code X8 may result in an edit error.) X9 Not documented in medical record
Number of Cores Positive not assessed
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3899 NUM OF EXAMINED PARA-AORTIC SSD3;29 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Number of examined para-aortic nodes is the number of nodes examined based on para-aortic nodal
dissection. Rationale: Number of Examined Para-aortic Nodes is listed as a Registry Data
Collection Variable in AJCC. This data item was previously collected as Corpus, CS SSF# 6. Codes:
00 No para-aortic nodes examined 01-99 1 - 99 para-aortic nodes examined
(Exact number of para-aortic lymph nodes examined) X1 100 or more para-aortic nodes
examined X2 Para-aortic nodes examined, number unknown X6 No para-aortic lymph nodes removed,
but
aspiration or core biopsy of para-aortic node(s) only X8 Not applicable: Information not
collected for this case
(If this item is required by your standard setter,
use of code X8 will result in an edit error.) X9 Not documented in medical record
Cannot be determined, indeterminate if positive
para-aortic nodes present
Para-aortic lymph nodes not assessed
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3900 NUM OF EXAMINED PELVIC NODES SSD3;30 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Number of examined pelvic nodes is the number of nodes examined based on pelvic nodal dissection.
Rationale: Number of Examined Pelvic Nodes is listed as a Registry Data Collection Variable in
AJCC. This data item was previously collected as Corpus, CS SSF# 4. Codes: 00 No pelvic lymph
nodes examined 01-99 1 - 99 pelvic lymph nodes examined
(Exact number of pelvic lymph nodes examined) X1 100 or more pelvic nodes examined X2
Pelvic nodes examined, number unknown X6 No pelvic lymph nodes removed, but aspiration or core
biopsy of pelvic node(s) only X8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code X8 will result in an edit error.) X9 Not documented in medical record
Cannot be determined, indeterminate if positive pelvic
nodes present
Pelvic lymph nodes not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3901 NUM OF POS PARA-AORTIC NODES SSD3;31 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Number of Positive Para-Aortic Nodes is the number of positive nodes based on para-aortic nodal
dissection Rationale: Number of Positive Para-aortic Nodes is listed as a Registry Data Collection
Variable in AJCC. This data item was previously collected as Corpus, CS SSF# 5. Codes: 00 All
para-aortic lymph nodes examined negative 01-99 1-99 para-aortic lymph nodes positive
(Exact number of nodes positive) X1 100 or more para-aortic nodes positive X2 Positive
para-aortic nodes identified, number unknown X6 Positive aspiration or core biopsy of para-aortic
lymph node(s) X8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code X8 will result in an edit error.) X9 Not documented in medical record
Cannot be determined, indeterminate if positive
para-aortic nodes present
Para-aortic lymph nodes not assessed
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3902 NUM OF POSITIVE PELVIC NODES SSD3;32 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Number of Positive Pelvic Nodes is the number of positive nodes based on pelvic nodal dissection.
Rationale: Number of Positive Pelvic Nodes is listed as a Registry Data Collection Variable in
AJCC. This data item was previously collected as Corpus, CS SSF# 3. Codes: 00 All pelvic nodes
examined negative 01-99 1 - 99 pelvic nodes positive
(Exact number of nodes positive) X1 100 or more pelvic nodes positive X2 Positive
pelvic nodes identified, number unknown X6 Positive aspiration or core biopsy of pelvic lymph
node(s) X8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code X8 will result in an edit error.) X9 Not documented in medical record
Cannot be determined, indeterminate if positive
pelvic nodes present
Pelvic lymph nodes not assessed
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3903 ONCOTYPE DX RECUR SCORE-DCIS SSD3;33 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?0.2AN1N) X I $D(X) D GEN3^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: Oncotype Dx Recurrence Score-DCIS is a numeric score of a genomic test to predict the risk of local
recurrence of breast cancer based on the assessment of 12 genes. Rationale: Oncotype Dx Recurrence
Score-DCIS is a Registry Data Collection Variable in AJCC. It is a new data item for cases
diagnosed 1/1/2018+. Codes: 0-100 Enter actual recurrence score between 0 and 100 XX6 Not
applicable: invasive case XX7 Test ordered, results not in chart XX8 Not applicable:
Information not collected for this case
(If this item is required by your standard setter,
use of code XX8 will result in an edit error.) XX9 Not documented in medical record
Oncotype Dx Recurrence Score-DCIS not assessed
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3904 ONCOTYPE DX REC SCORE-INVASIVE SSD3;34 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?0.2AN1N) X I $D(X) D GEN3^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: Oncotype Dx Recurrence Score-Invasive is a numeric score of a genomic test to predict the
likelihood of distant recurrence of invasive breast cancer based on the assessment of 21 genes.
Rationale: Oncotype Dx Recurrence Score-Invasive is a Registry Data Collection Variable in AJCC. It
is a new data item for cases diagnosed 1/1/2018+. Codes: 0-100 Enter actual recurrence score
between 0 and 100 XX4 Stated as less than 11 XX5 Stated as equal to or greater than 11 XX6
Not applicable: in situ case XX7 Test ordered, results not in chart XX9 Not documented in
medical record
Oncotype Dx Recurrence Score-Invasive not assessed
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3905 ONCOTYPE DX RISK LEVEL-DCIS SSD4;1 SET
'0' FOR Low risk;
'1' FOR Intermediate risk;
'2' FOR High risk;
'6' FOR Not applicable, invasive case;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: AUG 15, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Oncotype Dx Risk Level-DCIS stratifies Oncotype Dx recurrence scores into low, intermediate, and
high risk of local recurrence. Rationale: Oncotype Dx Risk Level-DCIS is a Registry Data
Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Low
risk (recurrence score 0-38) 1 Intermediate risk (recurrence score 39-54) 2 High risk
(recurrence score greater than or equal to 55) 6 Not applicable: invasive case 7 Test ordered,
results not in chart 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code 8 will result in an edit error.) 9 Not documented in medical record
Oncotype Dx Risk Level-DCIS not assessed or unknown if assessed
165.5,3906 ONCOTYPE DX RISK LEVEL-INVAS SSD4;2 SET
'0' FOR Low risk;
'1' FOR Intermediate risk;
'2' FOR High risk;
'6' FOR Not applicable, DCIS case;
'7' FOR Test done, results not in chart;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: AUG 15, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Oncotype Dx Risk Level-Invasive stratifies Oncotype Dx recurrence scores into low, intermediate,
and high risk of distant recurrence. Rationale: Oncotype Dx Risk Level-Invasive is a Registry Data
Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Low
risk (recurrence score 0-17) 1 Intermediate risk (recurrence score 18-30) 2 High risk
(recurrence score greater than or equal to 31) 6 Not applicable: DCIS case 7 Test done, results
not in chart 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code 8 will result in an edit error.) 9 Not documented in medical record
Oncotype Dx Risk Level-Invasive not assessed or unknown if assessed
165.5,3907 ORGANOMEGALY SSD4;3 SET
'0' FOR Organomegaly of liver and/or spleen not present;
'1' FOR Organomegaly of liver and/or spleen present;
'5' FOR NA, site not C421;
'9' FOR Not documented in medical record;
LAST EDITED: JUN 27, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Organomegaly is defined as presence of enlarged liver and/or spleen on physical examination and is
part of the staging criteria for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
Rationale: Organomegaly is a prognostic factor required for staging of CLL/SLL in AJCC 8th edition,
Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new data item for cases diagnosed 1/1/2018+.
Codes: 0 Organomegaly of liver and/or spleen not present 1 Organomegaly of liver and/or spleen
present 5 Not applicable: Primary site is not C421 9 Not documented in medical record
Organomegaly not assessed or unknown if assessed
SCREEN: S DIC("S")="D SCRNFIV^ONCSCHMM"
EXPLANATION: Codes depend on appropriate site
165.5,3908 PERCENT NECROSIS PST NEOADJVNT SSD4;4 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM
MAXIMUM LENGTH: 5
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-5 characters in length.
DESCRIPTION: Percent Necrosis Post Neoadjuvant is a prognostic factor for bone sarcomas. Rationale Percent
Necrosis Post Neoadjuvant is a Registry Data Collection Variable for AJCC. It was previously
collected as Bone, CS SSF# 3. Codes 0.0 Tumor necrosis not identified/not present 0.1-100.0
0.1-100.0 percent tumor necrosis
(Percentage of tumor necrosis to nearest tenth of a percent) XXX.2 Tumor necrosis
present, percent not stated XXX.8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code XXX.8 will result in an edit error.) XXX.9 Not documented in medical record
No histologic examined of primary site
No neoadjuvant therapy
No surgical resection of primary site is performed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3909 PERINEURAL INVASION 2018 SSD4;5 SET
'0' FOR Perineural invasion not identified/not present;
'1' FOR Perineural invasion identified/present;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: AUG 15, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Perineural Invasion, within or adjacent to the primary tumor, is a negative prognostic factor for
cutaneous squamous cell carcinomas of the head and neck and carcinomas of the colon and rectum,
eyelid and lacrimal gland. Rationale: Perineural Invasion is a Registry Data Collection Variable
in AJCC. It was previously collected as Colon and Rectum CS SSF# 8 and Lacrimal Gland CS SSF# 4.
Codes: 0 Perineural invasion not identified/not present 1 Perineural invasion
identified/present 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
Pathology report does not mention perineural invasion
Cannot be determined by the pathologist
Perineural invasion not assessed or unknown if assessed
165.5,3910 PERIPHERAL BLOOD INVOLV 2018 SSD4;6 POINTER TO ONCO PERIPHERAL BLOOD INVOLVEMENT FILE (#167.4)
LAST EDITED: AUG 15, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Peripheral blood involvement, summarized in "B category", refers to the percentage of peripheral
blood lymphocytes that are atypical (Sezary) cells and whether they are "Clone negative" or "Clone
positive". Rationale: Peripheral blood involvement is a prognostic factor required in AJCC 8th
edition, Chapter 81 Primary Cutaneous Lymphomas, for staging of Mycosis Fungoides and Sezary
Syndrome. It was previously collected as Mycosis Fungoides, CS SSF #1. Codes: 0 Absence of
significant blood involvement
5% or less of peripheral blood lymphocytes are atypical (Sezary) cells
Clone unknown
Stated as B0 1 Absence of significant blood involvement
5% or less of peripheral blood lymphocytes are atypical (Sezary) cells
Clone negative
Stated as B0a 2 Absence of significant blood involvement:
5% or less of peripheral blood lymphocytes are atypical (Sezary) cells
Clone positive
Stated as B0b 3 Low blood tumor burden
More than 5% of peripheral blood lymphocytes are
atypical (Sezary) cells but does not meet the criteria of B2
Clone unknown
Stated as B1 4 Low blood tumor burden
More than 5% of peripheral blood lymphocytes are
atypical (Sezary) cells but does not meet the criteria of B2
Clone negative
Stated as B1a 5 Low blood tumor burden
More than 5% of peripheral blood lymphocytes are
atypical (Sezary) cells but does not meet the criteria of B2
Clone positive
Stated as B1b 6 High blood tumor burden
Greater than or equal to 1000 Sezary cells per microliter (uL)
Clone positive
Stated as B2 7 Test ordered, results not in chart 9Not documented in medical record
Peripheral Blood Involvement not assessed or unknown if assessed
165.5,3911 PERITONEAL CYTOLOGY SSD4;7 SET
'0' FOR Negative for malignancy;
'1' FOR Atypical and/or suspicious;
'2' FOR Malignant (positive for malignancy);
'3' FOR Unsatisfactory/nondiagnostic;
'7' FOR Test order, results not in chart;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: AUG 16, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Peritoneal cytology pertains to the results of cytologic examination for malignant cells performed
on fluid that is obtained from the peritoneal cavity. Rationale: Peritoneal Cytology is listed as
a Registry Data Collection Variable in AJCC. This data item was previously collected as Corpus, CS
SSF# 2. Codes: 0 Peritoneal cytology/washing negative for malignancy 1 Peritoneal
cytology/washing atypical and/or suspicious 2 Peritoneal cytology/washing malignant (positive for
malignancy) 3 Unsatisfactory/nondiagnostic 7 Test ordered, results not in chart 8 Not
applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code 8 will result in an edit error.) 9 Not documented in medical record
Peritoneal cytology not assessed or unknown if assessed
165.5,3913 PLEURAL EFFUSION SSD4;8 SET
'0' FOR Not identified/not present;
'1' FOR Present, non-malignant (negative);
'2' FOR Present, malignant (positive);
'3' FOR Atypical mesothelial cells;
'4' FOR Pleural effusion, NOS;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: AUG 16, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Pleural effusion is the accumulation of fluid between the parietal pleura (the pleura covering the
chest wall and diaphragm) and the visceral pleura (the pleura covering the lungs). Rationale:
Pleural Effusion is collected by the surveillance community for pleura cancers. Prior to 2018,
Pleura SSF #1 was used for Pleural Effusion. Codes: 0 Pleural effusion not identified/not
present 1 Pleural effusion present, non-malignant (negative) 2 Pleural effusion present,
malignant (positive) 3 Pleural effusion, atypical/atypical mesothelial cells 4 Pleural
effusion, NOS 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code 8 will result in an edit error.) 9 Not documented in medical record
Pleural Effusion not assessed or unknown if assessed
165.5,3914 PR PERCENT POSITIVE SSD4;9 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3AN) X I $D(X) D ERR^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: JUN 25, 2020
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: Progesterone Receptor, Percent Positive or Range is the percent of cells staining progesterone
receptor positive measured by IHC. Rationale: Progesterone Receptor, Percent Positive or Range is
a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.
Codes: 000 PR negative, or stated as less than 1% 001-100 1-100 percent R10 Stated as 1-10%
R20 Stated as 11-20% R30 Stated as 21-30% R40 Stated as 31-40% R50 Stated as 41-50% R60
Stated as 51-60% R70 Stated as 61-70% R80 Stated as 71-80% R90 Stated as 81-90% R99 Stated
as 91-100% XX8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code XX8 will result in an edit error.) XX9 Not documented in medical record
PR (Progesterone Receptor) Percent Positive or
Range not assessed or unknown if assessed Notes: -Physician statement of PR (Progesterone
Receptor) Percent Positive or
Range can be used to code this data item. -Code this data item using the same report used to
record PR Summary. -If PR negative, or percentage less than 1%, code 000. -The actual PR (1-100%)
percent takes priority over the range codes. -If PR positive but percentage unknown, code XX9.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3915 PR SUMMARY SSD4;10 SET
'0' FOR PR negative;
'1' FOR PR positive;
'7' FOR Test ordered, results not in chart;
'9' FOR Not documented in medical record;
LAST EDITED: OCT 21, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: PR (Progesterone Receptor) Summary is a summary of results from the progesterone receptor (PR)
assay. Rationale: This data item is required for prognostic stage grouping in AJCC 8th edition,
Chapter 48, Breast. It was previously collected as Breast CS SSF # 2. Codes: 0 PR negative 1
PR positive 7 Test ordered, results not in chart 9 Not documented in medical record
Cannot be determined (indeterminate)
PR (Progesterone Receptor) Summary status not assessed
or unknown if assessed Note 1: Physician statement of PR (Progesterone Receptor) Summary
status can be used to code this data item when no other information is available. Note 2: The
result of the PR test performed on the primary breast tissue is to be recorded in this data item.
Note 3: Results from nodal or metastatic tissue may be used ONLY when there is no evidence of
primary tumor. Note 4: In cases where PR is reported on more than one breast tumor specimen,
record the highest value. If any sample is positive, record as positive.
Exception: If PR is positive on an in situ specimen and PR is negative on all tested invasive
specimens, code PR as negative (code 0). Note 5: If neoadjuvant therapy is given, record the assay
from tumor specimens prior to neoadjuvant therapy.
If neoadjuvant therapy is given and there are no PR results from pre-treatment specimens,
report the findings from post-treatment specimens. Note 6: If the patient is PR positive and node
negative, a multigene test such as Oncotype Dx may be performed, in which case another PR test will
be performed. Do not record the results of that test in this field.
Record only the results of the test which made the patient eligible to be given the multigene
test.
165.5,3916 PR ALLRED SCORE SSD4;11 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D ERTA^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: OCT 22, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Progesterone Receptor, Total Allred Score is based on the percentage of cells that stain by IHC for
progesterone receptor (PR) and the intensity of that staining. Rationale: Progesterone Receptor,
Total Allred Score is a Registry Data Collection Variable in AJCC. It is a new data item for cases
diagnosed 1/1/2018+. Codes: 00 Total PR Allred score of 0 01 Total PR Allred score of 1 02
Total PR Allred score of 2 03 Total PR Allred score of 3 04 Total PR Allred score of 4 05
Total PR Allred score of 5 06 Total PR Allred score of 6 07 Total PR Allred score of 7 08
Total PR Allred score of 8 X8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code X8 will result in an edit error.) X9 Not documented in medical record
PR (Progesterone Receptor) Total Allred Score not assessed,
or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3917 PRIMARY SCLEROSING CHOLANGITIS SSD4;12 SET
'0' FOR PSC not identified/not present;
'1' FOR PSC present;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: AUG 16, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Primary sclerosing cholangitis denotes a chronic autoimmune inflammation of the bile ducts that
leads to scar formation and narrowing of the ducts over time. It is a prognostic factor for
intrahepatic bile duct cancer. Rationale: Primary Sclerosing Cholangitis is a Registry Data
Collection Variable in AJCC. This data item was previously collected for Intrahepatic Bile Duct,
SSF# 11. Codes: 0 PSC not identified/not present 1 PSC present 8 Not applicable: Information
not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
PSC not assessed or unknown if assessed
165.5,3918 PROFOUND IMMUNE SUPPRESSION SSD4;13 SET
'0' FOR No immune suppression identified;
'1' FOR HIV/AIDS;
'2' FOR Solid organ transplant recipient;
'3' FOR Chronic lymphocytic leukemia;
'4' FOR Non-Hodgkin lymphoma;
'5' FOR Multiple;
'6' FOR Profound;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: AUG 16, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Profound Immune Suppression, suppressed immune status that may be associated with HIV/AIDs, solid
organ transplant, chronic lymphocytic leukemia, non-Hodgkin lymphoma, multiple conditions or other
conditions, increases the risk of developing Merkel Cell Carcinoma and is an adverse prognostic
factor. Rationale: Profound Immune Suppression is a Registry Data Collection Variable in AJCC. It
was previously collected as Merkel Cell Penis, SSF #22, Merkel Cell Scrotum SSF #22, Merkel Cell
Skin, SSF# 22, and Merkel Cell Vulva, SSF# 22. Codes: 0 No immune suppression condition(s)
identified/not present 1 Human Immunodeficiency Virus (HIV)/Acquired
Immunodeficiency Syndrome (AIDS) 2 Solid organ transplant recipient 3 Chronic lymphocytic
leukemia 4 Non-Hodgkin lymphoma 5 Multiple immune suppression conditions 6 Profound immune
suppression present 8 Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
Profound immune suppression not assessed
or unknown if assessed
165.5,3919 PROSTATE PATHOLOGICAL EXT SSD4;14 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1) X I $D(X) D PROPE^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: JUN 10, 2020
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: Pathological extension is used to assign pT category for prostate cancer based on radical
prostatectomy specimens. Rationale: Pathological extension is used in EOD. It was previously
collected as Prostate, CS SSF# 3. Codes: (See the most current version of EOD (Prostate)
(https://staging.seer.cancer.gov/) for rules and site-specific codes and coding structures.)
000 In situ: noninvasive; intraepithelial 300 Invasion into (but not beyond) prostatic capsule
Intracapsular involvement only
No extracapsular extension
Confined to prostate, NOS
Localized, NOS 350 Bladder neck, microscopic invasion
Extraprostatic extension (beyond prostatic capsule), unilateral,
bilateral, or NOS WITHOUT invasion of the seminal vesicles
Extension to periprostatic tissue WITHOUT invasion of seminal vesicles 400 Tumor invades
seminal vesicle(s) 500 Extraprostatic tumor that is not fixed
WITHOUT invasion of adjacent structures
Periprostatic extension, NOS (unknown if seminal vesicle(s) involved)
Extraprostatic extension, NOS (unknown if seminal vesicle(s) involved)
Through capsule, NOS 600 Bladder neck, except microscopic bladder neck involvement
Bladder, NOS
External sphincter
Extraprostatic urethra (membranous urethra)
Fixation, NOS
Levator muscles
Rectovesical (Denonvillier's) fascia
Rectum
Skeletal muscle
Ureter(s) 700 Extension to or fixation to pelvic wall or pelvic bone
"Frozen pelvis", NOS
Further contiguous extension including
Other organs
Penis
Sigmoid colon
Soft tissue other than periprostatic 800 No evidence of primary tumor 900 No
prostatectomy or autopsy performed 950 Prostatectomy performed, but not first course of treatment
for example performed after disease progression 999 Unknown; extension not stated
Unknown if prostatectomy done
Primary tumor cannot be assessed
Not documented in patient record
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years
of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3920 PSA LAB VALUE SSD4;15 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM
MAXIMUM LENGTH: 5
LAST EDITED: AUG 01, 2019
HELP-PROMPT: Answer must be 1-5 characters in length.
DESCRIPTION: PSA (Prostatic Specific Antigen) is a protein produced by cells of the prostate gland and is
elevated in patients with prostate cancer. This data item pertains to PSA lab value. Rationale:
This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 58, Prostate.
It was previously collected as Prostate, CS SSF# 1. Codes: 0.1 0.1 or less nanograms/milliliter
(ng/ml)
(Exact value to nearest tenth of ng/ml) 0.2-999.9 0.2-999.9 ng/ml
(Exact value to nearest tenth of ng/ml) XXX.1 1,000 ng/ml or greater XXX.2 Lab value
not available, physician states PSA is
negative/normal XXX.3 Lab value not available, physician states PSA is
positive/elevated/high XXX.7 Test ordered, results not in chart XXX.9 Not documented
in medical record
PSA lab value not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3921 RESIDUAL TUM VOL PST CYTO SSD4;16 POINTER TO ONCO RESIDUAL TUMOR VOLUME FILE (#167.5)
LAST EDITED: AUG 16, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Gross residual tumor after primary cytoreductive surgery is a prognostic factor for ovarian cancer
and residual tumor volume after cytoreductive surgery is a prognostic factor for late stage ovarian
cancers. Rationale: Residual Tumor Volume Post Cytoreduction is a Registry Data Collection
Variable listed in AJCC. It was previously collected as Ovary, CS SSF # 3. Codes: 00 No gross
residual tumor nodules 10 Residual tumor nodule(s) 1 centimeter (cm) or less
AND neoadjuvant chemotherapy not given or unknown if given 20 Residual tumor nodule(s) 1
cm or less
AND neoadjuvant chemotherapy given (before surgery) 30 Residual tumor nodule(s) greater
than 1 cm
AND neoadjuvant chemotherapy not given or unknown if given 40 Residual tumor nodule(s)
greater than 1 cm
AND neoadjuvant chemotherapy given (before surgery) 90 Macroscopic residual tumor, size
not stated
AND neoadjuvant chemotherapy not given or unknown if given 91 Macroscopic residual tumor
nodule(s), size not stated
AND neoadjuvant chemotherapy given (before surgery) 92 Procedure described as optimal
debulking and size of residual tumor
nodule(s) not given AND neoadjuvant chemotherapy not given
or unknown if given 93 Procedure described as optimal debulking and size of residual tumor
nodue(s) not given AND neoadjuvant chemotherapy given (before
surgery) 97 No cytoreductive surgery performed 98 Not applicable: Information not
collected for this case
(If this item is required by your standard setter, use of
code 98 will result in an edit error.) 99 Not documented in medical record
Residual tumor status after cytoreductive surgery not
assessed or unknown if assessed
165.5,3922 RESPONSE TO NEOADJUVANT THERA SSD4;17 SET
'0' FOR Neoadjuvant therapy not given;
'1' FOR Complete response (CR);
'2' FOR Partial response (PR);
'3' FOR Response to treatment, but not noted if complete or partial;
'4' FOR No response (NR);
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: AUG 20, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This data item records the physician's statement of response to neoadjuvant chemotherapy.
Rationale: Response to Neoadjuvant Therapy is a Registry Data Collection Variable in AJCC. It was
previously collected as Breast, CS SSF #21. Codes: 0 Neoadjuvant therapy not given 1 Stated as
complete response (CR) 2 Stated as partial response (PR) 3 Stated as response to treatment, but
not noted if complete or partial 4 Stated as no response (NR) 8 Not applicable: Information not
collected for this case
(If this item is required by your standard setter,
use of code 8 will result in an edit error.) 9 Not documented in medical record
Response to neoadjuvant therapy not assessed or unknown if assessed
165.5,3923 S CATEGORY CLINICAL SSD4;18 SET
'0' FOR S0;
'1' FOR S1;
'2' FOR S2;
'3' FOR S3;
'9' FOR SX;
LAST EDITED: AUG 20, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: S Category Clinical combines the results of pre-orchiectomy Alpha Fetoprotein (AFP), Human
Chorionic Gonadotropin (hCG) and Lactate Dehydrogenase (LDH) into a summary S value. Rationale: S
Category Clinical is required for prognostic stage grouping in AJCC 8th edition, Chapter 59 Testis.
It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 S0: Marker study levels within
normal levels 1 S1: At least one of these values is elevated AND
LDH less than 1.5 x N* AND
hCG (mIU/L) less than 5,000 AND
AFP (ng/mL) less than 1,000 2 S2:
LDH 1.5 x N* to 10 x N* OR
hCG (mIU/L) 5,000 to 50,000 OR
AFP (ng/mL) 1,000 to 10,000 3 S3: Only one elevated test is needed
LDH greater than 10 x N* OR
hcG (mIU/mL) greater than 50,000 OR
AFP (ng/mL) greater than 10,000 9 SX: Not documented in medical record
S Category Clinical not assessed or unknown if assessed
*N indicates the upper limit of normal for the LDH assay.
165.5,3924 S CATEGORY PATHOLOGICAL SSD4;19 SET
'0' FOR S0;
'1' FOR S1;
'2' FOR S2;
'3' FOR S3;
'9' FOR SX;
LAST EDITED: AUG 20, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: S Category Pathological combines the results of post-orchiectomy Alpha Fetoprotein (AFP), Human
Chorionic Gonadotropin (hCG) and Lactate Dehydrogenase (LDH) into a summary S value. Rationale: S
Category Pathological is required for prognostic stage grouping in AJCC 8th edition, Chapter 59
Testis. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 S0: Marker study levels
within normal levels 1 S1: At least one of these values is elevated AND
LDH less than 1.5 x N* AND
hCG (mIU/L) less than 5,000 AND
AFP (ng/mL) less than 1,000 2 S2:
LDH 1.5 x N* to 10 x N* OR
hCG (mIU/L) 5,000 to 50,000 OR
AFP (ng/mL) 1,000 to 10,000 3 S3: Only one elevated test is needed
LDH greater than 10 x N* OR
hcG (mIU/mL) greater than 50,000 OR
AFP (ng/mL) greater than 10,000 9 SX: Not documented in medical record
S Category Pathological not assessed or unknown if assessed
*N indicates the upper limit of normal for the LDH assay.
165.5,3925 SARCOMATOID FEATURES SSD4;20 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3AN) X I $D(X) D SAR^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: JUN 25, 2020
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: Sarcomatoid features: present or absent and percentage refers to the observation of sheets and
fascicles of malignant spindle cells in a kidney tumor which can occur across all histologic
subtypes. The percentage of sarcomatoid component has been shown to correlate with cancer-specific
mortality. Rationale: Sarcomatoid features for Kidney is a Registry Data Collection Variable in
AJCC. It was previously collected as Kidney, CS SSF #4. Codes: 000 Sarcomatoid features not
present/not identified 000-100 Sarcomatoid features 1-100% R01 Sarcomatoid features stated as
less than 10% R02 Sarcomatoid features stated as range 10%-30% present R03 Sarcomatoid features
stated as a range 31% to 50% present R04 Sarcomatoid features stated as a range 51% to 80%
present R05 Sarcomatoid features stated as greater than 80% XX5 Sarcomatoid features present
from metastatic site only AND
Sarcomatoid features not present in primary site,
or unknown if present XX6 Sarcomatoid features present, percentage unknown XX7 Not
applicable: Not a renal cell carcinoma morphology XX8 Not applicable: Information not collected
for this case
(If this information is required by your standard setter,
use of code XX8 may result in an edit error.) XX9 Not documented in medical record
Sarcomatoid features not assessed or unknown if assessed
No surgical resection of primary site is performed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3926 SCHEMA DISCRIMINATOR 1 SSD4;21 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S ONCSDND=1 D SDIT^ONCSCHMG
LAST EDITED: SEP 07, 2018
HELP-PROMPT: Type a number between 0 and 9, 0 decimal digits.
DESCRIPTION: Captures additional information needed to generate AJCC ID [995] and Schema ID [3800] for some
anatomic sites. Discriminators can be based on sub site, histology or other features which affect
prognosis. Rationale: A schema discriminator is used to assign AJCC ID [995] when site and
histology alone are insufficient to identify the applicable AJCC staging method and to assign
Schema ID [3800], which links each case to the appropriate SSDIs, Summary Stage and EOD data
collection system.
EXECUTABLE HELP: S ONCSDND=1 D SDHLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3927 SCHEMA DISCRIMINATOR 2 SSD4;22 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S ONCSDND=2 D SDIT^ONCSCHMG
LAST EDITED: SEP 07, 2018
HELP-PROMPT: Type a number between 0 and 9, 0 decimal digits.
DESCRIPTION: Captures additional information needed to generate AJCC ID [995] and Schema ID [3800] for some
anatomic sites. Discriminators can be based on sub site, histology or other features which affect
prognosis. Rationale: A schema discriminator is used to assign AJCC ID [995] when site and
histology alone are insufficient to identify the applicable AJCC staging method and to assign
Schema ID [3800], which links each case to the appropriate SSDIs, Summary Stage and EOD data
collection system.
EXECUTABLE HELP: S ONCSDND=2 D SDHLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3928 SCHEMA DISCRIMINATOR 3 SSD4;23 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: SEP 07, 2018
HELP-PROMPT: Type a number between 0 and 9, 0 decimal digits.
DESCRIPTION: Captures additional information needed to generate AJCC ID [995] and Schema ID [3800] for some
anatomic sites. Discriminators can be based on sub site, histology or other features which affect
prognosis. Rationale: A schema discriminator is used to assign AJCC ID [995] when site and
histology alone are insufficient to identify the applicable AJCC staging method and to assign
Schema ID [3800], which links each case to the appropriate SSDIs, Summary Stage and EOD data
collection system.
165.5,3929 SEPARATE TUMOR NODULES SSD4;24 SET
'0' FOR Single tumor only;
'1' FOR Ipsilateral lung same lobe;
'2' FOR Ipsilateral lung different lobe;
'3' FOR Ipsilateral lung same AND diff lobes;
'4' FOR Ipsilateral lung unk if same or diff;
'7' FOR Multiple nodules;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: AUG 21, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: "Separate tumor nodules" refers to what is conceptually a single tumor with intrapulmonary
metastasis in the ipsilateral (same) lung. Their presence in the same or different lobes of lung
from the primary tumor affects the T and M categories. Rationale: This data item was previously
collected for Lung, SSF# 1 and at least one standard setter is continuing to collect it. Codes: 0
No separate tumor nodules; single tumor only
Separate tumor nodules of same histologic
not identified/not present
Intrapulmonary metastasis not identified/not present
Multiple nodules described as multiple foci of adenocarcinoma in situ
or minimally invasive adenocarcinoma 1 Separate tumor nodules of same histologic type
in ipsilateral lung, same lobe 2 Separate tumor nodules of same histologic type
in ipsilateral lung, different lobe 3 Separate tumor nodules of same histologic type
in ipsilateral lung, same AND different lobes 4 Separate tumor nodules of same histologic
type
in ipsilateral lung, unknown if same or different lobe(s) 7 Multiple nodules or foci of
tumor present, not classifiable
based on notes 3 and 4 8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code 8 will result in an edit error.) 9 Not documented in medical record
Primary tumor is in situ
Separate Tumor Nodules not assessed or unknown if assessed
165.5,3930 SERUM ALBUMIN PRETREAT VALUE SSD4;25 SET
'0' FOR Serum albumin <3.5g/dL;
'1' FOR Serum albumin greater or equal 3.5g/dL;
'5' FOR Schema Discriminator 1 coded to 1 or 9;
'7' FOR Test ordered, results not in chart;
'9' FOR Not documented in medical record;
LAST EDITED: JUN 28, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Albumin is the most abundant protein in human blood plasma. Serum albumin pretreatment level is a
prognostic factor for plasma cell myeloma. Rationale: Serum albumin pretreatment level is a
prognostic factor required in AJCC 8th edition, Chapter 82 Plasma Cell Myeloma and Plasma Cell
Disorders, for the Revised International Staging System (RISS). It is a new data item for cases
diagnosed 1/1/2018+. Codes: 0 Serum albumin <3.5 g/dL 1 Serum albumin > or =3.5 g/dL 5
Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 7 Test ordered, results
not in chart 9 Not documented in medical record
Serum Albumin Pretreatment Level not assessed or unknown if assessed
SCREEN: S DIC("S")="D SCRN555^ONCSCHMM"
EXPLANATION: Codes depend on appropriate schema discriminator
165.5,3931 SERUM BETA-2 MICROGLOBULIN SSD4;26 SET
'0' FOR Less than 3.5mg/L;
'1' FOR Greater than or equal 3.5mg/L AND Less than 5.5mg/L;
'2' FOR Greater than or equal 5.5mg/L;
'5' FOR Schema Discriminator 1 coded to 1 or 9;
'7' FOR Test ordered, results not in chart;
'9' FOR Not documented;
LAST EDITED: JUN 28, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Serum Beta-2 Microglobulin is a protein that is found on the surface of many cells and plentiful on
the surface of white blood cells. Increased production or destruction of these cells causes Serum
�2 (beta-2) Microglobulin level to increase. Elevated Serum �2 (beta-2) Microglobulin level is a
prognostic factor for plasma cell myeloma. Rationale: Serum Beta-2 Microglobulin Pretreatment
Level is a prognostic factor required in AJCC 8th edition, Chapter 82 Plasma Cell Myeloma and
Plasma Cell Disorders, for staging of plasma cell myeloma. It is a new data item for cases
diagnosed 1/1/2018+. Codes: 0 �2-microglobulin <3.5 mg/L 1 �2-microglobulin > or =3.5 mg/L
<5.5 mg/L 2 �2-microglobulin > or =5.5 mg/L 5 Schema Discriminator 1: Plasma Cell Myeloma
Terminology coded to 1 or 9 7 Test ordered, results not in chart 9 Not documented in medical
record
Serum Beta-2 Microglobulin Pretreatment Level not assessed or
unknown if assessed
SCREEN: S DIC("S")="D SCRN555^ONCSCHMM"
EXPLANATION: Codes depend on appropriate schema discriminator
165.5,3932 LDH LAB VALUE SSD4;27 FREE TEXT
INPUT TRANSFORM: K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM
MAXIMUM LENGTH: 7
LAST EDITED: JAN 26, 2021
HELP-PROMPT: Answer must be 1-7 characters in length.
DESCRIPTION: LDH (Lactate Dehydrogenase) Lab Value, measured in serum, is a predictor of treatment response,
progression-free survival and overall survival for patients with Stage IV melanoma of the skin.
Rationale: LDH (Lactate Dehydrogenase) Lab Value is a Registry Data Collection Variable in AJCC. It
was previously collected as Melanoma Skin, CS SSF# 5. Codes:
0.0 0.0 (U/L) 0.1-99999.9 0.1-99,999.9 U/L XXXXX.1 100,000 U/L or greater XXXXX.7 Test
ordered, results not in chart XXXXX.8 Not applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code XXXXX.8 will result in an edit error.) XXXXX.9 Not documented in medical
record
LDH (Lactate Dehydrogenase) Pretreatment Lab
Value not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3933 THROMBOCYTOPENIA SSD4;28 SET
'0' FOR Thromb not present, Plt GT or equal 100000;
'1' FOR Thromb present, Plt < 100000;
'5' FOR NA, not C421;
'6' FOR Lab value unk, physician states Thromb present or RAI stage IV;
'7' FOR Test ordered, results not in chart;
'9' FOR Not documented;
LAST EDITED: SEP 26, 2023
HELP-PROMPT: Enter a code from the list that corresponds to the Thrombocytopenia for this patient's primary.
DESCRIPTION: Thrombocytopenia is defined by a deficiency of platelets in the blood. In staging of Chronic
Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), thrombocytopenia is defined as Platelets
(Plt) less than 100,000/µL. Rationale: Thrombocytopenia is a prognostic factor required for
staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition,
Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new data item for cases diagnosed 1/1/2018+.
Codes: 0 Thrombocytopenia not present
Platelets (Plt) >= 100,000/µL
Physician states RAI stage 0-III 1 Thrombocytopenia present
Platelets (Plt) < 100,000/µL 5 Not applicable: Primary site is not C421 6 Lab value
unknown, physician states thrombocytopenia is present
Physician states RAI stage IV 7 Test ordered, results not in chart 9 Not documented in
medical record
Thrombocytopenia not assessed or unknown if assessed
SCREEN: S DIC("S")="D SCRNFIV^ONCSCHMM"
EXPLANATION: Codes depend on appropriate primary site
165.5,3934 TUMOR DEPOSITS SSD4;29 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: JUL 26, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: A tumor deposit is defined as a discrete nodule of cancer in pericolic/perirectal fat or in
adjacent mesentery (mesocolic or rectal fat) within the lymph drainage area of the primary
carcinoma, without identifiable lymph node tissue or identifiable vascular structure. Rationale:
The presence of tumor deposits is a Registry Data Collection Variable in AJCC. It was previously
collected as Colon and Rectum CS SSF# 4. Codes: 00 No tumor deposits 01-99 01-99 Tumor
deposits (Exact number of Tumor Deposits) X1 100 or more Tumor Deposits X2 Tumor Deposits
identified, number unknown X8 Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code X8 may result in an edit error.) X9 Not documented in medical record
Cannot be determined by the pathologist
Pathology report does not mention tumor deposits
No surgical resection done
Tumor Deposits not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3935 TUMOR GROWTH PATTERNS SSD4;30 SET
'1' FOR Mass-forming;
'2' FOR Periductal infiltrating;
'3' FOR Mixed mass-forming and periductal infiltrating;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: AUG 22, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Tumor Growth Pattern refers to the growth pattern of intrahepatic cholangiocarcinoma. Rationale:
Tumor Growth Pattern is a Registry Data Collection Variable in AJCC. This data item was previously
collected for Intrahepatic Bile Duct, SSF# 10. Codes: 1 Mass-forming 2 Periductal infiltrating
3 Mixed mass-forming and periductal infiltrating 8 Not applicable: Information not collected
for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
Pathology report does not mention tumor growth pattern
Cannot be determined by the pathologist
Tumor growth pattern not assessed or unknown if assessed
165.5,3936 ULCERATION 2018 SSD4;31 SET
'0' FOR Ulceration not identified/not present;
'1' FOR Ulceration present;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: AUG 22, 2018
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Ulceration, the absence of an intact epidermis overlying the primary melanoma based upon
histopathological examination, is a prognostic factor for melanoma of the skin. Rationale
Ulceration is a Registry Data Collection Variable in AJCC. It was previously collected as Melanoma
Skin, CS SSF# 2. Codes 0 Ulceration not identified/not present 1 Ulceration present 8 Not
applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code 8 will result in an edit error.) 9 Not documented in medical record
Cannot be determined by the pathologist
Pathology report does not mention ulceration
Ulceration not assessed or unknown if assessed
165.5,3937 VISCERAL PARIETAL PLEURAL INV SSD4;32 SET
'0' FOR No evidence/PL0;
'4' FOR Inv of visceral pleura, NOS/PL1 or PL2;
'5' FOR Invades into or through parietal pleura OR chest wall/PL3;
'6' FOR Extends to pleura, NOS;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUN 01, 2021
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Visceral and Parietal Pleural Invasion is defined as invasion beyond the elastic layer or to the
surface of the visceral pleura. Rationale: Visceral and Parietal Pleural Invasion (previously
called "pleural/elastic layer invasion (PL)") is a Registry Data Collection Variable for AJCC.
This data item was previously collected for Lung, SSF# 2. Codes: 0 No evidence of visceral
pleural invasion identified
Tumor does not completely traverse the elastic layer of the pleura
Stated as PL0 4 Invasion of visceral pleura present, NOS
Stated as PL1 or PL2 5 Tumor invades into or through the parietal pleural OR chest wall
Stated as PL3 6 Tumor extends to pleura, NOS; not stated if visceral or parietal 8 Not
applicable: Information not collected for this case
(If this item is required by your standard setter,
use of code 8 will result in an edit error.) 9 Not documented in medical record
No surgical resection of primary site is performed
Visceral Pleural Invasion not assessed or unknown if assessed
or cannot be determined
165.5,3938 ALK REARRANGEMENT SSD5;1 SET
'0' FOR Normal/ALK negative;
'1' FOR EML4-ALK,KIF5B-ALK,TFG-ALK,KLC1-ALK;
'2' FOR Other ALK not listed in code 1;
'4' FOR Rearrangement, NOS;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUN 01, 2021
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Testing for ALK rearrangement is performed for patients with advanced non-small cell lung cancer
(NSCLC) to identify tumors which are sensitive to small-molecule ALK kinase inhibitors. Rationale:
ALK rearrangement is recommended by treatment guidelines for patients with advanced lung cancer as
a prognostic marker and factor in determining appropriate therapy. It is a new data item for cases
diagnosed 01/01/2021+. Codes: 0 Normal
ALK negative
Negative for rearrangement, no rearrangement identified,
no mutations (somatic) identified, not present, not detected 1 Abnormal Rearrangement
identified/detected: EML4-ALK,
KIF5B-ALK, TFG-ALK, and/or KLC1-ALK 2 Rearrangement identified/detected: Other ALK
Rearrangement not listed in code 1 4 Rearrangement, NOS 7 Test ordered, results not in
chart 8 Not applicable: Information not collected for this case
If this information is required by your standard setter,
use of code 8 may result in an edit error. 9 Not documented in medical record
ALK Rearrangement not assessed or unknown if assessed
165.5,3939 EGFR MUTATIONAL ANALYSIS SSD5;2 SET
'0' FOR Normal, EGFR negative,EGFR wild type;
'1' FOR Abnormal-detected in exon(s) 18,19,20,21;
'2' FOR Abnormal-detected BUT NOT in exon(s) 18,19,20,21;
'4' FOR Detected, NOS;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JUN 01, 2021
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Epidermal growth factor receptor (EGFR) mutational analysis is performed for patients with advanced
non-small cell lung cancer (NSCLC) to identify patients with certain activating mutations in the
EGFR gene which are sensitive to tyrosine kinase inhibitors. Rationale: EGFR mutational analysis
is recommended by treatment guidelines for patients with advanced lung cancer as a prognostic
marker and factor in determining appropriate therapy. It is a new data item for cases diagnosed
01/01/2021+. Codes: 0 Normal
EGFR negative, EGFR wild type
Negative for mutations, no alterations,
no mutations (somatic) identified, not present, not detected 1 Abnormal (mutated)/detected
in exon(s) 18, 19, 20, and/or 21 2 Abnormal (mutated)/detected but not in exon(s) 18, 19, 20,
and/or 21 4 Abnormal (mutated)/detected, NOS, exon(s) not specified 7 Test ordered, results
not in chart 8 Not applicable: Information not collected for this case
If this information is required by your standard setter,
use of code 8 may result in an edit error. 9 Not documented in medical record
EGFR not assessed or unknown if assessed
165.5,3940 BRAF MUTATIONAL ANALYSIS SSD5;3 SET
'0' FOR Normal;
'1' FOR Detected, BRAF V600E (c.1799T>A) mutation;
'2' FOR Detected, but not BRAF V600E (c.1799T>A) mutation;
'4' FOR Abnormal, NOS;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JAN 14, 2021
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: The BRAF oncoprotein is involved in transmitting cell growth and proliferation signals from KRAS
and NRAS. The BRAF V600E mutation is associated with poorer prognosis and predicts lack of response
to anti-EGFR therapies. Rationale: BRAF mutational analysis is recommended in clinical guidelines
for patients with advanced colorectal cancer as a prognostic marker and factor in determining
appropriate therapy. It is a new data item for cases diagnosed 1/1/2021+. Codes: 0 Normal
BRAF negative, BRAF wild type
Negative for (somatic) mutations, no alterations,
no (somatic) mutations identified, not present, not detected 1 Abnormal (mutated)/detected:
BRAF V600E (c.1799T>A) mutation 2 Abnormal (mutated)/detected, but not BRAF V600E (c.1799T>A)
mutation 4 Abnormal (mutated), NOS 7 Test ordered, results not in chart 8 Not applicable:
Information not collected for this case
If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
BRAF not assessed or unknown if assessed
165.5,3941 NRAS MUTATIONAL ANALYSIS SSD5;4 SET
'0' FOR Normal;
'1' FOR Detected in codon(s) 12,13, and/or 61;
'2' FOR Detected, codon(s) specified but not in codon(s) 12,13, or 61;
'4' FOR Abnormal, NOS;
'7' FOR Test ordered, results not in chart;
'8' FOR N/A;
'9' FOR Not documented;
LAST EDITED: JAN 14, 2021
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: NRAS is a signaling intermediate in the growth receptor pathway. Certain NRAS mutations predict
poor response to anti-EGFR therapy in patients with metastatic colorectal cancer. Rationale: NRAS
mutational analysis is recommended in clinical guidelines for patients with metastatic colon cancer
who are being considered for anti-EGFR therapy. It is a new data item for cases diagnosed
01/01/2021+. Codes: 0 Normal
NRAS negative; NRAS wild type
Negative for (somatic) mutations, no alterations,
no (somatic) mutations identified, not present, not detected 1 Abnormal (mutated)/detected
in codon(s) 12, 13, and/or 61 2 Abnormal (mutated)/detected, codon(s) specified but not
in codon(s) 12, 13, or 61 4 Abnormal (mutated), NOS, codon(s) not specified 7 Test
ordered, results not in chart 8 Not applicable: Information not collected for this case
If this information is required by your standard setter,
use of code 8 may result in an edit error. 9 Not documented in medical record
NRAS not assessed or unknown if assessed
165.5,3942 CA 19-9 PRETX LAB VALUE SSD5;5 FREE TEXT
INPUT TRANSFORM: K:$L(X)>6!($L(X)<1)!'(X?0.4AN0.1"."1N) X I $D(X) D DEC4^ONCSCHMM
MAXIMUM LENGTH: 6
LAST EDITED: JAN 14, 2021
HELP-PROMPT: Answer must be 1-6 characters in length.
DESCRIPTION: Carbohydrate Antigen (CA) 19-9 Pretreatment Lab Value records the CA 19-9 value prior to treatment.
CA 19-9 is a tumor marker that has prognostic significance for pancreatic cancer. Rationale: CA
19-9 Pretreatment Lab Value is a strong predictor of resectability in the absence of metastatic
disease. It is a new data item for cases diagnosed 01/01/2021+. Codes: 0.0 0.0 Units/milliliter
(U/ml) exactly 0.1-9999.9 0.1-9999.9 U/ml
Exact value to nearest tenth in U/ml) XXXX.1 10,000 U/ml or greater XXXX.2 Lab value not
available, physician states CA 19-9 is
negative/normal XXXX.3 Lab value not available, physician states CA 19-9 is
positive/elevated/high XXXX.7 Test ordered, results not in chart XXXX.8 Not
applicable: Information not collected for this case
If this information is required by your standard setter,
use of code XXXX.8 may result in an edit error. XXXX.9 Not documented in medical record
CA (Carbohydrate Antigen) 19-9 Pretreatment Lab Value
not assessed or unknown if assessed
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3943 NCDB-SARSCOV2-TEST NCR21;1 SET
'0' FOR Patient not tested for SARS-CoV2;
'1' FOR Patient tested for Active SARS-CoV2;
'9' FOR Unknown if patient tested for SARS-CoV2;
LAST EDITED: FEB 02, 2021
HELP-PROMPT: Enter the value corresponding to the correct SARS-CoV2 test
DESCRIPTION: This data item is designed to track whether patient received a SARS-CoV-2 test or not. Collection
based on diagnosis years 2020 and 2021.
Rationale: To evaluate the impact of COVID-19 diagnosis on cancer patients.
Codes: 0 Patient not tested for SARS-CoV-2: facility records support
that patient did not undergo pre-admit or in-hospital testing 1 Patient tested for Active
SARS-CoV2 9 Unknown if patient tested for SARS-CoV-2/No facility record of
preadmit hospital testing of SARS-CoV-2 Note: This item may be left blank.
165.5,3944 NCDB-SARSCOV2-POSITIVE NCR21;2 SET
'0' FOR Patient did not test positive for active SARS-CoV-2;
'1' FOR Patient tested positive for active SARS-CoV-2;
'9' FOR Unknown if tested or test done, results unknown;
LAST EDITED: FEB 02, 2021
HELP-PROMPT: Enter the value corresponding to the correct SARS-CoV2 test
DESCRIPTION: Data item is designed to track whether patient received a POSITIVE SARS-CoV-2 test or not.
Collection based on diagnosis years 2020 and 2021.
Rationale: To evaluate the impact of COVID-19 diagnosis on cancer patients.
Codes: 0 Patient did not test positive for active SARS-CoV-2:
No positive test 1 Patient tested positive for active SARS-CoV-2: test
positive on at least one test 9 Unknown if tested; test done, results unknown Note: This item
may be left blank.
165.5,3945 NCDB-SARSCOV2-POSITIVE DATE NCR21;3 DATE
INPUT TRANSFORM: S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: JUL 06, 2021
HELP-PROMPT: Enter the date the patient had a positive COVID-19 test
DESCRIPTION: This field stores the date of the first positive COVID-19 test for the patient. Collection based on
diagnosis years 2020 and 2021.
Rationale: To evaluate the impact of COVID-19 diagnosis on cancer patients.
This field will store the date the patient had a positive test for SARS-CoV-2, the virus that
causes the 2019 novel coronavirus disease (COVID-19) as documented by a medical provider. May be
blank if date of the test is unknown or the date of a positive (diagnostic or serologic) test is
unknown for SARS-CoV-2.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,3946 NCDB-COVID19-TX IMPACT NCR21;4 SET
'1' FOR Treatment not affected;
'2' FOR First course timeline delayed;
'3' FOR First course plan altered;
'4' FOR Cancelled first course;
'5' FOR Patient refused treatment due to COVID-19;
'9' FOR Unknown;
LAST EDITED: FEB 02, 2021
HELP-PROMPT: Enter the code evaluating treatment impact
DESCRIPTION: This field stores whether or not the first course of treatment (diagnosis, staging, treatment or
other cancer management events) was impacted by hospital avail- ability (limited access to
facilities or postponement of non-essential procedures) due to COVID-19 pandemic. Collection based
on diagnosis years 2020 and 2021.
Rationale: To evaluate the impact of COVID-19 pandemic on cancer patients.
Codes: 1 Treatment not affected; active surveillance, no change 2 First Course of Treatment
timeline delayed 3 First Course of Treatment plan altered 4 Cancelled First Course of Treatment 5
Patient refused treatment due to COVID-19 9 Not known if treatment affected Note: This item may be
left blank.
165.5,3950 MACROSCOPIC EVAL OF MESORECTUM SSD5;7 SET
'00' FOR Did not receive TME;
'10' FOR Incomplete;
'20' FOR Nearly complete;
'30' FOR Complete;
'40' FOR TME performed, not specified;
'99' FOR Unknown;
LAST EDITED: JUN 06, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Description: This data item records the results of a macroscopic evaluation of the mesorectum from
a total mesorectal excision (TME).
Rationale: Numerous studies have demonstrated the total mesorectal excision (TME) improves local
recurrence rates and the corresponding survival by as much as 20%. Macroscopic pathologic
assessment of the completeness of the mesorectum, scored as complete, partially complete, or
incomplete, accurately predicts both local recurrence and distant metastasis.
Codes: 00 Patient did not receive TME 10 Incomplete 20 Nearly complete 30 Complete 40
TME performed not specified on pathology report as incomplete,
nearly complete, or complete TME performed, but pathology report
not available Physician statement that TME performed, no mention
of incomplete, nearly complete, or complete status 99 Unknown if TME performed Blank
Site not rectum (C20.9)
165.5,3955 DERIVED RAI STAGE SSD5;8 SET
'0' FOR Lymphocytosis;
'1' FOR Lymphocytosis & Adenopathy;
'2' FOR Lymphocytosis & Organomegaly;
'3' FOR Lymphocytosis & Anemia;
'4' FOR Lymphocytosis & Thrombocytopenia;
'8' FOR N/A;
'9' FOR Unk;
LAST EDITED: JUN 06, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Description: This data item stores the Derived Rai stage value derived from the values coded in the
following SSDIs for the Lymphoma-CLL/SLL schema (9823/3):
Lymphocytosis [3885]
Adenopathy [3804]
Organomegaly [3907]
Anemia [3811]
Thrombocytopenia [3933] The Rai stage is only applicable for Chronic Lymphocytic Leukemia/Small
Lymphocytic Lymphoma (CLL/SLL) (9823/3) cases where the primary site is bone marrow (C421). For
cases with a primary site other than bone marrow (C421), the derived Rai stage will be 8 and all
the SSDIs will be coded to 5. Derivation will be run on all cases diagnosed 1/1/2018 and forward.
Rationale: The Derived Rai stage can be used to evaluate disease spread at diagnosis, treatment
patterns and outcomes over time.
Codes: 0 Lymphocytosis 1 Lymphocytosis and Adenopathy 2 Lymphocytosis and Organomegaly
(Adenopathy is any value other than 5) 3 Lymphocytosis and Anemia
(Adenopathy and Organomegaly are any value other than 5) 4 Lymphocytosis and
Thrombocytopenia
(Adenopathy, Organomegaly and Anemia are any value other than 5) 8 Does not apply,
primary site not bone marrow (C421)
(All 5 SSDIs should be set to 5) 9 Unknown
(All 5 SSDIs are 9 or blank; at least one is set to 9 OR
Lymphocytosis is 0,7,9 OR
Lymphocytosis is blank and one of the other SSDIs
is a value other than 5 0r 9)
165.5,3956 P16 SSD5;9 SET
'0' FOR p16 Negative, Nonreactive;
'1' FOR p16 Positive - Diffuse, Strong reactivity;
'8' FOR N/A;
'9' FOR Not tested for p16 - Unknown;
LAST EDITED: JUN 06, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Description: The p16 biomarker is over-expressed (produced) in response to HPV. It is therefore a
surrogate marker for HPV disease.
Rationale: Patients with HPV have a different survival or outcome so it is important to be able to
distinguish this by documenting the p16 results. Testing is performed by immunohistochemistry (IHC)
which is inexpensive and has near universal availability. It has an easily standardized
interpretation. HPV testing is usually performed through DNA testing which is more expensive and
less widely available. HPV testing also has technically more variability with the interpretation.
p16 is a tumor suppressor protein also known as cyclin- dependent kinase inhibitor 2A. The p16
biomarker is over- expressed (produced) in response to HPV. It is therefore a surrogate marker for
HPV disease.
Codes: 0 p16 Negative; Nonreactive 1 p16 Positive; Diffuse, Strong reactivity 8 Not
applicable: Information not collected for this case
(If this time is required by your standard setter, use of
code 8 will result in an edit error). 9 Not tested for p16; Unknown Blank Diagnosis
year prior to 2021
Note 1: This SSDI is effective for diagnosis years 2022+
For cases diagnosed 2018-2021, leave this SSDI blank Note 2: Code 0 for p16 expression of
weak intensity or limited distribution. Note 3: This data item must be based on testing results
for p16
overexpression.
A statement of a patient being HPV positive or negative
is not enough to code this data item
Testing for HPV by DNA, mRNA, antibody, or other
methods should not be coded in this data item Do not confuse p16 with HPV 16, which is a
specific strain of virus
165.5,3957 LN STATUS PELVIC SSD5;10 SET
'0' FOR Negative pelvic lymph nodes;
'1' FOR Positive pelvic lymph nodes;
'8' FOR N/A;
'9' FOR Not documented on medical record;
LAST EDITED: JUN 06, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Description: This data item describes the status of pelvic lymph nodes associated with certain
female genital cancers.
Rationale: Specific regional lymph node involvement is listed as a Registry Data Collection
Variable in AJCC. This information was previously collected as Cervix SSF #2. Variable in AJCC.
This information was previously collected as Cervix SSF #2.
Codes: 0 Negative pelvic lymph nodes 1 Positive pelvic lymph nodes 8 Not applicable:
Information not collected for this case (If this
information is required by your standard setter, use of code 8
may result in edit error.) 9 Not documented in medical record
Pelvic lymph node(s) not assessed or unknown if assessed
165.5,3958 LN STATUS PARA-AORTIC SSD5;11 SET
'0' FOR Negative para-aortic lymph nodes;
'1' FOR Positive para-aortic lymph nodes;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUN 06, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Description: This data item describes the status of para-aortic lymph nodes associated with certain
female genital cancers.
Rationale: Specific regional lymph node involvement is listed as a Registry Data Collection
Variable in AJCC. This information was previously collected as Vagina SSF #4.
See Lymph Node Assessment Methods and Status for Regional and Distant Lymph Nodes in GYN sites for
additional information.
Codes: 0 Negative para-aortic lymph nodes 1 Positive para-aortic lymph nodes 8 Not
applicable: Information not collected for this case (If
this information is required by your standard setter, use
of code 8 may result in an edit error.) 9 Not documented in medical record
Para-aortic lymph node(s) not assessed or unknown if assessed
165.5,3959 LN STATUS FEMORAL-INGUINAL SSD5;12 SET
'0' FOR Negative femoral-inguinal lymph nodes;
'1' FOR Positive femoral-inguinal lymph nodes;
'8' FOR N/A;
'9' FOR Not documented in medical record;
LAST EDITED: JUN 06, 2022
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Description: This data item describes the status of femoral-inguinal lymph nodes associated with
certain female genital cancers.
Rationale: Specific regional lymph node involvement is listed as a Registry Data Collection
Variable in AJCC.
See Lymph Node Assessment Methods and Status for Regional and Distant Lymph Nodes in GYN sites for
additional information.
Codes: 0 Negative femoral-inguinal lymph nodes 1 Positive femoral-inguinal lymph nodes 8
Not applicable: Information not collected for this case
(If this information is required by your standard setter,
use of code 8 may result in an edit error.) 9 Not documented in medical record
Femoral-Inguinal lymph nodes not assessed or unknown if assessed
165.5,3960 HISTOLOGIC SUBTYPE SSD5;13 SET
'0' FOR Histology is not 8480;
'1' FOR Low-grade appendiceal mucinous neoplasm (LAMN);
'2' FOR High-grade appendiceal mucinous neoplasm (HAMN);
'3' FOR Mucinous/Mucus/Mucoid/Colloid adenocarcinoma/carcinoma;
'4' FOR Other terminology coded to 8480;
LAST EDITED: SEP 26, 2023
HELP-PROMPT: Enter a code from the list that corresponds to the histologic subtype of this patient's primary.
DESCRIPTION: Histology code for appendiceal tumors (8480) is defined as "Mucinous Adenocarcinoma (in situ or
invasive)." In the AJCC 8th chapter for Appendix-Carcinoma, there are also low-grade appendiceal
mucinous neoplasm (LAMN) and high- grade appendiceal mucinous neoplasm (HAMN) diagnoses that are
assigned the same histology.
165.5,3961 CLINICAL MARGIN WIDTH SSD5;14 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
MAXIMUM LENGTH: 4
LAST EDITED: SEP 26, 2023
HELP-PROMPT: Answer must be 1-4 characters in length. Enter the clinical margin width in centimeters as measured
by the surgeon.
DESCRIPTION: Clinical Margin Width describes the margins from a wide excision for a melanoma primary. The margin
width is measured by the surgeon prior to the procedure. The measurement is taken, in centimeters,
from the edge of the lesion or the prior excision scar to the peripheral margin of the specimen.
0.1 Documented as 0.1cm or less (1mm or less) 0.2-9.9 0.2 cm - 9.9 cm XX.1 10 centimeters
or greater XX.8 Not Applicable. Information not collected for
this schema (If this information is required
by your standard setter, use of code XX.8 may
result in an edit error) XX.9 Not documented in medical record
No Wide Excision performed
Mohs or similar procedure
Wide Excision performed, but clinical margin
width not documented.
No surgical resection performed (B000)
Unknown if procedure performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5000 AJCC ID AJCC8;1 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1)!'(X?0.2"X"0.2N0.1"."0.1N) X
MAXIMUM LENGTH: 4
LAST EDITED: OCT 25, 2018
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: This field is the AJCC ID for the case. The values for this field are based on the chapters of the
AJCC 8th Edition Staging Manual. The value will be derived primarily by the Site/Histology fields.
For cases where staging is not available this field will be "XX".
165.5,5001 AJCC TNM CLIN T AJCC8;2 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1 D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: FEB 13, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION:
Detailed site-specific codes for the clinical tumor (T) as defined by the current AJCC edition.
EXECUTABLE HELP: S ONCNODE=1 D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5002 AJCC TNM CLIN N AJCC8;3 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2 D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: AUG 28, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION:
Detailed site-specific codes for the clinical nodes (N) as defined by the current AJCC edition.
EXECUTABLE HELP: S ONCNODE=2 D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5003 AJCC TNM CLIN M AJCC8;4 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: JAN 30, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: Detailed site-specific codes for the clinical metastases (M) as defined by the current AJCC
edition.
EXECUTABLE HELP: S ONCNODE=3 D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5004 AJCC TNM CLIN STAGE GROUP AJCC8;5 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="C",ONCSHLST="NO" D INP^ONCSGA8H
MAXIMUM LENGTH: 15
LAST EDITED: AUG 20, 2021
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION:
Detailed site-specific codes for the clinical stage group as defined by the current AJCC edition.
EXECUTABLE HELP: S STGIND="C" D HELP^ONCSGA8H
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^G^MUMPS
1)= D CSSG^ONCOCRC
2)= D KSG^ONCOCRC
Maintains STAGE GROUPING-AJCC Field (#38.5). See fields #38 and #88. This is an update for new
AJCC TNM staging fields 8th Edition and beyond.
165.5,5011 AJCC TNM PATH T AJCC8;6 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1,ONCTNMTP="P" D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: FEB 14, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION:
Detailed site-specific codes for the pathological tumor (T) as defined by the current AJCC edition.
EXECUTABLE HELP: S ONCNODE=1,ONCTNMTP="P" D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5012 AJCC TNM PATH N AJCC8;7 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2,ONCTNMTP="P" D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: FEB 14, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION:
Detailed site-specific codes for the pathological nodes (T) as defined by the current AJCC edition.
EXECUTABLE HELP: S ONCNODE=2,ONCTNMTP="P" D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5013 AJCC TNM PATH M AJCC8;8 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: OCT 30, 2018
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: Detailed site-specific codes for the pathological metastases (T) as defined by the currect AJCC
edition.
EXECUTABLE HELP: S ONCNODE=3 D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5014 AJCC TNM PATH STAGE GROUP AJCC8;9 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="P",ONCSHLST="NO" D INP^ONCSGA8H
MAXIMUM LENGTH: 15
LAST EDITED: APR 06, 2021
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: Detailed site-specific codes for the pathological stage group as defined by the current AJCC
edition.
EXECUTABLE HELP: S STGIND="P" D HELP^ONCSGA8H
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
CROSS-REFERENCE: 165.5^H^MUMPS
1)= D PSSG^ONCOCRC
2)= D KSG^ONCOCRC
Maintains STAGE GROUPING-AJCC Field (#38.5). See fields #38 and #88. This is an update for new
AJCC TNM staging fields 8th Edition and beyond.
165.5,5021 AJCC TNM POST THER (yp) T AJCC8;10 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1,ONCTNMTP="Y" D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: AUG 16, 2021
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: Detailed site-specific codes for the post-therapy path (yp) tumor (T) as defined by the current
AJCC edition.
EXECUTABLE HELP: S ONCNODE=1,ONCTNMTP="Y" D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5022 AJCC TNM POST THER (yp) N AJCC8;11 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2,ONCTNMTP="Y" D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: JUN 28, 2021
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: Detailed site-specific codes for the postneoadjuvant therapy Path nodes (N) as defined by the
current AJCC edition.
EXECUTABLE HELP: S ONCNODE=2,ONCTNMTP="Y" D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5023 AJCC TNM POST THER (yp) M AJCC8;12 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: JUN 28, 2021
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: Detailed site-specific codes for the postneoadjuvant therapy category matestases (M) as defined by
the current AJCC edition.
EXECUTABLE HELP: S ONCNODE=3 D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5024 AJCC TNM POST THER (yp) SG AJCC8;13 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="PT",ONCSHLST="NO" D INP^ONCSGA8H
MAXIMUM LENGTH: 15
LAST EDITED: JUN 28, 2021
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: Detailed site-specific codes for the postneoadjuvant therapy Path stage group as defined by the
current AJCC edition.
EXECUTABLE HELP: S STGIND="PT" D HELP^ONCSGA8H
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5025 AJCC TNM POST THER (yc) T AJCC8;20 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1,ONCTNMTP="Y",ONCYC="yc" D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: AUG 16, 2021
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: Detailed site-specific codes for the post-therapy clinical (yc) tumor (T) as defined by the current
AJCC edition.
EXECUTABLE HELP: S ONCNODE=1,ONCTNMTP="Y",ONCYC="yc" D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5026 AJCC TNM POST THER (yc) N AJCC8;21 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2,ONCTNMTP="Y",ONCYC="yc" D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: AUG 16, 2021
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: Detailed site-specific codes for the post-therapy clinical (yc) nodes (N) as defined by the current
AJCC edition.
EXECUTABLE HELP: S ONCNODE=2,ONCTNMTP="Y",ONCYC="yc" D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5027 AJCC TNM POST THER (yc) M AJCC8;22 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG
MAXIMUM LENGTH: 15
LAST EDITED: JUN 28, 2021
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: Detailed site-specific codes for the post-therapy clinical (yc) metastases (M) as defined by the
current AJCC edition.
EXECUTABLE HELP: S ONCNODE=3 D AJCCHP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5028 AJCC TNM POST THER (yc) SG AJCC8;23 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="PT",ONCSHLST="NO" D INP^ONCSGA8H
MAXIMUM LENGTH: 15
LAST EDITED: JUN 28, 2021
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION:
Detailed site-specific codes for the post therapy clinical (yc) stage group as defined by AJCC.
EXECUTABLE HELP: S STGIND="PT" D HELP^ONCSGA8H
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5031 AJCC TNM CLIN T SUFFIX AJCC8;14 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG
MAXIMUM LENGTH: 4
LAST EDITED: AUG 28, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: This field is the Clinical Suffix that may be added to the Clinical T-Code for AJCC 8th Edition
staging.
EXECUTABLE HELP: S ONCSFFX="T" D SUFFHLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5032 AJCC TNM PATH T SUFFIX AJCC8;16 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG
MAXIMUM LENGTH: 4
LAST EDITED: AUG 28, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: This field is the Pathologic Suffix that may be added to the Pathologic T-Code for AJCC 8th Edition
staging.
EXECUTABLE HELP: S ONCSFFX="T" D SUFFHLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5033 AJCC TNM POST THER (yp) T SFX AJCC8;18 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG
MAXIMUM LENGTH: 4
LAST EDITED: JUN 28, 2021
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: This field is the detailed site-specific codes for the postneoadjuvant therapy Path T category
suffix as defined by AJCC.
EXECUTABLE HELP: S ONCSFFX="T" D SUFFHLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5033.5 AJCC TNM POST THER (yc) T SFX AJCC8;24 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG
MAXIMUM LENGTH: 4
LAST EDITED: JUN 28, 2021
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Detailed site-specific codes for the post therapy clinical (yc) tumor T category suffix as defined
by AJCC.
EXECUTABLE HELP: S ONCSFFX="T" D SUFFHLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5034 AJCC TNM CLIN N SUFFIX AJCC8;15 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG
MAXIMUM LENGTH: 4
LAST EDITED: AUG 28, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: This field is the Clinical Suffix that may be added to the Clinical N-Code for AJCC 8th Edition
staging.
EXECUTABLE HELP: S ONCSFFX="N" D SUFFHLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5035 AJCC TNM PATH N SUFFIX AJCC8;17 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG
MAXIMUM LENGTH: 4
LAST EDITED: AUG 28, 2019
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: This field is the Pathologic Suffix that may be added to the Pathologic N-Code for AJCC 8th Edition
staging.
EXECUTABLE HELP: S ONCSFFX="N" D SUFFHLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5036 AJCC TNM POST THER (yp) N SFX AJCC8;19 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG
MAXIMUM LENGTH: 4
LAST EDITED: JUN 28, 2021
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: This field is the detailed site-specific codes for the postneoadjuvant therapy Path N category
suffix as defined by AJCC.
EXECUTABLE HELP: S ONCSFFX="N" D SUFFHLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5036.5 AJCC TNM POST THER (yc) N SFX AJCC8;25 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG
MAXIMUM LENGTH: 4
LAST EDITED: JUN 28, 2021
HELP-PROMPT: Answer must be 1-4 characters in length.
DESCRIPTION: Detailed site-specific codes for the post therapy clinical (yc) N category suffix as defined by
AJCC.
EXECUTABLE HELP: S ONCSFFX="N" D SUFFHLP^ONCSCHMG
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5501 PHASE 1 DOSE PER FRACTION RAD18;1 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) D RADPH5^ONCSCHMM
MAXIMUM LENGTH: 5
LAST EDITED: MAR 26, 2020
HELP-PROMPT: Answer must be 1-5 characters in length.
DESCRIPTION: Records the dose per fraction (treatment session) delivered to the patient in the first phase of
radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data
item is required for CoC-accredited facilities as of 01/01/2018. Rationale: Radiation therapy is
delivered in one or more phases with identified dose per fraction. It is necessary to capture
information describing the dose per fraction to evaluate patterns of radiation oncology care.
Outcomes are strongly related to the dose delivered. Codes: 00000 Radiation therapy was not
administered 00001-99997 Record the actual Phase I dose delivered in cGy 99998 Not applicable,
brachytherapy or
radioisotopes administered to the patient 99999 Regional radiation therapy was
administered
but dose is unknown, it is unknown whether
radiation therapy was administered.
Death Certificate only.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5502 PHASE 1 RAD EXT BEAM PLAN TECH RAD18;2 POINTER TO ONCO RADIATION EXTERNAL BEAM FILE (#164.81)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.81,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the external beam radiation planning technique used to administer the first phase of
radiation treatment during the first course of treatment. This data item is required for
CoC-accredited facilities as of 01/01/2018. Rationale: External beam radiation is the most
commonly-used radiation modality in North America. In this data item we specified the planning
technique for external beam treatment. Identifying the radiation technique is of interest for
patterns of care and comparative effectiveness studies.
165.5,5503 PHASE 1 NUMBER OF FRACTIONS RAD18;3 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) D RADPH3^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: OCT 09, 2019
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: Records the total number of fractions (treatment sessions) delivered to the patient in the first
phase of radiation during the first course of treatment. This data item is required for
CoC-accredited facilities as of 01/01/2018. Rationale: Radiation therapy is delivered in one or
more phases with each phase spread out over a number of fractions (treatment sessions). It is
necessary to capture information describing the number of fraction(s) to evaluate patterns of
radiation oncology care. Codes: 000 Radiation therapy was not administered to the patient.
001-998 Number of fractions administered to the patient during
the first phase of radiation therapy. 999 Phase I Radiation therapy was administered, but
the
number of fractions is unknown; It is unknown
whether radiation therapy was administered.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5504 PHASE 1 RAD TREATMENT VOLUME RAD18;4 POINTER TO ONCO RADIATION TREATMENT VOLUME FILE (#164.82)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.82,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the primary treatment volume or primary anatomic target treated during the first phase
of radiation therapy during the first course of treatment. This data item is required for
CoC-accredited facilities as of 01/01/2018. Rationale: Radiation treatment is commonly delivered
in one or more phases. Typically, in each phase, the primary tumor or tumor bed is treated. This
data item should be used to indicate the primary target volume, which might include the primary
tumor or tumor bed. If the primary tumor was not targeted, record the other regional or distant
site that was targeted. Draining lymph nodes may also be targeted during the first phase. These
will be identified in a separate data item Phase I Radiation to Draining Lymph Nodes [1505].
This data item provides information describing the anatomical structure targeted by radiation
therapy during the first phase of radiation treatment and can be used to determine whether the site
of the primary diseases was treated with radiation or if other regional or distant sites were
targeted. This information is useful in evaluating the patterns of care within a facility and on a
regional or national basis. The breakdown and reorganization of the sites will allow for concise
reporting.
165.5,5505 PHASE 1 RAD TO DRAINING LN RAD18;5 POINTER TO ONCO RADIATION TO DRAINING LN FILE (#164.83)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.83,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the draining lymph nodes treated (if any) during the first phase of radiation therapy
delivered to the patient during the first course of treatment. This data item is required for
CoC-accredited facilities as of 01/01/2018. Rationale: The first phase of radiation treatment
commonly targets both the primary tumor (or tumor bed) and draining lymph nodes as a secondary
site. This data item should be used to indicate the draining regional lymph nodes, if any, that
were irradiated during the first phase of radiation.
165.5,5506 PHASE 1 RAD TREATMENT MODALITY RAD18;6 POINTER TO ONCO RADIATION TREATMENT MODALITY FILE (#164.84)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.84,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the radiation modality administered during the first phase of radiation treatment
delivered during the first course of treatment. This data item is required for CoC-accredited
facilities as of 01/01/2018. Rationale: Radiation modality reflects whether a treatment was
external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of
modalities. This data item should be used to indicate the radiation modality administered during
the first phase of radiation.
165.5,5507 PHASE 1 TOTAL DOSE RAD18;7 FREE TEXT
INPUT TRANSFORM: K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM
MAXIMUM LENGTH: 6
LAST EDITED: OCT 09, 2019
HELP-PROMPT: Answer must be 1-6 characters in length.
DESCRIPTION: Identifies the total radiation dose delivered to the patient in the first phase of radiation
treatment during the first course of treatment. The unit of measure is centiGray (cGy). This data
item is required for CoC-accredited facilities as of 01/01/2018. Rationale: To evaluate the
patterns of radiation care, it is necessary to capture information describing the prescribed dose
of Phase I radiation to the patient during the first course of treatment. Outcomes are strongly
related to the total dose delivered. Codes: 000000 No therapy administered 000001-999997
Record the actual total dose delivered in cGy 999998 Not applicable, radioisotopes administered
to the patient 999999 Radiation therapy was administered, but the
dose is unknown; it is unknown whether
radiation therapy was administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5511 PHASE 2 DOSE PER FRACTION RAD18;8 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) D RADPH5^ONCSCHMM
MAXIMUM LENGTH: 5
LAST EDITED: OCT 09, 2019
HELP-PROMPT: Answer must be 1-5 characters in length.
DESCRIPTION: Records the dose per fraction (treatment session) delivered to the patient in the second phase of
radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data
item is required for CoC-accredited facilities as of 01/01/2018. Rationale: Radiation therapy is
delivered in one or more phases with identified dose per fraction. It is necessary to capture
information describing the dose per fraction to evaluate patterns of radiation oncology care.
Outcomes are strongly related to the dose delivered. Codes: 00000 Radiation therapy was not
administered 00001-99997 Record the actual Phase II dose delivered in cGy 99998 Not applicable,
brachytherapy or
radioisotopes administered to the patient 99999 Regional radiation therapy was
administered
but dose is unknown, it is unknown whether
radiation therapy was administered.
Death Certificate only.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5512 PHASE 2 RAD EXT BEAM PLAN TECH RAD18;9 POINTER TO ONCO RADIATION EXTERNAL BEAM FILE (#164.81)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.81,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the external beam radiation planning technique used to administer the second phase of
radiation treatment during the first course of treatment. This data item is required for
CoC-accredited facilities for cases diagnosed as of 01/01/2018. Rationale: External beam radiation
is the most commonly-used radiation modality in North America. In this data item we specified the
planning technique for external beam treatment. Identifying the radiation technique is of interest
for patterns of care and comparative effectiveness studies.
165.5,5513 PHASE 2 NUMBER OF FRACTIONS RAD18;10 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) D RADPH3^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: OCT 09, 2019
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: Records the total number of fractions (treatment sessions) administered to the patient in the
second phase of radiation during the first course of treatment. This data item is required for
CoC-accredited facilities for cases diagnosed as of 01/01/2018. Rationale: Radiation therapy is
delivered in one or more phases with each phase spread out over a number of fractions (treatment
sessions). It is necessary to capture information describing the number of fraction(s) to evaluate
patterns of radiation oncology care. Codes: 000 Radiation therapy was not administered to the
patient 001-998 Number of fractions administered to the patient during
the second phase of radiation therapy 999 Phase II Radiation therapy was administered, but
the
number of fractions is unknown; It is unknown whether
radiation therapy was administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5514 PHASE 2 RAD TREATMENT VOLUME RAD18;11 POINTER TO ONCO RADIATION TREATMENT VOLUME FILE (#164.82)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.82,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the primary treatment volume or primary anatomic target treated during the second phase
of radiation therapy during the first course of treatment. This data item is required for
CoC-accredited facilities as of cases diagnosed 01/01/2018. Rationale: Radiation treatment is
commonly delivered in one or more phases. Typically, in each phase, the primary tumor or tumor bed
is treated. This data item should be used to indicate the primary target volume, which might
include the primary tumor or tumor bed. If the primary tumor was not targeted, record the other
regional or distant site that was targeted. Draining lymph nodes may also be targeted during the
second phase. These will be identified in a separate data item Phase II Radiation to Draining Lymph
Nodes [1515].
165.5,5515 PHASE 2 RAD TO DRAINING LN RAD18;12 POINTER TO ONCO RADIATION TO DRAINING LN FILE (#164.83)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.83,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the draining lymph nodes treated (if any) during the second phase of radiation therapy
delivered to the patient during the first course of treatment. This data item is required for
CoC-accredited facilities as of cases diagnosed 01/01/2018. Rationale: The second phase of
radiation treatment commonly targets both the primary tumor (or tumor bed) and draining lymph nodes
as a secondary site. This data item should be used to indicate the draining regional lymph nodes,
if any, that were irradiated during the second phase of radiation.
165.5,5516 PHASE 2 RAD TREATMENT MODALITY RAD18;13 POINTER TO ONCO RADIATION TREATMENT MODALITY FILE (#164.84)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.84,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the radiation modality administered during the second phase of radiation treatment
delivered during the first course of treatment. This data item is required for CoC-accredited
facilities as of 01/01/2018. Rationale: Radiation modality reflects whether a treatment was
external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of
modalities. This data item should be used to indicate the radiation modality administered during
the second phase of radiation.
165.5,5517 PHASE 2 TOTAL DOSE RAD18;14 FREE TEXT
INPUT TRANSFORM: K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM
MAXIMUM LENGTH: 6
LAST EDITED: OCT 09, 2019
HELP-PROMPT: Answer must be 1-6 characters in length.
DESCRIPTION: Identifies the total radiation dose administered in the second phase of radiation treatment
delivered to the patient during the first course of treatment. The unit of measure is centiGray
(cGy). This data item is required for CoC-accredited facilities for cases diagnosed as of
01/01/2018. Rationale: To evaluate the patterns of radiation care, it is necessary to capture
information describing the prescribed dose of Phase II radiation to the patient during the first
course of treatment. Outcomes are strongly related to the total dose delivered. Codes 000000 No
radiation treatment 000001-999997 Record the actual total dose delivered in cGy 999998 Not
applicable, brachytherapy or radioisotopes
administered to the patient 999999 Radiation therapy was administered, but the
dose is unknown; it is unknown whether
radiation therapy was administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5521 PHASE 3 DOSE PER FRACTION RAD18;15 FREE TEXT
INPUT TRANSFORM: K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) D RADPH5^ONCSCHMM
MAXIMUM LENGTH: 5
LAST EDITED: OCT 09, 2019
HELP-PROMPT: Answer must be 1-5 characters in length.
DESCRIPTION: Records the dose per fraction (treatment session) delivered to the patient in the third phase of
radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data
item is required for CoC-accredited facilities as of 01/01/2018. Rationale: Radiation therapy is
delivered in one or more phases with identified dose per fraction. It is necessary to capture
information describing the dose per fraction to evaluate patterns of radiation oncology care.
Outcomes are strongly related to the dose delivered. Codes: 00000 Radiation therapy was not
administered 00001-99997 Record the actual Phase II dose delivered in cGy 99998 Not applicable,
brachytherapy or
radioisotopes administered to the patient 99999 Regional radiation therapy was
administered
but dose is unknown, it is unknown whether
radiation therapy was administered.
Death Certificate only.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5522 PHASE 3 RAD EXT BEAM PLAN TECH RAD18;16 POINTER TO ONCO RADIATION EXTERNAL BEAM FILE (#164.81)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.81,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the external beam radiation planning technique used to administer the third phase of
radiation treatment during the first course of treatment. This data item is required for
CoC-accredited facilities for cases diagnosed as of 01/01/2018. Rationale: External beam radiation
is the most commonly-used radiation modality in North America. In this data item we specified the
planning technique for external beam treatment. Identifying the radiation technique is of interest
for patterns of care and comparative effectiveness studies.
165.5,5523 PHASE 3 NUMBER OF FRACTIONS RAD18;17 FREE TEXT
INPUT TRANSFORM: K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) D RADPH3^ONCSCHMM
MAXIMUM LENGTH: 3
LAST EDITED: OCT 09, 2019
HELP-PROMPT: Answer must be 1-3 characters in length.
DESCRIPTION: Records the total number of fractions (treatment sessions) administered to the patient in the third
phase of radiation during the first course of treatment. This data item is required for
CoC-accredited facilities for cases diagnosed as of 01/01/2018. Rationale: Radiation therapy is
delivered in one or more phases with each phase spread out over a number of fractions (treatment
sessions). It is necessary to capture information describing the number of fraction(s) to evaluate
patterns of radiation oncology care. Codes: 000 Radiation therapy was not administered to the
patient 001-998 Number of fractions administered to the patient during
the third phase of radiation therapy 999 Phase II Radiation therapy was administered, but
the
number of fractions is unknown; It is unknown whether
radiation therapy was administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,5524 PHASE 3 RAD TREATMENT VOLUME RAD18;18 POINTER TO ONCO RADIATION TREATMENT VOLUME FILE (#164.82)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.82,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the primary treatment volume or primary anatomic target treated during the third phase
of radiation therapy during the first course of treatment. This data item is required for
CoC-accredited facilities as of cases diagnosed 01/01/2018. Rationale: Radiation treatment is
commonly delivered in one or more phases. Typically, in each phase, the primary tumor or tumor bed
is treated. This data item should be used to indicate the primary target volume, which might
include the primary tumor or tumor bed. If the primary tumor was not targeted, record the other
regional or distant site that was targeted. Draining lymph nodes may also be targeted during the
second phase. These will be identified in a separate data item Phase II Radiation to Draining Lymph
Nodes [1515].
165.5,5525 PHASE 3 RAD TO DRAINING LN RAD18;19 POINTER TO ONCO RADIATION TO DRAINING LN FILE (#164.83)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.83,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the draining lymph nodes treated (if any) during the third phase of radiation therapy
delivered to the patient during the first course of treatment. This data item is required for
CoC-accredited facilities as of cases diagnosed 01/01/2018. Rationale: The third phase of
radiation treatment commonly targets both the primary tumor (or tumor bed) and draining lymph nodes
as a secondary site. This data item should be used to indicate the draining regional lymph nodes,
if any, that were irradiated during the second phase of radiation.
165.5,5526 PHASE 3 RAD TREATMENT MODALITY RAD18;20 POINTER TO ONCO RADIATION TREATMENT MODALITY FILE (#164.84)
OUTPUT TRANSFORM: S Y=$P($G(^ONCO(164.84,+Y,0)),U,2)
LAST EDITED: JUL 11, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the radiation modality administered during the third phase of radiation treatment
delivered during the first course of treatment. This data item is required for CoC-accredited
facilities as of 01/01/2018. Rationale: Radiation modality reflects whether a treatment was
external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of
modalities. This data item should be used to indicate the radiation modality administered during
the second phase of radiation.
165.5,5527 PHASE 3 TOTAL DOSE RAD18;21 FREE TEXT
INPUT TRANSFORM: K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM
MAXIMUM LENGTH: 6
LAST EDITED: OCT 09, 2019
HELP-PROMPT: Answer must be 1-6 characters in length.
DESCRIPTION: Identifies the total radiation dose administered in the second phase of radiation treatment
delivered to the patient during the first course of treatment. The unit of measure is centiGray
(cGy). This data item is required for CoC-accredited facilities for cases diagnosed as of
01/01/2018. Rationale: To evaluate the patterns of radiation care, it is necessary to capture
information describing the prescribed dose of Phase II radiation to the patient during the first
course of treatment. Outcomes are strongly related to the total dose delivered. Codes 000000 No
radiation treatment 000001-999997 Record the actual total dose delivered in cGy 999998 Not
applicable, brachytherapy or radioisotopes
administered to the patient 999999 Radiation therapy was administered, but the
dose is unknown; it is unknown whether
radiation therapy was administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,7000 STATE AT DX GEOCODE 1970/80/90 NCR18;1 POINTER TO STATE FILE (#5)
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a valid state.
DESCRIPTION: Code for the state of the patient's residence at the time the tumor was diagnosed is a derived
(geocoded) variable based on Census Boundary files from 1970, 1980, or 1990 Decennial Census.
Rationale: Populating the GeoLocationID 70/80/90 [351] correctly requires FIPS code for state and
not the USPS abbreviations. Also, on rare occasions, the boundaries of states do change (North
Carolina and South Carolina border, for example).
165.5,7001 STATE AT DX GEOCODE 2010 NCR18;2 POINTER TO STATE FILE (#5)
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a valid state.
DESCRIPTION: Code for the state of the patient's residence at the time the tumor was diagnosed is a derived
(geocoded) variable based on Census Boundary files from 2010 Decennial Census. Rationale:
Populating the GeoLocationID 2010 [353] correctly requires FIPS code for state and not the USPS
abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and
South Carolina border, for example).
165.5,7002 BEHAVIOR (73-91) ICD-O-1 NCR18;3 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Type a number between 0 and 9, 0 decimal digits.
DESCRIPTION: Area for retaining behavior portion (1 digit) of the ICD-O-1 or field trial morphology codes
entered before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970] in
Appendix E. The item name includes years 73-91. However, some states may have used the codes for
cases before 1973. It is a subfield of the morphology code. Codes: For tumors diagnosed before
1992, contains the ICD-O-1 or field trial 1-digit behavior code as originally coded, if available.
Blank for tumors coded directly into a later version of ICD-O.
165.5,7003 GRADE (73-91) ICD-O-1 NCR18;4 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Type a number between 0 and 9, 0 decimal digits.
DESCRIPTION: Area for retaining the grade portion (1 digit) of the ICD-O-1 or field trial grade code entered
before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970] in Appendix E.
The item name includes years 1973-91. However, some states may have used the codes for cases before
1973. Codes: For cases diagnosed before 1992, contains the ICD-O-1 or field trial 1-digit grade
code as originally coded, if available.
165.5,7004 RUCA 2000 NCR18;5 SET
'1' FOR Urban commuting area RUCA 1.0,1.1,2.0,2.1,3.0,4.1,5.1,7.1,8.1,10.1;
'2' FOR Not an urban commuting area;
'9' FOR Unknown or census tract N/A RUCA 99;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: A measure of how accessible to an urban center a cancer patient's census tract at diagnosis is
based on the USDA identification of urban and rural commuting areas. The variable is a
binomial-either in an urban commuting area or not. The measure indicates proximity to large urban
centers and can be an indicator of access to oncology specialists and cancer treatment facilities.
Collecting the variable with each decennial census allows for retrospective and cross- sectional
epidemiologic analysis.
165.5,7005 RUCA 2010 NCR18;6 SET
'1' FOR Urban commuting area RUCA 1.0,1.1,2.0,2.1,3.0,4.1,5.1,7.1,8.1,10.1;
'2' FOR Not an urban commuting area;
'9' FOR Unknown or census tract N/A RUCA 99;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: A measure of how accessible to an urban center a cancer patient's census tract at diagnosis is
based on the USDA identification of urban and rural commuting areas. The variable is a
binomial-either in an urban commuting area or not. The measure indicates proximity to large urban
centers and can be an indicator of access to oncology specialists and cancer treatment facilities.
Collecting the variable with each decennial census allows for retrospective and cross- sectional
epidemiologic analysis.
165.5,7006 URIC 2000 NCR18;7 SET
'1' FOR All Urban;
'2' FOR Mostly Urban;
'3' FOR Mostly Rural;
'4' FOR All Rural;
'9' FOR Unknown or N/A;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: A measure of how urban a cancer patient's census tract at diagnosis is based on the Census Bureau's
identification of urban and rural areas (already collect at county-level). The variable is a 4 code
continuum. The measure indicates of the rural nature of the place of residence and can be an
indicator of access to recreation, access to food stores, exposures to pollutants, crime levels,
social cohesion, etc. Collecting the variable with each decennial census allows for retrospective
and cross-sectional epidemiologic analysis. Codes:
1 All urban-the percent of the population in an urban area = 100%
2 Mostly urban-the percent of the population in an urban area < 100% and = 50%
3 Mostly rural-the percent of the population in an urban area > 0% and < 50%
4 All rural-the percent of the population in an urban area = 0%
9 Unknown or not applicable-census tract not available or tract population was zero at the last decadal census
165.5,7007 URIC 2010 NCR18;8 SET
'1' FOR All Urban;
'2' FOR Mostly Urban;
'3' FOR Mostly Rural;
'4' FOR All Rural;
'9' FOR Unknown or N/A;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: A measure of how urban a cancer patient's census tract at diagnosis is based on the Census Bureau's
identification of urban and rural areas (already collect at county-level). The variable is a 4 code
continuum. The measure indicates of the rural nature of the place of residence and can be an
indicator of access to recreation, access to food stores, exposures to pollutants, crime levels,
social cohesion, etc. Collecting the variable with each decennial census allows for retrospective
and cross-sectional epidemiologic analysis. Codes:
1 All urban-the percent of the population in an urban area = 100%
2 Mostly urban-the percent of the population in an urban area < 100% and = 50%
3 Mostly rural-the percent of the population in an urban area > 0% and < 50%
4 All rural-the percent of the population in an urban area = 0%
9 Unknown or not applicable-census tract not available or tract population was zero at the last decadal census
165.5,7008 DERIVED EOD 2018 T NCR18;9 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X
MAXIMUM LENGTH: 15
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: This item stores the derived EOD 2018 T value derived from coded fields using the EOD algorithm.
Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 T can be used to evaluate
disease spread at diagnosis, treatment patterns and outcomes over time.
Derived EOD 2018 T is only available at the central registry level. Codes: See the most current
version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding
structures.
165.5,7009 DERIVED EOD 2018 N NCR18;10 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X
MAXIMUM LENGTH: 15
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: This item stores the derived EOD 2018 N value derived from coded fields using the EOD algorithm.
Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 N can be used to evaluate
disease spread at diagnosis, treatment patterns and outcomes over time.
Derived EOD 2018 N is only available at the central registry level. Codes: See the most current
version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding
structures.
165.5,7010 DERIVED EOD 2018 M NCR18;11 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X
MAXIMUM LENGTH: 15
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: This item stores the derived EOD 2018 M value derived from coded fields using the EOD algorithm.
Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 M can be used to evaluate
disease spread at diagnosis, treatment patterns and outcomes over time.
Derived EOD 2018 M is only available at the central registry level. Codes: See the most current
version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding
structures.
165.5,7011 DERIVED EOD 2018 STAGE GROUP NCR18;12 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X
MAXIMUM LENGTH: 15
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: This item stores the derived EOD 2018 SG value derived from coded fields using the EOD algorithm.
Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 SG can be used to evaluate
disease spread at diagnosis, treatment patterns and outcomes over time.
Derived EOD 2018 SG is only available at the central registry level. Codes: See the most current
version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding
structures.
165.5,7012 DERIVED SUMMARY STAGE 2018 NCR18;13 SET
'0' FOR In situ;
'1' FOR Localized;
'2' FOR Regional, direct ext only;
'3' FOR Regional, reg LN only;
'4' FOR Regional, direct ext and reg LN;
'7' FOR Distant;
'8' FOR Benign, borderline;
'9' FOR Unknown;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Derived Summary Stage 2018 is derived using the EOD data collection system (EOD Primary Tumor
[772], EOD Regional Nodes [774] and EOD Mets [776]) algorithm. Other data items may be included in
the derivation process. Effective for cases diagnosed 1/1/2018+. Rationale: The SEER program has
collected staging information on cases since its inception in 1973. Summary Stage groups cases into
broad categories of in situ, local, regional, and distant. Summary Stage can be used to evaluate
disease spread at diagnosis, treatment patterns and outcomes over time.
NOTES: TRIGGERED by the SUMMARY STAGE 2018 field of the ONCOLOGY PRIMARY File
165.5,7013 DATE REGIONAL LN DISSECTION NCR18;14 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: OCT 17, 2019
HELP-PROMPT: Enter the date NON-SENTINEL regional node dissection was performed.
DESCRIPTION: Records the date NON-SENTINEL regional node dissection was performed. This data item is required
for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. Rationale: It is a known
fact that sentinel lymph node biopsies have been under-reported. Additionally, the timing and
results of sentinel lymph node biopsy procedures are used in quality of care measures. This data
item can be used to more accurately assess the date of regional node dissection separate from the
date of sentinel lymph node biopsy if performed.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,7014 DATE REG LN DISSECTION FLAG NCR18;15 SET
'10' FOR No information whatsoever can be inferred from this exceptional value;
'11' FOR No proper value is applicable in this context;
'12' FOR A proper value is applicable but not known;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This flag explains why there is no appropriate value in the corresponding date data item, Date of
Regional Lymph Node Dissection [682]. This data item is required for CoC-accredited facilities as
of cases diagnosed 01/01/2018 and later.
Coding Instructions: -Leave this item blank if Date of Regional Lymph Node Dissection has a
full or partial date recorded -Code 10 if it is unknown whether Regional Lymph Nodes were
dissected. -Code 11 if no Regional Lymph Nodes were dissected. -Code 12 if the Date of the
Regional Lymph Node Dissection cannot be
determined, but regional lymph nodes were dissected.
165.5,7015 SENTINEL LYMPH NODES POSITIVE NCR18;16 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: SEP 18, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Records the exact number of sentinel lymph nodes biopsied by the pathologist and found to contain
metastases. This data item is required for CoC-accredited facilities as of cases diagnosed
01/01/2018 and later. This data item is required for breast and melanoma cases only. Rationale: It
is a known fact that sentinel lymph node biopsies have been under- reported. Additionally, the
timing and results of sentinel lymph node biopsy procedures are used in quality of care measures.
This data item can be used to more accurately assess the number of positive sentinel lymph nodes
biopsied separate from the number of positive lymph nodes identified during additional subsequent
regional node dissection procedures, if performed. Codes: 00 All sentinel nodes examined are
negative 01-90 Sentinel nodes are positive (code exact number of nodes positive) 95 Positive
aspiration of sentinel lymph node(s) was performed 97 Positive sentinel nodes are documented, but
the number is unspecified; For breast ONLY: SLN and RLND occurred during the same procedure 98 No
sentinel nodes were biopsied 99 It is unknown whether sentinel nodes are positive; not applicable;
not stated in patient record
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,7016 SENTINEL LYMPH NODES EXAMINED NCR18;17 FREE TEXT
INPUT TRANSFORM: K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) D GEN2^ONCSCHMM
MAXIMUM LENGTH: 2
LAST EDITED: SEP 18, 2019
HELP-PROMPT: Answer must be 1-2 characters in length.
DESCRIPTION: Records the exact number of sentinel lymph nodes biopsied by the pathologist and found to contain
metastases. This data item is required for CoC-accredited facilities as of cases diagnosed
01/01/2018 and later. This data item is required for breast and melanoma cases only. Rationale: It
is a known fact that sentinel lymph node biopsies have been under- reported. Additionally, the
timing and results of sentinel lymph node biopsy procedures are used in quality of care measures.
This data item can be used to more accurately assess the number of positive sentinel lymph nodes
biopsied separate from the number of positive lymph nodes identified during additional subsequent
regional node dissection procedures, if performed. Codes: 00 No sentinel nodes were examined
01-90 Sentinel nodes were examined (code the exact number of sentinel lymph nodes examined) 95 No
sentinel nodes were removed, but aspiration of sentinel node(s) was perf ormed 98 Sentinel lymph
nodes were biopsied, but the number is unknown 99 It is unknown whether sentinel nodes were
examined; not stated in patient record
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,7017 DATE OF SENTINEL LN BIOPSY NCR18;18 DATE
INPUT TRANSFORM: D DFIT^ONCODSR
OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES
LAST EDITED: OCT 07, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Records the date of the sentinel lymph node(s) biopsy procedure. This data item is required for
CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. This data item is required
for breast and melanoma cases only.
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,7018 DATE OF SENTINEL LN BIOPSY FLG NCR18;19 SET
'10' FOR No information whatsoever can be inferred from this exceptional value;
'11' FOR No proper value is applicable in this context;
'12' FOR A proper value is applicable but unknown;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This flag explains why there is no appropriate value in the corresponding date data item, Date of
Sentinel Lymph Node Biopsy [832]. This data item is required for CoC-accredited facilities as of
cases diagnosed 01/01/2018 and later. This data item is required for breast and melanoma cases
only.
Coding Instructions: -Leave this item blank if Date of Sentinel Lymph Node Biopsy has a full
or partial date recorded. -Code 10 if it is unknown whether sentinel lymph nodes were biopsied.
-Code 11 if no sentinel lymph node biopsy was performed. -Code 12 if the Date of Sentinel Lymph
Node Biopsy cannot be determined,
but a sentinel lymph node biopsy was performed.
165.5,7019 NPCR DERIVED AJCC8 CLN STG GRP NCR18;20 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X
MAXIMUM LENGTH: 15
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: This item stores the results of NPCR's derived algorithmic calculation of clinical stage group
based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives
AJCC 8th ed. stage group for 2018, however, updates to future AJCC editions are anticipated. The
derived values for 7th ed. were stored in NPCR Derived Clin Stg Grp [3650]. Rationale: The purpose
of the derived stage fields is to segregate data values for AJCC stage groups derived from the NPCR
algorithm from values directly entered from the medical record or by the registrar. NPCR's primary
interest is in the directly-entered values, but derived values will have a purpose primarily at the
central registry. It is important to not mix data values from the two sources in the same data
items. This item was added in 2018 because the required length to hold AJCC stage group values
increased from 4 columns to 15. Codes (in addition to those published in the AJCC Cancer Staging
Manual)
88 Not applicable
99 Unknown
BlankNot staged
165.5,7020 NPCR DERIVED AJCC8 PTH STG GRP NCR18;21 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X
MAXIMUM LENGTH: 15
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: This item stores the results of NPCR's derived algorithmic calculation of pathologic stage group
based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives
AJCC 8th ed. stage group for 2018, however, updates to future AJCC editions are anticipated. The
derived values for 7th ed. were stored in NPCR Derived Path Stg Grp [3650]. Rationale: The purpose
of the derived stage fields is to segregate data values for AJCC stage groups derived from the NPCR
algorithm from values directly entered from the medical record or by the registrar. NPCR's primary
interest is in the directly-entered values, but derived values will have a purpose primarily at the
central registry. It is important to not mix data values from the two sources in the same data
items. This item was added in 2018 because the required length to hold AJCC stage group values
increased from 4 columns to 15. Codes (in addition to those published in the AJCC Cancer Staging
Manual)
88 Not applicable
99 Unknown
BlankNot staged
165.5,7021 NPCR DERIVED AJCC8 PT STG GRP NCR18;22 FREE TEXT
INPUT TRANSFORM: K:$L(X)>15!($L(X)<1) X
MAXIMUM LENGTH: 15
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Answer must be 1-15 characters in length.
DESCRIPTION: This item stores the results of NPCR's derived algorithmic calculation of post-therapy stage group
based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives
AJCC 8th ed. stage group for 2018, however, updates to future AJCC editions are anticipated. The
derived values for 7th ed. were stored in NPCR Derived Post-Therapy Stg Grp [3650]. Rationale: The
purpose of the derived stage fields is to segregate data values for AJCC stage groups derived from
the NPCR algorithm from values directly entered from the medical record or by the registrar. NPCR's
primary interest is in the directly-entered values, but derived values will have a purpose
primarily at the central registry. It is important to not mix data values from the two sources in
the same data items. This item was added in 2018 because the required length to hold AJCC stage
group values increased from 4 columns to 15. Codes (in addition to those published in the AJCC
Cancer Staging Manual)
88 Not applicable
99 Unknown
BlankNot staged
165.5,7022 NPCR SPECIFIC FIELD NCR18;23 FREE TEXT
INPUT TRANSFORM: K:$L(X)>75!($L(X)<1) X
MAXIMUM LENGTH: 75
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Answer must be 1-75 characters in length.
DESCRIPTION: A 75 character field to be used when information for a particular primary site needs to be
collected by NPCR. This field allows NPCR to retain data collected through the CER project and is
a place holder when additional site-specific information is needed.
165.5,7023 STATE AT DX GEOCODE 2000 NCR18;24 POINTER TO STATE FILE (#5)
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a valid state.
DESCRIPTION: Code for the state of the patient's residence at the time the tumor was diagnosed is a derived
(geocoded) variable based on Census Boundary files from 2000 Decennial Census. Rationale:
Populating the GeoLocationID 2000 [353] correctly requires FIPS code for state and not the USPS
abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and
South Carolina border, for example).
165.5,7024 NUMBER OF PHASES RAD TX NCR18B;1 SET
'00' FOR No Radiation Treatment;
'01' FOR 1 phase;
'02' FOR 2 phases;
'03' FOR 3 phases;
'04' FOR 4 or more phases;
'99' FOR Unknown number of phases;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Identifies the total number of phases administered to the patient during the first course of
treatment. A "phase" consists of one or more consecutive treatments delivered to the same anatomic
volume with no change in the treatment technique. Although the majority of courses of radiation
therapy are completed in one or two phases (historically, the "regional" and "boost" treatments)
there are occasions in which three or more phases are used, most typically with head and neck
malignancies. This data item is required for CoC-accredited facilities as of cases diagnosed
01/01/2018 and later.
165.5,7025 RADIATION TREATMENT DISC EARLY NCR18B;2 SET
'00' FOR No rad TX;
'01' FOR Completed as prescribed;
'02' FOR Toxicity;
'03' FOR Contraindicated;
'04' FOR Patient decision;
'05' FOR Family decision;
'06' FOR Patient expired;
'07' FOR Not documented;
'99' FOR Unknown;
LAST EDITED: FEB 10, 2020
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This field is used to identify patients/tumors whose radiation treatment course was discontinued
earlier than initially planned. That is the patients/tumors received fewer treatment fractions
(sessions) than originally intended by the treating physician. This data item is required for
CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. Codes: 00 No radiation
treatment 01 Radiation treatment completed as prescribed 02 Radiation treatment discontinued
early - toxicity 03 Radiation treatment discontinued early - contraindicated due
to other patient risk factors (comorbid conditions, advanced age,
progression of tumor prior to planned radiation etc.) 04 Radiation treatment discontinued
early - patient decision 05 Radiation discontinued early - family decision 06 Radiation
discontinued early - patient expired 07 Radiation discontinued early - reason not documented 99
Unknown if radiation treatment discontinued; Unknown whether radiation therapy administered
165.5,7026 TOTAL DOSE NCR18B;3 FREE TEXT
INPUT TRANSFORM: K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM
MAXIMUM LENGTH: 6
LAST EDITED: MAR 30, 2020
HELP-PROMPT: Answer must be 1-6 characters in length.
DESCRIPTION: Identifies the total radiation dose administered to the patient across all phases during the first
course of treatment. The unit of measure is centiGray (cGy). This data item is required for
CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. To evaluate the patterns of
radiation care, it is necessary to capture information describing the prescribed total dose of
radiation during the first course of treatment. Outcomes are strongly related to the dose
delivered. Codes: 000000 No radiation treatment 000001-999997 Record the actual dose
delivered in cGy 999998 Not applicable, radioisotopes administered
to the patient 999999 Radiation therapy was administered, but the
dose is unknown; it is unknown whether
radiation therapy was administered
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,7027 OVER-RIDE TNM STAGE NCR18B;4 SET
'1' FOR Reviewed and confirmed as reported;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter 1 or leave blank.
DESCRIPTION: Some computer edits identify errors. Others indicate possible errors that require manual review for
resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been
developed to indicate that data in a record (or records) have been reviewed and, while unusual, are
correct. This over-ride is used with the following edits in the NAACCR Metafile of the EDITS
software: Primary Site, TNM Clin Stage Valid A- Ed 7 (CoC) Primary Site, TNM Clin Stage Valid B- Ed
7 (CoC) Primary Site, TNM Path Stage Valid A- Ed 7 (CoC) Primary Site, TNM Path Stage Valid B- Ed 7
(CoC) These edits check T, N, and M combinations against stage group. Adding this over-ride allows
the edit to pass when combinations of T, N, and M are entered that are not included in the stage
tables used with the edits. Rationale This over-ride will allow registrars to enter combination of
T, N, and M with a stage group that differs from the combinations documented in the AJCC Staging
Manual. Codes:
1 Reviewed and confirmed as reported
BlankNot reviewed or reviewed and corrected
165.5,7028 OVER-RIDE TNM TIS NCR18B;5 SET
'1' FOR Reviewed and confirmed as reported;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter 1 or leave blank.
DESCRIPTION: Some computer edits identify errors. Others indicate possible errors that require manual review for
resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been
developed to indicate that data in a record (or records) have been reviewed and, while unusual, are
correct. This over-ride is used with the following edits in the NAACCR Metafile of the EDITS
software: TNM Clin T, N, M, In Situ (CoC) TNM Path T, N, M, In Situ (CoC) If the patient has a T
value indicating in situ/ noninvasive, this edit verifies that the N, M, and stage group reflect in
situ/noninvasive disease. However, there are certain circumstances where AJCC does allow a T value
indicating in situ/noninvasive and N, M, and/or stage group that indicates invasive disease. An
over-ride is required to accommodate these situations. Rationale This over-ride will allow
registrars to enter combination of T, N, and M with a stage group that differs from the
combinations documented in the AJCC Staging Manual. Codes:
1 Reviewed and confirmed as reported
BlankNot reviewed or reviewed and corrected
165.5,7029 OVER-RIDE TNM 3 NCR18B;6 SET
'1' FOR Reviewed and confirmed as reported;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter 1 or leave blank.
DESCRIPTION: Some computer edits identify errors. Others indicate possible errors that require manual review for
resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been
developed to indicate that data in a record (or records) have been reviewed and, while unusual, are
correct. Rationale This over-ride will allow registrars to enter combination of T, N, and M with a
stage group that differs from the combinations documented in the AJCC Staging Manual. Codes:
1 Reviewed and confirmed as reported
BlankNot reviewed or reviewed and corrected
165.5,7030 OVER-RIDE NAME/SEX NCR18B;7 SET
'1' FOR Reviewed and confirmed as reported;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter 1 or leave blank.
DESCRIPTION: This over-ride is used with the following edit in the NAACCR Metafile of the EDITS software: Sex,
Name-First, Date of Birth (NAACCR) Rationale: Some edits check for code combinations that are
possible, but quite rare. If the code combination generates an error message and review of the case
indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit
in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.
Over-ride flag as used in the EDITS Software Package Edits of the type Sex, Name does not allow
extremely rare or nonexistent combinations of first name and sex, such as John/female. Codes:
1 Reviewed and confirmed as reported
BlankNot reviewed or reviewed and corrected
165.5,7031 HISTOLOGY (73-91) ICD-O-1 NCR18B;8 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>9999)!(X<0)!(X?.E1"."1N.N) X
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Type a number between 0 and 9999, 0 decimal digits.
DESCRIPTION: Area for retaining the histology portion (4 digits) of the ICD-O-1 or field trial morphology codes
entered before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970], in
Appendix E. The item name includes years 1973-91. However, some states may have used the codes for
cases before 1973. Codes: For cases diagnosed before 1992, contains the ICD-O-1 or field trial
4-digit histology code as originally coded, if available. Blank for tumors coded directly into
ICD-O-2 or ICD-O-3 (i.e., 1992 and later cases).
165.5,7032 RQRS NCDB SUBMISSION FLAG NCR18B;9 SET
'1' FOR Data Submission for RQRS;
'2' FOR Data Submission for NCDB Annual Call for Data;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This flag identifies the type of data submission from reporting facilities to the CoC National
Cancer Database (NCDB). This data item is required for CoC-accredited facilities with submission
starting 01/01/2018. Rationale: CoC-accredited hospitals make multiple data submissions for
various reasons: Rapid Quality Reporting System (current, generally incomplete cases) NCDB Call for
Data (older, complete cases) The NCDB is moving to submission of data via a single data portal
rather than the current separate data portals for RQRS and NCDB. This data item will facilitate
identification of the purpose of the data submission at the receiving end. Codes
1 Data Submission for RQRS
2 Data Submission for NCDB Annual Call for Data
165.5,7033 COC ACCREDITED FLAG NCR18B;10 SET
'0' FOR Abstract prepared at a facility WITHOUT CoC;
'1' FOR ANALYTIC abstract prepared at facility WITH CoC;
'2' FOR NON-ANALYTIC abstract prepared at facility WITH CoC;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: CoC Accredited Flag is assigned at the point and time of data abstraction to label an abstract
being prepared for an analytic cancer case at a facility accredited by the Commission on Cancer
(CoC). The flag may be assigned manually or can be defaulted by the registry's software. Codes
0 Abstract prepared at a facility WITHOUT CoC
accreditation of its cancer program
1 ANALYTIC abstract prepared at facility WITH
CoC accreditation of its cancer program (Includes Class of Case codes 10-22)
2 NON-ANALYTIC abstract prepared at facility
WITH CoC accreditation of its cancer program (Includes Class of Case codes 30-43 and 99, plus code
00 which CoC considers analytic but does not require to be staged)
BlankNot applicable; DCO
165.5,7034 VITAL STATUS RECODE NCR18B;11 SET
'0' FOR Dead as of study cutoff date;
'1' FOR Alive as of study cutoff date;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This variable is akin to Vital Status [1760], with the exception that any patient that dies after
the follow-up cut-off date is recoded to alive as of the cut-off date. This variable is used as
part of the algorithm for calculating the survival time recode variables (NAACCR items 1782- 1788)
and is used for survival, prevalence, and multiple primary - standardized incidence ratio analyses
in SEER*Stat. This recode is necessary to conduct survival and prevalence analyses outside of
SEER*Stat using other statistical software.
165.5,7037 RECORD NUMBER RECODE NCR18B;14 NUMBER
INPUT TRANSFORM: K:+X'=X!(X>99)!(X<1)!(X?.E1"."1N.N) X
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Type a number between 1 and 99, 0 decimal digits.
DESCRIPTION: This variable sequentially numbers a person's tumors within each dataset. The ordered values are
based on date of diagnosis and then sequence number central. This variable is used as part of the
algorithm for calculating the survival time recode variables (NAACCR items 1782-1788) and is used
for survival, prevalence, and multiple primary - standardized incidence ratio analyses in
SEER*Stat. Codes:
01 Record number 01 for patient in database
02 Record number 02 for patient in database
...
99 Record number 99 for patient in database
165.5,7038 SEER CAUSE SPECIFIC COD NCR18B;15 SET
'0' FOR Alive or dead of other cause;
'1' FOR Dead (attributable to this cancer dx);
'8' FOR Missing/Unknown cause of death;
'9' FOR Not applicable/Not first tumor;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: This variable was created for use in cause-specific survival and designates that the person died of
their cancer. Adapted from http://seer.cancer.gov/causespecific/: Cause-specific survival is a net
survival measure representing survival of a specified cause of death in the absence of other causes
of death. Estimates are calculated by specifying the cause of death. Individuals who die of causes
other than the specified cause are considered to be censored. This requires a cause of death
variable that accurately captures all causes related to the specific cause. Vital records offices
use algorithms to process causes of death from death certificates in order to identify a single,
disease-specific, underlying cause of death. In some cases, attribution of a single cause of death
may be difficult and misattribution may occur. For example a death may be attributed to the site of
metastasis instead of the primary site.
165.5,7039 SEER OTHER COD NCR18B;16 SET
'0' FOR Alive or dead due to cancer;
'1' FOR Dead (attributable to causes other than this cancer diagnosis);
'8' FOR Missing/Unknown cause of death;
'9' FOR Not applicable/not first tumor;
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Enter a code from the list.
DESCRIPTION: Using the same recoding logic as the 'SEER cause-specific death classification' variable, the 'SEER
other cause of death classification' variable designates that the person died of causes other than
their cancer. Adapted from http://seer.cancer.gov/causespecific/: The 'SEER other cause of death
classification' variable is used to obtain the other-cause survival probability for a cohort of
patients. It is used when deaths attributed to causes other than cancer are treated as events and
deaths from cancer are treated as censored observation. This variable is used in the SEER*Stat
left-truncated life table session. -specific survival and crude probability of death using cause of
death information.
165.5,7040 MEDICARE BENEFICIARY ID NCR18B;17 FREE TEXT
INPUT TRANSFORM: K:$L(X)>11!($L(X)<1)!'(X?1.11AN) X
MAXIMUM LENGTH: 11
LAST EDITED: FEB 06, 2019
HELP-PROMPT: Answer must be 1-11 characters in length.
DESCRIPTION: Congress passed the Medicare Access and CHIP Reauthorization ACT to remove Social Security Number
(SSN) from Medicare ID card and replace the existing Medicare Health Insurance Claim Numbers with a
Medicare Beneficiary Identifier (MBI). The MBI will be a randomly generated identifier that will
not include a SSN or any personal identifiable information.
165.5,10104 RX HOSP--SURG BREAST 3.2;4 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<4) X I $D(X) D RXSBIT^ONCOSUR1
MAXIMUM LENGTH: 4
LAST EDITED: AUG 29, 2022
HELP-PROMPT: Enter the surgical procedure code performed at this facility for 2022 breast cases, 4 characters in
length.
DESCRIPTION: This field records the surgical procedure performed of the primary site at this facility. This data
item is required for date of diagnosis 2022 breast cases only.
EXECUTABLE HELP: D RXSBHP^ONCOSUR1
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,10105 RX SUMM--SURG BREAST 3.2;5 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<4) X I $D(X) D RXSBIT^ONCOSUR1
MAXIMUM LENGTH: 4
LAST EDITED: AUG 29, 2022
HELP-PROMPT: Enter the surgical procedure code performed at any facility, 4 characters in length.
DESCRIPTION: This field records the surgical procedure performed of the primary site performed at any facility.
This data item is required for 2022 breast cases only.
EXECUTABLE HELP: D RXSBHP^ONCOSUR1
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,10106 RX HOSP--RECON BREAST 3.2;6 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<4) X I $D(X) D RXRECIT^ONCOSUR1
MAXIMUM LENGTH: 4
LAST EDITED: AUG 29, 2022
HELP-PROMPT: Enter the reconstruction procedure performed at this facility, 4 characters in length.
DESCRIPTION: This field records the reconstruction procedure immediately following resection performed at this
facility. This data item is required for 2022 breast cases only.
EXECUTABLE HELP: D RXRECHP^ONCOSUR1
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
165.5,10107 RX SUMM--RECON BREAST 3.2;7 FREE TEXT
INPUT TRANSFORM: K:$L(X)>4!($L(X)<4) X I $D(X) D RXRECIT^ONCOSUR1
MAXIMUM LENGTH: 4
LAST EDITED: AUG 29, 2022
HELP-PROMPT: Enter the reconstruction procedure performed at any facility, 4 characters in length.
DESCRIPTION: This field records the reconstruction procedure immediately following resection performed at any
facility. This data item is required for 2022 breast cases only.
EXECUTABLE HELP: D RXRECHP^ONCOSUR1
NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
FILES POINTED TO FIELDS
BLADDER PHYSICIAN SPECIALTY
(#166.12) MANAGING PHYSICIAN (PRIMARY) (#347)
MANAGING PHYSICIAN (SECONDARY) (#348)
CASEFINDING SOURCE (#166) CASEFINDING SOURCE (#21)
CHEMOTHERAPEUTIC DRUGS (#164.18) CHEMOTHERAPEUTIC AGENT #1 (#1423)
CHEMOTHERAPEUTIC AGENT #2 (#1423.1)
CHEMOTHERAPEUTIC AGENT #3 (#1423.2)
CHEMOTHERAPEUTIC AGENT #4 (#1423.3)
CHEMOTHERAPEUTIC AGENT #5 (#1423.4)
GAS CHEMOTHERAPEUTIC AGENT #1 (#1576)
GAS CHEMOTHERAPEUTIC AGENT #2 (#1576.1)
GAS CHEMOTHERAPEUTIC AGENT #3 (#1576.2)
CLASS OF CASE (#165.3) CLASS OF CASE (#.04)
FACILITY (#160.19) REPORTING FACILITY (#.03)
DX FACILITY (#5)
FACILITY REFERRED FROM (#6)
FACILITY REFERRED TO (#7)
SURGERY HOSPITAL (#50.1)
RADIATION HOSPITAL (#51.1)
RADIATION THERAPY TO CNS HOSP (#52.1)
CHEMOTHERAPY HOSPITAL (#53.1)
HORMONE THERAPY HOSPITAL (#54.1)
IMMUNOTHERAPY HOSPITAL (#55.1)
OTHER TREATMENT HOSPITAL (#57.1)
SUBSEQUENT COURSE OF TREATMENT:PLACE (#2)
GLEASON PATTERNS (#167.2) GLEASON PATTERNS CLINICAL (#3838)
GLEASON PATTERNS PATHOLOGICAL (#3839)
GRADE (#164.43) GRADE/DIFFERENTIATION (#24)
HEMATOLOGIC TRANSPLANT/ENDOCRI
(#167) HEMA TRANS/ENDOCRINE PROC (#153)
HEMA TRANS/ENDOCRINE PROC @FAC (#153.2)
SUBSEQUENT COURSE OF TREATMENT:HEMA TRANS/ENDOCRINE PROC (#.02)
ICD DIAGNOSIS (#80) LNG CO-MORBID CONDITION 1 (#1400)
LNG CO-MORBID CONDITION 2 (#1400.1)
LNG CO-MORBID CONDITION 3 (#1400.2)
LNG CO-MORBID CONDITION 4 (#1400.3)
LNG CO-MORBID CONDITION 5 (#1400.4)
LNG CO-MORBID CONDITION 6 (#1400.5)
LNG COMPLICATION #1 (#1426)
LNG COMPLICATION #2 (#1426.1)
LNG COMPLICATION #3 (#1426.2)
LNG COMPLICATION #4 (#1426.3)
LNG COMPLICATION #5 (#1426.4)
GAS CO-MORBID CONDITION 1 (#1571)
GAS CO-MORBID CONDITION 2 (#1571.1)
GAS CO-MORBID CONDITION 3 (#1571.2)
GAS CO-MORBID CONDITION 4 (#1571.3)
GAS CO-MORBID CONDITION 5 (#1571.4)
GAS CO-MORBID CONDITION 6 (#1571.5)
GAS COMPLICATION #1 (#1579)
GAS COMPLICATION #2 (#1579.1)
GAS COMPLICATION #3 (#1579.2)
GAS COMPLICATION #4 (#1579.3)
GAS COMPLICATION #5 (#1579.4)
ICD-O-2 MORPHOLOGY (#164.1) HISTOLOGY (ICD-O-2) (#22)
1ST PRIMARY HISTOLOGY (#804)
2ND PRIMARY HISTOLOGY (#806)
ICD-O-3 MORPHOLOGY (#169.3) HISTOLOGY (ICD-O-3) (#22.3)
ICDO TOPOGRAPHY (#164) PRIMARY SITE (#20)
1ST PRIMARY SITE (#803)
2ND PRIMARY SITE (#805)
FIRST SITE CODE (#1102)
SECOND SITE CODE (#1104)
LNG PERSONAL HIST OTH MALIG (#1403)
GAS PERSONAL HIST OTH MALIG (#1573)
RADIATION TREATMENT:TARGET SITE (#1)
ICDO-SITES (#164.08) ICDO-SITE (#.022)
INSTITUTION (#4) DIVISION (#2000)
KARNOFSKY'S RATING (#164.17) KARNOFSKY'S RATING PRIOR TO TX (#1311)
KARNOFSKY'S RATING @ DIS/TRANS (#1367)
KARNOFSKY'S RATING RECURRENCE (#1371)
NEW PERSON (#200) QA REVIEWER (#64.1)
ABSTRACTED BY (#92)
CASE LAST CHANGED BY (#199)
INITIATED BY (#244)
ONCO BRAIN MOLECULAR MARKERS
(#167.1) BRAIN MOLECULAR MARKERS (#3816)
ONCO LN STATUS (#167.3) LN STATUS FEM-ING,PAR-AOR,PLV (#3884)
ONCO PERIPHERAL BLOOD INVOLVEM
(#167.4) PERIPHERAL BLOOD INVOLV 2018 (#3910)
ONCO RADIATION EXTERNAL BEAM
(#164.81) PHASE 1 RAD EXT BEAM PLAN TECH (#5502)
PHASE 2 RAD EXT BEAM PLAN TECH (#5512)
PHASE 3 RAD EXT BEAM PLAN TECH (#5522)
ONCO RADIATION TO DRAINING LN
(#164.83) PHASE 1 RAD TO DRAINING LN (#5505)
PHASE 2 RAD TO DRAINING LN (#5515)
PHASE 3 RAD TO DRAINING LN (#5525)
ONCO RADIATION TREATMENT MODAL
(#164.84) PHASE 1 RAD TREATMENT MODALITY (#5506)
PHASE 2 RAD TREATMENT MODALITY (#5516)
PHASE 3 RAD TREATMENT MODALITY (#5526)
ONCO RADIATION TREATMENT VOLUM
(#164.82) PHASE 1 RAD TREATMENT VOLUME (#5504)
PHASE 2 RAD TREATMENT VOLUME (#5514)
PHASE 3 RAD TREATMENT VOLUME (#5524)
ONCO RESIDUAL TUMOR VOLUME
(#167.5) RESIDUAL TUM VOL PST CYTO (#3921)
ONCOLOGY CONTACT (#165) PRIMARY SURGEON (#2)
FOLLOWING PHYSICIAN (#2.1)
MANAGING PHYSICIAN (#2.2)
PHYSICIAN #3 (#2.3)
PHYSICIAN #4 (#2.4)
PHYSICIAN STAGING (#66)
ONCOLOGY PATIENT (#160) PATIENT NAME (#.02)
ONCOLOGY STAGED BY CODES
(#165.7) STAGED BY (CLINICAL STAGE) (#19)
STAGED BY (PATHOLOGIC STAGE) (#89)
ONCOLOGY SUBSITE (#166.3) SUBSITE (#519)
OTHER STAGING FOR ONCOLOGY
(#164.3) OTHER STAGING SYSTEM (#39)
PRIMARY CANCER STATUS CODE
(#164.42) LAST TUMOR STATUS (#95)
TUMOR STATUS:CANCER STATUS (#.02)
PRIMARY PAYER AT DIAGNOSIS
(#160.3) PRIMARY PAYER AT DX (#18)
RADIATION COMPLETION STATUS
(#164.8) RADIATION COMPLETION STATUS (#128)
RADIATION TREATMENT VOLUME
(#164.7) RADIATION TREATMENT VOLUME (#125)
RADIATION AUXILIARY VOLUME (#129)
REGIONAL TREATMENT MODALITY
(#166.13) REGIONAL TREATMENT MODALITY (#363)
BOOST TREATMENT MODALITY (#363.1)
SITE-GROUP FOR ONCOLOGY (#164.2) SITE/GP (#.01)
CANCER #1 (#148.1)
CANCER #2 (#148.2)
CANCER #3 (#148.3)
CANCER #4 (#148.4)
STATE (#5) STATE AT DX (#16)
STATE AT DX GEOCODE 1970/80/90 (#7000)
STATE AT DX GEOCODE 2010 (#7001)
STATE AT DX GEOCODE 2000 (#7023)
TUMOR MARKERS (#164.15) TUMOR MARKER 1 (#25.1)
TUMOR MARKER 2 (#25.2)
TUMOR MARKER 3 (#25.3)
TYPE OF MULTIPLE TUMORS (#169) MULT TUM RPT AS ONE PRIM (#194)
TYPE OF RECURRENCE (#160.12) TYPE OF FIRST RECURRENCE (#71)
OTHER TYPE OF FIRST RECURRENCE (#71.4)
SUBSEQUENT RECURRENCES:TYPE of SUBSEQUENT RECURRENCE (#.02)
TYPE OF REPORTING SOURCE
(#168) TYPE OF REPORTING SOURCE (#1.2)
TYPE OF STAGING SYSTEM (PEDIAT
(#164.6) TYPE OF STAGING SYSTEM (PED) (#849)
WHO HISTOLOGICAL CLASSIFICATIO
(#164.9) WHO HISTOLOGICAL CL (#1308)
INPUT TEMPLATE(S):
ONCO ABSTRACT-I AUG 30, 2024@07:54 USER #0
Template for complete abstract for fields in Primary file: data relevant
to particular cancer only as opposed to specific to Patient.
ONCO RECURRENCE FOLLOWUP AUG 22, 2024@10:17 USER #0
ONCO UTL CORRECT DATA AUG 14, 2002@13:50 USER #0
Utility tempate allowing for the correction of data entries in primary file.
PRINT TEMPLATE(S):
ONC EXTRACT REPORT DEC 28, 2010@09:48 USER #0 @
ONCO ABSTRACT NOT-COMPLETE JUL 12, 2010@11:31 USER #0 PRIMARY ABSTRACT NOT-COMPLETE Report
ONCO ACCREG-ACOS80 OCT 29, 1999@10:05 USER #0 ACCESSON LIST (ACOS) complete
ONCO ACCREG-EOVA132 SEP 14, 1999@10:08 USER #0 ACCESSION REGISTER
ONCO ACCREG-SITE/GP80 OCT 29, 1999@11:51 USER #0 ACCESSION REGISTER - SITE/GP complete
ONCO AJCC SUMMARY STAGE GPS OCT 29, 1990@15:20 USER #0 PRIMARY LIST
ONCO ANNUAL ACCREG80 JUL 12, 2010@09:55 USER #0 [ONCO ANNUAL ACCREG80-HDR]
ONCO ANNUAL ACCREG80-HDR JUL 12, 2010@11:11 USER #0 @
ONCO ANNUAL CLASS/PATIENT SEP 14, 1999@10:34 USER #0 [ONCO ANNUAL CLASS/PATIENT-HDR]
ONCO ANNUAL CLASS/PATIENT-HDR JUN 21, 2005@11:27 USER #0 @
ONCO ANNUAL HIST/SITE/ICDO SEP 14, 1999@10:59 USER #0 [ONCO ANNUAL CLASS/PATIENT-HDR]
ONCO ANNUAL ICDO/STAGE/TX MAR 17, 1998@14:28 USER #0 PRIMARY SITE/GP by STAGE by TREATMENT
ONCO ANNUAL PATIENT INDX APR 11, 2001@09:50 USER #0 [ONCO ANNUAL PATIENT INDX-HDR]
ONCO ANNUAL PATIENT INDX-HDR JUN 21, 2005@11:28 USER #0 @
ONCO ANNUAL PATIENT INFO SEP 14, 1999@11:25 USER #0 [ONCO ANNUAL PATIENT INFO-HDR]
ONCO ANNUAL PATIENT INFO-HDR JUN 21, 2005@11:29 USER #0 @
ONCO ANNUAL SITE/GP APR 11, 2001@09:51 USER #0 [ONCO ANNUAL SITE/GP-HDR]
ONCO ANNUAL SITE/GP-HDR JUN 21, 2005@11:40 USER #0 @
ONCO ANNUAL SITE/ICDT/ICDM SEP 14, 1999@14:09 USER #0 PRIMARY STATISTICS
ONCO ANNUAL SITE/STAGE/TX MAR 26, 1999@11:28 USER #0 [ONCO ANNUAL SITE/STAGE/TX-HDR]
ONCO ANNUAL SITE/STAGE/TX-HDR JUN 21, 2005@11:43 USER #0 @
ONCO ANNUAL SITE/STG/TX MAR 17, 1998@14:05 USER #0 PRIMARY LIST
ONCO ANNUAL TREATMENT NOV 09, 1990@01:39 USER #0 PRIMARY LIST
ONCO ICDO PATIENT LIST DEC 21, 1990@06:54 USER #0 PRIMARY LIST
ONCO ICDO-SITE132 APR 11, 2001@09:53 USER #0 [ONCO ICDO-SITE132-HDR]
ONCO ICDO-SITE132-HDR JUN 21, 2005@11:55 USER #0 @
ONCO ICDO-SITE80 SEP 17, 1999@10:50 USER #0 [ONCO ICDO-SITE80-HDR]
ONCO ICDO-SITE80-HDR OCT 29, 1999@14:04 USER #0 @
ONCO PATIENT INDX-ACOS APR 10, 2001@09:12 USER #0 PA [Patient Index-ACOS (132c)]
ONCO PRIMARY EXTENT CODE AUDITAPR 11, 2001@09:37 USER #0 ONCOLOGY SEER EXTENT OF DISEASE CODE AUDIT
ONCO PRIMARY INFORMATION132 APR 11, 2001@09:40 USER #0 PRIMARY LIST
ONCO PRIMARY SURGERY AUDIT JUL 15, 1994@13:54 USER #0 ONCOLOGY PRIMARY LIST
ONCO SITE/GP80 SEP 17, 1999@11:05 USER #0 [ONCO SITE/GP80-HDR]
ONCO SITE/GP80-HDR OCT 29, 1999@14:11 USER #0 @
ONCO SITE80 MAR 17, 1998@15:03 USER #0 [ONCO SITE80-HEADER]
ONCO SITE80-HEADER MAR 17, 1998@15:07 USER #0 @
ONCO TREATMENT NOV 09, 1990@01:35 USER #0 PRIMARY LIST
ONCO XABSTRACT RECORD OCT 05, 2015@10:22 USER #0 ^ONCOXU @
ONCO XADMISSION APR 10, 2003@09:25 USER #0 ^ONCOXS1 PRIMARY LIST
ONCO XINCIDENCE RPRT SEP 21, 2009@09:04 USER #0 ^ONCOXNC @
ONCOW1 APR 10, 2003@09:34 USER #0 ^ONCOW1 @
ONCOX1 NOV 01, 2002@14:48 USER #0 ^ONCOW @
ONCOX10 DEC 26, 2000@09:43 USER #0 ^ONCOX10 @
ONCOX11 JUL 23, 1997@09:59 USER #0 @
ONCOX2 AUG 18, 2003@12:07 USER #0 ^ONCOX2 @
ONCOX3 MAY 08, 2002@16:02 USER #0 ^ONCOX3 @
ONCOX4 JAN 31, 1996@13:50 USER #0 ^ONCOX4 @
ONCOX5 OCT 27, 2000@10:30 USER #0 ^ONCOX5 @
ONCOX6 APR 28, 2003@09:33 USER #0 ^ONCOX6 @
ONCOX7 DEC 19, 2000@14:16 USER #0 ^ONCOX7 @
ONCOX8 JUL 27, 1999@13:19 USER #0 ^ONCOX8 @
ONCOX9 FEB 05, 1996@12:55 USER #0 ^ONCOX9 @
ONCOX99 FEB 05, 1996@15:38 USER #0 @
ONCOXA1 APR 10, 2003@09:21 USER #0 ^ONCOXA1 @
ONCOXA2 MAR 12, 2003@09:40 USER #0 ^ONCOXA2 @
ONCOXA3 AUG 27, 2024@10:45 USER #0 ^ONCOXA3 @
ONCOXA4 JUL 21, 1998@10:38 USER #0 ^ONCOXA4 @
ONCOY49 OCT 22, 2008@09:12 USER #0 ^ONCOY49 @
ONCOY50 OCT 06, 2005@10:39 USER #0 ^ONCOY50 @
ONCOY51 OCT 06, 2005@10:42 USER #0 ^ONCOY51 @
ONCOY52 JAN 14, 2021@11:19 USER #0 ^ONCOY52 @
ONCOY53 AUG 18, 2021@15:32 USER #0 ^ONCOY53 @
ONCOY54 AUG 27, 2024@10:47 USER #0 ^ONCOY54 @
ONCOY55 FEB 09, 2016@11:44 USER #0 ^ONCOY55 @
ONCOY56 DEC 06, 2005@13:03 USER #0 ^ONCOY56 @
ONCOY57 OCT 18, 2005@13:20 USER #0 ^ONCOY57 @
ONCOY58 OCT 05, 2015@10:19 USER #0 ^ONCOY58 @
ONCQA AUG 18, 2021@11:06 USER #0 @
ONCQA1 AUG 18, 2021@12:13 USER #0 @
ONCQA2 AUG 18, 2021@12:17 USER #0 @
ONCQA3 AUG 18, 2021@12:21 USER #0 @
SORT TEMPLATE(S):
ONCO ABSTINCOM-TERMDIG JAN 08, 1992@12:54 USER #0
SORT BY: ACCESSION YEAR// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: ABSTRACT STATUS// (User is asked range)
WITHIN ABSTRACT STATUS, SORT BY: PATIENT NAME://
ONCOLOGY PATIENT FIELD: TERMINAL DIGIT// (TERMINAL DIGIT not null)
ONCO ABSTRACT DATE/COMPLETE MAY 11, 1992@18:14 USER #0
SORT BY: ABSTRACT DATE// (User is asked range)
WITHIN ABSTRACT DATE, SORT BY: ABSTRACT STATUS// From '3' To '3^3'
ONCO ABSTRACT NOT-COMPLETE FEB 11, 2009@16:14 USER #0 'ONCO ABSTRACT NOT-COMPLETE' Print Template always used
SORT BY: #+ABSTRACT STATUS;C25;L1// (ABSTRACT STATUS from 0 (Incomplete) to 2 (Partial))
WITHIN ABSTRACT STATUS, SORT BY: @INTERNAL(#3)// (INTERNAL(#3) not null)
ONCO ABSTRACT NOT-COMPLETE 1 FEB 01, 2010@15:09 USER #0 'ONCO ABSTRACT NOT-COMPLETE' Print Template always used
SORT BY: #+ABSTRACT STATUS;C25;L1// (ABSTRACT STATUS from 0 (Incomplete) to 2 (Partial))
WITHIN ABSTRACT STATUS, SORT BY: @INTERNAL(#155)// (INTERNAL(#155) not null)
ONCO ABSTRACT RECORD MAR 28, 1991@12:57 USER #0 'ONCO XABSTRACT RECORD' Print Template always used
SORT BY: SITE/GP//
ONCO ACCREG-ACOS80 OCT 29, 1999@10:08 USER #0 '' Print Template always used
SORT BY: ACC/SEQ NUMBER// (User is asked range)
ONCO ACCREG-EOVA132 JUN 06, 1990@15:14 USER #0 '' Print Template always used
SORT BY: @ACC/SEQ NO.// (User is asked range)
ONCO ACCREG-SITE/GP80 JUN 06, 1990@13:33 USER #0 '' Print Template always used
SORT BY: ACC/SEQ NO.// (User is asked range)
ONCO ANN/ANAL/STA/SITE/DX AGE JUN 29, 1991@17:08 USER #0
SORT BY: +#ACCESSION YEAR// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: CLASS CATEGORY// (User is asked range)
WITHIN CLASS CATEGORY, SORT BY: STATUS// (STATUS not null)
WITHIN STATUS, SORT BY: +SITE/GP// (SITE/GP not null)
WITHIN SITE/GP, SORT BY: +DX AGE-GP// (DX AGE-GP not null)
ONCO ANNUAL ACCREG80 OCT 18, 1990@14:13 USER #0 'ONCO ANNUAL ACCREG80' Print Template always used
SORT BY: @#ACCESSION YEAR;S2// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: @ACC/SEQ NO.//
ONCO ANNUAL ACOSACCREG80 OCT 18, 1990@14:13 USER #0 'ONCO ANNUAL ACCREG80' Print Template always used
SORT BY: @#ACCESSION YEAR;S2// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: @ACC/SEQ NO.//
ONCO ANNUAL ANALYTIC FEB 05, 1991 USER #0 ACCESSION YEAR EQUALS 90 and CLASS CATEGORY EQUALS 1
ONCO ANNUAL CLASS/PATIENT OCT 26, 1990@13:47 USER #0 'ONCO ANNUAL CLASS/PATIENT' Print Template always used
SORT BY: @ACCESSION YEAR// From '90.9' To '91'
WITHIN ACCESSION YEAR, SORT BY: +#@CLASS CATEGORY;S1//
WITHIN CLASS CATEGORY, SORT BY: +CLASS OF CASE;S1;C20//
WITHIN CLASS OF CASE, SORT BY: @PATIENT NAME//
ONCO ANNUAL CLASS/SITE AUG 23, 1990@18:21 USER #0
SORT BY: @ACCESSION YEAR// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: CLASS CATEGORY//
WITHIN CLASS CATEGORY, SORT BY: CLASS OF CASE//
WITHIN CLASS OF CASE, SORT BY: SITE/GP//
ONCO ANNUAL HIST/SITE/ICDO OCT 23, 2002@09:22 USER #0
SORT BY: +@ACCESSION YEAR// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: @CLASS CATEGORY// (CLASS CATEGORY equals 1 (Analytic))
WITHIN CLASS CATEGORY, SORT BY: +ICDO HISTOLOGY-CODE// (ICDO HISTOLOGY-CODE not null)
WITHIN ICDO HISTOLOGY-CODE, SORT BY: +SITE/GP;S1// (User is asked range)
WITHIN SITE/GP, SORT BY: ICDO-SITE CODE// (ICDO-SITE CODE not null)
WITHIN ICDO-SITE CODE, SORT BY: PATIENT NAME// (PATIENT NAME not null)
ONCO ANNUAL ICDO/STAGE/TX JUN 20, 1991@18:46 USER #0 'ONCO ANNUAL ICDO/STAGE/TX' Print Template always used
SORT BY: #@ACCESSION YEAR// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: @CLASS CATEGORY// (CLASS CATEGORY equals 1)
WITHIN CLASS CATEGORY, SORT BY: ICDO-SITE CODE;S2;C46// (User is asked range)
WITHIN ICDO-SITE CODE, SORT BY: +STAGE GROUPING-AJCC;S1;C55// (STAGE GROUPING-AJCC not null)
WITHIN STAGE GROUPING-AJCC, SORT BY: +TREATMENT// (TREATMENT not null)
ONCO ANNUAL PATIENT INDX OCT 22, 1990@18:18 USER #0 'ONCO ANNUAL PATIENT INDX' Print Template always used
SORT BY: #@ACCESSION YEAR;S1// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: @PATIENT NAME//
ONCO ANNUAL SITE/GP JUN 13, 1991@14:12 USER #0 'ONCO ANNUAL SITE/GP' Print Template always used
SORT BY: @ACCESSION YEAR// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: @CLASS CATEGORY// From '1' To '1'
WITHIN CLASS CATEGORY, SORT BY: #@SITE/GP// (User is asked range)
WITHIN SITE/GP, SORT BY: ICDO-TOPOGRAPHY//
ONCO ANNUAL SITE/ICDT/ICDM AUG 29, 1992@15:04 USER #0 'ONCO ANNUAL SITE/ICDT/ICDM' Print Template always used
SORT BY: @ACCESSION YEAR// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: @CLASS CATEGORY// From '1' To '1^1'
WITHIN CLASS CATEGORY, SORT BY: #SITE/GP;S1;C20//
WITHIN SITE/GP, SORT BY: +ICDO-TOPOGRAPHY;C20//
WITHIN ICDO-TOPOGRAPHY, SORT BY: +HISTOLOGY;C26//
ONCO ANNUAL SITE/STAGE/TX JUN 20, 1991@11:08 USER #0 'ONCO ANNUAL SITE/STAGE/TX' Print Template always used
SORT BY: #@ACCESSION YEAR// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: @CLASS CATEGORY// (CLASS CATEGORY equals 1)
WITHIN CLASS CATEGORY, SORT BY: SITE/GP;S2;C46// (User is asked range)
WITHIN SITE/GP, SORT BY: +STAGE GROUPING-AJCC;S1;C55// (STAGE GROUPING-AJCC not null)
WITHIN STAGE GROUPING-AJCC, SORT BY: +TREATMENT// (TREATMENT not null)
ONCO ICDO-SITE DEC 21, 1990@07:23 USER #0
SORT BY: ICDO-SITE;S1//
WITHIN ICDO-SITE, SORT BY: 20:CODE;"ICDO CODE: ";C24//
ONCO ICDO-SITE132 MAY 23, 1996@15:26 USER #0 '' Print Template always used
SORT BY: #@ICDO-SITE CODE;S1// (ICDO-SITE CODE not null)
WITHIN ICDO-SITE CODE, SORT BY: @ICDO TOPOGRAPHY-CODE;S1;// (ICDO TOPOGRAPHY-CODE not null)
WITHIN ICDO TOPOGRAPHY-CODE, SORT BY: @PATIENT NAME// (PATIENT NAME not null)
ONCO ICDO-SITE80 MAY 23, 1996@15:24 USER #0 '' Print Template always used
SORT BY: #@ICDO-SITE CODE// (ICDO-SITE CODE not null)
WITHIN ICDO-SITE CODE, SORT BY: ICDO TOPOGRAPHY-CODE;S1;"ICDO CODE: ";C35// (ICDO TOPOGRAPHY-CODE not null)
WITHIN ICDO TOPOGRAPHY-CODE, SORT BY: @PATIENT NAME// (PATIENT NAME not null)
ONCO PCE ANNUAL REPORT JUL 15, 1992@08:27 USER #0
SORT BY: @ACCESSION YEAR// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: SITE/GP//
WITHIN SITE/GP, SORT BY: +@CLASS CATEGORY// From 'ANA' To 'ANZ^ANZ'
ONCO SITE/GP80 MAR 18, 1991@18:51 USER #0 '' Print Template always used
SORT BY: #@SITE/GP;// (User is asked range)
WITHIN SITE/GP, SORT BY: ICDO TOPOGRAPHY-CODE;S1;"ICDO CODE: ";C35// (User is asked range)
WITHIN ICDO TOPOGRAPHY-CODE, SORT BY: @PATIENT NAME// (PATIENT NAME not null)
ONCO STAGE/SITE NOV 28, 1990@11:26 USER #0
SORT BY: CLASS CATEGORY// (User is asked range)
WITHIN CLASS CATEGORY, SORT BY: ACCESSION YEAR// (User is asked range)
WITHIN ACCESSION YEAR, SORT BY: STAGE GROUPING-AJCC//
WITHIN STAGE GROUPING-AJCC, SORT BY: SITE/GP//
ONCOS ANAL/STAGE 0 APR 30, 1996 USER #0 CLASS CATEGORY EQUALS 1^Analytic
and STAGE GROUPING-AJCC EQUALS 0^0
ONCOS ANAL/STAGE I APR 30, 1996 USER #0
ONCOS ANAL/STAGE II APR 30, 1996 USER #0
ONCOS ANAL/STAGE III APR 30, 1996 USER #0
ONCOS ANAL/STAGE IV APR 30, 1996 USER #0
ONCOS ANAL/STAGE NA APR 30, 1996 USER #0 CLASS CATEGORY EQUALS 1^Analytic
and STAGE GROUPING-AJCC EQUALS "NA"^Not Applicable
ONCOS ANAL/STAGE U APR 30, 1996 USER #0
ONCOS ANALYTIC APR 30, 1996 USER #0 CLASS CATEGORY EQUALS 1^Analytic
ONCOS ANALYTIC-140 JAN 11, 1991@12:06 USER #0 ICDO-SITE EQUALS 140^LIP and CLASS CATEGORY EQUALS 1
ONCOS ANALYTIC-153 FEB 08, 1991@15:10 USER #0 ICDO-SITE EQUALS 153^COLON and CLASS CATEGORY EQUALS 1
ONCOS ANALYTIC-154 JAN 11, 1991@12:05 USER #0 ICDO-SITE EQUALS 154^RECTUM/ANAL CANAL/ANUS,NOS
and CLASS CATEGORY EQUALS 1
ONCOS ANALYTIC-160 JAN 11, 1991@11:40 USER #0 ICDO-SITE EQUALS 160^NASAL CAV/ACC SINUSES/MID,INNER EAR
and CLASS CATEGORY EQUALS 1
Searches for all Analytic ICDO site codes 160.
ONCOS ANALYTIC-161 JAN 11, 1991@12:03 USER #0 ICDO-SITE EQUALS 161^LARYNX and CLASS CATEGORY EQUALS 1
ONCOS ANALYTIC-162 FEB 08, 1991@14:10 USER #0 ICDO-SITE EQUALS 162^TRACHEA,BRONCHUS,LUNG
and CLASS CATEGORY EQUALS 1
ONCOS ANALYTIC-193 JAN 11, 1991@12:07 USER #0 ICDO-SITE EQUALS 193^THYROID GLAND
and CLASS CATEGORY EQUALS 1
ONCOS ANALYTIC-196 JAN 11, 1991@12:08 USER #0 ICDO-SITE EQUALS 196^LYMPH NODES and CLASS CATEGORY EQUALS 1
ONCOS ANALYTIC_NON JUN 28, 1991 USER #0
ONCOS ANNUAL ANAL/STAGE 0 MAY 07, 1996 USER #0 ACCESSION YEAR EQUALS 90 and CLASS CATEGORY EQUALS 1
and STAGE GROUPING-AJCC EQUALS 0
Selects Stage 0 analytical cases for particular year.
ONCOS ANNUAL ANAL/STAGE I MAY 07, 1996 USER #0 ACCESSION YEAR EQUALS 90 and CLASS CATEGORY EQUALS 1
and STAGE GROUPING-AJCC EQUALS "I"
ONCOS ANNUAL ANAL/STAGE II MAY 07, 1996 USER #0 ACCESSION YEAR EQUALS 90 and CLASS CATEGORY EQUALS 1
and STAGE GROUPING-AJCC EQUALS "II"
This search template selects records with specfic accession year, analytic
cases, stage II only.
ONCOS ANNUAL ANAL/STAGE III MAY 07, 1996 USER #0
Selects Analytic Stage III records for specified accession year.
ONCOS ANNUAL ANAL/STAGE IV MAY 07, 1996 USER #0
Selects Analytic Stage IV records for specified accession year.
ONCOS ANNUAL ANAL/STAGE NA MAY 07, 1996 USER #0 CLASS CATEGORY EQUALS 1^Analytic
and STAGE GROUPING-AJCC EQUALS "NA"^Not Applicable
ONCOS ANNUAL ANAL/STAGE U MAY 07, 1996 USER #0
SORT BY: NUMBER//
ONCOS ANNUAL-ALLCASES APR 18, 1996 USER #0
ONCOS ANNUAL-ANALYTIC MAY 07, 1996 USER #0
ONCOS ANNUAL-NON ANAL APR 18, 1996 USER #0
ONCOS ANNUAL/ANAL-90 SEP 29, 1991@13:31 USER #0 ACCESSION YEAR EQUALS 90
and CLASS CATEGORY EQUALS 1^Analytic
ONCOS KAPOSI AUG 07, 1991@11:35 USER #0 SITE/GP EQUALS 38^SKIN (EX. MELANOMA, MYCOSIS)
and HISTOLOGY EQUALS 91403^KAPOSI'S SARCOMA
ONCOS LARYNX/AN/90 AUG 07, 1991@15:27 USER #0 SITE/GP EQUALS 28^LARYNX
and CLASS CATEGORY EQUALS 1^Analytic and ACCESSION YEAR EQUALS 90
ONCOS LUNG/NON-SMALL CELL SEP 19, 1992@12:00 USER #0 SITE/GP EQUALS 31^LUNG
and HISTOLOGY NOT EQUALS 80413^SMALL CELL CARCINOMA NOS
and HISTOLOGY NOT EQUALS 80423^OAT CELL CARCINOMA (LUNG)
ONCOS MEMPHIS LUNG MAY 14, 1992@12:51 USER #0 SITE/GP EQUALS 31^LUNG, NON-SMALL CELL
and SITE/GP EQUALS 42^LUNG, SMALL CELL
ONCOS NON-ANALYTIC JUN 26, 1991 USER #0 CLASS CATEGORY EQUALS 0
ONCOS RANGE-ALLCASES APR 18, 1996 USER #0
ONCOS RANGE-ANALYTIC APR 18, 1996 USER #0 ACCESSION YEAR GREATER THAN 84
and ACCESSION YEAR LESS THAN 90
ONCOS RANGE-NON ANAL APR 18, 1996 USER #0
ONCOS SITE=BLADDER MAY 29, 1992@17:13 USER #0 SITE/GP EQUALS 54^BLADDER
and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=BRAIN SEP 18, 1991@18:45 USER #0 SITE/GP EQUALS 58^BRAIN and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=BREAST SEP 06, 1992@19:02 USER #0 SITE/GP EQUALS 41^BREAST
and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=COLON SEP 22, 1992@22:33 USER #0 SITE/GP EQUALS 17^COLON and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=ESOHAGUS SEP 18, 1991@18:07 USER #0 SITE/GP EQUALS 14^ESOPHAGUS
and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=HODGKIN'S SEP 18, 1991@18:58 USER #0 SITE/GP EQUALS 62^LYMPHOMA, HODGKIN'S
and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=HODGKINS JUN 30, 1991 USER #0
ONCOS SITE=LARYNX SEP 18, 1991@18:51 USER #0 SITE/GP EQUALS 28^LARYNX
and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=LIP SEP 18, 1991@18:36 USER #0 SITE/GP EQUALS 1^LIP and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=LIVER OCT 01, 1991@11:35 USER #0 CLASS CATEGORY EQUALS 1^Analytic and SITE/GP EQUALS 20^LIVER
ONCOS SITE=LUNG AUG 29, 1992@15:14 USER #0 SITE/GP EQUALS 31^LUNG and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=LYMPH NODES JUN 30, 1991 USER #0
ONCOS SITE=NON-HODGKINS JUN 30, 1991 USER #0
ONCOS SITE=NON-HODGKINS'S SEP 18, 1991@19:02 USER #0 SITE/GP EQUALS 63^LYMPHOMA, NON-HODGKIN'S
and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=PHARYNX SEP 18, 1991@18:53 USER #0 SITE/GP EQUALS 13^PHARYNX
and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=PROSTATE SEP 06, 1992@18:45 USER #0 SITE/GP EQUALS 50^PROSTATE
and CLASS CATEGORY EQUALS 1^Analytic
ONCOS SITE=TESTIS SEP 18, 1991@18:48 USER #0 SITE/GP EQUALS 51^TESTIS
and CLASS CATEGORY EQUALS 1^Analytic
ONCOS TOTAL-ANAL JUN 28, 1991 USER #0
ONCOS TOTAL-NON JUN 28, 1991 USER #0
ONCOS TX-CHEMO JUN 30, 1991 USER #0
ONCOS TX-HORMONE JUN 30, 1991 USER #0
ONCOS TX-RADIATION JUN 30, 1991 USER #0
ONCOS TX-SURGERY JUN 30, 1991 USER #0
ONCOZ LUNG SURVIVAL MAR 06, 1996@09:56 USER #0 SITE/GP CONTAINS "LUNG"
FORM(S)/BLOCK(S):